0001437749-24-010010.txt : 20240329 0001437749-24-010010.hdr.sgml : 20240329 20240329120217 ACCESSION NUMBER: 0001437749-24-010010 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 87 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240329 DATE AS OF CHANGE: 20240329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTERNATIONAL ISOTOPES INC CENTRAL INDEX KEY: 0001038277 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 742763837 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22923 FILM NUMBER: 24802858 BUSINESS ADDRESS: STREET 1: 4137 COMMERCE CIRCLE CITY: IDAHO FALLS STATE: ID ZIP: 83401 BUSINESS PHONE: 2085245300 MAIL ADDRESS: STREET 1: 4137 COMMERCE CIRCLE CITY: IDAHO FALLS STATE: ID ZIP: 83401 10-K 1 inis20221231_10k.htm FORM 10-K inis20221231_10k.htm
0001038277 INTERNATIONAL ISOTOPES INC false --12-31 FY 2023 false false false false 0.01 0.01 750,000,000 750,000,000 519,787,870 519,787,870 514,889,916 514,889,916 0 0 0 0 0 6 6 March 31, 2026 March 31, 2026 4 4 March 31, 2026 March 31, 2026 6 6 March 31, 2026 March 31, 2026 5.99 5.99 1,046 1,046 5 4,442 8 10,000 no 4,063 243,780 5 5 5 0 0 5 10 5 1 10 50 50 1 25 25 10 3 0 10 0 00010382772023-01-012023-12-31 iso4217:USD 00010382772023-06-30 xbrli:shares 00010382772024-03-27 thunderdome:item 00010382772023-12-31 00010382772022-12-31 0001038277us-gaap:RelatedPartyMember2023-12-31 0001038277us-gaap:RelatedPartyMember2022-12-31 0001038277us-gaap:NonrelatedPartyMember2023-12-31 0001038277us-gaap:NonrelatedPartyMember2022-12-31 iso4217:USDxbrli:shares 00010382772022-01-012022-12-31 0001038277us-gaap:CommonStockMember2021-12-31 0001038277us-gaap:AdditionalPaidInCapitalMember2021-12-31 0001038277us-gaap:RetainedEarningsMember2021-12-31 0001038277us-gaap:ParentMember2021-12-31 0001038277us-gaap:CommonStockMember2022-01-012022-12-31 0001038277us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-31 0001038277us-gaap:RetainedEarningsMember2022-01-012022-12-31 0001038277us-gaap:ParentMember2022-01-012022-12-31 0001038277us-gaap:SeriesBPreferredStockMemberus-gaap:CommonStockMember2022-01-012022-12-31 0001038277us-gaap:SeriesBPreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-31 0001038277us-gaap:SeriesBPreferredStockMemberus-gaap:RetainedEarningsMember2022-01-012022-12-31 0001038277us-gaap:SeriesBPreferredStockMemberus-gaap:ParentMember2022-01-012022-12-31 0001038277us-gaap:CommonStockMember2022-12-31 0001038277us-gaap:AdditionalPaidInCapitalMember2022-12-31 0001038277us-gaap:RetainedEarningsMember2022-12-31 0001038277us-gaap:ParentMember2022-12-31 0001038277us-gaap:CommonStockMember2023-01-012023-12-31 0001038277us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-31 0001038277us-gaap:RetainedEarningsMember2023-01-012023-12-31 0001038277us-gaap:ParentMember2023-01-012023-12-31 0001038277us-gaap:SeriesCPreferredStockMemberus-gaap:CommonStockMember2023-01-012023-12-31 0001038277us-gaap:SeriesCPreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-31 0001038277us-gaap:SeriesCPreferredStockMemberus-gaap:RetainedEarningsMember2023-01-012023-12-31 0001038277us-gaap:SeriesCPreferredStockMemberus-gaap:ParentMember2023-01-012023-12-31 0001038277us-gaap:CommonStockMember2023-12-31 0001038277us-gaap:AdditionalPaidInCapitalMember2023-12-31 0001038277us-gaap:RetainedEarningsMember2023-12-31 0001038277us-gaap:ParentMember2023-12-31 00010382772021-12-31 xbrli:pure 0001038277us-gaap:AssetPledgedAsCollateralMemberus-gaap:SuretyBondMember2023-12-31 0001038277us-gaap:AssetPledgedAsCollateralMemberus-gaap:SuretyBondMember2022-12-31 0001038277us-gaap:EmployeeStockOptionMember2023-01-012023-12-31 0001038277us-gaap:SeriesCPreferredStockMember2023-01-012023-12-31 0001038277us-gaap:EmployeeStockOptionMember2022-01-012022-12-31 0001038277us-gaap:SeriesCPreferredStockMember2022-01-012022-12-31 0001038277us-gaap:EmployeeStockOptionMember2023-12-31 0001038277us-gaap:EmployeeStockOptionMember2022-12-31 0001038277us-gaap:SeriesCPreferredStockMember2023-12-31 0001038277us-gaap:SeriesCPreferredStockMember2022-12-31 utr:Y 0001038277inis:NrcLicenseForTheDeconversionFacilityMember2023-01-012023-12-31 0001038277us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberinis:AssetsAssociatedWithPlannedDeconversionFacilityMembersrt:ScenarioForecastMember2025-12-31 0001038277us-gaap:FurnitureAndFixturesMember2023-12-31 0001038277us-gaap:FurnitureAndFixturesMember2022-12-31 0001038277us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2023-12-31 0001038277us-gaap:FurnitureAndFixturesMembersrt:MaximumMember2023-12-31 0001038277us-gaap:TransportationEquipmentMember2023-12-31 0001038277us-gaap:TransportationEquipmentMember2022-12-31 0001038277us-gaap:TransportationEquipmentMembersrt:MinimumMember2023-12-31 0001038277us-gaap:TransportationEquipmentMembersrt:MaximumMember2023-12-31 0001038277us-gaap:BuildingMember2023-12-31 0001038277us-gaap:BuildingMember2022-12-31 0001038277inis:ProductionEquipmentMember2023-12-31 0001038277inis:ProductionEquipmentMember2022-12-31 0001038277inis:ProductionEquipmentMembersrt:MinimumMember2023-12-31 0001038277inis:ProductionEquipmentMembersrt:MaximumMember2023-12-31 0001038277us-gaap:SeriesCPreferredStockMemberus-gaap:PrivatePlacementMember2017-02-012017-02-28 0001038277inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember2017-02-012017-02-28 0001038277inis:The2013PromissoryNoteMemberinis:MajorShareholdersMember2013-12-012013-12-31 0001038277inis:The2013PromissoryNoteMemberinis:MajorShareholdersMember2013-12-31 0001038277inis:ClassLWarrantsMember2013-12-31 0001038277inis:ClassLWarrantsMember2014-06-30 0001038277inis:ClassLWarrantsMember2018-12-232018-12-23 0001038277inis:The2013PromissoryNoteMemberinis:MajorShareholdersMember2023-12-31 0001038277inis:The2018PromissoryNoteMemberinis:ChiefExecutiveOfficerAndChairmanOfTheBoardMember2018-04-012018-04-30 0001038277inis:The2018PromissoryNoteMemberinis:ChiefExecutiveOfficerAndChairmanOfTheBoardMember2018-04-30 0001038277inis:The2018PromissoryNoteMemberinis:ChiefExecutiveOfficerAndChairmanOfTheBoardMember2023-12-31 0001038277inis:The2019PromissoryNoteMemberinis:MajorShareholdersMember2019-12-20 0001038277inis:The2019PromissoryNoteMemberinis:MajorShareholdersMember2019-12-312019-12-31 0001038277inis:The2019PromissoryNoteMemberinis:MajorShareholdersMember2020-02-012020-02-29 0001038277inis:ClassOWarrantsMember2019-12-20 0001038277inis:The2019PromissoryNoteMemberinis:MajorShareholdersMember2023-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyOneMember2023-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyOneMember2022-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyOneMember2023-01-012023-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyOneMember2022-01-012022-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyTwoMember2023-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyTwoMember2022-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyTwoMember2023-01-012023-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyTwoMember2022-01-012022-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyThreeMember2023-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyThreeMember2022-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyThreeMember2023-01-012023-12-31 0001038277us-gaap:NotesPayableOtherPayablesMemberinis:RelatedPartyThreeMember2022-01-012022-12-31 0001038277us-gaap:NotesPayableToBanksMember2023-12-31 0001038277us-gaap:NotesPayableToBanksMember2022-12-31 0001038277us-gaap:NotesPayableToBanksMember2023-01-012023-12-31 0001038277us-gaap:NotesPayableToBanksMember2022-01-012022-12-31 0001038277inis:NotesPayableForPurchaseContractOneMember2022-12-31 0001038277inis:NotesPayableForPurchaseContractOneMember2022-01-012022-12-31 0001038277inis:NotesPayableForPurchaseContractOneMember2023-12-31 0001038277inis:NotesPayableForPurchaseContractTwoMember2023-12-31 0001038277inis:NotesPayableForPurchaseContractTwoMember2023-01-012023-12-31 0001038277inis:NotesPayableForPurchaseContractTwoMember2022-12-31 0001038277inis:ClassMWarrantsMember2022-02-142022-02-14 0001038277inis:ClassMWarrantsMember2022-02-172022-02-17 0001038277inis:ClassNWarrantsMember2022-05-122022-05-12 0001038277us-gaap:SeriesBPreferredStockMember2021-12-31 0001038277us-gaap:SeriesBPreferredStockMember2021-01-012021-12-31 0001038277inis:ConversionOfSeriesBPreferredStockIntoCommonStockMember2021-01-012021-12-31 0001038277inis:ConversionOfSeriesBPreferredStockIntoCommonStockMember2022-05-312022-05-31 0001038277inis:ConversionOfSeriesBPreferredStockIntoCommonStockMember2022-05-31 00010382772022-05-31 0001038277us-gaap:SeriesCPreferredStockMember2023-02-28 0001038277us-gaap:SeriesCPreferredStockMember2022-02-28 0001038277us-gaap:SeriesCPreferredStockMember2023-01-012023-12-31 0001038277us-gaap:SeriesCPreferredStockMember2022-01-012022-12-31 0001038277us-gaap:SeriesCPreferredStockMemberinis:SubscriptionAgreementsWithCertainInvestorsMember2017-02-172017-02-17 0001038277inis:ClassMWarrantsMember2017-02-17 0001038277inis:SubscriptionAgreementsWithCertainInvestorsMember2017-02-172017-02-17 0001038277inis:ClassMWarrantsMember2017-02-172017-02-17 0001038277us-gaap:SeriesCPreferredStockMemberinis:SubscriptionAgreementsWithCertainInvestorsMember2017-02-17 0001038277us-gaap:SeriesCPreferredStockMemberinis:SubscriptionAgreementsWithCertainInvestorsMember2023-12-31 0001038277us-gaap:ConvertibleDebtMember2017-03-24 0001038277inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember2017-03-24 0001038277inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember2017-03-242017-03-24 0001038277inis:ClassNWarrantsMember2017-03-24 0001038277us-gaap:ConvertibleDebtMember2017-05-122017-05-12 0001038277inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember2017-05-122017-05-12 0001038277inis:ConversionOfSeriesCPreferredStockIntoCommonStockMember2021-01-012021-12-31 0001038277inis:ClassNWarrantsMember2017-03-242017-03-24 0001038277inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember2022-12-31 0001038277inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember2023-12-31 0001038277inis:EmployeeStockPurchasePlanMember2004-09-30 0001038277inis:EmployeeStockPurchasePlanMember2020-07-012020-07-31 0001038277inis:EmployeeStockPurchasePlanMember2023-12-31 0001038277inis:EmployeeStockPurchasePlanMember2023-01-012023-12-31 0001038277inis:EmployeeStockPurchasePlanMember2022-01-012022-12-31 0001038277inis:The2015IncentivePlanMember2018-07-012018-07-31 0001038277inis:The2015IncentivePlanMember2018-07-31 0001038277inis:The2006PlanMember2018-07-31 0001038277inis:The2015IncentivePlanMember2023-12-31 0001038277inis:The2015IncentivePlanMembersrt:ChiefExecutiveOfficerMember2023-02-282023-02-28 0001038277inis:The2015IncentivePlanMembersrt:ChiefExecutiveOfficerMember2023-02-28 0001038277srt:ChiefExecutiveOfficerMember2023-02-28 00010382772023-02-28 0001038277inis:The2015IncentivePlanMembersrt:ChiefExecutiveOfficerMember2022-02-282022-02-28 0001038277inis:The2015IncentivePlanMembersrt:ChiefExecutiveOfficerMember2022-02-28 00010382772021-02-28 0001038277us-gaap:EmployeeStockOptionMember2023-01-012023-12-31 0001038277us-gaap:EmployeeStockOptionMember2022-01-012022-12-31 0001038277inis:QualifiedOptionsMember2023-01-012023-12-31 0001038277inis:QualifiedOptionsMember2022-03-012022-03-31 0001038277inis:QualifiedOptionsMember2022-08-012022-08-31 0001038277inis:QualifiedOptionsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-01-012023-12-31 0001038277inis:QualifiedOptionsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMembersrt:MinimumMember2023-01-012023-12-31 0001038277inis:QualifiedOptionsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMembersrt:MaximumMember2023-01-012023-12-31 0001038277inis:QualifiedOptionsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-31 0001038277inis:QualifiedOptionsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberinis:OneEmployeeMember2022-01-012022-12-31 0001038277inis:QualifiedOptionsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberinis:TwoEmployeesMember2022-01-012022-12-31 0001038277inis:QualifiedOptionsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-01-012022-12-31 0001038277inis:QualifiedOptionsMembersrt:ExecutiveOfficerMember2022-01-012022-12-31 0001038277inis:NonqualifiedOptionsMembersrt:DirectorMember2022-01-012022-12-31 0001038277inis:QualifiedOptionsMembersrt:ExecutiveOfficerMember2022-12-31 0001038277inis:QualifiedOptionsMembersrt:ExecutiveOfficerMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-01-012022-12-31 0001038277inis:QualifiedOptionsMembersrt:ExecutiveOfficerMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-01-012022-12-31 0001038277inis:QualifiedOptionsMemberinis:ExecutiveOfficersAndDirectorsMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-01-012022-12-31 0001038277inis:QualifiedOptionsMemberinis:ExecutiveOfficersAndDirectorsMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-01-012022-12-31 0001038277us-gaap:EmployeeStockOptionMembersrt:MinimumMember2022-01-012022-12-31 0001038277us-gaap:EmployeeStockOptionMembersrt:MaximumMember2022-01-012022-12-31 0001038277us-gaap:RestrictedStockUnitsRSUMember2020-12-31 0001038277us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-31 0001038277us-gaap:RestrictedStockUnitsRSUMember2021-12-31 0001038277us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-31 0001038277us-gaap:RestrictedStockUnitsRSUMember2022-12-31 0001038277us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-31 0001038277us-gaap:RestrictedStockUnitsRSUMember2023-12-31 00010382772023-03-032023-03-03 0001038277us-gaap:RestrictedStockUnitsRSUMember2023-03-032023-03-03 0001038277us-gaap:RestrictedStockUnitsRSUMembersrt:PresidentMember2023-05-082023-05-08 0001038277us-gaap:RestrictedStockUnitsRSUMembersrt:PresidentMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2023-05-082023-05-08 0001038277us-gaap:RestrictedStockUnitsRSUMembersrt:PresidentMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2023-05-082023-05-08 0001038277us-gaap:RestrictedStockUnitsRSUMembersrt:PresidentMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-05-082023-05-08 0001038277us-gaap:RestrictedStockUnitsRSUMembersrt:PresidentMember2023-09-05 0001038277us-gaap:RestrictedStockUnitsRSUMembersrt:PresidentMember2023-09-052023-09-05 00010382772023-09-05 0001038277us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-31 0001038277us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberinis:ThreeCustomersMember2022-01-012022-12-31 0001038277inis:ContractWithTheDoeForTheIrradiationOfCobaltTargetsMember2014-10-022014-10-02 0001038277inis:ContractWithTheDoeForTheIrradiationOfCobaltTargetsMember2014-10-02 0001038277inis:LandInLeaCountyNewMexicoMember2011-08-312011-08-31 0001038277inis:LandInLeaCountyNewMexicoMember2011-08-31 0001038277inis:The401kPlanMember2023-01-012023-12-31 0001038277inis:The401kPlanMember2022-01-012022-12-31 0001038277us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-31 0001038277us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-31 0001038277inis:TheranosticsProductsMembercountry:US2023-01-012023-12-31 0001038277inis:TheranosticsProductsMemberus-gaap:NonUsMember2023-01-012023-12-31 0001038277inis:TheranosticsProductsMember2023-01-012023-12-31 0001038277inis:TheranosticsProductsMembercountry:US2022-01-012022-12-31 0001038277inis:TheranosticsProductsMemberus-gaap:NonUsMember2022-01-012022-12-31 0001038277inis:TheranosticsProductsMember2022-01-012022-12-31 0001038277inis:CobaltProductsMembercountry:US2023-01-012023-12-31 0001038277inis:CobaltProductsMemberus-gaap:NonUsMember2023-01-012023-12-31 0001038277inis:CobaltProductsMember2023-01-012023-12-31 0001038277inis:CobaltProductsMembercountry:US2022-01-012022-12-31 0001038277inis:CobaltProductsMemberus-gaap:NonUsMember2022-01-012022-12-31 0001038277inis:CobaltProductsMember2022-01-012022-12-31 0001038277inis:NuclearMedicineProductsMembercountry:US2023-01-012023-12-31 0001038277inis:NuclearMedicineProductsMemberus-gaap:NonUsMember2023-01-012023-12-31 0001038277inis:NuclearMedicineProductsMember2023-01-012023-12-31 0001038277inis:NuclearMedicineProductsMembercountry:US2022-01-012022-12-31 0001038277inis:NuclearMedicineProductsMemberus-gaap:NonUsMember2022-01-012022-12-31 0001038277inis:NuclearMedicineProductsMember2022-01-012022-12-31 0001038277inis:FluorineProductsMembercountry:US2023-01-012023-12-31 0001038277inis:FluorineProductsMemberus-gaap:NonUsMember2023-01-012023-12-31 0001038277inis:FluorineProductsMember2023-01-012023-12-31 0001038277inis:FluorineProductsMembercountry:US2022-01-012022-12-31 0001038277inis:FluorineProductsMemberus-gaap:NonUsMember2022-01-012022-12-31 0001038277inis:FluorineProductsMember2022-01-012022-12-31 0001038277country:US2023-01-012023-12-31 0001038277us-gaap:NonUsMember2023-01-012023-12-31 0001038277country:US2022-01-012022-12-31 0001038277us-gaap:NonUsMember2022-01-012022-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:TheranosticsProductsMember2023-01-012023-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:TheranosticsProductsMember2022-01-012022-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:CobaltProductsMember2023-01-012023-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:CobaltProductsMember2022-01-012022-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:NuclearMedicineProductsMember2023-01-012023-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:NuclearMedicineProductsMember2022-01-012022-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:FluorineProductsMember2023-01-012023-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:FluorineProductsMember2022-01-012022-12-31 0001038277us-gaap:OperatingSegmentsMember2023-01-012023-12-31 0001038277us-gaap:OperatingSegmentsMember2022-01-012022-12-31 0001038277us-gaap:CorporateNonSegmentMember2023-01-012023-12-31 0001038277us-gaap:CorporateNonSegmentMember2022-01-012022-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:TheranosticsProductsMember2023-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:TheranosticsProductsMember2022-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:CobaltProductsMember2023-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:CobaltProductsMember2022-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:NuclearMedicineProductsMember2023-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:NuclearMedicineProductsMember2022-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:FluorineProductsMember2023-12-31 0001038277us-gaap:OperatingSegmentsMemberinis:FluorineProductsMember2022-12-31 0001038277us-gaap:OperatingSegmentsMember2023-12-31 0001038277us-gaap:OperatingSegmentsMember2022-12-31 0001038277us-gaap:CorporateNonSegmentMember2023-12-31 0001038277us-gaap:CorporateNonSegmentMember2022-12-31 0001038277us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberinis:PrepaymentForDufPlantMemberus-gaap:SubsequentEventMember2024-02-082024-02-08 0001038277us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberinis:DufPlantMemberus-gaap:SubsequentEventMember2024-02-082024-02-08
 
 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2023

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ______________

 

Commission file number: 000-22923

 

INTERNATIONAL ISOTOPES INC.

(Exact name of registrant as specified in its charter)

 

Texas

 

74-2763837

(State or other jurisdiction of incorporation or origination)

 

(IRS Employer Identification No.)

 

4137 Commerce Circle

Idaho Falls, Idaho

 

83401

(Address of principal executive offices)

 

(Zip code)

 

(208) 524-5300

(Registrant's telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Securities registered pursuant to Section 12(g) of the Act:

COMMON STOCK, $.01 PAR VALUE

(Title of Class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer    ☐

Accelerated filer    ☐

Non-Accelerated filer   ☒ 

Smaller reporting company    ☒

 

Emerging growth company    ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

1
Table of Contents

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the average bid and asked price of such common equity at June 30, 2023, the last business day of the registrant’s second fiscal quarter, was approximately $13 million. For purposes of this calculation, all directors and executive officers of the registrant and holders of 10% or more of the registrant’s common stock are assumed to be affiliates. This determination of affiliate status is not necessarily conclusive for any other purpose.

 

As of March 27, 2024, the number of shares outstanding of the registrant’s common stock, $.01 par value, was 520,081,365 shares.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Certain information called for in Part III of this Annual Report on Form 10-K is incorporated by reference from the registrant’s definitive proxy statement for the 2024 annual meeting of shareholders, which will be filed with the Securities and Exchange Commission not later than 120 days after the registrant’s fiscal year ended December 31, 2023.

 

2
Table of Contents

 

 

INTERNATIONAL ISOTOPES INC.

 

FORM 10-K

 

TABLE OF CONTENTS

 

   

Page No.

PART I

    
     

Item 1.

Business

4

Item 1A.

Risk Factors

10

Item 1B.

Unresolved Staff Comments

13
Item 1C. Cybersecurity 13

Item 2.

Properties

14

Item 3.

Legal Proceedings

14

Item 4.

Mine Safety Disclosures

14
     

PART II

    
     

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

15

Item 6.

Reserved

15

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

24

Item 8.

Financial Statements and Supplementary Data

25

Item 9.

Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

25

Item 9A.

Controls and Procedures

25

Item 9B.

Other Information

26

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

  
     

PART III

    
     

Item 10.

Directors, Executive Officers and Corporate Governance

26

Item 11.

Executive Compensation

26

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

26

Item 13.

Certain Relationships and Related Transactions, and Director Independence

27

Item 14.

Principal Accountant Fees and Services

27
     

PART IV

    
     

Item 15.

Exhibits, Financial Statement Schedules

27

Item 16.

Form 10-K Summary

30

Signatures

  

31

 

3
Table of Contents

 

 

Cautionary Note Regarding Forward-Looking Statements

 

This Annual Report on Form 10-K (the “Annual Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including statements regarding industry prospects and future results of operations or financial position, made in this Annual Report are forward-looking. Words such as: “anticipates,” “believes,” “should,” “expects,” “future” and “intends” and similar expressions identify forward-looking statements. In particular, statements regarding: financial condition, operating results and liquidity, future cash flow from operations, our ability to achieve profitability, the expected growth in business segment revenues, our expansion into new markets, the ability of our products to compete with several larger companies and products, the results of market studies used to support our business model, our anticipated improvement in economic conditions, the expected increased revenue resulting from sales of our U.S. Food and Drug Administration (FDA)-approved sodium iodide drug product, our ability to continue cobalt-60 production, the status of our proposed uranium de-conversion facility, and the sufficiency of our available cash and revenues from operations to meet our operating needs, are forward-looking. Forward-looking statements reflect management’s current expectations, plans or projections and are inherently uncertain. Actual results could differ materially from management's expectations, plans or projections. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Annual Report. Certain risks and uncertainties that could cause actual results to differ significantly from management’s expectations are described in the section entitled “Risk Factors” in this Annual Report. That section, along with other sections of this Annual Report, describes some, but not all, of the factors that could cause actual results to differ significantly from management’s expectations. We do not intend to publicly release any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are urged, however, to review the risks and other factors set forth in the other reports that we file from time to time with the Securities and Exchange Commission (the “SEC”).

 

PART I

 

Item 1.       BUSINESS

 

General Business and Products Description

 

International Isotopes Inc. (the “Company”, “we”, “us” and “our”) produces an FDA approved generic sodium iodide I-131 drug product, provides radiochemicals for clinical research and life sciences, manufactures a wide range of nuclear medicine calibration and reference standards, and produces a variety of cobalt-60 products for medical, research, and industrial applications.

 

We were formed as a Texas corporation in 1995. Our wholly-owned subsidiaries are International Isotopes Idaho Inc., a Texas corporation; International Isotopes Fluorine Products, Inc., an Idaho corporation; International Isotopes Transportation Services, Inc., an Idaho corporation; RadQual, LLC, a limited liability company (RadQual); and TI Services, LLC, a limited liability company (TI Services). Our core business consists of four reportable segments which include: Theranostics Products (formerly called Radiochemical Products), Cobalt Products, Nuclear Medicine Standards, and Fluorine Products.

 

During 2023, we focused our efforts on achieving profitability in each of our core business segments and reached several significant goals. During 2023, we:

 

 

●

Increased total company revenues by $1,085,397 or 10%.

 

 

●

Reached $12.3 million in total revenues which was the largest single year in company history.

 

 

●

Increased sales in our Theranostics Products segment by 13% primarily through increases in sales of our FDA approved generic sodium iodide I-131 drug product.

 

 

●

Increased sales in our Nuclear Medicine Standards by 10%.

 

 

●

Developed several new products for our Nuclear Medicine products segment and expanded our range of products in this segment including Positron Emission Tomography (PET) imaging standards.

 

 

●

Purchased medical devices and related assets and intellectual property rights from AMICI, Inc. that we plan to expand into an additional business segment, "Medical Devices" starting in 2024.

 

 

●

Pursuant to an option agreement entered into in October 2022, we worked to complete an asset sales agreement to sell our unused assets in our FEP business segment. In February 2024, we entered an Asset Purchase Agreement to sell these assets for a total of $12.5 million. The transaction is expected to close in approximately 12 to 24 months, subject to satisfaction of certain closing conditions.
4
Table of Contents

 

In 2024, we plan to continue efforts to further expand and improve upon our operations in our core business segments. Additionally, we are planning an additional business segment for "Medical Devices". We intend to continue to invest in these segments and work to pursue product development, reduce production costs, and expand sales in each of our segments. The following paragraphs provide a brief description of each of our business segments. Certain financial information with respect to each of our business segments, including revenues from external customers, a measure of profit or loss, and total assets, is set forth in Note 15 to our Consolidated Financial Statements which begin on page F-7.

 

Theranostics Products (formerly Radiochemical Products)

 

This segment includes the production and distribution of various isotopically pure radiochemicals for medical, industrial, and research applications. These products are either directly produced by us or are purchased in bulk from other producers and distributed by us in customized packages and chemical forms tailored to meet customer and market demands. Our FDA approved generic sodium iodide I-131 drug product is the only generic product of this type manufactured in the U.S. and offers customers an attractive domestic alternative to the single existing foreign commercial drug manufacturer. We have two suppliers of sodium iodide I-131 from whom we purchased material during 2022 and 2023 in order to produce this product in the most reliable manner possible. Going forward this segment will be called the Theranostics Products segment.

 

Cobalt Products

 

Our cobalt products segment includes the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy as well as various industrial applications, and recycling of expended cobalt sources.

 

The year-over-year demand for cobalt products has remained strong as a result of the introduction of several new types of cobalt therapy units and we have continued to see demand for cobalt-manufactured products for those devices. We have explored, and intend to continue to explore, opportunities to further develop cobalt products and sales on an on-going basis. The production, use, transport, and import/export of these products are all heavily regulated, but we have developed an experienced staff of technicians, shipping specialists, and supervisors as part of our efforts to comply with the regulations and support cost effective, timely delivery of these products.

 

At the present time, we are the sole purchaser of high activity cobalt from any of the DOE reactors in the U.S. There are a few other cobalt source manufacturers in North America. We believe both our product and service provide us with a competitive edge in competing with these other manufacturers.

 

Nuclear Medicine Standards

 

This segment consists of the manufacture and sale through our wholly-owned subsidiary, RadQual, of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Our nuclear medicine standards products include flood sources, dose calibrators, rod sources, line sources, flexible and rigid rulers, spot markers, pen point markers, and a host of specialty design items. 

 

There are over 5,000 nuclear medicine centers in the United States (U.S.) that require nuclear medicine products on a regular repeat basis. We have been manufacturing these products for RadQual since 2001. Most nuclear medicine product sales are to U.S. customers. However, in recent years, because of stronger marketing efforts, we have seen an increase in foreign sales, as shown in Note 14 to the accompanying audited financial statements. All these products contain radioactive isotopes that decay at a predictable rate. Therefore, customers are required to periodically replace most of these products when they reach the end of their useful lives. The useful life of these products varies depending on the isotope used in manufacture, but in most cases averages eighteen months to two years. The various isotopes used in manufacturing these nuclear medicine products are from several sources world-wide, and we are continually working to develop multiple sources of each isotope. In addition to the products themselves, we have developed a complete line of specialty packaging for the safe transportation and handling of these products.

 

5
Table of Contents

 

Fluorine Products and the Planned Uranium De-Conversion Facility

 

We established the fluorine products business segment in 2004 to support production and sale of various fluoride gases produced using our Fluorine Extraction Process ("FEP"). FEP was intended to be completed in conjunction with the operation of a proposed depleted uranium ("DUF6") de-conversion facility in Lea County, New Mexico. DUF6 is the waste by-product of uranium enrichment, and any uranium enrichment facility will create very large quantities of DUF6. In October 2012, we received a construction and operating license from the U.S. Nuclear Regulatory Commission ("NRC") for the planned facility. Changes in the nuclear industry near the end of 2013, however, significantly reduced commercial demand for this type of facility. Therefore, we suspended all further development work on the project. We still anticipate a potential future need for a depleted uranium conversion facility and have kept all licenses and permits current.

 

On February 8, 2024, we entered into a definitive agreement to sell all of our assets related to the Fluorine Products segment and the Planned Uranium De-Conversion Facility ("DUF6 Asset Sale"). We expect to close the agreement within 12 to 24 months of signing. Closing is contingent on various conditions being met, including approvals and agreements by the NRC and other third parties.

 

Industry Overview, Target Markets, and Competition

 

The industries and markets that require or involve the use of radioactive material are diverse. Our current core business operations involve products that are used in a wide variety of applications and in various markets. The following provides an explanation of the markets and competitive factors affecting our current business segments.

 

Theranostics Products (formerly Radiochemical Products)

 

In February 2020, our abbreviated new drug application ("ANDA") for a generic radiopharmaceutical sodium iodide drug product was approved by the FDA. This product is approved for use in treatment of hyperthyroidism and carcinoma of the thyroid and is the first and only generic sodium iodide I-131 product approved by the FDA in the U.S. and only generic product of this type manufactured in the U.S. The only other supplier to the U.S. of an FDA approved sodium iodide product comes from a foreign manufacturer.

 

Since the launch of this drug product in 2020, the corresponding sales have had a significant positive impact on our revenues including 2022 and 2023. We expect this significant growth in sales for this product to continue in 2024 and beyond. We are also considering other generic drug opportunities and plan to expand the range of FDA approved products offered within this business segment in the coming years.

 

We also supply theranostics Products in bulk form. The markets for most radiochemicals can be highly competitive. The target markets for these products are customers who (1) incorporate them into finished industrial or medical devices; (2) use radioisotope products in clinical trials for various medical applications; or (3) further process and include the radioisotope products into pharmaceutical products approved by the U.S. FDA for labeled use in therapy or imaging.

 

In February 2022, we sold the improvements and equipment in an expansion that had been constructed to our manufacturing facility for cGMP processing. Using the capital from this sale, we are currently developing a business plan and exploring other opportunities that support our Theranostics and Medical Device segments. We believe that we are uniquely qualified and have a competitive advantage for future opportunities because we have a unique combination of NRC licensing, GMP compliant operating facility, and trained personnel.

 

Cobalt Products

 

In 2014, we entered into a 10-year agreement with the DOE utilizing a new cobalt target design for high activity cobalt production to be produced at the Advanced Test Reactor ("ATR"). Due to lower than desired activity rates in the material from the DOE, we bought the low activity targets at a discounted rate. There is a high demand for lower activity cobalt. We have taken shipment of and sold this material throughout 2022 and 2023 and will continue to have supply for at least two more years. We are now working with the DOE on future purchases of both high, medium, and low specific activity cobalt after the expiration of our current DOE agreement. Our cobalt products are used in applications such as radiation therapy, security devices, radiography examination and in some commercial applications. While there are other technologies available to provide external radiation therapy, there are several new devices just gaining market approval that still depend on cobalt sources for their specialized applications.

 

There has been a significant increase in regulation by the NRC in recent years that has created a significant barrier to new entrants to this market. We expect steady demand for cobalt sealed source products over the next several years but are primarily dependent upon our contract relationship with the DOE for a large portion of our cobalt production supply. An interruption in the operation of the ATR could have a negative impact on our cobalt products business segment.

 

6
Table of Contents

 

Nuclear Medicine Standards

 

Calibration and reference standards are required for the daily operational checks and calibration of the measurement of SPECT and PET imaging devices frequently used in nuclear medicine. Calibration and quality assurance testing are required as a routine part of the normal operations of this equipment to ensure its reliability and accuracy. For years, we have been the exclusive manufacturer of RadQual reference standard products. As RadQual is now our wholly-owned subsidiary, we continue to sell these same RadQual products through distributors who make direct sales in the U.S. and internationally. We directly ship these products to all 50 states and many overseas locations. There is only one other major producer of these products in the world that competes directly with us for these products. Most of the products manufactured by our competitor are similar in design to our products because all must meet Original Equipment Manufacturer (OEM) dimensional and performance standards. However, we attempt to differentiate our products through increased levels of quality control and customer service. We are certified under ISO-9001:2015 and ISO-13485-2016 quality programs that have allowed us to start selling these products into several foreign countries that require this additional quality certification for manufacturers. We are also working to expand the number and types of products that are manufactured in this segment and expand our raw product qualified suppliers.

 

Fluorine Products and the Planned Depleted Uranium De-Conversion Facility

 

Our Fluorine Products segment was developed in conjunction with uranium de-conversion to take advantage of the anticipated need for depleted uranium de-conversion services. During 2013, we curtailed all further work on the de-conversion facility because of a lack of demand for uranium de-conversion services at that time. We have continued to maintain the assets and licenses related to our previously planned de-conversion facility. 

 

On February 8, 2024, we entered into a definitive agreement to sell all of our assets related to the Fluorine Products segment ("DUF6 Asset Sale"). We expect to close the agreement within 12 to 24 months. Closing is contingent on various conditions being met, including approvals and agreements by the U.S. Nuclear Regulatory Commission and other third parties.

 

7
Table of Contents

 

Government Regulation

 

Licensing

 

We currently operate under two NRC licenses, one for broad scope operations and another for exempt distribution. Our broad scope license covers calibration and reference standard manufacturing and distribution, radioisotope processing and distribution, large scale cobalt processing and recycle operations, radioactive gemstone processing, environmental sample analysis, certain field service activities, and research and development. The exempt distribution license permits the release and distribution of irradiated gemstones to unlicensed entities in the U.S. All of our existing licenses and permits are adequate to allow current business operations. We do not handle “special nuclear materials” (i.e. nuclear fuels and weapons grade uranium, thorium or plutonium); therefore, our facility is not designated as a “nuclear” facility that would require additional licensing.

 

As a condition of our NRC licenses in Idaho, we are required to provide financial assurance for decommissioning activities. We fulfill this license requirement with a surety bond which names the NRC as beneficiary and is supported by a restricted cash account held in trust by a third party. Similar financial assurances will be required to fund the decommissioning of the proposed de-conversion facility.

 

In October 2012, we were granted a 40-year construction and operating license by the NRC for our planned depleted uranium de-conversion and fluorine extraction processing facility (the “de-conversion facility”). The de-conversion facility is planned to be located in Lea County, New Mexico. Further engineering work on the proposed de-conversion facility was placed on hold in 2013 until additional contracts for utilization could be obtained. There is no specific timeline required by the NRC for the start of construction on this project. The majority of the pre-construction design, licensing and state permitting has already been completed for the project and a ground water permit from the state of New Mexico remains to be obtained before the plant could begin operation. These licenses for the de-conversion facility are included in the DUF6 Asset Sale as described above.

 

Regulation of Radioisotope Production Waste

 

All our manufacturing processes generate some radioactive waste. We must handle this waste pursuant to the Low-Level Radioactive Waste (LLRW) Policy Act (LLRW Act), which requires the safe disposal of mildly radioactive materials. The estimated costs for storage and disposal of these materials have been included in the manufacturing and sales price of our products. Actual disposal costs are subject to change at the discretion of the disposal sites. We have obtained all necessary permits and approvals for the disposal of our waste materials, and we do not anticipate any negative changes in capacity or regulatory conditions that would limit or restrict our waste disposal capabilities.

 

Nuclear Regulatory Commission Oversight

 

We operate under two NRC licenses and are subject to NRC oversight and periodic inspections of our operations.

 

Other Regulations

 

We are registered as a medical device manufacturer through the FDA for several of our nuclear medicine reference and calibration standards. We are registered with the U.S. Department of Transportation (DOT) for the shipment of radioactive materials. We also have an NRC license for the import and export of radioactive materials. Because of increasing security controls and regulations, it is likely that we may encounter additional regulations affecting transportation, storage, sale, and import/export of radioactive materials.

 

We are also subject to inspection by the FDA to manufacture our sodium iodide I-131 product in compliance with our ANDA for sodium iodide I-131 and all applicable cGMP requirements for this and other contract manufactured products. We are registered with the FDA as a drug manufacturing facility, and we are subject to periodic and random inspections by the FDA for the continued manufacture of drug products.

 

We are subject to government regulation and intervention both in the U.S. and in all foreign jurisdictions in which we conduct business. Compliance with applicable laws and regulations results in higher capital expenditures and operating costs and changes to current regulations with which we must comply can necessitate further capital expenditures and increases in operating costs to enable continued compliance.

 

8
Table of Contents

 

Environmental Compliance

 

We are subject to various federal, state, local and foreign government requirements regulating the discharge of materials into the environment or otherwise relating to the protection of the environment. These laws and regulations include, but are not limited to the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), the Resource Conservation and Recovery Act (RCRA) and state statutes such as the Idaho Hazardous Waste Management Act, the LLRW Policy Act, NRC regulations concerning various irradiated, radioactive, and depleted uranium materials, and U.S. DOT regulations concerning shipment of radioactive materials. Certain of these laws and regulations can impose substantial fines and criminal sanctions for violations and require installation of costly equipment or operational changes to limit emissions and/or decrease the likelihood of accidental hazardous substance releases. We have incurred, and expect to continue to incur, capital and operating costs to comply with these laws and regulations. In addition, changes in laws, regulations and enforcement of policies, or the imposition of new clean-up requirements or remedial techniques, could require us to incur costs in the future that would have a negative effect on our financial condition or results of operations.

 

Distribution Methods for Products

 

We sell our products directly to our customers who, in some cases, are both end users and distributors. We use common commercial carriers for delivery of our products.

 

Dependence on Customers

 

Combined sales, on which we are dependent, to our three largest customers, accounted for 22% of our total gross revenues in 2023 and accounted for 23% of our total gross revenues in 2022.

 

Patents, Trademarks, Licenses and Royalty Agreements

 

In 2004, we obtained certain patents related to the FEP. In 2010, we were granted an additional process patent on the FEP process. During 2012, we were granted additional process patents for the FEP process in the United States. These patents are included in the DUF6 Asset Sale as noted above.

 

In May 2021, we entered into an exclusive licensing agreement with Memorial Sloan-Kettering Cancer Center (MSKCC) for commercial development of a Radioimmuno Assay (RIA) test lit for the detection for SARS COVID-19 virus in the blood. A patent application for this test kit was submitted to the U.S. patent office in March 2021. The useful application and commercial viability of this opportunity will continue to be evaluated; however, at the present time we do not plan commercial development of this product but may pursue other related commercial opportunities.

 

Employees

 

As of December 31, 2023, we had 40 total employees, including 39 full-time employees.

 

9
Table of Contents

 

Available Information

 

Our internet website address is www.intisoid.com. We are subject to the reporting requirements under the Securities Exchange Act of 1934, as amended (the Exchange Act). Consequently, we are required to file reports and information with the SEC, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. These reports and other information concerning us are available free of charge through (i) our website as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC, and (ii) the SEC’s website at www.sec.gov. Information contained on, or accessible through, our website is not incorporated by reference into this Annual Report or other reports filed with the SEC.

 

Item 1A.      RISK FACTORS

 

Readers should carefully consider the following factors that may affect our business, future operating results and financial condition, as well as other information included in this Annual Report. The risks and uncertainties described below are not the only ones the Company faces. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. If any of the following risks occur, our business, financial condition and operating results could be materially adversely affected.

 

Risks Related To Our Company

 

We have incurred, and may continue to incur, losses. We have incurred net losses for most fiscal periods since our inception. From inception through December 31, 2023, we have an accumulated deficit (including preferred stock dividends and returns) in the amount of $127,329,859. The negative cash flow we have sustained has materially reduced our working capital, which in turn could materially and negatively impact our ability to fund future operations and continue to operate as a going concern. Management has taken and continues to take, actions to improve our financial condition and results of operations. The availability of necessary working capital, however, is subject to many factors beyond our control, including, among other things, our ability to obtain financing on favorable terms, or at all, economic cycles, market acceptance of our products, competitors' responses to our products, the intensity of competition in our markets, and the level of demand for our products.

 

We may need additional financing to continue operations. Because we may continue to experience negative cash flow, we may need to obtain additional financing to continue operations. Management will continue to plan and take actions to improve our financial results which could enhance our ability to obtain financing. However, obtaining additional financing is subject to many factors beyond our control and may not be available to us on acceptable terms or at all. If we are unable to raise additional funds when needed, we could be required to delay development and construction of projects, reduce the scope of, abandon or sell some or all our growth projects or default on our contractual commitments in the future, any of which would have a material adverse effect on our business, financial condition and operating results.

 

Our operations expose us to the risk of material environmental liabilities.  We are subject to potential material liabilities related to the remediation of environmental hazards and to personal injuries or property damages that may be caused by hazardous substance releases and exposures. The materials used in our operations expose us to risks of environmental contamination that could subject us to liability, including remediation obligations that could be very costly. In addition, the discovery of previously unknown contamination could require us to incur costs in the future that would have a negative effect on our financial condition or results of operations. We have a Surety Bond in place supported by funds in a restricted cash account to provide the financial assurance required by the NRC for our Idaho facility license for decommissioning and a similar mechanism will be required to fund the decommissioning of the proposed new depleted uranium facility. However, if a contamination event occurred within, or outside of, our facility, we may be financially responsible to remediate such contamination and could have to borrow money or fund the remediation liability from our future revenue. We may not be able to borrow the funds, or have available revenue, sufficient to meet this potential liability, which could have a significant negative impact on our financial condition and results of operations.

 

We are dependent upon key personnel.  Our ongoing operations are currently dependent on Shahe Bagerdjian, President and Chief Executive Officer. The loss of Mr. Bagerdjian could have a material adverse effect on our business. There is no assurance that we will be able to retain Mr. Bagerdjian or our existing personnel or attract additional qualified employees. The loss of any of our key personnel or an inability to attract additional qualified employees could result in a significant decline in revenue.

 

10
Table of Contents

 

General economic conditions in markets in which we do business can impact the demand for our goods and services. Decreased demand for our products and services can have a negative impact on our financial performance and cash flow.  Demand for our products and services, in part, depends on the general economic conditions affecting the countries and industries in which we do business. A downturn in economic conditions in the U.S. or industry that we serve may negatively impact demand for our products and services, in turn negatively impacting our operations and financial results. Further, changes in demand for our products and services can magnify the impact of economic cycles on our businesses.

 

Volatility in raw material and energy costs, interruption in ordinary sources of supply and an inability to recover unanticipated increases in energy and raw material costs from customers could result in lost sales or significantly increase the cost of doing business.  Market and economic conditions affecting the costs of raw materials, utilities, energy costs, and infrastructure required for the delivery of our goods and services are beyond our control and any disruption or halt in supplies, or rapid escalations in costs could affect our ability to manufacture products or to competitively price our products in the marketplace. For instance, an interruption in the supply of isotopes such as cobalt-57, cobalt-60, or iodine-131 could result in lost sales of nuclear medicine and calibration standards sales, cobalt product sales, and sodium iodide I-131 generic drug product. We also purchase some of our theranostics Products from overseas suppliers and the price of those products could be adversely affected through changes in currency exchange rates.

 

We are subject to extensive government regulation in jurisdictions around the globe in which we do business. Regulations address, among other things, environmental compliance, import/export restrictions, healthcare services, taxes and financial reporting, and can significantly increase the cost of doing business, which in turn can negatively impact our operations, financial results and cash flow.  We are subject to government regulation and intervention both in the United States and in all foreign jurisdictions in which we conduct business. Compliance with applicable laws and regulations results in higher capital expenditures and operating costs and changes to current regulations with which we must comply can necessitate further capital expenditures and increases in operating costs to enable continued compliance. Additionally, from time to time, we may be involved in legal or administrative proceedings under certain of these laws and regulations. Significant areas of regulation and intervention include the following:

 

Radioactive Waste. All our manufacturing processes generate some radioactive waste. For waste that cannot be decayed in storage we must handle this waste pursuant to the LLRW Policy Act, which requires the safe disposal of mildly radioactive materials. The estimated costs for storage and disposal of these materials have been included in the manufacturing and sales price of our products. However, actual disposal costs are subject to change at the discretion of the disposal site. An unexpected or material increase in these costs could have a material adverse effect on our financial condition and results of operations.

 

Health Compliance. Health regulations dictated by the United States Occupational Safety and Health Administration and NRC are extensive in our business. There is no assurance that our activities will comply with all applicable health regulations at times and, as a result, may expose us to liability under applicable health regulations. Costs and expenses resulting from such liability may materially negatively impact our operations and financial condition. Overall, health laws and regulations will continue to affect our business worldwide.

 

NRC License Enforcement Actions. The NRC may take enforcement action in the event that we are found to be in violation of NRC regulations or in violation of any of our license requirements. Consequences of violations depend upon the severity of the violations as well as the adequacy and timeliness of corrective actions implemented by the licensee to investigate and correct the cause of the violation and to prevent reoccurrence. The NRC has discretionary authority in the action they choose to take against license violations, but these actions can include civil penalties and restrictions upon licensee operations or license suspension. The imposition of any such penalties and/or restrictions upon our operations or suspension of our license could have a material adverse effect on our financial condition and results of operations.

 

Environmental Regulation. We are subject to various federal, state, local and foreign government requirements regulating the discharge of materials into the environment or otherwise relating to the protection of the environment. These laws and regulations include, but are not limited to CERCLA, the RCRA and state statutes such as the Idaho Hazardous Waste Management Act, the LLRW Policy Act, NRC regulations concerning various irradiated, radioactive, and depleted uranium materials, and U.S. DOT regulations concerning shipment of radioactive materials. Certain of these laws and regulations can impose substantial fines and criminal sanctions for violations and require installation of costly equipment or operational changes to limit emissions and/or decrease the likelihood of accidental hazardous substance releases. We have incurred, and expect to continue to incur, capital and operating costs to comply with these laws and regulations. In addition, changes in laws, regulations and enforcement of policies, or the imposition of new clean-up requirements or remedial techniques, could require us to incur costs in the future that would have a negative effect on our financial condition or results of operations.

 

11
Table of Contents

 

Import/Export Regulation. We are subject to significant regulatory oversight of our import and export operations due to the nature of our product offerings. Penalties for non-compliance can be significant and violations can result in adverse publicity. Because of increasing security controls and regulations, it is likely that we may encounter additional regulations affecting the transportation, storage, sale, and import/export of radioactive materials.

 

Taxes. We structure our operations to be tax efficient and to make use of tax credits and other incentives. Nevertheless, changes in tax laws, actual results of operations, final audit of tax returns by taxing authorities, and the timing and rate at which tax credits can be utilized can change the rate at which we are taxed, thereby affecting our financial results and cash flow.

 

We may incur material losses and costs as a result of product liability claims that may be brought against us. We face an inherent business risk of exposure to product liability claims in the event that products supplied by us fail to perform as expected or such failures result, or are alleged to result, in bodily injury. Although we have purchased insurance with coverage and in amounts that we believe to be adequate and reasonable in light of our current and planned operations, if a successful product liability claim were brought against us in excess of our available insurance coverage, it would have a material adverse effect on our business and financial results.

 

Catastrophic events such as natural disasters, pandemics, war and acts of terrorism could disrupt our business or the business of our suppliers or customers, and any such disruptions could have a negative impact on our operations, financial results and cash flow.  Our operations are at all times subject to the occurrence of catastrophic events outside our control, ranging from severe weather conditions such as hurricanes, floods, earthquakes and storms, to health epidemics and pandemics, to acts of war and terrorism. Any such event could cause a serious business disruption that could affect our ability to produce and distribute our products and possibly expose us to third-party liability claims. Additionally, such events could impact our suppliers, thereby causing energy and raw materials to become unavailable to us, and our customers, who may be unable to purchase or accept our products and services. Any such occurrence could have a negative impact on our operations and financial condition.

 

Our future growth is largely dependent upon our ability to develop new products that achieve market acceptance with acceptable margins.  Our businesses operate in global markets that are characterized by rapidly changing technologies and evolving industry standards. Accordingly, our future growth rate depends upon several factors, including, but not limited to, our ability to (i) identify emerging technological trends in our target end-markets, (ii) develop and maintain competitive products, (iii) enhance our products by adding innovative features that differentiate our products from those of our competitors, and (iv) develop, manufacture, and bring products to market quickly and cost-effectively. Our ability to develop new products based on technological innovation or U.S. FDA approval can affect our competitive position and requires the investment of significant resources. These development efforts divert resources from other potential investments in our businesses, and they may not lead to the development of new products on a timely basis or that meet the needs of our customers as fully as competitive offerings. In addition, the markets for our products may not develop or grow as we currently anticipate. The failure of our technologies or products to gain market acceptance due to more attractive offerings by our competitors could significantly reduce our revenues and adversely affect our competitive standing and prospects.

 

We are dependent on various third parties in connection with our business operations.  The production of high-specific activity cobalt is dependent upon the DOE, and its prime-operating contractor, which controls the Idaho reactor. Current activity at the Idaho ATR may continue to affect the supply of cobalt material needed for the manufacture of cobalt sources. Loss of the ability to use, or cost-effectively use, these irradiation services would significantly impact our cobalt products business segment because there is not currently another reactor available in the U.S. that is capable of providing this type of service for us. Our radiochemical iodine is supplied to us through two supply sources. Unanticipated contract terminations by these suppliers or suppliers the key raw materials of our other products or other third parties would have a material adverse impact on our operations, financial results, and cash flow.

 

We are dependent on a limited number of customers in connection with some of our current business operations. Combined sales to our three top customers accounted for 22% and 23% of our total gross revenue during 2023 and 2022, respectively. Although we are making efforts to reduce our dependency on a small number of customers, the loss of any one of these customers could have a significant impact on our future results of operations and financial condition. Unanticipated contract terminations by any of these current customers could have a material adverse impact on operations, financial results, and cash flow.

 

12
Table of Contents

 

We are subject to competition from other companies.  Each of our existing business areas has direct competition from other businesses. High-specific activity cobalt is supplied by other reactor facilities around the world. Nuclear medicine calibration and reference standards are being produced by one other major manufacturer in the U.S. We have one major competitor in the U.S. for our sodium iodide I-131 drug product. Most of our competitors have significantly greater financial resources that could give them a competitive advantage over us.

 

Risks Related To Our Common Stock

 

Trading in our common stock is limited and the price of our common stock may be subject to substantial volatility.  Our common stock is quoted on the OTCQB Marketplace under the U.S. trading symbol “INIS”. The market for our securities is limited, the price of our stock is volatile, and the risk to investors in our common stock is greater than the risk associated with stock trading on other markets. These factors may reduce the potential market for our common stock by reducing the number of potential investors. This may make it more difficult for investors in our common stock to sell shares to third parties or to otherwise dispose of their shares. This could cause our stock price to decline.

 

We currently do not intend to pay dividends on our common stock.  We do not plan to pay dividends on shares of our common stock in the near future. Consequently, an investor in our common stock can only achieve a return on its investment in us if the market price of our common stock appreciates.

 

We are contractually obligated to issue shares in the future, which will dilute your interest in us. As of December 31, 2023, there were approximately 19,372,500 shares of common stock issuable upon the exercise of vested stock options, at a weighted-average exercise price of $.05 per share. An additional 34,932,090 shares were reserved for issuance under our equity plans as of December 31, 2023. Our outstanding preferred stock and certain of our outstanding debt is also convertible into shares of our common stock at the holders’ option. In addition, we expect to issue additional options to purchase shares of our common stock to compensate employees, consultants and directors, and we may issue additional shares to raise capital to expand our manufacturing capability, develop additional products, or fund our planned uranium de-conversion plant. Any such issuance will have the effect of further diluting the interest of the holders of our securities.

 

Item 1B.      UNRESOLVED STAFF COMMENTS

 

We are a smaller reporting company, and therefore, are not required to provide the information required by this item.

 

Item 1C.      CYBERSECURITY

 

The operation of our business is dependent on the secure functioning our computer infrastructure. This infrastructure is used to maintain key processes including management of sensitive company information and operation of sales, record-keeping, and accounting functions. 

 

We employ a specialized third-party information technology ("IT") management firm to monitor and manage our cybersecurity functions. Processes employed include real-time monitoring of company communications and IT activities and consultation and risk assessment of company procedures. Additionally, our third-party IT firm provides education to management and employees regarding our specific IT risks. All our employees receive information security training (including data protection and fraud awareness) on an annual basis. Department managers are given additional risk management training as part of periodic management meetings. Our activities are monitored at all times by our IT firm; we regularly meet with our them to review our cybersecurity response plans, discuss any needed updates, and identify risk management actions to be taken. The IT firm reports all matters of cybersecurity including any threats, breaches, or risks directly to our Chief Financial Officer who reports directly to the Chief Executive Officer. Updates regarding cybersecurity are provided to our directors at least annually and as needed for any important developments including cybersecurity breaches and risks.

 

We carry a cybersecurity insurance policy to help cover any costs that may occur from a cybersecurity incident. Although risks from cybersecurity threats and implementation of our cybersecurity program have not materially affected our business strategy, business operations or our financial condition, a cybersecurity incident could have a material adverse effect in the future if it were to cause business disruption or data loss.

 

 

13
Table of Contents

 

Item 2.       PROPERTIES

 

We lease one property which serves as or main corporate headquarters and houses all of our current manufacturing operations for our core business segments. We also hold the conditional title to 640 acres of land in Lea County, New Mexico for the proposed de-conversion facility. The following paragraphs provide a brief summary of these properties.

 

4137 Commerce Circle, Idaho Falls, Idaho – The facility located on this property houses our main corporate headquarters and all of our current manufacturing operations. In January 2020, we entered into a new lease agreement due to new and expanded facilities made available to us. The initial lease term is until January 2030 and provides an option to renew for an additional 5 years. The lease provides for the Company to expand its leased space as needed into additional areas of the building. The facility was new when leased in March 2001 and remains in excellent condition. We have a right of first refusal on this property that allows us to match any offer to purchase this property.

 

Land - Lea County, New Mexico – In August 2011, we received land from Lea County, New Mexico, pursuant to a PPA, whereby the land was deeded to us for no monetary consideration. In return, we committed to construct a uranium de-conversion and FEP facility on the land. In order to retain title to the property, we were to begin construction of the de-conversion facility no later than December 31, 2014, and complete Phase I of the project and have hired at least 75 persons to operate the facility no later than December 31, 2015, although commercial operations need not have begun by that date. We did not meet the performance milestones set forth in the PPA and we executed a modification to the agreement extending these due dates to December 31, 2016 and 2017, respectively. We plan to work with Lea County to execute an additional modification to the agreement to further extend these dates once an estimated restart date for the project is determined. If we do not succeed in extending the commitment dates or in reaching performance dates set forth in a modified agreement then we may, at our sole option, either purchase or re-convey the property to Lea County, New Mexico. The purchase price of the property would be $776,078, plus interest at the annual rate of 5.25% from the date of the closing to the date of payment. We have not recorded the value of this property as an asset and will not do so until such time that sufficient progress on the project has been made to meet our obligations under the agreements for permanent transfer of the title. These land rights are part of the DUF6 Asset Sale as described above.

 

Item 3.       LEGAL PROCEEDINGS

 

We are not a party to any legal proceedings that we believe to be material and we are not aware of any pending or threatened litigation against us that we believe could have a material adverse effect on our business, operating results, financial condition, or cash flows.

 

Item 4.       MINE SAFETY DISCLOSURES

 

Not applicable.

 

 

14
Table of Contents

 

PART II

 

Item 5.       MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Our common stock is traded on the OTCQB under the trading symbol “INIS”. The following table shows the high and low prices of our common stock on the OTCQB. The following quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions:

 

OTC Bulletin Board (Symbol “INIS”)

  
                 
   

High

    

Low

  

Period

  

(US $)

    

(US $)

  

First Quarter 2022

     0.34       0.04  

Second Quarter 2022

     0.15       0.09  

Third Quarter 2022

     0.14       0.08  

Fourth Quarter 2022

     0.11       0.06  

First Quarter 2023

     0.10       0.08  

Second Quarter 2023

     0.10       0.06  

Third Quarter 2023

     0.09       0.04  

Fourth Quarter 2023

     0.07       0.03  

 

Holders of Record

 

As of March 16, 2024, there were 486 holders of record of our common stock.

 

Dividends

 

We have never paid any cash dividends on our common stock. In the future, and based upon our profit performance, our Board of Directors (the “Board”) will evaluate and determine whether to issue dividends, subject to compliance and limitations under any applicable debt or other financing agreements in effect at that time or retain funds for research and development and expansion of our business. We do not anticipate paying any dividends to shareholders of our common stock for the foreseeable future.

 

Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities

 

None.

 

Purchases of Equity Securities by the Issuer

 

None.

 

Performance Graph

 

We are a smaller reporting company, and therefore, are not required to provide the information required by this item.

 

Item 6.       RESERVED

 

15
Table of Contents

 

Item 7.       MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion of our results of operations and financial condition should be read in conjunction with the accompanying financial statements and related notes thereto included in Item 8, “Financial Statements and Supplementary Data,” within this Annual Report. Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report, including information with respect to our plans and strategies for our business, statements regarding the industry outlook, our expectations regarding the future performance of our business and the other non-historical statements contained herein are forward-looking statements. See “Cautionary Note Regarding Forward-Looking Statements.” You should also review the “Risk Factors” in Item 1A. of this Annual Report for a discussion of important factors that could cause actual results to differ materially from the results described herein or implied by such forward-looking statements.

 

Overview

 

International Isotopes Inc. (the “Company”, “we”, “us” and “our”) produces an FDA approved generic sodium iodide I-131 drug product, manufactures a wide range of nuclear medicine calibration and reference standards, and provides radiochemicals for clinical research and life sciences. The Company also produces a variety of cobalt-60 products. A more detailed description of each of these product lines and services along with a description of our business segments can be found in Item 1, “Business” within this Annual Report.

 

During 2023, we focused our efforts on achieving profitability in each of our core business segments and reached several significant goals. During 2023, we:

 

 

●

Increased total company revenues by $1,085,397 or 10%.

 

 

●

Reached $12.3 million in total revenues which was the largest single year in company history.

 

 

●

Increased sales in the Theranostics Products segment (formerly Radiochemical products segment) by 13% primarily through increases in sales of our FDA approved generic sodium iodide I-131 drug product.

 

 

●

Increased sales in our Nuclear Medicine Standards by 10%.

 

 

●

Developed several new products for our Nuclear Medicine products segment and expanded our range of products in this segment into Positron Emission Tomography (PET) imaging standards.

 

 

●

Purchased medical devices and related assets and intellectual property rights from AMICI, Inc. that we plan to expand into an additional business segment, "Medical Devices" starting in 2024.

 

 

●

Pursuant to an option agreement entered into October 2022, we worked to complete an asset sales agreement to sell our unused assets in our FEP business segment. In February 2024, we entered into an Asset Purchase Agreement to sell these assets for a total of $12.5 million. The transaction is expected to close in approximately 12 to 24 months, subject to satisfaction of certain closing conditions.

 

 

16
Table of Contents

 

 

Business Strategy and Core Philosophies

 

Broadly defined, our business strategy is to continue to build our reputation as a leader in radioisotope applications, such as theranostics, radiopharmaceutical, radiochemical, medical device, cobalt, and nuclear medicine product industries, and to maximize the revenue potential across our product segments. We also intend to continually seek ways to improve our customer service and expand our market share, with the ultimate goal of providing greater return to our shareholders. Specifically, we are continuously working with our customers to improve and develop new products to better serve the needs of the end user which, ultimately, we believe will boost product sales. A key part of our short-term and long-term business strategy is to develop, and enter into additional markets for our Theranostics, Nuclear Medicine, and Medical Device product segments. In addition, we will manage costs and cash flow in such a way to support further expansion of our products and services to exploit additional market opportunities.

 

Our core philosophy is to strive to provide high quality products and services as a profitable and environmentally conscious business, while offering excellent customer service and providing a safe and productive working environment for our employees. We operate in accordance with an ISO Quality Management System and in accordance with all current Good Manufacturing Practices under which we seek to maintain the highest level of quality and continuously improve our product manufacturing processes.

 

Results of Operations

 

Following is a summary of results of operations for 2023:

 

 

●

Revenue in 2023 was approximately $12.3 million, which was a 10% increase compared to 2022 and was the largest annual revenue generated in the company’s history;

 

 

●

Our 2023 sales in our Theranostics Products (formerly Radiochemical Products) increased by approximately 13% as compared to 2022;

 

 

●

Our 2023 sales in our Nuclear Medicine Standards segments increased by approximately 10% and sales in our Cobalt Products segment decreased approximately 10% as compared to 2022;

 

 

●

Our total gross profit rate increased to 60% in 2023 from 56% in 2022;

 

 

●

Our operating costs for 2023 increased approximately 9% as compared to 2022;

 

 

●

 Our 2023 cash provided by operating activities was $582,589;

 

 

●

Our operating loss for 2023 decreased approximately 35% as compared to 2022; and

 

 

●

We had a net loss of $869,016 in 2023 as compared to a net profit of $303,238 in 2022.
17
Table of Contents

 

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022

 

The following table presents comparative revenues for the years ended December 31, 2023 and 2022:

 

Revenues

  

For the year ended December 31, 2023

     % of Total Revenues 2023    

For the year ended December 31, 2022

     % of Total Revenues 2022  

Theranostics Products

   $ 6,842,898       56 %   $ 6,045,767       54 %

Cobalt Products

     1,037,073       8 %     1,157,536       10 %

Nuclear Medicine Standards

     4,387,414       36 %     3,978,685       36 %

Flourine Products

     —       0 %     —       0 %

Total Segments

   $ 12,267,385       100 %   $ 11,181,988       100 %

 

Revenues

 

Total revenues in 2023 were $12,267,385, compared to $11,181,988 in 2022, which represents an increase of $1,085,397, or approximately 10%. The performance of each segment is discussed in the following paragraphs.

 

Revenues

  

For the year ended December 31, 2023

    

For the year ended December 31, 2022

    

$ change

    

% change

  

Theranostics Products

   $ 6,842,898     $ 6,045,767     $ 797,131       13 %

Cobalt Products

     1,037,073       1,157,536       (120,463 )     (10 )%

Nuclear Medicine Standards

     4,387,414       3,978,685       408,729       10 %

Flourine Products

     —       —       —       — %

Total Segments

     12,267,385       11,181,988       1,085,397       10 %

Corporate revenue

     —       —       —       — %

Total Consolidated

   $ 12,267,385     $ 11,181,988     $ 1,085,397       10 %

 

Theranostics Products

 

Sales of theranostics Products accounted for approximately 56% of our sales revenue in 2023 as compared to 54% of our total sales revenue in 2022. Sales in this segment increased by $797,131, or approximately 13% to $6,842,898 in 2023 as compared to $6,045,767 in 2022. The increase is primarily the result of increased sales of our generic sodium iodide I-131 drug product.

 

Sales of our FDA-approved generic sodium iodide drug product make up the bulk of sales in this segment. We expect continued growth in sales for this product in 2024 and beyond. Within this segment, we also currently distribute sodium iodide (I-131) as a radiochemical product. The radiochemical product is being used for a variety of applications including industrial use and use in investigational and clinical trials. We believe that the market growth, new customers, and entry into new territories, in addition to the theranostics API we plan to submit to the FDA, should increase future sales in this business segment.

 

18
Table of Contents

 

Cobalt Products

 

Cobalt products sales accounted for approximately 8% of our total sales revenue in 2023 and approximately 10% in 2022. Sales in this segment decreased by $120,463, or approximately 10%, in 2023 to $1,037,073, as compared to $1,157,536 in 2022. The decrease in revenue within this segment was the result of decreased Cobalt Sealed Source Manufacturing due to timing of receipt of additional cobalt material from the ATR in 2023, delays in customer contracts for Cobalt Sealed Source Manufacturing, and delays due to maintenance and repairs to our manufacturing equipment. Our sealed source manufacturing generates the majority of our revenue within this segment and sealed source sales depend on our ability to produce or procure cobalt material.

 

Periodically we have been able to acquire recycled material that can be used to manufacture sealed sources for customers, and in some instances, our customers have supplied their own cobalt material for source fabrication. We will continue to have access to additional low specific activity material produced by the DOE and expect to obtain, process, and sell additional cobalt products as a result during 2024.

 

We have entered into cobalt supply agreements with several customers. The terms of these cobalt contracts require some advance progress payments from each customer. The funding received under these contracts has been recorded as unearned revenue under short- and long-term liabilities in our consolidated financial statements. We recognized some of this revenue in prior years including in 2023 and 2022 when we fulfilled contract performance objectives by supplying sealed sources manufactured with cobalt from the ATR or alternate suppliers.

 

Nuclear Medicine Standards

 

Sales in the nuclear medicine standards segment accounted for approximately 36% of our total sales revenue in both 2023 and 2022. Sales in this segment increased by $408,729, or approximately 10%, to $4,387,414 in 2023, as compared to $3,978,685 in 2022. This increase in sales in 2023 is due to increased sales of our RadQual nuclear medicine standard products both domestically and internationally.

 

We anticipate that our sales of RadQual products will remain strong by creating future opportunities through new product development and expanding markets.

 

Fluorine Products

 

In 2023 and 2022, we had no revenues related to Fluorine Products. Work on our de-conversion facility project that is the entirety of this business segment has been on hold since 2013 because of a slowdown in the nuclear industry that specifically impacted fuel cycle facilities. Since that time, we have limited our expenditures to essential items such as maintenance of the NRC license, land use agreements, communication with our prospective FEP product customers, and interface with the State of New Mexico and Lea County officials. In February 2024, we entered into an Asset Purchase Agreement with a Company to sell the NRC license and other assets related to this business area ("DUF6 Asset Sale"). We expect to close the DUF6 Asset Sale in approximately 12 to 24 months, subject to satisfaction of certain closing conditions.

 

During 2023, we incurred $113,019 of planning and other expenses related to the de-conversion project, as compared to $144,860 in 2022. This is a decrease of $31,841, or approximately 22%, and is the result of decreased professional services allocated to this project in 2023. The largest expense in this business segment is $104,379, approximately 92% of the total expenses for 2023, for the amortization of our NRC license for this project. We expect that our costs in the future will be limited to essential items such as continued interactions with our customers, the state of New Mexico, and Lea County, New Mexico. If we are able to close the DUF6 Asset Sale as expected, we anticipate dissolving our Flourine Products segment. 

 

19
Table of Contents

 

Cost of Revenues and Gross Profit

 

Cost of revenues for 2023 was $4,888,409 as compared to $4,891,927 in 2022, a decrease of $3,518, or less than 1%. Gross profit percentage increased to 60% for 2023, from 56% in 2022. The following table presents revenues and cost of revenues information:

 

   

For the year ended December 31, 2023

     % of Total Revenues 2023    

For the year ended December 31, 2022

     % of Total Revenues 2022  

Total Revenues

   $ 12,267,385       100 %   $ 11,181,988       100 %

Cost of Revenues

                                

Theranostics Products

   $ 2,370,048       19 %   $ 2,217,468       20 %

Cobalt Products

     482,670       4 %     577,417       5 %

Nuclear Medicine Standards

     2,035,691       17 %     2,097,042       19 %

Fluorine Products

     —       — %     —       — %

Total Segments

   $ 4,888,409       40 %   $ 4,891,927       44 %
                                 

Gross Profit

   $ 7,378,976             $ 6,290,061          

Gross Profit %

             60 %             56 %
                                 

 

During 2023, we continued to monitor and control direct costs. Raw materials used in our theranostics Products and nuclear medicine standards represented the bulk of direct costs for 2023. In each of these business segments, we have purchase agreements in place with suppliers to obtain optimum pricing. Periodically, the cost can increase for these raw materials or we may also use alternate supply sources for our material which might not carry pricing as favorable as our contracted suppliers.

 

The increase in gross profit percentage in 2023 is a result of increased overall sales activity, increased sales prices, and better cost controls. Additionally, we have worked to find more effective cost controls and to increase our overall utilization of our raw materials.

 

 

20
Table of Contents

 

Operating Costs and Expenses

 

Total operating costs and expenses for 2023 were $8,155,275, as compared to $7,492,958 in 2022. This is an increase of $662,317, or approximately 9%.

 

The following table presents operating costs and expenses for 2023 as compared to 2022:

 

   

For the year ended December 31, 2023

    

For the year ended December 31, 2022

    

% change

    

$ change

  

Operating Costs and Expenses:

                                

Salaries and Contract Labor

   $ 4,032,155     $ 3,390,652       19 %   $ 641,503  

General, Administrative and Consulting

     3,545,766       3,568,590       (1 )%     (22,824 )

Research and Development

     577,354       533,716       8 %     43,638  

Total operating expenses

   $ 8,155,275     $ 7,492,958       9 %   $ 662,317  

 

Salaries and contract labor expense increased by $641,503, or approximately 19%, which was the result of an increased number of employees, increases to labor rates, and temporary increase in executive salaries during our CEO transition period. In addition, non-cash equity compensation expense recorded for the year ended December 31, 2023, was $464,041 as compared to $352,458 for the same period in 2022. This expense is for equity compensation recorded for outstanding stock options and restricted stock units granted to directors, officers, and employees.

 

General administrative and consulting expenses decreased less than 1% to $3,545,766 in 2023, as compared to $3,568,590 in 2022. Research and development expense was $577,354 for 2023, compared to $533,716 for 2022. This is an increase of $43,638, or approximately 8%. This increase in research and development expense was the result of increased costs associated with product development in our Theranostics and Nuclear Medicine Standards business segments.

 

Other Income (Expense)

 

The following table presents other income (expense) for 2023 as compared to 2022:

 

   

For the year ended December 31, 2023

    

For the year ended December 31, 2022

  

Other income (expense)

   $ 160,173     $ 2,110,576  

Interest income

     78,890       9,502  

Interest expense

     (331,780 )     (613,943 )

Total other (expense)

   $ (92,717 )   $ 1,506,135  

  

Other income was $160,173 for 2023 as compared to other income of $2,110,576 for 2022. The large decrease is primarily due to a $1,797,978 gain on the sale of assets to Pharmalogic Idaho, LLC in 2022. In February 2022, we entered into an Asset Purchase Agreement with Pharmalogic Idaho, LLC, pursuant to which we sold certain assets for $4,000,000 in cash. The assets consisted primarily of manufacturing equipment and a sublease acquired by the Company in connection with the previously announced termination of the manufacturing and supply agreement with another company.

 

Interest income in 2023 was $78,890 as compared to $9,502 in 2022. This increase of $69,388 was due to increased interest rates and increased cash balances held at banks and other institutions in interest-bearing accounts.

 

Interest expense decreased during 2023, to $331,780, from $613,943 in 2022. This decrease of $282,163, or approximately 46%, was due to a decrease in non-cash interest expense. In 2022, non-cash interest expense was $274,443 with no comparable expense in 2023. Interest expense includes dividends accrued on our Series C Preferred Stock (as defined below) issued in 2017. In 2023, we recorded interest expense of $243,780 for dividends payable on our Series C Preferred Stock.

 

21
Table of Contents

 

Net Income or Loss

 

Our net loss was $869,016 in 2023, compared to a net income of $303,238 in 2022. This is a decrease in net income of $1,172,254. This decrease is the result of the approximate $1.8 million gain on sale of assets in 2022 with no such gain in 2023. 

 

Liquidity and Capital Resources

 

On December 31, 2023, we had cash and cash equivalents of $2,688,141 compared to $2,375,817 at December 31, 2022. Net cash provided by operating activities was $582,589 in 2023, compared to net cash used in operating activities of $1,497,719 in 2022. This represents an increase in cash provided by operating activities of $2,080,308. This increase is due to improved operational performance, decreases in accounts receivable, decreases in Prepaids and current assets, and an increase in accounts payable and accrued liabilities in the year over year comparison.

 

Accounts receivable at December 31, 2023 were $1,469,298 as compared to $1,596,886 at December 31, 2022. Our allowance for bad debt at December 31, 2023 and at December 31, 2022 was $0.

 

Inventories at December 31, 2023 were $927,111 as compared to $744,793 at December 31, 2022. Part of this increase is due to acquisition of inventory as part of our purchase of business assets from AMICI, Inc.

 

Included in our work in process inventory are in-process and completed nuclear medicine products, irradiated cobalt, and nuclear medicine-related materials and products.

 

We recognized a net loss of $869,016, for the year ended December 31, 2023, and have an accumulated deficit of $127,329,859 since inception. To date, our operations and plant and equipment expenditures have been funded principally from proceeds from public and private sales of debt and equity as well as through asset sales.

 

Net cash used in investing activities was $149,058 for 2023 and net cash provided by investing activities was $3,879,986 for 2022. During 2023, we used $149,058 to purchase equipment, and we used $120,014 to purchase equipment in 2022. We had proceeds from sale of equipment of $4,000,000 in 2022, and we had no proceeds from sale of equipment in 2023.

 

Financing activities provided cash of $80,504 for the year ended December 31, 2023. We entered into a note payable agreement for $452,100 to finance the purchase of assets. We received proceeds from the sale of common stock in the amount of $8,398 and made principal payment on loans in the amount of $83,389 in 2023. For the year ended December 31, 2022, financing activities used cash of $472,004. We received proceeds from the sale of common stock in the amount of $76,571 and made principal payment on loans in the amount of $540,032 in 2022.

 

In February 2017, we entered into subscription agreements with certain investors, including two of our directors, for the sale of (i) an aggregate of 3,433 shares of Series C Preferred Stock, and (ii) Class M warrants to purchase an aggregate of 17,165,000 shares of our common stock (Class M Warrants), for gross proceeds of $3,433,000. The Class M Warrants were exercisable at an exercise price of $0.12 per share, subject to adjustment as set forth in the warrant, and expired in February 2022. In February 2022, 515,000 Class M Warrants were exercised at a price of $0.12. The Company received $61,800 for the exercise.

 

In March 2017, we amended our 8% unsecured debentures issued that were scheduled to mature in July 2017 (the Notes) and gave the noteholders certain additional rights (the Amendment). Pursuant to the Amendment, the Notes were modified to provide each holder the right, at the holder’s option and exercisable prior to May 12, 2017, to convert all or any portion of the principal amount of the Notes, plus accrued but unpaid interest, into shares of our Series C Preferred Stock at a conversion price of $1,000 per share. Holders that elected to convert their Notes into Series C Preferred Stock received a warrant to purchase up to 3,750 shares of our common stock for each share of Series C Preferred Stock received upon conversion of the Notes, with each warrant having a five-year term, a cashless exercise feature, and an exercise price of $0.10 per share of common stock. As a result of this modification, an aggregate of $780,000 of the Notes was converted to 780 shares of Series C Preferred Stock and 2,925,000 Class N Warrants. The Class N Warrants were exercisable at an exercise price of $0.12 per share, subject to adjustment as set forth in the warrant, and expired in February 2022.

 

 

22
Table of Contents

 

 

In total, 4,213 shares of Series C Preferred Stock were issued for gross proceeds of $4,213,000. The Series C Preferred Stock accrues dividends at a rate of 6% per annum, payable annually on February 17th of each year, commencing on February 17, 2018. Shares of Series C Preferred Stock are convertible at the option of the holder at any time into shares of our common stock at an initial conversion price equal to $0.10 per share, subject to adjustment. At any time after February 17, 2019, if the volume-weighted average closing price of our common stock over a period of 90 consecutive trading days is greater than $0.25 per share, we may redeem all or any portion of the outstanding Series C Preferred Stock at the original purchase price per share plus any accrued and unpaid dividends, payable in shares of common stock.

 

150 shares of Series C Preferred Stock have previously been converted to common stock at the option of the holder At December 31, 2023, 4,063 shares of Series C Preferred Stock were outstanding. All outstanding shares of Series C Preferred Stock were required to be redeemed by us on February 17, 2022 at the original purchase price per share, payable in cash or shares of common stock, at the option of the holder. In February 2022, based on approval of a majority of the Preferred C Holders, we extended the redemption date of the Series C Preferred Stock to February 17, 2023. In December 2022, based on approval of a majority of the Preferred C Holders, we extended the redemption date of the Series C Preferred Stock to February 17, 2025. Holders of Series C Preferred Stock do not have any voting rights, except as required by law and in connection with certain events as set forth in the Statement of Designation of the Series C Preferred Stock. 

 

In December 2013, we entered into a promissory note agreement with our then Chairman of the Board and one of our major shareholders, pursuant to which we borrowed $500,000 (the 2013 Promissory Note). The 2013 Promissory Note is secured and bears interest at 6% per annum and was originally due June 30, 2014. According to the terms of the 2013 Promissory Note, at any time, the lenders may settle any or all of the principal and accrued interest with shares of our common stock based on the average price of the shares over the previous 20 trading days. In connection with the 2013 Promissory Note, each of the two lenders was issued 5,000,000 Class L warrants to purchase shares of our common stock at an exercise price of $0.06 per share. The warrants were immediately exercisable. In June 2014, we renegotiated the terms of the 2013 Promissory Note. Pursuant to the modification, the maturity date was extended to December 31, 2017 and each lender was granted an additional 7,500,000 Class L warrants to purchase shares of our common stock at an exercise price of $0.06 per share. The warrants were immediately exercisable. In February 2017, the 2013 Promissory Note was further modified to extend the maturity date to December 31, 2020, with all remaining terms unchanged. On December 23, 2018, all 25,000,000 Class L warrants expired. In December 2019, the 2013 Promissory Note was further modified to extend the maturity date to December 31, 2021, with all remaining terms unchanged. In January 2022, the 2013 Promissory Note was further modified to extend the maturity date to December 31, 2023, with all remaining terms unchanged. In February 2024, the 2013 Promissory Note was further modified to extend the maturity date to March 31, 2026.

 

In April 2018, we borrowed $120,000 from our then Chief Executive Officer and Chairman of the Board pursuant to a promissory note (the 2018 Promissory Note). The 2018 Promissory Note accrues interest at 6% per annum, which is payable upon maturity of the 2018 Promissory Note. The 2018 Promissory Note was originally unsecured and originally matured on August 1, 2018. At any time, the holder of the 2018 Promissory Note may elect to have any or all the principal and accrued interest settled with shares of our common stock based on the average price of the shares over the previous 20 trading days. Pursuant to an amendment to the 2018 Promissory Note in June 2018, the maturity date was extended to March 31, 2019 with all other provisions remaining unchanged. Pursuant to a second amendment to the 2018 Promissory Note in February 2019, the maturity date was extended to July 31, 2019 with all other provisions remaining unchanged. Pursuant to a third amendment to the 2018 Promissory Note in July 2019, the maturity date was extended to January 31, 2020 with all other provisions remaining unchanged. Pursuant to a fourth amendment to the 2018 Promissory Note in December 2019, the maturity date was extended to December 31, 2021, and the note was modified to become secured by company assets, with all other provisions remaining unchanged. In December 2021, the 2018 Promissory Note was further modified to extend the maturity date to December 31, 2023, with all remaining terms unchanged. In December 2023, the 2018 Promissory Note was further modified to extend the maturity date to January 31, 2025. In February 2024, the 2018 Promissory Note was further modified to extend the maturity date to March 31, 2026.

 

23
Table of Contents

 

In December 2019, we entered into a promissory note agreement with our then Chief Executive Officer, Chairman of the Board, former Chairman of the Board, and one of our major shareholders (the 2019 Promissory Note). The 2019 Promissory Note authorizes us to borrow up to $1,000,000. As of December 31, 2019, we borrowed $675,000 under the 2019 Promissory Note; the remaining $325,000 was borrowed in February 2020. The 2019 Promissory Note is secured and bears interest at 4% per annum and has a maturity date of December 31, 2022. According to the terms of the 2019 Promissory Note, at any time, a holder of the 2019 Promissory Note may elect to have any or all of the principal and accrued interest settled with shares of our common stock based on the average price of the shares over the previous 20 trading days. In connection with the 2019 Promissory Note, we issued 30,000,000 Class O Warrants with a term of five years to purchase shares of our common stock at $0.045 per share (the Class O Warrants). All the Class O Warrants were exercised in January 2021. In December 2022, the 2019 Promissory Note was modified to extend the maturity date to December 31, 2024, with all remaining terms unchanged. In February 2024, the 2019 Promissory Note was further modified to extend the maturity date to March 31, 2026.

 

We expect that cash from operations, cash obtained through securities offerings, and our current cash balance will be sufficient to fund operations for the next twelve months. Although we may seek additional debt financing for our projects and operations in the future, there is no assurance that we will be able to secure additional debt financing on acceptable terms to us, or at all.

 

Goals for 2024

 

Based upon the investments we have made in our facilities and investments we anticipate making, and based on projects, and products developed in 2023, we have the following goals for 2024:

 

 

●

Continue to expand sales of our FDA approved sodium iodide I-131 generic drug product, including entering new territories;

 

 

●

Complete development of and launch a fully automated I-131 capsule loading system to pharmacies in the U.S and select overseas customers;

 

 

●

Launch our Medical Devices business segment beginning by offering products purchased from AMICI, Inc. in 2023.

 

 

●

Expand sales of our nuclear medicine products and increase cash flow by offering new products and further expanding our international sales and distributor relationships;

 

 

●

Explore acquisition opportunities to expand our product offerings and increase, revenue, cash flow, and profit margin;  

 

 

●

Continue to expand our customer base, increase revenues, reduce production and operating costs, and attempt to achieve profitability in our core business segment operations; and

 

 

●

Continue efforts towards closing the DUF6 Asset Sale agreement.

 

Critical Accounting Estimates

 

Asset retirement obligation – The asset retirement obligation is based on the expected future cash flows of the decommissioning funding plan. The decommissioning funding plan is based on the estimated number of hours of specific personnel, estimated wages and disposal costs. Once the decommissioning funding plan has been developed, we use a discount rate to determine the estimated current value of the liability.

 

Item 7A.     QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company, and therefore, are not required to provide the information required by this item.

 

24
Table of Contents

 

Item 8.       FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The following financial statements are included herewith and are hereby incorporated by reference:

 

Index to Consolidated Financial Statements

 

 

Page No.

Report of Independent Registered Public Accounting Firm

F-1

Financial Statements:

  

Consolidated Balance Sheets as of December 31, 2023 and 2022

F-3

Consolidated Statements of Operations for the years ended December 31, 2023 and 2022

F-4

Consolidated Statement of Shareholders’ Equity for the years ended December 31, 2023 and 2022

F-5

Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022

F-6

Notes to Consolidated Financial Statements

F-7

 

Item 9.       CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

Item 9A.    CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15I and 15d-15(e) under the Exchange Act) that are designed to ensure information required to be disclosed in our reports that are filed or submitted under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Management, with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), has conducted an evaluation (pursuant to Rule 13a-15(b) of the Exchange Act) of the effectiveness of our disclosure controls and procedures as of December 31, 2023. Based on that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of December 31, 2023.

 

25
Table of Contents

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15(d)-15(f) under the Exchange Act). Internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with accounting principles generally accepted in the U.S. Internal control over financial reporting includes maintaining records that in reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; providing reasonable assurance that receipts and expenditures are made in accordance with management authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition of company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of our financial statements would be prevented or detected.

 

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework and criteria established in Internal Control — Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission. This evaluation included review of the documentation of controls, evaluation of the design effectiveness of controls, testing of the operating effectiveness of controls and a conclusion on this evaluation. Based on this evaluation, management concluded that our internal control over financial reporting was effective as of December 31, 2023.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the three months ended December 31, 2023, that have materially affected, or are reasonable likely to materially affect, our internal control over financial reporting.

 

 

Item 9B.      OTHER INFORMATION

 

During the quarter ended December 31, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

 

Item 9C.      DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

None.

 

PART III.

 

Item 10.      DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

 

We have adopted a Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer and controller, or persons performing similar functions. Our Code of Ethics is posted on our website and can be accessed, free of charge, at http://www.intisoid.com. If we waive, or implicitly waive, any material provision of the Code of Ethics that apply to our executive officers, or substantively amend the Code of Ethics, in each case that is required to be disclosed, we will disclose that fact on our website.

 

The other information required by this item is incorporated by reference from our definitive proxy statement for our 2024 annual meeting of shareholders, which will be filed with the SEC within 120 days after December 31, 2023.

 

Item 11.      EXECUTIVE COMPENSATION

 

The information required by this item is incorporated by reference from our definitive proxy statement for our 2024 annual meeting of shareholders, which will be filed with the SEC within 120 days after December 31, 2023.

 

Item 12.      SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The information required by this item is incorporated by reference from our definitive proxy statement for our 2024 annual meeting of shareholders, which will be filed with the SEC within 120 days after December 31, 2023.

 

26
Table of Contents

 

Item 13.      CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

The information required by this item is incorporated by reference from our definitive proxy statement for our 2024 annual meeting of shareholders, which will be filed with the SEC within 120 days after December 31, 2023.

 

Item 14.      PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

The information required by this item is incorporated by reference to our definitive proxy statement for our 2024 annual meeting of shareholders, which will be filed with the SEC within 120 days after December 31, 2023.

 

Item 15.      EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

(a)(1) and (a)(2) Financial Statements

 

See the index to and the financial statements beginning on page [31], which financial statements are incorporated herein by reference.

 

(a)(3) Exhibits

The following documents are filed or incorporated herein by reference as exhibits to this report:

 

2.1++

Asset Purchase Agreement, dated February 10, 2022, between International Isotopes Inc. and Pharmalogic Idaho, LLC (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed on February 16, 2022).

 

2.2++

 Asset Purchased Agreement, dated February 8, 2024, among International Isotopes Inc., International Isotopes Fluorine Products, Inc. and American Fuel Resources, LLC (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on February 8, 2024).#

 

3.1

Restated Certificate of Formation of the Company, as amended (incorporated by reference to Exhibit 3.1 of the Company’s Quarterly Report on Form 10-Q for quarter ended June 30, 2010).

 

3.2

Statement of Designation of the Series C Convertible Redeemable Preferred Stock of the Company (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on February 24, 2017).

 

3.3

Certificate of Amendment to Statement of Designation of the Series C Convertible Redeemable Preferred Stock of International Isotopes Inc., dated February 16, 2022 (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on February 22, 2022).

 

3.4

Certificate of Amendment to Statement of Designation of the Series C Convertible Redeemable Preferred Stock of International Isotopes Inc., dated December 28, 2022 (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed December 28, 2022).

 

3.5

Bylaws of the Company (incorporated by reference to Exhibit 3.2 of the Company’s Registration Statement on Form SB-2 filed on May 1, 1997 (Registration No. 333-26269).

 

10.1†

International Isotopes Inc. Amended and Restated Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed on July 21, 2020).

 

10.2†

International Isotopes Inc. Amended and Restated 2015 Incentive Plan (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed on July 30, 2018).

 

10.3+

Lease Agreement (4137 Commerce Circle), dated January 20, 2020, between the Company and Adrian Rand Robison and Dorothy Robison.

 

10.4†

Form of Director and Officer Indemnification Agreement (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K filed on September 17, 2008).

 

27
Table of Contents

 

10.5

Memorandum of Agreement, dated October 22, 2009, between the Company and the New Mexico Environment Department (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K filed on October 27, 2009).

 

10.6

Registration Rights Agreement, dated February 17, 2017, among the Company and the purchasers named therein (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on February 24, 2017).

 

10.7†

 Executive Employment Agreement, dated December 23, 2022, between the Company and Shahe Bagerdjian (as amended) (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed on May 8, 2023).

 

10.8

Promissory Note Agreement, dated December 23, 2013, among the Company, Ralph Richart and John McCormack (incorporated by reference to Exhibit 10.19 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2013).

 

10.9

Modification #1 to the Promissory Note Agreement, dated June 30, 2014, among the Company, Ralph M. Richart and John M. McCormack (incorporated by reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2014).

 

10.10

Isotope and Technical Service Order Form, dated October 2, 2014, between the Company and the U.S. Department of Energy (incorporated by reference to Exhibit 10.18 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014).**

 

28
Table of Contents

 

21.1+

Subsidiary list.

 

23.1+

Consent of Haynie & Company.

 

31.1+

Certification of Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002.

 

31.2+

Certification of Chief Financial Officer under Section 302 of the Sarbanes-Oxley Act of 2002.

 

32.1*

Certification of Chief Executive Officer furnished under Section 906 of the Sarbanes-Oxley Act of 2002.

 

32.2*

Certification of Chief Financial Officer furnished under Section 906 of the Sarbanes-Oxley Act of 2002.

 

101.INS+

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH+

Inline XBRL Taxonomy Extension Schema Document

101.CAL+

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF+

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB+

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE+

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

† This exhibit constitutes a management contract or compensatory plan or arrangement.

 

++ Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to supplementally furnish copies of any omitted schedules to the Securities and Exchange Commission upon request.

 

#  Certain portions of the exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is not material and is the type of information that the registrant treats as private or confidential.

 

 

+ Filed herewith.

 

 

* Furnished herewith.

 

29
Table of Contents

 

Item 16.      FORM 10-K SUMMARY

 

None.

 

30
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

International Isotopes Inc.
   
   
 

By:  /s/ Shahe Bagerdjian
 

Shahe Bagerdjian
 

President, Chief Executive Officer, and Director
   
 

Date:  March 28, 2024

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

March 28, 2024

By:  /s/ Shahe Bagerdjian
 

Shahe Bagerdjian
 

President, Chief Executive Officer, and Director

 

March 28, 2024

By:  /s/ W. Matthew Cox
 

W. Matthew Cox
 

Chief Financial Officer, Secretary

 

March 28, 2024

By:  /s/ Robert Atcher
 

Robert Atcher
 

Director

 

March 28, 2024

By:  /s/ Christopher Grosso
 

Christopher Grosso
 

Chairman of the Board of Directors

 

March 28, 2024

By:  /s/ Steve Laflin
 

Steve Laflin
 

Director
31
Table of Contents

 

 
 

INTERNATIONAL ISOTOPES INC. AND SUBSIDIARIES

Consolidated Balance Sheets

 

  

December 31,

  

December 31,

 
  

2023

  

2022

 

Assets

        
         

Current assets

        

Cash and cash equivalents

 $2,688,141  $2,375,817 

Accounts receivable

  1,469,298   1,596,886 

Inventories

  927,111   744,793 

Prepaids and other current assets

  672,934   1,023,129 

Total current assets

  5,757,484   5,740,625 
         

Long-term assets

        

Restricted cash

  880,752   840,049 

Property, plant and equipment, net

  2,465,077   2,024,486 

Capitalized lease disposal costs, net

  688,462   228,125 

Financing lease right-of-use asset

  6,611   12,621 

Operating lease right-of-use asset

  2,183,988   2,311,082 

Goodwill

  1,384,255   1,384,255 

Patents and other intangibles, net

  3,538,458   3,703,353 

Total long-term assets

  11,147,603   10,503,971 

Total assets

 $16,905,087  $16,244,596 
         

Liabilities and Stockholders' Equity

        

Current liabilities

        

Accounts payable

  559,597  $382,392 

Accrued liabilities

  1,482,179   1,472,504 

Unearned revenue

  932,682   879,365 

Current portion of operating lease right-of-use liability

  140,733   131,572 

Current portion of financing lease liability

  2,832   5,513 

Current portion of related party notes payable, net of debt discount

  —   620,000 

Current installments of notes payable

  155,733   23,348 

Total current liabilities

  3,273,756   3,514,694 
         

Long-term liabilities

        

Accrued long-term liabilities

  75,000   112,500 

Related party notes payable, net of current portion and debt discount

  1,620,000   1,000,000 

Notes payable, net of current portion

  270,732   34,406 

Asset retirement obligation

  1,474,463   942,378 

Financing lease liability, net of current portion

  —   2,832 

Operating lease right-of-use liability, net of current portion

  2,091,511   2,232,244 

Mandatorily redeemable convertible preferred stock

  4,063,000   4,063,000 

Total long-term liabilities

  9,594,706   8,387,360 

Total liabilities

  12,868,462   11,902,054 
         

Stockholders' equity

        

Common stock, $0.01 par value; 750,000,000 shares authorized; 519,787,870 and 514,889,916 shares issued and outstanding respectively

  5,197,879   5,148,899 

Additional paid in capital

  126,168,605   125,654,486 

Accumulated deficit

  (127,329,859)  (126,460,843)

Total equity

  4,036,625   4,342,542 

Total liabilities and stockholders' equity

 $16,905,087  $16,244,596 

 

See accompanying notes to consolidated financial statements.

 

F-3
Table of Contents
 

 

INTERNATIONAL ISOTOPES INC. AND SUBSIDIARIES

Consolidated Statements of Operations

 

  

Years ended December 31,

 
  

2023

  

2022

 
         

Sale of product

 $12,267,385  $11,181,988 

Cost of product

  4,888,409   4,891,927 

Gross profit

  7,378,976   6,290,061 
         

Operating costs and expenses:

        

Salaries and contract labor

  4,032,155   3,390,652 

General, administrative and consulting

  3,545,766   3,568,590 

Research and development

  577,354   533,716 

Total operating expenses

  8,155,275   7,492,958 
         

Operating loss

  (776,299)  (1,202,897)
         

Other income (expense):

        

Other income

  160,173   2,110,576 

Interest income

  78,890   9,502 

Interest expense

  (331,780)  (613,943)

Total other (expense) income

  (92,717)  1,506,135 

Net income (loss)

 $(869,016) $303,238 
         

Net income per common share - basic:

 $—  $— 
         

Net income per common share - diluted:

 $—  $— 
         

Weighted average common shares outstanding - basic

  517,777,847   510,794,145 
         

Weighted average common shares outstanding - diluted

  517,777,847   510,794,145 

 

See accompanying notes to consolidated financial statements.

 

F-4
Table of Contents
 

 

INTERNATIONAL ISOTOPES INC AND SUBSIDIARIES

Consolidated Statement of Stockholders' Equity

Years ended December 31, 2023 and 2022

 

  

Common Stock

  

Additional Paid-in

  

Accumulated

  

Total

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Equity

 

Balance December 31, 2021

  502,584,176  $5,025,842  $124,469,034  $(126,764,081) $2,730,795 
                     

Shares issued under employee stock purchase plan

  245,081   2,451   12,320   —   14,771 
                     

Shares issued for exercise of employee stock options

  648,948   6,489   (6,489)  —   — 
                     

Stock grant

  187,231   1,872   (1,872)  —   — 
                     

Stock issued in lieu of dividends on preferred C shares

  2,271,980   22,720   181,760   —   204,480 
                     

Warrant exercise

  515,000   5,150   56,650   —   61,800 
                     

Conversion of preferred B stock

  8,437,500   84,375   590,625   —   675,000 
                     

Stock based compensation

  —   —   352,458   —   352,458 
                     

Net income

              303,238   303,238 

Balance December 31, 2022

  514,889,916   5,148,899   125,654,486   (126,460,843)  4,342,542 
                     

Shares issued under employee stock purchase plan

  316,866   3,169   5,229   —   8,398 
                     

Shares issued for exercise of employee stock options

  —   —   —   —   — 
                     

Stock grant

  343,560   3,436   (3,436)  —   — 
                     

Stock issued in lieu of dividends on preferred C shares

  2,266,500   22,665   67,995   —   90,660 
                     

Shares issued for issuance of RSUs

  1,971,028   19,710   (19,710)  —   — 
                     

Stock based compensation

  -   -   464,041   —   464,041 
                     

Net loss

              (869,016)  (869,016)

Balance December 31, 2023

  519,787,870  $5,197,879  $126,168,605  $(127,329,859) $4,036,625 

 

See accompanying notes to consolidated financial statements.

 

F-5
Table of Contents
 

 

INTERNATIONAL ISOTOPES INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

 

  

Years ended December 31,

 
  

2023

  

2022

 

Cash flows from operating activities:

        

Net (loss) income

 $(869,016) $303,238 

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

        

Depreciation and amortization

  350,094   374,196 

Gain on disposal of property, plant and equipment

  —   (1,797,978)

Accretion of obligation for lease disposal costs

  53,126   50,292 

Accretion of beneficial conversion feature

  —   274,443 

Equity based compensation

  464,041   352,458 

Right-of-use amortization

  (4,478)  (2,528)

Changes in operating assets and liabilities:

        

Accounts receivable

  127,588   (743,211)

Prepaids and other current assets

  350,195   (18,706)

Inventories

  (182,318)  179,982 

Accounts payable and accrued liabilities

  240,040   (441,317)

Unearned revenues

  53,317   (28,588)

Net cash provided by (used in) in operating activities

  582,589   (1,497,719)
         

Cash flows from investing activities:

        

Proceeds from sale of property, plant and equipment

  —   4,000,000 

Purchase of property, plant, equipment and patents

  (149,058)  (120,014)

Net cash (used in) provided by investing activities

  (149,058)  3,879,986 
         

Cash flows from financing activities:

        

Proceeds from sale of stock

  8,398   76,571 

Payments on financing lease liability

  (5,513)  (8,543)

Principal payments on notes payable

  (83,389)  (540,032)

Net cash provided by (used in) financing activities

  (80,504)  (472,004)
         

Net increase in cash and cash equivalents and restricted cash

  353,027   1,910,263 

Cash and cash equivalents and restricted cash at beginning of year

  3,215,866   1,305,603 

Cash and cash equivalents and restricted cash at end of year

 $3,568,893  $3,215,866 
         

Supplemental disclosure of cash flow activities:

        

Cash paid for interest

 $163,920  $54,071 

Cash paid for taxes

  10,176   9,097 
         

Supplemental disclosure of noncash financing and investing transactions:

        

Decrease in accrued interest and increase in equity for conversion preferred dividends to stock

 $90,660  $204,480 

Increase in equity and decrease in liability for the conversion of preferred stock

 $—  $675,000 

Property acquired in exchange for a note payable

 $452,100  $— 

Non-cash increase of capitalized asset retirement obligation for increased funding plan

 $478,959  $— 

  

  

December 31,

 
  

2023

  

2022

 

Cash and cash equivalents

 $2,688,141  $2,375,817 

Restricted cash included in long-term assets

  880,752   840,049 

Total cash, cash equivalents, and restricted cash shown in statement of cash flows

 $3,568,893  $3,215,866 

 

See accompanying notes to consolidated financial statements.

 

F-6
Table of Contents

 

INTERNATIONAL ISOTOPES INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED December 31, 2023 AND 2022

 

 

NOTE 1 – DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

 

Description of business – International Isotopes Inc. (the “Company” or “INIS”) was incorporated in Texas in November 1995. The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include all operations and balances of the Company and its wholly-owned subsidiaries, International Isotopes Idaho Inc., International Isotopes Fluorine Products, Inc., and International Isotopes Transportation Services, Inc. The consolidated financial statements also include the accounts of wholly owned subsidiaries TI Services, LLC, (“TI Services”), and RadQual, LLC (RadQual). TI Services is headquartered in Youngstown, Ohio and was formed with RadQual in December 2010 to distribute products and services for nuclear medicine, nuclear cardiology and Positron Emission Tomography (PET) imaging. RadQual is a global supplier of molecular imaging quality control devices, and is now headquartered in Idaho Falls, Idaho. 

 

Nature of Operations – INIS and its subsidiaries, (collectively, the “Company,” “we,” “our” or “us”) manufacture a full range of nuclear medicine calibration and reference standards, a wide range of products, including cobalt teletherapy sources, and an FDA-approved radiopharmaceutical drug product. The Company also holds several patents for a fluorine extraction process that would be used in conjunction with a proposed commercial depleted uranium de-conversion facility which would be located in Lea County, New Mexico (the “De-Conversion Facility”). The Company’s business consists of four major business segments: Theranostics Products (formerly Radiochemical Products), Cobalt Products, Nuclear Medicine Standards, and Fluorine Products. The Company’s headquarters and all operations, with the exception of TI Services, are located in Idaho Falls, Idaho.

 

With the exception of certain unique products, the Company’s normal operating cycle is considered to be one year. Due to the time required to produce some cobalt products, the Company’s operating cycle for those products is considered to be two to three years. Accordingly, preliminary payments received on cobalt contracts, where shipment will not take place for greater than the operating cycle, have been recorded as unearned revenue and, depending upon estimated ship dates, classified under current or long-term liabilities on the Company’s consolidated balance sheets. These unearned revenues will be recognized as revenue in the future period during when the cobalt shipment takes place. All assets expected to be realized in cash or sold during the normal operating cycle of the business are classified as current assets.

 

Principles of Consolidation – The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, including RadQual and TI Services. All significant intercompany accounts and transactions have been eliminated during consolidation.

 

Significant accounting policies

 

a)      Financial instruments and cash equivalents

 

The carrying value of notes payable approximates fair value because they bear interest at rates which approximate market rates.

 

Cash and cash equivalents, totaling $2,688,141 and $2,375,817 at December 31, 2023 and 2022, respectively, consist of operating accounts and money market accounts. For purposes of the consolidated statements of cash flows, the Company considers all highly-liquid financial instruments with original maturities of three months or less at date of purchase to be cash equivalents.

 

At December 31, 2023 and 2022, the Company had pledged cash on deposit in a money market account valued at $880,752 and $840,049 respectively, as security for a surety bond.  The surety bond is required as part of the Company’s operating license agreement with the Nuclear Regulatory Commission (“NRC”).

 

The Company maintains its cash accounts in various deposit accounts, the balances of which are periodically in excess of federally insured limits.

 

F- 7
Table of Contents
 

b)      Accounts receivable

 

The Company sells products mainly to recurring customers, wherein the customer’s ability to pay has previously been evaluated. The Company generally does not require collateral. The Company periodically reviews accounts receivable for amounts considered uncollectible and allowances are provided for uncollectible accounts when deemed necessary. At December 31, 2023 and  December 31, 2022 the Company had no allowance for doubtful accounts. 

 

c)      Inventories

 

Inventories are carried at the lower of cost or net realizable value. Cost is determined using the first in, first out method. When indicators of inventory impairment exist, the Company measures the carrying value of the inventory against its market value, and if the carrying value exceeds the market value, the inventory value is adjusted down accordingly.  No impairment was recorded for the years ended December 31, 2023 and December 31, 2022.

 

d)      Property, plant and equipment

 

Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the asset.

 

Leasehold improvements are amortized over the shorter of the life of the lease or the service life of the improvements. Maintenance, repairs, and renewals that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Gains or losses on dispositions of property and equipment are included in the results of operations.

 

e)      Goodwill and other intangibles

 

Goodwill is not amortized but is tested for impairment at least annually. Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets recorded as a result of the change in ownership of RadQual. As of  December 31, 2023 and 2022, there has been no impairment of goodwill.

 

Patents and other intangibles are amortized using the straight-line method over their estimated useful lives and are evaluated for impairment at least annually or when events or circumstances arise that indicate the existence of impairment. The Company evaluates the recoverability of identifiable intangible assets whenever events or changes in circumstances indicate that an intangible asset’s carrying amount may not be recoverable. Such circumstances could include but are not limited to: (1) a significant decrease in the market value of an asset, (2) a significant adverse change in the extent or manner in which an asset is used, or (3) an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset. When indicators of impairment exist, the Company measures the carrying amount of the asset against the estimated undiscounted future cash flows associated with it. Should the sum of the expected future cash flows be less than the carrying value of the asset being evaluated, an impairment loss would be recognized. The impairment loss would be calculated as the amount by which the carrying value of the asset exceeds its fair value. The evaluation of asset impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and actual results may differ from assumed and estimated amounts. During the years ended December 31, 2023 and 2022, the Company had no impairment losses related to intangible assets.

 

f)      Impairment of long-lived assets

 

Long-lived assets are reviewed for impairment annually, or when events or circumstances arise that indicate the existence of impairment, using the same evaluation process as described above for patents and other intangibles.  There was no impairment recorded during the years ended December 31, 2023 and 2022.

 

g)      Income taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in income in the period that includes the enactment date.

 

F- 8
Table of Contents
 

h)      Use of estimates

 

Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period to prepare these consolidated financial statements in conformity with GAAP.  Actual results could differ from those estimates.

 

i)      Revenue recognition

 

Revenue is recognized when products are shipped. No warranty coverage or right of return provisions are provided to customers. Amounts received as prepayment on future products or services are recorded as unearned revenues and recognized as income when the product is shipped or service performed. See Note 14 Revenue Recognition.

 

j)      Advertising Expenses

 

Advertising expenses, which include promotional expenses, are expensed as incurred and totaled $142,188 and $118,465 for the years ended  December 31, 2023 and 2022, respectively.

 

k)      Research and development costs

 

Research and development costs are expensed as incurred and totaled $577,354 and $533,716 for the years ended  December 31, 2023 and 2022, respectively. These research and development costs were incurred for corporate business development and in our Theranostics Products and Nuclear Medicine Standards business segments.

 

l)      Share-based compensation

 

The Company accounts for issuances of share-based compensation to employees in accordance with GAAP which requires the recognition of the cost of employee services received in exchange for an award of equity instruments in the financial statements and is measured based on the grant date fair value of the award. Compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (the vesting period).

 

For the years ended December 31, 2023 and 2022, the Company recognized share-based compensation expense of $464,041 and $352,458, respectively, related to stock options, stock grants, and restricted stock units. This expense is included as part of salaries and contract labor in the accompanying statements of operations.

 

m)      Net loss per common share – basic and diluted

 

Basic loss per share is computed on the basis of the weighted-average number of common shares outstanding during the year. Diluted loss per share is computed on the basis of the weighted-average number of common shares plus all potentially dilutive issuable common shares outstanding during the year.

 

The table below shows the calculation of diluted shares:

 

  

December 31,

 
  

2023

  

2022

 

Weighted average common shares outstanding - basic

  517,777,847   510,794,145 
         

Effects of dilutive shares

        

Stock options

  —   — 

Series C redeemable convertible preferred stock

  —   — 

Weighted average common shares outstanding - diluted

  517,777,847   510,794,145 

 

For the year ended December 31, 2023, the Company had 24,787,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were not included in the computation of diluted income per common share because they would be anti-dilutive.

 

For the year ended December 31, 2022, the Company had 24,993,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were not included in the computation of diluted income per common share because they would be anti-dilutive.

 

F- 9
Table of Contents
 

The table below summarizes common stock equivalents outstanding at December 31, 2023 and 2022:

 

  

December 31,

 
  

2023

  

2022

 

Stock options

  24,787,500   24,993,500 

4,063 Shares of Series C redeemable convertible preferred stock

  40,630,000   40,630,000 
   65,417,500   65,623,500 

 

n)      Business segments and related information

 

GAAP establishes standards for the way public business enterprises are to report information about operating segments in annual financial statements and requires enterprises to report selected information about operating segments in interim financial reports issued to shareholders. It also establishes standards for related disclosure about products and services, geographic areas and major customers. The Company currently operates in four business segments.

 

o)      Recent accounting standards

 

In August 2020, the Financial Accounting Standards Board issued ASU 2020-06 Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). The update simplifies accounting related to convertible debt instruments. The standard is effective for fiscal years beginning after December 15, 2023 including interim periods within those fiscal years. INIS is currently evaluating the effect this standard will have on its financial statements.

 

 

NOTE 2 – BUSINESS CONDITION AND LIQUIDITY

 

The Company has a history of recurring losses with an accumulated deficit of $127,329,859 at December 31, 2023 and net loss of $869,016 for the year then ended. The Company’s working capital has increased by $257,797 from the prior year. The Company has cash flows provided by operations of $582,589.  During 2023, the Company sought to improve future cash flows from operating activities through execution of new sales agreements, improving operating cost control measures, making improvements in current manufacturing processes, pursuing new service contracts, and developing new products. The Company’s net loss was $869,016 in 2023, compared to net income of $303,238 in 2022. This is a decrease in net income of $1,172,254. This decrease in net income is largely the result of the approximate $1.8 million gain on sale of assets that occurred in 2022.

 

During the year ended December 31, 2023, the Company continued to focus on its long-standing core business segments, which consist of its Theranostics Products (formerly Radiochemical Products), Cobalt Products, and Nuclear Medicine Standards, and in particular, the pursuit of new business opportunities within those segments.

 

Due to changes in the nuclear industry, the Company’s plans for the design and construction of a large-scale uranium de-conversion and fluorine extraction facility were placed on hold. The Company will continue to incur some costs associated with the maintenance of licenses and other necessary project investments for the proposed facility. The Company holds a Nuclear Regulatory Commission (“NRC”) construction and operating license for the depleted uranium facility as well as the property agreement with Lea County, New Mexico, where the plant is intended to be constructed. The NRC license for the de-conversion facility is a forty (40) year operating license and is the first commercial license of this type issued in the United States. There are no other companies with a similar license application under review by the NRC. Therefore, the NRC license represents a significant competitive barrier, and the Company believes that it provides it with a very valuable asset. In February 2024, the Company entered into and Asset Purchase Agreement to sell all the assets associated with the planned de-conversion facility. The Company expects to close the transaction in approximately 12 to 24 months, subject to satisfaction of certain closing condition. Proceeds from this sale would be $12.5 million in total.

 

The Company expects that cash from operations and its current cash balance will be sufficient to fund operations for the next twelve months. Future liquidity and capital funding requirements will depend on numerous factors, including, contract manufacturing agreements, commercial relationships, technological developments, market factors, available credit, and voluntary warrant redemption by shareholders. There is no assurance that additional capital and financing will be available on acceptable terms to the Company or at all.

 

F- 10
Table of Contents
 

 

 

 

NOTE 3 – PURCHASED ASSET AND INVESTMENTS

 

AMICI Asset Purchase Agreement and Medical Devices

 

In June 2023, the Company acquired several medical devices with related assets and intellectual property rights from AMICI, Inc. and has been working on FDA 510k transfers, and start-up of manufacturing. The Company anticipates the assets will be part of a fifth business segment of the Company called “Medical Devices” that is planned to start by mid-year 2024.

 
 

NOTE 4 – INVENTORIES

 

Inventories at  December 31, 2023 totaled $927,111, and inventories at  December 31, 2022 totaled $744,793. Our inventory consists of work in process material for our Theranostics Products, Cobalt Products, and Nuclear Medicine Products segments.

 

 

NOTE 5 – PROPERTY, PLANT AND EQUIPMENT

 

Property, plant and equipment are summarized as follows at December 31, 2023 and 2022:

 

  

2023

  

2022

  Estimated Useful Lives (in years) 

Furniture and fixtures

 $287,463  $284,020   3 - 5 

Transportation equipment

  114,708   114,708   5 - 10 

Plant and improvements

  526,205   501,334   5 

Production equipment

  4,569,980   3,997,193   5 - 10 
   5,498,356   4,897,255     

Accumulated depreciation

  (3,033,279)  (2,872,769)    
  $2,465,077  $2,024,486     

 

Included in fixed assets are assets purchased during the planning phase for the construction of a de-conversion facility in Hobbs, New Mexico; these de-conversion facility assets are included in the DUF6 Asset Sale. Although construction of the facility is currently on hold, the Company has determined that these assets continue to have future economic value based on what it considers a strong likelihood that construction of the facility will occur in the future.

 

Depreciation expense was $160,567 and $185,193 for the years ended December 31, 2023 and 2022, respectively.

 

 

F- 11
Table of Contents
 
 

NOTE 6 – PATENTS AND OTHER INTANGIBLE ASSETS

 

The Company owns certain patents and patents pending related to a fluorine extraction process (FEP), for various uses of some fluoride gases as fluorinating agents, and some of the RadQual nuclear medicine calibration sources.  The FEP patents were developed in an effort to expand the potential markets for the high purity fluoride gases the Company had planned to produce with its fluorine extraction process. The feasibility of expanding the fluoride gas markets through the use of this patented technology is uncertain. The RadQual product patents were developed to give RadQual a unique competitive advantage by offering calibration standards exclusive to RadQual.

 

In October 2012, the NRC issued the Company a 40-year construction and operating license for the de-conversion facility.  Capitalized costs associated with the licensing and planning process for this license are being amortized over the 40-year life of the license.

 

The following table summarizes the patent and intangible activity for the years ended December 31, 2023 and 2022:

 

  

2023

 

Beginning

 $5,370,878 

Additions

  — 

Disposals

  — 

Ending

  5,370,878 

Accumulated amortization

  (1,832,420)
  $3,538,458 

 

During the year ended December 31, 2023 the Company recognized $164,895 of amortization expense, and during the year ended December 31, 2022, the Company recognized $164,370 of amortization expense.

 

Patent and other intangible asset amortization is based on the remaining life of the asset and estimated amortization expense is as follows:

 

Years ending December 31,

    

2025

 $164,895 

2026

  164,895 

2027

  164,895 

2028

  164,895 

2029

  164,895 

Thereafter

  2,713,983 
  $3,538,458 

 

 

F- 12
Table of Contents
 
 

NOTE 7 – CONVERTIBLE DEBENTURES AND NOTES PAYABLE

 

Convertible debentures

 

As discussed in Note 9 below, in February 2017, pursuant to a private placement transaction with certain investors, the Company issued 3,433 shares of Series C Preferred Stock and warrants.  In connection with the private placement, two investors holding convertible debentures exchanged aggregate principal totaling $205,000 of the convertible debentures for shares of the Series C Preferred Stock and warrants.

 

Notes payable

 

In December 2013, the Company entered into a promissory note agreement with its then Chairman of the Board and one of its major shareholders, pursuant to which the Company borrowed $500,000 (the 2013 Promissory Note). The 2013 Promissory Note is secured and bears interest at 6% per annum and was originally due  June 30, 2014. According to the terms of the 2013 Promissory Note, at any time, the lenders may settle any or all of the principal and accrued interest with shares of the Company’s common stock. In connection with the 2013 Promissory Note, each of the two lenders was issued 5,000,000 Class L warrants to purchase shares of our common stock at an exercise price of $0.06 per share (Class L Warrants). The Class L Warrants were immediately exercisable. The fair value of these warrants issued totaled $384,428 and was recorded as a debt discount amortized over the life of the 2013 Promissory Note. The Company calculated a beneficial conversion feature of $15,464 which was accreted to interest expense over the life of the 2013 Promissory Note. In June 2014, we renegotiated the terms of the 2013 Promissory Note. Pursuant to the modification, the maturity date was extended to  December 31, 2017 and each lender was granted an additional 7,500,000 Class L Warrants to purchase shares of the Company’s common stock at an exercise price of $0.06 per share. The Class L Warrants were immediately exercisable. In February 2017, the 2013 Promissory Note was further modified to extend the maturity date to  December 31, 2020, with all remaining terms unchanged. On December 23, 2018, all 25,000,000 Class L Warrants expired. In December 2019, the 2013 Promissory Note was further modified to extend the maturity date to  December 31, 2021, with all remaining terms unchanged. In January 2022, the 2013 Promissory Note was further modified to extend the maturity date to  December 31, 2023, with all remaining terms unchanged. In February 2024, the 2013 Promissory Note was further modified to extend the maturity date to  March 31, 2026, with all remaining terms unchanged.

 

At December 31, 2023, accrued interest payable on the 2013 Promissory Note was $301,734.

 

In April 2018, the Company borrowed $120,000 from its then Chief Executive Officer and Chairman of the Board pursuant to a promissory note (the 2018 Promissory Note). The 2018 Promissory Note accrues interest at 6% per annum, which is payable upon maturity of the 2018 Promissory Note. The 2018 Promissory Note was originally unsecured and originally matured on  August 1, 2018. At any time, the holder of the 2018 Promissory Note may elect to have any or all of the principal and accrued interest settled with shares of our common stock based on the average price of the shares over the previous 20 trading days. In June 2018, the 2018 Promissory Note was modified to extend the maturity date to  March 31, 2019 with all other provisions remaining unchanged. In February 2019, the 2018 Promissory Note was modified to extend the maturity date to  July 31, 2019 with all other provisions remaining unchanged. In July 2019, the 2018 Promissory Note was modified to extend the maturity date to  January 31, 2020 with all other provisions remaining unchanged. In December 2019, the 2018 Promissory Note was modified to extend the maturity date to  December 31, 2021 and the 2018 Promissory Note was modified to become secured by company assets, with all other provisions remaining unchanged. In December 2021, the 2018 Promissory Note was modified to extend the maturity date to  December 31, 2023 with all other provisions remaining unchanged. In December 2023, the 2018 Promissory Note was modified to extend the maturity date to  January 31, 2025. In February 2024, the 2018 Promissory Note was modified to extend the maturity date to  March 31, 2026.

 

At December 31, 2023, accrued interest on the 2018 Promissory Note totaled $40,970.

 

On December 20, 2019, the Company entered into a promissory note agreement with four of the Company’s major shareholders (the 2019 Promissory Note). The 2019 Promissory Note authorizes the Company to borrow up to $1,000,000. As of December 31, 2019, the Company had borrowed $675,000 under the 2019 promissory note. In February 2020, the Company borrowed an additional $325,000. The 2019 Promissory Note bears an interest rate of 4% annually and was originally due  December 31, 2022. According to the terms of the 2019 Promissory Note, at any time, the lenders may settle any or all of the principal and accrued interest with shares of the Company’s common stock based on the average closing price of the Company’s common stock for the 20 trading days preceding the payment. In connection with the 2019 Promissory Note, the lenders were issued warrants totaling 30,000,000 warrants to purchase shares of the Company’s common stock at $0.045 per share (Class O Warrants). In January 2023, the 2019 Promissory Note was modified to extend the maturity date to  December 31, 2024, with all remaining terms unchanged. In February 2024, the 2019 Promissory Note was modified to extend the maturity date to  March 31, 2026.

 

At December 31, 2023, accrued interest on the 2019 Promissory Note totaled $159,131.

 

 

F- 13
Table of Contents
 

Notes payable as of December 31, 2023 and 2022 consist of the following:

 

  

2023

  

2022

 
         

Note payable to related parties bearing interest at 6% all principal and interest due on March 31, 2026, secured

 $120,000  $120,000 

Note payable to related parties bearing interest at 4% all principal and interest due on March 31, 2026, secured

  1,000,000   1,000,000 

Note payable to related parties bearing interest at 6% all principal and interest due on March 31, 2026, secured

  500,000   500,000 

Note payable to a financial institution bearing interest at 5.99% monthly installments of $1,046, secured

  34,365   44,521 

Note payable for purchase contract bearing interest at 5% monthly installments of $4,442, secured

  —   13,233 

Note payable for purchase contract bearing no interest until the 25th month after the anniversary of the closing interest at 8% thereafter monthly installments of $10,000

  392,100    

Total notes payable

  2,046,465   1,677,754 

Less: current maturities

  (155,733)  (643,348)

Notes payable, net of current installments and debt discount

 $1,890,732  $1,034,406 

 

Maturities of convertible debt and notes payable, excluding debt discount and debt issuance costs, at December 31, 2023, are as follows:

 

Years ending December 31,

    

2024

 $155,733 

2025

  124,838 

2026

  1,745,595 

2027

  20,299 

Thereafter

  — 
  $2,046,465 

 

 

F- 14
Table of Contents
 
 

NOTE 8 – LEASE OBLIGATIONS

 

The Company leases office and warehouse space under operating leases. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments under the lease. Operating lease, right-of-use assets, and liabilities are recognized at the lease commencement date based on the present value of lease payments over the reasonably certain lease term. The implicit rates with the Company’s operating leases are generally not determinable and the Company uses its incremental borrowing rate at the lease commencement date to determine the present value of its lease payments. The determination of the Company’s incremental borrowing rate requires judgement. The company determines its incremental borrowing rate for each lease using its then-current borrowing rate. Certain of the Company’s leases include options to extend or terminate the lease. The Company establishes the number of renewal options periods used in determining the operating lease term based upon its assessment at the inception of the operating lease. The option to renew the lease may be automatic, at the option of the Company, or mutually agreed to between the landlord and the Company. Once the facility lease term has begun, the present value of the aggregate future minimum lease payments is recorded as a right-of-use asset. Lease expense is recognized on a straight-line basis over the term of the lease.

 

  

Year Ended

 
  

December 31,

 
  

2023

  

2022

 

Operating lease costs

 $287,108  $285,159 

Short-term operating lease costs

  7,200   12,066 

Financing lease expense:

        

Amortization of right-of-use assets

  6,023   4,172 

Interest on lease liabilities

  395   649 

Total financing lease expense

  6,418   4,821 

Total lease expense

 $300,726  $302,046 
         

Right-of-use assets obtained in exchange for new operating lease liabilities

 $—  $— 

Right-of-use assets obtained in exchange for new financing lease liabilities

 $—  $— 

Weighted-average remaining lease term (years) - operating leases

  11.1   12.1 

Weighted-average remaining lease term (years) - financing leases

  1.2   1.1 

Weighted-average discount rate - operating leases

  6.75%  6.75%

Weighted-average discount rate - financing leases

  6.75%  7.93%

 

Maturities of lease liabilities as of December 31, 2023, were as follows:

 

  

Operating leases

  

Finance leases

 

For the years ended December 31,

        

2024

 $287,108  $2,929 

2025

  287,108   — 

2026

  287,108   — 

2027

  287,108   — 

2028

  287,108   — 

Thereafter

  1,738,084   — 

Total minimum lease obligations

  3,173,624   2,929 

Less-amount representing interest

  (941,380)  (97)

Present value of minimum lease obligations

  2,232,244   2,832 

Current maturities

  (140,733)  (2,832)

Lease obligations, net of current maturities

 $2,091,511  $— 

 

 

F- 15
Table of Contents
 
 

NOTE 9 – SHAREHOLDERS’ EQUITY, REDEEMABLE CONVERTIBLE PREFERRED STOCK, OPTIONS AND WARRANTS

 

Warrants

 

On February 14, 2022, 515,000 Class M Warrants were exercised for an exercise price of $0.12 per share. The Company received $61,800 of proceeds as a result of the exercise. On February 17, 2022 the 3,625,000 remaining unexercised Class M Warrants expired. On May 12, 2022, the 2,925,000 remaining unexercised Class N Warrants expired.

 

The following table summarizes warrant activity for the years ended December 31, 2023 and 2022:

 

Warrants

 

Outstanding Shares

  

Weighted Average Exercise

 

Outstanding at December 31, 2021

  7,065,000  $0.11 

Granted

  —   — 

Exercised

  (515,000)  0.12 

Forfeited

  (6,550,000)  0.11 

Outstanding at December 31, 2022

  —   — 

Granted

  —   — 

Exercised

  —   — 

Forfeited

  —   — 

Outstanding at December 31, 2023

  —  $— 

 

At December 31, 2023 and  December 31, 2022 there were no outstanding warrants.

 

 

Mandatorily Redeemable Convertible Preferred Stock

 

The Company is authorized to issue up to 5,000,000 shares of preferred stock, par value $0.01 per share. The Board is authorized to set the distinguishing characteristics of each series prior to issuance, including the granting of limited or full voting rights, rights to the payment of dividends and amounts payable in event of liquidation, dissolution or winding up of the Company.

 

At December 31, 2021, there were 675 shares of the Series B Convertible Redeemable Preferred Stock (the “Series B Preferred Stock”) outstanding with a mandatory redemption date of May 2022 at $1,000 per share, or $675,000 in aggregate redemption value. The Series B Preferred Stock were convertible into common stock at a conversion price of $2.00 per share. These preferred shares carried no dividend preferences. Due to the mandatory redemption provision, the Series B Preferred Stock were classified as a liability in the accompanying consolidated balance sheets. In 2021, 175 shares of Series C Preferred Stock were converted into shares of common stock. On May 31, 2022, the Company paid with shares of the Company’s common stock all 675 outstanding Series B Preferred Stock outstanding with a mandatory redemption date of May 2022 at $1,000 per share or $675,000. The May 31, 2022 average price of the Company’s common stock was $0.08 per share. The Company issued 8,437,500 shares of common stock to satisfy the $675,000 redemption amount.

 

At December 31, 2022 and December 31, 2023, there were 4,063 total shares of the Series C Preferred Stock outstanding. The Series C Preferred Stock are convertible at the option of the investors at any time into shares of the Company's common stock at an initial conversion price equal to $0.10 per share, subject to adjustment. At any time after February 17, 2019, if the volume-weighted average closing price of the Company’s common stock over a period of 90 consecutive trading days is greater than $0.25 per share, the Company may redeem all or any portion of the outstanding Series C Preferred Stock at the original purchase price per share ($1,000) plus any accrued and unpaid dividends, payable in shares of common stock. All outstanding shares of Series C Preferred Stock were to be redeemed by the Company on February 17, 2022 at the original purchase price per share, payable in cash or shares of common stock, at the option of the holder. In February 2022, based on approval of a majority of the Preferred C Holders, the Company extended the redemption date of the Series C Preferred Stock to February 17, 2023. In December 2022, based on approval of a majority of the Preferred C Holders, the Company extended the redemption date of the Series C Preferred Stock to February 17, 2025. Holders of Series C Preferred Stock do not have any voting rights, except as required by law and in connection with certain events as set forth in the Statement of Designation of the Series C Preferred Stock.

 

The Company pays dividends on the Series C Preferred Stock in February each year. Dividends payable totaled $243,780 in February 2023 and February 2022. Some holders of the Series C Preferred Stock elected to settle their dividend payments with shares of the Company’s common stock in lieu of cash. The Company issued 2,266,500 shares of common stock in lieu of a dividend payment of $90,660 in 2023 and 2,271,980 shares of common stock in lieu of a dividend payment of $204,480 in 2022. $153,120 of dividend payable was settled with cash in 2023 and $39,300 was settled with cash in 2022.

 

F- 16
Table of Contents
 

The outstanding 4,063 shares of Series C Preferred Stock originated as follows:

 

On February 17, 2017, the Company entered into subscription agreements with certain investors, including two of the Company’s directors, for the sale of (i) an aggregate of 3,433 shares of Series C Preferred Stock, and (ii) Class M warrants to purchase an aggregate of 17,165,000 shares of the Company’s common stock (the Class M Warrants), for gross proceeds of $3,433,000. The Series C Preferred Stock accrues dividends at a rate of 6% per annum, payable annually on February 17th of each year, commencing on February 17, 2018.

 

The Class M Warrants were immediately exercisable at an exercise price of $0.12 per share, subject to adjustment as set forth in the warrant, and expired in February 2022.

 

The Company allocated the proceeds to the Series C Preferred Stock and Class M Warrants based on their relative fair value, which resulted in $2,895,379 being allocated to the Series C Preferred Stock and $537,621 being allocated to the Class M Warrants. The allocated Class M Warrant value was recorded as a discount to the Series C Preferred Stock and will be amortized to interest expense over the five-year life of the warrants. At December 31, 2022, the balance of the discount to the Series C Preferred Stock was $13,440 and the net carrying value of these 3,433 shares of Series C Preferred Stock was $3,419,560. At December 31, 2023, the balance of the discount to the Series C Preferred Stock was $0 and the net carrying value of these 3,433 shares of Series C Preferred Stock was $3,433,000.

 

On March 24, 2017, the Company entered into an Amendment to the 8% Convertible Notes (the Amendment), pursuant to which the 8% Convertible Notes (the Notes) issued by the Company in July 2012 were amended to give noteholders certain additional rights. Pursuant to the Amendment, the Notes were modified to provide each holder the right, at the holder’s option and exercisable prior to May 12, 2017, to convert all or any portion of the principal amount of the Notes, plus accrued but unpaid interest, into shares of Series C Preferred Stock at a conversion price of $1,000 per share. Holders that elected to convert their Notes into Series C Preferred Stock received a Class N Warrant to purchase up to 3,750 shares of the Company’s common stock for each share of Series C Preferred Stock received upon conversion of the Notes, with each Warrant having a five-year term, a cashless exercise feature, and an exercise price of $0.10 per share of common stock. On May 12, 2017, the Company completed the retirement of $1,835,000 of the Notes in early cash redemptions, and $780,000 of the Notes were converted into an aggregate of 780 shares of Series C Preferred Stock and Class N Warrants to purchase an aggregate of 2,925,000 shares of the Company’s common stock. In 2021, 150 shares of Series C Preferred Stock were converted into shares of common stock.

 

The Class N Warrants were immediately exercisable at an exercise price of $0.10 per share, subject to adjustment as set forth in the warrant, and expired in May 2022.

 

The Company allocated the proceeds to the Series C Preferred Stock and Class N Warrants based on their relative fair value, which resulted in $675,947 being allocated to the Series C Preferred Stock and $104,053 being allocated to the Class N Warrants. The allocated Class N Warrant value was recorded as a discount to the Series C Preferred Stock and will be amortized to interest expense over the five-year life of the warrants. At December 31, 2022, the balance of the discount to the Series C Preferred Stock was $4,737 and the net carrying value of 630 outstanding shares of Series C Preferred Stock was $625,263. At December 31, 2023, the balance of the discount to the Series C Preferred Stock was $0 and the net carrying value of 630 shares of Series C Preferred Stock was $630,000.

 

Employee Stock Purchase Plan

 

In September 2004, the Company’s Board approved an employee stock purchase plan for an aggregate of up to 2,000,000 shares of the Company’s common stock. The plan allows employees to deduct up to 15% of their salary or wages each pay period to be used for the purchase of common stock at a discounted rate. The common shares will be purchased at the end of each three-month offering period or other period as determined by the Board. The plan is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code. An amendment and restatement of the plan was approved in July 2020 by the Company’s shareholders, which increased the number of shares available for purchase by 3,000,000 shares. At December 31, 2023 there were 2,224,544 shares available under the employee stock purchase plan.

 

During 2023 and 2022, the Company issued 316,866 and 245,081 shares of common stock to employees for proceeds of $8,398 and $14,771, respectively, in accordance with the employee stock purchase plan.

 

F- 17
Table of Contents
 

2015 Incentive Plan

 

In April 2015, the Company’s Board of Directors approved the International Isotopes Inc. 2015 Incentive Plan (as amended, the “2015 Plan”) which was subsequently approved by the Company’s shareholders in July 2015. The 2015 Plan was amended and restated in July 2018 to increase the number of shares authorized for issuance under the 2015 plan by an additional 20,000,000 shares. The 2015 Plan provides for the grant of incentive and non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and units, and other stock or cash-based awards.  The 2015 Plan amends and restates the Company’s Amended and Restated 2006 Equity Incentive Plan (the “2006 Plan”).

 

The 2015 Plan authorizes the issuance of up to 80,000,000 shares of common stock, plus 11,089,967 shares authorized, but not issued under the 2006 Plan. Unless earlier terminated, the 2015 Plan will terminate on July 13, 2025. At December 31, 2023 there were 20,292,546 shares available for issuance under the 2015 Plan.

 

Non-Vested Stock Grants

 

Pursuant to an employment agreement with its Chief Executive Officer, the Company awarded 560,000 fully vested shares of common stock to its then Chief Executive Officer in February 2023 under the 2015 Plan. The number of shares awarded was based on a $28,000 stock award using a price of $0.05 per share. The employment agreement provides that the number of shares issued will be based on the average closing price of common stock for the 20 trading days prior to issue date but not less than $0.05 per share. Compensation expense recorded pursuant to this stock grant was $22,400, which was determined by multiplying the number of shares awarded by the closing price of the common stock on February 28, 2023, which was $0.04 per share. The Company withheld 216,440 shares of common stock to satisfy the employee’s payroll tax obligations in connection with this issuance. The net shares issued on February 28, 2023 totaled 343,560.

 

Pursuant to an employment agreement with its Chief Executive Officer, the Company awarded 307,692 fully vested shares of common stock to its Chief Executive Officer in February 2022 under the 2015 Plan. The number of shares awarded was based on a $28,000 stock award using a price of $0.091 per share. The employment agreement provides that the number of shares issued will be based on the average closing price of common stock for the 20 trading days prior to issue date but not less than $0.05 per share. Compensation expense recorded pursuant to this stock grant was $27,692, which was determined by multiplying the number of shares awarded by the closing price of the common stock on February 28, 2021, which was $0.09 per share. The Company withheld 120,461 shares of common stock to satisfy the employee’s payroll tax obligations in connection with this issuance. The net shares issued on February 28, 2022 totaled 187,231.

 

Stock Options

 

A summary of the stock options issued under the Company’s equity plans is as follows:

 

Stock Options

 Outstanding Shares  

Weighted Average Exercise Price

  

Weighted Average Remaining Contractual Life

  

Average Intrinsic Value

 

Outstanding at December 31, 2021

  20,777,500   0.06       627,615 

Granted

  8,150,000   0.09         

Exercised

  (1,200,000)  0.04       57,000 

Forfeited

  (1,734,000)  0.08         

Outstanding at December 31, 2022

  24,993,500   0.07       — 

Granted

  3,100,000   0.04         

Exercised

  —            

Forfeited

  (3,306,000)  0.08         

Outstanding at December 31, 2023

  24,787,500   0.05   5.4   17,000 

Exercisable at December 31, 2023

  19,372,500  $0.05   4.6  $16,000 

 

The total intrinsic value of stock options outstanding at December 31, 2023 was $ 16,000. The intrinsic value for stock options outstanding is calculated as the amount by which the quoted price of $0.04 of the Company’s common stock as of the end of 2023 exceeds the exercise price of the options.

 

F- 18
Table of Contents
 

The Company recognized $199,554 and $280,393 of compensation expense related to these options for the years ended December 31, 2023 and 2022, respectively. At December 31, 2023, the remaining compensation expense was $99,768 and will be recognized over 1.71 years.

 

During the year ended December 31, 2023, no qualified stock options were exercised.

 

In March 2022, 1,000,000 qualified stock options were exercised under a cashless exercise. The company withheld 388,889 shares to satisfy the exercise price and issued 611,111 shares of common stock. The options exercised were granted under the 2015 Plan, and, accordingly, there was not any income tax effect in the condensed consolidated financial statements for the year ended December 31, 2023.

 

In August 2022, 200,000 qualified stock options were exercised under a cashless exercise. The company withheld 162,163 shares to satisfy the exercise price and issued 37,837 shares of common stock. The options exercised were granted under the 2015 Plan, and, accordingly, there was not any income tax effect in the condensed consolidated financial statements for the year ended December 31, 2023.

 

During the year ended December 31, 2023, the Company granted an aggregate of 3,100,000 qualified stock options to 32 of its employees. These options vest over a five-year period with the first vesting at the date of grant and expiration at ten-year anniversary for all grants. The exercise price for these granted options was $0.04 and $0.06 per share. The options issued during the year ended December 31, 2023 have a fair value of $82,176, as estimated on the date of issue using the Black-Scholes options pricing model with the following weighted-average assumptions: risk free interest rate of 3.94% to 4.26%, expected dividend yield rate of 0%, expected volatility of 68.65% to 79.21% and an expected life between 5 and 7 years.

 

During the year ended December 31, 2022, the Company granted an employee 1,000,000 qualified stock options with an exercise price of $0.10 per share and 25,000 qualified stock options with an exercise price of $0.08 per share to one of its employees and a total of 125,000 qualified stock options with an exercise price of $0.03 per share to two other employees. These options vest over a five-year period with the first vesting at the one-year anniversary of the grant and expiration at ten-year anniversary for all grants. On February 21, 2022, the Compensation Committee granted 3,000,000 qualified stock options to the Company’s executive officers and 4,000,000 non-qualified stock options to members of the Board. The exercise price for these options was $0.09 per share. 2,000,000 of the options granted to an executive officer vest one half immediately and one half at the one-year anniversary of the grant. The remaining executive officer and board member options vest one fourth immediately and one fourth each subsequent year. All these granted options expire at the ten-year anniversary of the grant. The options issued during the year ended December 31, 2022 have a fair value of $442,295 as estimated on the date of issue using the Black-Scholes options pricing model with the following weighted-average assumptions: risk free interest rate of 1.37% to 4.14%, expected dividend yield rate of 0%, expected volatility of 65.19% to 70.09% and an expected life between 5 and 7.5 years.

 

All options exercised were issued under a qualified plan and accordingly, there is no income tax effect in the accompanying financial statements.

 

 

F- 19
Table of Contents
 

Restricted Stock Units

 

A summary of the non-vested restricted stock units issued under the Company’s equity plans is as follows:

 

 

 

Non-Vested Restricted Stock Units

 

Number of restricted stock units

 

Weighted average grant-date fair value

Outstanding at December 31, 2020

 

—

 

$ —

Granted

 

—

 

Exercised

 

—

 

Forfeited

 

—

 

Outstanding at December 31, 2021

 

—

 

Granted

 

—

 

Vested

 

—

 

Forfeited / Cancelled

 

—

 

Outstanding at December 31, 2022

 

—

 

Granted

 

7,250,000

 

0.04

Vested

 

(250,000

)

0.04

Forfeited / Cancelled

 

—

 

Outstanding at December 31, 2023

 

7,000,000

 

$ 0.04

 

 

 

The Company recognized $121,202 and $0 of compensation expense related to these restricted stock units ("RSU") for the years ended December 31, 2023 and 2022, respectively. At December 31, 2023, the remaining compensation expense was $168,798 and will be recognized over 1.72 years.

 

On March 3, 2023, the Compensation Committee of our Board of Directors approved the cancellation of 1,000,000 outstanding stock options held by a member of the Board in exchange for the grant of 750,000 RSUs. The RSUs vest over a three-year period beginning on the grant date.

 

On May 8, 2023, pursuant to an executive employment agreement entered into with its newly appointed President, the Company granted 6,500,000 RSUs to its President. 1,500,000 RSUs vest on April 17, 2024, 2,000,000 RSUs vest on April 17, 2025, and 3,000,000 RSUs vest on April 17, 2026. Each RSU represents the contingent right to receive one share of the Company’s common stock.

 

On September 5, 2023, pursuant to an employment agreement with its President, the Company awarded 2,500,000 fully vested RSUs under the 2015 Plan to the Company's President upon his promotion to Chief Executive Officer. Compensation expense recorded pursuant to this RSU award was $150,000, which was determined by multiplying the number of shares awarded by the closing price of the common stock on September 5, 2023, which was $0.06 per share. The Company withheld 778,972 shares of common stock to satisfy payroll tax obligations in connection with this issuance. The net shares issued on September 5, 2023 totaled 1,721,028.

 

 

F- 20
Table of Contents
 
 

NOTE 10 – INCOME TAXES - TO BE UPDATED

 

The Company paid no federal or state income taxes during 2023 and 2022. Income tax benefit on losses differed from the amounts computed by applying the recently enacted U.S. federal income tax rate of 21% to pretax losses as a result of the following:

 

  

2023

  

2022

 

Income tax expense (benefit)

 $(182,493) $72,207 

Book and tax differences

  40,577   (72,207)

State taxes net of federal benefit

  —   — 

Change in valuation allowance

  141,916   — 
  $—  $— 

 

The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets (liabilities) as of December 31, 2023 and 2022 are presented below:

 

  

2023

  

2022

 

Deferred income tax asset

 $—  $— 

Net operating loss carryforward

  7,918,996   7,736,618 

Valuation allowance

  (7,476,180)  (7,363,815)

Total deferred income tax asset

  442,816   372,803 

Deferred income tax liability - depreciation

  (442,816)  (372,803)

Deferred tax asset (liability)

 $—  $— 

 

At December 31, 2023, the Company had net operating losses of approximately $37,000,000 that will begin to expire in 2024. The valuation allowances for 2023 and 2022 have been applied to offset the deferred tax assets in recognition of the uncertainty that such benefits will be realized.

 

In accordance with GAAP, the Company has analyzed its filing positions in all jurisdictions where it is required to file income tax returns for the open tax years in such jurisdictions. The Company currently believes that all significant filing positions are highly certain and that all of its significant income tax filing positions and deductions would be sustained upon audit. Therefore, the Company has no significant reserves for uncertain tax positions, and no adjustment to such reserves was required by GAAP. No interest or penalties have been levied against the Company and none are anticipated, therefore no interest or penalty has been included in the provision for income taxes in the consolidated statements of operations.

 

The Internal Revenue Code contains provisions which reduce or limit the availability and utilization of net operating loss carry forwards in the event of a more than 50% change in ownership. If such an ownership change occurs with the Company, the use of these net operating losses could be limited.

 

 

F- 21
Table of Contents
 
 

NOTE 11 – COMMITMENTS AND CONTINGENCIES

 

Dependence on Third Parties

 

Sales during 2023 to the Company’s top three customers was approximately 22% of its total gross revenue. The Company is making efforts to reduce its dependency on a small number of customers by expanding both domestic and foreign.

 

The production of Cobalt is dependent upon the DOE, and its prime operating contractor, which controls the reactor and laboratory operations at the ATR located outside of Idaho Falls, Idaho.  On October 2, 2014, the Company signed a ten-year contract with the DOE for the irradiation of cobalt targets for the production of cobalt-60. The Company will be able to purchase cobalt targets for a fixed price per target and with an annual 5% escalation in price.  The contract term is October 1, 2014, through September 30, 2024.  However, the DOE may end the contract if it determines termination is necessary for the national defense, security or environmental safety of the U.S.  If this were to occur, all payments made by the Company would be refunded.

 

The key isotope materials used to manufacture our radiopharmaceutical product and nuclear medicine reference standards are supplied to the Company through agreements with several suppliers. The loss of any of these suppliers could adversely affect operating results by causing a delay in production or a possible loss of sales.

 

Contingencies

 

Because all the Company’s business segments involve the handling or use of radioactive material, the Company is required to have an operating license from the NRC and specially trained staff to handle these materials. The Company has amended this operating license numerous times to increase the amount of material permitted within the Company’s facility.  Although this license does not currently restrict the volume of business operation performed or projected to be performed in the upcoming year, additional processing capabilities and license amendments could be implemented that would permit processing of other reactor-produced radioisotopes by the Company.  The financial assurance required by the NRC to support this license has been provided for with a surety bond and a restricted money market account, in the amount of $880,752, held with North American Specialty Insurance Company and Merrill Lynch, respectively.

 

In August 2011, we received land from Lea County, New Mexico, pursuant to a PPA, whereby the land was deeded to us for no monetary consideration. In return, we committed to construct a uranium de-conversion and FEP facility on the land.  In order to retain title to the property, we were to begin construction of the de-conversion facility no later than December 31, 2014, and complete Phase I of the project and have hired at least 75 persons to operate the facility no later than December 31, 2015, although commercial operations need not have begun by that date. In 2015 the Company negotiated a modification to the PPA agreement that extended the start of construction date to December 31, 2015, and the hiring milestone to December 31, 2016.  Those dates were not met and the Company is currently in the process of renegotiating a second modification to the agreement to further extend those dates. If we do not succeed in reaching an amendment to extend the performance dates in the agreement then we may, at our sole option, either purchase or re-convey the property to Lea County, New Mexico.  The purchase price of the property would be $776,078, plus interest at the annual rate of 5.25% from the date of the closing to the date of payment.  We have not recorded the value of this property as an asset and will not do so until such time that sufficient progress on the project has been made to meet our obligations under the agreements for permanent transfer of the title.

 

Defined Contribution Pension Plan

 

The Company has a 401(k) defined-contribution pension plan (the “401(k) Plan”).  Employees are eligible to participate in the Plan after completing six months of full-time service. Participants, under provision of Internal Revenue Code § 401(k), may elect to contribute up to $23,000 of their compensation to the 401(k) Plan which includes both before-tax and Roth after-tax contribution options. There was no employer matching contributions made for 2022. Beginning in 2023, the Company began matching contributions according to safe harbor 401(k) rules. All amounts withheld for employee contributions for 2023 were paid into the 401(k) Plan. The employer reserves the right to terminate the 401(k) Plan at any time.

 

 

F- 22
Table of Contents
 
 

NOTE 12 – ASSET RETIREMENT OBLIGATION

 

As part of the Company’s NRC operating license and as part of the Company’s facility lease agreements, the Company is responsible for decommissioning any facilities upon termination or relocation of operations. The Company has developed a decommissioning funding plan using guidelines provided by the NRC and has estimated the cost of decommissioning the facility in Idaho Falls. The decommissioning cost estimate is reviewed at least annually to validate the assumptions and is revised as necessary when changes in the facility processes or radiological characteristics would affect the cost of decommissioning.

 

In accordance with GAAP, the Company has recognized future estimated decommissioning costs as an asset retirement obligation and a related capitalized lease disposal cost. The Company has recognized period-to-period changes in the liability (accretion) in the statement of operations as amortization expense. Changes resulting from revisions to the original estimate are recorded as an increase or decrease to the capitalized lease disposal cost. Capitalized lease disposal cost is amortized on a straight-line basis over the remaining life of the facility operating lease agreement.

 

The following summarizes the activity of the asset retirement obligation for the years ended December 31, 2023 and 2022:

 

  

Obligation for Lease Disposal Cost

 

Balance at December 31, 2021

  892,087 

Increase in lease disposal costs

  — 

Accretion expense/amortization expense

  50,291 

Balance at December 31, 2022

  942,378 

Increase in lease disposal costs

  478,959 

Accretion expense/amortization expense

  53,126 

Balance at December 31, 2023

 $1,474,463 

 

 

 

NOTE 13 – FAIR VALUE MEASUREMENTS

 

At December 31, 2023 and 2022, the Company had no assets carried at fair value.

 

F- 23
Table of Contents
 
 

NOTE 14 – REVENUE RECOGNITION

 

Revenue from Product Sales

 

The following tables present the Company’s revenue disaggregated by business segment and geography, based on management’s assessment of available data:

 

  

Twelve Months Ended December 31, 2023

  

Twelve Months Ended December 31, 2022

 
  

U.S.

  Outside U.S.  Total Revenues  

% of Total Revenues

  

U.S.

  Outside U.S.  Total Revenues  

% of Total Revenues

 

Theranostics Products

 $5,685,244  $1,157,654  $6,842,898   56% $5,338,010  $707,757  $6,045,767   54%

Cobalt Products

  932,915   104,158   1,037,073   8%  1,137,066   20,470   1,157,536   10%

Nuclear Medicine Products

  3,405,508   981,906   4,387,414   36%  3,173,755   804,930   3,978,685   36%

Fluorine Products

  —   —   —   0%  —   —   —   0%
  $10,023,667  $2,243,718  $12,267,385   100% $9,648,831  $1,533,157  $11,181,988   100%

 

Prior period amounts have not been adjusted under the modified retrospective approach.

 

Under ASC Topic 606, the Company recognizes revenue when it satisfies a performance obligation by transferring control of the promised goods or services to its customers, in an amount that reflects the consideration the Company expects to receive in exchange for the product or service.

 

Product sales consist of a single performance obligation that the Company satisfies at a point in time. All transactions in the Theranostics Products and nuclear medicine standards segments fall into this category. Most sales transactions in the cobalt products business segment fall into this category but other cobalt product sales are recorded as deferred income as discussed below. The Company recognizes product revenue when the following events have occurred: (a) the Company has transferred physical possession of the products, (b) the Company has a present right to payment, (c) the customer has legal title to the products, and (d) the customer bears significant risks and rewards of ownership of the products. Based on the Company’s historical practices and shipping terms specified in the sales agreements and invoices, these criteria are generally met when the products are:

 

 

•

Invoiced.

 

•

Shipped from the Company’s facilities (“FOB shipping point”, which is the Company’s standard shipping term). For these sales, the Company determined that the customer is able to direct the use of, and obtain substantially all of the benefits from, the products at the time the products are shipped.

 

The Company’s revenue consists primarily of products manufactured for use in the nuclear medicine industry, distribution of radiochemicals and radiopharmaceuticals, and cobalt source manufacturing. With the exception of certain unique products, the Company’s normal operating cycle is considered to be one year. Due to the time required to produce some cobalt products, the Company’s operating cycle for those products is considered to be two to three years. Accordingly, preliminary payments received on cobalt contracts, where shipment will not take place for greater than one year, have been recorded as unearned revenue on the Company’s consolidated balance sheets and classified under current or long-term liabilities, depending upon estimated ship dates. For the year ended December 31, 2023, the Company reported current unearned revenue of $932,682. For the period ended December 31, 2022, the Company reported current unearned revenue of $879,365. These unearned revenues will be recognized as revenue in the periods during which the cobalt shipments take place.

 

Contract Balances

 

The Company records a receivable when it has an unconditional right to receive consideration after the performance obligations are satisfied. As of December 31, 2023, and December 31, 2022, accounts receivable totaled $1,469,298 and $1,596,886, respectively.

 

Practical Expedients

 

The Company has elected the practical expedient not to determine whether contacts with customers contain significant financing components.

 

F- 24
Table of Contents
 
 

NOTE 15 – SEGMENT INFORMATION

 

Information related to the Company’s reportable operating business segments is shown below. The Company’s reportable segments are reported in a manner consistent with the way management evaluates the businesses. The Company identifies its reportable business segments based on differences in products and services. The accounting policies of the business segments are the same as those described in the summary of significant accounting policies.

 

The Company has identified the following business segments:

 

 

●

The Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry and includes consolidated reporting of the wholly-owned subsidiaries RadQual and TI Services.

 

 

●

The Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources.

 

 

●

The Theranostics Products Segment (formerly called the Radiochemical Products Segment) includes production and distribution of Iodine-131 generic drug product and various isotopically pure radiochemicals for medical, industrial, or research applications. These products are either directly produced by the Company or are purchased in bulk from other producers and distributed by the Company in customized packages and chemical forms tailored to customer and market demands.  Iodine-131 is the predominant radiochemical sold in this segment.

 

 

●

The Fluorine Products segment historically involved the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. During 2013, these testing activities were completed, and the pilot plant facility was closed.  The Company has developed or acquired all patent rights to these processes. Future work in this segment will involve license support and, as financing permits, further work related to the de-conversion facility.

 

F- 25
Table of Contents
 

The following presents certain segment information as of and for the years ended December 31, 2023 and 2022:

 

Sale of product

 

2023

  

2022

 

Theranostics products

 $6,842,898  $6,045,767 

Cobalt products

  1,037,073   1,157,536 

Nuclear medicine standards

  4,387,414   3,978,685 

Fluorine products

  —   — 

Total segments

  12,267,385   11,181,988 

Corporate revenue

  —   — 

Total consolidated

 $12,267,385  $11,181,988 

 

Depreciation and amortization

 

2023

  

2022

 

Theranostics products

 $25,287  $63,493 

Cobalt products

  53,331   49,202 

Nuclear medicine standards

  114,833   114,990 

Fluorine products

  115,879   115,598 

Total segments

  309,330   343,283 

Corporate depreciation and amortization

  40,764   30,913 

Total consolidated

 $350,094  $374,196 

 

Segment income (loss)

 

2023

  

2022

 

Theranostics products

 $3,037,375  $4,182,151 

Cobalt products

  (126,504)  (95,779)

Nuclear medicine standards

  386,592   39,223 

Fluorine products

  (105,099)  (139,860)

Total segments

  3,192,364   3,985,735 

Corporate loss

  (4,061,380)  (3,682,497)

Total consolidated

 $(869,016) $303,238 

 

Expenditures for segment assets

 

2023

  

2022

 

Theranostics products

 $3,420  $3,379 

Cobalt products

  49,774   17,105 

Nuclear medicine standards

  35,137   75,478 

Fluorine products

  —   4,100 

Total segments

  88,331   100,062 

Corporate purchases

  60,727   19,952 

Total consolidated

 $149,058  $120,014 

 

Segment assets

 

2023

  

2022

 

Theranostics products

 $849,351  $1,075,252 

Cobalt products

  274,513   406,629 

Nuclear medicine standards

  3,538,558   2,744,394 

Fluorine products

  4,980,118   5,147,325 

Total segments

  9,642,540   9,373,600 

Corporate assets

  7,262,547   6,870,996 

Total consolidated

 $16,905,087  $16,244,596 

 

F- 26
Table of Contents
 
 

NOTE 16 – SUBSEQUENT EVENTS

 

On February 8, 2024, International Isotopes Inc. (“INIS”) and its wholly-owned subsidiary International Isotopes Fluorine Products, Inc. (together with INIS, the “Company”) entered into an Asset Purchase Agreement (the “APA”) with American Fuel Resources, LLC (“AFR”), pursuant to which the Company agreed to sell to AFR all the assets and certain specified liabilities of the Company’s depleted uranium deconversion and fluorine extraction plant (the “DUF6 Plant”), subject to the terms and conditions set forth in the APA (the “Transaction”). The Company expects to close the Transaction in approximately 12 to 24 months, subject to satisfaction of certain closing conditions (the “Closing”).

 

The purchase price to be paid by AFR in the Acquisition will consist of (i) $50,000 to be paid within five business days of execution of the APA (the “Prepayment”), and (ii) $12,500,000 paid at the Closing, less the Prepayment. The APA contains customary representations and warranties, covenants and indemnification provisions for a transaction of this nature. Closing of the Transaction is also subject to certain closing conditions, including (i) transfer of the U.S. Nuclear Regulatory Commission (NRC) license related to the DUF6 Plant (the “NRC License Transfer”) and (ii) transfer of Purchased Assets (as defined in the APA), which includes licenses, patents, agreements, and other records of the DUF6 Plant.

 

The APA may be terminated, among other things, (i) upon mutual written consent by the parties to the APA, (ii) by either party upon material breach of the APA by the other party, subject to applicable cure periods, and (iii) by AFR if there is reason to believe that the NRC License Transfer will not be completed by March 31, 2026.

 

In February 2024, the 2013 Promissory Note was modified to extend the maturity date to  March 31, 2026, with all remaining terms unchanged.

 

In February 2024, the 2018 Promissory Note was modified to extend the maturity date to  March 31, 2026, with all remaining terms unchanged.

 

In February 2024, the 2019 Promissory Note was modified to extend the maturity date to  March 31, 2026, with all remaining terms unchanged.

 

 

 

F-27
EX-21.1 2 ex_569257.htm EXHIBIT 21.1 HTML Editor

Exhibit 21.1

 

SUBSIDIARY LIST

 

 

Name of Subsidiary

  

State Incorporation

International Isotopes Idaho Inc.

  

Idaho

International Isotopes Fluorine Products Inc.

  

Idaho

International Isotopes Transportation Services Inc.

  

Idaho

RadQual, LLC

  

Idaho

TI Services, LLC

  

Ohio

 

 

 

 
 EX-23.1 3 ex_569258.htm EXHIBIT 23.1 HTML Editor

Exhibit 23.1

 

haynieconsent2023.jpg

 

 
 EX-31.1 4 ex_569259.htm EXHIBIT 31.1 HTML Editor

Exhibit 31.1

 

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002

 

I, Shahe Bagerdjian, certify that:

 

1.       I have reviewed this annual report on Form 10-K of International Isotopes Inc.;

 

2       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.       The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

 

(a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)       Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)       Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.       The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2024

 

/s/ Shahe Bagerdjian

Shahe Bagerdjian, Chief Executive Officer

 

 

 

 
 EX-31.2 5 ex_569260.htm EXHIBIT 31.2 HTML Editor

Exhibit 31.2

 

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002

 

 

 

I, W. Matthew Cox, certify that:

 

1.       I have reviewed this annual report on Form 10-K of International Isotopes Inc.;

 

2       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.       The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15(f)) for the registrant and have:

 

(a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)       Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)       Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.       The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2024

 

 

/s/ W. Matthew Cox

W. Matthew Cox, Chief Financial Officer

 

 
 EX-32.1 6 ex_569261.htm EXHIBIT 32.1 HTML Editor

Exhibit 32.1

 

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

 

In connection with the Annual Report of International Isotopes Inc. (the “Company”) on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “Form 10-K”), I, Steve T. Laflin, Chief Executive Officer of the Company, in my capacity as such, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

 

(1)

The Form 10-K fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)); and

 

 

(2)

The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

March 28, 2024

 

/s/ Shahe Bagerdjian

 

 

 

Shahe Bagerdjian

 

 

 

Chief Executive Officer

 

 

 

 
 EX-32.2 7 ex_569262.htm EXHIBIT 32.2 HTML Editor

Exhibit 32.2

 

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Annual Report of International Isotopes Inc. (the “Company”) on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “Form 10-K”), I, W. Matthew Cox, Chief Financial Officer of the Company, certify, in my capacity as such, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

 

(1)

The Form 10-K fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)); and

 

 

(2)

The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

March 28, 2024

  

/s/ W. Matthew Cox

 

 

 

W. Matthew Cox

 

 

 

Chief Financial Officer

 

 

 

 

 

 
 EX-101.SCH 8 inis-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statement of Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 995452 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 995453 - Disclosure - Note 2 - Business Condition and Liquidity link:calculationLink link:definitionLink link:presentationLink 995454 - Disclosure - Note 3 - Purchased Asset and Investments link:calculationLink link:definitionLink link:presentationLink 995455 - Disclosure - Note 4 - Inventories link:calculationLink link:definitionLink link:presentationLink 995456 - Disclosure - Note 5 - Property, Plant and Equipment link:calculationLink link:definitionLink link:presentationLink 995457 - Disclosure - Note 6 - Patents and Other Intangible Assets link:calculationLink link:definitionLink link:presentationLink 995458 - Disclosure - Note 7 - Convertible Debentures and Notes Payable link:calculationLink link:definitionLink link:presentationLink 995459 - Disclosure - Note 8 - Lease Obligations link:calculationLink link:definitionLink link:presentationLink 995460 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants link:calculationLink link:definitionLink link:presentationLink 995461 - Disclosure - Note 10 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 995462 - Disclosure - Note 11 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 995463 - Disclosure - Note 12 - Asset Retirement Obligation link:calculationLink link:definitionLink link:presentationLink 995464 - Disclosure - Note 13 - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink 995465 - Disclosure - Note 14 - Revenue Recognition link:calculationLink link:definitionLink link:presentationLink 995466 - Disclosure - Note 15 - Segment Information link:calculationLink link:definitionLink link:presentationLink 995467 - Disclosure - Note 16 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 995468 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 995469 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 995470 - Disclosure - Note 5 - Property, Plant and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 995471 - Disclosure - Note 6 - Patents and Other Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 995472 - Disclosure - Note 7 - Convertible Debentures and Notes Payable (Tables) link:calculationLink link:definitionLink link:presentationLink 995473 - Disclosure - Note 8 - Lease Obligations (Tables) link:calculationLink link:definitionLink link:presentationLink 995474 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Tables) link:calculationLink link:definitionLink link:presentationLink 995475 - Disclosure - Note 10 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 995476 - Disclosure - Note 12 - Asset Retirement Obligation (Tables) link:calculationLink link:definitionLink link:presentationLink 995477 - Disclosure - Note 14 - Revenue Recognition (Tables) link:calculationLink link:definitionLink link:presentationLink 995478 - Disclosure - Note 15 - Segment Information (Tables) link:calculationLink link:definitionLink link:presentationLink 995479 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995480 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details) link:calculationLink link:definitionLink link:presentationLink 995481 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies - Schedule of Common Stock Equivalents Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 995482 - Disclosure - Note 2 - Business Condition and Liquidity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995483 - Disclosure - Note 4 - Inventories (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995484 - Disclosure - Note 5 - Property, Plant and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995485 - Disclosure - Note 5 - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 995486 - Disclosure - Note 6 - Patents and Other Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995487 - Disclosure - Note 6 - Patents and Other Intangible Assets - Schedule of Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 995488 - Disclosure - Note 6 - Patents and Other Intangible Assets - Schedule of Future Amortization Expense (Details) link:calculationLink link:definitionLink link:presentationLink 995489 - Disclosure - Note 7 - Convertible Debentures and Notes Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995490 - Disclosure - Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) link:calculationLink link:definitionLink link:presentationLink 995491 - Disclosure - Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 995492 - Disclosure - Note 7 - Convertible Debentures and Notes Payable - Schedule of Maturities of Long-term Debt (Details) link:calculationLink link:definitionLink link:presentationLink 995493 - Disclosure - Note 8 - Lease Obligations - Lease Cost (Details) link:calculationLink link:definitionLink link:presentationLink 995494 - Disclosure - Note 8 - Lease Obligations - Schedule of Future Minimum Lease Payments (Details) link:calculationLink link:definitionLink link:presentationLink 995495 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995496 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Schedule of Warrant Activity (Details) link:calculationLink link:definitionLink link:presentationLink 995497 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 995498 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Restricted Stock Units Activity (Details) link:calculationLink link:definitionLink link:presentationLink 995499 - Disclosure - Note 10 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995500 - Disclosure - Note 10 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) link:calculationLink link:definitionLink link:presentationLink 995501 - Disclosure - Note 10 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 995502 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995503 - Disclosure - Note 12 - Asset Retirement Obligation - Schedule of Asset Retirement Obligation Activity (Details) link:calculationLink link:definitionLink link:presentationLink 995504 - Disclosure - Note 13 - Fair Value Measurements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995505 - Disclosure - Note 14 - Revenue Recognition (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995506 - Disclosure - Note 14 - Revenue Recognition - Disaggregation of Revenue (Details) link:calculationLink link:definitionLink link:presentationLink 995507 - Disclosure - Note 15 - Segment Information - Schedule of Segment Information by Segment (Details) link:calculationLink link:definitionLink link:presentationLink 995508 - Disclosure - Note 16 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 9 inis-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 inis-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 inis-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Note To Financial Statement Details Textual Significant Accounting Policies Note 1 - Description of Business and Significant Accounting Policies Income tax expense (benefit) Note 5 - Property, Plant and Equipment us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Note 6 - Patents and Other Intangible Assets Note 7 - Convertible Debentures and Notes Payable Note 8 - Lease Obligations Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants Long-term liabilities Note 10 - Income Taxes Note 12 - Asset Retirement Obligation us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Income Tax Disclosure [Text Block] Note 14 - Revenue Recognition Note 15 - Segment Information us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Note 1 - Description of Business and Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details) Note 1 - Description of Business and Significant Accounting Policies - Schedule of Common Stock Equivalents Outstanding (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Note 5 - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) us-gaap_LiabilitiesCurrent Total current liabilities Schedule of Maturities of Long-Term Debt [Table Text Block] Note 6 - Patents and Other Intangible Assets - Schedule of Intangible Assets (Details) Note 6 - Patents and Other Intangible Assets - Schedule of Future Amortization Expense (Details) Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year) Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) (Parentheticals) Note 7 - Convertible Debentures and Notes Payable - Schedule of Maturities of Long-term Debt (Details) Note 8 - Lease Obligations - Lease Cost (Details) Note 8 - Lease Obligations - Schedule of Future Minimum Lease Payments (Details) Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Schedule of Warrant Activity (Details) Additions Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Option Activity (Details) Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Restricted Stock Units Activity (Details) Note 10 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Note 10 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Note 12 - Asset Retirement Obligation - Schedule of Asset Retirement Obligation Activity (Details) Note 14 - Revenue Recognition - Disaggregation of Revenue (Details) Share-Based Payment Arrangement, Option, Activity [Table Text Block] Note 15 - Segment Information - Schedule of Segment Information by Segment (Details) Notes To Financial Statements Granted, weighted average grant date fair value (in dollars per share) Notes To Financial Statements [Abstract] Assets Associated With Planned De-conversion Facility [Member] Represents assets associated with the planned de-conversion facility. Exercised, weighted average grant date fair value (in dollars per share) Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Forfeited, weighted average grant date fair value (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Outstanding, weighted average grant date fair value (in dollars per share) Outstanding, weighted average grant date fair value (in dollars per share) NRC License for the De-conversion Facility [Member] Represents the NRC license for the de-conversion facility. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Forfeited, number (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Outstanding, number (in shares) Outstanding, number (in shares) inis_LicenseTerm License Term (Year) Period of the license. Class L Warrants [Member] Represents class L warrants. Granted, number (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) Conversion of Convertible Debentures Into Series C Preferred Stock and Warrants [Member] Represents the conversion of convertible debentures into series C preferred stock and warrants. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares) Exercised, number (in shares) Current installments of notes payable Exercisable, weighted average exercise price (in dollars per share) Exercisable, weighted average remaining contractual life (Year) Exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Notes Payable for Purchase Contract, Two [Member] Represents notes payable for purchase contract two. us-gaap_NotesPayableCurrent Less: current maturities us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Notes Payable for Purchase Contract, One [Member] Represents notes payable for purchase contract one. Exercised, aggregate intrinsic value Exercisable (in shares) Outstanding, weighted average remaining contractual life (Year) Outstanding, aggregate intrinsic value Granted, warrants (in shares) The number of warrants or rights granted. inis_ClassOfWarrantOrRightExercised Class of Warrant or Right, Exercised (in shares) Exercised, warrants (in shares) The number of warrant or rights exercised. inis_LongtermDebtMaturityAfterYearFour Thereafter Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Exercised, warrants, weighted average exercise price (in dollars per share) Class of Warrant or Right, Exercise Price, Exercised (in dollars per share) Exercise price per share or per unit of warrants or rights exercised. Retirement Plan Name [Axis] Retirement Plan Name [Domain] Granted, warrants, weighted average exercise price (in dollars per share) Exercise price per share or per unit of warrants or rights granted. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share) Outstanding, weighted average exercise price (in dollars per share) Outstanding, weighted average exercise price (in dollars per share) Forfeited, warrants, weighted average exercise price (in dollars per share) Exercise price per share or per unit of warrants or rights forfeited. inis_ClassOfWarrantOrRightForfeited Forfeited, warrants (in shares) The number of warrant or rights forfeited. Forfeited, weighted average exercise price (in dollars per share) Unearned revenue Granted, weighted average exercise price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) Exercised, weighted average exercise price (in dollars per share) Accrued liabilities inis_ContractTerm Contract Term (Year) Term of the contract. Three Customers [Member] Represents three customers. Contract With the DOE for the Irradiation of Cobalt Targets [Member] Represents contract with the DOE for the irradiation of cobalt targets. Accounts payable us-gaap_ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Outstanding (in shares) Outstanding (in shares) Book and tax differences Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to book and tax differences. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares) inis_NumberOfMajorCustomers Number of Major Customers The number of major customers. The 401K Plan [Member] Represents the 401K plan. Theranostics Products [Member] Represents Theranostics Products. Proceeds from sale of property, plant and equipment inis_NumberOfEmployeesHired Number of Employees Hired The number of employees hired. inis_AssetPurchaseInterest Asset Purchase, Interest Percentage of interest on asset purchase. us-gaap_PolicyTextBlockAbstract Accounting Policies Conversion of Series B Preferred Stock Into Common Stock [Member] Represents the conversion of series B preferred stock into common stock. Conversion of Series C Preferred Stock Into Common Stock [Member] Represents the conversion of series C preferred stock into common stock. Schedule of Change in Asset Retirement Obligation [Table Text Block] Property acquired in exchange for a note payable us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares) Decrease in accrued interest and increase in equity for conversion preferred dividends to stock inis_SharebasedCompensationArrangementBySharebasedPaymentAwardPercentOfGrossPay Share-Based Compensation Arrangement by Share-Based Payment Award, Percent of Gross Pay Percentage of gross pay for share based payment arrangement. inis_PreferredStockConvertibleStockPriceTrigger Preferred Stock, Convertible, Stock Price Trigger (in dollars per share) Price of the entity's common stock which would be required to be attained for the conversion feature embedded in the preferred stock to become effective. inis_PreferredStockConvertibleThresholdTradingDays Preferred Stock, Convertible, Threshold Trading Days Threshold number of specified trading days that common stock price to conversion price of preferred stock must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature. us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchase of property, plant, equipment and patents us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Stock options (in shares) Subscription Agreements with Certain Investors [Member] Represents the subscription agreements with certain investors. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares) us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock Series C redeemable convertible preferred stock (in shares) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year) Non-qualified Options [Member] Represents non-qualified options. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) Executive Officers and Directors [Member] Represents executive officers and directors. inis_EmploymentAgreementMinimumPricePerShare Employment Agreement, Minimum Price Per share (in dollars per share) The minimum price per share under the employment agreement. Grantee Status [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year) The 2006 Plan [Member] Represents the 2006 plan. Grantee Status [Axis] Cash paid for taxes One Employee [Member] Represents one employee. Two Employees [Member] Represents two employees. us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Share-Based Payment Arrangement, Tranche Three [Member] Right-of-use amortization Amount of periodic reduction (increase) over lease term of carrying amount of right-of-use asset from operating lease. Current liabilities Vesting [Axis] Vesting [Domain] Share-Based Payment Arrangement, Tranche One [Member] Share-Based Payment Arrangement, Tranche Two [Member] Segment assets us-gaap_Assets Total assets Supplemental disclosure of cash flow activities: Common stock equivalents (in shares) The number of common stock equivalents outstanding. Plan Name [Axis] Plan Name [Domain] us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-Based Payment Arrangement, Expense, Tax Benefit Award Type [Domain] Business Description and Accounting Policies [Text Block] Surety Bond [Member] Net income (loss) Net Income (Loss) Attributable to Parent Net income (loss) Award Type [Axis] us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization Accumulated amortization Patents and other intangibles, net Finite-Lived Intangible Assets, Net Restricted Stock Units (RSUs) [Member] us-gaap_FiniteLivedIntangibleAssetsGross Beginning Ending Share-Based Payment Arrangement, Option [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] us-gaap_PreferredStockConvertibleConversionPrice Preferred Stock, Convertible, Conversion Price (in dollars per share) Commitments and Contingencies Disclosure [Text Block] us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated depreciation Property, plant and equipment, net Property, Plant and Equipment, net Goodwill Property, Plant and Equipment, gross Long-Term Debt, Type [Axis] Long-Term Debt, Type [Domain] us-gaap_IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital Cash flows from investing activities: Convertible Debt [Member] Accounts payable and accrued liabilities Notes Payable to Banks [Member] Notes Payable, Other Payables [Member] us-gaap_IncomeTaxExpenseBenefit Income Tax Expense (Benefit) us-gaap_OperatingExpenses Total operating expenses us-gaap_DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost General, administrative and consulting us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Salaries and contract labor us-gaap_AllocatedShareBasedCompensationExpense Share-Based Payment Arrangement, Expense Non-cash increase of capitalized asset retirement obligation for increased funding plan Accretion of beneficial conversion feature us-gaap_MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature Accretion expense/amortization expense Amendment Flag City Area Code Maturity date Use of Estimates, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] us-gaap_GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment Gain on disposal of property, plant and equipment Periodic payments Balance (in shares) Balance (in shares) Balance (in shares) Common stock, outstanding (in shares) us-gaap_PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding (in shares) Current Fiscal Year End Date Stated interest rate Debt Instrument, Interest Rate, Stated Percentage us-gaap_LeaseCost Total lease expense Prepaids and other current assets us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Weighted-average discount rate - operating leases Document Fiscal Period Focus Operating lease costs Document Fiscal Year Focus Short-term operating lease costs Lease, Cost [Table Text Block] Right-of-use assets obtained in exchange for new financing lease liabilities Document Period End Date Right-of-use assets obtained in exchange for new operating lease liabilities Weighted-average remaining lease term (years) - operating leases (Year) Entity File Number Entity Emerging Growth Company us-gaap_DebtInstrumentFaceAmount Debt Instrument, Face Amount Document Type Entity Small Business Entity Shell Company Document Information [Line Items] us-gaap_DividendsPreferredStock Dividends, Preferred Stock Document Information [Table] Entity Public Float Entity Filer Category Debt Instrument [Axis] Entity Current Reporting Status Debt Instrument, Name [Domain] Entity Voluntary Filers Entity Well-known Seasoned Issuer us-gaap_ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-Lived Disposals us-gaap_ImpairmentOfLongLivedAssetsHeldForUse Impairment, Long-Lived Asset, Held-for-Use Schedule of Long-Term Debt Instruments [Table Text Block] us-gaap_GoodwillImpairmentLoss Goodwill, Impairment Loss us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage Accounts receivable us-gaap_IncreaseDecreaseInAccountsReceivable Stock based compensation Entity Tax Identification Number Entity Central Index Key Entity Registrant Name Entity [Domain] Customer Concentration Risk [Member] Legal Entity [Axis] Entity Address, Address Line One ecd_NonRule10b51ArrTrmntdFlag Non-Rule 10b5-1 Arrangement Terminated [Flag] us-gaap_AmortizationOfIntangibleAssets Amortization of Intangible Assets Entity Address, City or Town ecd_Rule10b51ArrTrmntdFlag Rule 10b5-1 Arrangement Terminated [Flag] ecd_Rule10b51ArrAdoptedFlag Rule 10b5-1 Arrangement Adopted [Flag] Entity Address, Postal Zip Code Entity Address, State or Province ecd_NonRule10b51ArrAdoptedFlag Non-Rule 10b5-1 Arrangement Adopted [Flag] Concentration Risk Type [Axis] Material Terms of Trading Arrangement [Text Block] Concentration Risk Type [Domain] Entity Common Stock, Shares Outstanding us-gaap_AdvertisingExpense Advertising Expense Stock issued in lieu of dividends on preferred C shares (in shares) us-gaap_StockDividendsShares Stock Dividends, Shares (in shares) Revenue from Contract with Customer Benchmark [Member] Inventories us-gaap_IncreaseDecreaseInInventories Stock issued in lieu of dividends on preferred C shares Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Conversion of preferred B stock Conversion of preferred B stock (in shares) Shares issued under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares) Local Phone Number Shares issued for exercise of employee stock options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares) Exercised (in shares) us-gaap_TableTextBlock Notes Tables Shares issued under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Shares issued for issuance of RSUs (in shares) Shares issued for exercise of employee stock options Shares issued for issuance of RSUs Related Party, Type [Axis] us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture (in shares) Related Party, Type [Domain] Stock grant (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares) us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares) Forfeited (in shares) us-gaap_WarrantsAndRightsOutstandingTerm Warrants and Rights Outstanding, Term (Year) Line of Credit Facility, Lender [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Stock grant us-gaap_StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues (in shares) Lender Name [Axis] us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders' equity us-gaap_StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues UNITED STATES Asset Pledged as Collateral [Member] Related Party Transaction [Axis] Related Party Transaction [Domain] Research and development Research and Development Expense Accumulated deficit Retained Earnings (Accumulated Deficit) us-gaap_AssetsNoncurrent Total long-term assets Production Equipment [Member] The production equipment member. Debt Disclosure [Text Block] Increase in lease disposal costs us-gaap_InterestExpense Interest expense Asset Retirement Obligation Disclosure [Text Block] Changes in operating assets and liabilities: us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] Inventory Disclosure [Text Block] Subsequent Event [Member] Operating lease obligations, net of current maturities Operating lease right-of-use liability, net of current portion Restricted cash included in long-term assets Restricted cash Present value of minimum operating lease obligations Subsequent Event Type [Axis] Current portion of operating lease right-of-use liability Current operating lease maturities Subsequent Event Type [Domain] Current portion of financing lease liability Current finance lease maturities Finance lease obligations, net of current maturities Financing lease liability, net of current portion Subsequent Events [Text Block] Operating lease right-of-use asset us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue Total minimum operating lease obligations us-gaap_FinanceLeasePrincipalPayments Payments on financing lease liability us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Less-amount representing interest, operating lease Present value of minimum finance lease obligations us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Thereafter Operating lease, 2026 Operating lease, 2027 Operating lease, 2028 Financing lease right-of-use asset Operating lease, Thereafter us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo 2026 Fair Value of Financial Instruments, Policy [Policy Text Block] us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree 2027 us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour 2028 Operating lease, 2024 us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive 2029 Operating lease, 2025 Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Segment Reporting, Policy [Policy Text Block] us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths 2025 us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares) Capitalized lease disposal costs, net Represents the amount of capitalized lease disposal costs, net. Share-Based Payment Arrangement, Employee [Member] inis_IncreaseDecreaseInNetIncomeLoss Increase (Decrease) in Net Income (Loss) The total amount of change in net income for the company. Equity based compensation us-gaap_DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued (in shares) Earnings Per Share, Policy [Policy Text Block] us-gaap_DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount Debt Conversion Description [Axis] Debt Conversion, Name [Domain] Operating costs and expenses: Income Tax, Policy [Policy Text Block] us-gaap_AssetsFairValueDisclosure Assets, Fair Value Disclosure Schedule of Finite-Lived Intangible Assets [Table Text Block] Research and Development Expense, Policy [Policy Text Block] Increase in equity and decrease in liability for the conversion of preferred stock us-gaap_Depreciation Depreciation us-gaap_ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued (in shares) us-gaap_PropertyPlantAndEquipmentFairValueDisclosure Property, Plant, and Equipment, Fair Value Disclosure us-gaap_ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued Depreciation and amortization Depreciation and amortization us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares) Intangible Assets Disclosure [Text Block] us-gaap_ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted (in shares) us-gaap_SharesIssuedPricePerShare Shares Issued, Price Per Share (in dollars per share) Stock Conversion Description [Axis] Conversion of Stock, Name [Domain] Related Party One [Member] The related party one member. us-gaap_AssetsCurrent Total current assets Long-term assets Related Party Three [Member] The related party number three member. Share-Based Payment Arrangement [Policy Text Block] Equity [Text Block] Related Party Two [Member] The related party number two member. Major Shareholders [Member] Represents the major shareholders member. Advertising Cost [Policy Text Block] Common stock, $0.01 par value; 750,000,000 shares authorized; 519,787,870 and 514,889,916 shares issued and outstanding respectively Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Common stock, authorized (in shares) Common stock, issued (in shares) Common stock, par value (in dollars per share) us-gaap_DeferredTaxAssetsValuationAllowance Valuation allowance Statistical Measurement [Domain] Maximum [Member] Supplemental disclosure of noncash financing and investing transactions: Minimum [Member] us-gaap_DeferredTaxAssetsNet Total deferred income tax asset Statistical Measurement [Axis] us-gaap_PreferredStockValue Preferred Stock, Value, Issued us-gaap_DeferredTaxAssetsLiabilitiesNet Deferred tax asset (liability) Cash paid for interest Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Property, Plant and Equipment Disclosure [Text Block] Geographical [Axis] Goodwill and Intangible Assets, Policy [Policy Text Block] Property, Plant and Equipment [Table Text Block] Accretion of obligation for lease disposal costs Represents the amount of accretion of obligation for lease disposal costs. Geographical [Domain] us-gaap_PreferredStockSharesAuthorized Preferred Stock, Shares Authorized (in shares) Inventories Inventory, Net Portion at Fair Value Measurement [Member] us-gaap_PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share (in dollars per share) Estimate of Fair Value Measurement [Member] Nuclear Medicine Products [Member] Relating to Nuclear Medicine Products. Cobalt Products [Member] Relating to Cobalt products. The 2015 Incentive Plan [Member] Relating to the 2015 Incentive Plan. Employee Stock Purchase Plan [Member] Relating to the Employee Stock Purchase Plan. Measurement Basis [Axis] Warrant exercise Value of stock issued as a result of the exercise of warrants. us-gaap_PreferredStockDiscountOnShares Preferred Stock, Discount on Shares Warrant exercise (in shares) Number of warrants exercised during the current period. Customer [Axis] Class N Warrants [Member] Relating to Class N Warrants. Customer [Domain] us-gaap_PreferredStockRedemptionPricePerShare Preferred Stock, Redemption Price Per Share (in dollars per share) Qualified Options [Member] Relating to qualified options. Class M Warrants [Member] Relating to the Class M Warrants. inis_ClassOfWarrantsOrRightsExpirations Class of Warrants or Rights, Expirations (in shares) Represents the number of warrants or rights expired during the period. The 2019 Promissory Note [Member] Relating to the 2019 Promissory Note. Property, Plant and Equipment, useful life (Year) Unearned revenues us-gaap_IncreaseDecreaseInDeferredRevenue The 2018 Promissory Note [Member] Relating to the 2018 promissory note. us-gaap_PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage The 2013 Promissory Note [Member] Relating to the 2013 Promissory Note. Cash flows from operating activities: Schedule of Segment Reporting Information, by Segment [Table Text Block] Revenue [Policy Text Block] us-gaap_WarrantsAndRightsOutstanding Warrants and Rights Outstanding Statement [Line Items] us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current Class O Warrants [Member] Relating to class O warrants. us-gaap_NumberOfOperatingSegments Number of Operating Segments Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Furniture and Fixtures [Member] Chief Executive Officer and Chairman of the Board [Member] Relating to the Chief Executive Officer and the Chairman of the Board. Additional paid in capital Building [Member] Fluorine Products [Member] Relating to Fluorine Products. Property, Plant and Equipment, Policy [Policy Text Block] inis_OtherCommitmentsAnnualFixedPriceEscalationPercent Other Commitments, Annual Fixed Price, Escalation Percent Represents the escalation percent of an annual fixed price as part of an other commitment. Other income Long-Lived Tangible Asset [Axis] Percent of total revenues Represents the percentage of total revenue. us-gaap_NonoperatingIncomeExpense Total other (expense) income Segment Reporting Disclosure [Text Block] Long-Lived Tangible Asset [Domain] Land in Lea County, New Mexico [Member] Relating to land in Lea County, New Mexico. Net operating loss carryforward Lessee, Liability, to be Paid, Maturity [ Table Text Block] Tabular disclosure of undiscounted cash flows of lessee's lease liabilities. Includes, but is not limited to, reconciliation of undiscounted cash flows to lease liabilities recognized in statement of financial position. Chief Executive Officer [Member] inis_FinanceLeaseExpense Total financing lease expense Represents the amount of finance lease expense during the period. Current assets Fair Value Disclosures [Text Block] us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Total cash, cash equivalents, and restricted cash shown in statement of cash flows us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash and cash equivalents and restricted cash at beginning of year Cash and cash equivalents and restricted cash at end of year Inventory, Policy [Policy Text Block] Private Placement [Member] Interest income us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net increase in cash and cash equivalents and restricted cash us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by (used in) financing activities us-gaap_Liabilities Total liabilities Sale of Stock [Axis] Director [Member] Sale of Stock [Domain] Executive Officer [Member] us-gaap_OperatingIncomeLoss Operating loss Asset retirement obligation us-gaap_NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities Net cash provided by (used in) in operating activities Other income (expense): us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash (used in) provided by investing activities Prepaids and other current assets us-gaap_GrossProfit Gross profit Cost of product Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Consolidation Items [Domain] us-gaap_InventoryWriteDown Inventory Write-down us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount Stockholders' equity Consolidation Items [Axis] us-gaap_InterestPayableCurrentAndNoncurrent Interest Payable us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred income tax liability - depreciation Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Nonrelated Party [Member] us-gaap_PaymentsOfDividends Payments of Dividends President [Member] us-gaap_ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity Scenario [Domain] us-gaap_ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants Forecast [Member] us-gaap_ProceedsFromWarrantExercises Proceeds from Warrant Exercises us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Retained Earnings [Member] Sale of product Sale of product Title of Individual [Domain] Proceeds from sale of stock Title of Individual [Axis] Scenario [Axis] us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock Additional Paid-in Capital [Member] Parent [Member] Common Stock [Member] Equity Components [Axis] Equity Component [Domain] us-gaap_LongTermDebt Long-Term Debt us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) Outstanding, warrants, weighted average exercise price (in dollars per share) Outstanding, warrants, weighted average exercise price (in dollars per share) us-gaap_NotesAndLoansPayable Notes payable, net of current installments and debt discount Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Notes payable us-gaap_ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding (in shares) Outstanding, warrants (in shares) Outstanding, warrants (in shares) us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) us-gaap_DeferredRevenueCurrent Deferred Revenue, Current ICFR Auditor Attestation Flag Disaggregation of Revenue [Table Text Block] Revenue from Contract with Customer [Text Block] Transportation Equipment [Member] Document Annual Report us-gaap_RepaymentsOfConvertibleDebt Repayments of Convertible Debt Receivable [Policy Text Block] Entity Incorporation, State or Country Code us-gaap_UnrecognizedTaxBenefits Unrecognized Tax Benefits Accounting Policies [Abstract] Document Transition Report Document Financial Statement Error Correction [Flag] Entity Interactive Data Current us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) Related Party [Member] Title of 12(g) Security us-gaap_ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt Collaborative Arrangement and Arrangement Other than Collaborative [Axis] us-gaap_AssetRetirementObligation Balance Balance Discontinued Operations, Held-for-Sale or Disposed of by Sale [Member] Expenditures for segment assets Auditor Name Auditor Firm ID Auditor Location Segments [Axis] Segments [Domain] us-gaap_RepaymentsOfNotesPayable Principal payments on notes payable Pledging Purpose [Domain] us-gaap_SharePrice Share Price (in dollars per share) us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) Lessee, Operating Leases and Finance Leases [Text Block] Disclosure of the operating leases and finance leases that the entity is a lessee in. Weighted average common shares outstanding - diluted (in shares) Weighted average common shares outstanding - diluted (in shares) Pledging Purpose [Axis] Non-US [Member] us-gaap_OperatingLossCarryforwards Operating Loss Carryforwards Statement [Table] Statement of Financial Position [Abstract] Net income per common share - diluted: (in dollars per share) Weighted average common shares outstanding - basic (in shares) Net income per common share - basic: (in dollars per share) Statement of Cash Flows [Abstract] Statement of Stockholders' Equity [Abstract] us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration Disposal Group, Including Discontinued Operation, Consideration Income Statement [Abstract] us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree 2026 us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour 2027 Disposal Group Name [Axis] Disposal Group Name [Domain] us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths 2024 us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo 2025 DUF Plant [Member] Relating to the DUF Plant. Interest on lease liabilities Prepayment for DUF Plant [Member] Relating to prepayment for DUF Plant. us-gaap_FinanceLeaseLiabilityPaymentsDue Total minimum finance lease obligations Amortization of right-of-use assets Finance lease, 2028 Finance lease, Thereafter Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount Less-amount representing interest, finance lease Finance lease, 2024 Finance lease, 2025 Finance lease, 2026 Finance lease, 2027 Weighted-average discount rate - financing leases us-gaap_LiabilitiesNoncurrent Total long-term liabilities Weighted-average remaining lease term (years) - financing leases (Year) Cash flows from financing activities: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Change in valuation allowance us-gaap_DividendsPayableCurrentAndNoncurrent Dividends Payable Mandatorily redeemable convertible preferred stock Asset Acquisition [Text Block] Corporate, Non-Segment [Member] Series C Preferred Stock [Member] Series B Preferred Stock [Member] Pledged Status [Domain] Pledged Status [Axis] Accrued long-term liabilities us-gaap_StockholdersEquity Total equity Balance Balance Class of Stock [Axis] Class of Stock [Domain] Notes payable, net of current portion Schedule of Weighted Average Number of Shares [Table Text Block] Operating Segments [Member] State taxes net of federal benefit EX-101.PRE 12 inis-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 13 auditopinionjpg_page1.jpg begin 644 auditopinionjpg_page1.jpg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

J>K'Z ME;.\];U@FXXL> HW;%7G/EC_ )R@\D>:-'U?S/:Z9K%KY1TNQN+Z/S0ZV5Q# M,MM)Z1BD@L[NXNK2>1_@CANX89':JA>0(Q5)_P P_P#G(C6O+_DGSMKW_E'S+IWD71=:O?+^M_F)/;VOZ*M+VQU"33I&D"73 M71@]5!6=(3$H;XV4JX550\N_\Y-^1?,&J6U@]M?Z/!J]I>WOEF^NGL)_TC%8 MVSWDP2ULKRXN[>3ZO&TJQW,,3LH-!4$8JR[\LOS@T[\T;>6\TK0=3TRQ-O#> M6&IW,EA=V=W;SBJ&*ZTN[O85D H6AD995!5BE#7%7L6*OF?2/SRU"STS1[?5 M?+NI^;_-'FKS9YTT3RSI/E^"V5I(O+FKWEO&DKW5Q;PQ4MH5K)(X4L"6(J 5 M4SA_YR$TG4K:V/EGR5YK\VZM';75WYD\O:;9VPO-'BL[VYTV?ZXMS=0HSBYL MYT2.!I'E]-C&K"A*KWZVG6Y@BG2O"90Z9_F+YMU MC1]0\C>5O+?ICS#YWUT6T9#5344*EE6?:C_ ,Y0^2;.+3UM=,U+4M5N+2YO=6\OB;3+&[TN*SNY M["X6\.HWUK$94N;6:(1PR2.YC8H"N^*O??+GF#2_-6B:3YDT.]BU+1->LK?4 M='OX:\)K6ZC66&05 (Y(P-#OBJ=XJ[%78J[%78J[%78J[%78J[%78J__T_OY MBKL5=BKL5=BKL5=BKL5=BKL5=BJA=6\5U;7%K-<-S&T4T+='1P593\P:8J M^;/*?_..5CY>_)WSA^5-_P"8[C7+GSA];:Z\USPTFB<10VNE,D;2R$FPM[2V M5*O\1CY?#RH%4HO/^<:YK8^3[SROK>B6^I>7?*%CY.U9/,WE^+S!9WMO8"Y$LTKEA(ROS_>*] <5?4&CZ>-)TG3-+64SC3;2&U$[1Q1%_10)R M,<"1Q*32M$15'[( VQ5XU?\ Y,O>^3?S(\HC7_3'Y@>:)_,GU\VH;ZIZUU;7 M/H>GZH]2GU>G*JUK6FVZK ++_G''S!8Z_HEW_C?37T/R[YM_Q9;1P>7H8M9U M24WTUWZ6M:N;EGN2@N) K1Q1$MQ9^8JI53W3?^<:/+%AY9_-;RI+J=[=Z5^9 M,DD6FQL%_P!P>G+++>6MA:!V<-%;WEQ-,H;X3SXE:#=5F7Y9_EOKODJZU2_U MS5/+M_=W\=O;00>6?+=MY>M$CA%7DE59KJ>661MS6;TQL%C&[%5=^;'Y9:A^ M8,OE*^TK5].T_4/*5_<7L%EKNEC6M(NOK-K):M]8L3/;$R1!^4,@D' EMF#$ M8JPK0_R.\V^5;?RU=^7/S MAYI\N7/F@?IS5-'2YAN[+S7J,>J7D1?,'DVVU$:-/K<$:6^KF$7*V\T,T<\3O 7B]1><8#* M'4D5HP.^*L>/Y6W5QH?YOZ?=Z[&;[\V+@W<]U':\8[*5M&LM);A$9F+KRLS( M 6!HW DTY%5Y[Y4_YQWO?)_F&S;2M>T >2]/UJYUJRLY/+%G+YBC%Q-)<_4O MTW++(# LTAHQM_7X?#ZP/Q8J]]\W>6QYM\G^9?*S-(MU%>W N)/K*R-S7@R>G'152B_)WSYI] MUHGFS2?S0Y_F5!8ZEIOF77]6TQK[3;^VU.[2\].#3A>0FU6SD2EJJ3$*I82" M4L6Q5&^4?R-@\GV6O:;I^N7-Q::OY%T[R;'+>QK)<>I92ZI/+J$LBNH=[B75 M'=D"J%*T4\2.*K%?SM_*S7=8:R\Q>7M0N!K'I^4/+]O;VMJD\ELMEYLT_4YM M2^-F5EA2)F="OV026Q5&>8/R%\Q^:$?7M=\X:1J7Y@3:MIE_<7=SH9G\MRV> MD07MO::?+HLM\TCQ+]?FN 3\NZ[J'FX:]=Z+ MKNOZ]=2_H^*S%S)Y@LH+:2)8X'$<2P/$2@53\'%6JP+LJ\]\U?DK<_P J M/+5M=ZE>V0\T>:?,'G_4(+$+I]QY?U'57\Q1Z3>3/S0%M2CM550>3HDI/%&* MLJ]BO_R M/?%7F7GKR=KGDS\QCY_\N7.J#6O,^L:G=#S!::%=>8;#3;:XTC2+"33=1TNR MN8;F5+A],2>.>-E].1 C JQY*O3_ /G'C0/,?ES\L=.L_-@N?T]J.J:YK5\U M]##;7A&KZO>7\9NK>!FCBF,9M0\H?F'_A#0 MO/M]9:AYTT\::MS?B>T@@M))=+OQ<1?57N;:VCBA^8_P#$NE^5!I]-3$D5\^I6UA/JANRLEG!=.'0"W64JB(TI M'+DJGX_):X'DG\H/)T?FN>SD_*FW$,>N6MNJ3W3+H-[HBRQJ[NL3#ZYZPJ'% M5XD$&N*O.])_YQ>FM6UC6)->T+R]YLNI]%OM+U#R;Y=CT+3UU'0[R2\AU"^T M[ZYHV]A M]5L3%HML;6UTZRM#2$K4JI5JO\ SC1K MMW+K5OIOG?2['3?,NF:=I^KW]WY#3M0DN0MO;3K"'>,PNR MEY2DBEZJJG&N_P#./6J:Y#YGAD\UZ>JW7G8^??)7UK14O%L-0N+>2VO+;489 MKHPWUM+'(RA0D+H&J'+A6"J9P_DGYITR+RUKOE_SCH^A?F'Y>NM2)U*T\O10 M:!-I^KF'ZUIS:/;7,#^F/JL#I(URTP=*F0HQ3%7IOY6^1KS\O/*/^'+_ %Z3 MS/?2:KK&K7>N2P);//+J^HW&H/RBB/!>+7!7X:#;8#IBKS_S%^4?G>\\V>?? M,'EG\P[;0=-_,FWTRP\Q:/R--Y?BO?,,26<5HD.G#69+D5L@;- M $]$2!/A$HV(5375O^<>==GO+74]&\WZ3'?PW/F>1UU[R_'K-M GF76Y=:,] MA!)=1""[MVD](2L75U52T>P&*LW\@?DY)Y'N?*=S^GOTE_A7\OK7R%$AMO2, MT=I.LB7C'U6HS*H!0"E:D&FV*L/\L_D)YQ\E:-9^6?*'YG?H+0[VQT.V\YNF ME!K^YGTBQM=.EN=+O!=+]2>[MK2..3U$F"4Y1<&))57>5O\ G'F[\H^8;9]* MUOR^?)ECKESK=C83^6+.;S#$MQ/+=?4/TW++)R@2:3X6-OZ_ !?6K\6*OHK7 M]-FUC2K_ $N"_NM*DU"VFMUU6Q=8[FU,L9030,RN!(A/)25(J-QBKY@T+_G& M)M-FU?4KG5_+VG:OK%]Y9NKT>5?+RZ%87?\ AS6H]9-Q>V:7DRS7ETRF-IPR MA%/PI0D%5/O/7_./C^;?.&I^>K77;*VUZ34].U+1(-4TF+5=.C6TTZ73KFVO M;26>,3QW"2!ZHT;QLJE&ZU52O4O^<<]2N!Y2UBQ\P>6SYP\OV%_IFIR:EY2L MKK0;JUU"=;KA!I$4UO\ 5C;S+6)UF9R"1,TM:A5E[?D[K=MKVCZII'G%=/MX M/)5UY.UOT],MXKF19G:XAO+%K9[>WM)8YVY<#;R1E?AH/M8JL_*+\DG_ "X\ MQ^8?-=]/Y<76/,.G6NG7UMY0T(>7-.N/JTTTYO+JT6ZNA-=R-,U9:K1?A W. M*LK\]^0=]OM2U>;6 M;R_=XV"IZD\[TB"444 -!BK-_P S/);?F'Y*UGR@NH_HK]+_ %;_ '(>EZWI M_5[F*X_N^:Y MMKCT.'J?'3ZO3E45KTVW58+JO_..FNWUU#J<'FO0YM1T/S'YDU?RG%K/EU-3 MLEL/-=\=1U&PU*VDO5$[+<<6AF@,#($"D,"U57IF@?E3/HNJ^2-7EUR*[N?* M?EG6] NHX-.M["&ZFUNZL;J2XC@M?3B@2-K(JL85C1OBS_ .5:V+60UNVMU6:ZY>7[[0O416D81$?7/5H2WV>/>H58YIW_ M #CWYA63SA=:OYPT99O-'DV]\GV>F>7O+D6CZ;IT5Q*)DN8+<74SNY!C -54^U7\DM?U+5+SS>OG:*P\]'4O+^NZ5J=MIQ%A!J>C:9<:9<"6T> MZ+RVUY%=S*T7K*Z*WPR6_)D8,'HED\N/?%+ICZCCE.MX R 44K4$AJ*JS#SUY+ M?SD?)Y74/T?_ (4\S:?YC_NO5]?ZAZG[C[2\>?J?:WI3H<5?.%[_ ,XF)KNJ MSWOF?S+IU\\,.H0V'FO3M!M],\U7@NHWCMQK>KV]P$OUMRR2!?J\8DDC1Y*F MM567:[^1/FKSC8^>+SSEY[M+_P Y^:M!L] TC5M-TEK+2]+MK"\.H(5T^2]G MDF>>XXF8M<"JJJIZ>Y*J(U+\D?-=X?.&CV'Y@Q:1Y*_,C44U?SUHL>EF2^^L MS1V\>HQZ5>O><;:"\]#XTEBF9.;\'&U%6)>5/R@\Y>:O+OF;RIYSUV.R_+37 M?._F?4M7\A2Z5Z>IS6K^8;R\MX(M3%RJK9W(].4@V[2LK%5E"L.*K*?(/Y#Z MWY.N;&*Y\UZ-=Z3HNFW&G:/>Z7Y7T_2]?E]6'ZO#-J&J!IQ))#&=C!##S?XI M.2U0JI!Y>_)7S%^6%]K_ .8>E2>6=6\]RZ(-%LX/+?EA-"CU9I;NVD:[UF*" M^*75S^ZH)%,:1AI&"4/'%7USBKPSR_\ DX^AZUY-U@^8#ER]4\?JYGX\J'G2M%Q5B=O^1?F_P NW6LZCY%_,2#R_JOFC]+P M>9+N[TGZ[%):ZCK.HZQ:O;*MW \-S9-J4T:2+=V$1BCT92K^O%;QP1H5N9I)96GE,BNYD^&H8 J2"S*O-OS)TC5(O-/Y6^ M>]-L;C5%\G:]+::S86Z^H_Z-UVW-A-;:2>QUQ*1PW+FZE5I8'9B9%55<4'IJ06* MK#Y_^<9[ZWU>3S%H7F/1/TU?RZTNKQ^9/+D.N6,MMJ>M:AK-LT,#W4#PW%FV MH21B19"D@WDC.P"KZ@T+3?T/I=CI0D,R:=;PVT>7]'O=0M+.A(EEMX7D13QWH2HK3MBK MQH?EWY_\KV%CYLB_/75]0\QVDUM<^9)O,QMCY) M^:,$Y&4%PZJCH'YYZ_J@\C>8-3\B'1_R[_-"^&G>2/,'Z2];4UDN(9I].EU+ M3A:JEO'>K#\!CFE*EXQ(JU;BJQG1/S^_-/S!;?EI<6/Y.V,!_./3'U#R-%<> M9E4VXM[:.[F?5N.GOZ,31-RB,'KNU5#QQDGBJF.A?GYYW\Z_5H_(_P"6$%_/ M'Y4LO-&M#5=<6S2W:XN]2LI=/A,-IG:CY*=-&N6F?6677WL]7CM9?K*:7;V-Q#$(DNU8I=W4+L!R HR/Q M3)J+?5PM1NDC?L$8JSG\K?.%QY]_+CRGYNNH%M=1U?3XVU6UCJ4CO828;M(R M0"RB:-PIIN*'%7A6B_\ .2.KZCYHTS1[OREIS:=YAGU2UT@:'K9U?4HKBPLK MN_@BNXTL8[)6N8[&5 (+R9EDXJ1]ME59K^3OYWI^9^LZUH4\7EZ'4-*LH=0D MAT+7TU62!)7,9M[ZTN+:QO+:9#0FL+1&M%E+ C%4X\W_ )C>:K#S;>>3/(WD MV+S9K&C:&GF/S'/?ZD=,M;>TN)YX+6W@=;:Z:6YN#;2E%*J@"?'(M5Q5YM^4 M_F[S?^9GYP><_-0U*XC_ "XLO+WE^[\CZ7'J3K$UOKE@M['+=:;]216F<.69 MS5[7R9Y)&I>=O,#:XL^ M@ZEJ/U#3K6+R[+#!>7?Z1^JRO-%*]S L!C@//U07$823BJD?F'_G)B[TG41I M=OY-2PU32-#L=9\XZ+YDU%M.O;62^$SKIUG':6M^EQO:)^6XU[R7^6]]I=IK.IR:LMG?WRZM8:?>Q"PL9+8@RQB_ M42)/+$.G%R2P55*=>_-_\T)?,OE3RS#Y/@TWSKHWGJVTG6_+5EK*SZ9J5GJG MEC5=1M3+J$EG#)&D,D >8"W9@8_W8EJ 54PU7_G)>XTN2/RS<^5;72_S$M]7 MU+2==TK5=4D@T>S&E06=R]T-1ALKB:6*XBO[8P!;;F?4_>+&%>BJ<^6?SS\R M>=O,?DG1?*_D0+:>8M"FU_S-?ZSJ1LVTN*SU0Z58+7RQ%&==U.*"%FBL[&XE)$): M2A8A"S@< R!B<5>%Z?YI_.+S5^0_Z0\J>8M.TOS1I7Z:V 5&>5BRKQ"A5-;W4?-OG?\ +70?S4UO\R]9\F6FK>3] M%O?)WEORNT<,UQKUY:F:03J;>5[V2>=TCAMT^#B#\/)JA50_,J?\S/)XT?SW M?>;O-%SYAO;S3Z:/HUK$/).@V<:V\>H+KR4GG>(F69VG4^H*+P$:QDXJ^F/S M \SOY*\H:SYHM[*&_FTJ%9([2YO8=.@=GD2,&>[G^") 6JS4)H/A5FHI5>!6 M7_.1^K7'ECS=J,GDRWOO,?E37_+>BII.D:G++8Z@OF:YMK>UFMKR^L;&4<6G M8,'@5:K\+E34*IH_YW^<(M?E_+V3R'9O^:?Z5ATZVT:'66;0VMY=-?4VOY-3 M:Q2>.*&-/3=?JATU33_/>MZ;#I,T M\=Q]1@MC$L=M'-$JJ\:U+(U 2I!8*:J%7GWYC67YB>6KM/,EC^9.L:I^8VH^ M8XW\D_EMI_I?H2;1EO8TDMKNR]$R&*.S9GN;QY 8Y""K@".,JI!Y?UWSU8>7 M_P E/S7?\PM6UV]_-W5=-M]>\JW_ *!T6.V\Q6MS+91VL$40> V3F'XT>LJH MP?=^2JIP=-_,CRYYV\KZ'Y=_-;6O.GG#4].OO^5HPZM'!/H>F+)I\LEEJ"0V M\$:V+F_6-((*DRPF2JMPYJJRO\O8?,&C_FOJOEW2_/7F#\P?)UKH,S><[W7I M(KN+3O,*7%O]5M[2[BAB59);>29Y[<5$06$T3G1E7O.O:BVD:/J>J)%]8?3K M2>Z6V,B1>H8(VDX>I(51.7&G)B%'4[8J^8M"_P":=8<)ED115$DC(:O,$4Q5--3_/3S;Y7U27R MMYM_+N&'SCJEMI7X;#0[>\6_LH?K%@TLLUG<>C [QS M-0_O(T8,""H%"57DGFO\Q_SDL8OSPFCL[:2+RI^9_D_1O)5MIVJ?Z3/;WEQH M'J:G?F+!JT M.G#31K$S:'Z$^GMJ0OGU/Z@)Q&D2E&06C/ZE.(9#R"KV7\K/S!7\R?*\7F'] M&3:+<17EYINHZ;(6D1;FRF,3O;W!2,3P2 !XI HY*PJ%8,H5>/ZQ_P Y#ZWH MH\]:G?>1[.#RSY:\V-Y'\N:@VL,+G5=9:6W1&>'ZF4MK95ED:21I&<>F0D;\ MEJJ@=+_.O6/.&N?EU;Q0G0[BR\^3Z-YKM-,N'O=,U.U/E;5=2A:TO)[:T:6( MRQ)4-'&Z21T< 4+*I!_T,MYLU:TU33K#RSH,&K:QY:U_4O)][IGF"74XK>]T MJU%T(=0G&E+;*3"_-3;27*EEXFB,'Q5,;S_G(_7=!CTS0+G0-&O_ #3HOEC2 M=8\[K:KG4A8ZK'?BRBN)I;'3GMG21+(W"K*99XR65Q&KT7D MJ^A_/?F^Q\A^3M?\W:E')L"#3;"ZTK M3[?5%NUOEM'DFM)[:ZB966#U/B"F*O+BJDFM_P#.3MWH^BZ'J=WY3L= :Z;6 MX->U'S-K7Z-T:UOM!U.72[C3[?4XK.YCEGEDA9X?56%3'1F9&^$*LCN_SV\P MFW\T^9M \AKKWY=^0[R*S\UZ\=5CCU%W$%O<7CZ=910307,5FMR [FY0.4?T MN8XEE6+6?YNWOEWS#KLOF6YU75;+3_-OG[ZOZ-RJ1P:?H&GP7:6[6_IGUMB1 M%5UXL:DMTQ5':E^:/YHZ%Y_T\^NZ'JUCY8T+1+/S-H?F/R M*LE_8ZS=RZ9=Z5YBUSZ@4BN;G289>;2VTD$M+?BL;^HDCLO#%657O_.3UO:> M8]0MX_+]O=>5-'\Q/Y;U&\COYGUQI(+L6%U>V^E1V+I);07'(-6X$I1&=8B. M(*J%U+\W?S$\QQ?D_P"8=,\KMY8\A>?/.VD0:3K::FLNH7.E3_6"GZ0L&MD6 M&*]1%=/2FD8 H'5"6XJO9OS9_,:]_+?R_::S9Z,FL?7=1BL)[NZGDM--TQ'C MDD-YJ5U!;W@>3F\S^7]1TS6;F]TWTO5>WND>YN=)MF]>U(Y*L<,L3 M[ R+O15.-4_YR;O-*U;5]//E6PNX?)]];:/YQMX-7G?4I-0X0&]71[4Z>%NH MK9IJ:=1TS\KH=9\M>5?.J^1Y+TZ[';WU[? MW5Q;V5I+:VK6C1^E]8NHEE,DR,GQ,BR!=U4#J7_.26L:)>OY2UKRKI.E_F-; M:SJ&EZAI\^MS#08X+"ST^_:]34DTY[AUDCU.W18_J?,2,W(!%YE5--,_/OS? MYOO/+VG>1/RV2]O=9\L77F*_&NZO^C(;(V&HR:9<6Q>*TNGE9Y8R8)$CX2+\ M1**02JQW3/SS\_:AYA\V^<-/\HOK7Y=)^5WE;SCY>\MVUXSZP)=8;4'7_18[ M-E+.T928B=A''"LB!V=HPJ]@_)S\V(OS3M=?E5] EG\O7<=I2JE^15[Y^\P>:_SG\P M>=;V0VUCYNOM \O:7!J\E[8V]M8,H58[)K"T6%@I4F3U':0LW(+Q')5=KOYT M^9+.X\[ZOH?D$:_Y!_+/5SI/F[73J7U?4I)84@DOI=-TXVSI/%9K/^\,EQ$6 MX.(U:B\E4'>_G?YRMT_,#78?RYCN?(GY:>8+O1?,VMKK &HRP631&XO;&P%H M4D2".4O(LDT;'BPCY[552CR;_P Y.)YMUKRQ'%Y?MAY9\[7#VOEO4+34)KK5 M(0T4LUK*Y6(4,=Q*8RZB54^+BJI67_ #D#^8%SY)\A><;S\OO+ MFA'\R8H[WRY9:KYJ>-8K)K=9PUSZ&F33M-(77A%;03 *>4KQTXXJED?YU>>? M-FN?EEK^AZ-#8>1?,_Y<>:O,'F/2I]3:WOX;O2[FQ@F,7"RE#O;,_"$ET#B5 MW=4,:JRK-M7_ #L\RVO^,]8T?R#^F?R__+B^32_.&NR:GZ&I22PQ6\E_+IUC M]5=+B.S$])#)/$6*/Z8;X:JH/4OSX\VZ://.O?\ *N8)?(/Y>>9Y/+>NZU^F M0-1N>,]O!]9L+#ZJ4D$9N%YK+/$:A@G/8E55_+G_ )R#E\]>=(_)M]H^D>7] M1O+>ZN4T$ZXC^8=.^JL*PZKH]S;VDL3L*[VS7"(PH[ %6*KZ?Q5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*O_U?OYBKL5=BKL5=BKL5=BKL5=BKL5=BJ$O[.WU&QO M-/NX$N;2^@DM[JVD%4DCE4HZ,.X8$@XJ\(@_("QD_0.FZ_Y_\V>;O)?E>YMK MO0OR^UFYM)=-62Q=);(74T5I'>7JVSQJR+=7$@+!6?F5&*HC0OR!\OZ'>^7^ M/F+7]3\L>3+R?4?(WD.^N8'TO2+J=)HQ)"4MTN91"EQ(($GFD6($< .*<562 MZ)^4NA:#'^5,5I>7LJ_E!IDVD^7#*\9,\,UFEDS71$0Y-Z<8(*<1RKM3;%7C MNC?D!?Z9YUU:WT/S;YD\J>5;7R?H^AV6K6%Q8N^I :GK=[J%I=07%O,HX?7H M^$J1I(JM2.3[>*LBU/\ YQF\N7R:QI-GYP\SZ#Y(UJ_BU6[_ "\TNYM8-*%[ M"D*)*K?56N^ -O&Y@:7K_ROYX\J37VH)I_GW7)O,&L3 MI)&)H[F:>"=EA)CHJ!K=0 032N^*L!_*GR%J_E.Y_/#\PO\ #5[IGF'SYK]] M?^7?+%]>0W$D5E:HSVL2&.22"!;R]FN;PHK45ISS)?D<5>N?EOY.B\C_ )?> M6?)9F^NR:+IZ6^I79%!<7;@R74M/V1),[M0;"M!MBKS'1_\ G'+2-)E\HQR^ M?/-NLZ+Y ]2/R5Y9OKRW6QT^UEM+K3VM@+:V@EFI:W31)+/(\R!5*2 \BRK+ M/)/Y10>4?,%OYFU/SEY@\^:UIVD2Z#H>H^87LGFLM.FEAFEA5[.SM6F,CV\9 M:2CEM(=8LM(T\:9R#6]K; M:):?4[2. <>0 BV/)C7%4C\V?E5<^8O-MGYVT?\ ,#S#Y%UVVT8-+\UZ9K3>8[?\QX+N M.36WU.:V%G<3323PRP2)-;JL+0F'TN"HJHH1:*HN]_)J.YT[RY'!Y^\V6/FG MRVMZEK^8B7L$^L2KJ7'ZY'.+FVFM7BF*(1$( D;(C1*A1<52A_\ G'W1K":S MN/)7G#S-^7$J:+:^7]8.@74!_2EE9&3ZNUY]=MKH_6$]:3_28BDQY'X^E%63 M:I^3WE[5M'_,'1+B_P!12U_,C4[/5=;D296EBFLK:PM8U@>1'/$II\9;GR)) M;?<452SS3^1VB>9O,-UYK7S'KN@>8)M9T_7K74=*N(8FMKW3-,N]*MVC66"5 M63TKQV>.0,KD ,"G)2JE8_YQZT""UTBYTKS3YBT/SOI5]>:E)^9UIW M6HQQ17S7QGM9+6=)D@B7TS!Z:".,1JGIK15G'EK\L]-\N:_I_F0:QJVL:KI_ MEP>6WO-4NC>37,7ULWKW$\LB\VE:5CT(0 \515 51GGKR%;>=1H5S'K&H^6 M->\L7CWOE[S/I+PI>6DDD302J%N(;B"6.6-RKQ2QLC?":2T6H)Q5B_YF_E6OYFR M^7/K/F_6/+=KY;NVOX;#38].N+:ZN@ (9;NWU*RO8I3;DB>?/)=CY_P#+5SY9U&[N].BF MGM+RVU/3Y%BNK2[L+B.\M+F!G61.44\*. Z,AI1E*DC%7F^F?D%HUHGF!M3\ MV^8_,NH^:-9\OZ]KNM:I***,F)(VBBC5 B_ JL68JH M_P S?DAH?F+S!JOFZ#7=8\O>;;Z^T_4M,\R:9);+=:9<:?:26(^J^O;S1E)X M)62>.5'1Q^SL**LK_+O\O-/_ "XTG6=+T[5=3UEM=;BYDN[\J MTQ,BI'\)9:@4VZ"B@ *L$M/R/U"P\Y:]YXT_\VO-5EJOF:]2YU:'ZMH-PIMH MGY0Z='/ZN8IX?4A*VRW$WHK6?S!U[6H+?2I[3R[Y>N;;R_96UM=2'FERC66DVY]3G4L92ZM MR8LK-OBKU;S)Y?L_-?ES5O+6J\WL-=L)K#43"[1/Z=Q&8W,;C=6%:@]L5>/V M_P"05E)=^9M3\Q>??-/F_6/-OER;RMJNIZK/9 IITLBR(MM!:6=O;PM&0Q!2 M/X^9]3F0O%5DGGC\FO+7GS69->U.[U"TU1=*MM-TZZLI8XI+&6QOUU*UOK5S M&[)<0SH.+;KQJK*02"JB_(GY86_D;4O-FM_XFUKS5KOG62QG\P:OK4T#R22V M$!MXC'';0011+Z= 4C0("*@ EJJI5J'Y,:5J.L^;=2E\P:NECYPUW0O,M_H" MO;?58M5\ORV$D%Q"S6[3#U5TZ".1#(4X@E%5V+8JAO,OY&Z)YB\R:GYPB\P: MUY=\U7>HV&J:7YATF>!+C3KBPLI-/'U=9K>:-XYX)G6:*9)$?8\05%%7HWE+ MRT_E;2;;2WUO5/,W,\C%GDD951%!)H$C1(T% B*-L58/J' MY+>6=1T'S-H4E[J4(\Q^:7\Y0ZM!.L5[INK^K%-%/8RK'1/2>)2H8,".2OR5 MB,566_Y.VDJ:&_F3SAYB\YZCHVLW6M/J>K7,(:XDNM-N]*>W,-M!!!# MO>/ MQ2WCC^,!R2:U58OI_P#SCKIMO=:+=:QY^\V^;1Y;TJ]T+0++5KJT6WM-,O[- MK&:!(K.SME=S&5(FDY2U0#GQ+AE48_Y")"]G>:+^9OG'RSK?Z#L_+_F+7M*F MTZ*;6;2PYK:O>1/8/ L\22,BSP1QR!33ELM%6_,'_./^D:W=>9UL_.7FCRQH M'G=4;SCY4TB[MTLM0N4A6'ZW(\UK+LT4R>MQ_>AZMR5>O>9O+.E^; M_+FL>5]=@^M:7K=L]M=QABC -]ET<;JZ, RL-U8 C<8J\B/Y :3=PWEWKGG3 MS-K_ )SFU2PU?3OS%NI[./5=/GTN*6*R2T2WM(;-(HUGF#1FW*R>K)ZH?F<5 M3;RS^27E[RUK.A>8$U/5=4US2-2U?6;_ %J^N(Y+C5-1UJWBM+FXO D*(.,4 M,:1)"L:1JH55XBF*I==_D/I_&%O+_G?S-Y1O8[O7I[B_TV>TD^LV_F'4)M2N M[6XMKRUN+5T2>8F)_2]6,"BR?$W)5*E_YQI\I6EE/H&AZ_K_ )=\C:H;!O,G MY>Z?:?<21F"5O,]JEG>PL!$&],1I\ K4$[DXJQV;_ )QRTO5C=2>; M?S \X>01Z51H_.NFV=H=>U;RQJ6DW MT6HZ'YAT.X%O=VES$&3E21)89D>-V1XIXWC96-5)H0J\P@_YQP\L6\]S.OF' M7&?6M*UG2?.;>I:(=<77)FN;F>Z].U7TI4G!XFY$%(OC+'U ]%X MJJL'Y%+9ZI3>G9"2UENEA4 M3_4G@5^O$&N*LCE_*+R_+I6M:0U[?BWUWSI;>>;QQ)'S&H6E_:ZA'$A,=!#Z MEH@((+<:_%6A"J1Z]^16C:MY@U#S?IGF?7O*7G"]UE]:M_,VD36PN+8SZ=9: M9Z-Y)<32.G)IFE)Z$(!\*HJ@ *L-LO^3= M4U_S#>^8]3\X^:/,T5G;:OYEU=;*.XDMM/\ 6^JP!+"ULX0L9GD-?3Y$GXF. MU%6*:]^0VBZYJ?F>8>9=>TKRWYVU"'5/.GD2PN+>/3-5NX5A0R2E[9[F 2K; MQB9;>:-9:'F#R?DJ])\I^3]/\H?XE_1T]Q-_BC7;SS!?_6&5N%U>\/46/BJT M0?(FG7%O'I6K7<*PH99" M]L]S#ZJV\8F6WFC66AY@\FJJQ#RQ^2&I:EJGYD3>:]?U[3_+?F?SUJ&LW7D1 M+FTDTK6+(FW:TDF'HR7$*.8OWD44T8D I*K MR59SY4_).V\GWMC'I?GWS8_ ME#1Y+F30/R]EO8!I5E]8J!$IBMH[J6&'D1##-.\:5%%^%>*JE-^1>G1:1^7> MF^7O./F+RE>_EGH3^6M!\Q:9+:&\FTN:*WBGM[E;JUN(&]3ZI"_-(E=66J,N M^*H2Q_YQ]T#2K#R7IFD^9-A6U)H+A[W2]?D2:ZM+U[F"5GH\4; M+*A66J_$[5;DJJ:Q^0.A:O?:^5\S>8-+\M>;[RVU+SKY&L;BWCTS5[RW2",R MSLUL]S#ZRVT8F6WFC64 \P>3553Z^_)SR_J/E7SSY2N+Z_\ T?\ F!KDNOZU M*LD?JQW,\T$[I 3$5$?*W4 ,I-"=\58];?DC%HM[8ZM;^<_,FO\ ^%/TCT-Y,(XIVCC^LSRA%/0T%%7O4(D$40E-90B^H=M MVIOTIWQ54Q5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_];[^8J[%78J[%78J[%78J[% M78J[%78JD7F?4;[1_+>O:MIFE2Z[J.F:?F*OB36OSO_,3S=Y6U'3?+>K>5[#S?H'F_R7!J4ML=:L)/J6J:[%92V\VG M:A;6MW /558I'JZ21M(%XNO'%7I^J?G9YST^S\P_F%_A;2S^4?E7S/<>7-5D M>\F_3DT=EJ8TB]U2")4,"Q0W',B!CZCHA8,&95Q59#^9GYG:]Y7'FRZ\LZ/I MGD'SUY;U6_\ *VIV.K2#6=-4:=->Z?-=Q3)"DQN(8RQ6U)>!B 0ZAY%58'YE M_.KS9YU\I^8M1_+>S%IIOE#S3Y*T&SNM0N+K2M6U36KK6M+:XBGMGC6:TL9; M>X"%IDYS*[,J>EQ9U629 M4]2Y>25A&K! 68FBCY8J^9O)G_.1?FGS/<^7/,%UY(D7R#YO]2>VDL++7'U# M2K P37%O?7UQ/I\>GRQR+&H?TIAZ1<4:4 DJHQOSA_-G3K7R#K_F#R;Y;L_+ MOYCQ7=SIUM::E=37^F+!H%_K=O!=\H5BG>06BHSPD*OQ;-LV*L]_-#\QKSR^ M?T0NF)6-)\HV^CW&L>9Y;E0=634[LI%9HC.8-/TBVN;F M6-G*BK#$LLRR/=,%!",/A+4HRE5)K/\ .S\Q_P R/+NOO^7_ )8T;39O+WE> M+4_-]QK&HW*L+V\2\ LM->WAY!D2U]43R*!\:+PJ&(5?1&@:W)8_E5H/F2_D MGO9;+RK:ZG?2,W*:9HK%9I"68FK.0:DGJ<5>37WYF?FQY7TK5M4\Z>5?*=HD MVD1:IY8NK36YQ;P7,MS!:M8:@DENUU*R&Z0K+:6[B0_N_31VCYJL1M_SX_,< MZ+YK@E\F6EYYD\KZUIEC?:Q;6.O)IMMINIV$EZFI7&E/9G5"L4D7H,B(:EED MYK'S*JH:S_,[\Q//_FG\H-4_+U_+EW<^8/+?G--?LY=7O9-!BFTK4M)MUN3& MEO%/+*#5%BDCCDA]5PQ^$AU7T3Y"\Z3^?ORTT_SK8V2:7J&LV-Q*EA-(9HH+ MR!I()$]0!6>-9HSQ;BI*T/%2:!5\;?EYYS\U?EUY,_*GSIYLU6_\Q7.L?E=Y M@\UZKIOZ8U*]CU+4+NZ\LPZ>\C:E+,(9"]V581@11EZ+Y0R6 MZ1@U3U9./(@%L59)^3/YS:GY]\SZ]Y3\P?H2#6M)TZ/4CI]BNK6-[;J\HCD@ MN=/UFSM9F],LH]>.J,3Q*H1\2K#?S'UOS5H_Y\'5[Z_:;\O_ ,OORYO?-AT& MRU+4[.>>ZAN)$)>WMY4M;AF940"X5T5"2%Y8JBO.'YS?FC^7ECK]GYK\I>7; MGS(?+JZ=;14E5SQN(C0E&_=?9.*I! MIO\ SD+YVM9M;TOS-Y7TV\US]%Z1=^4I-/CU?2;:XO=7U>+1$M)QK-I#-P2Y MGC8SQHRE.7PAA0JHOSAYQ_.J+5/RVT8Z3H=GYWB_,-M+9;+5Y4T+5M-NO+FJ MW4=Q7O-%QY9N&GO9OTU,+35!H]UJ<:+&8!#%=:-1OKJ[O#J6HWT;+%=2PCA%?RR);4*L!';JD?$+\/*IQ M5XK-YL_.N.PUJ5]2T[4]2C_/VVT/RS8Q7][9PO:];U%U6"/@P 1N;-(550ZKZ*_+KS/J7G+R9IWF+5?+]WY2U:^-Q'?Z%?).CV M\UO,\#%/K$5O*T3F/U(F:-"T;*W$5IBKR*R_/"]N]*\K)-HL0\U'_$$_YE:) M'(Q_0]MY5CDCU)XR.IDNS;QP!C\2RB3X@IQ5B^E?GSY\2'5KKS)Y*M(;9_+] M[K>FZK;P:]I^GZ;:IID,;"42'C-!7D4*K"69*JH,_\Y >?+#RW M^:MQJGEK3+CS)Y"TK1M6T%XX-7TFPOX]9O)[%(YH-4MH;N,Q2VLE752C*5*[ M@XJB/-/YZ?F#Y!\PP:1YST+R[HMI;SV-I=ZE='68+/6&O(XC-/IFIBRFL[=8 M&=HQ'=R ]13%7F?DC\R?S1T'1[S7]?L=*U+\O_P#E9VL^5Q>2 MZA>3:Z8[WS5-Y) M=O)?GJ<+IOU'3]<-_IEK-%)):7U]V_+Z\TF+]-^:KRSU6RU66[BBN^&A:E<;>749TU2^N;2&WDU6;3?W?HQQ M6K3N$$QY3>F:>F&4XJS/6OSP\M-!:7OE>]BUO2M&\R:=HGYA74D=Q:_HNUU. M66SBNPTZ1JP2Z$88G71(?+GE^U>?SI?:[/Y0U*Z@ MU6^MV\O:#);VS:C/;:9:SW#/=7$X$2!441D2,YV5U4)K?Y]_F -)T.YTGR;8 M:'J\FBW6K^8?+NMV^O7=_&UO=SVBI!:Z?IWJQ6\S6Y>.ZNA$K*RD1[/Q5>@Z M-^8OGGS1^8^D^7?+VC:+;>4(_*?E_P V^8M6U"YN&U #79;^-;2VA@7TBR"T M#>H[<>HIN"%4[_,[SKYRT#S1^7OE'R1I&DZAJWGQ]51K[69YH;:Q33+5;GUF M6W5GE!)XE!0DD?$HJ<5>'2?\Y)^<]1U/4_*6B>3+.V\X^3OK"^?HKE-9U:S% MS!>W%I;V]@VD6,[E;M;9I5EF"",$(R._+BJSFZ_-+S[K&OW^GZ1Y5LM)\K:7 M^7NF^=/-*:[->VFMPMJR:BOZ-C@B5#%+$;+XG9@5-13E0A51U7\X//T2^>?, MWEOREI%_Y _*_4'TCS(E[J$T>LZ@UG#;R:C/8@(8(TM?78*LS%I3&U. 93BK M"_S1_,K\T-;\@?F!YD\J:?IVA>1-#U]_+L&K)J5U#YAF;2];BTZ\OX/2011Q M"9)$$+-ZCH"W(<@F*OHC\W_S!D_+CRO9ZO::8VL:OK&KV&A:#IM)S&]YJ$HC M1IOJL5Q-PC4,[".)W/'BHJ:A5XV?SP_,%?+MG3R- _FR[\Z:5Y1L;F[BU72= M&U"'583(+^U.H6<5R@A*LLL91RI4@,W)<51%I^7C^9MC MJ.IVNKZI-?70T".PTRRTJ^:]1/3%R6F.KP0B'?@W-R[*H!5>?^6OSM\^:;I& ME^5H=+COO/&J:CYSUK7KC5?TQK%IIUE8>:;S3X+*(Z3:7,\GQ?NHW81HD: T M)(3%69W7YN_F5YWTO7[?R)Y,M/+5YY;\I6FK^=K?S7=7EG?6]]JEKN/TE)Y%6[.HM(XN/7.F<_5]3 MER#\OBY5K7>M<5>4^J>9-5UFRU:WO MKVUMI[.:WU.XNT#R+*?2DB59%?C0D54JI1IW_.1?F;4M1AUNV\FR7_Y>76KW M.GQBRT_7)=6@LK>ZEM3JTEQ]0&G-$&B+O&LU8XSR,K%67%4ZN_SG_,3RIY9G M\^>>O)FC#RCJ?EQ]XO[6Y(B:VT^^CFCC:7+70M2AM]:TO1[YM?UJ+2);5WU:RMY8KBV, MHD/'F'4AOAH1BKI?SE_./2(_.-]K?E#RC)I?Y6>8;#1/.ES9:E?^KJ/Z0%C/ MZFF12P 0F"#4(BPG=@[\E!51R*J0>0/S5_,SRA^6OE#SCYULK#7?R_N-8?1- M0UD7]Q-Y@B6[U:>QMM0F$J^C)&93&GHJW-48-R/$KBJ>^6_S[\^ZJ+>^U+R& MOZ(US0[_ %?318V>N1'26MK"2_MHM3O+W3H+65)UC]/U8'"K(551('#8J^C? M),WG&\\MV5]Y[@TFVUZ\ FEL=#>>2UBB:JMSY4:UU:=[2VT>/1;>Z=89/6,$$, MT-JH1B&EG8M(,59[^5=8?--S+Y8\K:K8Z5IUJ;'2=)^M M76M0R6UC \DLC _5E+S2L9)#UXJJ(JKZ4Q5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*O_U_OYBKL5=BKL5=BKL5=BKL5=BKL5=BJ6ZQI.GZ]I.IZ'JULEYI>L6LME MJ-H]>,L$Z&.1#2AW5B-L5?/VE_D]^5NO:1YCMXO/NL>=+PG3[6_\WS^8?TAJ MFF#1KQ-2LX(KI"1;^CNWMSYRLM;[ M;S5/<>4;>RU"R\OQW6OM<>7]'CU4-;7CZ:'E,4+.':-3R(C#-'&$0\<59AJ/ MY.>1M?UJY\T!KF*ZUJ+R_)J9L+GA;7[^7+V/4-*NID 8/)$\83U :M$>!JH7 MBJ[S+^2GDWS/JNJ>8;N74]-\RZC>66HVWF/3+V2TO+"\L+.:PBFLY%J(RUO< M21NI#*X;XE.*NLOR1_+VPL_+]E#ITLUKY?&MF)+FYFG-Y)YC1EU2:_>1V>YD MN#(S,SGJQI04 52*P_YQV\AV]UK:EYB\XS7>@W_E=CYDUBYU'CH^HO;R2 M6B,2)/"K2*%#/7]XS;454M;_)C\N[W7]9\P:GJ^HV%AJ=]::O MYN\H1:J]OH-]>Q,GH75]8\N!9VACY;JLI0>HK[U5>XLH*<2U*=SX^^*O&?+7 MY%>3O*NK6U]H^I:^-'TV6XN-&\C3ZMWL'8J .;E$8E(RS<%7: MBK!M1_YQ[TO3/,_Y:WOEZYU74/+GE[7;^2^\M:EJLTNG:3I%]HFI6,EOI=HY M(C0RW,2*@)]./X8RJ#CBK)HOR#\BZ>^JZKK7F+S)KU+RU/J>O:S+LZWY>UK0 M(KJUT_6?+VH2Z==?5+XQFZM9)(R><4K01,014,BLI!&*H'R3^57D;RJGDZ\\ MI/*]GY,TO5=%\KD7;7,,=CJMW!=7,18L?4XR6J*C,2R@$$DDG%6+W'_.-_Y> MM:6EEIU_YA\NI#ITVC:G)H^KW%G)J>G33S7!M-0*-^^1'N9?3- Z!V". 2,5 M>QVN@:7:>7;+RO&GJ:/9Z?'I:6\IY\[:.$6_IN3]JJ;'%7CD'_./7Y>7-CJ0 MFU;S!KPU2SL[+1M7OM;NKRYTFTL+J.]M$TFZ9R\'IW,,4H>K.S1IS9PH&*MQ M_P#..7D.*SU>$ZOYFFU;6;ZPU>[\VSZSA';%6*+^2OD$Z1Y=T"XL9;[2/+'E&Z\D:?8W,[NK:/>BS$R2FH M+2?Z#%QDJ&4@D;G%4#H?Y7>1/+P\T6MWYBU#S'K?F^SAT'S#K?F'5FO=4EM) M$G^K6*RLR^DH$\K1JBJ6)+GDV^*I[IWY3^1]*U636++2TCN9O*]MY.>%I9'M M_P!#VA/"#T6 M9=5FU%M.L)I(F-G:-,?@21XHN1-7;@@9C08JG5YY)\H>9-=U;S#<%-4O;O0[ MCR=K,*3<[17M-:@U?4/,/F:[UVR@TJ M76=;U6>]O+?3;:ZCO8K*UE<@1QB:-6;8N]!S9J+15[1/^C-4CU'2)WM[U&B] M#5+ LK$1W"$<)4!J ZDTKU&*O(-$_(/R9I%MJ6GW&K>9O,ND7VCW&@V>C:]K M5YJ%KI^G72E)8+))7JA*$()&+2!550X Q5 VW_.._D..?6KK6=4\Q^:]3\PZ M5^A]7U;7=:NKNZ>SCN8[NV6)^2>@;6:,20M"$96)8EF-<5333ORG\@>28K'S M!J6L7T]UY=UR;S5?^=^4C&I^*0]<58$WY0^1K#5[W5 MY]2U"(:WYOLO-MOIEQ?D6<>NP*ZJ]K$U.)GY$R("0Y V%,54_,?Y'>2-=U#4 MM?EO-7T#S)>:L^NQ>:M(U*:POK.Y>PM=-G^KRHU!%+;6<2R1.&1BO(KRH0J] M(\M^7].\K:#8Z!ITL;/S5J^K:O/>7=W'IEW) M>69]1_[KTFE95$01>!H5)WQ5'>:?R6\D^8_,.I:]J.L:SI)\QQ1GS;H&FZK- M8Z;K4=DJHKW]K&P$G"/C&[(5+(%20LH Q5Z#YL\L:'Y\\LW?ES6':?1=66!I MFM93&SK%+'<1%)$.P+1J=NHQ5(G_ "N\K/Y>?RRPN3I;^9SYN8>NWJ_I,ZS^ MGBW.O]W]QTO5;+4M,UZ"_73)K74+ M9R;=XKER%#$DKQ(/($BF*H6R_+GR3?>5(] L;I[_ ,O3>9?\6P3PW?K%]176 M3K983*3R07HKPZ^5M7BUK0]2T MF[-I<0W,4,MNPY ,&22&>2-U8$%6/0T.*L9N_P E?RYGCU9KW3F:+5?-<'GG M5':ZF53JMH$*O7U/A@^ EX?[MN;\A\;550.M?D5^7_FG5]1UZ>YU5=-\TW-M MJGFCRW8:G-#HNMW5ND*P75[:1,%D;A;Q \659 JB0..JJ??FUI<_F[\NO.WE M/1]*MO-6H:S8S:)BT1&O8U1GFG6K1&&.43"GQ&@XT)4XJ@]<_)GR?KN MB>3M'CGU'RW+^7]NEKY+UWR[>RZ9?Z="($MI(8IHFHT86TK7[R";5[**22Y$&K3B5IIGYW,S&3F MLA$KCEQ:F*L_\O\ D7RWY1U-=5L)Y$O[K0]'\KH]S-426>BFY>S15^$&3_29 M2Q ^+P^'%6#_ )J?EI??F#YU_*V^CO;W2M+\J2ZW/?ZUI=\UCJ%I+>V*V]M+ M;,E>1Y=GD4N)&9U92QJJS2+\MO*UO<:W<6\$EN=?\ +=EY4O84 MF?@NEZ?];%ND0+$JRB]E!>M3M7IBK$=9_(+R%KNK:CJ5U-K$-CKMQ;7OFSRM M::E/!I&L7=FD$<%Q?VD; 2.%MH@W$J) @$@<5JJ@-?\ ^<>_R\\V7FO74^J: M];:5YBU&/4O,'E?3-7GM]'GU:UGCE^NO9QMP6?U85:3C17<E>E^8+7S/^G=9U*>]O[C4+(,MN9IG(!B1&XB)55 . MU:DJH+6?R9\B>9-3UK5H]0U+2_,\VOC6I_,>BZE)::C87[Z;:V$D44L1)CCF MM+>$20L"K[.5KQ8*I6/^<<_(-OI6@Z=HM_YB\L7?EF;5'T/S)HVL75MJD<.M M7;7U_;277-C/#+.W/A*&H0K AARQ5&:]^0'D76C:F&]U_P M-'HZZ!J;:%J] MU9-JFEISX6VHN'9KCB97*R,?57F]'')JJO3AY:TP>5%\FJ9!HZ:4-& #GU1: MB#ZMLXWY<._COBKS;1OR.T#3[_2;[5O-GF[SO^@9X+S0]/\ ,NLS7MG;7=L: MPW2VR"&-Y(SNAD#<3\2@-OBKK+\A_)FFZ^^L66I>8+;2Y-1N-8;R&-6N3Y=. MHW+M+-7=*T M76]4NKZTTG2KL()[;34EDY0!Q&@Y\C( BJKA5IBJKIOY,>38(KS1[_S/YA\V M:F+K1-4FNM=UJ:_OH$T>\2]TZ-.9 CA-Q:EFH@,I#;] M)U&>2%/S1UFVU+6(_K1CDN+VRMK6.-;:IJM(=.C)5:[*S>)Q5C6@_P#./?D# MR_>Z9-;W&LZAI.BW5QJ6D^4=2U*>\T:WU&YEDFDODLI24];G*[(354+%D56^ M+%53R_\ D#Y,\ML\%EK'F:[T:#3[G3-"\K7^MWEUIFDVMW$UO(EC;2.>%(F, M<9B@ ;GOBKQ2S_ "9_+JS\P:?J5MJV MI?4EU6?6] \BMJ\SZ%#JJ3/<37=KIQ?CSCE=Y. )B1SS6-6 (59]<>4K*#6? M,GFNQ>2/S)YCT6TT6XNC*RQB+3WO);0JM&",LE[(2P!/3;X<53OR];7UEHNE M66IW/UW4[.RMX=1O=_WT\<:K++N ?C<%M\53K%78J[%78J[%78J[%78J[%78 MJ[%7_]#[^8J[%78J[%78J[%78J[%78J[%78JDGF6RL-2\NZ[I^J73V.F7MA< MP:E>1RB!HK>2-EE<2G9*(2>7;KBKX3_,7RQY:N+;4?//E;RW8>3/RJ.E>7/+ M.O-;VPTPZ_I5[YDTN2^N+FS"1,EK9V22QQRR*)&]>?B!'1G59[=>7/RMA\__ M )U:5J46FZ/^66D6?DC5O-6D6G"'3I->BGOF6VN;:)2LIF@6P+0*O[W]V.+% MJ,JIZ;^7OD^._P!;O_,OE[0?+USY\\TR7WY-?EOJXD_0T>JV>CO;1W-]8V]+ M475XB23M#0NJJ"O[X/Q5>C_\XR7!C_*^#2;A+>&Z\NZYKND7)T^19-(>:VU* M,[Q(GI-\49)59Q^<'F*3RMY"UC5H-;D\NW;/9V%AJT-I#? M3)06<"0P7#Q0M+(\P1#*XC5F#2?"I&*ODS1?S2_-*7RW^:6A?XDO;#7_ M "OY\\DZ#HFK:W^@M4U6Q@\Q:A8VUW;ZA^A533V95E"&\T.?45T]&2T33Q/<7,06!W MM]D#(%D?BP5>E_\ .-#22^7_ ,SS-KEOYFG'YE>9(Y_,-M'%%'=M%+%&9>$# M-&'^&C\*#F&HJCX0J\!_-C1M1%[_ ,YAW"^;;^=;BU\F16>D7$5B]K:RS&W: M&8!;9)F] K\*M+1@S<^3<655F?YB_F'^8?Y5GSIY57S;J7G)TG\CFP\UWEII M":EIT?FO4]0T^[H@33M/8*;%%@:XX*CRCU&< !E7K_Y%^9/.FL'SSI'G%+^7 M_#.IP6VC:AK4^B/K+PS6R2R0ZC%H$\]JDL4A/%@(V=&6L2TJRJ1>?]<\ZQ?F MRVEZ)YOO-%\M^5_R^O/-]]YU:ZNO,,OE.(+-#:1RP7&CPZ!>SW# MVLAD>-TG23A5*S<@RLJG'YL?FSYZ\NZYYD\Q^5/-NLW6C^5O->F^7I+0Q^6[ M'RY;3"2T2[TZY6\:36+^YE6XV^K>DM2.!HAY*I)IGF#SK^7?ECRYY7T;S5YH MU[_E8/YL^?-)NM:M(_+HU*T;3]4U>1;:RDU"*RL$GOY83*6N#(:AUAC-5556 M<^4?/GYE>;];\I^2_,'G1ORZ*V7F2]?S7"FAW6H:TVCZG%;6EK(8VU'3(98; M=S)>10NSG8KZ(Y *O7O^<6&$GY!?EU(+B&\]6UO'-Y;#C!,6OKAC+$ ST1R> M2CD: C<]<58%YBU?\R[K4?\ G(#S)8?F5=:'I7Y3ZHD?E?RS#I^G26DP30=- MU*>/4)9X))Y(Y)+AN(B>)UJQ+M\(55BD'YA^>[ORKY?_ #&?S^T=QYN\^R>3 M+K\IDL[/T+."?5;C2FMK=_JQO1J%C$GUJ225VC;TY*PA".*K ?)?F[SYY>\C M_P#..GY<:'YA\U7T&O\ Y;+YD76]&C\K_I&66!;*)=/@;6C96GU>RCFYNJK+ M<.I7DZA2[*IXGYN_FUJ5Q976IZG?:5;Z3Y1T;6M5C\E)Y5/R0T/3_.;>0KK\XM!UOS_P"K3K:WSV,!OXY+<-2\9R3&S M>A;%%"*"R*K[3S]YX\V/YF7(?R\\A:3YFLM0T73[>*S\QRWL=[,^IR M1ZK#=0WP[K7VKMBK7E?\YOS9.C^6?.*R:MYBL?-WEK5=6N8=9/E6'3 M/6MM,EO89=#BTB_GU$K#/$(Y(;A96X,6D:)TH54Z_-&V\Q2Z9+Y4N/SYG\RQ M1^8/RYUM9(;'28]4L3?^9+6V1GFALS9FTE;_ $BV1T]8/%\3RQ?\K:\ MR>2-<\P^9M=FAN?R[3SOYL\J:K#';P6XL[^*."ZT.>1X(A(_KM'+:.S%F:26 M'PQ5C6N?F#^=-CKFH>2KO4]<_P 3^0_)6D:]JESH$?E6WM;[4+Z.YEN[F^;7 MKFU?ZA!-#]7"VJJ556,D_-@ JFLGGS4_*'YB>??S#U"6/0_+-K?^1W_-:(M% M-!;:7J>A7$!N&GH6"V=W)"Y=" 4YE@10A5]1?E7=^:-4\C:7KOG!GCUGS*9] M8&F.J*VGVE](TUE8-P45>WMFCC=C4LX8]\5?/GFWSK^8?EX_\Y+^?;;S1>ZE MIGY6W::=Y2\AP6=B+2,2Z'I=W-=W,K0_6)6BEO'E ,\:!5(<\?B55Y1YUN_S M \V:-J'D3S-K7F*#RX-?\@7]MJ/F(^3;G5I'OO,UK:-;SV^CF]MI;21'2>)I M((R7C*%IHV(Q5DL/YL?FA>:_YDU+1K?6(K+RC^8#>4/\+L_E.R\M+I]KJ$=B M(;E[N]BU=+FYMJW$4B(%JR+'!(@JRJ9:=Y@_-B]_+#R'Y@/YM:DNO_F?Y]L= M$.I)INE"/2]+;4K^%X[.%K0AI'MXD4O-ZG[P!U4 LA524_FU^;-UJWF?5]-_ M3U['Y/\ .[>4Y?+]R_E*ST">UL]02R]*]DN;N'5EO;RW!N(Y(XU7G(BQ6\B# MXE5-M;\Q^:])_P"<=_//F+\S5U.[\Z?F3I+WWY<&UL8+;3;J$WCM96:B*.^2 MXL OIW(GDDJ5<\(ZCBJ^I?\ G("TFO?R7_,V+G0I?\.7TGZ1M1 952*,R M.E+B.5.,BKP8\:@$\2K4(5?/VL>>?/5CI'YL^:H_S9.FW/Y,:W;:#IGE"[LM M/>+5HX;>Q=)=6I:1W#7&K&Y8P&T:*->^8;Z[K^6&M^;-+ MN/.K^65>.]TYK+ZM?I;>7.36EE*+IJK=.[-P''CP?DJ]G_(WS=KVIZUK?ESS M9JGFB?5X=*L=8T_2?-MAHR7L-K<230R3Q:EY>D:QNH)9(QZ2^FCJ%))<-\*J M3?FQI-W/^=WE"_'FG4;&S@_+/SO)/Y=A6R-M MDG K63FJP:U\R?F)^4WE+\NKNY\XW/Y@#S%^7>L:E_AZXL+&VMK:[T/1(M0M M%TY;6&.;@:&-DGFE+"AY#?%6;?E#YN_,2[\\)H7F"YUK5_+.K^66UNWOO,L_ ME47R7:7$$<8-2.BZ7I7JRWL&OW%G;B(3VLD,48C6DBB.K;4*MR M8JL#U7\[_P Q=3\EVOG_ $7S=JB3Z3Y>\NW?F*QTZ#RWIWERPU2_TRVU.:"_ MDU=YM1NWN5N5,<5FJ *PC5^8+8J]J\P:M^8]S?\ Y^^9=-_,BZT+2OREU2*/ MROY9AT[3Y;6=4T'3=2N(M1DGA>>6-Y+A@HC>)TY-\;?"%52W2_._G/5-%TOS M]??FE::?+YFU7S#HTWY27>GVDMM"M@EZ%L;8Q1?7!>VBVHDG>X=HBO/G%&"O M%5@'G3\V//MAHM]K_EKS?JQ3R=HWEQ=7L+2W\KZ;Y?T^_N]+M=0>#49-3+WU MV]TDZ<(K%(P%98T8."0J^IORMX_XV_YR#X@ GSU9EJ>/^%M"ZXJ\E_-_SUY^ MT;\RAH>@ZKK%OY=TWRO'K]Q;^58M$O-0MYA>31SW6K6&LO'-<6 1$ %@PD!6 M0.REXL5>>>6]7UKR[Y=_,.71?S+\Q3:GYZ_.'4;'0+:RT_0Y=1N/]'-_+!IW MU^*SM;>:>%/BDO"Z(L8"1AS\2J4:9YI\Z?F%I?Y.:WJ_G/4;;5_*/YL>:M)M MY;&31;J:_33O+^K3P+=7%M9RV;-?NK71M&66SN]._1P2+2S) M:R"**5M2K(+@3L1'1'0L2%7FFD?GE^;?G:TO-3LI=:TR^\L>5O+6JFTT5/*T M&CSRZMHUMJ,MYJOZ>OK>\-M/<3M"GU4HL8C/[UY#Q55Z)J_FO\TK71/S:_,2 M#\Q;BUM_R]\]3:+Y>\FC3M.?3GL(KNRADBO96@-S(Q%PXC>.6(K\/+F0:JO. MM(U/\Q/)>F:/Y<\M^>?,?F&'S-YY_,EK^PTL>6$\R"72]>N422QAU.WMK6>$ ML7EO(P3-R93#PA5@JKW3R]YDAU/SY^1?G;3-0.H_\K3\H:II7FG41:/IJ7XT MF**_M+MK-I)C$T,K7"HO-@%F8!V'$XJ^JU='7DC!E_F!J,5?%6O:SYHTGS'^ M9=GY/UX>6M3\T_GCY;T*]U86L-V4M+SRQHXN*13@J6*+\)/1J'XA52J]P_*; M4O,,M_\ F7Y8\Q>89O-3^0?-*:/I&O7D%O!>3VD^D:=J2_6Q:1P0/(CWCIR2 M) 5"_#7?%7GOGGS3YNU+SW^:FD6'YA'\NK'\JO*NG^8-+T^"VLIGU9[N.\EE MNKYKZWE8V:-;"#C;E&Y!ZR E0%4+_P K4UF#R/\ G[K^K:S%YW4JJ9%)9JKVXA5F_Y1WGG#S!YJ_-36]>\ZWNH M:+HOF[5O+OESR<+:QBL[2UM/JI25I4@%S)+R+@%I>/%J%2P#8JN_,_7O,4_G M_P#+'\NM*\TOY"L/.5KKE_?>9K:"VFOII=)CMC%IUF;Z&>W1Y!4+6^\G:YJK:U/HOF&?2HM3L MUU**X5+>:VB6>10K#BXX,@^(JH:'\U/S.UCR^=4BO;/ROYIUKR]^55;^'3H) M4CE\P^:;[2[RZ"SJ)6AN;91)%$[GTPWPT8L2JRR7S;YV\N_F)#Y%U'S!+YZM MO+OG"UBLM0U*QL%U*ZM[WR;KFJM;,]I;0QJPN;10DD,4;\"8V+"M54IL_P P M//FE:/\ E9YC'YJP>>IOS@\MZQJ-YHOU&RBM=.>TT*?58[W21;0I,L%M<1I; MR)=2R5,J596V95ZUY3NO._EG\RO*7EGS%Y_N?.VG><_)VKZ_J"W]E8VHLK_3 M+G2XP+ V<,++;NNH2?!.TKCBO[PGE55]"S+ZD3*LK0EQ19DX\E)V##D&6H.X MJ",5?F_^7?ECS#>Z'_SBOINF?F/JME>7M]YYF?S)]5TR>]MK00RI+:V8-H+= M2[J'YS12L"S#IQ"*IN/S?_-37=<_P3;:EKZW_EW2]=N!K?ER+RS!<:Q-I'F' M4]%^M78U^>W@2&&.PC>XCM$KREY%X5"AE7V[^7VLZGYB\E^5=>UNT@L-9UK1 M[&^U:SM9DN+>*YN+=))DAFC9T=%=B%96((W!/7%698J[%78J[%78J[%78J[% M78J[%78J_P#_T?OYBKL5=BKL5=BKL5=BKL5=BKL5=BJ!U/3M/UC3K[2=6LX- M1TO4X)+74=/N466&>"92DD4L;@JRNI(((H1MBK =%_*3\IO+3WL_EW\O/+6@ MRZG9OI^I36&EVMNUQ9ST+V\QCB'.-RH)5J@TW&*JA_*C\J_\.?X//D#RY_A# MZPMX?*OZ+M/T>;F-@R3FV]+T_45@"&(J.W3%5*T_*'\I;#1=3\LV7Y=^6;7R M]K 1<7912A(J,53*3R5H<-_Y,N]+M[?2K+R,MVF MD:39VT,4*)=V_P!7X1\5'I(J$GBE QH3]G%535=4\C>9UU7R?J\ECKT$]^?+ MNNZ#7_+%FVG>7])L MM#L3*97L[&".VB,A"J6*1*JU(516G0#%6*>;="_*^P.K>>?.6BZ%&SV,.FZY MYCO[.!Y)+(W$;0V\TS1L[1B?@RH30-0TKBJ#_,#7/RH\IQ-5M%M=.\EZ+I_EW M0'4W5IIFEVJ6=N/7_>&00QH@4O6IVJ>^*IF=,T?](G6/JEN-6^J_4CJGIIZ_ MU7U/5,)DIRX<_BXUI7?KBK$]+_*_\L="_3C:'Y%\O:,?,T1A\QM8:;:VYOXG M9B4N?2C'J*2[&C5%2<56:O\ EQ^5]WJNH><=;\D^7[W7FMG34O,=QIEO->O; MQ1<&5YC&TC 1@+2O3;%5:7\M/RWU"QUVVN/)6A7NG^<;I=2\S6\VG6TD6I77 M5;B[1HR)9._-P6]\52V#RC^4?F[0D\M1>6?+FN>6O(NHMI]MH+Z?;2V6EWUC M0-'# \92)X^8^R!UQ5EAE\J>1/+[G_0/*_EG1E+%41+6TMUED[*H55Y/)V&Y M/B<514GE_P OR)KD4FD63Q>8W,GF*)K>,I?/Z*6_*Y!6DI]*-(ZM7X5"] ,5 M8KI7EC\KK[S3J?G/1]!T"Y\Y6%U-I6K^:;:SMSJ"7,:+ZUO+=*GJ+]4L )Q()&2ZN&CA:@;BRQ]JE5G>M_E[Y \S3:-/YC\HZ)Y@GT!@= EU"P MM[EK-E(*_5S)&QCIQ% M!MBJ92^5O*\UY)?W.BZ?<:G)=6U[-J$MO$\[75FA M2VG:0KR+PHQ",=U!VQ5*=&_+C\NO+FLZIYC\O^2M"T37]=1X]:UJPT^VM[J[ M65A(ZSRQQJSAV 9@QW(WQ5"6GY5_E?8:'J_EBQ\A>7;/RWK\HN=>\OP:7:1V M5[*I4K)<0+$$D8% 06!(('ABK(I/+/E>2VOM.DT33Y+/4KU=1U*Q:VB:*>\$ MB2K<2QE"K2!XD8.17DJFM0,52KS)^7OD#SG/87/G#RCHOFRXTER^E7&KZ?;7 MLEJU0U8GFC4]&\Y6?F#R#I6L:5Y?\ ,'GBUMKGS=-+8QWM MY=Z)!,EO.#&TD1!9"88Y7Y",L2JDC95FMQYW\G:?YJTWR!-K44?FO6+5KRPT M)5DDE-NHDI(Q566-3Z#A2Y'+B0M:8JB[V'RQH4.I7=U;6UE'YBO;=-8E6W#? M7+J[]*PA,X1"9"X].*K#90 2%&*L5L_)?Y0^1(=+\M:;Y4\M^5K7S5K$/Z*T M6ST^WM8KS5+")KZ!EBBC56E@2S:5&(JO"H.V*IWZ-Y,T+2=)MKO2+&TT?2=2 MM7T6T6T5HK:_GN!';RPQI&?3?UIMG %"Q)(%3BJ%N/R[_+NZ\T0>=KOR;H=Q MYRLN/U;S5)86[:C'P5D4K=&/U 55F /+8$@4&*J7GF&/3;9;V6YC-4F>X6,.74]&)K7%41K_FCR,CZIY=\Q:K8U]'3K;5] M)NP'1HO,-R^GV,5[>&U M\MZC^CK7ZQ800+PACMI/3Y1K&-D"D<>U,59K(D$D#PRD20RJ4D#@,&##<$'8 MU';%7GFF_E[^4_Y?V=YJ>D>3_+?DVRLX;FXOK^ST^TL4CBDC5;EY'2- %9(U M#UV(45Z8JG/E'R+Y#\AP75OY(\IZ/Y2M;YEDO+?1[*"R25@/@9Q"BG M;%5GFG0?(]Y+I&N>;=&T_4Y](O(X]!O[VS2[EL[K4'2T!MV,;O$92ZHQ6@I] MKX1BJ<3Z'Y?78I(M(E]"/E9PO&(I$@)4^FK1KQ8+2JBG3%6*^0 M/*WY7:5I$6O_ )9>7M T32/.$%MJ:ZEH%C;V<>H12+ZEO.Q@C3U 5>J\AM7% M6;7NGZ7?7&GW-]9V]U6I]2TBRCTS2-0?2K1IK:SBC>&.VAD,7)(TC=D55- I('7%63OY? M\N-!J\$NE63V_F)S)K\301E+YO1CMRUR"M)/W4:1_%7X5"]!BK&-1\I?E9H> MKWGGK4O+GE[3/,&K^EI%_P":Y;*V2]N?TC+':1VLESP]1_7D9(PI/Q&@WQ54 MOORN_+#4]4M->U+R'Y>O]:TVU6PL=6N-+M9+B"VC1XE@CD:(LJ*CLH4&@!-, M598EIHN@IJ^J);VNEI=DW^N7RHD7JM! D1GG< RV,.HO*D%S'ZR-Z8F:U< K2O#?IBJ M(U'\L?RRU@>8#JWD?R_JB^;)K:X\T_6M.M9AJ4UIM;279:,^L\5?@+U*]L55 MYORU_+N73H-"N/)FB2Z/!>V^IVVC/86[6J7EHBQV]RD/I\%DB2-51P 0 ,5 M:TK\MORWT35]9UO1?)6@:5KGF".6/7]5L].M8+J\2=N4JW$L<:LZNPJP8T)W M.^*LB30]!BGL;F/3+..YTFRDT_39TA0/;60/+FH3>4XHK?RS+/IEK(VG16Y5H8K4M&3$D952JK0 @$;X MJR&7RUY6:PU2PGT33Y--U>X:_P!:LWMHVANK@E9'GG3CQDCFKTZ[' M=55TOR]Y:U'\R-9OSJMG>3^3O+=MY8L?)=O;JD>CVNJ$75P9!NK&[2" * H5 M8X@*?$V*O1?TAH&B3Z+Y=-Y:Z?<:BDEOH&D\EC:5+.+G(D$8I\,48!( HHIB MJA+Y:\KR3/=3:+I[W,VI1:M)3WM)$MK[35OYM-EO9;=;;C*\$BQ.[SPMQY5 97(" M[XJS+6?RW_+KS%J\&O\ F'R7H>N:[:0&UMM:U#3[:XNHX74J8UGDC+A2&((K M3I/)Q Y.W$: M+?ZOJNC^3M#TK5/,$;Q:_?VFGVT$U\DN[K<.D:M('+?$#L3UQ5'>8?*NC:[8 M7MN]K:)?S:5=Z1:ZE);13R6]K>A!-&HD!'!S&A9#\+%5J-ABJO=^9O+ND-)8 MZEJL=C)9#3A+ZY9174[DVEBOJ,O%GFG7@J@\N5-MQ55)O+?EC\NK:XO;SRQY M>TFQNM,UF_EO+BTL(K>2/5;A$COIN0C0F25 JR./M@ $D#%5NK?EE^6?F*TM MK#7O)&@:]8V-Y<7]I9W^FVMS%#=W9/)$NH>5H_P S-=CO[K6X]"L[J\_W M(75KJTWK3VUQ-"JI6O-%GJUW)/>Z>WE+4[O4=-@UDNT]U:QW<*<9O49E9F5)N<:E%6,^<==\S MZ+I"V]SYYGE\J^4//?FWRU!I'F'S3J?E=KR&)+6;2T;S7!%(1-:@2K#'>RA9 MPQY.[QC%4[D\\V>O)<:E^8GGOS9Y 0?E_H6H?D[I6HZE+H]]J&I2VURUW8]3DM9[C3?,^M?F4#K&FVP9(I MKT?E1'X#8JQ%=?\ R^C\V_ECK/DG\S_,?GJ\L/*G MG&]\W5U2[U2]M[V+1ARN!#=K-^C[UF5Z6ZK&O_%!"@A5Y3K.K/K_ )8_.#0' M\W-J/D2'R=I.LR'1?.FO^:+:*\T[6K=;B=M=OA;EG6WF#3Q6](4' R*' ;%7 MIWF;SCYIE_,+SCIO^,K/R[YCL]?LK3\J?KWG76;&2727BM!I\MGH$&F7UOK, M=V3(9I&EF=RS O!Q'!52_-35]%U#RW^:4?G+\P-9MOS>M_-QAT_\NQJ5U#;C M0H]:@&FPQ:,I:VGM9K%%GDNO39E=V_?(R@(J][_/C0[6]_,W\H-7^N:M9WNE MZ=YQEMI=/U._LD62WTM9XRR6L\:-\:BO('FHX-R7X<58Q#IFI><]T\O\ Y/\ E/6].L--UF^T^-M7NEU@R7LQM9(GEE'H+568H_\ NQ'(7BJ\ M'\]_F?K4ES/K&E^<;S3_ #UI]WY;,EGJ/FG5;>_/&UT^YNGTSRA86B6,EA,D MTA>YNRZ-^\8T'"BKUCS!;Z]!Y4_/#\S(/./FA?-'DK\P[JS\EVJZO=QZ;96D M-[81?51IRNMM-%*)'#>NDE Q"%!2BK?E;S'ID]E9ZA%^:GFJZ_.6\\M>8+C\ MS_(OURYNX+*ZBL9I)4O-/D_=Z.MC=A([66%8VD^%:S!^>*O/?S<_,'4;/S5Y MGNM \VW>E^;_ "_KND6T%A?^:]5AU$0VZV4TS:=Y3L;<6DMC)'(Y:ZO&=7'J M,QIQ(5?7/Y01W#Z;^=L<$K6D\GYB^9A;7*Q>H8V(A"R+'^V0=Z=^F*O@35/, MC>8/('GGRMK^M:IK31^6TU+S)YCT+SUJ>KV#7.EZGIQGO-7TV^CM=1T*?XY: M0'A#\,@9#Z:,JKT/\W/S!GMO./F.Z\F^R@6R MG>73?*]I;FTN+&:"1F:\OI)%D'J.S?9(506H:F?)6I^==(T?79K31;W\WM=' MYI+JGF_6-(2RM9;1I=&^MZA"FH7&FV][,S'UDCB$W!%:=54 JO4O+H77ESS'JGG)QJ'EG7-1)U+0[>#U-/M[C5FM=.N+GTR0!<)'&S!5* MR-R9W58KIC^?-"_+C\JOS T+SCYK\T?F!YLN/,^E75IJFIW-Y9W<%GHNMS6% MN+ _Z.CPRZ=;LLR1>LS!B[2%V!52!?-7F*[\F_F1/Y,_,*W;0XO+%D=1.A^= MM9\VWUGJUUJUG%:WBWFH:=:G3Y7MS<++ )=R$/H(%;DJS?\ -SRYINAW?G?R MCJ'FCS(/(WEV^_*OS.HO_,.IRM827WFF[L]3N?TA)<&Y2+ZO;I(0\ICB91*@ M1@&"JC:>=]:\O_GPFC:MY@OO-6H7?GF2SA?2O--U;:E!IM^Y^J6E]Y*U"V$$ MEE;Q2J3>V=2R(LWJU+C%7H_YN:QY7B_.O3-(_,3\Q]6\B>29?(DEZL5EK5WH M=G/J@U,1Q22W5J\1]54J(T]1?5^R5DIQ"K!- 3\T=2'F#7=?U?S'/^8'D/\ M)W1M5T+RX+RZL+6YUN6YU^..^O=/MG$6+2^\P/8^;_,7G.2"]74K:3U)KR728[G2?K5HMS!< M>D6>)2)EMXO29BJAI/S*UZY\E:#!;3WFF>1X?.UQ8^:(D#Z.EQ8 MVEKYXTVSN;P6)N7/J/* ZS#TGN(T(4JO1/+:>:O.?_*B]!U[SUJ%QY;\R:MY MQECOO+6NZERU/1;6W$FGVUQJYMM.N;D1L:"X1(W=54J[;= \KOJFLW8;4(]#\WZC8P6_U3%FFTK6[RQBB6_U;5;*61R3-;VL M*)&&DG$)-NAFF3B[,Q585^77G/S%)I/GNULO-C7NCV7YC_EPOEV;2=>U77;5 M;+5=:L;74(;;6=45+J\MYN#I(P_<$^HL8"\EQ5'^6_+>H:KY._(W69O,?F#5 M?-WGKSGYD%QJNIZQ?W'U67]">:H;-;1'E*6BP!E0&%5)"KS+,*XJ]D_*+\R& M\_WFM_FMK6H2^6/)?ES2;/RPMC?R&TM1KJLLFO2SI+P0O;71CLD<57DDH5FY M8J]0_./4=0TWROH-QIM[<6$\WG?R9:S36TCQ.UM=>9-.@N8F*$$I)"[HZG9E M)!V)Q5\P^3;;7-.\H_DI^8+>9O-GGV+2-?^OZM=W-E-I-U?:A#]3-A M(WU8)&D:<9/2]6J@F0XJB/\ G)OSC%IGF<:./,4!E"(K1_#^\)*J \P7]SJVJOJMW-]:N]3T3\A M+R\N@ !)-+YPO))7H@"[DU--ABKW3\W=.O/,'YD_DMY5_3^MZ'H6O2>8CYC@ MT._N--DO8K73TDBAEN+9DE51(>0*,K@CX6%2"J^=- GUWRYY#_*+\Q;_ ,]> M>=8UWS3>>9]+\V.VJ7-X9]-LM&UN>VCM[!@UJDT#Z= TJ6!,C/R8%5@> MDZM+YDTO\]/*R>:CK'DI_P KIM2CBT+SAKWFF%=0TV?XY?TY>K [2E)$]>&U M(BXE1*I)W53?5?.6MS^;_,6GZ;YZL],U.TU;3;3\G+K4//6M6\ESH;P6:Z;< M66BPZ;?6^NQWA9C++)-.[EW#/!045>I,NLP1?F3YW7S7YEEU@?G7I/EJRM3J M]\;*UT<^8-&BEM+>Q$@@"RJ7#'AR*N\?+@Q7%7FOY?\ GRZU'\T_RXGT3S;< MW-GYCU35;;S?HM_YMU;7]7]*XTW5)HHM9TA[>#2]&ECN;6-$@C E#+P4DWVF?\X16FH:9>7&FZMI_P"3*7&G7UJ[Q7-O/%H@:.2)E(971@""-P<5 M>-?F3J>I^2_-]]Y0U/S7-H/EK1O+.GS_ )=:MYC\_P"N^79KFZN!<2ZA>Q7$ M-AJ/Z4N4N&C7T9Y&"*%5+;@U655M0\Z^9O+/YOVUKYG\Q77FK5[CS#H @L=& M\SW>C:M:6EZMG$]E'Y0U"U6SU2S:1I7>XMP9?3]0\HI$^!50\D>99[ORKY-U M/R;^9FN^;/S[_P 1NNJ^1[S5[J\CN-(34YX;N&XTF:1(([2&SK)'=%%9G2," M9F?BRJ3>0_.GGK4!9WOE+SC9ZIYRC\KZS=^??+S>;=9\Q:K<7,.G/Q:?0+S2 M+:#2KBWO@G!4:%*%HE2:JD*I_P"=XORPU7RMK)\L_FQYH\W>2=%\P^0-3\S7 M4VOZA=:=IEW_ (AM([FX.M&<2PRFU=I)[8R>E 528)#( <51UKYUUCR_^>[: M+JWF*]\T7UUYXEM(?T3YINK?48-,OI";6UOO)FHVP@DL;:*4$WME4LB+-ZM3 M)BK[ \^G1O-OY4^:S9:@VH:-K/EF]FL]2TJ[EB,T$EH\D4?+GFCS=YIU?R]YR\PW?EWR[^3_ ):N/+-]H_F34!%>3?6_,$D5 MU/?P7'KWC1&,JHDF=*,P96-.*KRVZ_,/SSK/F35!J_F[3_+'GN>^T7_E7UO> M>;=6T=WM+NTLI();'RS:Z3=6NJQW4SR>K5Y6)9D)M^*\57V%^>>J2Z?I?DW] M(:Y>^6/).I>9K>T_,?S)83R64EGI0M+J1"][#^\M89KM8(99D92BN?WD?VPJ M^?H]?\LRW7DZP\U_F]YIM?R/DTG7KCRIYZOM2NM$DU6_AU"*.U@FUN!H)KE+ M6VY&S,CAKL$NWK\:XJWY0LO-WGY=0O//OFOS;::AY?\ RDT#6(=/LM1O=#$F MJ276OK%J=S;VCP.+B2WMH6DB<^F2?CBJJA56'#\Q/,VC_F+I%WKWF6\\U:MJ MNH^6[RPT_2_,]QI&LP6NI6UC6Q'E&[MEL-3LVD>4R7-J6DX>H><;I\*K)_)' MF5YKC\I)[7\Q==U[\Y]>UAH?SO\ (MU>WD\5K:26UVVJ1W.C2-Z&F16,@C%M M*DK\:K'O+_F'S+8?E]Y.L+?S%JNA^5;?\M?RAE\V7]A+*)-)T>[G MU==9O;4+7T7DC@BBEF12ZQ_%MP5E52+4/,GDS1]?_,5/+_GS4]4\GZOYD\O) MI?FF_P#-]_H^CNEIH-S.+6_\TQ0W-[+:\T/H".4O-)^[]4HA4*IGY:OWU)/^ M<:_,OFWS-J$^O:3K?Y@:%H5]<:MJEE#_T(EO7O&E:WFE"UDM@X"<5/I1\B65:_1/\ A37OSMUG0]5U MNSO-2_.[R'I]R#JM_+ ;6^D\KM=1I!),T2B1;F2)N*C]U2'^Z54"J0^5HM=T MCR+^3GYCGSEYNU7S)YG\\?HK7A=:I=7EO/I5S>:A$;%--D9K;]VD:"-Q%ZO) M5K(=ZJO-_)/G[5)?->CGRSYUEN]/U[R9YEFUR!/..J^:[\7@TTWUHVIK9_-6M7_F3\MM=U;6(]3U&Y MU>26_L+_ $2(ZA;QW+2K;S1V]]9_)7F?_ !/IS>;=5\VWCW#:8UY:KJPN;>#3].NT M,;@6]JJN*2#>,;*OL/\ /O49]+_*""\MM>U#RQ77/)]O>Z]I3O'=V]IX$I$!GE42QT81JL5\S^9M>M]%BO;+\P)]9 M_*K3_-VN:9Y'EUWS+JOE1-;L386-S9O'YO@CEY_4KH7<-M];D$=VF_J2F,%E M4=YWUJ/SOY8M=2\TZKYITCRWI^A_DSY@GAU?4I].NK)KCS1>P:A>W[V#6T*R M&! \DJJJ_"DH"\$XJLKO?,TMUYJN]/\ S%\^ZSY8_*Q?/GG:VU;6TU*ZTN$7 M=DFF_H73)M6@DBDM("LUS+&JR1J[QJE37@ZJWR%:>9?S&\Q>6]*\W>=?.,FD M6WD+6+^R:"^O= N-5BA\R7-KHNIWHMC;S"9K!(I#]CGRK(A%%"KZH_)35]3\ MP?E%^66O:W=O?:WK?E71[_6+V155YKJXLXWED=5"@,S$DT Q5ZCBKL5=BKL5 M=BKL5=BKL5=BKL5=BK__T_OYBKL5=BKL5=BKL5=BKL5=BKL5=BJUPK*0VZG8 M]?X8JQ7S%YE\K^3O+VI>9=;NTL-"TI0]_:94H0.-?BH < M57:-YA\L^8SJ\>EW4=X='U2YT?5(WC=.-[9\?7BI*J\^'(?$M1X'%4[/U&5Z M,(WDB//B=V4G]JG4?/%6+>://'E'R=-HEKK=XZZGYENGMO+NC6=M<7M]>S1) MSE,%M:QRRL(TWD?CQ0?:8 XJUY:\X^3_ #/YMY;2] MLI+B/U8GGMYTCD594^)9*<6 -&/$T59.%T[C&0(^'$^D?V>)%6IVH0*GQZXJ MVS:?R16:+FB!XEV+*AV!7N :=L5<%L))6-(Y98Q1OVF4'>GB >N*KA/8.O,2 M12*NP8$,!6@H"*]<5;62R8!D>-@_PAE((:FU*CK3%6@EB[EE6-Y%_=L0 6%: M?#XC;MBK:R64A>-6CD(WD1:-0^+4K^.*NABLV#20JC!OMRKOR VH6WJ!2G7% M5H2P:4*!&T[+]G8OP/XT_#%6-^4_.OECSII$FL>7+B6[T4R2I#J,EM/;Q7'I M.Z220&9$,BAD8.CJO/@6%66H]\53YC93 MN>7"1U2K*=R%;^8>!KWQ52:72XTEO7D@5+9'::[)4>FB"K\G[ #K4XJ\6T#S M)^6GFC\P-)\YV&IZA'J7F'RH]CY[MXA*REE?X7V MC(?CQ^+%6>>1?S%\@_F9:ZU?^0O,=IYHL/+VJRZ)JFHV)9X%OK9(Y9(DF("R MA%E7XD++O2M0<53KS)KGEWR?HM[Y@\P72:9I%FT0NKG@[%I)Y5AB14B5GD>2 M1U154%F8@ $G%6$O^;GY;VWZ0L;J]N=.U#3+W3]-N?+=QIM[#?&XU;U#81QV M9@$DBW!BDX,BE"4?>J-156A_-K\O9A916=[=7FHW=]?Z9;:#;:;>R:@+K2U0 MWT;6BP>JGH"1.;,H7XEH3R6JJ&B_.+\L[Z'0;G3-3N-;FUZSOM0TNSTW3;ZZ MNTMM.G^K7TLUO% 9;?T9P8G$JJWJ QT+@C%7HFE:CHOF72M-\P:1>0:KI&L6 MD5YIFI0-SAN+:=!)%(A&S*R,"/8XJBHVT\(/2,7 *.%* *:@;=@3BJG*UO- M:R&UG1"5;T[I.+"(]&=2P905KW%/$4Q5Y5Y2\K>1Y?)FN?E9I6LW^MQ>5[PZ M=YQO[B1DOY[^]$6LW,EQ<)'$KO="\661HP%/J$;'8*IC;?G-^75\FBRG5YX] M,\QS2V_E_7[C3[R#3+Z>!))62WO)(5A8E87:/XOW@4F/EBJ)L?S5\@7I13?S MZ=&^BW'F2R?4;"[L8Y]*M/2:>\@:XAC#I'Z\9;C\0Y TWQ5 7/YO_EK8O=IK M-_=:)8F>6./C$&<.Z J"ZU59/Y<\Z M^5?,^HZWHFER30:UY:%M^FM$OK.XL;JWBNPSVTAAN(XV,E-\54&.F0H7HQ?X-ETB/6[36Y(I%4:?)")TE$;( M)%!0@\>-?:N*IAI?F/RWK-]K^G:;>QW-[Y9U!-.UJ#BRF*[>TM[Y4!8 2'T+ MF)ZI4?%2M00%4W/U!"RTC5V_>E:?$:?M4ZFGCBJK(+6&/][PCAIQHU E.E-] MJ8JI,]@W$2%">7[M7&_+J.(;OX4Q5HM8!UD_=>NI*PEJ<^5*D+7?OT&*L5\C M>4-$\B>6],\I:;/+=6^D+,+>XNV1[HQSSR7!]1D5-@TII\(VIWQ5D5[>Z186 MNHZA=RQQ0:?;R7.I3*"SI%$A=F8("QHJDTI7;;%70W&FSF:-(62.-$7M7NO,5II=\C7WE>[CTK7'XM&;>XEM8;Q$#N M&K#3#H=R1^LC?%6$^8_P P_(/E2\N;?S!K M$5A=:;I,>L7!,,T@2QFNULDD#QHP/*=PG$'EOTIBK-O]#$K@%5GI^\ -'(&P MKW(\,5G LM(@RDR.HH""-BQ ^="<52G4O,?EO2;KR]9:AJ,5M=>:+YM+\OI\3&X MN8[::\:)64$"D-O(U20-J5J0"JF-M,P.'J0:HX4@FA/ M2O?%50C3H31O2C+,&930?$PX@D'N14>^*L<\X>6-*\Y6%EH>I7$L-O!JVE:R M%MV596ETB_@U"!3S5O@:6W57V^S4 @[XJR9TLH5*NJ01@$-6B)1CT/0;UQ58 MYTXJ5D,7IKQ4JQHHI]G8[=]L54KZ]TNQM+R\OI4BM;6&22ZD8$_!$AD;:A+4 M4$T%<54+?4-)O])T[5[-'O=-UF.UFL7CA=_4CN^!BD,?&H6C!B6 XC=J4Q5" M^7/,GEOS+H]KYD\OZBE_I&I%UM-1'-5D,4K0L )0K?;C(Z;]<59#$8J$0T"I M\- * 4[#%57%78J[%78J[%78J[%78J[%78J[%7__U/OYBKL5=BKL5=BKL5=B MKL5=BKL5=BK"_P Q[?7+O\O_ #M:^66E7S#8[+\L_RMO[?R9<^4([?S/HCZ)<65I>:[;:YIDFG MR)I]S"CSW<-L;TRW"(:HX#R-L J^F_\ G(;R;HWF#\M=+T^?RA#YDT[0/-7E M._71XM/^O>A96>M67UQX;6.-V*I9>J&6-2?3Y* 0:8J\*UG\IU7RS^>WGK3O M)$S?FJ_YC7&I^2?,8LY'U.***[T\03Z:[*S)"T:L7](<)!SY\A7%4F_*;\O_ M #9:>8_R]U#798=!\_Z-J,MY^8%S:>2-6M]5U RI.E]#J?F6?5)+"\MYGF#J MP1P*)Z$417BBKZ1\X65YY9_-_P N_F-7WY@W.BRR_EOK$OY56'FC21YO MO9+26._\P:3'8ZA(RS:1)"EY)86=]);%XV4F4&3C$8P>:K$=/_+7]-W/E31) MO)VJ#\IW_.*_U/RUY8O[>:*"W\O/Y5N@WJVIXM;V,NIM($MYE5>#K&8PC!,5 M8\GY06/E?R1H7F31O)$VE>;M,_,S7X&UI;>?Z[9^5EO=6M(+82R5>+318+"% MB!$'#BW'>N*H*;R;H_\ @KR#JGY5?EKK,FOV?E>=/S7B%IJ&F-K>FZCH9B:W MU"\/I2ZE*UVT$J&&:20(D@21>8Y*I1#^7VNIY:_YR!T/2M!N+G0?.&@>5I-% ML= \HWOE'3)[F#5;J'4%L=+9WF]5+<0&25CS8<3NBKBKT?SWY,A_*CSGYK_, M#\O_ "5)I'EO\M;#RKYGBT+1+;ZK87JR3:Y8>8X[:).$!G-A-#+(%%6:*'E4 M\2%7T/Y)\KZMY._*I+#4[=M4\V7NG7^K^9XH',3WFN:F)+V^6-XC5 UQ*T^6%BOX[G2KBU@ MD&KW"RZG<"+ZP2T\B\T]6.-A)(5Q5]*?\XW6NMZ2WG?3[[RAHWE_1Y+NRN], MUGRUIFK>7](OI7CDAGBBT+6&+V2&%OY0>X\C MZS_ROV/\PXM0\Y^=U_+J#R_<>69M U*U7Z\=-%K)!+;6N-"\X0^2-6U766LK.\0V M#VGF-=2CL([1K2%8WAEC2,+S66%W:LBK+-(\FFU\K:/%Y8\B>8M-_P"6<LVIZC.(X-4CFOC&;5$E8QG@\?I)&:*L.O?RWU&;R ME^8T?EVW'U/4?+-II&J>5/+/D;6O*=O=W;:M8R)<3B_OKEKBZAB6<>I!'R*. MS2RGC&,59[KOY$>4X=1_YR,N-,_+2&&+2M*TN[_*N&ULI$@M-36P>>:ZT6) M(X;DW*1F26W D+!0S'%4KU#R+I%ROYVU\@:Y+^<.L^>=5O?RN\SQZ7>B6)T^ MJR6-S9:LR?5[.W65>4M98UD DY*_*C*L8\@_EUYQC7RU>:LD>D_F7IL-]<^? M7L_(^K0:OJD8@FN=1-G$DSWCN.3SNR!7>2K$_:.V*O'X-. MF\X?G!Y$\X6.F^:9_K%GJ&F_F)Y-\U6,XT;0]/N],//ZC]9A2%;E[J**%VMW MD$L;2\O@XG%7I'Y>6,?D_6OSUNKC2)=$T"'S3:W6CI%:/'"VGVWEG1H2]I%& MGQQH\+I^[!H5*]J8J]!\\:UINA>5K[S!J.D7GF&STL1WD6DZ=92:A=SS(RFW M6WMXDD:CYE\L?F[>Z?K.I>8++S;97WG?2H-'U* M)-&T,:/K&GVEIIZ7-I;R7B6L]^\]P\:LS.[NJ\?33%4ZA\UZAY,O/S!\X6?D M/6M1U7\R_.#MY&=](OB]KIT.CZ5937^HF&VFFM;=Y+,R+$RB2:B (#7@JG4% MOH.A_EWIWD:%_/L7EGS!97US>_FGI%C?6VMR:O-J!GO3/;0VANK>6\FEEF#F M 1%>2@J.-54;967FZP_YQBM]'UGR<-1\RVOE!=.N/).F*UD'1 +=(FBLY4:. MEOQ::&%@?MQQ[T&*OFB'R!KMOY8_YR!T/1]!EFT+S?H'E:31[/R_Y0O/*6ES M746K7<.H"QTQY))A)'!Z/J2NPD8!6J452%7HGG;\L;;0_P R+S2="\C7EO\ MDD9?*6K?F!Y4T"SD&G7B0_XC2X<6$"TN>-Q]0>\BA5FDC5?41QL57KOY!:'I MWE^;\XH])\N7OEKRCJ/G2.\\J6%[9W%FKV3:#I*-):P7 #I;^LDB1H @' * MO'B%6 ZMK5M^:VHC1DT'7?*GECRG]>3\O?+=QH&HVGZ6U86=Q:6=W=/+9+!9 MVL'-C;Q-(K,Q61^"JJ,JRK4=2'FOSC^6^O1^6-=_P_\ ESH7F*Z\ZQ:AHUW$ MR/<6%O;)I\,$L-;N=R7/& .A"-\52@95*-&\W:=K>H:U^;?G/RUYD?6]!T)K M7RO^6Z:!JEP^GVCW<$S$.]C&D]_=7$=NS^F2D*QIQ-$DE95F7Y9ZQIJW7F[\ MQ/-EUJ,/FOS/+H]CJEK/I6I6MGI-H)7M],TRTDNK.W:X5)KF1I9J&LDC,>$7 M!550W_.1NEC6[+R5IEUY8MM=TIM6EN=0U/4M'O\ S)INF-#:RF"6ZT+3I8GO M#)(>$?J5BC;XVWX@JO$?(/Y87>LV'Y!^5_._E:^UCR]Y5\P?F#'JNF:IITMM M9I9&XN#I"75F2T*6[PM$8H&+1 <%4'@ %5#RUY$L+;5M1M?S7\AZSKWD73+; MS!I'Y5:=-IEWJ]IILX\TZRU([6))9+>1['ZC]4N'4*L2\8I%&Q5>NV_DV?5/ M^<-M'\FZYY7DU'4D_+*PMI?*U]:&2X^O6VG1F.)K:52WK1S(**1R#CQQ5@+_ M )0>4]2L/^=?,-UK=Q!HGGR;SW8XM3CL([4V4:0O#(B1JO-98G9JNJ^D/SET'3=8\X?E]/YY\M7/FW\J]/T_ M73KND1V%QJUL-8E^I)ILMWIULDK3H(3=*A:-U1V5J*W%@J\07R3HUQ=ZVWYF M_EUYHUO2)?)NBZ?^3MG?6UQKUYIO&.\:XMHIX%H>JT9,\I1@OI+ZO[LA5 M46/R@76/+WY^>9_,WDNXU7\P4.GR>3]7NHI)[Z*[L_*>C@SZ5*M>$AO4D5Y; M>A=TXL6X@!5B\GE7SAH7YJZCJOESRK%YFUB[\WWU[;WNL:%J>G>9K.._D=!< M0^9[2>73;W3K>.;U([:Y*_N@(FC]6-5*J9Z5Y'L+2T_+D>0O('F#0_.&G^7] M9M/SFU&XT^ZM9KU+CR]2>9?)EWYYT^VMI9DU#2++0;Y&'U9%YWD,&H&U-Q#&'+*K! MD857%7G5SY)TPZQYETRQ_+4Z=^7=YYWOM3\MWWF;RKK6OZ;9Q?X>T.WC6V\O M0R0D^N_KBW>=?1MQ$\:JK,$Q5O1_R]\PIY:_)N_OO)E]+^8VD_ECYV\M:!K^ MH:2\MYIVO17=G^A(9IN+FT9(EN/J[M(L: L$D 8$JIQIGY=>:;?0_P PYOR[ MEBTFZU#R>^DW/ESR[Y,U3R7!Z+IYOTU1F,<5K=0P*DWIT,I M6,%OA+%B-E6":W^5^M?X._YR#\P^6_*3P_F#YH_,"Y1]6:SD>^O?+'Z0TPWL M%N/5MII;>6UAE/I031^J>7%A(W+%6)7WY8W[>6M9FTZXIY;D\Q:+J$?E?2_R MZU*T\I1W%I;WL-Q)?>6KS4FO+JVN!+$)A:(%65(9N#D2L%7I'Y;'7O+=_P#E M5YB\R^2+KRYH?E[1O.>@,FBVNJZA;<&OO1]!D8F= M;;DX107*_9!KNJSS2O*.M>7?S>M]5T#R='YAMI_.LEY&VI>7M4T?S)I^F7UQ MP]2W\Q6L[6%WIMM;REXK2ZX%8E6%HA+&JXJ]I_-3RYI>K?F;Y;O_ ,Q/*=[Y MS_*NR\JZC;V5A%83:M9P:_->6P$EQ8VR2R&5K8<;>5D*Q_O*-&S595@_Y+_E MOJMC^8'Y>>9_/7DUV\T:1^5<=F_FC5;6*YO[>ZCU*2*W@GU!58&[2P<1R$.6 MIR!)!-54L_-'R,-:_,K7=8U_R/-YC\OZ;Y__ "_U))9M+?48Q9P6,]O>30Q" M*5G2-W19?34TVY;#%4E_+CREYC\H_FSH4]EY1'F.-_,6J#6-=U/0M2T;S=8V ME^]VS7&HZ[!<2Z5K5M&)(Q&K/RX,I6,2QA0J]9_-/RUH6K?FCJ=[^9GD_4O. M7DO_ 7;6?D6*'3I]6L[36GN[QK\K;V\5+[SMYLM/R;\E6MVHT^XUH0ZT\NM)<24M4FCANC(I$=R57C\5 M)5J:JL(TS\M/S,N+G4+;\T)H8OS)EO-+71O.+>3]6\PZND5M8V"0RZ5YAL-1 MM[6S"3(XD1XX@7$CS"97+,J]*U?\M["'0_SE\P7WY8IK>O\ F[\SKBVO]5OM M.OKHKH#3V;"XEMK)XKN\L$] .UM"WIS.*N"O,XJPOR;^6UO:7_E.7S9Y&?7- M \M?G&^J:3.?*$NG6EII6J>42JSV.B\)WL[1M6"<@!\,JB67BU6Q5-_*GDB# M]'Z*/SB\@:[Y@\OVWDJ>R\HZ=/I=SJ<=EKLVN:K+?'ZG$DCP7?FSY1?S3YCTS\F/*5F+K5(?KL)\P0#63>O"=X'O M(G:,^H@YIS^$@/NJ\[B\K><=(\[:5YDB\HR>=/,-UJOE_5+BT\R:%JL'F:,K M;6*7!TGS98SM;+:)QEZO',I#U95]!?\Y"Z-#YCU'R%I^H^6++6M'B. MIW$^OZOY?U#S9IMCX5Y#%-< QQ<&I\3@%5X[^4GY2R>99 M?R[M/S5\EWFNV7EK\KKO2S:^8K25K:/4(=47KQP(IB!Y&-36(T^( MJH+2/)RZAY;BD_.KR+KWFN_NORI\KZ;^7LEYI=[JTEEJ,.E2_I2)5ACDDL=0 M-XP9IIO3=AP"R40A57T9YJT/4KW\E?RQT=M(NKN[M]6_+LZOI@@=Y8X+76=* MDO?6BH6"Q1(YDJ-E#:QY;N-0NKA!%)J-A8M!>>OZ$OY42:M+^7?D]M= M\OR^5=7CTJVAOO+TUU->R6KPKZ7 W-PSS2;("&E/J4(Y_%7%7HF*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*O\ _]7[^8J[%78J[%78J[%78J[%78J[%78JLD:-(W>4 MJL2J3(S4XA1U)KM3%6 67YI?ECJ.B:QYGT_SWY68O.3>?O+H\GSS&VB\SG4K4:>TRL4,2W/J>F M7# CB#7%4FUO\Z_RU\M>8++0?,/F;3M"BU+0TU[3/,%_>6MOIMQ;R7/U9$AN M))E#NQ/(!01QWKBKTR>^L+6Q?4I9XDT^*%KJ2\Y#TA"JF1I.73B%%:^&*O#O MRV_YR(\E_FC%Y?NM(TZ_L-/\S:;J^LZ+J=Y+ITL#V.C/8I/+(]G>7/HDF_3] MW)Q=>+^HJ$"JKT/1OS)_+GS%9VVI>7_.F@:Y8W&H)I5I>V.H6T\;WTH+);(\ MRU>R\L>:-(\VVBK)8:T-)OH;OT?55E:.4V\C%"14"M/;% M6$^8/S8\C?EIYM_+G\GT@DO/,7F.V$>BZ3;W5C$UEIUH8[=;B0WD5SIE_)]2O'L+@.$>6SE4 M31K-'1XV)1BO%U/3%4PL_P PO(6JZ[J'E6Q\W:+J/F31U=M5T"WOK:6\MA&: M.98$D+KQ/VJC;OBJAY=_,[\MO.3ZI%Y5\]>7_,[Z+$)]873-1MKOZK%5J23> ME(W!:HWQ-ML<58]?_GE^5]KY?TCS99^:M,U[ROJ^OV_EMO,>F7EI<65K=W ) M_P!*N!,$C2,#XZFHJ-M\59_Y=\Q>6_-FD6^N>5M8T_S%HEP6%IJFF3Q75NY0 MT;A)"S*2#L17%4LO_P P?(FE^8+#RCJ7F_1=/\TZJ%.F>6[F^MXKZXYU"".W M=Q(W*GPT&_;%6(_E[^='E+\SO-'GKRUY4BDOH?(%X=.U77TN=/EM9;I24>.* M*"[EN@ RL \L*(W%N#-0XJE.O?\ .0_Y7>7[[\RM*EU=+[5_RJ@L;KS;I-G) M;O<)%>O''S2-IE)6 S)ZQ:@3D 37;%6?Z7^8WY>ZWHNH^9-%\Z:%JWEW1RXU M77K/4+::RM3'NXFG20QQT_RB,53CR]YF\N>;M-AUOROK5AYCT>XK]6U?3;B* M[MI.)H0LL+,I([BNV*M'S/Y;6SU/49-:L8[#0YY+76;UIXQ%:3Q<1)%._*D; MKS%58@[CQQ5*H/S!\@W/F67R5;^;M$E\WPH7G\J)?6QU%%5>1Y6HD]447<@K ML,506B?FK^6/F2\U/3_+OGWR[KE_HD,MQK%G8:E:W,EK# W"6698I&X(C;,Q MV!ZXJAI?SB_*2+2;'6I?S)\K)H>JWDNG:=JKZM9BUN+J A98(I3+Q=U+ , 3 M2HKBK/+F\@M+"XU)DK#:023'=%/!%+&C.54 @=20/$TQ5YYYD_,?\K[;28;/ MSEYOT+0(/,=G;5TW5=2M;=Y8=223T4!]:CB41R!61BK<6XD@5Q5G.M:UIGEW M0M2\P:O/':Z1HEC-?ZA=N55(H+:)I9'))"@!5/>F*O'M+_YR0_)C4[BT23SG MH^EVFHZ-I>N:5K&H7]E#:W::I->0);P2F<\YH9+&195 ^ T%2:@*O1=9_,#R M'Y;U33]#\P>:]&T'6M;(_1>D:A?6UM3UX^*DU/-:?:&*JVM?F#Y#\N6F MI:AYA\VZ-H=EHEY'I^K7=_>V]O':WDT4727MQ=IJ"2(\!@X\_5$JDH4XCER!I3?%4)>^8_+NF&%=1UBQ ML&N+6XOK<7$\<7.ULU62>X7F1^[B5E+OT4$5.XQ5([7\R_R[O_+5YYSLO.NA M7GE"P#?7_-,6HVKZ=!P(#"6Z$GIH02-BU=QBJ%/YK_E5K MZX>RL?,;:G:BQFN8PY>".X,G!G41L2H-1Q/ABK-=0U'3]-LKC4=2N8;33[2% MKBZO9W5(8HD%6D=V(55 W))IBK!8/./Y9>?=-U&ZL/->@>9M&\LW$-WK7&\Y_\K \N'RFDYLW\ MT?I.U-@)Q7]R;GU/3#[?9K7%5-_S2\B6.D:EKVN>8=*\N:%INIR:6=8U'4;& M.UDE559.$J3NHYJP*HQ62FY0;8JFNL^??(OE[3]-UGS#YKT;1-)UEHDTG5;^ M]MX+>Z:4 QB&5W"R<@01Q)VWQ5?Y)\XZ5Y^\IZ7YMT>WN(=+U<3&V@ND02@0 MS20-R6-G7=HR11CMBJC8_F'Y!U37[_RKIGG#1-1\S:4';4_+UM?VTM[;K'0N M9;=9"Z\*[U&V*H;0_P T/RV\R:E+HWEWSSY?US5HK5+^73+#4;6XN%M719$G M,49]-\PA],U75KS6].O;2YL+&+2 M)+..Y2ZG28^D_P#IJ,H(IQ#$D4%562:=^8'D36-!NO-&D^:M&U/RQ8A_KWF& MVOK:6QA],?&);A)"B<:[\B.N*H'R7^9?E#SYJ7F/3?*5['J]KY=6PDFUFSDA MGL+E=2A::,VTT,CA^(4AZ@4;;?%6-:S^;MQ8^;O,?D[R_P#E?YI\[WGE6*QE MUN_TA]&BMHVU")IH47](:E9R.W!"3Q2G:N*IW_RM[\M8- MO,^K^:]-\LZ5/ M?3:69==GCTQXM0MI6AN+.1+IHV6:.1"K+](JI!*J=:_^8'D3RI#IEQYH\VZ- MY=M]99$T>?4[ZWM4NF<*5$#2R*)*\A]FO4>.*K9OS#\A6WF>/R5/YMT6#SC. MH:#RK)?6RZBZD7Y5Z;/Y=DN_-NE)H'F;2=0U M;2_.9O;4:.8=.NK.SDC-V90I=Y;Q%15K7BU:$;JLGU?\Q_R\\O'15UWSIH.B MGS)Q/EY;W4+:#Z\'("M;_),7F>W\E3>:-(C\X7(Y0> M5GO(!J++Z1EY+:E_4(],%JA>@)Z8JA/.7G*;RJVG6^G>2]?\[ZMJ;R>AIFA0 MV]8XH0#)--=7L]K:Q <@%5Y@[G9%:C45>?:__P Y(?E7Y?\ +>@^9'O[S4_\ M3VZW>C:-I]C-<7SP&[CL99IHU7C!'#/($DDF9$!! 8[55>\\4('P@@';;N,5 M>=>6=0M-$TOR9KOGC7[NUDO?T1HD5JIBLXG$;2RW%_<6ELM7:BIZO-M M^*D G%6)G\]O+FH6NDW'DORMY@\_RZEI*Z[=V>C6]O')8:<9Y;7U;KZ_<6BJ MWK6\L:Q(6D8QOQ1@M<55+W\[M%6%]3\L^3?,?G;RU9VEI?ZSYMT:WM5L+2UN M[:.\26M[I7(U'R7YE7RAI=Q;VN MJ_F.;6WCTBVENBB(56:XCO)DYR(IE@MY(ZM]KX6XJO8RB**\!1=P*#;Y8JPF M;S]Y5LI->;6M2LM!AT#4TT>XO]0O+.*-[B6TBO%0$3$QL8Y=DE".0.07@59E M4/Y5?R+YCU*Z_,/R?J-AK[>8[&UTR?S!IMVMU;3VNF27$EO$K1N\58I+J4_# MO\7Q=!15,+[S]Y&TSS-8^3=0\UZ/9>;M5^+3/+,][;QW]S\):L5LSB1_A4G9 M>F*J%K^9'Y?WNLZKYKZ/Y3U/5-=TORC>^>(3<>7/+^K:MI7URZB,K11O$;2\N(91 M(1\)CD8;T-&J JR"_P#S/_+32=5O]!U/SQY?T[6]+B:?5-'N=0M8KFVA18RT MDT3R!D4++&26 %&7Q&*I;#^=?Y.W$6FS0?F?Y4E@UF\;3M*D76+(K3]9\Q6&A:_K4.M3V5K>WMB 8M$O?J M,I9X[AU#2N':-*\Z1R:WI]J?+@B?S TUQ$@LA.H>%KDLP]+FNZ M\Z5'3%4LUOS[Y9T.46MSJ%K)<07UI8ZI:B[M8I+'ZY')+%).D\T1 ,<;,%6K ML!5%:AQ5Y=H7_.3WY+:[%Y=U!?-^G:5I/F?R_'K^FZ[J5Y9VUH%><6S63RM/ MM=1NWQQ=5[G%7T!!+%/&LL#*\<@#)(A!5E855@14$$=,55L5=BKL5=BKL5=B MKL5=BKL5=BKL5?_6^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*L,_,;2-1U_R!YUT M/2)/3U35]$O[/3FY;=/\R>8CJFN>6/R1D\MI'! MY9TS4-7N['2I==>VM;UYYSIVGS23V4OZ,0J8'F!^-V,094HRKS6P_*WSS#9Z MEK\FA>?]-UM/S%N=?\O^;A=:'=^:;6UO_+EEILE]=:>T,NG7B3S0-'/;@I)$ MG$I6A7%7JGY5?EWYJM_-7E?7O._DG2[";2/RXU+0+>>UT^RLH8))];EEBA2S MMY)H[62>S$4D\<3,@8E>34Q5[?\ E%H^L:+^3OY<^7-?M9+;7]'\HZ7I^K6< M[B22.ZM[..&6-F#,"58$$@D>^*OF'5?RE\_7OY;?E9Y)W59/Y@\B^:/S"\S>?O.>A>4KWR M!Z/E70X?*;:G';QWNH>9/+^IS:O8S-:0S,HCMN(@#R."ZRR*/W8-56/>3?R0 M\]6>MV&D^8[,W/E"UT>[\Z:G:_6R([_SKKVE?HN_M#,9I61(6-Q,K&-@IF5^ M;N"0JR[\B= _,72O.GKZ]!K=YY93RO'8#4_.>E:)::]87$$T)MM+AU+1PGU^ MW13,S,\84. RLW,A56:?F_Y*\R>:?-*3Z'9,T:=3T7\LK[RI8Q_E-K/E"2TU$6EO-J ME[J$UN]I8);P3R*T5FD,M)'/"LQ6.HYXJ^QA;*+40P 6W[O@A0!>-5H*!:=/ M;%7Y]^0/RK\_:;HWY?>6O,6G>=[[7_RZDO;B&VNT\J0^6'O8[6ZB:=+^VLTU M"XAU)ICSB,GJ2Z-=KI&GV&D")((9H;2:(R251B>)8J*E5ZMYC\H:A^86O6FL0_DVGE_ M2&\]>3+S4YM4BM8[_5+?11=RS7=Y:)+)&(K,RQ)"6_>,RL:<%CQ5[?\ EYH& MIZ+YC_.BZO+!K+3?,?G"+5-!(*\+B!M!TFWEF14)X\KB&4-4 E@3WJ57SYYG M\E^:8]._/?R:WY977FS5?S2\T#5_+/F^*6U^HO;SP6,5K->W,TRS6[Z48#Q0 M*21&AAJ6H%7O/Y2Z#JN@/^97Z5L&L?TYY^UK5=+)*'UK.Y$/I3#@3L_$TKOX MXJ\4_,SR/YJUW4?^<-4\KZ5>?HQD_+R_>/3/J GU'] :KJ\U_#;PZ@D MMI)/##<6\J"YC*,41>H4JJ]2_)#RK>Z')Y]UV^'FH7/G#58+RXF\V+I-M=74 MEM:QVINULM'MX(8?46-5)D'JR< ST''%7EWF[0=8N_S[B_+RRMENO(_YE+I? MY@>?V:6$I;GRP1:26\L&[LNHRIIZBHXLL,X)(^'%6!>6ORI_,"WCTSRMYBMO M/.I:GH7G6]\Q6TT:^6(O+=Q.NHW&H0:F^IFT;4^-RD@CF0N;AN;Q,WI,6Q5" M:5^7GYB:GYB\E7=UY;\W"WT7R=YDTG4[/5[?0-,T72[O5-*]&+3]&T[2@C>F MTR%?4?FH7TU]1L5>G?G!Y UW]*^3=4\E:7YBT*]L/*5WY;.O>5K?2-4CC@=X M)%TK4-!U6'TI+67@0LL,BLC#B_PD,%7T#86/F"?\I[73=8TRSL?-,WE1+74M M'TVBVD5^UEPD@MALHC60E4'0"G;%7C7EW\N=7AUKS1JNJ>64:YN?R<\L^5=, MO91#)(;RW&K&_L48DL/BE@Y=%;X>M,5>Q6.D7\'Y2Z?H$UJ8]5C\IQ:=)8L5 MJ+D6 A,1()7[>U:TQ5X9Y*\DZO=:CYEU_5/)6 M3ZPM_:(5=V569X'._%P4.]-E7F,_Y9>?[74_.%GK%CYYGTSSWHWEJWC7RS!Y M7O;:<6FC6FG7-AJ,VL6MQ6EI;\N322/;/&BEWH"6)I4TQ5\J^>](N.%K=V>M^6;6XBTU952Y^U=/+;54*Z@6H)9#0E5=H'D;S?Y3U;\K M/S$\Q^4+OSIJ\TGF[6?S!TRQ]%[[2]8\T-:26MQ#;S7'IR"TM;;]'?NY&*(U M5)0OBK-_RH_++S]H_D[RUI^IZ[%Y.\LF;6)]7_*:.RM;^.&RU34[VZ@T\:@) M*QB"VN8X2(:HO"B&F*O -.\D_F+^9'Y;>?.=J][K'Y<'3ORY\C207%H\FM6' ME/6X+G6KJW-PDMH'U(6D,!6=60O;\95"\EQ5G,OD?S>NE^=/,>FZ'YQ\P:IY MEUKRO'J][YJT_P L-J1L])ED:;4],TBWM8;1KJV65422Z5G;@"B%88PZJ#_+ MS\L/-YUW1[_7_+.NS6*_G&_G"2[\URZ=?4B;='^O *L<8K M'5?A%*XJ^G/SS4/^3?YIHT NE?RGJZM:-0+*#:2 QGE\-&Z;[>.*OFG\U_R^ M\V_F@M_YA\H>1=2\FRZ%Y8L]'ETF\%A:7VN>AKFFZK^CH87:XLVCM[>RF2)K M@-$SSE.)CYG%5\'Y6ZYK&L6?F.;1?-NM3:A^8'D[4=>N?.4.A6LDUMY?%XQO M4L=)@MT7T/7C7U):R/P0*H2-"54ULO)_FSRO^9,'GK4/(5[YGT73_-WGN=;" MQ:"6\MTUY--^H:M;V\LJ+("EI-;FAYJ)B:<>>*H'R#Y$\V_EY?\ Y>>9M9_+ M:XUC2X-"\T:2GD_2)+6]G\KC7->DU:VMUCFGC@>(VACM)&@8\#&J[Q?$JKW7 M\@_+&K^4_P E/)7EC6]'/EK5=-LKB*?1%:-OJ7.YF>.)6MSP(C1E *&E.F*O MFS\K/RL\ZZ2OY5^7O-EKY\&I?EO?S78_+.F7-OY@1?2@^H3W MGE'5;"X,LL1!'JWEPB2,A)+-RW J%6/_ )M>2?.GYJ:C8ZCY2_*75_)QTGR3 M+IFH-?+H]M/>]!U$:)&&DNK>0?5[*X6,SJULS,5:JEJJIO/\ EIYGU+3O M,OFN+0?./FF\?S1Y0UG6/+7FX>7]/NM?M/+<\DTD-O9Z9#:6WJ1B9"KW3_OF MAC2JHB,57LWY1Z5JL?Y@?G1YMN_)-WY+TGSG>Z%<:1'>K;17%ZUKI_H7-U-% M;22!'+@*0QY$ $]:!51CO-=\E_FO^;&KW/D+S)K^D>;(M ET74-%MX+F.3ZE M9R0SHWJ7$11E<@?$*=^F*O#+K\LOS+TKSAI?Y@7-EYFL8?,J>:[K6=(\HIH& MJW^B76M:A;7$%O*FLPSPRI/:6Z13/;;B1>+%H:$*LIT?R-JWY=FUCD_+76?S M!T6X_*^P\HZ3IMS+IE_>:?<6UW?37&G:@X:VA6*[CNH%9K=!$H@XG98B56%Z M3^47GF"76O)OF.V\[B&_\]G7[63RX/+7^'Y87OTO;2^_2EY9R:K UG'&D3!4*J]!;\H;V\\K>6;&^\D6MQ=-^>FH>U,52W3_)WF;RA^:EKYTO?ROO_,NBV.O?F+:,GZP+:=3P(8 L6^&N*O,-!_)?\ ,GR=<^:HM2TWS;9Z'YXT8Q:/ MH7D=/+FI1:9:37NISCRW=/KMK-)"D$=XG!X"+?ESVJH9E7U?^6_DJ^\O_F/^ M9>N:AITAAU2P\IV&E:_=/%/<7::7I\L,P:< ,WIRR-4D+5F8@;XJR#\TYK^6 M&UT*[\BW7GWR)YBM+RR\Z6&F.HU"WJJ-:ND33VYDAD(=).#\U)0@<.9"KRB7 MR!YW_P"A7'\CR:5955(M$\O37$-Q=V>EQZR)]/L)KE7,LB8Z_YNL+=;K]&6P 0K! +B!WNI0Y,1)]-*%WY$ M*C*O.].L=2_+_P P/K?E#\L-=NO*>O?E_I/E[1="M4MDO-+O-"N;]H+:]BEN M>5+A+^IEJP4H2YJ^*L?33O.>E^5O)'Y+:IY0\S/Y&\I>6=%TWS?Y@T&W22?7 M)H+:-9K&TFCNHS;VRLG"XD/QR M'&%6LF*IG^;FA^8//#WVE7?Y8:I>^;?+& MJQ7/Y,>>-(NXH=/LZM;2Q7]S(]S'Z,EM(K":*2)@ZQTB#H:!YJ_ M.>[N],&GV7F?SE#JNC2J$"W4'Z TJVEG 0[$W$$JFH!)!/>I5>-7WE?7K'4O MS)\L7_Y4MYVOO/?GZTU_1/-]P+;]%16E+(V]U>7(G6ZBDTH0,(U"9?RQU"XN_,?G*2:U%G+Z5AJ$-UX'-"HIZKF:A7=5GNM_E;K$.E?DA9Z'Y3B@3RGY(\PZ/JEO;)!"+.6^T** MWCMZ J*2W"4/&HY;GQQ5+M<\K>8-,NOSUTJ?\K+KSH_YK6.G1>5M8MC:/;&. M'18-.&GW\D\J-:I9W49+'S-Y93 M6_*>H?HK6/\ E:VD:G?VP@E^I)YH\RP7VG3SCU.0CEMHW;DH;B2 P!.*I[_S MC,_F;S?9ZK^:/G:T2/6[N"W\G:)*LLP/$SJ(]0U#ZQ.OQ&L8 MBJQH**KOSD_+#S5YJ\[V(\MQAO*OY@65KI/YH;B,0IH%PVIZ;<\O51CZK-): ML%1^090PXBJJL?T;\N_/MWY9\G>8O,NC2/YZ\T?FEIOG'SSIY>-OT98VT;V4 M%N#Z\JF.UMH8E(5V^)F(K4G%5GY,?ESKL.I_EQJ'F;R/+IFXJ[%78J[%78J[%78J[%78J[%78J_ M_]?[^8J[%78J[%78J[%78J[%78J[%78J@]1U"STG3[[5-0N$M+#3;>6ZOKJ0 MT2*&%2\CL1795!)Q5YG;_G9^7$]KJ]Y+KKZ5'H.EQ:WJ::O97NF2KI]PYCBN M8X;VWADEC>12@,:M5Z+]H@%5:GYV_EQ)8RZ@FNL?0U<:!-I7U*]_2BZHT1N% MLCI?H?7!*T*F4+Z.Z?&/AWQ5;)^>?Y7K8:-J5OYIAU2UU_3)M9TS]&076H2' M3[63TKBZEBM(97ACAD^"1I54(X*-1@1BK,(/._EJYN=1M(-5@GFTG1[77[_T MB75--OOK'U:Y#J"K))]5EIQ)/P^XJJPNX_/?\KK>YU&U_P 2B=]&6T?7)H+. M^F@T]+^WANK62]GBMVCMTEBG1U:5E%"?Y6HJE?EC\\M'\TZS>:1;Z=+I,EAY MUU'RZN/JMY/ D$QBAC=W5'+*$>H^%J*IKY: M_-_R#YM\PP^4]'U:8^9+C2VURWT:\L+ZPFDTU)$A-Y&+RWA#Q%Y%4.I(-=NA MQ5"ZU^=GY;Z!J^O:)J.OE+[RI)!%YJ,5G>3PZ6;F*.>!KZ>&!XK=9(Y596D8 M*17?X6HJA[K\Y_)SW^KZ/H^I0W^J^7O,&F^7=?6>*^@L[6^O[RSM/JK7JVDD M)N?],C,<0;XN2U9$)=55^B_GE^67F"[TZTTGS(+D:Q?RZ5I-^UI>16-QJ$)D M$EG'>R0+;M.OHR QA^55(IMBJ$C_ #W_ "YU"SU"71/,5K=74&BW>OZ8+Z.\ ML;:_L+,TFN[6XDMB+B",E>HZ3<^8Q'8+GZK=M9Z=J$TD<4=M>WJP&VMW=ID"^I(M>2TV-<52;0/S\\HWWEKR_K6O MB71-3UZRO]2/EZUAN]5GM[+3KQ[2:ZF%G;.R0JRBLCJJ@FE=CBK)-5_.7\NM M%NY;.^\PJ[6EK:7VI7-G;75[:V=M?@FTFN[JUAEAMTF +(974%1R^SOBK(/, M_GGR[Y.MK"Z\Q7OU(:M>)I^CVD4,]U=7EY)&\RP6UM;1RRROZ<;O1%- I/0$ MXJQ*T_/7\L-1TNRU?3?,AU*WU+5;W0]/M;2RO9[V?4=-#&]MX[*.W:Y+6X5O M4_=T2GQ$8JZ?\]/RRA.BHOF-;^?S%I17^CV_F&*?3;6[U"*/2;KD8;^XDLX)E M@@?@Q$DI52%)[&BJW4/SL_+C2]2\T:3>:^RW7DH0_P"*FCL[V:&Q:ZBBFMHY M9XH'B]2=)D,488M)6B G;%6,3?F!^7UF^J^<_+.C07WFN;S#Y6\H^;I)[&;2 M-7C36-0M;.T^N+=VT=R8X8[[UHE9>+"H4BI8*L@_+[\X/+_GCRW/K4OIZ-J& MEV#:IK^C-(TK6=D9[R&&X,GIH'23ZC*05!H59>HQ5F/F'SMY=\JZ#_B;S!>F MPT\1%4Q_&/@WQ5 S_GS^5<&G:1JR^:H;_3 M=EWGF!1+82V4&I7T-M=3V%I+J2Q/:1W5_#"]M TRS1LHDD6H=3T(Q5#)^ M>7Y9RZG)I?4XM9CN#:G3I+ST/02X,PX+&7Y,Q4*#S6J MK'O*?_.1/D?S%Y2\O>9[^/4-#N/,IU#]'^7SIVH75Z\6F2\+F9(8;0R/#&K( MSRJGIJ6X%N0IBK+-3_./\O-+@T>9]?2_/F#2&U_1HM,M[G46FTM0G^G,MG#, M8X*R*#*X"@FE<50>G_FI%??D]Y=_-BXL[31H->T/2M9:QOKN06]O^DQ 1&]S M#;RLP7U@ PB^(TV4&H558?SM_+:XU1])B\P\IXM-?5]9JNS!8^(Y[R)55 ^4?SQ\A>>-%T>]L]1:S?6]!.O MQ1W=M=VT$EI#%')=O:W-U;PQ7*0>H [1$[;TIBJ9_EOYI_+6Z5/*'D&&'0XM M'L8[ZU\K)I=QHRI8W,C\;JWM;F"WY0O+R^.-2I;J:G=5D7E;SA_B77/S"T;] M'_4_\":]#H@N/5]3ZUZNEV.I>KQXKPI]=]/C4_9K7>@5>;^7_P#G(;R1?Z+Y MQ*J6>;/ MST\FK]0TV6P@\Z>7_->K^7M$MQI:W.I"2U\R6KW4=Q=01V;H8GB6L:JS^J#^ MR01BKT"W_.+\O[K6H?+\.M$W]QJLVA6\YM;I;&75;?F)+"+4&A%H\ZM&ZF-9 M2W)2O44Q5B.J?\Y#^2(]1\FZ9Y?E?S#/YP\U0^5[2Y6*YM[1Y"TR74EI>26_ MU>[-LT+!TBD/1MZ*<55_S0_.<^1/-WE3R%IFFZ/-YE\VV-YJ6FW?F?64\OZ2 M\5C)%');PW;6]T\]T?5#"&.(T0%W912JJCIOYYJGF7RAY.\X>2M6\F^8O,6C MZSJNIPS))>6E@-&N+>!B+VVB>"6"99C*LW)0J!?45&=5Q5$:M_SD+^7]AY;U MW7K"74M3GT?0)?,EIHS:5J5G.*IE^;OYP1?E:OE^&WT";S3JNLR7-Y+6[O39-8M-*M;2 MZO;B2PA?TY;H1VD4S"*,_;"[M[>YTR.9+=KNREF@1+N+U9$3E 7')T'[:U57W?YZ?EG8:9>ZK?:])80Z M=JMCHE[8W.GW\-_'J.I<396QL'MA=<[@,/2'I?'T6N*KO^5R^3[."[FUG4H( M)!KM]HFFZ?I\5]J%[/)80BXG4V<5H)UEBC):951EC'5SBKKG\\_RSMQ:O#Y@ M;5H+G28=?^N:197NJ6\6E7'/TKR>>RMYHX8VX,>4C+0!B: '%7K:E6570AE8 M JPW!!Z$'%5V*NQ5V*NQ5#):PI)(8@S.(XU"+R=BS&@VJ6))\3OBJ(Q5V*NQ5V M*NQ5V*NQ5V*J,\$=S!-;S(KQ3HTCZ/I?E_3++1M$TZ MVTG2=-B6#3],LXD@MX(E^S'%'&%55'8 8JF6*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*O__0^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*L<\WVFN7_E3S)9> M6;F*S\Q7>F74.A7<]?3CO'B80.Q ) #D&M#3K0XJ^([#\A_S%O-;\R^9(/*4 M/E*6]TG1SIMEK7FN^\S7][J?E[7[/6XEU&]N1*8H;E8#"@A+A "S $A<5>IW MOES\XM4UO1?S8N?)6BP>8_+6L7S:=^6D6I1)/-I-UIHL6>;5U@,4EV9E]1%8 M"-8O@Y\M\50EEY0_.CROK5QYX@\J>6O-.N^>/+$>C>:?+UC=+IL6DWL>I:CJ M%N\,SP@7-NJ:BT<[4661T$@4\R%50L/Y9_F1^6]C#IGDKR]8^>X]0_++0/R_ MN+NZU%=*^IW>AKJ"B\D#0RF6&;Z]6B?&O&G$\JA5/="_*KS=IOY=_G1Y:FM; M4:KYXM;2+00LX,;O#Y3TK2']1J? /K-G(!6OPT;OBJ"TO\N//\'G8R7&B6L> M@:;^:.K>=;/7$O58W-AJ_E_4;#A]7X+)')#<3QJP)H02RDA<52GS)^4GF.7\ MC_R9\GZD8-.F_+O1IH_.UW&6N5ME7REJ>E2201QHS7%+BY3X4')EJ0*[8JA? MRP_,/5/S;_/#RUY@M-+T$>6_*?D76K.[U30-937(EN]3OM)DA26>"%((?42T M9HXBWK !C+'&./)5%)'^86I^<_\ G)#RGY;\H:;K.A>;_,UOIM]YCO-0^K_H MTW'E;1X)Y)[-HG-S&(WY(L359@5;B*-BK+$_+#S4GE[S/IHMH#<[ M,&XZZ39ZWI=[([MQVD]"T>B4ZT'?%4GA_)[S<_Y2_E7Y)N(;:'4_+7FR/4_, M7"8,D5D;J_DDDB-*2.$N58+W/RQ53E\I_G1K_E"Z\CZQY2\OZ'9^7?)%_P"7 M[+5HK];]]9U*XLTLK9[1F@CDL;<(A>3U/C8LJ4*J6*K&?+VG?F!YF3\[_(>E M>5--N/*?F_\ ,77;:_\ .ES> -IT#_55NFDTUH^4\@56,!CDX\N//CQ)*K'K M;\A?S%\NGRWJT?EZX\T2-Y8/ES6_+^C^<]3\J2VL]MJ^IZA:71GT]X8KN*2/ M4"DJN.:4!C#59<53WS?^1OG&QU;RX?(/EQM%DTWRSH^AZ5YI\H^:M0T&?3Y- M*B:!(=6MKIKF'5[./D&A,D;3!5:-^50V*O1/SVU6#R3?_E1^8UW?:;%=>4-4 MOK9+'6;@Z;8WHU33WM9$_2;I)!93"@:)K@K&_P 49=693BKP'RUY!_,#SWI] ME^:]EY=.H._G+SM=/Y8T7S1J?EUK_2M>GL/J]YI^K6RVCRA&T]3QF1(IE+.O M^ZRRKZ _+7\JM;\G^:-+U5M$M=&TN/R/>Z;7=>TK3/.^J^5E MT[4]$L&L)S,M@\<5[:RHX/.GJJ0RJI5_A5>RW7Y:^?M&\K_G%8>3EM['4O,O MF'1;[RK';WLEJ\VE:=I.BV-U:I=D2/:32I83PQ2MR9"RR$UWQ5@7D[\E//6F MP^=)Y/*]MY:7S5YS\A>9++1Y-?N=>N(K;R_JUM8>4K;56UMKN(1* M*TXM9!F*K6[(^(BF*OK'\X=#\YZOY2CM/(O-]2CU*PGU/3[:^?2;F]TR*8&\ MM+348_BM)9$V60$;57DG+FJKYT\D?D[^9GD:Y_QCI?DW3H]2TKS9?:_I_D$^ M89[QKC3M7\O6.E31-K%[%([WL,]GZC&4>F_)J/T.*LUM_*OYT^6-1O?-UAY5 M\N>9O,?GGRW#I7F71;>]73K32+V+4-2O;>2,O;E;N!$U)HYV/&61HPX0^HW% M5AE[^17G*T\T^;+%_+4WG3RUYYUM-6768?.FL^7=/LXKJ"UAOK?4- LY5AF" MM$[QB$'U5*QR\>/+%5WE#0//GGGRAYD_+MO*UC;^1M4_,CS+>W?GL:@/7AM; M'SA=7DL(T]HBYN6>WX1N&]-0RR'=2A52.T_)/\TM-/E?6)_*LNJ77E6RUKRS M>:%HOG.^\MS7EM<:K^E+'5+:]T\PAE+,\0^O_ *-]:TU[0W(68KNO[EN) MIOMBJ(?\M/-+?EW-Y92UMAJDGYJGS<$,XX?HP^>/T]R+D?;^I[\?YOAQ5._S M*\K>;]4\^>5-<\O:-!JVD_X5\T>6-9?->A?EAH$9M[./0O)>O\ ESS!>^LP-K<:IH2:="\/$^T[1I-)L[W4O.^K^;IYFNYH)KI; M9+V5H;> M;1GDP]5R%J$"GDJF5UIWYJ>0O.WYA:KY/\ )=A^8.@_F)J%KK=N M)-672;G3+^WTZTTV2*<312+-#(MHDBM&>2_$I0U!Q5+_ ,LOR=\P^0_,/E^2 MYO+?5;#2?R\E\OWNKQ_N&EU6YU9]0F]* EF6+]X>)+$TH#4UQ5Y5Y?\ R5_- M'RWHGEJ=-#T_4=5\MW'Y:3MI"Z@D0N/\+Z2;'4U29HRJE9')CY4#@=JXJK>4 M/R#\TZ'J>D^4M:\JW&N>6]%\R2ZO9^=I?/&MC3C:1Z@^IV;#RTLJPK=12,J^ MF!]7YKZM3_=E5/M(_+S\W[31_P G?RUG\I:*OEG\H?,VC7#^=XM4"MJ6DZ4D MT4,T6G"$-#<,KJ9E9RM>7!G#"BKT[\UO+'FS5]7$X\B^7OSC\A7NFI9W_P"7 M&N):036M_'*[B^M+F[AEBD6:-Q'+')Q*^FC1MNZE5Y;Y/_*/\R/(4X/,5W8WFF0VS7$7.[M[3ZEP95 (9_P!VOI@458I8 M?DI^9-[J_F/7YO)/^'[O5OR]\Q>59)=8\XWOF6_O=2U%=/EMYIIKD21V]L'M MI$58=P6Y-&JT 53SS!^4GG^^\Y>;_,3^2+S6=/\ S3_1FH7^G6WGW5O+\.B7 M@TZUTV^M+^UTYTAO8@D'-98E,C_%&0%XG%47YD_*+\RT_,_5-;\C6,WE,:MK MMCJ:^=-#\QW=GI4UJGU9;N/7/+%P9X+NY,4#QB6 )ZH=2S1,&;%7KGGCR[YW MT;\RM'_-#R3Y=M/.C+Y9NO+&L>69KY--N45[V&]M[FVN94>,KR5TF1J$C@RU MXD%5COY4_E'YD_+[S%Y6N;^2UOK#2/R_.A:A=P,5KJDVKOJ,T<41 /I*)"$8 MTJ *@'%57S#^3.K_ )@?F%YK\T>9O-.O^6=%ATBW\L^3K#RW?"SDFT^5/K.I MS7;<)>1GN'6-5VHL(/[6*I3Y3_+7\R;:Y@N/-;6=]?V'Y7WOD9M5BE -Y=P: MA(+2Y:, \/K-LDZ9I1L[.[\G^1SITKR7D] MLC:M::GY=U*WMA/:\9XXY?T3+&9XB'CJKKO3%5'1?R=\TSW.CZ_)Y,E\L:DG MG3RSJ.I0ZOYNU'S1J#Z5H?UR1FDNKV2:- DMX_I0PGH2S-4A5536U_+S\S/) MOFW4_P PM \NZ=YHOD\Q^<&B\KR:D+![G2O,CZ7-!GP, MQ!Y!595A_G/\IOSBU^&31=8T&P\X66H^7K*WT]=,\Q7OEC0=)U8K.U^]UI-D M$-]&99$>(L&Y!%5EC^)F5?9>C7.J2--:WVD-I]O9P6HM+QIXY#<.\59E]--T M])AQJ31NHVQ5/<5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?__1^_F*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5HBH(/0[8JH):PQL#&@0 UXJ !7QV& M*J@B02&4"CM]H^.*JF*NQ5V*J<<4<7+@H7D:M3N<55,5=BJA);Q2DF10X(HR ML 0:>Q!Q5550BA5Z#H,578J[%78J[%5&2".1E=E^-/LN-C2M:5^8Q56Q5V*N MQ5V*J:1(C,RBA\W:M5 X!!()45H1BK\U_R$_P"6FAM1=M+J:Z@3#1!6-HXV9BU>+&@Y*OK*'_ )RG_+C_ !%Y4\N:G9>: M?+DWGFZO;+R9JFL:#=V5IJDVGAFG%NTB\P J$@NBAA0@T(Q56\K_ /.2'E?\ MPO+UUY@\FZ1YE30Y]%U'5M%\[:AH=Q^A9%L(G>M3\EZ-YQUNP\I:#=2(EEJT"21W,=K-(TRHY)(C5I M)$&S[]565_\ .2GYRZM^2_Y0:OY^\N>7WU[61/8V&E6\\,C6UO/J$\<$[:59Q:C:_7+222^+"/C+'LM*DML!U.*O,/S0_.;\V;W\U[C\ MD/R \N^6[[S?Y>T.V\R>>/,_G.>XATJPM+V1X[2"&&TI//+,T9J0>*"E:[T5 M8]Y7_P">;?\N/-7E[R_!)K$$NN7MNUU9O8- M%\;PSQ+45^)&^$UV.*LBU+_G*'R_K%KY2?R;JR:)J%Q^:NF_EMYPT+S+HMZU M_;7MT)"UD8()H_J\LG"L<[EX@ :ANRJ8:-_SE[^56MW_ )'S/#9>:?.$ MOD/2O,,^B7$>FMK\5PUO]2-S0J"SJ>+4XD=Q0T52GR;_ ,Y3^77\G:=K7FO5 MAYDU[S)YTUWRGY1T'RKH6H)>7\VD7#H\,-C/)/([0(O[Z8NL1^T.((&*LB;_ M )RR_*?O,5[Y4T31[/1[M]2CUK3T9[FPN[)E66&1./1A3H M:\?BQ5ZE^4_YK>4OSE\HQ^<_)D]W+I)O;O39XK^UDLKJ"[LI3%/#+!* 59&% M#VQ5Z7BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5?_T_OYBKL5=BKL5=BKL5=BKL5=BKL5=BJ0>:M(E\P>5_,F@P2K M;S:WI=YI\4[@E4:YA>(,P%"0"U3BK\\?)'_.&?YP6FK_ )+P>?OS$\D2>4/R M7O[#4]'3REY;73=;N)=+@$-M%-J$A=F1Z#UB?M@;BM"%4Q\I?\X9_F1HGF[\ MN_-6O_F%Y:\RW_Y>^?+KS3)YC?2;A/,.OVMXLZ,-8U-YY3+) LBB&-4$:BHK MLM%4W\G_ /.'_G30OS!UWSI+YB\F^5;;4]#U[2;_ $OR)I%]HUOK\NK020V\ MVLV4E[<6@^K%_4'U>-6+]6VW54/S _YP^\[>;O)?Y5>4+35_()G_ "^\EZ7Y M97S=J&BZ@FO:=?6$,<9U+1]4L;^WE3XDYI#*I13]H/4T5?2?YW_E'JGYJ_D[ MJ7Y96&N);:A>3:(XU_5%,QD_15_:7F*O'?.W_.,7G^^ M\Q_F^/RY_,72O*?D+_G(CTO^5KZ-J>DO?ZA;R?5UL[N;2+A+B-%:[M@499E8 M(3R3>E%7J/Y7_DE=?ES^:WYQ>>X]1MIM!_,.U\K67EW1(D?ZQ80>6].^H<9I M78A^8H13PWJ<58I^;GY ^?M5_,VU_.K\C/S$M?RZ_,6?1E\O>:[76+']):-K M.GQ.SVYN+=61UE@9CP8'?8;;U5?-OYF_\XU^+%<1"_EM$YK%9V:E% 8TIU(K0*O4;#_ )Q)\XL=)\Q: MWYZTK4O/&I_G9HWYN^?[RVL9K;3I$TB%K=--TZ$RR.E$("R2,2?VAW*JOH7_ M #B5YHTGR9^7?EF7S=INRJ9Z)_P XA:UHEW^3VK/YYM]9\P>4OS.U?\T/S-UF M>S-N-8U/6;9H)TLK>)RMNB? JAB=EJ=SBKV[_G'+\H-4_)/R)J_E'5M8M=;N M-1\UZ[Y@BN[2-XXTAU:\>YCA(D)/*,-Q)Z>&*O?,5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK_]3[^8J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%5A1&))&YV)Q5< *#88JWB MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5?_5^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*I1KVD_IS1]0TC]) M7^C_ %^(Q?I/2YOJ]Y#4@\X9:-P;;K3%7R7Y#T+S!:Z1^<7F>X_,WSOK5[Y" MUKS3I.@6&H:L)K4P6-G2V]6+TE$CHTA8,37D%)K3%4]UC\__ ##^7VEB;\T/ M(L.A7=]H*ZQY8M=)U19M2@+-'ZJ<>9#,5 95*H/^ M<->/DV74]3\F7.EPW[:-+J%WHIM=5DDC6_>\DTR"[$-J8W-R%LV>, M ,%=6#8JMN_^2M4L(-"U+5O.TFJ?4[BVUR2[T".#1S MQ.VI6%C= MW YM=1".)K1)06_>I'Q.*OH;\L?/5K^9/DO2/.5II]YI,6J"9)=-OE9989K6 M>2VF +*G-"\9*. ZT8=:8JQ#S%^97FYO-NN>5?('D6'S:_DZWT^Y\VSWFK) MI+C](\I([?3T>WF6>80HTA]5X8^B^IRKQ58U=_G?KL$6K>:X/)"3?E7H7F*3 MRYJ?F=M55=5,EM?_ **NKV+2_JYC:VANN2FMRLK!69(C\(95+-#_ #W\WZA8 M>4/,FJ?EQ%IWD[SMKLGES2;NSUI;O5%O0]S#%*]FUI%%Z$LEJ5#?6/4')2T8 M%:*L:\H?\Y9:7Y@TWSAJ6K:/8Z?<^6-(_2LWE73]8:77;>0SPVZ6&I:7?V>G MSV\QDN8U,D8E@!.\OV>2J<^:OS1\^0/;^3M?T>#R+YT@UOR1?PW.C:F=7L+S M1]5\TV.EW<8GEM;2577F8I4>$ J]4=M^*J+\H?G%K^N:;Y*T3R1Y2E\Q>9-9 MTK4-=U&/S!KA@@L]/M-4DL09+Y;.62>::0$1(L'%0OQLHXEE7E.D?\Y,>:O* MWY?^2+C4-&MO-NMZEHUSJ^II>ZK M+D([*JS*?\\O.'D:\_.W5_.>FV=_Y?T?SQI?EOR#!:ZA*\GK:CI>FRV\,ZK8 M 0P<+CZS+(&E979XU5PJ,ZJ>^7_^5M)TN"\GB MT:[N9[";4OK46IW=G;2_5XK:WE:7_13*K+P$;%EJJSS\F?,GF_S#J?YP1>?# M^;_Y?:)I5Y<6'DBS\K^8?,^N+IVM/IEU=2Z5-IZ<9(UT^Y$J1K5=?3RQ^7<&M:7Y"\MZ+K_F#4]3U\VL]Q#J&FF^:"V5;&;U M;A%0U]0QQL:$NM:!5)M0_P"*\O+:WTY[&V19[F-6CFOEEH=DY%495.9?SZ\T65A>^;]4_+ZWM/RVTSS M==>3[W7(M9,VJ>M!KDFAI>1:>MHL;0&8*6#7"R#XJ(P4%E4VN/S.\_2^3O,/ MF?7_ ,NFT#RQ<>5;K7M U;3?,$,UZJI%ZL=M>Q_5HS:W$L3*R-!]8C4U#,"! MR58]K?\ SDE=:%^9MOY);RQ9:EI+>:-/\LW5]8ZI=7NHVQU">&SCO+J"WTZ2 MQMHUGN(U:.:^26G^Z^?%&5>J_D-K>L>8ORI\K:UK^H2ZIJMY]>^MWTQ!DD,5 M_<1K6@ V15 ^6*O/OS/_ .6FN-?>W@CMU9$]*5OT:).,*!2BPQS32LS#TQQJRJ2Z/_ ,Y!>=_.?F'\ MI-0TKR_#H.@3:EYNL/S'TB^O+J"4MH5NCF2VCFTQ+AT6%_7B66.!W<\'6,4D MQ5/?)?\ SE3!YNU:PL#Y:B@MM>TZ_P!0T-K&[N[NYMOJ5I)?+'K$6=)M?RCTP7OGGRU-YI\K";S1PCBL+/ZM M]:74F73W:&6MY"(E@696+'DR!2<58?=?\YAZ5)):S:-Y=66QCTK2=3UFVU.Z MNK?42VK6$&HK;:?#:V%Y!/)##<)R,LT*LYX(2:G%6<:A^>GFZP7SIKH_+R"; MR)Y \SR^6]>UDZSPU&?C/;P?6K*Q^J,CJAN%+K+/&=CPY[55>:VW_.1'YA^0 M?**ZC^8GES26;4_.?G#2X/-]SK%XNA6$.CZM-9 $N+=Y(I5%=GC8J MW521BKYS_-O_ )R-N_RT\TW>BV_E?3M>M--@M)[V"/5;HZO)'./4G>&PL=-O M4B6&$,_.\GMT:E0W#X\51.I?GYK&A:?^:/F?6O*%M:^2ORZUR3RMIVI1:H\V MH:IJQN;.UM_]#6S*P0/)=A7D,K,O$D1L*$JLM_)K\XT_-*?S+82Z=#9:EY8^ MJ-B4Q-;75Y9V$I>,PLLB- K*>)^)64XJ[\V?,?Y@Z%YO_)' M3_)T&GW&G>:/-T]CYFBO;V2S,MO'I&H7(A!2TNJJ!"TU1Q/.-(Z<9&=%7D/Y M;_G7Y\TKR'Y-U_\ ,#R^EUY4UG4M1TB'SB-5^LZO--% MF*7!=?A+)2M%67_E=_SD8OY@^;;#RK=:#!92ZWIUQJ>EW>DW=YJ"0+;"-VMM M2-QIUBEO,R254QM+&Q5E#UI55[!^:WG6X_+KR'YA\Z6FE#7+C0X8GM]':?ZJ M+EYIXX%0S\)/3%9!OQ.*OGWS+_SE#>^5=>U3RSJGEC3#K/D];2/SM:0ZK?.Y MN[FWCO#;:-PTAUNRD$R$M.;8,S<%Z%L53V[_ .E?EMJ-_\ HZ75;365N]5MWDO'L+>X:P-K$A@EN%5*K<&5>88QA0U% M62I^;WF_1KNUL_/WD&W\NOKVA:KKGE0Z=K*ZD)&TFW6ZFL+^MO;^A.8FJ#$9 MHMF'J5X\E4A\P?GQYT\FP7!\V_E7,+N[\N3^9O+=CH.J-JLC6EK>V5I=+J*I M91O UNNH1S2_5UN%$:R%"[* RJ66/YZIYX\J>4]=TR>R];6->U?0X]0\K>8$ MU'3DGM?+6HZHD[M]6AF=:1 >A<0P2*_&0J5"\U47IWYN>>=)\J^4F\]^3OJ% MCYR\M3MY=\Q6&MK=59:/0E:JI9I_YC M>:/TMK-M#/>:M=7_ )YBTKRA8W&H_58+8'\NX=;2&ZE6VF,L+3AV;X*^HWJ; MA>!591H/YTZQH?EQU_,O2;72]@Y!3M6F*OG33OSP\QZ MC;Z1YKC\@HOY9^8O,,/EO1?,)U8?I1IKK4#I5G>3Z;]6XQVL]WQ6JW#S(KAV MAH& 55O^<7[GSQK7Y=_XN\]ZI<:CK'FG4KZYX2ZH^HPQ10W,L*K;QM96:VJ@ MH5])0XH W.K%552_SQYR_,G3OS>\R>7=,%FGDRR_*W4=<687SI>17R32HES' M;_4V1G5T2,*TX7@2]>0X,JE^M_\ .0/F'\O=+6;\S_(\.A7=]H*:OY9M],U< MZHUU)]=L--:UO6%G;BWD$VI0%FC]5./,JS<:,JS[\F?SCC_-*3S/82Z9%9:G MY7-HUS=Z=+=W>E7,5Z)3&UK=7EE82LZ&%EE1H5*GB=U93BJK^;>M>:&UO\M_ MR]\J:P_E6X_,74KV'5_-T4:2W-EI^F6;WEQ'8K,KQ"ZN.*HC2*P1/4<*648J MD-Z^K_D;;>8-O)J*W,4"-9WP$1>WF-PD;K. MK")^#*X5BN*I;K?YX>TMGBDMIYE+K)"%((X.1R*JI7)^>WYAZ:OFJZUW\KM/L]-_+?7;'0OS"O M[/S&;HJVH&SECFTF)M/B:Y$=O?122"?ZN:U1.=*XJB]*_/GS=/H.C>>]<_+J MWTG\O-:U9-$35H-YGLWM88A;2W(1"PG,B!^;1A5:BJ4>1/ M^O:)J7E.UM9-,\JZCYGT[4M&U"\O[&8Z6T N;&2ZN],T^)I@+J$\ MK9IXZ$U8#B753O4_SS\Y>4[W3+?SO^75OI%IJM@-<2YT_6OTB]MH\5_86-]+ M>1_4X>,]K^D893'"TB,@DI)51R59G%YLU_S8VHZ]H%M<0^7OR_\ ,^I6CFVG MYS^8(-*L+FUO(HH.'$\=2;T4#.*M"7K3BK*L=_)+\_+;\W[W5]/6+1+.]TNV M@O+BPTO67O;NV$QXM;7]C>6>G7EM+&2.1,+1$GBLA8%<5>F_FAYUO/('E<>8 M;#1CYANWU;1](M=&%PMJ99=8U*WTY#ZSJRKP:X#[C>E*C%7BMQ^>WYAZ3#YL MO=>_*ZPM=,_+?6['1/S O[/S";DEK_ZG(DVCQ-81-="."^BD=;CZOO5$Y$5Q M5">6_P#G)2\UO\R=*\B7?E>Q^HZ[?:GIUEK>C:I=:G]5N+&WNKJ%;^4:;#8* M9XK.6BV][,RL "IHY55,?+OY\><-0TG\O?,OF'\NK70?+7YHV/2+C652_BDM8(8898K20+(L[E?A]14JP55CGE7_G*R/4X/.S^8_+"6K^ M5/+UMY@LKK0;J]O+'4!:QY=BO=(\E'5O,@\WZ9Y1;3[:^G32KB7586EAN[/4+RQ MMGDB2A$@>!&4AAQ/PVMK[7-?_ "RM-+\K>5_-*.2L9G: M&T>.#U%9?592RL!0JO.?,P\T?D;=>5M;MO/7F#SQY4U^_N-)USRMYCN(KVY$ M\EC<75K=V5['!%-'PDM0LR.7C])G=5#)\2K.O/\ ^:TWDJ9(8M!;59)/(_F' MSE$@NA!R;0C8*MEO&U/6-\!ZG[/'=3795ZAY:F\Q7.CVEQYKTVQT?790QO=- MTV]DU"UB^(\.%S+;VCO5:$UB6AVWZE5/L5=BKL5=BKL5=BKL5=BKL5=BKL5? M_];[^8J[%78J[%78J[%78J[%78J[%78JT14$=*XJ\]TO\NM*TK2?/.D0W5P] MOY^U+4]4U:1BG.*75HQ'.L)" !5"CCR!/B3BJ2^>?R:\K?F$]B_F":]!TW1+ MO1+$VDP@:);JZT^]2[CD"ETN+>?38)(G4CB0:@UQ5!M^3KWN@:KI.N?F5YQU MW6-0OK74K/SC+?0VU_IUS8T-J;*&RM[>RC5#R+H;=/,FF>?HM7O-:F_,RS>PBU2XN-0@M[6[2>#ZD;!X9(;2!?2-MQ!C5Q\ M8Y8J]F\M:$OEO1;'15U._P!9^I1"-]7U6Y>[O;ER2SRSS/U9V8FB@*OV455 M 5><^;OR:T_S5K.I:U:^;?,/D^;S%:6^F^<;70KB"*'6+*U9S%%WF:-@L MCQF6!HY2AXN-3O"/,6N0>3=2\P1^:=4_+*.6V&B7&JQ7"78 ME8-;M=+&]Q<D"SB%WJ6C/)@54\@_)ORY!Y4\G>3_K^HRZ9Y)UN/7=,FDE0 MSS7$W7E^:7S3JCV:72V_EK4TU>RLHHK.UMK>*%KE"TO"(/)7XGJJE55B M?D'HEA8>4H?+?FOS!Y2UGR=!>V5AYHTR6T^O7%AJ-P;JXLKL7%K-#+$92&4> MF"C ,C!JDJL;LO\ G%WR_I&F/H>@_F%YTT#0]1TRWTGS3IME?V_+5H+5[AHF MN+J:UDN8GXW#1NUO+$9% Y\FJ2JR?5/R%T+69_-TMYYFUU(_-M_I6MFWMI;6 M Z=KFC0VMO:ZMI\R6PFBGX64092[1$!AZ=&8%5%W7Y*VNJ>7/T1KOGOS5KFO MQ:M'KNE_F!=75N-6T[4(5,<,MBD5M'96ZK&S1M&EL$D5G$BOS8E5E'Y>_EW9 M?E]'YF:#7M6\R:CYPU?].:_J^LRQ2SRWIM+:S9E]&*%$0I:J1&BA$^R@5 JA M5%Z_Y$TOS#YAL_,EW=7,5[8^7]7\N10Q,HC-KK3VDEP[ J3S4V:<#6@JU0:B MBJ0:1^46@:+:^;[6TOKYT\Z:-I^AZH\KQEDM].T]M.A:*D8HYB;DQ:H+= !M MBK!8O^<;-$@6STZ#S]YN@\J:7KD'F72?)275HNG0:K#?PZF9V(M!<3(US$9# M#-*\0+MQ1:)Q59O/^3WERY\HS>2I[BZFT>Y\TOYLN>;1M(]W)KAU]H22E#"; M@E"I%?3^'E7XL58M;?\ ./.AQV]U8ZCYR\S^8M,B\O7GE?RMINJ75O-'HFG7 MZJEPMHZVZ222M&BQB6Y:60(.(:C-559<_P#./.ESW[.GG[S7;>7(_,X\XZ?Y M'AN+--+M]9&I1ZLT]1:"YF0W49D$,TSQ@NU%%%XJO6/(WD[3O(7E?3?*>E3W M%SIVE^O]6FNF5YC]8GDN&Y,JH#1I"!0=*8JPKS=^3UKYKUC4-6C\Z>8O+<&O MZ?'I?F[0M-FM9-/U6UBY*JRP7UM="%S&[1M);^F[*:%CQ0JJDU]^0>FW-WK- M[8>=_,>A7-[YJ_QEH$MBU@3HNK26LME=26GK63;1-*TG2?,5 MGI%U:1QZQ'H]O%:03W/K6DK03M!$L3RVK0NR@;_"M%687OY/>7;[RQYW\IS7 MU\NF^?==F\P:Q*CQB:.ZFG@N&6 F,J$#6ZT#*32N^*L?;\B8H)[J\T/\R?-W MER_.NZOK>D75A-8%;$:_RE@N()[A_5 NDE>-P/2=!4%5ZGY,\HZ M/Y$\K:-Y/\OQO#H^A6PM;!)&YR<022SOMR9F)9C0;GMBKRWS3^0FE^9]5\VW M7^./-.@:)Y\DBN/./E+2;JV@LK^YALTL4E>1K:2ZCK#%$KI%,L;\!R0@MR53 M^Z_)ORM?^6?/'E2_FO9]/\]ZW<>8KZZ280W5IJ$TD,Z362[ORH-3FU/SKK_ )ZU/594DFU77IH"8XXTX)#;VUE!:VL*C- MXYH+F2-AQY"M596 .*L5'Y)^53Y-\I>19;B\N-"\H:L-7LUDD0RSR"6XD,4[ M! #&WUEP0H#4I\5=\517DG\K+CR;>6T\WYC^;?-UEIEE^C] T?7+N!K:RM^6 MU5M;>W:YD"@()+II7 &Q!+$JLK\\^3=.\_>6-3\J:M/<6VFZL(!<36C*DZ^A M/'<+P9E=1\48K\/3%6#:W^35OJ7FC6?-6A^>O,_D:Y\U?5O\9:;H%S;1VVJF MS"1PRR?6+6>2"7T4$+2VSQNR L2JD*H76_R,TC6]9U*]N_-OF)/*^NZI::U MYA_+T36T^DW=]9R12I*IN+::ZMU>2"-Y([>>-'9:E:LU56"_EG^0%Q;^3_+N MF_F%KFKZA9V-S?:C-^7%Q<6MQH\%_<7=S)' M*K-M)_(?2K*=;G6O./F/SG+I^@WOEKRL=;FM7_0^G:A&D5PMK]6M8/4E=(D4 MSW'J2\5H7(9N2K(?-WY3:)YSNM,OM1U35=/O-'T2\T73KO2[IK26%;NYL+L7 M221CF)H9M.A9#7A]I71U8C%6-V?Y!Z%'<+J>J^9-9\P>8IM8?6]6\R7OU&.Y MOK@Z+=:#$DT=I:6]NL<5K=OQ6.)?C^)B=P55#2_^:U>*VCDEG:!S&);EI75254A68%5/;+\E?+5CJ M5KJB7^HR36GF&/S(D3R1\#=1^7!Y8$9XQ@^F;0O'X<5>>^8OR5N=3 M\S?D#I5U/JWF/0_RLO;K4]4\WWMS:6[SV\"(VG:5<6UFEO\ 6%%W#:S[Q!!] M61G+R'EBKZC85! /$^(Q5X19?D#Y?L]4T]U\RZ_)Y0T;7V\TZ-^6K3VXT6UU MXN=/TGUOJ M\]TRO,WKSR3MR*J@^U(:;=,58WYD_*ZQ\Q^;4\W/KNIZ9?R<\L?F%+92:_->#]':'=Z)9&U MF$,D7UJZT^]2\CE5>:7%O/IL,D3J: UJ#BK(_)7DZ\\IQZF^I^=?,'GK4M5F M22XU77IKGS&WO].U"WY"*ZM9@#Q8*[(P8%'1F1U9&(*K ;;\@_+MR?-EUY MS\P:W^8VN>TM[91,%E+1Q!V=49F)1:*K M8_R'TJXDO=1\R>;]>\X^9;^ZT"6;S/JK62W*6WEO4DU6SLH8K2TM[>.)KE"T MO&,.]?B8E5*JLBU?\I?+NK:?^8.GW=Y?):_F3K-EK>OF.2,/%/8P6%NB6Y,9 M"H5T^.H8,:EM]Q15Y+^7/_./EVGDS0]*_,#S%K5U:6T^H7\OY>-=6TVDVU_= M75T\=U%,D'UH\$GYQQ-<-%&Y#+&&1>*K--+_ "%M;75FUW7/S%\V^<]6_P / M:AY5AN-8GLA'#I6HI;K+%%;V=G;0JX>V1_5X>HYVD9EH JG7YA^0K?5+>XUV MVM+O6-;T[R?KGE;1]$BEMXDNH]9^J&0R//P565K.,@\P .6S'C15/_)'Y>Z9 MY,_+WR_^7L$DESIFCZ/'I4\SRR>O.3$4N9GFY^H9)G9Y&;ERY,37%4C\F?E% M;^5->MO,VI><_,'GK6].TA]!T34/,#V3RV>G2RPRRQ+):6EL\S2/!&7DG,CG MC]K7JVOYHZK;:OKS0NB/%+:VUC:HD#>F:*R:?'7E M4U+4-* *L4T+_G'G3-$U+R;>-^8'F[6-._+F9F\A>6[ZZM#8:;!);7-DT'"& MTB>XI;W31+)5=3\D>0O(%U>ZBVA_E[9-8Z5(LRQW$ M\1T>ZT3]_(B#<07;M5 OQA3TJI58;KOY$S6VF^=M>DU_6?S:\Y:_Y:ET'ZAY MKN;6*UN;=9DN8((TL[6V@M61T8I(D8^-N6]4UO4M);7+;4-.U%]1AOK,:)$MG:"W<( :.TY9O5' <65>X M6_Y0VSV>CQ:_YS\Q>;=3TCS-:>:OTYJMQ"TLMW9!E@A$$$$-M# JM0I!$E?M M$EB2552Y_)KRU>:+YAT"YNKR73_,WG"'SIJ*,\9/UZ"]MK\0K6.GH,]JBE2" MW$L.6]0JDWE[\C8/+]K^A_\ E8WG'5_*MII5UHWE_P HZA?0/9Z=:W<7H45X MK:*>Y,,1*1?6Y9@@W Y $*LG\U?E5H?F^5)M2O+VW>+RKK/E&/ZJZ)2RULV9 MN)?B1OWJ&RCX'[(^*JMV59=Y?T;4-'MS#J'F2_\ ,LA6$"[U!+9)!Z4$<34% MI!;I^\9#*WP_;9N/%.**J@///D?0?S!T"7R]Y@AF]#ZQ!>V%_:3/;7EC>VD@ MEMKRTN(R'AFAD4,C*?8U4D%5@-I^25A<:K%K?G;SEYB_,K4["SO;'19=>EM( MH+"/4(6MKF2WM=,M+* 3/#(\?K,C2!&90P5B"JEA_P":_ M-=Y=>6-4\H02ZE/9*EMI>JO;22+##:VD$?JJ;5:2LI=NCLX"\57T -@!X8JW MBKL5=BKL5=BKL5=BKL5=BKL5=BK_ /_7^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*I!YLU*YT;RMYDUBSCCEO-)TN\O+2*7EZ;2P0/(@?C0T+**TWQ5\I:Q^:'YS M:;K5MY%ACT?5_-MAY8M/-/F'5M,\LZG?VCC4[BXBL].@LXM362-5-I)ZEU)* MU?@XP=0%53S?^=/YF:/=V6HIY6B\I:!%HFDZI?6][HVI^87%Q?0-/>VFI76C MS,^D"T"\?5DM9E?[>RC%47J/YH_FQ;:=^:OGNU_PF_DK\J_,E_IC>77@NOTE MJFG6/H-<2+?&[6*WG"2MZ:F&02L%'[OGLJK>7?S<_,2YTS\JO/NM6_EZ3R+^ M<6J1:9I'ERSBG35=)34H+B?39I;UKJ2*[8B%1<1K#'Z7)N+.(SR52'1OS>_. M6#R=^5OGG7K;RAJT/YM:7+)I/E/3X[O3Y;*\&@W>LVIDU*YNI8Y4F-F4=##' MZ?/:1^-6576'YQ^8M3M;[0?-,=A>Z]I/F;R,8K"]\OZUY8N?JVK>8K?3IYFL M+Z:42K;R;Q3P74L;O02(%H)%4H_+?SO^9GD_\L/R]\T:Q>:%K7DC5O,B^6IM M'*71UI(M4UJ?3[>^_2$MR8YG6:1"UL(!2/EQE)3=5*] \XZA-#HNNK962?IO MR9^1QMM!E:[DTVRFUOS)>VKR0Q&Y$I,7J!EY2DMP42%QMBJ??E!^8_F_R9Y% M_+JZ_,K6;'7?+?F>R\T20^8(K:>VNX=3TNXGOHK6>2XO;D2_6+:&[96^"GIJ ME"34JOIAKWS'%^4\^J>;+2Q7S3'Y8FO-=TZT]06:W?U1I)8$/+U#&K52O($C M?8XJ\"UC\Z?._E[SH;;6;.PT+R';Z[9:-!=2Z/JE_9S64[VT#7D_F*RDN+:Q MF$DY"VUU;* 0JO,O+FJK/OSH/G2+S?\ D''Y6\RVFA6EYYSNH]:ANK*>[^LI M'H.IW 5A%>6H*B.&0!6##U#')_NLJZK$/+'YM_F%>V/Y2>?M=@\O-Y"_.35K M;3M)\MZ?'/\ I32(]3AN)]-FDOWN)(;QRL*BX18(O3Y,59@GQ*LV_.+\Q_,O MECS%Y(\E^3[&-]<\W6VJ:C+JTNF7.M?5;32C:JXCTZTN+229Y)+N,5,R*B\F M/(\5*KS'6/\ G(#SWY2M/*$WG#R?::7JGYC6D^D>5= E>:WDM?,EI>BS:6_> M3DR:95,59-J7GO\X)=4_-Z\T*X\HIY?\ R>U".W?3[ZTO M&O-8":)8ZK=)]82[CCLJ&X<1N8YJU 95X\F58W)^<_YF6?E#5_.UW!H5U#K_ M )[NO(GY=>7++3[QYX'AUNXTV.]U&;ZV6G/I0,WH0Q(6<*HD <\%52Y_-G\Z M;?24M[CR=]5OX-:DMKCS;_AV^D:YTQ;);I+NT\KK?K?2N)B8)E2X<1BD@YAN M*JI;J7Y^>?9]'\O>8]&M=,306T)=0\Q:SI^A:WYBB;4X;NYM+RRN+6V^JZCI M4,1MB3/<6LA5C(O F%N2KZ._,7SA+Y?_ "^N?-NA7>G27,D=G^@KFY6YN[26 M74)H;>WX16*//A$YY#BQ0;J57N/Y:^:?-NH^ M8OS#\E>=)-*U#5O(]QIOI^8-'MI[&"\@U.T^L)6SGGNFA>)@RFDSAA1OA)(Q M5Y1I/YN?F%=Z7Y6_,F:'R]_RKCS;YSM_*MIY56*:/6;>UO=7;1;6_:_-P89) M?7X/);"W'%"P]1F3XE6.P_F_^;$?Y<:+^:/F"T\JWWE;S)JK:#<>3["VO(=0 MBCN[V?3+:\2[DO"LK>HJ-);+"*(7*S53=5-]-_,/\U]7;S2OE=O*.C^7_P N M?*GE[6FMKZTO;RXOI+[2C?362LEY$($ CHDS>J17>-J1_ M*%EHNDZ]YK\\OI=GK^I1W-U;V]I8^4M-UBXNI[1;J)KB<^NL*11R0IQ'-MU; MFJA=%_-7\V/./F#0/(VAP^5_+_F".;SEI_G+7;RVN]0LEN/*FH:;:Q3V%O%< MP.Z7*7PY1RS QL3\3&.DBKU_R)^8][Y@_*&T_,G5=+@MM1_1%]?:CI=K*Q@] M;3C.DJQ/( P1V@)7D*@'>M*XJ\W;\ROS/\IZAH5KYU7RSK)\[^4M;UWR^^AP M7%L-.U#1[2&]-G<&>ZN?K<#I*0+B,1GDHK&.8XJLJ\I>:OS&M//N@>4?/LWE MS5(?.?EG4O,FG7&@VMW9MILFF3Z?%)9R-<7-P+I6&H+QF"PFJ;Q?%LJ\!_-: M]_,.&;_G+-HO-5H=*TNR\I)Y8TM(+NVEM+B=H)(3]:6]<+']L3!(@9"W(%.) M5E6;^;_SE_,CR+KT_P"7FJV^B>8_.FKWNAIY=U_2=)O8[1+?6$U>:;U=+^NS MSSRVZZ-+P5+A1(77D8P&.*O3*M7/YF?G'I_FF/\LS<>4M0\W-YQT_06\U MBPO;;3CI^I>7=0U@3'3_ *[-()[>2Q(XBXXS*0*Q$\@JEUY^XN)8T%I!%!(50WEO\ YR$\SZ]Y7AA;0M.L_P P/.+^5[G\O-$Y2R6TUAYJ MLENTGF93S9;,VU^)62GPV_+BO*F*HC\P/,_G_P#*J6+1_*T$5[HMW^FO,NK: M\-#U'S)/'-=ZD\T-@=*TZ[2\@@XS-RN@)5!%!%V"KU[S7^9-GHGY/2_F=IL4 M&M6\FCV>I:1%:S.]M/)?^DML1,41S"9)E+,4#<*GC7;%7E^K^?\ \V?*VJZ? MY"U>]\E:QYV\UZ]IFE^5O,=IZ]K:VUK?6E_=SW&H:+)=RW"M"NFS+ %N>-RQ M #1E),50+_FK^9]Q+IWDZRA\LQ^>H_S)G\@Z[KLT5R^ER6R>7YMGRMVF:C!X_4 I(%6-W_ .=GYN1?7-/BTC3?5\L:CK.D^9O,^E:!JGF% M;FYTNYBAM^&BV%XM[:13QR\WFY7 1AP'+KBK)+K\W?S#\P67YA>9_(4GE'_# M7Y7:597U[!J'UJY;79Y]'AUN=+>[CGM_J$"P7$:1RRP2,S?F]YMEACO)IA-;6UMY7U#5(U@*RA$8_5_3HP9 KM1>5&"J%\ MY^:_S5\L^9ORL\U><-<\IM#-H'FK5M.@TV+4;.RM+LZ7"\5I=\;B[:_B#R#A M+&D;L]%2*L@*JI+Y\_,?\VM8\@?G)YZ+++9: MQJD]I+ ^G-JD\L;*]DW&7U_C1N)B&S%5GMK^9_/'YE> M=/)'E[SY;WVAZ5Y!UG\R?+^G6&A01W2:S%9VWF^UL8[B74%N6A=YVAI+:^@H M5'*^H2A#*LU_//R_K'F7\T_R(T-M5M%\J3W6N:CJ^@W,%XXN9].M$FC8R6M_ M:;JI(CY*P1SS(PE(N-D.,LDCNG=9.5557>;/SN_,F(:MKOE.UTF30?+FCZ7JNK MZ*-&U'4I!)<6$6J75O>ZN+FQM;)A!* @6.X>C([*.:IBJ9ZC^:OYK65M^8_G M& >5F\G_ )=^V_PBGY;^9KW6-*L?+%V;FSUF&&W^M0VEQ];:X,5U-,UL?4M( MXD(5OWGW%_Y3MM'GT'RAY>T:]U;2(=#U34*22:;#J-U M;W6JM>6MO8T@D7TU"W+@%7D%752J]J_):YN96_-?ZS6&VO M)+%K3S%;7+Z?J$TZVU?2)M64L>!9D".JRCS7^8_YMZ#*^BZ+J6@:SJ7E3RS: M:EYI>U\MZG>B>ZFBEF47#C4[>WTN)XH3Q+S7$G5RH7@&58SKOYD?F#Y'_,/\ MX=1AO[/S!9:QJGDGR_Y*\MO8W;_4KK6K?]U*72^)D6-?59XXHE:>0I1HARJJ MRV;\V/S>M= L+:X\KV=GYIU#SSI'E;2M>UC3+S2M/U"QU6$NUXM@US+<026[ M*RLGJNK%1Q?XR4529?S<_.+1])UOS3YA/E&]\N^1//D/DCS#I^G6-]%>:NDM M[!9/J%O))>/'8LAND98&6<-Q:LJ\AQ53+R;^;_YM:L=&UC6_*<<_EWS1HEWJ MOUBVT6_L(=":/3WO[3GJ%S=21ZC%+P])F2*!N15E0J6*JL;\]_F!^=D'D.T3 M4M6\K6-Y^9_D;6=8T>?2K&_670Y].TV+4'C,S7RF[]6)W19%$)B?BW&0;8JR M3SE^;?YF^1O,5Q9:M;Z8OEGRZ^EVE[K4/E_5K^PU+U;>W>_N;C4--GO?T'Z; MR.$AN;>84",\G"3FJKT3_G(.XU^VTC\LAY7N8+?6I_S$T"WLFO))8[5C(TRD M7'HE7>,#XB@(YTXU6O(*O,[_ /-W\TX/,VK?EBESY_YG:AY*\A>:-,\NVF MF0ZWH%UJ?FF^M=(U#S0\5_:79L_JHTW3+B&[@MY"CO\ 6:3!/L<6I4JHZY_/ MCS]YDUG73^6VB6NKZ+Y5MM)C=(D4DD$ MC,W(NB 4*J1_F=YX_,OSE^67YE>:M'NM"T/R1I'F23RS!HP6Y_3;1Z3KD&GW M-ZVI077I0R--&_&W] U2E907V5?1GYJ^<-?\LCR7HWE6WL&\Q?F#YDA\NZ9J M&J\VL;(-:W5[<74T4VO[6QCNDD#O%>QI);OK1:LJ]G M_+_SWJ7F'\NKWS/YCL[:+5= O?,&G:S'IC/Z$TGE_4+JPDFMQ,2Z";ZKS",Q M*\N/)J*V>.1TC@XMQ*@JVRK-?S._,SS#Y/N([;1[73[B67\N?-/FV M'ZXLM/TAHITQ+2-RDB_N6-ZW,4Y;#BPWJJ]I\M6WF&UT:SB\U:E8:OKP#&_O M]+LY;"U0((JI(J#7%7G?F_\ *'R'YWN]*U+7K*[CU;1[633].UC2]1O=)O!9 M2@"6SDN+">"26!R*M'(64G>E<50FM_DC^6NOW]IJESHTNGW-KIT.CN-'O[W2 M(;K3;WCNH(@2J1S*ZJ"R@48U58!Y4_)GR=8^;/.&L>:Y[:YUW7 M_.]YKMEIEKJUU':W2SI'-IXU'3!+';W-Q"D#/&98G*A 5:B"BK.]!_)C\L-) MUFV\T:)I;>O:SW=YH=O^D+NXTS3Y]0$@NY].L'G>TM7F$TG)X(U)YO\ S'%4 M\D_*OR-+H/E+RM-H<=QY=\CP?5O+6DS/))'#";"?2S&_-R95-I<21$2YN M;;3Y[AK<74BF1FE2/U*%CRIRQ5/+3\G?R[LK>QL[31?2@TVR\NZ;91BYG/"V M\IW;7VCQU,A)^KSN7J=WZ/R&V*O./.WY!Z'JGE[RS^7N@:/9CR-_C:R\U^:; M;5M0OKEK6.QN5U#T=*MY3.J">= AC#QQ(CR%5+'%7T/?V5GJVFW>F7X$]GJ5 MO);7L5:* M&]Y7=I+Z2W"R*>5!5BRXJ]8N_P K_(NI>5-5\CZAHL5_Y:UJ^N]4U'3)I)6Y M7M[?/J4MPDG/U(Y!=.949&!C:G#CQ%%6-'\A?RO.C0Z(^EWS/;:I^G+?S$VK MZBVO1ZCP,/UI=:-R;\/Z1,51-_=_N_L;8JU>_D)^55]%HL2Z-Z3JFH:==36=U*;B:VO;FTN8IKN.68F1UN'<,[,QW9B56>>:?)_ECSCY;G\I M:]8QSZ!,( ;*%VMS$ULZR6SP20LCPO#)&KQO&RLC*"I!&*L+TC\C/RQT*UU* MST_1I0FM:CI6KZS/=7]Y=W-YJ.C70N[&[N+BXGDEEE255)9V)=55&JJ@8J] MT_RWH>EZUY@\Q65N(=9\U_51K=[ZCDS_ %&,PP?"6*KP4D?"!7OBK 8_R;_* M_3?,Y9A)?PZ6\_U*.ZD:9ZRK$'+.QKR:N* ML!_*7\A/)OEWR[IT>LB+5O,.F3ZFFIP6FJWMQI,5]=W%PTMQ%8/*+>&[]*Y* M/*(5EJS?%O4JO8=._+SR=I$>O06&GBVC\RZ?::9KB^M*WK6EC:FRMXZLYX\( M3QJM">I).^*I/K?Y1?EYK%MJK:IITD)U'5X?,,VK6U[=65W;:G:V$>F1WMK> M6\T5?M-55WDCRG^5FGR:'>>13IMP?+FFWUIH\VGWOUKA:: MQ>)<7LCL)9/5:YNK/F\LA9F=7^*O/%64Z)Y0\N^6_+L'E71K*.U\OVT<\,.G M2,TR<+F1Y)48RLS,':1J@GO3%6&^7OR/_+;RU)>RZ3I5R[W>E3:$CWVI7^H& MSTJX"B2PL#=W$OU.!O33]W!P7X5_E%%6;OY7T.36](\R/ #K6A:==:1I5]S; M]U:7KVTEQ'PY<#S:UB-2"1QV(J:JL6UO\H_(7F#4_,FL:K87$MWYOL;33_,D M<>H7<-K=Q6$R36KO:QS+#ZL31@+*$]3C5.7$D8JM\W?EG^6WG&^O_P#%6G6] MYJ?F>WL+=F-U-;W+#0Y;BZLI;1XI4DAEM7NY7$L)5QRW:E,53[RSY0\L>0]) M_1>B*UC8O<27-W=7=U+=75S=7;CG-;].O]-%Q:>>K^#4O-.XJ355YO^8'Y->6?S \P>5]>MH[>XAB\UQZMYXO(;ZY@N)FTO1] M2TJT-I-:N&@N+:>Z4@QM&RE2:\U Q5.M0_('\J]2M=+M9])O+W$<)61V?U)"Q&V*L^\]?EKY"\[W M^F:CYH2>WUG1X+I--UC3M3N]'OX[.94^MP?6K">WF:W>B&2-F,9(5B*@'%66 M2>6_+TWE@>4'TZU;RPVGC2OT-Q'UB( G3AZ?PCVQ5YY;?D1^6,6B:MH M!TJ[OXM:U"VU;4M6OM4O[S5VO[%$2SN4U6>X>]CDM511"4E'IC[-*FJJ&C\O M_DCY$D\OZ+/JVBZ!?>5M4G\PZ7!J6KA;XZC?P7%M/?W+W5P9[F6>.YE#23ER MU:UJ 0JC-3_(W\LM66JR7]_J@U[2-5U#3+_U-6X?75%Y8W$,WHS^ MDA:(-Z9*J0M0#BJ'UG\D/RC\S7THO]'#R6]C9:7KFCV6HW=I:WME:QE;.VU6 MRMKB.&[C2,D1K<(XXU'V=L53F'R+^6XU&W,<=G)J*>9=2\Q00?6V9FUFZLY; M._D],R'D?J]PZO&054-7B#0XJQ6W_P"<:_R8M_35_+<]_#!8WFE:=;:CJFHW MT5G87ZA9[2R2ZN9%MX3Q5E2(*J,JL@#*I"J%O?R?_(SRIIGF&PUV9-.M_P Q M;6/2_,FHZ[K]XU[JWU>5Y[ M96TFZ_2,MW;ZG?6BZIJ TZ^O[9!'%?7NG?6?JEU< *I,LL3.S ,Q+ '%5.[_ M "%_*V]UZ?S'=Z19'M/TG?KIZ:S;3I<)J*:>+@6B7!DC!:18@S58 M,2&:JKT75/+.@ZQK&@Z]J%L)]7\M"[31;OU'4PB_B]"X'%6"MS04^(&G:F*I M'H?Y;^2/+5K)::/I8M+>7R[I_E1T-Q,]=(TL7"V=M5Y"?W8NI!R^V>7Q,:"B MK#M6_P"<>OREUNY>XU'09YHKF&T@OM+34]0BT^\^H6PL[26\L8[E;>XFAA14 M266-G'!-ZHM%677'Y:>2KO0_,GEN;3O4T?S?J8[43R@W-[))%+)+S#AE MJ\*$A2!MTIBJ3)^2?Y;IY@N/-*Z/+]?GEO[H6YOKPZ?!=:K&\5_>6U@9S:P7 M%PDKB2:.)7;D]6^)JJI!>_D1^3'F:\OIIM.-^L MM.UW2+;5[U;":?3K2.VM MCJ%C#/ZY( Q5/-7_ "8_+K7KO7+W6-*FOY?, MNGV6F:]%)?W@ANDTUUDLIWA681BYMV13'<*HF2GPN,54;'\K/RQ\O6%K9+%\ M.E^8K37&U+4]4NKR^DUI:):2W5]>7$MQ-)214C25V%"JJM*#%4_D_+?R7+8: MGILFF*UCK/F&'S7J,!FEI)JT%S#>1W)/.HI-;QMP!X?#3C0D8JQGR]^0WY7> M5KY[O1-%N( +:[M--TN;4K^ZL=-@OQQNDTRRN+B2"R$BDJ?JZ)125%%)&*IU MYC_+W\O+W1]/@\S6D*:+Y6T>^TJSDN+J2WCM=.O;/ZE=(\HD39K=>/-C5?M M@[XJQ=?R8_*+S,]EYCMQ_D1^44&BZ#I_Z)?R[IODFWO(-!O-+U2\TB:PL M+QS+=6:WEG<03"U8[F%G,8HOPCBM%45JOY$_E;K%_:ZC+HDMC/#86>E2PZ5J M-]ID%Y8Z<5^J6M[;V5Q#%=Q0A0JI,K@+\/V33%4'J_Y&?E#YWO\ 4O,5[ITF MIKYBG@O=3@L]6O8]+N[VR9!#>O8V]PMH]Q&85 F]/F.(^*HQ5G_FGRAY6_,# M1%T_7X%U32FGAU"SN8)Y(9(+FV;G!=VEU;NDL,L3"J21N&'CBKSWRAH'Y%V& MJ>6K7R?K.AW>N:!<:I=Z.D&L+?7\UWJB4U&YG9KB2:ZFF5:R/*7;:M<5>H:# MY9T;RU87&F:/%]7L[F_OM3FB+M)6YU.YEO+IR7+&CS3.W'H*T X[8JP+R]^1 MGY7>5[Y+_2=!<-;6=SI^D6-W?7E[9:;9WBA+FWTVSNIY8+..55"LL"("H"]- ML50UC^0?Y6Z?/?7@TN]OKO4-%O/+MU?ZGJ^HZA.-(OFB>:R26[N96CA!@4HB M$!#4K3DU57L=K@ M>4/-&N2WRZ7'I&E7=X^I/ ;I;<0PL_JF %3)PIRXU%>E1BKX2N?S4_-7RO?? MFEY8'\NW>JVEQ-JL=I<2-#H,8@@@EA=B$G#L.)=7 M"U 5>J_F;^:NO:3YW\Y>6/+7FBST^RLA^7VF7FK-'#=1^7&\R:IJD-_?S J0 M'-O!;K'ZY]-&>-V'$D.J\_T2\U?1_P Z_-/EW_' \U7%_P"=M'T/5?,DMMI_ MU]8D\C:Y=HDQAA$*74$D<9+Q1Q\EHK)Q+AE6*?E]K_YB^7_(OY4>7M*\^:S> MZ)I_Y4Z+YG*:0OEJ;5;4R!UE.H66HQVIN=-@C1$C%FXGJ'61R[QG%7Z+:3J4 M&KZ=9ZE:L7MKZWAN;=F1HF*31K(A:-Z,A*L#Q;<=\5?#/G"VEE\X><_^<:?J MC&Q_.+SI8>9D4,R ^4[Z#Z[YD^-2H6MSITT!XL&K,J\C&"3BKZ5_*; M7O/1\W>8?+GF35+W7]#AT>RU;2K_ %ZX\O-K4,TTLD;*T7EZ1HVM9HPKQN\: M$$,M9 1Q5>-_FY^;'G;0-0\T>;/*_G?4KG2/+/F_3O+DVBO#H%AH-O*DUJEU M8SK>>IJ]]/(LY(-NT0/(>G4(>2J(\P_F!^96BV'YD>;QYVO[JS'YHK^7VA:3 M'9Z2EIH6G3W5G#]>]2YCA]6Y5V:.-[FY6%3*O-6X_$J]X_);6_-]^_G71?-M MY+J9\M:E!;Z3J.H7&DR:OZ,]LDLD&I1Z))):I+%(6XL%C+HRDQJ15E7@'FS\ MT?/.G>;-)U_0_.>HZKY9U'\SK7R<^EW*>7]/T-8?TQ'H][8PVDADUJZN8F:1 MO55XU+*) AAV*KWS\_O,VN>6-!\CMH/FF#R9-Y@\[Z+H.H>8;F&":.&TU!WC ME'&Y_=\G-%0GH_'J*J57F?EKSUYWTW\X--_+S5O-[>9?+&G^8M4TC_%ES;VD M,^H\- M]22RNY+:&*$W-G,SU:%8^:$!DJCXJP32O,6I?F-^8/Y5ZA'^9\?EN M;5K;\V['3/-FFIILMS=Z;I?F>PAM;:Q:ZBFMC2WM8V=S%(6C1CLQ,@52/R_^ M8'F;5;S7_-]^]G?>8;B'\LM&EU6"S5+75K-/S!UK2EO[:WN$D$:WML!+$R@\ M"X>)OLG%7LWY7>;/-.KWGY3^;M:_-FTU _FM;ZA+>_E9)I]N8K*2&WDN&ATR M:SC%Q#)IS1^A=-=R2([%@?2E:-,53C\[O,WF&TUVU\O^5/-^L:'J=CY>O_,> MH:/HD>AP2RVL#K MU=:EYA]2VAMXG:CI%$TAKR)510JO,O+OYE>>/S#T4:W? M?F?:_E.WEK\O/*7F^0PV5G<6FIW.M69N[J[NTO$DE-DLB&V$=LT;\@U)2Q5% M59 OGSSCC_E3YC'YI0>>7_-WRYK&HZAH4=G8I::;):Z' M/JL=]I)MH%F6"VN(DMI%NI)>1D2K*PHRK.?S2_,[6=(U-=-\J^:+1+P?E+YL M\VM;HMO=,E_9/I2:;>O'0MP#3S4&ROOUX[*O)_S?M_/-GJ=G^7FI_FOK6JZ= M/=>1O,\6MS6>CP7UM=R>4+#6OS$\[Z;JM_IVG:>]U]1TBSMKB!83<6\D8F$CFLLB2$@G MDK?"557^6?.WYA^Y\M>8I-'MXE% MY#/9Q\+=!<72H@9N0X>DH.*LV\FZ[Y@_,+_G%)M5-7>Z\WZ=# M:Q>N8_K*+<01-'+ %D1!0<6'$[&OQ8J\Y\QWWF;R+%K?DKR9YFCT6XTS1/RM ML=*\R+I&DBYCD\Q^:;^POYWBM[2"!B\)HJ>F$4U95#,Q95,O..K?FC;W_P"> M":)^:M_IEK^3F@:)?:%$VF:7<-J-\^G275P^J,UJ.<4[1@M';K"02Q5U6BJJ M]?\ RYNO-FE_F-^8'D3S%YSN_/%CIN@^7O,&FZEJ-K96US#+JTNIV]S OU&& M!&@!L%:,,A=>3 N^U%7A'F'\P/S,T/3?S)\VIYXOIK/_ )6DGY?Z'I45EI"V M>A:=<7=I#]=YW$<7JW(9VBC:YN5A4R)S5N/Q*ILOGW\T+2V@\GZAYC?2#JOY MA:;Y7_Y6!J'Z$O-:TW3[[39;UXKV'2S<:=%=O<0I;022QJK>O&6AY !U6+)^ M9'GS3M?\S:2/S$TSSE)Y0U[SOIVC>9]2L]/ACB32O*.F:C;Q79/R\UZUBU6S\N27JVEWY MGM[$S#4])6XL+B!I^,L"&&.53'63U(G9 JRB'\S_ ,T=6UWS/KNF:G=P0^6? MS!F\JR^4;F;RU9:";.VU)+(17,)#(F[*H"W_,#\S- M)_*OR-YJU+SYJNLZI^;/G$Z%+J"6>B6BZ%9I/J?H+IXN8K:W$]P+:&V]2\E= M>;!U0FD3*IYH_GC\S-7\Q>5?RWUGSH_E"WU#6?,-J//Z_H2ZUJY32;:PFM-+ ME^KB^TN"^9KR8RJ$Y/%;LRQ1ESP5>@?\X]'4M1_)C5I-)UNUU/5KSS)YY.G^ M8[6-5M)[J37]3X7<<=94"/(>8 ++OW&*O)1_SD+Y\OKZ?4K'0IUT[7=-@\F> M5=':-5GB_,1%MFNX97:,@)%];D1ZLR#ZJY%?BHJH+)K7F;\Y?)DMUYKN]+C\ MO>>_S$TVWL;"UTR)+BWL["UDXW!DLW=VE0E'<-S*'X65Z,%4Z_(V;SMY-\F? M\XKR7WGNZ\QZ/^8FGV>BW'E6>QL;>QT^V7R[=ZE9M8O! MSZD0LDC=I9G$E6 M:B; *LF_.O1[NY_.#0+^'S7J&FPQ?E3Y[=]#B2R-M<"&32@\LI? MA(I_=)P*5DYJI#YM\X?F1^3.EW2S^;[K\R;J\_+C5O,L,>HV%A:KI^H:3=:3 M;&2SCLX8*6P347E:.>1R!&*R@>6\X^8?+'F35;W7M%BT6RU72 MK_S!<>7FUN&6>:5'5H_+TAB>UF0*\3O&C AEK(""JKSF]L[^Y_/;\ZC8_DOI M'YJ@6_E;UK[4;O3K=[0_H^6D(%[#(Q4CXOAVWQ5D/Y22ZU^5USYL_+WS5KFG MZ9I'E+R79^:+'3HY%&G:6VIZMK\]S!9W%PD4CVME#';VZ0+[3O)_D_S#>A;?39$N[B319"MS?B[BF;ZIS'$I (V M+5I)]D*JE'EWS_YAT&74M;L;:U%[J/F/\Q];O=+DMHY#];L]"M+Q(D>13-$% ME)#!64L-FJ,5?3'Y?7&M6'G+6_+&I?FLOYFH=#T_6XX+BRMXK_3S>/)%R-SI MT,-H;:Y$1>"-U]9>+'G(FX58/Y1\O^1_,7YD?G;H)#R3BJK'O+VOVNJ7OY;?EW^5_Y MA:KY'_+2_P#*6N>9?+OFJZ$=YJ6H16.I1VT-I9RZU#<)]2M8YC)NI=H##P98 MQR*K'O+GGS\U_P S-(N];A\_2>2$T?\ *G1O.'U+2=-LI8[S5;BXUJ/ZP3?P M32+974>GQR>D &*LO"5:-S55?//G/\SOR[N;_1KK\V#?2:OH_D[63YHU73=- MABTF;4O--EH^H"".&.)/JKV]PQ"3EW0@'UNN*IUK7G#SSH.M^9_RT3\RM4UF M9=7\OV?E3SE:Z;H\FNSW6HV=_?7NAM-/':Z5%,L%B)TGDBHL4JIP>0H2JQ7R M'^8OYH^?Y?R[\K'S_-H;:AYN\[:%KWF*SCTC4;^XL=#@CGME%S%;M8-<1M)P M::*#TS0UB+;A5,=*_.[SKY:@OK'S;K46O:AYQ?5_+'Y531P6UK+=^9]$\Q7? ME_T2J#B9+B&2UNG%.*B.X@'>@&*OAKR;)YI_(DZAJ&JZ/JOZ5_,OR;?ZIK-QJ44;07GG_ M $M+O5IWC]*ZN.(N;6:50&"U2T45KMBK//,'F[S?Y)NI_+4'YSP><)O,$_E9 M)O,E_IME];\L0:]>-;-?-+:106#07(BXVD1F]D:>2&#BT<#($C ME$G!5.?RK_-3S-YEU3\K%\Q:Y82Z7KWE_P \'4=3MHXX++6)_+VM6%E9:E;E MQ5%GMFDG"(W&CD[JJD*L \A>=/S._,S3[K5+?\U+G1]/T7\OK+S8DNEV&ERM M?W]SJWF&"-I)9[:9!;/!I\2LD: M0,LB?%R50WE'4=>LT_,OS=)YLN=3N?,_ MYH_ENMWH=U:Z=+9P#7(/*;W3PH+42@K#>&"-F=BB(C@^L#*54W\N><_S2LO) M_P"6'YEZIY\NO-+^<_-;Z%J'D=]/L(K![*6XOX8!"T%N+H72_5X_WGJE&-1Z M6^*IIY6\U^>(]:_YQMUB\_.B/S1'^<-S<2>:/)HL=,AMBHT"]OS^B_2A2\BA MMKB)$D$LDKD\0SH>2LJSG\S;?ROJ?YV?EIHWYF+9OY*N-'U&?R;I^J$'3;[S M4L]NBI<1R5@EN(;0LUJD@K\4S(&9*JJ\I\YZE:?EE^:^K:_^24-J-#\LZ1;Z MS_SD-Y/T2.-K$VZ7D-O#)Z$*^G#?BRENKAN'&22.WC#_ E>2J)U#\SOS+U6 MY_+V"#5-0T32_P YK[S#KWE.718=(CU&+1+".T&C6$+:[Z=LDUY!*U],)%DE M YQ*JA2451_E/S7^:GG#S/Y4L-2\_P .B0:5Y'U'S!K5KH\.EW5KJ]Y8:[+8 MVLMS/$M^L49]3U&_P#-?D'6 M-:\OQW]EY>U/1KJ[T^"&>6ZTJ_T5F"V:+-00WT+,]5^/DK!U4R\U^?OS#3RK MY[_,:V_-9O)M[Y:\^'ROIWY?-8:<]H+2#6;>PB@G%Y ;M[N]@?UXW27APE3A M$P%2JEOY:_XT\H?EU^5>J0_F!>W.B^UOKF<6/HP)?^KI'U4"Z]>1PX244C8K MQ58WIGYH?F3I/FSR_IT_G34M?T[SKY'\Q>8+.ZUQ/+D8,EG9+>V5[INFZ1RN M;> %@*7ZW?7 M5Q.ES"@DL1;+96"0*9(XU]6DZ5?*GERTL[!ET3S?H=AI]O% .<0OEM+J%(PC@I?>J%8$?O">K'%5 M]OY:_*?R*VE6]AY;T/RP8#->Z5]3T^*W2$Z?:RK),K11!8S%;S2*&)!XLRC[ M1&*K)/R>_)V^T[2]/F_+7RM=:5I-S-J>D63Z3:-!;7-V5>:XA3TN*/*54LP M+4%>F*LON)O+?E6TU[S!<_5](M'#:EYCU4IP#^A"D1N)W JQ6*)5Y'?BH';% M4M\Q_P"!/+4DOY@^:#I>C3Z+8263^;KX1126]E<2HS6PN7 8)+*J?NP?B?C0 M%J8JPORWY]_([6+'SOYL\NZWH'H&:W'YBW_IK:SF9H5MK8ZG'*D4O+'F'7)I;G2;[S,]A:W%TTEG(UG<6[W#1LY,31 M&)@3MQX]L59:_EGRO-8:OI$NAV$^F:]+-/KVG26T;V][+< "9[F-E*RL]!R+ M D]\52OR79>0/+Z:KY-\AZ?I.@P^69T_2GEO2;>.SCM);V,7*NT$2(H]96Y! M@/BWWJ#15BVN>5/R0T_S1<:QKOE;RO#YPURRN]3O-5FTZW:_N+32S;RW-S), M(C(5@80DN3LW#>M,58!YC\\?D[^=UUY*\JV'GS3Y)[3S%9:U#H]_93JFK):) M*7L$6\2%)#+&['B.1XACP(!HJCH_,G_.+NL):?D['+Y,U#2K*_.GZ?Y.-G;R M:1'J*.2;: F(V?U@2.1P1N?(LM.51BK+]>\M?D=-J?EW\N_,?EKRM:?;2":)9H[S46AA:(J TJK*_3DR\MRIHJI>=O-/Y'^2;^WL_.E[H& MF:Q?06#PZ=+ L]XUKI5PTUA*;>&.258;6?DT6=)O\ \R%=;#SCI5G'<7&LHJ":0K^U*/RWY\275KNP\JMJMG'=-#JEK%]9N;:)+J(M!.(HO4*$*Q5>5"!7% M69:A^6'Y;:G'Y?&I^1-!U"/RJZ2>5UN-.MYAI[(_J(;0-&?2HP!'&F],513> M1_(;^:D\[MY4TA_.D$1AC\V?48?TBL93TRHNN'J"J'B?BZ;=,54M)\@_EYY< MU'6==T/RAHFAZKK0HC]CU*VT.P@U&"ZN+Z.^BMXUF2YO55+F8.J\@\RJ%=JU8"AK3%7D/YD?DVWFZ M?1SY=NO+.GZ58M=S7WE7S'Y:@U_1Y[J\F-P=0CMO7M##>+*SMZH8A^;!U;KB MKT?R/Y(T/R1Y!T/R!:JSLQ10%%>*@+08JF MUSY8\JWDSW5WHEC=W$PLDDN);=)'8:7,US9 L5)/U:9C)%7[#$LM#OBJZ\T/ MRP(_,%W>:5:.NM6X3S+*\"N;R&"(H%N1Q)E"1DJ U:#88JBK"#1)9V\P6-M" M;S5K.VCEU81<9Y[6/G+;QNY4.53UW95;[)9MA4XJA7\L>5IK'5M+FT/3YM-\ MP2S7&N:=);1O!>RW 'K27$3*5D:0 J:#-^5/YYC]+4M*!MTFANFBD:JNKB2,.&JNZJM^4'Y:> M1O+&G:Q':/H?F+7(?,%_)K%WIFFV]C9Z=?RVEO93V5C9Q^H+2..U@AB9.;,P M%969B<59G8_E/^5&D:!J_E[3OR\\M:?Y9UHK+KFB6^EVL=G=F)@RM<0K&%DX M%01R!IVQ53T[RI^4_FZ_T'\U-/\ +/E[6]8O+2WO/+OGP6%O)>M;R1?N)(;M MH_5IZ;_":U -,59')Y.\H7/EZ3R?<>7-,NO*T\;I+Y:GM(I+)T=S(P-NZ%"" MY+&HZ[]<58P/(_Y2ZIHTWY:'R;H%WY:\M/;R-Y+DTN$Z=:O-RGA>.W:+T0QJ MS545!._7%6<:5IFB:!:#3=%TZVTBR$DLRV%G"L,8DGD:65Q'& 7=RS&FY). M*L:T:S_+W6_KOZ#LM*O3Y<\QWDUX(+>/_1->3E];F^P.-Q^_;G(/B/,_%N<5 M15YY%\AZD]M-J'E+2+V6RU8Z[:2SV,,C1:HU ;U"R$K.>(_>#XMNN*IG;^7_ M "U!!HEK;:1916OE9E_P[;) @CT\I"]JOU50M(:0NT8XT^$E>A.*H;6O*GD_ MS+>:7J'F#R[INNWVAO+)HMY?6L=Q):/.GIRM TBL8S(GPL5I4;'%5#7SY,TI M+/6O,:6-NJF/0K'4+J)6(&KW$%LMDC%20MS-Z*%.C$+7H,5:\I^2/(OD"TN; M#R3Y4TCRC97LOKW5EHUE#91RRJHC#ND"(&(50HKT&V*IK]6T'1IM8U\P6NGW M%[&LNN:MP5'ECLXV"M/( "PB0$ L?A&*I)KWD7R!YQGTN_\ -'E31_,]UHS" M?1[W5+*&[DM6)#\H7F1BE2 ?A\ <50FI_EE^6&LWEEJ>K^0O+VJ7^G/!-87U MWIMM-+"]HJK R.\9(,2JH2GV0!3%4&+S\J;4WNM\=&MYM(L)/-6HWAMT2>WM M=662.6_E!0.OUE;9U9B*N$(-:8JG_ECR7Y(\EQW<'D_RQI7E>#49S=7T.DV< M-FD\Y%/4E$**&:FU3O3%4-YL_+W\O//3V7?4NYUTFS$E_90Z9>RBW0&:RA]7T;5R%^*)/6DXH?A')J#(Y< MN)I3%4>WY8_E@?*Q\D-Y#\O'R69CZQK>G:5I]BC&ZUR^^L66XV MI7%4JEN/)^O:J^AW+66KZOH,5CKWZ.F19I+5+EIXK.\564\2YAF56&^S8JE^ MD?EQ^6VA:1J^AZ'Y)T+2M"\P2-+K^D6>G6\5K>R.H5FN84C"2$@ ?$#BJ7:_ MY*_*'1O(,FC>9_*_EC3_ ,L_+D37DFE:A9VD>CV4<9:5I?2=!#'0LQ+4&Y/C MBK'])U+\AOSBTT:#9V_EWSII_E6.RNH4>-/AXHZH%V* M@[$8J]*T_P K^5-'2:#2] T[3DN;-+"XAMK6*(/:(\TJ0,$45C#W$K!3M5W- M*L<52Z/R#^7\.H7&KQ>4-%BU2XCT^&ZU%+"!9WCTIXY=/5W" M^*O!/(O_ #CZWE_SEH'F_P QZMY;U2]\KRW%Y9:AH?E>WT'4=2OKBWELOKFL MWD=Q.;F18)Y/AC6)&=S(RDA>*KZ(US0?+OF;3[C2?,FD6.OZ3=_[T:9J-O'= M6[\0>L7-*;R[Y=\MZ9H6AR*ZR:)I]I#;6K!UXORAB5 M4;DNQJ-QL<52[4/+_P"7_P"8.@OI.L^7]+\U>6[6Y>U_1.HV,<]K'/I\KP$) M#/'0&)T*@@4V^';%4ZL/+OEG2Y;2XTS1['3I[#3XM)L);6WCA:"PB8/':Q<% M'")2M0@^'VQ5(--_+/\ +/19]7]*NO,R21^8IK33;:%[])F+R)3=$\X2V]SJ^@"VT:S@ MO!%8R01SW$+K""OI/[D>:=['2[:V:5Y8 MI('9C'&I/**5T(/56(Z'%4T\Q>1/(?G"*PMO-?E/1_,T.C2"72XM3LH;M;60 M #E#ZJ-P- /LTVQ5DFF:?IVE65KIFDVD.GZ;IT,=M8Z?;(L4$$,8XI''&H"H MJK0 4 Q5,,5=BKL5=BKL5=BKL5=BKL5=BKL5?_3^_F*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*L8\[3SVODSS=_M/*OY=77Y8V_EKRYYENI%BTI;FVNXKB*UDN]H8GDMSSCYE? M4 ;C4@C%6#EI?.GF.SU+0M>UG2?)'YM_G&TMAKFB7"0Q3Q%9 M1;RW=@P61.)8*)(F'P/BK'-0O=?O/KOD*]\R>8+WR[9:Q^:'E^-6U*\%W)IV MGZ3%/8PS7DFQ8[U58_YV\Z2V.NII>G>=K6S\BV?DO2;O\G- M?U'\P-:T>&]E=9Q=7<%S:V>I?IFYCN B&&>9CQ"*L#!RQ537\PM=L+K3/SDM MOS3\_P"K>7_S3MT,?D;R/I^H7EG:W.E2Z?;B%K/1T)BOXKJ7UVN'FBD>&KG>8-*U*P\\Z-9Q:@WEZ\LI3-;:G=VTP M=7MDD41RDQN%$G-N**TB*OD7SSK%SYY\A_G.OF;S#Y<_,RR\N>7_ "\[?GAY M'%[H\K>K+IU^;6[GA=K<*\Y]&9D16K*L9*\E7>8OS ]+\R=/NO+'G2\A MNK7\R=+TNZLM2\W:M>:HVC#5;/3Y^/EJWMQI]OITEK.7CO+MV:1'282&5T;% M4-'J">2O*-OHOEWS%<1>7W_-OSCI_P";<=7T[]'!;_4SHUO?:G$M_=:9 M#= )(TB)%ZK<&DF7U"754O,/G/SE9>7/(^JZ]YWMM<\MW<7F"/RU;'SCK/EF M*\BAOHWT^ZM_-9TZUBU*[@MV>..&ZC2.X1?43UFYMBKZS\M:G]?_ #B_+O6; M5;ZWN/.?Y3W%YYILM0"QWBBSOM-?3&O88@J),IOKM:\0*\U4 XJEVI?Z7Y\ M_P"_G M1^9'E.ST'SC>^3K/1['ZIK-M'H$=^VHSWVF 7-A%%/>.B6W^DI&S2@,W$% ! MS+*JA(_S/_YQ_/Y>Z!^7$=I:ZMZL-EHEM^1D=GRUR*ZA9%6VDTE@LL#02H)& MFDXHE/5]3CQ._EN+^,\7'JQF)A3;%7K?E/SWY$_+OSI^:5Y^8NNV/E;6O/& MMIKN@^;M4_T:SUC0'LK>+3(K2_D BD-LD;QM &#JW)^#"3FZKQ&ZU:'ROYJ\ MB^;=$U_1ORC\G>:///G+5?(FJ>::\/UZ^CN;B%6D4 ME7#\/BXA5D^3[+4=4NM$L=6UF:-KY_ M,5SY2T>MM9RSK'JNMV<$US%&_']W%"5:62B\J XJ\2\@W'F+S]H__./GES7O M.'F1+/4-:\_V'F233M2U+3KB_L]&GN(M/@N;ES#?\5C2(H\C)<%0&9JLW)5! M:1YFAEOCH_YP_F9K_EOR;ID/F;3/RXU3],76EG5-2TOS-JUE(MWJ%K)%)=75 MK8V]FD4,Q(F#NW"5^155[-Y9U0Z!_P X>^3]5DFUB(V'Y9:6TDND4CU-/]Q\ M*F2%VBE]%P"2TAC/I"KT^#%7S?H7F37-8L?S1\L:5Y]N4T*\UK\MHM$U'ROY MIUGS EK^D?,[:=JWU#S!JL:2S%X$C28P?N$)X@!R]562?F5YCU_0/S&\Y>5K MOS.GE8>78=(M_P GGUGSQKFB2S6QLH +FVLX=.U!=*83RS2-Q5#&G+ MFZKZ6_/B+4=0T'\N-'AUK5= 7S'Y]T#3=>N]$O)M-NI;29I3;/-EI^9/G70;_P TVWE;S1HOF&RT_P#+&UO_ #CK5AI4!IV,C(RJ,F_-5H? MR\_++R>?.]V?S3L_.*)E5 AE(5_@"%JKBJV M2X\]7NG?G#YUT37O,>K>;?)7D3RG+Y0TK8Q3W^BM)J-Y]3C9HYYW1V?D M\4I#HK)&7J&52O2/-OFU_*_YGW'D?SK;WWDZVT[09+^]\O\ FC5?/-SI FU. M/],7MKJ>I6%LT"JO$M.N/+WEK MS5YLT&_\]ZQY9\G7_P";FO\ _*V;L>8M1CELK9[![C1$NKAKLRZ;:WLQ8FXC M]/U3''&9:4&*OJW\CM7UC6/R\U:6^U:^U[1H-;UVV\C>8=35A>:AH$-S(MA/ M*\E'E'&J)*P!EC59#7ER95\F?E9K45EY$_)"/\IO/FO>9OS470[;_'7D>YU* MYNXK?2HM'E24W>DS%;?3UMI_0^JND4;2G@ 9A(Q95G7_ #C[YMUC6?/>@+I' MG"QUC3+OR]=7'GW1X_.&M>;;PW-8A;W5S;:AI5I'I-PLRR(T7J1JP+*D!X!E M59'^8^K>9;G7/SCT>R\SZSH\$?FS\K=/TVXL;B2.2R@U74;.*^^J]5C]9'8/ M04:OQ5Q5B?F2^F\G^>M9\AZ[Y\\QZ#^1FD>9-*/F;7+G6K[ZS8QZCH<\MO:3 M:Y).;Z"TN+Y0SR>L.#!4]2.-Z%5X[9^;;C3+J[L_\4N/RHU/S7YSN+'S9K_F MO5?)ZW^I0W5FMN+K6+*QN)I&2TJ]LLOIK/O(S7#4&*O6/\1PS^8ORSL/SQ_- M+5?*VFW/Y7_7KZZTW5-3\OV%]JHU(16]S->+#2-&_P !R:OYLU7RI-J?FEH M,/F?\N6U.Z^K6\*^;+5K>V.C!GM8K&*V$+1W:J"YX\IRSLK*I7Y&\\^>M2U# MR]/=^;K:U_,2=M6/YG^6I_-VLZAJ/"&SNC>6[^5SI4=KI@MI#&UO-'+&@XI^ M^G#_ +Q5Z'K/EZ]T?0OR[M#YR\WZK'^:GY?^8G\_?7]S6^A0WD,T2B5 M19NDM1_HHB#*2K!@<5>_:KIYU?\ (ZT_Y5)Y@FU2ZL],M-4\EZO'JTMY^D)= M.FCO([>749II'EBNC"8)&=V'!B&JNV*O"O*'F;\S_-7FGR[Y>N[K4[+2_P S MM;M_S1M9I"\4;1Y3^B>8F)1I9(=/22)/A*W$YW')558$8='N5_,75M7\ MR:H///F__G'?1+RP6ZU>\:2]?T-8AO[B"SFF:&9H (F)]-O2=R]%:5BRKZ@\ MFZ9)Y*_..\\DZ?K.N:GY?U'R3%KUQ!KFIWFK2+J,>HM:M-%-?22O%ZD;#FB, M$JH*HN]57C6MOYPTSR;_ ,Y%_F'H>N>8M3\S6/GB]T2VADU:^-II?EV.\TY+ MXV-I&+F*W:&V]:43);22QU8J& "8J\[N/-'F@>4?,5_H_P"8.E2?EWI_FC08 MI(K'SEYBU?36]>"\2_L+CSNNGQ7-A!)(]K+S#RB*7]W++%',%55D%AYYT#7) M?R9C\_>?O-/DCR-=:/YXBU:]NO,SI#?W&FZKI:633>8=.%J)[5!(RVMSS1I1 MQ5GD+L)%6"WWGG\R;>YDT_\ ,'S3^A[:TT 7'Y3:_P"8?-FJ^2Y]2M_KM\MO MJ+VVGZ;=)J-^T2VWJV\YK3A2V)D=BJ]K\R:_9S>:_,R_F=^9GF3R-YYTN;RY M'^5F@^7[F[MA>K<6=F\TMAHX'#4S/J+W$$\7]9_,#5_+'Y8-=^;H?S%U1/,.H6_P!7\QVEQ%^C MM*O]3^M";3$,+2SB)9(5DD5.7)I*.J^D_*KZUYM_YQEUP>;=1UC49+[1_,<. MGZY6?,_G'S9JWE M_P X^8+GRWY?_)[RQ<^5K_1/,FHA+V1;K7Y(;NXU""X,]XT31E5$LSI1F#(V MW%5Y?J/YB^>M5\RZQ)K?FNQ\N^>VN]&;\OK:Y\V:OI,DEG>V=C):M8>6+32K MRUU1+J6219JM*_(LG^C<%XJOL+\^K&&33/RZUK6].FU;R3Y0\XV6M^?M-MX6 MN?\ 0K>UNTM[F2VCJTT5I?26]S(H#<5C+\6X4Q5YS^8OYE^2_-\'F+5/R@6# MSY^8WE#RKJ,EC^8GEZ-;^WT:SO'@6X@^OQOZLOI?F"ZU;T)$T_6+B6>5GEM" M'FB#NL1"U">H595/]9\HW>E:E_SD,MCY[\\PV7Y7Z?IFK^0[%O,FIRQVE[<6 M+7MQ-(\DK272R21 &&Y>6(+R"HO(XJQ.W\TB?2O-6H>7OS,\RZE^?FF_F%K= MOY9\B'5;N9IM,M/,MQ$;2/0Y&6WFLOJ2RE>8/*GF*77K4><-7\V7IN/T>;^T.K?6((-/TV]1HV(MK0*ZTD MZQKLJ]#UGR_YKT+3?RE/E;S[YLF\Q>?/*U_JFOW>HZO>7D=YJ.D:?::M:-Z$ MK-#;\I8S$RP1HCQNRR*^*OH3\D_,-W^8,/F7\U4NKUO*WGN]C_Y5YIMR)(HX MM"T^+T(+M;:55>)[V8RS'DH)0QUZ5*KQ&Q.N>==:_*[R[JWF[S';Z7K7GG\U M(-=33M4NK*:\L]+U.]CLK26Y@D29(H55 GINK*JA58+48J]2\B:]JMK^1_FZ M_P!9U?6=3N/*M[YUTVUU>-OK&KFRT;5=1M+3A(Z.99D@@0!V5BQ 9N1K55\K M>3_//G2VN?S:L/(7F5-GRC+D9M9_)F?S=I-I^87FG])WE_;Z-#- MI]Y++%9^9':6Z6*XN5LUNR)BMMS:DD/-N"J'3S!Y:DF\CV/FK\W_ #5:?D5/ MI/F"X\I>>+_4KK1)-4U&WU***T@N-9@>"XN$M[;D;(R.#>*3(WK\02JI>4G_ M #'\RQ:CYEUG6_-$OGGRE^3>A:OY;T+ZW=6%K-K-W/KZ1:A>Z9#+%#+--LORF\VW.M7EIK%WK%U: M7,M]H:L]O?7JW9L[EQO-$-H%42^A&=V52+R]YJ\P:G;_ )G>7M$\^R0Z'<:S M^6ZZ'?>6?,VL>9([7])>9VTW5#9:[J\227'J0Q1I-Z(,"-\/'D7JJ]/UZZO_ M "AYE\W>1KCSGYETS\I],\X>6(?,FM7&JWL]YI6DZGHUY<3(=8G>:\AMY]1B MMTEE,M8DD?C)$OQ*JPKS-YPN;)/R_M+?SYJ6J_DSJ%CK\OEKSQYG\T:CY-6] MO+:_CBM(9M=L+&YGNEAM@[6;3M']:2LC-<'CBK[8_)ZY\RW?Y:^2[CS??1ZI MYCETF ZKJ44<\2W+BH6*K4DU.*IS:9<_6+'5=/T&X\RS:9<6LDRNU26%4<,/4! %1S%=_ D=:[XJDWF#7_+OEA=#_33 MK;#7M7M=&T=1$T@>^N^0A2B@\:\3\1H!XXJI^7?,OESS7:2ZIHL@NHK:_P!2 MTQG>(HXN-+NYK"[55O3%60^O:R,4Y*[K177:J\NS#J,58]YK\ MQ>7/(WEV_P#,6O\ ^B:)I8B-V\4+2\?K$J0+2- 2:NX!H,57ZQKGE[1=1\N: M7J0X7GG#4'TG1U6(N);B*TGO61V4$*HAM7(+;5 '6F*I#YJ_,+RKY5UFR\N7 M-IJ&M>9]9M)K^#R[HUA-J%VUE;NDG3XJ8JX7=BJ,HDC6)=F-0%%>Q^=<52>?S!H$/F/1_)\QKK& MM:=>:MIMMZ):-K;3I+:&=R]"JE6NX@ 34UVZ8JG@&YV-?IZ/+E6:4?L(M#R8],52KR[YL\N^;-,\MZQH(EO]%\SZ8NK:/J8 M@=83;NL;QARP!C=UE!", :!MMCBK(U-BRJ4CC94!",J@@ ?$0"/ [[8JK!+: MX$)R 0#XJ?XC%6/2>8_+_ /BD>2Y'9M=BTG].K;&)RBVGK_5O4$E. M/+U-J5K3?IBJ=&6PD>-CZFVNEWLLUNEK MJNDZNDUL465IM(OH=0MT)=6JC26ZAP!7C4 @[XJRR,6D_*1%CE+?;F4 U(VH M6'AX=L572"U@'*0)$&I5S0#X>E3^K%5$26,(XTCA4T8#90>6P/;K3%4/=WNE M:58W5]<<+>TLH);B8JO[$0,C\57J=B:#?%7:;>:7K6E6.LV2K/I^LVD-Y;RL ME#)#.BR1EE85W5AL>F*L4L_S(\EWHT$6=\TL?F+7M2\KZ2ZP2!6U'2%O#=Q, M2HX*@L)J,?A-!0GD*JLS'U!5Y\(T1J?O-E!_EW_5BJ)2&$-"2> MY]\54&>R60(ZHLLI'%& Y-0[4!W-*8JT)+%R8P(Y"ZGE&*,64;';N!TQ5"WE M]I-G8WMU<>F;2QMY+R[55#TCA4LS44S4XU/=6 M.U3XC%4C;S-Y<3S.?)LDO'6_T2NMM;M&PC^IFX^JAC*1PKZFW$FN*NL/,OES M4]>\R:#:-SU?RJMD-<1H641+?1&>W^-@ P*+4T.W?%60I':NQ=84Y2H 9 H^ M->WQ#J,5:>>T4A79%*D(H- 1R[#[L50.H:II6C:9?ZK=.(=/TNUGO+IT7D%A MMT:60JJ]?A4F@ZXJJV5_IU]:6=];.&@U*".YM2PHSQRJ'4\#OT.^VV*JH^H. MZQA(FE1:*E 6"M[=0/PQ5$F.%"TIC 8;E@-\50Z2V*!C$8^#-1V0BA8^)!ZX MJM1M/]*B)%Z!!KQ"\*$_%6FU/'%7GVGVOE/S;^8%WKUI=S7&M?EG;WWE*_L" M@6U4ZQ'I>K/4.E9"(H[BKT.1[$,%E$997!4/0GF=@17OBK?^A2 M-RXK(\3$!J596;J*]0=M\5;2>S4N8VC4NW[QEH*ML-SWI48JDGF37O+WE/3X MM1ULBWL[K4=/TU2D1DY76J7<5E:JR("?CFE05(H.IV&*II?:KIVGVNH75U.J MP:;!)PU33(=4LK\0%(&@GHR M*6H*.0W(J14#?%4W]2P?TY (W"U$4JT('6O$CIT/3%54W%LR!BZF)0"'J..^ MPWZ8JW%%;*"D4*1A34JJA0#2G;VQ514V$=(56-.566 M3J0HZ],58CY>\] M^7/-FK^:=%T:WO;@^5+Y]-UC4I+22.R:^@XB6VBG8!97CYCD!L,52/1V\E_E M?*/)\E_,VHZL/,_G*%9X_4E^KOJ'U_4BKQHH"QS:B B'XBO\W%CBK/=*U#1] M7TZQU7356:SU*WAOK=A'Q8I^USR=^4/E7ROI5P)K:Q@-G MY:\J:-96\MY>7<\<16"VMK>W1GD?TXF=B% 559W*JI(55_*/G_RQYTN-:L]. MMM0TW6O+,L2ZYH>KZ?<:=?6OUE6>&8Q7"(6CF"MQE0LC$,.558!5F@ELN(<< M!%QY^K0<*'N6Z8JZ,60/&.- 4Z* -@U*D = =L54))].M[=V$:E$21Q;1*"S MT4E@J#J6'WXJQZU\X>6M1EUW3]/$NHS^5M5M-&UJRA@9C;W5S!;7*#B0 52* MZC=V7917>JG%64![,NRH%>5:A(&_TXJZ+ZD[?N8XR69@Q0#[5!R!* M_17%5Y@M($Y&&.-(QUH %!-=O#??%5,R6(5RWIA&3XV-*,I%-S6A&*KBMF42 M-XD])BH1'4<:[<:5V^6*I/Y2\SZ)YRT&Q\R>7I7GTG4O5-K/)&T3-Z,KP/5' M 84>,C<8JR3%78J[%78J[%78J[%78J[%78J[%7__U?OYBKL5=BKL5=BKL5=B MKL5=BKL5=BK"_P Q?+*>06LM5T6_P!?_+R^_P 3:M^5/F;2=+UV319I;B'4QJ5_ M(L,MVD+&UD>TE*QF5DYJW!"U>.*OHGR;^7&C_E[^:/D5?(WE1/+OE[4/(>KP M>;[FP@98;J_M;O2/J#W\N_J7/![DJ\C&1JR58[XJB?\ G(_RQI&OZ5^66H:S MY1_Q=8>6//\ HFH:E"FE/J\MO9\I(IY1;1132E!R7U.*';=MALJ\3'Y3-IOD M'5_.F@>2GM/SCN?S;OK_ $_S/]68ZM'9W?G-XS)'(X9X[.2P;FR >B8RTA4U M+%5"_D3Y*UJS\[>2;J2W?RQK_EVRG_Q_%#Y%U?1;G4FFM##+!JWF"]U6ZM-2 M?ZTRS)+&)G+*2C1QL^*OJ3\]O+^L>:ORL\W:%Y?L#J>LW<%M+9:>K(C3_5;N M&X>-&D*KR*1GB"14T%<58+J7FR#\R_.?Y67?EGRUYEBT[R!KUWYB\UZEK6A: MCHT=O;2:'JEA%'"NH6\#W,SS72@) KT )8CX>2J2_G)IVFZOYIT/S/J=M^87 MDV&PT,+Y:_-/\OUO+C4 ]])SN-,U32+:TNI6C01Q2Q_6+>2,.S@^FZ_$JS[\ MDK_S6GEVTT[SVES<>8+Z\U:[TS79M(.EW&IZ9#/&EM?:G;P1K!:W1=4UBZT_0[:*UCTZ M/2->T_4[:STN.W])@\,B0J/C,HF5R651?G[R99W.@?F7I^N_EOYAUO\ /'4/ M-MUJV@><(-(N[X/I/Z8C?3EM=7@C:%+6.P6-)+1I!N).4+5JRK?Y4^1_-4/F MWR;)KD1T#\Q="NKB_P#S!U.'R1JD%]JG**9;V#4/-VE9@2L'*1'"2A&6,T5?+=]Y>\Z7VE_EQ- MYG\A6FF?E_HVEZ]8VNA7/E?7_.>EQW\VIK):WJ:']4_,6D_D]YET/5+4Z3/I)C\P/=>6_KR2+*MKRFN5@N"DBNOK48QR_MA5.- M)_+J[U3R;^:B:UQN=.1)59#$JK$S R)4LQ*K'?SQTC69O./FS4K7R==^:M,G_+F MUTVXACAO'MY.?F&%[A7%B\<\XAMRT\EM$WJ31J8U!YT*KQGR=Y+\ZZ-HOYD> M8O*&@22:AY.\P>7O/?Y:Z!;^79_)VG:CZ=E-9:M:V&D2M,]N;FV,T1#?O6D* M/(#R4LJR+RU^5GYAJU_Y \PRZTWE;\NM!US6-%\S6C0B\U'7O-NFI$#8F011 MF6QDGU,4,@%98JE5( 59_P#\XOV>M:;JOG*TD\DZ7HGE^>SL)+7S'H?E_6?) MUGX!BAX-6C.*JO'/RH_*27S M'/\ E[:_FIY*N]>M?*_Y77>DM!YCM9'MX]1M]=FCBBDAE+P^M' @,->11#6) MN)Y%5*[+RUZOEVR;\[/('F;SIJ&J?E;Y:TO\NY)M'OM:DT_5(=,D_24;B".2 M73[Y[R16:XFX,0$'JCA0*ONOR#;S6GY?^3+2^MWAN;70--AO;65?C21+2)9$ M=2*U!!!!Q5\4^6ORD\JZC;^3?)#_ )72Z?INE_GAYGU+SQIHT6XL+*XL3;^8 MY=)GFE6*.*ZM3#);1@AGBHRPOUX8JQ?S!Y&\T:=YAEL-2\K*?RC\NZUYJL_* M^AZGY0U/S=IME)DZ7#;W&K7T)M;F4(*1^K TURRLB44\Y7;;XF9JG%7PQ^ MK_2O(\^F><;'S#IU[H6J6WE+4]7UF^L]->SE6]M?-&.S61OC*!85XD0P3K/?Z)I^F :I;0HO%Y_3D"":*(\F4-&0W(HRK&? M-WE?R_>)I>G:!^5&H:)Y OI-:NO)5UYD\I:MYKMK:YNC:QO!I?E>*2!='$S^ MK)$][&J)0^FJ)(5Q5-=*\OZ7)<_E!JOYR_E[YB\Y:;IOY.:=I&J17&BW^M>E MKJW4:R17EM#',S7 XMQD=#P-7YKR#%5BS?E_^;-IY7=(.A7?EN#3;21(D-M::9?W-U:_^<@]*\P:YY636K#R]Y"<:!JE[;F:SM-5.K+(CQLP,8N$5 R- M]M14J14U5>'A];U#\N?R,_+R'R;YJ7S+^7&F7ECYV6?1KZ&TMKB/R3K6G!4N MY(EAN1+4;[R5IS+9>:9(]7D MM]+>1[B-HK18C-+*5E= &/[M5.*O1?,WY>'R_P"8_-ND:?Y'U)/R3L/-_EC5 M?,7DK0+*0V%WIB:+>B[%IIL*\;F+](?59+J"W4F0*W)'/)65>Q?\X\:+8Z-< M?F^^B>6=1\J>5=6\X17OE'3=1LY]/K8MH6E)RM[6Y"R10B5)%2/BHC X<$X\ M JE7YA?E]_BS\Y9M?F\L?IB?0/RSO%\EZK%>2/)>OVMOYDU#RD1Y.UO3/(FLZ=K6G67DG5/* O+^YM@EN=0U M75=3NH+RY@N(BZ3Q"1JDEI_3<\E4J\W^5_)>I>9[FP_)[\M=6\LZC=_EMK:: MAIKZ'?:$+^33]>\NW++%;W<< N;A$23E*B$R55?4?8!5ZIYKN=1\^^:_-_F3 MR]Y7\R?H:ZD_*6+3;C4-(O=.>X.D^<;RZU!XX+R**55MX7#2%T7BOQGX*,57 MBNA^1[_5/-/E34+/\O3H3WLGF"Q_,#R];^3-3M)E36=%U:,VNL>9M3GF;6@U MV(5+1@P%^+[+Z9Q5FMWY1U*Y\LZ%;^1O)&N:1Y=3\L-#T[6=%T[3I]$N6B@\ MSVTWF*RA@FCMF6XGM4NCQHK3>6=.C87&@V0H=UJ6IU.*L7_.+RMH\WYQ>0?-=WY*;6 M-1/DKS;HVC^98='DU!K/5I&T^735EN(H9?JQX"Z$4DA506=0U7H57C_FK\HM M9\H^3/RYM_R7\H2^6_-NL^1-4TSS;?V%NXN;J3]'6DBQ:I.SI)+,7218C-() M.9*I)&34*O5/^<=/+;TI/3D:&)$:B\WD91Q59Q^?&C6VO:7Y?M=4\O^9+_0]/U5=2O/-? MDVZG@U_R]<6\3_5KZSBM5:XN _-X94A#-Z;FL;J6Q5\Z:OI7YL:]Y+\V6FFZ MGYB\^>3EUORL;;7_ #5Y;-CYAO=%MIYWUBPO-/MQH]UJ-M;TBDH!!),'FB7U M!42*J6B^26M=.T6^UW2+OS+^2-QYFO=2\Q?E]IODS5-&L;1HM+^JVTD7EFXG MO;V6T>Z#.T0B$0DI((#]O%6?>7%3\NO,7E;S$_DWSGIODJ]\BWOEWRYILMI? MZ_J-G(VM275C:W:6J7,UNIM70QB:@B0>C(X:,XJQ3\G_ ,K)8]$\T^8O,/D. MXC\WZ;^5?E'1_+-[J-D_UNVGB\KRVU[!9^H"4E]61HIO3HQ/P-6@&*JTWDFV MTS6OSA@T#\O;K2_-.M_F1^7VNPZO:Z'-$MWI"7/ER2ZD%\D'I2K%=PW4LT?, MLI#RNM#R*K"/RT_+_P XRZMY:MM;-UY<_,734OIOS!UC3_)&I6NJZ@T]K/#> M0W/FR?56TV]2X>97A*\@I$;110G?\XR:7K&B^<=7LSY)L+#17T&..[\ MW:;Y9UKR5SO+:6-4M]1TC49'M+F[D$DLC7=HS[+P9^/"JKUC_G(ZWDOO)VDV M4WE=/-.ES:_:_I87&FW^NV=A#'#/(MW=:+IDL5QJ,:RB-/1!*_EIY7\[>3[W5/*&C><_.]RVFZCH\FEZ6MA>V$%Q8!]*JT$%K+) M*QCMF+1AQQ(YH555.-(\I0Z7>^4X/S.\BZ[YF_*W09O.FD^7- .EW>L0:=?2 M^:;@Z9-+IL*33>E^C(XTLY^#)"E>+1AP2J^DO^<;]'O= _)?R/H^HZ;>:/=V M%O=1OIFHAQ=0J;VX:,3>H2Y8HP)+$DUK4]<5>XXJ[%78J[%78J[%78J[%78J M[%78J__6^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*I;K.IP:+H^JZS=1O-;:19SW MMQ%$ 79+>-I&"!B 20NU2-\58'8>?-=N#;SZG^6&N:!I,J>O>Z[>WNB&VM80 MA=IIA!J,LG%0-^*$CPQ5E4_FWRU:QV4MQK>GV\6H6,^IV$LMS$BS6-LB2374 M99@&BC2169Q\(!%3N,58-J7YX_EEIFG>4]>'FO2[[RMYOU:XT>Q\W6=]:2:9 M!/:V=U>RFXNO6"(JK:.AH2>944W-%4]O_P U?RVTKR_I_FW5?/GE[3/*VK,% MTGS'=:G:Q6-T2"0(+AY DAV.RDXJUJ_YI_EMY?M;*_U[SUY>T6SU*""\TV[O M=3M8([FVN3Q@GA=Y '20[*RFA\<517F+\Q_R_P#*/Z-'FKSIH/ELZNO/2!J> MHVMI]:2@):#U9%YC<;C;%5LOYE?E];ZQI'EZZ\ZZ#:Z]KT<\U'5O,FH+I7EG0=.A]>\O[QHW MF,<2$JJJD4;R222,J(JEF8#%4JTO\RK*;4KK2/,OES5O(VJ6VF2:S(=92 V; M6%NXCFF&H6DUQ: Q%EYHTH=0P;CQWQ5,['\R?R_U+07\UZ;YRT.]\L),EM)Y MDM[^WDL5F>184B:X5R@WU>SE>_F60Q&.V5929&#CC1:GEMUQ58?SG_*-;B[LV_,KRJMQ86C7]_;' M5[,/#:HP5YY%]7X45B 6.U2!BJ91?F/Y.F"74.O:7)H4NB#S#%YC74+,V;6! ME](3AA-R].N_J7HO)]Q*(;?S0VIVJZ>\C M&G!+@R<"U?V0:XJF/^-O+HOFMCJ-DMJNBMKYU7ZY:^A]063@9_[WGZ5/B]7C MZ=/VZ[8JAK#\R/(&I:"WFG3O.6A7WEB.=+5_,5OJ%M+8K.[K$D1N$E1B;5-.T_4+:YGMXS_NR:..1F1=^I&*I% MH7YQ?E]YI\TZ9Y4\I:_8>:[K4=/U/4'U#1;NVO;2V729;.&>&>2&5BDC-?1E M%X[@,:B@JJQ:Z_YR3_*:TU;7M&;S#;/>>6/-%EY4\Q%;FT"V=S>PK*+FCRNOGAO.>A#R8:\?-IU"V&G5Y<*?6N?IUY M;4K6N*IXOF'1Y_+\GFJRNX=3T5;)]0AU"QDCN(Y[>-#)SADC8JX(!H0<5>6' M\ZH[+0;+S?YC_+WS%Y<\H7D5E.WF2X?3+F."+4'B2WDEAL[Z><*3,O(B,\14 MML,55[7\Z+/5K&\\P>6_(_F7S-Y,L7NE?SA8Q68MYULG>.XEL[::ZCN[F-6C M;BT4)$G^ZN8Q5$^>/SL\E^0IO)Z:U'?7$?G&DUOK;6[ZC>ABK1 M6Z37MNC&A8&0?#0,0JFNJ?F3:6_F35O*/E_RSJ_G'S%Y?MK2ZUZTTQ+:*&SC MO2YMUENKZ>V@]1U0N(U=F"T8@!EJJQ^Y_/#1::?;:5Y9US5_,-[YIF\G7'E8 M16]G?6FIV^GS:HRSF\G@A]-K6+U4D21E=64H37%65>4/S!M_-.LZ_P"6;SR_ MJ?E7S/Y;M[*]U#1-4%N[&SU$SK:7,4]G-<0.LC6TJT$G)2AY**K55Z#Q7?X1 MOUVQ5W%1T4"O7;%6\5:H/#IBKJ"M:"OCBK=!X8JU0> \?IQ5(/+OEK2O*UC< M:=HUM]4L[F^O=3DAYO)6ZU&ZEO;J2LC,?CGF=J=!6@H !BK7E?ROH_D_1+/R MYH-I]2T?3_4^I6?-Y>'JR/,_Q2,S&KNQW.*L@H/ 8JZ@\.O7%74'ABK7!1T4 M?=BK=!4F@J>IQ5P '04Q5U!TH*>&*NH/ 8JZ@V%!0=!BK>*M$ FI )\<5:XK M_*/NQ5=BJTJI%"H(/44VQ5 :KI=EK6GWNE:E:Q7NG:E!+:W]G,O))8)D,&*NH/#%7 =!2G3%6Z =!3%74'ABK@ M.@IBKL5:XJ.@&*NH*UIOXXJ[BM:T%?'%7<5.Y45^6*NH.M!7%7 = !BK= . M@IBK7$=*"GABKN*_RC[L5=05K05\<5=0>&*NH/ 8JZ@\!BK@ .@IBK>*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*O\ _]?[^8J[%78J[%78J[%78J[%78J[%78JQOSE M8W.J>4/-6F6433WFHZ/?6MI"K!2\LUNZ(H9B *L0*DT&*O ?)'EBU\OZEHU[ M!^7GYL075G 49M:\VRZGIX)@9&$MG/YANHY :D*#$U&(.U*A5XIH/Y$?F-I6 MF>9++5O*]CJI\S-H^H^7M.CNH9(?+VA:7Y@CU6?R,'GX\X);>O&15,O7/D+4O-7G3RCYJ?\JK/ROI,7YC0^9=9M[LVCW\ZV?ES4;&/5+^&& M::W$HNY84B])GDXJKO0CX56,W'D'\QM.U6\FL]#U&QTBZ\[>;M5@U?RW'H-Q MKUM;ZH;(V9LFUGU(;6"YXSM.T8]8,(_A +,%5WY(_D]YH\KWWDF3S;Y8@A/E MK\M]1\L"ZGEMKMX;R?6Y9S$DBDU$UMP8N %8;$ _"%6">4](N?(&@^<=$\S> M6(/,^M1_E!Y5T+S!I$=[ISW.AQ:=H]W%/;7ZWT\,8LY)6:426[2*SF0,O)1R M5;T'\F?/-QI>NZ3KH3:O:2:E;S6;V MQ4&,R<%56AX-\*JOJ7\P_+WF*Y\P?EOY[\LZ;'KFH^0M2O6U'0GG6V:ZTS5+ M1[6Z-M(X"&XC81R()&5& =2REE8*L!_,FQ_-+\U-&U71[3R)%HOE"(:1?2^7 M/,%S"FIZW=6&LV=[<6?*RN+FW@MI;.WDB_>LQDD< JJ*Q95CGF?\M/,WG;4_ M/^OCR)^A=*\[:O\ ER;CRKJ,MHUS=IY;UP76IZA>QP336R_Z(4C51([ND0KO MQ7%4=YF_*35;_2?^.6]M=/M-%'JM)52OI36 M]PRAR#RJP'Q@E50\L?DU?V6@?\X^6&I>3=/^L^2?/6L>9/-43I:O]7^M6VM> MC>NMI5M8ZE9V,Z7 M+_F!/YBT^6T=TN8EECM_3N8DEC])F"Q2E*MQ554_*_\ -FXTNUU;6(-:E\R: M+YHFUCRWYZT:V\M:3YL OM)6QNY]4TH)/HU^SLBQ,3+'(80I%"O%E5&[_)K\ MS=5TBPM-1\J:+)/9^4M/L+C2K 6NE:?>IIOG*'6#I[6ML7B@>[TZ$"14Y0B1 MV3F5WQ5E_F?\M/,OG35//OF)/(IT72_.FK_EPTWE349;1[F[7RYKHN=3U&]@ M@EEMU_T1DC"B1W=(14=%Q5[3Y/\ *VJ:)^9OYQ^89].2UT;S<^@2:/<1E*7+ MV6GM!AQ6<,9,%&X-Z5+:6R)83SEH52VF9"2 -_A6NZK#?,7 MY;>9M<\X>9;6[\EF_P#+^H_FYY8\[+?SM:/97&F6.D6-G/SB>7U#)!R]6*\BF#"14DXL[QN"?C5>Q_EUY$OO*_Y5>9M C@U?Z]KTNMZE#8: MY+IS72SZKSE9&CTJ&WL8.^3M5UIY]+%[9I$\8>WA5%D6":,%$9FC) )#4&*N\ER_F7^7/Y=Z/ M^6R_EU=:[KOE/3CHWEGS-97=C^AKBWM 8=.N;QKBY@N8B8U1KA%@:AY>GR!7 M%6)>9?R?_,O\Q?-?GS7=3\TZ?Y0M;SR_;^2M&LVT:VU);^P$7UJ]O")Y7>V6 MXOIB%16+\(8V;XJ8JRGR)_RLSR?J7FCS#K_Y?W&KI^8*Z3K>K:;H][927VFZ MY!IUMI>H6S)=3V\4ELPLXY89$E+?$X=1MBKSWSC^5_G+S!Y@C\[:[Y4U>>/5 M_P P+;5;[RQY5UH6>J66B:7Y(-14D?3BJIBKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BK__1^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*L8\Z:[>^6/*?F#S'I^F M+K%SH5C+?C3&E]#UDMU]255DX/1N 8KMN:#:M0J\W\P?G19Z'^9'EWR)'I+: MEI^HI8#S#YFBF CTRXUU[F+1(FA"LT@NY+.568$",^G6H?95 1?\Y">48+C7 M$UA+JUCL=9U33]&BTVSO-8NKNQT65+._U.:WT^"9K:VBO1+!ZDAX?!4L"2JJ MO;#J^F)I/Z56GY_?E=>:;Y MAU0^8I--B\KI9RZQ9ZIIU_I]Z(M2<16$L-E=017$Z76TTR73-034TUE;5KS]'2Z:;?ZW'<-"O)(VC#/5 M M2ZU51$_P">?Y;0Z)IFNKKEQ=QZQ?W.EZ=H]IIE_=:O)?6:E[NU_14,#WBR MVRJ6F4Q H!5J#%5'\M/SH\N?F3:*]C)'#?7'Z9O+&TB:29)M*TK6+G2$OA*8 MT4>L]OR]/[2UIO2I56:A^?WY8:;:Z#?7'F&1[+S#I-GKUK=6^GW]Q';:5J!X MVM_J#PP.+&WD-0)+GTU'%JGX315(M$_YR.\EZI#YNGO[36=%_P ,>:[CRE9V MDNCZI-=:K=PJS*-/MTM/4N9&6.1S%"KLB+S>BL*JLON_SJ_+FU\O:!YD77I+ M^S\T7$]GH%EIMA>W^H75Q:<_K<,>G6L$EUSMO3?UE,58N)Y\:8JC_P L?S$L M?S,\ICSA811P:7/JFL6%A+'+ZT<\&E:C<6*7(?BE!,L'J4(^&O&II7%4BT7\ M^?RS\P7,EMIGF"1@;&[U33;RXT^_MK74K*Q7G'D#6K77KJ&_U'3!Y;TI==U6TUK1]3TFZ&F/S"WD-M?6T$L\-8V7G M$K+7:M=L53WS1^9_DSR;AM/?PZA:7TEQJ]I+ M=- =.>Q-Q%<1B,!8I%7G4'DM5Y*HG0_^I^4_+'F6_36=-N?,FFMJH\N MKH6K7-];6D159[J6"*T,JVL;N%^LLBPL?LL<5>O>8/,MKHWE+4_-L,]KGCN=$U/\ M0NOZ@NF:@^G:=J!:-4M[[4!;_5K=I#*@3U)%Y70G0KZ-OS?OQXFN*I-H__ #D;Y*U&W\RZA<+?0V.D>:8O*FB6UIIVH7NJ M:C>/IMIJ$J+I4%J;R*2'ZPR2QM'5/3+/QK0*IU=_G_\ EE;6?EF\77+F^;SC M#?3^6],T_2M2O=1N?T7-';W\0L+>WDN5EMI).,T31AXZ/R X-154U3_G(#\I M]*M-(OI/-7UZPUC3H-7CU'3;*]U"WMM.N9F@BO;Z6UAE6S@:5'3U+@HH*N"? M@:BJ.N/SI_+ZU\S-Y4GUF87\6HQ:-<:E'I]])I4.J3E!%I\VJK";*.Y?U$ B M:4/5@*5-,59MJWFC1]&U?0-"O[L6^I^9VNDT2%TD*3-90FXG4RJI1"L2EP&( M) -*T.*L$NOSH\DGRQI/F72M:MKVU\RZ/J6M>5Y94NHH;FUTJ(2W,DC)!*\* M(" 2R5J:!6.V*O-;G_G*;RU:V&L:I<:#JFGZ=Y?_ #%MO(6K76HV.H6@I=.T M27D DLZSL9%X^A&&>I3EQYK55[QY3\[^7_.NDW&K^7[F::*RN9++4+2\M+FP MO+6YB57>"XL[N.*>*0*ZMQ= 2&4C8C%7@EM_SE5Y8FTKR]KL^@:OIFE:QY[U M+R1<&]T[4H;A9;./4FMY;6W:S$MW)3@QYH5Q5Z5=?GI^7%MI& MCZLNKWMV=<>\BL=(LM(U*[U0/IK+'?B;38+9[N'ZJ[*LQDB41DCE2HJJ]%M/ M,F@W^@6_FFSU:UN?+MU8+J=OK,<@:W>S:+UA.LG0IZ?Q5\,5>&>:?^4/,GFBQMM9U>Z\N165S+Y:DT;5;&_GMM0N!;0744%Q:"5KNJ,E1QKR* M@JLK'Y[?EU^GE\N_I/4/K;:G#HCZDVC:JFEQ:G#6[BTO;"R>RL], MO-0EU"PN;FV2"_A0V@1F@D(7FK$TI55.;#_G(#\M=1M=9O5U74-,M=$T*X\S M3R:OHNJ:89](M32>^LUO;:$W44=5Y- 'IR3^=:JHC4?SU\@Z78:3>7<^KQSZ MW9W.H6.B?H+5FU-+.TE]&:[NK!;0W%K;K(0#--&B;@\J;XJQSRQ_SDG^7^M: M'Y3U+5+N;1[WS!I>CWVL+#9WU[IFCW&M6\%Q:VE]JT-M]4@D<7$? 2NA8,K< M0&&*O7?.'G/R]Y%T<:YYFU#]'V3W,-G;*D,MS/W626::5S1$C M5F)Z#%7B7G7_ )R/TK2]+\C3^0]&F\[ZGY\\Q7'ENTLY+?5;5-/NK*&66\CU M$6^FWMQ;31&/B89( _5S2-'957H?YA?FIIWY>:W^7&AZAI.IZA-^8FM/H]O< M:=87EZEJ8[2:Y,DGU6"7J8U4*:'B6D^Q%(0JPS\N_P#G(_R1YYM-(%S)/H&J M:I=7]@R3VE\=,6]T^6X2:S35Y+>*SDG"6SN8UDY BFV*LY\H?F[Y(\\:K^A MM!U"[-_):-J-A!J&FW^F?7K%61#>6#7L$*W4 :1/WD)9?B7?<8JDGF_\P?/5 ME^85K^7_ )%\GZ-YAO&\N-YBO[_6M9N-+CCC%X+1(HEM].OR[$U8D\0 .^*L M:MOSUU>]O?\ !MCY%-_^:D6IZAI-UY9M[]6TB-],M+&[N;Q]7,(*VJ+J-NM? MJYE]1_3]+D#15G>B^=O-<*ZW%^8/DM?*TN@Z<^JSZSIEY^E='N+:/D72&Z>* MTF$R!:M') HI0JS"M%6#^6O^<@;?4O(WF?S1YC\K7?ES7O*5[8V6I>28Y4O+ MR5]9CMI]&6W*< [7D=["H! XR^I'5O3Y%5.KG\Q_/_E9K;4?S$_+[3=%\JWN MHV=@=;T;7/TE+8"^N$M89M0@GL[()&))4$CQ22! 2QJHKBK [3\^?S ;R 8L1BKZI1RZ MEJ=S0=_I]\5?.VI?F/\ G=8^>-+\CQ?EEY.GN]=T[5=7TJ]?S9>I']3TJYLX M']91H3%)'^O1D*O)?M?%L*JHS0_^'Y:ZWKR:!8>86,UQ+> M0:;J4]C>6VFWTVGK(]W'8ZE-"EI=-"L,A=8I6(".>BFBK6C?GA^7&NC4FM-; MGLHM,TJ;7GGU;3K_ $N.XTFWX^KJ%G)?6\*W5NO-:R0EE^)=_B7%4_\ )?YD M>5_/DFIV^AW-Y'?Z.L+ZEHVJ:=>Z3?PQ7//T)GM+^&";TY?3;@_'BW%J$TQ5 M([O\ZOR^LO,XUF?Z_;ZC'HUS?Q:;?S:9%JDO#T].DU*.!K1;I_40+"9> M99E4#D0,58;Y7_YR4\EZ]Y*\M^<+ZPUW2)?--[>V.D^64T/5KW4IY+%CZKP6 MMO9F::)8^+-+&AC4G@7Y*1BK*;_\]ORUL++RE?KKTNJ1>?+"XU/RA;Z5IU]J M5UJ%M:&$7!AM;."68M#ZZ:&W MF"T72+"^U!4T_P#>K'=7CV<$PLX'>%T]2<(H*/7[+454[;_G(7\OQ^CH-4O+ MRQNYHM*&LW4.F:C=:3I=UJ\4,EO;7NL16QLH&K<(*R2+]I:TK3%4RF_/G\MH M+WSC93:Y/%_@.Y^H^:+]M-U#ZE;WYD@B6P6[^K^C-=2/FQ71!:B^2XBCB9C M%Z98I^\H$%<5>S>6?->@><-"M/,GEW44U+1[Q9#%=*KQD-!(T4T9=+U/5-0TO6KGZMY<-OH.L27&K$1& M=WTVV6T]:[CBC!:22%'1*?&RG%4TU#\]ORTT^ST"^'F!]7A\S6#ZMI$>BV%] MJTS:=$XCDO9H;&":2""-V"/)*JJK?"34$8JGVA?F?Y.\S6LE[H>L)?6D?ES3 M_-OK"&= ='U5+A[.Y^-!_>"VD/'[0X[@5&*L2N?SY\DZ7#<7FL:D%LYM?LO+ MWEY--L]1U"\OKR_T>#68(1:06AD$KP2EE5 XX@58.6154YF_.G\O;;S(?*]S MK4/R95IR-,5=^8/YKZ;^ M7NN_EWH=_I&J:E)^86N/HUK<:=87EZMKZ=I-=&646D$W>-5XFAXEI/L1N0JQ M/\MO^Y2 M.6-A3HZ@^V*I]BKL5=BKL5=BKL5=BKL5=BKL5=BK_]+[^8J[%78J[%78J[%7 M8J[%78J[%78J@=3T^#5M-U#2[H5MM2MI;6X'C',A1OP.*OD/RO\ D'YYB_)_ MS_H7FK5;27\T/,LUE=:+KEG,4@MYO*T5I#Y;/,1*4 >P2>0*GPM)(!RZXJD: M_P#./'FWR_<^4[^RL)?,D:>1+#R[YJL-+\UZKY3E76;6YN[^:]5M-98[F&YG MU";FLF\>QB!#,N*OI2\_+T/^3S?E?IJV^D(/*O\ AVS2WDG>WMN-G]6C"/<- M+,T:$ 5U;RKH$EX;TZE/<7RW.H+;(T,+QOPME"-QD'J.!]G%5/2_RK\\7OYC6OYEZY8Z9I,^H>>+77 M+_0+:Z:X:UTO3O*VH:);EYO319KF2XN^3@ *L?$!F*U*J'M?RN_,/RMYV_Y6 M+HNEZ1YBO;;S-YND_P /7-XUHTNC^9VTV5+B&Z,,BQW$,FFH#&R<6C=QS! ! M52_R=^6OYL^1[Z#S2-#T+7M#J51E('$-4\56O)/Y9_FY^6>B1V.AZ/Y>\RWWF+R3Y6T'5Y+S4'MX-,U7 M0]._1LTAC-K)];M60B0"JN2"A4*W(*I+K_Y&_F#?:Y=:M'807D&C?F!K/F;3 M[:P\QW^@SZGI?F"Q^K3QK>:>J3VUQ;.B,$8M%*.2L1L0JRK1/RH\Y^3;OR1Y MV\N>5]+EUW2Y?,:>9?)UYK]]?R/%YEELYI+M-:6[C;3X@X=%C97=5*\ M065>D?EGY(\RZ+^6VJ>5_-PL[37-=U3S1>WWZ*D:>V@77M4O;V,1/*D3-P2Y M'51N.F*O,(/RR_-+S%IOY8^6_,FC^7O+UG^5^DW]K)K5A>R7(U&[ET&YT*V% MI ;>-K>W*W332!V+ JB+R%6Q5$^9?(GYK^?-3N+K5/+NC>7+&T_+;S+Y1L8E MU5KR:?4M9DTUDE8K;1JD'&R(!^W7JHVQ5]"^;=-UJ^\K>8;#RS;6UO\Q]2ET:/RQ:^=/(5QY8M MY=1\SZCYIU.6_>;U!<7MS?@E8RK!$6-VXA:D58 *IIYO_+7\W?/GGJS_ #!G M\NZ!Y?F\IV6BR^6O+]QJCW?UV^TG5_K\T5U-%;!8(Y8F(B=%D:$NH^>?)^OV^EP:@UW+%IV@V7T(U:9FDJ HX MT-.514JL>UG\EOS U3RS^7%O-Y:AM=<\E^7Y_+AUKRYYIOO+^N0/"83;7,&I M6J^E/:3^D?5M;B!N!(9>7Q*57T/KGE7S7JWY,WODK4=1M]9\Z7_E,Z1J.KD> MA;W.HO9^C+.0 >"O+5MAL#T[8J\WUC\IO-M[^7?YP^5K<60U3SSYRN]>T1FG M81?59KRSG03/Q)5N$#; $=!7%7H'YQ^7/./F71-"L_*;R2V\&L1S>;-)M=6N M-"O+_2_J\Z-;VVIVH,MNWKO%(Q4J6163FO+%7A/D3\E/S \@VWEK7K#0=%;6 M/+'G#S%K,7DN#6+F6V;2_,-HD/IQZG=V[2O<6[(M3*@#_'\0JN*LBT#R1^=' ME*\\Y:U;:#Y3US6_S/L;235HH[M[*QT;4HFNHV0Q&T9_P IK?3="/E3S-YWG\Q?XZ^MLD\.G7NMIK=PDFGB#X[Q M'YQ1,LGIT]-V((*XJG\_Y7>>+/R_Y\TRTALO.'G:? M7/,7DS1/,EWI-U<:8?+]CIEE&=8M88I5>*XM2\T:E5<4HS*O%E61?DW^3GFS MR+J7D&XUFVTNRM?*UAY\MKJTTZZFN8HV\RZ_9ZI8QV[W""614@A=':0AN0&Q MKBK'OR__ "M_-S\K=.UFWT71?+WF*Y\WZ7:V=RUUJ+P0Z;>6L]]&'DB-K)]9 MMS;W*2%00W,,E.)#!5++?_G'[S1!J_F'1=3T$^9_+.N><+O7K76)/.VOV&GQ MV-_J!U22*[\NVLB6SS02L518R(Y**[E3RJJ^@OSG\BZMY[\IP6WENY2R\UZ# MJ-OJWEF\E<11K/'R@GBD-9TYOS?6SFM/J.K M^7K_ ,M?E'IHD"1:?9:Q(VHZBLRK"#&9;UU6O*0E(U.WV0JG&U&^MY M;2PBTZ+\X+;S_9:B+SF9].D#&:)H?2!26(JHI4AJ[,*8J]<\E^4M3\O^9OS6 MU6^]%K3SGYHM]9T?TFY.((]%TRP;U:@4;U;1Z"I^'C]"KRORY^6/G:SO/)L& MHV-C!9>3/S2\S^;1>QWGJF[TS7HM=:%EC])3')&^J1HR$]F8,0!55Y_JGY!> M>;;SYJ_GJUMFUNVU75/,8FT+2_->J>5KH6NIW5I>6-TMWIP02,K0.DL4NP!5 MT)9:,J^D/*ODA_+7Y;V'DFTTS3K(VND368TWUKJ_L5FN%D9T>:ZD^LSQEY#S M9V#N*GX:T"KY:MOR(_-@>5_.&@V37.DZ-J/ER"UM/(VL>;KWS'IYU>UOK*YB M;3KB^@:XL[9(;:2)0[MRYJ2B\"653;S#^3?YI>:?,EAJNM:/#J.H:;Y\L_,U MIYCN_->H-96>C6FM0:A%9:?H*1BS2Y6U3ZN\C 9M3_* MC5/(;RVUM?ZK^8MQYCEN$E/%=,N/-[:T6!XBLHM&^R13G\-:?%BJ2IY'_.K4 M(/RAT2[T'RWH4/Y4R7?J>8K349)EO)(_+^H:1I]Q:V9M5]%?4N(Y)(W8\/LJ M7"\BJPNU_(;SY=:UYAUQO+D&C3:O^7VN^59[S5?-FI>9-1O=2U,Z>\4=#TSS3:^:O*UIY9U?3;Z].GW M%A)IMQ>7%K<02>E,LL4IOG69#Q9>",I:I4*OGG3_ /G'?\T=!L?+,6A1IY=\ MT:?Y;\MZ>?.7E?S-?Z3 UYIEA%97(UO272XM-26,QDQ2I&CO&5B8(8UD*KZF M_-;RCYA\PM^7NO>5K>PU#6OR[\TQ>8(M&U*1H(+V!K&\TZXB694D]*417C21 M,5*\U4-0'D%7G.A?E9YW/F31?.6N6VE6-_??F?>^=]*_$TY*"*UIBKR:3\D_-D_Y/?EW^7S7%C!JOEWS$=0 MUFX$C-"+9Y[]V:/X06<+=*:;;]\55_RK_*GS%H_FCRYKOFORO)87OE;3)[=- M7NO/&O>9T:[N8TMYOT?9ZBXC@B>..K/("_1 NQ?%64^E:TT$M\JW*"4I=^O:Q3K+(C^HRLLC#F7"J1^:/* MOYY_F#I/G/3M0O=-\BZ/YMCT[0+#0;"Z6^N+'3'N6;6]3ENVMHJW<]LQA@BC MK'%M(69B0JK']<_YQY\R1:SK$_EGSKJNH6OFC2K(WU]YGNAJ$]EKGEG48M4\ MNW<5$7G"LGK1S1GGQ):6U!<20A&FE=&2,DK&7/PJO#=._P"<>;V'R7-Y8O?R M!\CWGG262^:'\T'OH+>XBN[F]FN8-2]:WLOKHDA+HX*.'Y*%# ?$%7W)I3:@ M89TU&W]"2"=HH)?563ZQ$@ 6.*L*U7ROJUW^:_D[SE!Z'Z&T+ MROY@TB^5G(F-SJ=WI,T'!:4*\;*3D:[&GCBKRC6OR@\T:G^7'YR^4XS9IJ/G M[S?>ZUH[-.?2^IW-W9S RMZ?POP@;:AH:;[XJD>D?E/^9+Z%^4?Y;ZOIF@6G MEO\ *;5K>^E\VQW+7)U2#2[:ZM[!8]/,*&*2?UD-URDI3U%0MS!"KS^W_P"< M<_S.O?+WF#RE#J%QY+\O:MY:N]-U#RS)YIU'7M$DU*-K9].?28KM#=Z;;J\# MEN,Q9$?@JL0'55[U^4WY=ZAH'F76O->L^5Y] U"ZTR#2K:?4?-^L>;;V2,2M M4O(WE M6ZTB.]T#RM+Y@MM<\NZ/YHO-"?4VO+I+G3+PWUE''-Z$:M,DMN2*E@YY\>)5 M97^4/Y0^:_(K_DZ-:BTX+Y!\G^9= UA+&>26/ZUJFJ:?=6QMO556:/T[5ZL] M''P@@DG%6'>3/RF_-O\ +;2/,=GI&AZ!YGF\]^7ETW4OK&IR69TZ_M'OHK=R MWU67U[:2&Z5F HZ.&H'#U55BWFK_ )Q__-7S+I,_E_5+"VUVXM;C2#Y7UV?S M7J=II.FZ?IT%D##'H,,9MY+H-!*HED!Y%_49P*1A5ZWJ'Y0>;VT/S'+IYTR7 MS!;?FNWYC>5M/NI76SO(H98F2UNI4C9H6D0/1PC\'XM1@",58KYB_*3\Q_.- MWY\\Q:_Y2T/UM?\ ,/ES5-$T"#7K^SU&UMM*T^:RFGM-9L%MWL[]6F+(ZAXV MCK"VSEPJ]S_*3RSYT\M>1_T-YWUFXUO5S=ZA)8RWUW^D+NWL)YF:SM;J^$4/ MUJ6*,@-+Z8_EJ_'FRKPN_P#R*\YV_EG_ )Q]]"W_ $MJ?Y6>4Y?+'FK0=.\Q M:AY=_RQNF\R^4_*^C7 MTGF/RU^BO,_EF76KV9].O(K_ %+5%NHM5OXYY[U9I-3D6X]0(Q95>/;X JQ/ M\LO*WYA0?EMY/\Q>4-"TWS&OGK\E_*GEB2"]U Z<=/O-.MKQUFD'U>8R1.-1 MWX_&O"G$\JA5FWEC\F_.&CZYY5U*]>QD@T;SOI_F&[]*9N7U2U\@Q^6G"#B* MO]<0D"N\?Q5K\.*L1C_YQ_\ ,L6K^8]&U+0&\S>6]>\XWNOVNK2>=]?L-/BL M-0U)M5>.[\OVSK;R2P2N0BQD1R_"\C*>6*O?_P QO+7F35M7_*S7/+]A;ZE) MY)\V-JVJV,]R+5GM+C2M0TUVBG>6=T8 M5:%5]G>6CJC:+IK:UIRZ3J?U:);S3DG6Y6&11Q*B950.-@:\1BJ?8J[%78J[ M%78J[%78J[%78J[%78J__]/[^8J[%78J[%78J[%78J[%78J[%78JQWS;YDL_ M)_EO5_,^HP7-QI^B0&ZODLXQ+,(5(]1PA900BDLV_0'%7F]Y^>GD>SO//.G_ M %Z:ZOO(&KZ1H6JVL*1E[B_UN2.&TAM 9!ZA,KF-JD<71Q^R<5:T/\\/+FM7 MOEOCH^N6/E_SG>OI_E#SA=VT*:9J$X65X?3*SM/$MRL+&!YXD64<>!/):JLK M\^_F%IOD*/RR+O2]5UJ]\WZN-#T'3-'MA77[;5_+]QI"1V<,$$DB2>M M'J/-2A=9 R,KA:XJF8/+-QH>L>6O,?ENULK_ M %#2-7AA5S9ZBTZ6T\4MK-<0NKM:RJ0'Y*5/)1M55B_G#\\="\DWNH#7O+?F M*ST'2]2L])N_-LMO;0V#7%Z\2(;9)[F*ZND1I0':WAD HU*\6HJ@KS\_O+=C M<>:)9O+OF9_+WDC7AY=\V>;EL8AIUG>&2&*OQ3K/-&IG0L\,3A ?BI1J*I!J M?Y_O?R?EQ<^4/+6K-Y;\^^<;/0;#S?J%FOZ.O;)VN%FFMC'<>O%S]$M#)/$B M2+NG+DM57JOGG\P;+R$/+*7NEZKK=YYOU<:)H&FZ/;K<7$MXUK<7@5P[QHB> MG;/61V"KU8@5(585;?G]Y7/,>K>\DV]M;)J.F'3&A69 MKSU[F.!%?ZQ$8665O6# Q;]"U'S-Y\U M/R]_C#6-%\LZ7!;+IFC32&.WDN%GU2Y0M(5?TPD[22A6(B3BRA5D,O\ SD#Y M4,OF:33=*U[6]$\H>7+/S3KOFNRM(CIZ:??V,NH6IB,DR2S22Q1&D<<;,"5Y M4#5Q50G_ #_L[;4]9T:?\N//":OY=TB+S#KEB+"S(M])F]3TKMIOKAB)@C"D75S%#ZC^I+#\ M($E:!JUIVK15@W_*_+G1]=_.&V\Q^3];D\N?E?J=FM]YDTZT@:VL=/N-'L=0 ME>[>2[#32P//(91;(_",*2-P6595<_GKY8M+F^FDTG6Y?*VE:XOEW5//L=O M=(AOC.EHP+&<7#11W#B&2983$CA@SCBQ"KT'SAYJ_P ):;:WXT#6/,DUY>16 M4&F:+;K//RE#'U)#*\44,2!27DED5%'>I *K!O+/YV>4_-5MY9N--%Z'\S^9 M;_RC!;21PN8-4TVUNKR=)9;>::%D]*T9_,EK>:K:W>BZ7:PF6*+19((KN[D>>>*-8>=RB1DN'D:H1&XM15XK;_\ M.3'F63\JM6\]P:-%K'F*Q\NZ+KB^6(+)K1(DU?7-1TM)9);J[1F'"S%8N*NC M#=F#TC5>\_G%^86L?EQ^6NN>=M(T&76-2TP69BT=S$"INKF*!C*3-&I$?J=$ M_ES2+GS&TNA>8;W0_)-_;:7YU\T6EK!-8:7>7"02-#,RW'J MRFW6YC]=K>.18ZGD?A:BKTGSIYQT;R)Y9U'S5KLDRZ=I_HIZ=K$9[B>:YF2W MMX((EW>2:61(T7NS#%7A_F[_ )R"?1A:VECY9U:S\QZ;YN\O:'YJ\H7]DD^H M_4M>68V\UD+.XDAE]8Q,J.)&56602<>#457ZQ^?\\>O>4] T3R7KYU2U\NW M^@:]Y/US6=%U+6= MMTM[N6XA;BP8)<+%R *@AP0%5"'\^ M=+YZA96_EOS+YDN?+.AZ5KOFW4M+T^".TMK74[3ZW'*/7NE+'@K,88S)(H'1 MJJ65>L^9_-5AY6\JZWYQO$GN-)T#3)]6O8K:/U+AX+>(S,(8S3DY4;+W.V*O M.KG\Z[.SGO;*3R3YHN-2T738]7\U:=;PV,CZ1:3&7TOK3"\"-+)' TJPPM)) MPHQ05 Q52\R?GUY:\K3276J:#K\?E6*]T^Q7SMZ%K'IMP^I&(0O:":YCNKJ, M&9>3V\#C[5*A6HJC]+_.C0M8UJ]LM/T'S!Q:#>7.@>8]!TCS=IE[J_ MDW6=2L4C@U6VL;4W\BP(DTDT]F\OW7F;1-/NM-1[G5+&S>WCE6U@MIIG6?E=0CT9A&XYBJBC4589YG_YR M'AL=*\R?HG0=1M/,_DK6?*=IYD\N7T,%]/\ 4_,>JQ6-8%TNZN4:8IZO%#(& M5PI=.!%54RU#\](H_-'ESRX-+N_+=_%KYL?/FC:]#&MW:Z;)H&JZO;WEJUI/ M-#*COIQ3FCN!QD0@.-E69^6?S;TK7];T;0+WR[K_ )4U#S+ITNJ>5UUNW@A% M_!;^F9Q&8+BM9W-]=W.F M0VRVEI;VH!=KJ\OKBU@C+5^!.99J$A: G%6$V/\ SD'Y4UJ>.+RKH?F+SC&F MBZ-YAU"72;2%WM;#7HS-9.UM-/%8(ORZ\Z?4M;TZ36+;UK73[80Z7;R?RM:^6]!\Q^<+CSAY5C\Z:1%I-E&H&CR,@$LTEY-;QQO\:T MC9N35^$$@T541_SD-Y/O+#]-Z!HGF3S1Y;M;'2=1USS'I.G&>WTZ'68([JV] M>,NMP[I;S1S3)!%(T2,K.!7%4;9_GEY6114@"I.*O&)_\ G()-1NORAU#RAH6H>8-# M_,:]\PZ?=:7!;QR:DEUHD;J8T<7"VJ*LT,@>5I3$5 *2?$I*J, M,E&Q5G&E?FCY8UM]1_1%W)J%KIWE?3/.'Z0BCK!/I6K?6S:R0M4%G864A*D" ME5WWV58]^57YIZE^8VN?F%:R^6;S2-%\L:E9V^@ZG/Z %S;WFE6&HIZJQW$K MK*1=\P. 7TRF_/D JJZW^=_DWR\M\VL375@=.\XVWDB[AEB1734+N**YBF-9 M*?5S;RK,7ZA*FFU,58E>_GW)+Y\\I:!Y7\L:KYNT77HO-]I,=,MH6N'O_*][ M86DDT4\]U#;I:AYYXR[L"TBJJ[[,JG\/Y]>6M2MM(G\M:)K_ )NEU70CYDFL MM,M85EL=/]:2W#7@NIX%64RP2HL2,TCM')Q4\3BKS'S'_P Y(:[!I?YR:SY: M\NF]T3R%I/ES5_*.OO''/!J4&M)#-4Q170F9I8IJP*$7[)YD,0I5>IW/YYZ# MI\][HVJ>6_,>F^;H;K3;73_)LMO:OJ-\=7^LFTDMC#=26YC*V5PSN\JB,1.9 M.-,549_SW\OQ6FD^EH'F*[UW5?-3^3/\(PV<'Z1MM6BM);\I8=!T=[6'TB8HM5U*WLY)& M#S0@L%E*I0_WA7E\')@JP'2/^<@)8;W\Q1YJ\KZK:^7O(WG6?RS<^<[2UB72 MK>W9[:.VEGDGNA-)Q:X'K/#$R)^U3BV*LPT7\\?+FL7?EL'1==T[0O.=])IW ME#S=>6\$>G:C-;A86,#S1(LHIP)Y+55F/G3SUI_DUM!M)-.U' M7M<\SW;V7E_RYI$<22147X16K*"JP"+\_?+M\M MC%HGEOS3K^ISZ+-K^K:%;Z:MO>Z39P7,EG)^D(KV6V].3UX)42-"SR>FYC5D M'(JK?^5_>7+F\U>'0- \P^;;'0=(TW7]7US2;.$V4>F:K;&\MKA)+B> REH5 M+&.(/( /L;BJJ9Z1^=F@:_J-S!I&A:_>:%9ZU>Z!>><8K6&33K>]T\R+<_65 M2=KJ")'B9?6E@6*M/BXLI*J46OY\:3J=GI,\'E_7]"3SCI&H:I^7FJ:S9Q0V M>K"RLVO0JB*:26%G@4RJDZ1NR!B!\)HJE^F?GO9VT(_3BW.JZO>#RO9:7Y9T M;3C]9GU/S!IS7P@@EEN2D@XQR2%G])8HT8NS4Y8J[RY^=^I:G<>>1=^2/,,\ MF@^<1Y:TS0K2P2.]MXDT:RU">;4Y;BX2TB1);APLWK")U]/@7)J54)I?_.1% MIYA\S^1[?0]!OIO)?F7R_P"9M7UGS%(+8/I\WER_M["YCD471JD#O()6B$G+ ME$8BZEB%62#\_/*UA!+=>:M%U_R7;RZ)<^8-)DUJU@3Z]:6@B,L<"V\\[+< M31TMY0DIY;+LU%7>6?S3UOS#^:MYY#N_*FH^5;.R\HIK\T&LP1I=M/-??5XS M'/:W%Q;/%P!Y*K%U8?%2HJJP;S]^C:SK.MW M.DC4Y;N;6KVYM(A;^EJMHT2!H HK"Y+!^7!54NJS*\_/_P N6,WFB6;R]YE; M0/)&O?X<\V>;DLH?T=9WIEAB!^*=9YXP9TY/!$X6OQ4(("J.LOSOT>?S+Y<\ ML:EY9\Q>6;WS?-?P^69-9MK:V-VVGP37$A-J+E[N%6B@=T::%%-*$@E054GT MC_G(ORKJ6E^5_,-WH/F7R_Y7\ZVD]WY7\S:K8Q16MT+:PFU*1/32=YXB;>WE M9#+&JR[T/7_(^K6]]Y<7ZOK^E+*LUGKVJ0:=')"UK M=&(GU)?3<&7U(">&D7'F'R]Y:U#RWYA\L7_G![Z'RI+K=O;6 M_P!<>QAFN&)M$N7O(5:*!V1IH44@4J&*J569?E5YHU'SO^6OD'SCJT4$&I^: MO+VFZO?P6P98$FO+9)G6-69F"@L:58FG?%6?XJ[%78J[%78J[%78J[%78J[% M78J__]3[^8J[%78J[%78J[%78J[%78J[%78JE^K:;;:SI6IZ/>J7L]5M9K.[ M4&A,4Z&-P"/\ECBKYB\K?\XVW&D:M^5^M:YYG77KWRA'?7GG*JW*+K6L//<7 M&GWC&ZJ4?EE_SC/31_- MT'EI(_-EW'&"+2.YNF9H4E0.1+<1@O)0$+&S,<5>D?G9H_G'4]1_)>7R2L*: MSHWG.:]>^O+62ZL(8U\O:Q%_I@A*LD4KR+#S!!5G4BIHI58+J?\ SCSYJUB3 MS!KLWG*TL?-_G30_,5OYHU*U@F%N-0UEM#CMTMH^:N+6&TT9;9ZL)) Q>H8T M"J3:=_SC7YFBTG\R;4R>2?*K^?\ 2M"T^TT/RGI,FG:9IIT34[B]!XU+W#3K MT71H+$V\T:K%JMIYTU?2);WS/800 MFVD32+6X,BQPVX>V 61-U1F_=ER7*KTG5_R6U/5/R_\ S7\FG6+-+G\Q/--W MK]I=F.0QV\%S=6L_HR"M2P6W(JNU37%6.6?Y,?F=;+^77E27S;Y?N?RZ_*SS M)IVJ>6V-EUMRK%H)[)]59IY#T*L-04 #?X3XC%47^9GD/4//'Y8:]Y)TV_M=-UC4+&W MCT_4;J-I;=;BTDBGB,J(RN49X@#Q-0#4;XJQ+4_RDUS5O*?Y]Z+/JUC#J7YR MB:2SG1)6@L9;CR_9:.X<&C.HEM6<4WXD#J,5>9VW_.+\NG^<-1O+?1_RWU?R M]K/F*;S%/YBUSRRE[YHLS=W+7MS:0W+L8)AZ['T9I5Y1(>/!^*G%7M'YT?EY MK'YC>7-$TW1YM'FDT?6H-4O?+OF."6YT;5X$@G@:SOXX65V0-,)E^T/4C3DI M%<5>8^7/R&\Y>5/+.GQZ5KGEE?-OESSU?>>/+\-OIDMCH);4M.FL)[!K.&5I M((HUNI1&R.Q^%&8,2RXJI>7OR2_-7RCK=UY[T?SCY:O_ #UK&J:P_F*WO;"[ M32;C3=7N8+Q(X4BG,T4UI+$>#5I?-^FWF MLZSY-T;0+;4Y+640?I'2-:U76/K$L2N"(IC?HA535>+$5VQ5[M^9_DC6_P P M?RQ\P^48;VRTSS!K-I;F&]D662SCO()8KD)B!(GK M6ZAUJ*K6A!WQ5X?K'Y*?FAYCOYO.NJ^;_+UI^8$NN^6-0M;>TLKA]&L[#RNU M])#:JKR+/,UQ)?S-([,M P50. +*JMW^27Y@WEQ:>=9?,NAC\R[SS1;ZWKQB MANH])BLX-&OM"AM;$!C.'@@OFF$DA/J3#<(E%55BGE#_ )QF\T:+K>@:M>'R M%HH\OZ3JVCW$WEO2)[>^UDZEIQL_TCJ=[-(\DDP=$8Q_$/B=C(S<<5>M>6/R MAU70+;\PH)M7M+H^205W5W;F -P/?%7H/G#RK>^ M9?(7F+RA;W,-K=:WHD^EQWLG)HT>: Q!V4;D [[8J\(_,K_G'6Y\T>?-5\\Z M/I'Y?^9)O-&FV.G:U8^?="_2S6,NGK)'%=Z=,C!@'CEI) XX.45@Z_%R58OY MR_YQ?\R^9-8\U"VN?(\FG:Y?VU_I7F_5=$>Z\R:=;VBVGIZ1:2*ZP6]LK6H5 M&C *(Q C+58?S-N/-]Y<>6+2"?6OTJ?/&F:?+IOFUK(NKOH] MQ-9O%:W43*/0]:='I7=SI%QHL%YJ?.1DB]&WN9"8X*AW;E50H4JLH_,S\H=;\\RVTNF M>8XM"EM_(^M^51<>DSN9]5N-+G60\66L)73WCE4$,5D^$@C%7E%E_P XV>=; M:Q\VRV.H>1O)>I>8I/*%QI.E>5M%DM-)TR7RIKTNK F$ORN6N4E(=VX'E0<> M(KBK,+C\C/-OFGS%:>=O//F73&\S75X8=8L]%@FBL+?1X=&UO2[:VLQ.SR/, M)=:DGDEE-"?A5%"BJJI^47Y$ZAY!\P6NK:IY?_++3?T-826-CJWE#RRNF:G? MO+1&N+J>1Y/JX,:CE% 2&H;>>0HDH!5^)(Q5 MD%__ ,XWZUJ/YJ0^>)KSRQ;FWUV'68_/UAITFG>;GM8W25M)NI;-H;2[B?AZ M)FGC9S#165G428JB]/\ R2_,U+/\M_*NH^:O+C>2_P IX[JU\OBVL[I=0U"& M30K_ $6VDO&DD:.*2%;I681@JYY'X?A7%41Y[_(?S+YC3\OQ:/Y/\QP>5?*Z M>7;G0O..G2ZCIMO(50'D_\ YQBF\G^:[%K;1ORXO_*VF:]/KEAYHN_+:3>;UBDNGO8[-KQV M:%GBE8*+LCU."CX1)1PJ]6_.O\LM;_,:'RHVCMY>U&/RY?SW5]Y1\VVDM[H> MIK/;O C7,,+*Q>V9O4BJ&6M:@'BRJO.-+_(C\Q?*NF_EV?+'FCRT^N>0-:\W M:HWUK3[BWTZ^A\S2S3+;+;6TO*U6(ST'!GXA%I6I&*HC2?R._,?R5JFN>:_) M?G31;OS7^85K(GYE'6K*<6,E]+=OR'B\V^?-8\X)J_U*TUKRQ=:7>:/28JVL>C+: M6&J_#*J![>WN)4V7G]@AQQW53CR?^3L?DO5_RMGTR^C?2OR[\G:KY9N(Y%(W/\ SBIJL">5M0@@\@^<]7TO0Y/+ MVK6'G30WU&R$2ZC?:A:WEA(KB6&6,WSI*A!644W0J#BK,M7_ "$\T3P_F!H6 ME:UH5MY7\ZZ!Y9L;:(64EI+97OEPP1*(X+8^@MM)#$U$0*48A1\(Q5%?FU_S MCW7IO+NAZ_IQU/3);O1FUI9X]1MBRC_ )K>3=5\[>3VT;R_>66GZU::OHNM:9-J"2/: MM-HVIVVI+%,(2KA9#;\"5W%:T/3%6 :K^2^J:EY"_-7R?^F+03_F'YJN?,%K M=LD@CMX+BZM;CT9 IJ6"VY%1M4CWQ5@WY;?\XT3>0/,7E^FC?EO<:!Y1N'GT MCS;!Y9CC\V74: K:1W-TS-"DL8:DES&.2Z5%K$,L^G7<&H6S6US;SB"2.1*CBRR*25*TXL&.*O-U_* MG\V]$OD\T:!Y_P!(UCSEK_E^+0?/ESKME-]4E>&[O+VWO-/6WDYQ?56OYHHX M7+*T7#DX9*LJG'D[\DIO)FF^>]$L=6BNM-\P^5]#\M:'+.K^O"FC:.VEB6Y( M-&+DA_A]\5>;ZE_SC%JVL_F%_B>_O?+,$1U.._;SWIMA-IOFR2R!1I=)N9;- MX;2ZB=5,/K3H[^CQ#*TBB3%66:;^3OYE7D?E#2/.7G+1-0T'\LK"[MO*,NFV M$MO>:E.+T8+F0F."H=FY54 +BJ$/Y!^:K*=]>T3S5I]IYJ MT:;RQJ/E*:YMI9K'ZWH6BW&BW4-]"'5W@NH+N51Z;!HRP?IZ_K'DSS5JNK^V,D+O4- M7DRJ]"BJ9>7O^9_1LI+$2:=YRU&'4O5T^W MB9XX);9XA&L;%DXFO*NV*I+H7_.+EP=-U;1O,&D_EQH$;:*^E:;YE\E^6UT[ M5KF?FCQ7EU+([>BH:&-W@A)61N7)^-%Q5ZQY*\B?F5%^8D_YB?F'K?EV[N9/ M*R>7(M'\O6UU##&Z7OUM[@R74DC-ZI)JM!QH .6[%5"_F+^3NJ^<[[\R;JPU M>SL%\[^7/+.BV:31R-Z$NA:I>W\LDG$@%9$NE50-P0:[8JI:I^3&JW_D'\UO M*,>M6L-[^87FNZ\PZ??%)"EK%<75K<"-QN2RBW(J-JD8J\W\H?\ .-WFS0?- M?DK7KZX\CAO)6I7-W=^8].TB:/S#YD-S8W^GFZU;4)I'82A+P2LB\D:3E\2K MQ 59Q>_D->ZM^6GY._EYJ6M6Q3\O+ 6&NW\22?Z4O^'+_1"]NM1Q(DNUE 8[ MA2-B:XJKWWY9?FOYOMK@^>?.>C)+#JWEBYT?1]#M;B+3XH=!UFWU6YNY!10_DG4)KJ^\QZ;H\\7F M#S*UQ87^GM=:MJ$LKMZO&\$I10RO)RW5>("KZ9_++RI=>1/R[\C>2[Z\CU"[ M\IZ#I^D7-]"I6.9[*W2%I$5MP&*U .*LYQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 M_]7[^8J[%78J[%78J[%78J[%78J[%78JD?F?7(/+/ES7O,=U;7-Y;:#I]SJ% MQ:6<9EN)([:-I62)!0LQ"T \<5?+NM?\Y :MK_D&'S+^75IH^K7@\T^5=,N+ MO2_,.FZI:&VUC5K>VEB$L)=HY61O39984X>H&4L4:BK)/,7_ #D=H?E?SW8^ M1M2L;0WVH:[9Z#;6,.MV-SJWK7\\=K!/+I=N99(;=I9D^.5T;@>7"OP%5A?E M7_G)2?2_R]\AZA^9,>F:=YO\[OK4NFG4=7LM)TZ6TTJ\6&666[N!%'$RF9(T MB17=R.1''DRJLTL/^WNO+M_YDN;TW]G;V\,&EZE)IEU M&)5>996]6%S$T19)%%0X!!*J,N/^6KNUUB"PL+?S'Y M@TJ31%.C^6M;T_6()4U[5XM&@(OH'$<5&TKS18^>O+VA^<=,GOK>6!K'689;F(6USZ;!_52.C$HK(105J&Q5E M7Y5_\Y!>7OS5UDZ7HEM;1D1R2261U>QDU:P,1*/%JVD>JMU:2AU9.(60!E;D MR[555OS9_/;2ORIU)+/5;.Q,;6HNU%[K=G8W5TO+B4T^PK-6/S(US5?*VGW&F2:[H^GQZG.-%UBTUVQ-K+,\ M"_Z79,52563XHY%4T(*\Q4A5Y1_RM;\P]%_,/\RKO5M.U/6M&L?/&E>0/(WD MRSO=,BLS-J6GV-VEW-)):K7&G++Y6OOT7YEM)M=TZUU-;P1PO)'8Z9-+'<7:QF8+R 0N0WI*^W)5;IO_ M #E;^7FI:]ING6U_I\VFZQKG:O<:1>6M^DUM=2%(;BW:,"WG3E_>!V7;%7I'G'\V-1\O>9/-GE_2/)= MWYC/DORW9>:-=O4OK>TB2SNWOD].,25=YE%@[*M K5W=:;JI(_YYS67Z3CU? MR=+H]S!H%KYGTEKW6-/M[2;2[NX%L);R[GEBBM&C=E+J3)L?@+G;%7GTW_.1 MFJ>;]"\J:O\ EUID$[M^9FF^3O-'^G1R6LMO<6ZWA:RNFAI+'-%*@$@12#RX MU%&*K(_*?_.5_P"7OFO6/+6GV5YITMMYTNTL/+(M=:T^\U0SS122Q&^TF&5K MBT5Q'2IY%"RB58ZGBJB_+WYU:CYFB_*[S!=>6-8\LZ=^8&F:GK/E_2!?:=/] M:M+?3([Y3?%D_TL_-7D_RC/Y MAM=4T75+;7=/2@>,+]:CC6$RQR**J ZTZM6JXJ]W_,'SS)Y#L/+TZ:-=^8KS MS+KUAY>T_3[26*%_K%_S"2.\Q551>%6WK3I4[8J\S@_/C4&M;C4+_P#+W4=- MTG1_-,7DKS-J*ZC:3-:ZM8O+.B:]$_F75]+TB]U&'5X0T?U 2_5K6^G1@5F6$Q*K[**=%6 M2Z=_SD)HVN>==>\C:79VZ:YHM]>Z3/I%[K%A9ZT+BSY 3MH]Q(DYM9:*TO$%5UE_P Y%SIK?FOS?JNGRV7Y/:?^7'EGSGI] M[+/ M[#^FY+[B98.-0TK1)"0TO"/@7)H]0JFEK_SE)Y9O8-7AL+*U\Q>8=)D MT1?T-Y9UO3]8@F37=6BT>!OKT#B..2.:4%XY0AX[H7%2%4WNOSXU?3XO-%YJ MWY;7UE8^0-9M-&\\W<>J6WFN6VFQ:AI\EC?ZV/+M@\>M6#ZNU\UZVGQO+HJR?6HX6F7[1!=5(=XE7D M553"'\]M:U'REY8\R+Y!OM#M_P Q]&N+GR!O^0/)^M^8K-;'6M4TFTN=0A699P7DB5O4YHJ+^ M\!YT ^&M.V*O./,GY]>7_*UQK5GK&EZE%?Z)YPL_*MU8VR_6']*^LTU&+4Z( M*K;BV+L2?VHW0588JQ*+\Y_,WF/SWY,C\C^7[G6_+FO:;YU2+39KFULXKQO+ MVK:9I\&J?6)5,B1,9)UB5 Q<.C,.-&55=J?_ #E;Y#@@T(6S6EI>ZKHZ:]+9 M^8M9T_0?3M&N[FR"1O=RGUYC-9R@*@*T +.O)>2K ]:_/CSYJ6C?G5YB\K1> MCY:T31/*&L_EUJ:M UR8]=6WG"/;3Q"CW,5/,J3Z='96-WJMFNFRIJPU!K:675)6BB@51ID_J8-.T"?R=H#><-5UGS?)Y*DL=/U2SDLH=0BTF76'F74D=X9K?ZO& M/BC!8$T*!E90J]3\X^??\+7'EC0;/1+GS!YJ\YS74'E_2(94@BK96S75S+7&DSBQT[6;&;4OKMEKFN:?HT M7U?3=7OM(YV\UVX]>2:33Y'6-%^%:>HZDK55Z/YV_,2Z?\B]5_-'\O8SJ$EU MY7'F#RR;DB ^C/;B>.619%851&YE"-R./?%4!=?FYJ<,WF>*S\C:AJL/Y>1V M_P#RL.XAO+=/J=Q)I\6I2VUD'XF]DA@E1FIZ:GDH4L:@*LD_,_\ -3RY^6&B M:)K&M7,,:^9-1CTG0S=7<&G6CW4L$URIN;RZ9(H(Q' [%FJ>BJK,0I5>5!01EN(95L_GK>7&NZ-Y3T[R#J%WYPO==U'R]JVB37L%O#I]SI MFGVVJ2S&[)=9H9+:ZC:-D7D2P!13RXJO1_.GGY?*UUY8T"PT>X\P^:?.5S=6 MWE[2(94MXR+&V:ZN)KFZDJL,:1J!6C,690%-20JP"Q_/&YUW7=!\L>7O(^HW MVO:A/Y@MM?L[N\MK*/2IO+5U8VM\LLA,GK!OKZ/"T0(=:5X&O%5*OSK\W^>= M&\Y_E7Y?\LW][I6A:T=:U'S-J6G26 NI(=&M%N1;A;^TO%X$$LW!5=ME5T.^ M*IAJ7YX7>B^2_+WG3S#Y7L_*MOYF"3:;!KOF33;"%+>:".>$33R,:SR"0JL, M*2FJFK4I55-OR^_.[1OS'F\OIHVF7UM;>8?)Y\WVUQ1/)M]J%[;^4--\T:S)/=VULFF+KEA)>V<*-) M474Z1IS=5 0 K\=20%7N/DC4+S5_)?E/5KZ4S7^J:+87=Y.P"\YI[:.1V*K0 M"K,30;8J\!UGRW^8L/YL>6/)]O\ GQYQMM'\R:!YAUVX1+/RXTD$NFWNEQ00 MPN^CD^F%OG!#\F-%^+K553T?\Z?,FA#\T-9\V:%=:MY+\F>>M2TB;S)%/:1O M:V*O:10)!9)^]G6%Y_C9BK]>//:JJ)\J?\Y4_E]YJU_RWIUE>:>]GYTO8]/\ MM?5M:TZ]U,S3)(\)O-)@E:>V1_2(K\10E?56/XN*K*?.^L^3!<:/<>9?-?F]+>*[O4L8KE+2"STZ*Y62W6661F+RRQN(T6BHS/5%4(? M,GGC\L9H]#\T:D_YHGS5K-MI'Y67$:0V6L7%S):W5U=0:MZ,4%FD=O':/*+B M-5++5?1+H#(JJ2_G;)STW2+?R9J36A,+IFX M26SVZ*P=1RH^Z<@4Q5*;3\_[E[#3=5IM0>_M99(]9T^6Z MMYHU@C9B]OZ]G)&LU5)^UZ?'%4R_Y7=>V%GY;U'S%Y#U+1+#SO:27'DZY.H6 M,HFFBTV35&M[YS)'#9L;>*1@[2-'\#6]4T#\R=8L],76)O MRVM],N[V'0=3MM3M+V/5;B2UA6UOPL43.LL+AA3CT^,U(55FL'YSRV'G/2O) M'FOR?=^7M7O;FPM[FX2^M[VTMUUA-0_1CM)'P8^O+ILT1' <6*;L&JJK+]!\ M]P>;?(=_YYL+:[L-'N+?4KK0IN<9FN["V,BV]]"&5E07"H)8@P/P,I8;E<5> M3VG_ #DEY>3S)I/DJ2%1K#6&D3S1:SK&F:5J=\-4LH;J*?3[2Y:WCO442,)6 MB9 'CD54- "J]>\_^>;CR;+Y,L+'R_<^9-5\[:R^B:7:6\\-LJ3)I]YJ'J32 M3$ 1\;1@:585J%:E,58+9?G:VL7=GY=T;R=J-YYXGO\ 6M/N_+TMS!!;6S^7 MFM$U"9[_ .)3%RO85B(C+.SCX$HQ55CWDW\XO,7GG\VM,T?2-%GM/(]QY5OK MK4XKZ6*&]LM6TW6I]*O%EB59"QBFMFA 20JP/J D8JS;S=^;H\K^;O,6A2>6 M[J?1?)7EBV\V>E?\ .4_D M*[77UO+JRGN-$T277T@\NZQ9>8%FM8[FWLUB>2R?]Q.TUW"JI( I#MZ[;Z#%PD4*U8I+@22 H M!QV4L3LJCO,OYKV]IYN?R>D.J6=SH_FORUHMQ?6KVOIW1UVVFN$6031R,L2B M.DG#C(33@PWQ5A*_\Y.Z=!Y;\C:_YA\OV_DZ3\RM.;6?)EGK^OZ?80R:?''; M222W5Y*PBB>MU&J1)ZCM6M%4.559'HG_ #D#8^?H((_RS\L7GFNZCTIM6U>1 MKNUM;6TA%]>::JK=!YHKB1[BPG],1%HV5.?J %:JO0?R9U[5_-/Y3?EIYFU^ MZ-]K?F'ROI.I:O>%$C,MS=6DI#*A#(ZUJK#<'?%7S=%_SC6TL7F34M3\^277G;7FT0 MQ>;+/1M.T](SH&J)K-K)/96Z".ZE>Z2LCRFI4E4].KG]9N+?ZS&Q6,LI"E5YE8U&*J=I_S MCM>:1I?EV#0/S*U#2==\DWNL'R7YA_1]E.8-)UN9)KK2KVVE4Q7-Z*1HKXEMZ2R,Q-#1 @%"JWYJ_)"/S#KFN>9;'S7*UN/+L3PQH8I/[Q)DD8,"01MQ.V*H'RU^0GZ(\[Z#YPUSSO?>;CY.DN MW\GKJ%G:?I.!+N"6U]*]UE4^N7R103,B"5M_A:3U'4-BJ(\Y_DEJ?F3S1YF\ MP:%^9.I^3K7SUIMIIGG+3;6RLKN6>&SCFBC^IW5U&[VG*.=E?@"#4LO!R6Q5 M-K[\E]'UB'\R[76M1GO+7\T+#3+'5DB583:'2[4V\4]J:-1P])5Y5"L!U&*I M_P"0O)?FGRQ+J%WYL_,6^\_7UY'%!;&6RM-,MK>*(;E;:S15>61B6>1R2=@H M510JI%??DY8WNLZAK)URZ234//NF>?'@")Q6XTS3;;34M02"?3=;8.3U!)IB MJ5S?DSK%IYJUO6O*?YE:GY2T'S7JR:WYJ\JVUE8W*R7O"*.XDL;RXB::T^M+ M"OJ\2V]7C]-F)Q5;Y9_)35?*.M0)H?YFZO9_E[:ZK<:Q9_E\MI9?N9+F9[I[ M--2]+ZT+,3R,XAKRI^[]3T_AQ5EOG[\NKKS;JGEKS/H'FN[\D^M:AJ+6 M.@7&BW)U!TEENY[W5)-7N]0GE55K--<3.S +OL *#%4]U/\N;;4M>\^ZZ^J M3POY\\K6?E>ZMU5>-M%9MJ++/&>I=CJ#5!V^!??%6!^<_P @K;S7>:+JEOYM MO=#U;RUI&DZ=H=Y';P7,:3Z-?)?6]S-!,I28,R\6C;;]I2&"D*H&'_G'R\CT MN_BN/S,U74O,=_YRTGST_FB[LK(N-3TVUM[)XQ;11QPBWDAMPJQA08Z_:;%4 MW\E_DKJWDFYTS3;#\S]9NOR_\O+*GESR1+:V*-!"R%(+6?4HX5N9[>V#'THV M(-.(D=PH&*K9OR"TBX\J_EWY3D\Q7Z6GY>>5M1\JVUW"D237,.HZ8FF/.QH> M#HB\QQV)V.V*I=;?D'J=U<>9]3\V_F9J'FG5_-'E.Y\H3R_HZRL+2TLIIA-& MUK:VRA5=6+ER[-S)'V0H&*O5?-WDF'S>OE076H26G^%/,5AYB@,*J3-+8<^, M+\NBOSW(WQ5B%U^3%A=:'YBT(ZY<+#YB\]6_GF>\M>4;?\P;U?*^D^7M-\N:UH.HZ=9:K:W<6F0?5D MO+2*]61-/NI(F97D@%&^%BI9:E5,]5_YQ]36_-UIK.L^>-0U?RSINMP^8M'\ MM7UK:W-[8WD$RW*0VFMRJU]#:^NO/T5;928@PB/#%4HL?^<==>T>P\GP:+^; MFHZ=J/E#0)O*,&L?HJPGDET%I89(85BF5XXKB$0J/K"CX^KHU%HJB[;_ )QM MTZWTZ'R_)YPU"X\M2^0=-\A:SI;6\ EN8=$:X?2M02YH7AN+=KEF- 4=@I*@ M"F*I^GY.^8M2TB6P\Z_FCJ/FV\.L:#JEK :#J-OJ2HMK:JJM)<26 M_&65F)XFB!0*%5-=;_)ZQUK2OS0TM];NK9?S0UNQUR]G1$+6DEC;:=;+'$#L MRL-.4DMO5CX#%4G\O_DKJWEC5A#HWYF:K9_E]%J5WJMIY"%G95A>\FDN7M$U M,1BY^J">5G$5>5/W?J>G\&*IG#^2^F1^4ORF\HOK5W)9_E1;BWLKK@@EO4&B M7>A_O>R_N[LR?#^T .F*IS^7WESS9Y12R\MZQYD'F?0]$T*PL=-U)[6"TF>Y M@DN5=GCA) 'U?T%]V4L/M'%4H\V?DCY5\W^<]0\[Z@SQZCJ7E*^\I74$<4/I MO%>AT6Z9FC+F6&*:6-*GCQD:JG:BJ;>7_P JM$\L:I^7][I$\EK9?EUY4O/* M6D:6J((Y+>[?3W,TA4+1U_1Z]!0\V)Q5YS:_\X\7?E^+0Y_)'YE:GY4UO3-+ MET+4]3^HV-]#J.GM>W5_ LMK^6Z8!R[QQ<)%8$$DOL=L53'SQ^1]IYS M\SWOG.#S3?\ EOS,D.BGRUJUC#;R-IMWHKZH4FX3I(DZ7$>JS131R+0IT*L: MA5-;#\K;\?X$NO,/G:_\S:SY,\QW'F234IK>WMH[F6XTZ\TWZM';0*L=O#'' M=\E5*GDM69BS$JIK^8/Y=GSJ="U+2_,-WY/\V^4KM[SRMYHLHH;AK=IXC!

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end GRAPHIC 14 auditopinionjpg_page2.jpg begin 644 auditopinionjpg_page2.jpg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

5)5\C.Q*+&T76M MKLM!+ [0$2&\_1^DY)3FMXV@0-C&MOLG:-=Q+7?3VN?^;_US_1R?;<[U M'/<&;H>(NL@.B*V/V;/2W^]^QO\ F).%+=A9>RQKWLK!KKW1O.VNP^G;_-[_ M &;_ /T7ZMBBVW&.YSLJNHUO+"VQK?<08%C:Q<[V^[8S>DIDXV/<*0_V-,.( MNMF702'1[WN:WZ%;GJ!L<7/+W [I)C)N )GW>GM'T?3]WZ/V*SCXAL8+:LAC M]='^F8,1NC]+[OH?24QTZWVS 6ML =8UL.-UD"?YP.?SG=Y\_Y22G,8]XK!+F2QQ].+["0UXV.WNA MW]6O?_UM6\$'[38-V[:W@V/<1)_/JL"IUXU- M;S8QL/(@NDDD3NUDI*2I)))*?__2]563GY#JLM\/:WV!H#F#5QT:WU"QWL]V MW_C%K(-E-KGES;WU@Q[6AA C^O6YWN_K)*:6);G9+Q95=NJ:YH=N #7,(:YV MS:S?ZG_06E F8U&@/Q0/L]^OZU9K_)KTYX_1>:1Q[R01E6 #D;:]?_ TE-A) M5_L]\N/VJR#$#;7 @]OT7YRG758QQ0 9&5S8P 2D!\@'Z @,"# (4 M AT")@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+! LL"U0+@ NL" M]0, PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#QP/3 ^ #[ /Y M! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P!/X%#044%]@8&!A8&)P8W!D@&609J!GL&C := M!J\&P ;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@?"#(( M1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)N@G/">4)^PH1 M"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X +F NP"\@+X0OY#!(, M*@Q##%P,=0R.#*<,P S9#/,-#0TF#4 -6@UT#8X-J0W##=X-^ X3#BX.20YD M#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[! )$"800Q!A$'X0FQ"Y$-<0 M]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3@Q.D M$\43Y10&%"<4211J%(L4K13.%/ 5$A4T%585>!6;%;T5X!8#%B86219L%H\6 MLA;6%OH7'1=!%V47B1>N%](7]Q@;&$ 891B*&*\8U1CZ&2 911EK&9$9MQG= M&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H< APJ'%(<>QRC',P<]1T>'4<= M:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@;""8(,0@\"$< M(4@A=2&A(B>K)]PH#2@_*'$HHBC4*08I."EK M*9TIT"H"*C4J:"J;*L\K BLV*VDKG2O1+ 4L.2QN+*(LURT,+4$M=BVK+>$N M%BY,+H(NMR[N+R0O6B^1+\<-]1B)&9T:K1O!'-4=[1\!(!4A+2)%(UTD= M26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\ 3TE/ MDT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H5755PE8/ M5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N56^5<-5R&7-9= M)UUX7&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1 M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5&YXS'DJ>8EYYWI&>J5[!'MC>\)\ M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82 MA..%1X6KA@Z&I+CDTV3MI0@E(J4])5?EAMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>IJ:H< MJH^K JMUJ^FL7*S0K42MN*XMKJ&O%J^+L "P=;#JL6"QUK)+LL*S.+.NM"6T MG+43M8JV ;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;V/O@J^A+[_ MOWJ_]_R#W(O,DZR;G* M.,JWRS;+MLPUS+7--:6YQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1 M[9SN*.ZT[T#OS/!8\.7Q$S%F+P)'*" M\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*&!F$E$5&I+16TU4H&O+C M\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_(B8 MJ+C(V.CX*3E)66EYB9FINGM\?7Y_(B8 MJ+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H # ,! (1 Q$ M/P#[^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%7_T/OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_1^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]+[^8J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_ MT_OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5?_4^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]7[^8J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_UOOYBKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_7 M^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5_]#[^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%7_T?OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_2^_F*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*K78(*D5W V]S3%5,3H>G(FM* '\?#%6FN$52Q#&FU .^^W7 M;IWVQ5=ZJ>]*LGQ &I6FW2M>G7%7&:.JJ#R9J$**5H:[_ ('% M6C.@K4$4-#6GT=^^*N]>*M.8[[U'4'B1]!VQ5LS(I(-10@$TVWZ8JTTX5>8C MD9=ZT4U%/8[[XJV)XF( :K;54;D5%16E:;8JT9DWH&(7[1I2G7K6GABJWZS' M4 5);["@;FO@/HQ5?ZR@JI!!/8]NG]>V*MK*K L 0HW!VW'B/;%6A,K-Q56- M/VJ;?><5:6=6D],*W+X/3%5WJIU) '\U13]>*M>LE>)-#0G>G;KBKO67X?A;XC0;=\5::=%8*0W(B MIVV'S/3%6O72E2&4$FA(H-N_R.*MF>,,$K\9%>.U>W]1BK0N$-0*U'[.U>_O M[8JWZZ5 ))W %.FU3UZ"N*N$Z'G6JK']ISL.E:XJT;B(,]#4;;[4J>U>E<5:,ZA MPG!JLI(VITZCG^*K'ND0@%)"6.W%:BGC7I_'Z,57F=%W>J#]HGM[G MV]\57"16K2I KN.FVQQ5QE 8J5847ERI\-!UWZ#Z<5=ZJ=C6G6A&WXXJUZT> MWQ5KT W)^0&_;%5WJ+MUW/$;=\56">,J7)XJ*U+;=/GBJ]'$BA@" >QQ5?BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BK_]/[^8J[%78J[%78J[%78J[%78J[%78JENL0W%QI M>H6]H_IW5Q;RQ6T@8IQD=&5#R&XH36HW&*OBWR%YKU/S[Y5_(#\L++6+]=1T M'2[/6/SB\QBYE%V4\FW7Z,,2W?J*[C4M8L&8R$MZEO%,LR+]8!"J_2/^K[4;;RW<>7K+6KD1V-A:RW3ZL?,4ELFC7ENGIJLPM MI/W;S+'R+(W)5)_RI_.;S/IGY*_F1Y@N;$:[JWD/\N[+\SK(WUS--)KI!9NR6L)'Q>D%J.F*IGYN_YR@U#0O.^DZ;H<>@>:_+5]YATWRN MNC:)8ZYJNHW6J7DJV]U%^EK.V?2+2XLR9))K2=S*L<#EN)=>*K'-*_-#S'Y, M_(O2/S$_,X6?FVP_,K\Q-2UFYU/2;C48"_E21[W4M,O;%'G$L?\ H.G0&&&L M:F)D68>JTQ95G/FK\[_S4_+RT@UCSMY<\JW.F^;_ "QYEUSR9IFDRWOUNQET M31YM:CM]2N92$F#QQ")F@1/C/)13;%68_E[^8_YJZI^9.B^4_/\ HWE73M-\ MU^1KCSIHT.AS7MQ>Z>;>ZT^V^I7<]P%BG/&^-9(TCJ4V6AV52+S;^=OGW3-+ M\V?F3H&AZ#=_E3Y"UZ\\N:QIVH&Z'F#4+G3-5.DWTUJ\;?5H8UN05B$JN76/ MU"5]0*BJG_SCCI?FS6O,'YO_ )G>?K^PN]>U7S;K?EC2I--N]8^IP6&@7\FE MB-=/O+N6SC!6PA7DEIY?$.LV 33K>&#][/ JZ@\4:^I'P"JPJJLF*K/R9_-_SMY_ M\S^9OS;\[WGE[0/R\\I?EOIL-_9_7KFRLM,\Q7-Q<7FH>K/I>5O(FH>>=*@TO3?,6DVD"V MMQ';VEI=ZAJUI%'>)J#2.+>YM/@?ZM*P5EX@*O0+C\Y_S8T#\Q[O\K/,GE_R ME+YM\V66DR_EP=,DOOJ5M<:FVLR2QZO+,:R"TMM(DEY0*AG;]VHCYAE50C_G M)YS/FF?R#Y_\J:''J>B>==*TJYU+1K^^2VN0GEC4/-4=\BDQR1@7&FQQ-#(S M H6#EPU,5>;^4/SC_-7R!^3VDW7G'3=,UJY\]?EAYK_,KR1&;Z]GO;26SMXM M8DL=2NIO[Q2VJ1Q0&%5:-$XGD0#BJ:>1O^F'R?Y:\NZ-JWG?REY8U*Q M\@7,]_Y=\TW/F#5I-.O$\OWFMRZS'9MHT:K-&]S+RF?E&C_O!(X557U-^>/Y MLZ/^4'Y;ZYYSU.^TRPNXI(-,\M+K-TMI9SZQJ$HMK"*:8L"L0E!Q5\L_EI^;^LZ/^7/YGQ>0O.,/Y[7GD_\ ,*+18/-;SOKOU73+K1["ZN-7 MN+/1S-=W,4U\URPBM58AY&6,+#$515Z/JGYT_F=:_EUY8\RZ=H7E_6[K7-1N MK6_\Y:/8:[J^E6=O M4-QH=E"^L0S-.)+22)D)@EB;UBE>"JO.-6_P"^6.]L[JZOK6:VN;:0B2)+>5W:-G2(JL8_+ M#\R/S;U?1/RTTCR;9Z-J&M?G!H?FG\R]8UKS7=WLEOH-=:LWCT^"*"DL]NBZ MBT,(]1."HI^R"F*H35/^70U"; M7/0NIK1+Z[9?JR17IM'5>*#TFDC]1V"-55Z#KOYX^=D\F:7YUM M[+1M4\ERQ7&H-8W$>NW&HV\6GBT5)KW4+VW72I93#9H'N%($:H:MBK =-_YR M9N_,'EU)O,NCZ6$ M=G#,7!V(3%696/YH?\Y!ZG<_E;Y?;R-Y-\N>;/S1\NZIYF>RU*ZU)H_+ M<&E1Z,YM[^()%)_N=8_3IEO;:WOI?3AE L[B>P9?2B@DG19$;]XRE&53" MQ_YR1_,^WT7S)+)Y#M/,^J:9=>4[?0-3.D>9/*&D7LGF/S!;:)+8L_F*S$YF M@CF-QZD2N@4KR'6JJ7?F!^8_YWZII_G/\IY9_)]EY^/G3R5Y?TJ\TAM6AM=4 MT_7.>HZI:!C,)K>1;"SG:1TF4^B'])EF,>*OIO\ /#\T-)_)O\NM:\XW^H:? M9WBFWTORU#JEP+2TGU?4YEM+&*>X9E*1>K('G=:M' DD@!"'%7RC^6_YT:OI M'EW4O+/Y?^==)_/35I/SBM?(^D>8=8U9)D6TU'R]#J$NJ2S67JED:\2ZGX+\ M+5DAB**J!%7IO_*]_.^D^5?.UKYIF\D6GYB^6_.\WE#2([?]*36.H)%IEAJD ML]GI<"7.I7L\:WA1K>W!;X2]0BMBKQ?S1_SD/YN\T>5_(FM167H-Y7\]:Q>Z MYJUE#JNB6.K6?DRSCN]3=+34TAO%M81<7$-Q',&/KVCJH8E5"KZ(\Y_G9YNM MI?.3_EWY7M_-6A^3FTS3=2\R/%>7C1:GJ427DSG3K%/K<\6GV4L$DT<"/(YN M$"4,4H"J2>5OS:\U^9M=\O66I^7-%\U:K9>3O-7FO1;GRU>W^GI>WVEW-AIJ M:<]AJ7HFTF8W\MM)%? M%-%R(0U5%62?D]^:7F_S:_F.;SF?+NFV>B6:W5_9 MVUMK&B:CI1%65+VSUV*)IH759>%W"1"3!(J\Z? JS_1?S_\ R-U[4-.T/R_^ M<7DC7-9U69;;2])L=?TZ>XN9I#1(H8HYBSL>RJ*XJP?\V]"M_P P_P UORG_ M "VUNZU.T\M_HSS+YRU2#2]3O=,:]?25L=+MK.YEL)[>3T2VM-^43JFOZ!J%KH5KY/L+P:UYGBTKS+J4>LWNH17 M+VHU#4C$FG:=#>?5E#O653RBBF#JJR7RI^>_YF^<(X/*&F^5=.M_S'O]5N;? M0]T30KC1K"Q@O;[54T[58K;4&BMY;JWL"%;XIY5D7]VD@"J8:?^:'Y MY:[/YU\MZ;Y:\GZ%YD_**40>?K[6'OKBQU(3VPOK.71XK60RQQRVU')N'+JQ MX<*#D56#ZG_SDG^:FK>4?S%\^^0O)_E:Q\M?EQY.T/SIHVOYZ:E=>8=3\GV>AV4FO1?F%JOEV%&>5 MD3R[Y?LK.]U359E/&K@720)&C?WDL;49%DHJ\W\E_P#.56M>;-9\M:X_EQK7 M\L?."/?17=SY?\RZ?XN%B@BC!CD:E>7&D6H MN[:ZU/54NEMQ$LRV_P!7C2!HHU>3D:LB@@JH9?SM_->;S)H_Y:6'ESRG=?F% M+YHUORMY@UF2:]AT6!]-T*QU^*]MX?BN70QZA'"\3.&+@LKA:#%6;Z'^:WF< M?D5YZ_,OS%IFD2>;O($7G>/]&Z:]PFF7<_E&^U&QC:,S1)!;8G M%7A/Y4Z=Y/\ *7E_RUYK\S?EQ^9V@ZIY;T,:U>_FI^8?FGZCH5Q>K;*_JZ@R M^8[V&$7#L%'.U,:D_9'3%4RT;_G*_P T+JNO^7-3\OZ=YH\Q'3[&;RM!I&D^ M8="MEU+5M1CT[3+"ZGU^VMUG^O,\TD,T)",EK/T^&BKTOS)YR_-#0]+M_+_Y MG^6/+^J0^8O-/E+1+;S%Y:N[^PL9K3S#J+VEW'&IG-W'Z'%H5I;>??,6M:W9^>=#C MFD:#0;3RQ=&'5YR^WK,LLEM:H$8CU;A7HT2245?2UN&$?Q=2237;K[=L55L5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5?__4^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*K67D *T MH0?NQ5YCY'_)_P C_EY_BO\ PUI\L(\Y7CW>L+/,TH"N9&$$-:<(E:>4J.H+ MMN=J*O,_^A4?R\EMY+&_U_S9JFG0^5];\E>7]+N-446NC^7M=M([*?3["&*& M-$6*&%%BD2]1EU?S+H7Y<:+JWEW0X=5NQ(\VE:S9MI\]K=/"D)D5+5O2C(X ML% )8M\6*H%O^<:O*>H6,]EYL\W>;O/3!+>+1;W7=0@DFTF&WN8;HQV'U:VM MTC]9K>-9'96=HQPYA68%5ZU8^2='T_SAYF\\6SW USS9IVE:7JO*2L M]&DO M9;;THZ? Q;4)>9K\7P^&*O._^5 ^5G\P7.IW'F#S%<^6KS5Y=?NORQ>[A_PW M)JEQ<->S73VH@]=S)=NURR/.T9D->'$!0JRW1ORN\LZ)^6L7Y4VK7DOE6+1; MC00\\W.\-II_ M0^E+?+;\#Q^&4C4)>3_M43;X<52#3?\ G'?R!IVD^?/+TDFJZIY<_,;2M(TG MS%Y?OKH26P31M-ATJ":#@B.DLEO;Q"1N9#,BL%&]54%I_P#SC?Y0M]2N]=UC MS/YL\W>8M0G\M7&HZ]K>IK/-,WE/5I-8TM?3BAA@C5)Y2KK%&@=/M5>KE5BG MYO?E+K$FHZCYH_+W0KK6O-/F/6K36KZ\M_,$>AZGIE_IVF#1[6]TNXN;.]M@ MILGN+>>.6%^?K>4LTU.W6\E EGD7ZC'PG(3XRY1%0JJJO3(O^<=_)[LDNLZ_P"9O--W8W^E MW?EW4-:U 7=QI%OI&IVFK6UC8R&)2L+7%E#ZK22MFMQ=Q+#Z\EN05>6)5/I.?B MCYOQ/QG%6 >:?R"\J^9O-5_Y[M]?\P^4_.EXMG'!YFT*Z@AN+6*TBF@,<"W% MO<1 31SD2\D8FBTXTQ5 S?\ ..GE>"VT$^6O-GFOR3KNB6]];2^;M$O;9=2O MTU6];4]0^N-=6MS"QN;Z1[ERD2?O&/'BGP8JUI7_ #C?Y+\MW=FGE#S!YI\F M^5X/J+W_ )"T;4_0TJ_FTZV@L[>:Z8Q->%O0M+>-A'3]SQV^'%7EOYC?\XZ:9YVUO\C$AEOHO*_Y:1W6BZQ"F MI26L\FE+9Q3Z?-')"@E-S;ZMIFGSHZR)0(_+DK%"JRO_ *%W\L'23"?-GFIO M.'Z<7S&OYI&\MCY@74EL&TD3+)]5^J#_ ''.UIQ^K4],UIZG[S%4O_Z%;_+$ MZ)J>@R3:]<6FL6/FFPU&XN-2DGN)4\XW=C?:M(TTJNQ=YM/B9&)^"K ;&@5> MI7GY=>7K_P S^8O-MP;HZKYG\LP>4]459>,/Z/MYKNX0I'3X9.=[+5J[BFVV M*L&UK_G'GR!KFC^0M'NI-5@'Y9:$-#\DZE!=!;JS$3Z9-;7H9D97N;:;2+:6 M-V4KS4\D96*XJF&E?DIHMG)Y:N]8\V>:O..L>5_,*^9K'7-=U%9IWO(].O-+ MC1XX8H;=8DM[Z3X8HDJW%F+$8JI7OY$^4;JZAOK?4];TR^@_,)?S+CNK2[56 M_3'U,V$D)#QN#:RV[,CQ4K1C1@=\59OK/D30]?\ ,GE'S/J1N);OR5+>W.C6 M DI9&XO85MVN)K>A626*,,L3GXD#O3[1Q5C;?DUY./YG+^;8^NKYK6$6[*)E M^J,BVKV@!AX?[[<]#UWQ5(]1_('RGUS0?-6DW<2 MZG:W'F6]N+_4XXWN8+B$QS/LZCH/F+RC!:^:=6GFL8[#SAJDFJ:EH)'CK&) QYXJR M>W_(#RG'Y-\@^3=/U?6?+&J?EG"3Y;\Y:-=1IJ\<]Q"8+ZY>:YAGCFDO%=O6 M>:-W8L6+I^: M?,L\%S>M8V#3R6EDOU:WMHEBADNIW6D?+E*_)B.(55Z(UG QY&-0^WQA0#0= MJC%7CWF_\D[;S1YOD\[Z=^8WG/R'K=UHMEH&HCRS>6<,%U::=<7=S:^K'>65 MW\<;WTU&4C9M^@Q50E_(+RJ^@VNG0Z]YAL_,MGK!\PQ?F;#=Q'S$VJO:O82W MDEQ+!) [26 MD6^KVUM;>=].M-6'#S(+:/T.>J3S0R7)=X?W3-!-">&R\:"BK(;3\C/(=AY? MU7RQ96]U9:/J_F^P\[36EM*L2Q:EIEY8WUK' J(%CMTDT^%1$!3@"O3%4TT+ M\HO)?ESS9YR\ZZ792QZ[YZ4IKK22N\'%]YA%$31/619F53'SE^0'E7SIJNJ:E=:_P"8M%M_-&G0:/Y_T32;N&&R\QZ= DD* MVNI++;S2[B6^M+F\T^STNYBMCW5[>$J!)<230)\8"JJ@1HJQJB*JI-^2O MDUORJT7\G.6H_P"#]"LM*L+/_2:W;0Z//!<6W.;CN>=LG,\?B%1WQ5F'G/R7 MH7G[RUJWE/S)#)=:-K,2I=11OZ;JT/1_\XR^3 M&7S#=ZGYH\W:]YH\R-H<]UYWU+4DEU."\\MS7DVE7EJ%@2UADMS>N %@]-@% M+HS\V95-KG_G'SRIJNDZ=IOF;S)YI\W76GW.K73Z[J^HB6\N)-9T>XT*<2"* M**!$2RN65$BB10P$C!I"S,JA?^5!^3]"N-%UO0[C6X=7\M:]8^9].*7Z(+F\ MTORVOEB*VN6DAD7T)[",)**5YGF"IQ54_)/\KY_* \]>;_,&F6.D>=/S/\Q7 M/F'7=-T^=[N#3TE)]&QBN)!5N +22E L;SO+*B)S(Q5[U&@C7BI)%217M7MB MJ_%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%7_]7[^8J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78JD6N>8M&\LZ5?:[YBUFQT'1-.02:AK6I3QVEG;1E@@::XF98T! M)I4GJ0,58KY3_-;\N//FH7&F^2/S'\K>3!2S "I ZG%7H^*NQ52EYN76* M"$,Y4%Y9'"(HW9B%&YIBJ/,08;ZUDO[+R\US$M[-:0N$DN([9(FN+ET:1;>)78TW3M._2NH:E:6&F@QAM1NIDAMZW#JD ]5V"TD9U537XB M0!N:8JG2-R4-6M>]"/P.*J1F*LZD&BBH('O2F*J_4=>O?%5#ZM$71R"QC)** M>@)[T_S^_%41BKL5=BKL5=BKL5=BKL5=BJUE#BAQ5I45345KOO\ /<^V*K\5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL56E0U*^!!'8@^(Q5I(UC# M!:T8UH232OA7H,57XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7__6^_F*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*OG'_ )RL16_(KS7RC6;EJ7ET&)Z4;_<_ MIWPGE4;XJPG_ )RLOQY)\K^3_-GEN&RL/-GE[S2FIZ++#$%F-O9V%[/>I^YX M2O 8HJW*!@#'RYD+T5>?>3/,/_.1T&CZW9/)#:UH6H^?/,&@7[ MQZFUU8)"^GQ:78Z?Z%L8KJ6-GN!,!*]M_E+(JF'^.O/FA>7Y_)MQYW\Y:;YT MU3S?Y+T#7K7S9;Z-/K6CV?F:_FL9M0TK4-/M8;&YMY_J\J6SR6Q*RP2LZLKJ MJJLQ>T_,"+\W_(_Y46?Y_:WJ.@Q:'YFUSS3,;31I=?9["Z\MFSLKNZBM5BB/ M^Y"1^0M59K>3A0GA.%7B?DC\Q_S-\_6TD5U^=-[Y;N-!_)Z'SW;Z'HUEH\-U MJ>I0ZWYAM9IS]8MIR+5([2WBFCCBW)C/J1M7U54#Y!\Q>=_TOYU_,X^>M8_2 M'G7SQ^3=MK/EMDL&T<)YHM/*[7WH0O:&>,K%<201GUR50UWD DQ5Z[^7/G;\ MP+Q_R0_,'5//FJ:LGYR>=-:\LZ[Y(N(K :+86EG8Z_=0OIJ16L=TDJOH\(+2 MW,H*M*"M64HJA?RU\Y_F:\/Y*>>=?_,B_P#,2_FAY[U_RCJ?E2>TT^'3+?3+ M./S#D_F#?^;_,WYKZCY$TOS]KGD31O M+'Y?Q>;DNO+BZ>MS>7L]_=VIANGU"SOE,2);+Q6-4:I:K'8*J\I_YQK:CY:B2T32([G6= 6\D]%!;FZ1(G#>F/K!%'8 M/S-"%7F5YY2UZ7SGJXM/S'\PQ3:G_P Y2BQT_P"MIIUU%I2GRK+<236$?U6( MK+Z4IA0RM(B!48;2\T7 M3/,=S8:-H>D:K$TU[>6$NG\A-J4B.$M%+1B,#BRNSJO8?,5_YPU'_G#[\UW\ M_P!Q:7GFF#R+Y[LK^:UO+;4*1V<6IVUM'6_R,DMKMM!_(34M+UE;IT862]?T/0=>L?6T6P\N6-W MJKV(33Y[>ZMI-0U.[>*\,[BVN(>*R0*H9@YQ5Y;Y+_+[7SY__*6?_E3%0&;TQ&>/%5ZGH'G3\_=?\ S+N/ M,EK=367D:U_-#4O)]P=1UO0[?R])I6G:S/I;1V^F&R_29OGBAHG^F$//\83T MR(@J];_YQMD\[>;OR\\E?F-YR_,W6_,>J^8X?KMUHYM].M--2.(W5JD*Q0V@ MF.SH\C^K\7]*\S6VIVH0TM)[/5D>%563C)R J2M,5? M*/D__G!'\XOR^O[G5/(W_.6MOY2U*\@-K=W^E?E5Y-M99(&8.T3/% I*EE!( MZ&F*HCR]_P X.?G7Y3A\P6_EC_G+R+08/-:\/,T-C^5GDZ!;]/C^&Y"0 2#] MXVS5&YQ5;I/_ #@Q^=.A>6=8\EZ-_P Y=Q:7Y2\P,S:[Y;MORL\G1V5XSJJ, M9X%@".2J ?$.V*IEY:_YPQ_/[R9#IUOY2_YS,D\M0Z/#=V^EIIGY8>4+46\5 M_+%-=I'Z4*\5FD@C9P/M%%)^R,58KJ7_ #@%^:NI75M=ZK_SEHNH-96MG:6, M%Q^6'E*6VMHM.GN[JU]&V:,PQE);Z=N2(&;F>1( HJR&;_G"C\\[[S-<>=I_ M^:M3\\Z/_P YCG2_.6M(\>K>:;7\K_)\5_<+*59Q+<)"';D44FIWIBJ; MV_\ SB1_SDG:0:1:VO\ SF[>6UMY?O9=1T*WB_+3RDJ6=Y.LZ2W%NHB CD=; MF8,RT)$CU^T:JI3YQ_YPJ_/G\PQIJ^>_^72OTQ^6'E"\^KO)QYF M(S0MQY<16GABK)+7_G%O_G*.QOM1U2Q_YSJU.SU'6! -5OH/RX\J1RW(MD]. M 2NL0+B-#Q6OV1L,58U%_P X4_GO!YCO_-\/_.8QB\U:K=6]]J7F-/RO\GB] MGNK6-H8)Y)Q#S:2.-BBL34*2 :8JMU__ )PG_/7S5IVI:3YE_P"*YU!8D@%W*KPD/*(XU3F=^*@5H!BJ>1?\XF?\Y+P>7!Y/ MA_YS@OHO*:Z>=*'EI/RU\I"Q^HM'Z)MOJXB]/TS&2I6E"-L50]U_SB#_ ,Y& M7POUO?\ G->YNUU2"QMM2$WY9^47^L0Z9(TUC'+RA/-;:1V>('9&)*T)Q5*] M:_YPE_/3S'KJ^:/,'_.88UOS&MHEBNN7WY6^3KBZ^K12>M'%ZTD#-Q63X@*[ M'<8JD]S_ ,X"_FQ=WMYJ-U_SE;9W%_J.LIYCOKU_RH\F-+-J\?J%=0=S!4W M]:3]X?B^)M]SBJ=?]"4?GO\ XR_Y6)_T.,?\><.'^,/^57>3_P!)<1%Z/^]/ MH^I_=_#UZ8JR/1/^<4O^AZL,LD99*$*[8J^\XR6=#5@$Y*1R.Y(&U#UIX_PQ5%8J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J_P#_T/OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BJVJFH!!\0,58EY8\V^7_.%I-JGEK6[37-/MKV;3Y[NQF66- M)[=^#QL0*5H P/[2E70LCJQ59<2%W) 'B<58_P":?,NA>4M"U#S#YDU6#1=# MTM5?4M4N"1'"CN(U+4J=V8 ;=\51&BZK9:M#=O8W#726%Y/I]U(TU:@ MXJF<[&B\22=S0'Z>V_R ZXJP&W_,?R5>^6?,/G&T\T:==^7?)LVKV_F;6H)Q M)!82Z$\B:C%=$*?3:W]%O4''EM45!!*K/+.ZAN[:&Z@D$D%PBR0S5^%T2&19%$UO(T4T9*D@-&ZLK#J&!!W&*J_)?Y MAV[^/3%7E"_G/^6;>=S^70\WVW^+EN/JATST;CT/K-.9MQ>>E]6,O[/IB7GR M^&G/;%7K%0.I [8JU5:TJ.7AWQ51N-U50"3R'V=R#V(!J-CXXJQSR[YFT?S= MHMGK_EO4HM8TB^$HL]3M6+02F"9H) A(4DJ\;+2@%?;%6.V_YG>1;WR;J?YB M6GFS3+OR?H$=^^K^9H)_4M+8:5(\5ZLS!24,+1L'''D"I]L5>DQL*$$%64FH M;J??Y'%5"UU"POFNDLKVWNWL9VM;U89%D,,Z!6:*0*3Q<+6?S7;RM =.$4ZP//$.4D$-XT0MI94W!C2 M0N"K BJL J],N=1T^R:V2\OK>T:]G2ULUFE2,RSN&*11AB.3L%)"CPVGUN9;:T]658Q-,]>$25(+.U-E7^*KJTQ5"WEW!9VEU>7$RPVUI$\UQ. MWV4CC!9W/LH!)Q5BGEKS?Y>\VVXN/+6L+K-K+:65_#=0K*D3VVIVXNK.1)'4 M!UDA8,.!V[TZ8JF7E[S)H_F%M;CTG4H-1D\NZE+H^LB%B3;7L*1RR6\H(%'5 M95) J*$;XJG$NH6$%U:V,][;PWM\LKV5F\BK+,L !E,:$\F"!ARH-JBN*HH$ M'H0:&AI[8JQF?S)HZ^9X_*(U*$>89--;6!H_)A.;))EMVN* 4""1@M:]3TIB MJ0:O^8WD_P OZ[;>6-5\PK;Z[5O, MFB^;M"L/,?E_4[?6-'U-7:RU.V8M#*(W:)BA(4[,A'3J,53>]OK'3+2XO]2O M(-/L;2-I;J\N9%BBBC7[3N[D*H'E/'3G%)Q)XNO(54[BN*HNH\<5<&4UHP/'9M^F*M7]CIT#76H7L%C;*\<;7%Q(L2!YG6*-2SD"KNP51W) &^*HKD-]QL:'Y^&*N M+*!4L /&N*L0O?./EJ'4M%T9MZN=,CDEO8(N(=><"Q M/ZBD@CBPZBF*LKB8&--P-AL#6GW[XJO++2O(4(V(_ABKQS5OSU_*/0/,T7E# M5_/.GP:\URMK/$J2SP6]RTG 17=U!&]O:RA&*M!E-:,#0D&AZ$=<5;J/'%6F=% +,%!Z$FG:OZL5;+ 5J0*;G%6+ZOYDT MG0;O0[?5]2BL'\RZFNCZ*D[$&ZO9(IIUMXZ*1S,<#L!MLIJ<59/S0F@85\*^ M&V*M.1Q(KOT K0U[#%6.^6/,.E>:]%T7S-H6HQ:MH?F&SAU#1]3MF+07-M<1 MB2.6,LH)1E8%30'QQ5DN*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O_T?OYBKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKQ'\^?.^N>1/RVUN^\HQ"[\^ZU) M;Z%Y TQ&A66XUG4Y!!;B$7(,3R1@M,J2<4;TRKLJU(5?(>@_XC_*G_%7Y=1: M#>?\XY>5O.OE&UE\I^:-:U33]2BCU_RY;6FGW*QS6%S>2Q&[TB&(.S%?JZ6Q MFB#-S(5>^_\ ..7F'3M6/G32++5]4O[K0GL&U%9O-LOGK1B;CZRBW.EZY/)- MNZ;>6'_.13HM6DM[74-(N=/T2[G7]"EO1O$EO+JY4W9A+QD%5FC]'X%63[C5O.4FF7+ZR^KZQ:Z MG''JUG7[O\ -*YF\ZZI_P Y M :+I>AV-Y=M%K%UH%SYFL."&T14>.UN;/D-XXX2K\5H&52JF/D/S3#:?F?#I ME_\ FCJ?FSS'KMUKL=AYJT;S+-JMA^[M[R58-7\EW+E=(:U6$L);:!8RT449 MG#7+12*O)[W\PM7T/RYJ>D>7OS*U'S#YSU9=#74O-EKYXOM6\LZEIEUK^E6> MJWU\Y$]YY2E2UNY7;T(X5A5Y3"9?JJF)5F&EZ_K]GI5AI.N_G!IY_+C7?S%T MW3?,.H^6/.NKZT-&TEM U2\E2?SG?):7D)N-0MK<_#..%5@# 3<&5>X_\XJ3 M:/<:5^G>8IYOK$MU%'8::B^K<<%];@%X"4U,@42,TC M,9&5>30:AYD\[?GI)Y"OOS!\SZ7Y9G\_^>[&^L-%U>>QDDL-,T#RY<6UBL\# M":".*:Z>5?19'5F;BP5W#*OIK\@M>U36_P MK.[U?5)=:FL?,7FK1+6_N9/7 MN'M-$\Q:CI=DLTQJ\SI;6L:M(Y+NP+NS,2<5?#>OV]WY$_(?\\?S&T^-KSRW M^8,'YL^5OS&M;="RVD\7F'S,FE:Y(5#D1Q!VMI@E"5DC=N?ICBJS/S;YRN=. MM_S!U9?S&U72_P S/)OF?RGH_P"5ODJ'7+FW@N]#N=/\NR7!3R['.MOJ*N]] M?F:;) MYMUN-C=7Z375SHHN(TY27,2I)(U)&+%N6*OJ_P#YQTNMR?67FEJQ81B00A@(^*JL1\RZ[^ M6?FS\SO*OY/^6O,7E?2K;R9YUB\W_F-:V]]96MQ+YBAG;5;73[2V]0R2WD]] M*ES=_NS2,D%UED3%7JGYY^8+'RU^7>H7NI:AK.F17-W8V!?0KX:5*[W5PL"1 M3ZIQK86[L:3W2M&T,?)U=&H<5?&'D'S1YK\Z:[HOY>W'YF7]IY=MOSAG\O27 MGE/S9J>M-<:1_P J\O-:N+)/,>HQ1:A<1R7@,GJ \HB +>51&I"K*M#\U2W6 MOZ3Y(_,'\TM;\N?EWY>\R?F9IUKYAE\Q7.E7;7/EO5=&MM!M+G6O6CN+N1;> M[NR(9Y7,]"TBR>B"JKW;_G$"YBF_YQV_+*X2]?4TNX]2>._9%1K@/JUXPG:- M$C5"]>1"HH%:!0 !BKXEO[>\\A?\XG_F!YVBC>_\G_FMY=\UZ#YQM[:,D:9K M%MJ&LQ:?K$I^,^ATUGS+_P Y"7%AY^LM7\ZZKI5K8Z'+HDE]'-/>6TL\^D++ M3-377/.>C^=H[?S)>1:%?:1K%[YBM MK/3Q% \=E^F]1ABN+^2.0NS2OR/Q>GS^ *%7R[^6^JS:9J7Y;:/<>==/\R:G M/^=/FVV/Y-SV.FO)H%K/K/F.Z76C$8WU..Z6H*W)E2 Q3J!#\0=E7MW_ #E? MIWE:]LOR-N/-?F*\\L:-9?FGI7UW6;?7+K0U@6:QU$%WO;>XMRI!%$8N"M:+ M3E0JO,M-\XW)\P^2]5M?S$U6]_,S6?SAU7RQYL\CRZ__**Y\T^8+ORUHME^:? MEI[W6K76KK0UABE:9"\EW;SVYC*UJK2^6;6_\ *EEH?GK1/.OF M$W?F#_G(O7_*TFE2:K,VCC2-0\W:I:W,"Z\8VMQ)'%)Y6NK=; M'0V@G6.23T"G *8*D2<65?1_Y]:U%9W_ .4>BZQYJO?)?D/S/YCOK/SYKUIJ MP0@%94$G]T>0?B57S[YB\R^4CJ?G.P7\]M>E M\H^4?(4.I_E)K;^;KO3'O]>:^UN*ZM1>P7%JVNB 65F@]=K@A2I9F,[-(JQJ MZ\Q>?+WR+^??YIZQ^8?FJP\V?EEHGE+5/+>APZA+8:98:G<>4M)U"]>XTN'T MHIQ-<3LTEO,2,TA=5ZA/YDM]%_/1X]7_,;4?,4NI>;X--TBV\O^:IH MI])2::.W32M3\D7#FWGMR9!&;RW@ED$9DNI&@],3!5@WEGS?<7]GY&U4_F-J MNK_F7YPUWS=I/YJ^2;C7;JZ@L]&MM+\Q2P._EUYVM].5);*Q E2"(U8+R_?, M'58;^7OG75O\.>0O+&J^?=3\N_EU<+^5VE^9KZ#59]*CTS2+G\N[O46$>HQ2 MQ2:>L]_;6W*1)4+L1'R/J%651N@>9] BT/SGHNG_ )A:GJ%OKOYN^:D\O^8K MGS7<>4M(O(]/L=+'JZQYFTZ)+HF)&$<"1,6NF/J.LRH\RJJGD_S!IWGG5?\ MG#[SWY[\\W5KJ4R?F1I^DZG:^8;^RMKZ72=7BM=,MP97M);YI8X41O7C]:Y4 M?Z0C$LN*I/Y%\]?FZOD>[\ZVGYEZ++YUG_*7S!Y@U_R?9>:M8\V:U<>88]'2 M[M7?RYJ%I]4T66UO"Q>U@"KR/U=594"XJ]O_ "IN/*"_\Y'K;^2?S$O/S!MD M_*5Y[UKW7I?,HL[F;6[<.L>HW$L\I]0KO$9F5.(XK'S/)5BOYJVC1(52L?PEY"M#(] M54U\^7WF/3S_ ,Y%?F+#^87F>#4?RV_,WR]HWDO0HM4FCT:PL[S3O*OUN)]. MC98;I9_TA*Q6Z$JHS5]4U73UMM,DYVT* M'U90I$KREY"RK,(/,WEW2-#_ "HN_)'YUZYYB\T>:O-'D2+S[H.XGN6L>33O"8$:))%9@T3^DIC52[SG^95WIGYS:#<^6O.UQ%&15F MGY]?F3IGDS3/-&J?EG^9NH75Y^76@VEYH&JZ]^8&JQV\SR1B:U;2=.MA=?XD M)9N<\E^9(:GT6E"1RK$JE4ETGE:;\S=-\G>>VL]5U_\ YR!U33_S"L=;\\:K MI-I8Z,-)OK^"6XO[:2XN-(6>[@B5;B)$:8B.V9S&_'%7H/DV+S=YL\T_E+Y& MUK\X[O4?+.L7'G^XND\C>:=4NDFL-.31#8V$GF*:.WO[QK66Y=_K"NK_ !>E MZACYHRK"?,OFO\P_*/Y+^7OS7\L_F!YJU+\P-8\S>=_*EC:75_-J-D+#1K3S M2NFVT>DL&MYYTDT>W)N'A>[D8-SE?FP*K(;'6_-^B>0O^6&LV]I=/'JRZIJ\*/9$*H5(HGH6'J<=JXJDG_.0>DK MH O/(VL?F)YJO?*NJ>7?*'G'S'?ZQYCO$D&IQ^=]&LI+U+D31K8Q>E.[&*W] M*W1N+K&AC0JJ]"UWS+H/ES\P[)W_ #9UCS5H7U_0[#RH?+_G6Y?5],MIK>T2 MWBNO+=S++;Z];W!D]5[_ (7%PXG8M06ZRJJ^[K:\M+N,3PW<5VB33PR2VT@E MB6:&1HI8_A)!,3J48'=6%* U&*OR_P#(_E#RE?\ G'\M_*NC^?=>6XN/SE_- MV'S7';>:;RYU.R2";S$(X5DEN)9]/:ZC4O))"8II#^\]0L>>*IQJ_G+SI=ZA MY3\HWGG>WM?*>DWWYFZ>^I^9O/&L>3/4D\M>;(M(T:*;S#IB2W=W<)8^H#%/ M(3+1IY.9[/SAYADTBV?6_--@'2UOIRM7F@$L< M#E&IL612P^(C?%7SO^3GGK\JO*'Y0W_DK\RM8T:R\Z:?=ZS9_FSY7U$*-2UO M6Y+B07TPLI$6;56O:KQFC203UHA)!4*O/=*\VM#JUGJ=EY[UG3/S(MOSELO* MFE?E>VL7$,N:#YRNQK]PBRZ-:V/F#44M+2$$Q6C\M,A3ZW J7@0, M!<*6+8JQ71_-\$WYE_FCY*\]_GAYF\O:!Y$TK5H/(&E2^:KO3?KEUI>NZC;V MQN=3]6.XN;B) B%)+@M,I_>K-Z2F-5G'YB_F%JEUY)_*^X\R^:[[0_/.-I4]55B-AYQ\[^: M?R[_ #H_-K4_S&\QQ:]^7GY6>3O.?E73[#4Y+#28=:N?*8U:>ZN;"U:.&>.: MX :2WF#V[ ?W7Q,2J]NMO,OG?_E8(_YQYEUW5SM=R+8L3'Z1M5>$'U!RQ5F7_ #D7IC:W+&=$UIIDBGH3$9%#)S2CH&)C9) KA5X=K/FQ]+LO-/Y?ZCYWU\0^7_ M ,RM4\N^3KC5O.-]Y>LUL[71=)U$KKOFV/U-2I%)>RF&,3-)*75"KQ1?NU6, M_E]^9D_G*T_+M_S+_-O4?*/E&#RYYRO-%\S:5KMY8+/JNB>;KC2=.5;RX2WF MU5X=/@6D-Y%(;BGJ3V[NS55?6W_.*DIG_P"<Q'W8JAM*T+2M%MWT_1-+M M=$LWD,LMKI\$=I&6V!7T>HW.BV-UJ<4'U1+Z>V MC>9+=J\HED*EE1JD\:TWZ;XJJ3Z)HU]83:=>Z19ZAI5\WJWEA/ DT$SEA)S> M)P58EQRJ03RWZ[XJD&LZ1Y62ST87?E.UU2TTVZMK+2;.+3$NUL?7E2)72+TV M%O$GPM(Z@!57D=EQ5.9M&TDZ@=5DT:S.JW/IPRZI]6B:ZD1&$B)ZK+SI&R*X MJ2!Q\0**KK?0-'MM2N=:MM)L;76;] M[JL-K$EW*@*,5DE">HPJJU!)Z#IMB MJ0V]OY(A\PZWY8L+#1;;7]4TY=4\R:-#;0QS75GZIINE#2;?3HWMGN]8U&WT^S!M$0H>5U<1 MU8K1?M'I7%686EK:V8,5E;Q6XC #P6\2QK1%5*<$H*\5516M ,5>:_FQ^97 MD?\ )GRIJWG?S'I[7,FG6MY?:9H^E6R7.JZA+;6[3SK:0J 6;TH:R.65506[#6/+L>MW][?ZQJ.B)Y$T_0;T^8H-3TOC+J<$^CK& MEQ&T F220E:<9$>K"1257K_E+7= \Y^6K/6-"0-HFIR7<%S936P@DBN(IY+> M^M;NW=08YHITEBGC9:K(KJW?%7G?EG\P_(/GOSK6]MK$L/"D=Q'+&.#T+!N.*L@\]Z_^67Y;:1^EO.D>EZ/ MI7GC6M/T*\U"33TDAO+W59O1M([S@AYAY&XEY=JMN17%49=>;/(ODOS1Y&_+ M'U[;1O,'G5-4D\D^5+*V,4E$D8D7DQI5G 'Q-BK#KKSM^3M MKYDLI-4\OPZ9YNNIO+S@WV@&+4(9_-M[>V6E&5S!ZD-5-"KK0]\55K31M*LA M;Q66DV=K;V1C%M!#;)$L'IQF%?2"+\-$)4 4HIIBJG6*XM(I(UN14"8*RM20CV%]J6F$/I^HW-M%+-;-7D##(R\XRK $%#UWQ5*[;2? M+OF&VOM2D\H01?IJ1H-7AU+38X;FZ-G,T:?64E0F2/E'RC+U!4JZ]CBK(+'2 MK?3;6WM=.LK>PLK1>%GIUHBPP1H37BD: *HJ:D@5Q51CT/0H]3GUZ+1;!-;N MX_2O-;CMHQ=R1*JC@]P%]0BB**$]@,57:GI.G:S:R66L:;::OIS\"MG=VZ7$ M3./VC'(&0^QX^.*H=/+NAQ:K+K4>A6$>LW$7IS:REJ@NV0!4]-I@H=DXJ!3E M0 =,506O7/E26YTSRQYF:PGE\S2SQ:/H>HQ).+][2$W4PCCE4ARD:ER*; ; M8JG(TZTBBAB^I6T4,0D4 #X@37D!7]>*H2T\O:)IU]=:E8Z+ M8VVJZBK"_P!4BM84N;@,P8F:5%#2"M">1Z[FN*J^H:58:M9RZ=JMC!JU@S7X(KO38PME M>:3.5+.XLX7@#1 (C^DZ%0RH %^& MHIX;8JEFKR^4(-7T'1=;BTI]9NC>:MY9TVYMXY)WDL2DMU<6RE31HS*C%E^( M%@=R<50_D:X\GZ]Y?TC\PO*.G6D%C^8.GVFN6^L1V2V=S>6VH1K=6\EQ1$D+ M,LH9A)OR)KBK(-/T/1M(0)I&CV>E0!69(+.UBMQRE(9R!&J[L5!(\0#VQ5C' MGGS1Y6\C:7^F_,EK)B<6EC9?M#@N[;CB/ 8JD>A#RAYEMK+SQ MY?ATG5H?,EO;W5GYHMH(G:]M@JM!()^/-A104JQH *8JGT=C8PI;"WT^&$6( M(LXXXT7ZO6/B2@ '#X6H>)Z8JEUCY8T&PDN?T;Y=TW3OKM13_ &U4H_PKH)O-2U(^ M7]):_P!7@>VU:]:PA]:ZA;[<4\O'E(C<5)5J@T^Y5G\+* &WMY0RR0QMP^%&#D%5H#4@UKBJ4:5;^1_.6EW6N:/9:+Y@TOS)*T.I MZI%:P3)>M83O RS,8CZWI2Q,*,/A9?;%626>DZ=I\=G%86%O9Q6(*6%O%!'& M+6.2G-(U0 (IH*A0 >]<50.JWGEORU86^I:O]2T;3HK^U@MIIHU1$O=1N5M+ M8)\.TDUQ.[-)3N<50VA:9Y:@BU[3-'\I0Z'9174EKJ=FNF)907K>DC-( MBA%2>-EDXA]P2&7L<53B\TG3=0CN(;K3;2\CFA:WFCN+=)U:/GR]-@R_$O( ME3M7%4!_ASR[!?:??)H>F)J&D6R6^E7@LH!+;6\8*+# ZJ'C5>1"JI H: ;X MJI^6O+&C^4]*NM,\NV?Z/M+O5-5U>:)FDE'UW5[^?4;Z4O(Q8>I<7,K4!XK7 MBOP@8JC8/+VAV=U<7UGH]A9W=Y-]8N[Z.TB2668J4,DD@4,[$,1R)K0T\:JL M7\T7/DBWU+RCY0\T:;97UYYUU&]'ES3Y]/6YMI;NTM)[ZX=PT:C9:M=Z/97FIZ: MA MJ-Q:PRW,*@EE$<[*70*22*$;_355I="T/]+_ *;.D6+Z["GI-K'U2(W@0KQ" M^N$]2G"HZ]-L512:;8Q10I':P!;-W>V*1*OH,X()0!2%)#$&@%03XXJ\T\P^ M2_RZT+7/-'YL^:Q;6=E#Y?M;36SJ<<#Z7;6VDW-Y?B^:)XJB8->R_T%I[WRQ=136FI:CIX:)99HQ(LMC/*K&(NAG=I"\S/)4\0_"BXJS)K< M2R0M+ DH@E62'DG/@X!4NI8&AH2*BAI7%6 6VM^2?-^O^:/):Z/^G6\LSQ/Y MG>73/4TH:C(D;BW:YF0PR74<3Q.R@EU1D/0XJS&?0](O#;_7=)L;T:?<&^LE M>UBD$%X7+_6(2RGC)RJ2P%:[UQ5,K2*& 0P6Z1)#$O%$C 10 -@JC8"@V [8 MJF.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O\ _]/[^8J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J\B_.:]M=/_+3SCJ%WH.I^8[.&RK?:)I5Q-9S7,3/& ML@,]N1*D 6K3LBLPA$E%<_ RK\R[._TZRCUO2K75O4_*EO.WY87*3>0]*US0 M]'G6]NM+B\N[F[K';10W__+G3M,_,_4O)>FRS7L.F3:3#YNT/_"YDC#*LL,=D5DLUEK15 M#*-L5>=>39/R^*?EN=>2^7\QA^GS_P Y:&,:A^E_T:-(U/\ XZ9AW_XZ7U+@ M(CR];TN&*O0[Y?-\?^$!Y^'FO_'DGG?R0?)IU$#_ )0X>9]-]7UOT?\ N/KV M\?Z4Y_$3P_W1PQ5(O(GY7Z+J/E'_ )QUU36+37FU7\Q?-^NZ1^9VJ3W^I)=7 M^AQV'F.\CTF^)DJM@UQ:6H]$@(0J)T-"JA]<@T'3O*MWY(\V:=#I_E33OS+\ MVZ3Y,U3S?!J^H>6-'LK.6U^I6OZ-L+FUFNYYE:1+%3*J*@N7$M5$4JKQGRW: M7+V=UKTUEJD/_.0.K_D3K-I^4^KO8ZA9ZNVLZ=JGF2UC@LX)')AEALEC002/ MZB1A5Y,?BQ5Z7H'EWRW-Y>\TS>2_.6C>;_+%QYD_+*&\\L^1/+FLZ-H<%POG M;39)[R2>^U+5.=VT!HXC9>$*J[>.*O<_RRMO-&K?F/H?Y3ZN]_%Y=_YQLDO9 MH-9=W#ZMZRM:>6EN6#!_]'TZXF!]1Y?K++ZTGQ@$*HW_ )S7@\O1_DKYUUG5 M[;5-+OM.\K>9X='\_P"F)&ZZ4;[3'C:TOU?U"+34>*V\A,31JWIEC&XB<*MV M?YJ_HK\N])OO/6I:CY/LM?O;VQ\J_P#.0EEI%BC365O!:M9ZM>65U;7"6LNH MQAH(U-NR2+%ZJK&DD2(JS_\ (/4K/1/RN\LMK%RUI_B7S1YB&A7UQ')$^L#4 M]?U*[M-1,=!Z;ZI"1>T1$B'J$1QQQ\4"KP;\BKSR[I/G7\M/)/Y4>WDVCI! L5O;W$<_*SM[X:BX65+0U8"0[Q[XJ]H_YR=\O0 M^VN5NH'NDJCJAB+AU=EXJP#>&*O ? MRRLO.FN_FM^27GWSWH\NG^9;+6M0\B7$$"RR6L-OY5\JZE!?3EI&D9&FU>YN MHC)S].>.&VD2H*NRK O(EEKTVF_E1-=Z?JDEU]2_(AKV:XBN'EK#YK\U//ZS M2J7K&K@R[U>^\ MJZ+=:M=7A/UB6YDLH))Y9@P!YEV):HJ3BKX@_+GRG>Z!Y0_(;SOHEIKG_*P_ M.?F/SAI'F?6I+B]FOKC3OT3YJNK*QE:7/+6M65Q/YB2"UN8I_,5[<:I>Q2WMI=0 M3^BD<,9DD:=E% 5Q5^LGY;GR1_@SRZ?RV-K_ (%^KG_#:V:NL/HF1Z^GZGQ4 MY1M-_,+S*++\P=)U37M!TWR7YGO++2=0GU!;&2]7SYK@ADDA MYJLDL]C\HV/YP^: M=+M;K4_,7G?7M0UZ*\\S>6X]5T[\P_+L4\%RZO<6[++9ZA8P1E%M'"QTC6T MAN3^\Q5XY?/HO^%[[0?R^/EZ/0+36]"D_,_\Q?+]MKTGE>YT@W$@N(_,N@3W M44L,JL5%(+R0R*KNTD(/HXJRO3?*WY;6OF'_ )QSU_S3K.D^=?)L?YA>8XO* M6M:?H>JZ1H&EM/H-NEK8Z7'=W=_*T#ZE 9/5:;@UR\J"G&F*O3_R);R7I'YP MIH>A\?.?F.Y743YA\\VRZMIOF6T(1VE@\Z:==UM9F:10#<1NG*Y9 MI$JF0J MO=?^S MU*/_ )R'\Q?D)9_\J^UB2TOX-8EU*RU'S-:WB6\3-\$D-BD2O"S^HL85>1/Q M8J]3T/2]$L_)?G^_\H>=],\R?EK-JODF'SMH?D;0-8T3R[::5%KT;>9+FZEO MM2U)I99=*D9+M(V7C:HE1N#BKZ _YQAM_*R^ M>=+@F2.#S+8:3J<\5Q($U-OT=)I<0:&JJ[3\C'RZFN*O/_R,\DP_E\/^<0[_ M $&PU:PU#SS^6ER_YDW,DMW/->SVFAZ;+9PWQF+;_)^I7GGO3)?S(L_+EPWYQ^3]&\NZS;:I<:Q/;Q"Y'FO4KS5+NW:X MMKOU*\88_4FYE H''%7T'_SD[Y(\N>?+?\C[#S%Y?3S%8K^:6CQW,4L),6]$KQ5N(!+;#%7BMYYALY8/)WY1WDFJ3^:[;\^]7NO-'EU8;YGM?+6H M^8-;GLY+Z8+PCM+BRN(/2Y-Q*/&HWV"K#_\ G&[S-^7?Y8Z9^1FM6GJ:#Y47 M\N]4\M>:%M[6_=)//,MUH4ITY[=HRYOI(('XJ%J:,%]U4P_*SR?J?F?RC-K= M]8^9;KSKY5_YQ\\H7WY?Z?<7%]%);>89'\V%;B.WF<(=1C81Q\G4R(&"G9L5 M9M_SB'I6FQ>:FU#1?/N@ZQ<)Y0$'GSRQY6\N:OID7Z6DGLWCN=;OM1U34$DO M(BEQ'$J)&6#W#4HM J]K_P"K^6C^0HO^A>%UD:J;7_$ M(O\ 5Q>G0_4JX4I^CC'MQX>CZ>U<52N_\HZW>^1O^1/*_ ME"]\GW5[/?-/IFO0^4=-DNKK3X4;@MT;K^]9%)+HH;[-,5>AZG'Y(TG_ )R+ M$1(V^H2(#97^CI"S/*K?5^%FL_P =TQ]/ M%7EOY ?ES^6VNZA^3GDZST&X@TG2I_S1/YE>6[9M0M+5M4MM8TT:;!JD995E MX6Y22)')4E5=:E<5>@^5O.$S1_D=^68N=;;\PO+/YL>:;KSKIP@O'DTZUN;7 MS;/I_P"D;@H8D2X6XMVMU=J-\/'[(HJ\CUC2_P @]7_(_0H]3TRYU'\S=)/D M._\ S\!CU9UAU&'7='779O, C_=&=7DNZ$@D'URF_+%658"?/8F/_.. M!_,+S)Z_UT7WZ&$'^&?+I\N_"*MP_OO0_9KS/VML59UY=\IGSO#_ ,XR^7/- M%IK.H>1[S5/S-:/3'FO8;.Z\NI=W+>7(KFC(SVAL/JS6ZRFA58]JC%7TY_SC M^)XORSCTZYCN8XM'\T^;]+T:TF]3G;Z9IOF75++2X(S,.0ABLX8HX23]A5H: M4.*OCO\ YR*U&#_E8^LW7E^V30OS%\MZQY:_1-QER^7OS&L8-9?SYJ/_ #D5KNBW MVM337L\\/EV?S;J\36,22,RPV#P*&"*HC^)G'V\58?\ D[!Y;F_,+_G&"2"# M6)/S>M+KS!_T,%,R7[QQZRWEV_1CK+N#;"],I81&M:>L%^&N*OK7_G)(R?\ M*O=*>Z:Z;RHWF[0/^5BF#U/2/ED7B#5CV*OC[4KG\N([WR MR@EU*+_G&RX_-NZC\NP:4VH+I4FBK^7]R^HJ5@/K-8_I43FY5AZ?(.6% 3BJ M7:S;>OH7D1=?UO2/+OYOS$/E.Z\Z:3JNK^7WLOTGIA\JI!;V.H:;*CFP- MZ;1Y)"OHB8<:L"JKUW\M?(,&I>=-/F\UZGYH_,>+R)^4OEK4_+6HW$.H:1]9 MU/\ 37F)X[J#39K@JEW%"L<=L9':1(V6K4>N*OE?S-9:1Y@T'\U=/T31K5O+ M'F/\H?.NI^8-6N[J9-1U6T,LTA2*")D=I#216 M#8J]NO6\C'7/,AA,_P#T+5_C3R>=;"_7OT)_AO\ P=J7HE@ 6]#],?5?L_[O M]/EBJ+\A>3='\^>>?(?EW4;/5=2_)2;5_P RIO(VE>O?6^D7.A1IY=_1T3(& M3U;43&X>%)33U%Y*/AQ5]??\XTR:FWY.Z!%JQNQ/8:MYDT^SBOA()8K&RU[4 M+:PA E^/A%:QQI'7]@+UQ5\M_P#.0#Z#_C?\[CYI-W_C\>4K'_H58/,ECJVM:(;OU45-.L=%TF[LGN=3N"U$+2IQC#4YEN.*OU?\B_R:U3S5Z[K5_%I.DZ7!)<7NH74@C@AC4 M(\?D,5?-US^>H]4,5J=2N;G5(X(GC0 M*RF!["I5BWJ>H/AH!55E.K_F)^0FLV?D'\T]7_,#19++RW?ZG)Y*\QR:CZ$$ ME\VGW-M?1JBE?5=;5I3Z94D#XPO0XJG'_*Y?*5UYB\L:;8ZE8W?E7S/Y.UKS MHOGN.]06<=OHUWIEJ\1#)MS&H\BQ8%.!7C4_"JQK7_\ G*?\C]!\J6/G,>?[ M#5_+UWYDTWRI+>Z=*KBWOM290AF$C*5CCC)E=J5X*Q7DPIBK.+;\XORNNO-% MMY%M?S!T:;SCJ 62VT&.X!GE]6'UT7C0CD8Z,!7E[=L58_??GSY ?S]Y2_+K MR[YATWS-YA\P>8I]!UVRM;U&ETTPZ/J6J&22/BWJ#EI_I44CB7J3MQ95ZSL_G+ M^57E[3M,UC6?S$T+3=.UQ;S]#7DM\@2\-A/':78MZ$^J8)I%23B"5)W]E4'I MWYW_ )0:S_BB33?S-T.\C\C6\]_YHDCO%,=E:6W,3W$SDA?2B"$O(IX@"I-# MBK#_ "GYD_)S2K#\WO-_D+SII'F;5]/>]U3S]K>JZY+)'$]G'*\27FH,MPUO M9VR!U0QQND4?+@IZ%5ZE?^;/)SZ9K3ZGJ^DW.G:;J,/EWS"+B:)[>+4+YH(% ML+@&JB28W<2!&'Q>H@/VL58O/^>WY-0ZEJ6CG\TO+R:CID-Y/J5M^D(N=N+& M>2WNPQ!H'AEB=7CKR!7[.*LV\K>;_+'GK1+7S'Y0URU\RZ#?.ZP:E92F2-FB M;@Z;;@AEW!_5BKRL_P#.0?D*^_,+RIY!\LZ]IGF675KO6;+S%=6M]&!H[:19 M27C/-&4/-6,31\@P5>M3MBK./)?YJ_EM^8[ZG!Y%\XZ5YIN=*"C4HM.E]1XS M-4 LM*E25.^X\<54_-WYJ_EK^7UYHND^(3*NQH6X&H4&M M/?%4!IGYV_E%KEY?6.B_F9H%]=:9IDFKZA%;WR,(K&W7U)9R]>/"-*E^ZTWI M0XJR:Z\]>4;"PT34K_S+IMA9>94:3RYJEQCZG-J'*V>1@K 6L$LU:_8 M1F^R*XJQG2?SN_*'7O+U[YFTG\R/+][H&G7UMIFI:Q)>)###7M7\Y_F!Y8T4>89KN/26M]2-Y:SM97,EN_HSF&% MCQ9.,A9 %?DE3QY%5-]7_.7\I_+VKVOEW6_S%T&QUJ[N+:VATJ:^C:X,E\BR MVO( GB)4<%6:BE3UVQ5#?G/^;_E_\EO(EWYT\PRP"%KZPTC1X[N8VL,VH:I< MI:VRSSB*4Q0H9/4ED6.1EB5V6-V 1E6M(_/3\LKW4?+'EB^\]>7(?.OF6PLK MJW\O6.H&Z5WO(!.JP3/% 75AO&72-F7B2BE@N*ICJ'YL_EGHGF^T_+_4?/FC MZ=YPO^)M/+T]TJW'*128EXGX4+!20K&I[#XA55A/E[\\K77?,L7ENF@0QM9^ M4;NVUQ=;>6RU/_%=KJ%U&FDN;)6NF1;"L7(1^LC%_P!WQXE5,/RK_P"<@ORK M_.6?5;'R%YMMM2US1Y]3AO\ R\TZ?74ATW49=,-[Z(+'T)I(0T;#JKIR56)4 M*O4[#S%HVJ6%]JVGZU:7>FZ==WUEJ%Y%.C0PSZ7/):WT4DE>*-;S0R1R D<6 M4@],58-Y?_.C\I_-UIYBO?+/YD:/JMKY4A^M>8+R.Y7TK.+BP]64OQ 3X#N- MOI(Q5-O)/YD>1?S+T^YU'R%YLT[S/:6,_P!7O[C3Y YC8@.(Y8WHXY(=MO&A MVQ5 7'YR?E=:>:;GR+<>?]'M_-UK$S7&@-<@3IZ(C!) /+VKMBJ0?D M/^=&C?GSY2NO//ET62Z(VH26>E+;7KW5V+=41T.H1&W@2VN#RY&*-YE"E3ZI M)*JJP'RM^=WYM>:/)4/YH6_Y3>6U\@3PWE_-]7\X7,FN#3K*:6.:2.RET."U M,_" LL;7:J3\)E'7%7I;_GI^4:3>4;&Z_,'3;"]\[Z=9:GY7TN\G-M=7-KJ4 M8>TD*2 -&90PH).)^[%4TG_-K\LK3SHGD.\\^:1#YXF'"W\M27*B<.R&0)\1 MXAB!L":]!BJ"T_\ .[\H]8C\TG3?S)T&YA\DV\M[YOEBO%XV-M;\A-.[GBOI MQE#R<5 ZU&V*H)_^\N:2]_'+-K$4%G:W:W4:A5 M$8E%R51&)Y4JK&NRK,;'\V/RTO\ S=>>1+/SQH]YYRL^37OEZ*X1KE3$JNR< M>A9 XJH-1X5!Q5,?*?Y@^1OS M[RX\D>;M,\UVVE"V>^N],N5NX8UNX5G@)D M3DIYQGD*$^_?%7F5W^;?G'1O,7EX>8/RZA\O>1/-/FYO)OE[5Y=5D.MR7GJW M$$-S/I+6*P1VMPUJ\D;K?.YB:)_3#,455E?D[\T)/.'Y@?F;Y#D\J:CH4?Y> MPZ3)!K&H,B?I5-4DU"%IH+4_'' DE@ZQO(:RCXU7T^#NJ]%UR\?1-$UG6([& M_P!:;2K&:[31K!!->W9MXVD]"V1F4/++3@BE@"Q&XK7%7S1K'_.0?F;R/:ZE M_P K0_+V#0]0D\JS^;?*^GZ)K#ZF\EM;7NGZ=+;WYN].TXVTRS:K;U5!.O'U M?B!55D59+%^;GYB65QYF\IZK^6%I??F7HJ>7[FST70=:GU#2'LO,UW>V5K=7 M>HS:9:SV\=O)ITSW16SD$>)OS# MT'4;^[TQ=!UKRYKNI>7/,FG071O+==0TFX:WN?JUR8[=I869:HSQ1L1U13BK M$?SO_,?\Q/RI\L:]YT\M^1=!\Y^6?*>C3ZKKSZEYBN=(ON<)9FBMH(](OXY/ M@ /)IDWVX]"54@U?\]-2_+_7O+>B?G=I?EG\N[3S)I^N:A#KVF>8IM4M(H]' MDTJ(1/\ 6]+TUVDG?4B J(W$)RKN>"KTWS'^;'Y;>4_+ND^;O,?GG2]*\LZ^ MRKHNMRW(,-T9$++Z)3D6VW) V[TQ5E%EYET/4]$M_,=CK%E=>7[FS%_'KR7" M?5/JW'FTWJD\54+O4].].RK%O)WYL_EGY]L]4O?)GGG3/,=KHB\M8GMK@$6R M%"WJS%N/IIQ4GE]D>.*O,-:_YRW_ " T2+R]>#\QM/U.U\P:]'H'UBSG5Q9S M2V\]UZMT'*NL($/'D%/Q,JTW-%7LL7GGRA+::5?V_F;3[BTU[5Y-"TFY6=/3 MN]3ADGAFM(CL'E22UF4H-P4<=5(Q5YUK?_.0WY7Q^7_S+U#ROYLTCSCY@_+; MR_K&MZGY;T^^43N-)MY99(UD"O\ M1\>2AN/6AQ5ZD?,FEVGEF'S1K-[%H6E M0:>P_G_P#DM/Y8O?.,/YF:!_ARQN4T MV[U=+D&**ZD4.D#*:.20:@<>E??%4WU+\V?RQTWRYHGFO5?/^BZ?Y9\QI)/H M.JS7JK#>K%$US(L-35BB(S% .0 ((ZT50^L?G1^5>@>7-$\YZQ^86BZ?Y6\Q MT/E_5FN!Z=WL6_=<0S$JHHPXT!V.]!BKS"/\\O\ G'?SWYYNX[WSSI]MK7Y' M:Y%+I^JW%_%!9O=ZSI4=D)X9$D].9&35C:CG_NZH4;*V*O7[/\S_ ,O+_0-9 M\VVGGG3)?+>A00W.N:ZMT@MK*&XMX[N%[AB08A)!,CCE2JE3W%56.>;OSZ_* M'R5?>8-$\R?F%I%AY@T&QN-1U'0A<1B[6.UMWNF7@QX>H8T-%+5;84W&*N_+ M[\\/)'YFZ1:^:/+?F/2O\-77EFS\R.TVH*NHV27#SQR"]M63THHXC"R&03,# M(LBT'#DRJ-T?\\/RCU[0;_S%I?YG:%D2:UY%\R6/FG3(Y&ADO;&3U%25*563E\2G MN PW'2N*I;=_G!^6FG>H64]M>I!?6TT5U!=1++;W< M#AXI4905="I*L&4U!!Q5,<5=BKL5=BKL5=BKL5=BKL5=BKL5?__5^_F*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O%/SU\HZ[Y\_*WS%Y9\NPPWF MM3RZ9>Z?932+'Z[:7J=KJ#1B1Z(KNMNR)R(7F5Y,JU8*OE?SW^5WYG_F7YE\ M_P#GJ3\M=2\AVNH:A^76JV.EZ?K>DVOFF_3RO/K1OV6ZL[DVUM>A+N%(6>[* M-"$!F5N44:J#N?+&H^1?-'Y':S:_EIYEU/S'K_YD>8/,5SY:\X>9++6/,E^U MMY,EL!>>QBGCBLT%O$+OAP16::)W=$55/,GY ?F=YN\M>8K:+1$T6Y\V MZ#^9TWU66^MEN=/O?-WF_1]?TZRDD@>5!;-*UC7=2TWRMK*TDC.&10B,ZJMY>_)GS-#^85W)YF\G>>[[3-4_,F7S[:W">;[2T\EV M4E:W;0G2;>.22\:*66]@$XF6!@PC(BE7 MDT:KW+\P],\UZ?\ F)^6WYB>7/)]UYW@\K:1YCT/4M#TZ[L;6\637)-*E@N> M>HSVL)@B&G.LH60R M&4C<5XJO'ORM_*;\P]&F_YQ_U+S)Y5T^UU3R%HGYD? MIU9+JWO8=.U/S)J=K<:>L,J /*LL(F4R1("$J'"%N!5>.>8/R1_.SSG^F;G4 M/*.LM?R_E/Y^\H75KJNO:8=$;6M:L+&WLK?R_I%K/)%9ZMV?, MA&*3F6>^0/PY$\RS?M'%6)Z]_P XX>=M=\F?FSY'DO$O='T#RYJ7E3\@EN9_ M35;+6I8[^ZFDE629Q-"J0Z?$\J\T$,DB%8[IE"J'C_)G6_,%E>:I)Y \YQWN MI>:OR[&K/^9/FBP\P7USHWEGS*NJW21P6]W?6L=O#%++(!ZYDEQBFG^KH%1@2T>*O-_(OY=?FE^5JOJ+_ES?^:Y_,7DO4O*,VFZ-J6CK M=:=1PP<,@VY*KM)_YQ^_,'0/RJ_YR$\H) MH5A>^8_-GY4^6?)/E:_LY[<)J5UI/E5M*GB66;TFCA%T6"^L$!!)H-\5?3_Y MS>7-=\U^1X=(\NV376I1>;?)^HFW65(7^K:3YETO4+J17=E%8[>WD?KR-* 5 M(Q5\V_G#^6WYN>I:/I?GGRIYO\ S+T%ORJF\YZ)^9'GF/S1 MIWFIKW2XM%LK5K'3;5A>Q7$YOO7@DT]Y$$=G(I8Q4D6K-&J\.\D?D1^:FCZC M^4LFI>74AC\J6WY0QZU(+RT?TW\K:)K=EJ].,K<_0FO(E'&O/D2G( T54O.% MG^8?Y?>1Y_-$.C2>2_S \D?F5YND\F:YJ-U8W=MKFE^>M=U-X/J=M:7$\LRH M]]:3R1W42,G%V56*XJ^Q]'\FGRA^5<7D3RQI]A>WNC^7I-,TZQUMY+BQO+SZ ML4#:A)Q:6>.XFJ9W(+N&=OR^\R>9-&NORXU/ M1;[2/-WFO2ZW6NS:KI-]PT>UTZ2ZM]+@*V1EMV5@"\:+*L'IH[JOHW\DK#\P M87\RR^<=)UFVT98["T\I2^<9=)N?-'I0B8J]\_(#RIK_ )+_ ">\A^6?-%K]0\P:/8-#JEH) MH[C@YGE<+ZL3,C;./LG%7S[^7$7YO>6_R7% MT1/KUQ=".\=XM4FO1"J3ASQM&DVH(R<58%J/_.-WF72]2\P^4K_0_._GSRQY MNT7RSHGUGRSYJM_+/EZ>#2M"L]$NO\06CW:W0]8VK,YM[>Y/HLB#DXX8J]DT M7R]Y\\O7WYG^09/RO?S'I7Y@>=-7\RV7G>:_TR/0K2VU)H9HWN())GOS<6S1 M<&_*WS%Y.;R5YVN_._E_\G]<\A:%JGFOS=8Z MCH\]UJ5A;6DD.B6"7=RL=O=/9K1[L6YCC$:\26<1JOK:7\OK^+\[=0\XVGE^ MSM?+L/Y6P^4_+MZ@@C>WNQJ5S.UI!&*/%'Z)B)*T0T4?LBBKY6_*W\GOS:\M M?EL?RJU7\LDT^?S!YJ\BZ_-YZ@U/2IK6UM_*T/EN6[BU"-)Q8/*GG75(?+OGOS+YQTK7I?-EM_@NV_2E]JE MU:S:?HL-S)=/.D6HB,Q2VD2>IZK^I\*&15]+_D/Y*O?(GY(_E-Y,U;3(-#UO MRUY2T>PUO3;7T3'#?PV<:W@#6]8G)GYEG4D,Q+5-:XJ\5U_R=YZ\V?FOY/UJ M]_+(Z%YF\G^:/6U'\T[74;,Z-?>5+::\DMK&&T:^EO/K,L,T*R\[*-1,)>$H MCX,RKV'R]Y8UJR_.S\SO-UY8\= \S^7?*5EHE\9(Z27.DR:TUW&T8;U%X"\B MW9:&NU>)HJRWREYYM_._D30?/6CZ)J(M?,6CIJ]AH5RL4-^1+'ZD=LZR2K&D MK=/B<*#U8#?%7R!?>4OS4_-KRC^;DGFO\K-9\E_F-YTT6PM]'CU;4M#FTFSL M-*U 7EOI%D^GZC>3>O+SDDFN)88EEDXAN$<4*(J]%FO?S:M=5_-S\X=%_);5 MF\P:QY8\L^6?*?Y<:IJ>B)?W-UI5[K%Q/>2S6NI36:6H75DH/K(E8QR#@M49 ME4%H.D><['\L[S3[K\H-=\SR>9_,&HR_G%Y>UN_T2+7=;BU2VD>6[TM[+66L M(46[>*-8IKM#';1NL8++'R59_P#DGH'F3\NOR_.F:CY6NK)-0\T:A=:%Y3CN M+2:XT;1M2U FU@NIA<-"[VD+\I?3FF8T(C:5J553G\^_+FN^=?R:_-+RMY:T M\WWF+7?+][I^C67J10_6)YHPJ+SD<(O([5:/*.HZG^>'Y1^=!I,5]H MGD_0_-]I=ZE)Z)>QOM7?1DM&B60B0&2*WN%+QC925)H^ZKY;;\EOS#TKRQ^2 MMS=Z%YKDO_([^?;77M#\AZ_8:1KI'F36HK^RD6\GO+.V>V,5ORF3UPW-HB$; MBW%5](^5O)6I>6/R-/E/RWY4M++S!^B=6;2_+OFO4I-;@_2.HRW-UZ>L7JH6 MN/6FGK<<.8JSJC.H#E5\TV7Y(_FAYNO_ ,[[O5-*\RV"?F7^3VH^3=*U'\P- M?T_4KDZU>S71:MKI4MW;V%JQF5U2W9TX[<$XA"J]'\[7GYJ><)_RZ\UVGY!Z M]8R?E[YOTW5-2M;K5O+GZ;U"TCL]1MIX[<0ZF]J88WN(W/JW:,6K2,TY8JDV MF>1/S2MYORR\C_X EFT;R+^;VJ^>-=\^MJ.GK97&FZOJ&N:A;_4K;UVNWDA_ M2<:3K-%#Q96,?JBA*KRWS1^37YX^<[H7E_Y4U6'4;/R1YX\O7]G/KVFKY974 M=5T"33M+B\LZ/#.1;67(B%)9_1GX<3/'R>1PJ^N?S:\C:_YN_)*]\FZ+;P2> M84M="EM[":14$LFDWEG>R0*Y^$22+;,B58+R*\F5?B"KS_S(?S#\T>@MYDU.WU#2KRQ1XO2OVL%AMY;ODHEO^9!EI$I"^ MHJEWEO\ *CSC'J_Y,:[K'EB&UATK\ROS!\]:_IEQ+:3S:3%YG76)]-618Y)8 MWN8I+Z))#;O(%?D5=D^/%4JN?RW\\:!92ZK9^2O,S^;(//'G_4="\T>2M5T6 M'5[+3]?UZ74K1);?6+BWL;NRND6.6:&28LLL<*M"?B:-5B5A^6'YP:G-JFA> M;?RTM/2UC\Q?RY\YZCJ5CS:Y^L!XS8ROP-OP;B?3=B M4!593^;_ )%_-6ZM_P#G)#ROY1_+]O-Z_G?^C;[0O,$>I:?96=DEEI&GZ9=6 M]Z+F9;@W'*R=XUC@:)@T8>:.KE%62V/ES\PM"MOS5_+Q?RNEU^Q\\^:_,'F' M2_/!U#2H=$MX=7E:ZMVDCEN&U#ZW ].(6TX&8+^]5/WJJO,K'\F?S2\V?EUY MHT+4_)I\G:KJW_./V@?EI:VVM7^GS5UO2IM267E)IUQ>IZ+K/&Z/7<-1@K!@ M%65^=?R_\_\ YM>9M;\XZA^6%UY7T^\C_+O17\I^9KG1KFYNK;R_YVBU_4[E MA8WM_:F!;,M\#R>H[*56,U4LJ]V\C^5]=TG\W/SO\T:AIWU71_.+^66\O7Y> M-FNET_3FM[C]VK&1!'*:?&!7JM1OBKQC4O(/Y@C4?/?D.'R3<7>F>>OS:T/\ MP[;S]'>:8ND6NGZ=J6BZA+!=PR72W_UCCI,D:B*U="[Q_O O-D5>Y?DCYHZA:NSQLRUDM[B-Z$U%:'XA0*O!/ MRZ_+WS]'YU_+";S1Y%FTK3ORT\V_F?J=SK=]=Z7=1W,/FC4[N\TR^LT@NIIU MY17'!O4CCD0D@KQ).*L#G_)/\P],UK0_,\^@>=KR&W?S_97%A^7GF73]&UC_ M '.^=;W7+*YNY[N_L898)+5U8J)3(LC?%&-R%7V[^6/E6S\C^0O)/D^QTDZ' M:>5M#L=)MM(%Z^HK:I:VZ1B$7DJ1/<<0 #(4!<[D#%7H&*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*O_];[^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J\ M2_/+\TO^50_EMK_GY=$N-8O=.>TL;*P@M+F](GU&[BLXV>.SCDF,:/*)& + M#X 59EQ5*M/_ #T\I:=;Z+I_G&\U :M-::>GF77H/*^N66B:??7T<3I#?SW- MO)'IDC^K&1!>3K+&'C]3=Q559YB_.[\M+&\UFWFNYTU/RL=2ALO.-UYOZ'I&JA8[>)S*D\TFH-'#RJ% 3FK&M54U_)#\_?*/YY> M6X;NPT[5_+&LKI-KK&I^7=;L+ZQ>.TNYKF"*:&XO+:UCNXB]K(K/!55.S4)% M57I>C>=_*^O^3(?S TB[>[\K2V>,FWM2WJ2+!+&LQIZ3$#A5MN-: MXJDUE^;/Y>ZAJ7E#2+3S3;RZOY\TE=;\J:>%>-[BSEB>>)V#J!&SQ0S.B2\6 M989B%/HR<56)?]#$?E3QBO(=2U6[TN6(2ZAYBM=!U>?3-.@YO'ZFIWZ6GU>P M0<&?GA>:?,.@^2?+'F+SCYFU#]&>7/*VFW.K:] MJ;J\JVUE91-//*4179@B*20H)VZ8J\QTW\__ ,K]3@O9DUN\L;>UETQ+?](: M3J-DUY!K5_#ING7MC'=6\;7-I<75PD:7$0>+>I<+OBJ0?F5_SD3Y._+GS'H/ MEFXTG6/,NM7WF+3=!US2]%TS4-0GTY=5L+V^MKDI9VMP9^:63*(T^(_$?V#B MKW'4=5TW1M*U+6]8OX-(TO1K.6]U2^O)%BM[6V@C:66>21@ J(@+,6V 'MBK MQJ3_ )R-_*:UTC5]>UW6-3\J67EFVM]0U-O,>A:MHLPL;NYBL5OH+>_M899K M<3S1H\L:LJ%AS*XJSSR7^8?E3S[^EK/0)=0@O= :$:KH^J:;>Z3?01W)?ZM. M;34(8)F@G])_1E"%'X/Q8E6HJP/S]^<]AY#_ #/\L^2-;LKJZTKS%Y3U;6K1 M-&T_4-7U>XO;"^L;8P6UAIT4\LJ"*[>21A&> 6I(6N*I]JOYR?EYI%EY7U.V MU&^\RIYPL#JGE^T\K:5J/F&\NK!. :\%KI=O<2B!&F1&E9 H=U0_$RC%6-I^ M?GEA?,/F22>_MKGR)8^5/*6O>6-7TR*YOKS5;KS-?:S:):VMO;J\D\C-IJ+# M%%&9&9F!!V 53K\J?S7M_P TM5_,Z/3[=5T7R5YBM-#TLO!*AARJ<53/S+^:/E7R;J'G9_-WF*RTO0?(GE>P\R^ M8839W;3V=GH:;?:5+):3LZVM[;QW\,#7%M,8G$<\0:)RK!6/$XJB?/'Y@> M7/(":7'JL.K7]YK+S&PT;0M(U#7+^6. *;B86>FP7$_I1F1 \G'BK.@)JR@J MIOY:U_1?-VAZ?YB\NW\6I:+J/*6TO8^2\C&YCD217"NDD:+SRA;ZS=MJFE:U_AK6KI-+U!M/TW5YC$L%G?ZA]7^JP/IW(UV.TDO;S M1[^QO-/O;9(9A#)'R2V6M'0W:W26!2JH]&84("KT'RUYCT;SGH=EYBT"5[G2M4=E1;B":UGAE@D:.:*> MVF2.6*:*9621) K(RD$5!Q5((_S0\C7?E[R7YL@U;GHGY@W]EIWE"[%M<"2> MZU!BEO&;=HQ)%6AY^HJ\*'EQ[*I'I'Y[?EOK>H+IUEJ][:Q3PW=SIGF+4M*U M"QT;4XK*)Y[A],U6ZMXK2^"P1O*#;RR?NU:05120JEH_YR'_ "M&E:WY@U?5 M-7\LZ3Y>TJ36]0GU_0]6T@3:3$\<4U]9B]M86NX(6GB#R6X=4]6/D0)%JJ]3 M\L^:K+S9I5OK6CB]&G7;R):2:A87.G22*CE!*L5W'%(T;$N^>_._E+\LO+-WYQ\Z:S M%Y>\M:?/96MWJTZR/%!)J%U%8VW(1*[ ///&I-*"M6H 3BK H?SX_+J31[W5 M9Y]8BNK&]BTNY\JSZ#J\/F"2\NHGN(((M#EM5OY6D@C>5.$!#1I)(/@1B%4' M>?\ .0WY3V]MHDDVKZFE_P"8[B_L-'\KQZ'JTNN/?:7'%/=V3Z0EHUW'<1Q3 MI,8GB#F,^H%*5;%7G/Y>?\Y-Z-YFT?5O-&O:;K.E6-]Y@U#1?(OE"P\I>8Y- M] -OZDC6T*K;!Q#/^]&ZKU6+\_ORREOO*.CV&MW6H:MY MWMI+GRUHMEI6H7%X\=K>#3[SUK>&W9X#97)].Z655,!5O5X<6HJQ>P_YRD_) M;6K33-5TO7=6U*P\PP\_*5[;Z!K#IKC W^L:W<6.A:O=KH\,,LL$QUST+21=,,,L$R2"\] M)D,4H<+Z3451%S_SD)^5-AY@U+RS/YDN9+[0+NSLO,NH6^FW]QIVF2ZG:V]W MI\FH:C%;M:6T=W%=QM%)+(J.3Q!Y*P"J*E_/'\N+77;[0+C5[^V-I>3Z;>>9 MY=)U"/R]'?6G/ZQ;-KK6WZ/]:)HVC>,S\E=6C(YJ0%4[\E?FMY.\]ZC-I&C2 M:Q::A]4?4+*WUO1M2T5KZR1T22ZL/TC;6_UN&-IHPTD/)5]2.I_>+55.//GG MGRE^6F@IYB\X:LNA:$U]:::+YHI9E%UJ,Z6EK&$A5VK)-(JB@I4]L5>:P?\ M.1_Y533-:3ZMK.GWUJ\S1M*BN%/*&2\$:.E61 MF4$A5C>@?\Y":3=ZKJT6N:CI]_Y3L/*.D:W:Z]I6GZ@ES>:CJFNZMHPT^VT^ M0S7$DC26$<442*TDDK$(""HQ5FX_//\ +J31YM:-UKR75KJ*:(OEA]!U=/,9 MOI[=[M(%T)K0:@[-:Q/6SA>WU2![+G:G_2^4K3^F($"M)19$;%4WM_\ G(;\J);3 M6]7N=ZM8TU""*%DB*_TK4;.?4;2\F6ULKG2X+JWCDOXK MN=UA@>V602R,JH2SJ"JX?GW^6QT:^U:6ZU>RN["]M].D\IWN@:M:^89+J\22 M6UB@T.:V2_E:>.*1X_3A(98Y&&T;\56>>4O.6A>>=(DU;1'O3!:W+V5_9:A8 MW6F7UK<(BEX;NQO8X;B&0(ZN%>-:HRL*JP)5>/:S^?GE_P I?F?Y[\C>;^=I MIWEC1=!U>QO=,T[4=2GAM=1.H?7+S4?JD,T=K:6YM4_TB0)&M6YMBK,-6_.G M\O\ 1_, T6^OM2>19K6UN_,EOI&I3Z'93WHB:"&[UJ&WDL+>2031,JRRJU)( MZ_;6JJ97'YM_E[!Y3\L^?;GS$EOY5\U/;KH&JW$<\()ND=U,R.@>$(B,93,J MB, \^-#150\G?FQY.\\:G-I.D_IJQU$6AU"&UUS1=3T22[LU=(VN;%-1M;RE\T7TFG>6M-M+.ZO[J_O8 MX);SZM;VUG%+(\S11,54+R8@*M6(&*I5+^0^5K#S6FI:A=6>LZA-I.FZ M'9:3J5UK3M1\^> M0?(FAZ;YBU(>>-*U>^75K?1-5,6FW>C7UA82V&I1?5*VDBO=M]8]=HS;\4$W M'UHR564_G#^8R_E9Y.L_-T_U.'3#YG\N:/K%U?F01V]CK6KV>GW5P!'OZD<5 MPS(*$%@NQ!W54H_SS_+EM%GUE9=:$MIJ*:,WE1M!U>/S$;^:![Q+9-":U&H, M[6J-< "'>%6E_NU+!59+^>_Y:1:5INKVMQK6ISZE/=6=OY6TO0=6O=>CFL/3 M6\2YT:WM9+V$VOJQB8R0KZ?J1\J>HG)5 W__ #D7^4UE+I-G::Y?:QJ.MZ6= M=L='T71=6U6^.G1W,ME<3M:V5K-+']6N(FBG5U5H7^&0*=BJ]HTJ^TO7]+TW M7-*NX=2TK5[2.[TK4;:0207%K/5;Z[T>>&6]=HHE2PU2TOI>;JCD'TX6"U7=J TZ MXJ^>OSW_ "/_ #,_-;S#JZP0Z+K&DM?:-?\ DC7K_6]1TX:%;65Q:3WEB-&M M8C#=3SS022_6IY&4!XXO0I%R=5D=WY"_..Q\M?FG^66C:+Y9F\I^>[[SCJ4' MGF]U>XBN1'YKN+R]^J_HI;(B-XI+OT?6-TR[&7TZ$1A5+['\AO.UKIYMWGTL MN?S(_+OS8JB>4#ZAY5T;0M/OD%8!25I=,E,2]&4J2RDT"KQWS'^7WGCRW^77 MY,?EIJ5_HOE3\T1=ZI^7^BMH=ZVKW6M>5-;6.'5;KT);:T:."TE:WO;J-5?B MELO[Y>1(5?HOING6.CZ=I>E:99QV6E:+;QVNEV<576.V@011(@W;X5 7V'?% M7Q59?\XLZSH_DGS6FGZE97?YC6&H6ORVUK6]< MU'2%T)]/L([:>2YTS3(O3U&:[>+EZLD@2.J+Z#I&XE5>L:G^7WYD1?FZGFGR MIIFC>3]+O-:M[[S!YQT_7+N*/4M,B*&XMM3\LR6LD%Q9;?RSHFO66C^6].T+2["^N;RVU9_+7F:V\R&X>66UC>Q6[-OZ M"QE;AHN06K>>;[\V)_+_D\ZV_F_RGYBT_R5!KURL:V6@Z M1J^F7,$VIMIS"E694,O+B&4M3MBKYB\U?E%^;GYEW,VO:[H_ESR9 MJ&G:%HGE[1M+M-8FU:.\BL?,NEZW<74EU^C[,0$16#(D?IOR9A\: &JKZ%T# MRAJFF_FY^9OGF[: :)YMT3RQIVE1J[&X6;1GU9KDRKQ"JK"^CX$,:_%6E-U6 M[OR;K$OYU>7_ ,Q(WMVT/3/).K^7+J-G871N[[4]-O(BJ<>)C$=G("2X()6@ M()(5>&^3_P K?S3_ "OTK\D-1T#2?+WG/S%Y"_+Z[\D:_P"7;C6)])MR]Y&\M[X6-WZ@1M/X%#"I8/SY?#Q*K&]._P"<;?/GE?1/+\.E:AHFLZEY+T?\ MMH]-AEGGLX]2O_)6LZYJ=W;/)Z,QMHYEU&)(Y>,FX8M&*"JKWC\I/+'GW1=6 M_-KS)^8-OH]AJ?YB^8K37--TG1+J:[BL[6UT/3=,%M+-<10&257LVJZHJN*. M%2O$*L+_ #>_)GS5Y^G_ #GFT&XTR(?F#^7&@^4]$6[FDC*7^FZGJ][.UP$B MD"QF.^CXLO(EN0(% 2J];T[R=J]O^='FC\P7>W&@ZSY+T/R]:PB1C0(%!55B_YY^3?.GG.W\MV.@6UKYA\LQR77^*_)%SK% MWY>%_(XB^I7+ZE8Q33F*T99&:W0+ZKM&QD41%751'Y >0-9_*[\H_*/D37&L M9-7\OI?17DFER32V8$U_@]P3,0$E44D+-V9G-6*KY\\J^6?S"\W:O^:W MEJPT_1%\C/\ GM'YDO\ S1/=SPZA8'R[?Z/J[P?43;LEV+IK/TE=9XA&'JPD MXD,JR#7/R!\P:I^47DGRA=:=IGF76O(OY@:MYQN?+#:M=Z7;ZE;ZA>:W);VZ MZK:1^M:ND>JI*66)@3&8J$-S"JQ?^<>]?M_(>D+Y-T[2OR?_ ##LO,-[?6-U MH6I76J&UL=7/,FGZW:69"I)Z4$D&GB#U3R,98-Z; MTXE5 :K^4WYL^8_,VH_FO?:+Y=TGSA!YB\JZUI?Y=QZS-=6D\?EBVU6U(DUD MV$)B:X&J;;'0[#7 M]2TFXTF!]$TO3K9K+7$M'DBN8)+(^I_H_IS@5XQAO355]&_EOI7G+1/(V@V/ MGS5EUKS1:I,+NY5S6 M++4O^%Y:O:WL] MRA)VU1?A2@Y*L9_*;_G&WS)^75WHL4'DSRSIVN>2],U*VT#\X9=;U;6;BYO; MJTFM(KR#R[/Z-K8ES-SE59I!Z8>%:Y^G%7P]YX_)#\S/./YE:5YAU*+1-7@\O>?]!\S:)YPNMJVUT='M?+]O&+59TB1JW$TDOJMR/&(NAA595HOY&^;K+\OOR4\I7EWID M=]^7VO\ F/4?,5S#+))']6UC1_,>GP_5JQH9'635H2RMP% ]&J!55WY6_EO^ M:^E>;_R@N/-MGY:TWRO^37D35?)%JVG:EKR?E9;+H M?TX//7D!M)-\DLEJ+A?-^D&,SK 5D, M=1\?%@:5W&*O$O-_Y!^?OS!N-=\[>:?+>A+K6H>;="\P_P#*L+;S#?QVMS!H M>BW^CK"WF&VM+:6!Y&OQ/5;8T]/TSR#\E59I^6_Y):UY7\S_ );>9+?RKY?\ MD:=Y=F\VW7F/RUI>IWVJS"?78--@MW>_OD#WDI^I-ZDA$8"\%53Q)Q5"6?Y2 M?F1Y,M_RU\PZ%I^A>9O,GY?^8/S NI/+5SJDNF6MS9^<]8N;RW=;\6=R4>"% MX^49@(+$A7^&K*IU^4_Y-^;O)/G+2O-FM3::\$WEOS+#JUG9SO(T&H^8_-<_ MF7ZO&S11B6*V2X:'UCP+LO+TU#455;Y(_)WS5Y?LO^<3[:_N-.DD_)'RY=Z3 MYO:&>619IY]$CTY#9DQ#U5$JFO/A1=Z5VQ5XS^87_.-_YL^:/*_G/R<3Y?\ M,6A>:Y?.MUY7@NM==3_ "Y_.?RG#>::-3\_Z]Y:U309))Y%B2+2=)\MV%SZSB'X6:72 M)BH"L"IC-1R(55$1?E]^;5GI7YC_ )7V.G^7(?)'Y@:OYMU*3\Q9]0N)+V"W M\UW5W>/ FAK:J#+ UUZ06_\.P^8+/S-JOF2^U!#);.Q1;Z*"*QA)M0[QJ)"S%*,HC/-5[#^;?DW5_.V MD^4+/1FMDGT#SOY8\QWANG9 ;/1]4@O+E8^*/60Q1L$% "U 67KBKRGSC^3W MFSS!HO\ SD]8VL^G)-^;]UIDWE8RW#HD0LM%TZPE-V5C;TZRVCD<>55XGN0% M7CLO_.+GG:X\L:EHVJ-HNI!M#\KQ?H==0N[5=0N/+OG35?-$EDUW#"DELES; MW44(N%Y&-RQX,%^)5F^G_DA?Z?Y#UW3H?R=\G66HZ]YAL]5G\GGS7K<]Q/\ M4[8V\=RGFB6'ZQ#=1T#(8[>@@#P$'U"X57:=^67YXIJ7Y7:QKMUI?F>XT>U\ MV^7]=34=9DDOM(TKS(=+]!OKJV &JSV@L968F.V+\E6JT+8JQ/4?R&_-KS+Y M"T_R'JECY;T7_E7/Y1^9/RU\J:O!K$]XNN7&L:59Z7!>W,/U&#ZA&OU!9&7E M.P]3B#\%65>B_G7^1'F'\T=?\Q:E%^CYM&U#R?H6E+IEU=3VTMY=Z)YG@U][ M22:!"T$=U%!Z'UA&9XV;F$;C0JI!IOY'ZIIWDGS9:Q_DOY-L+[S'J>GW-UY/ MF\U:W?SWD-A'*GJGS-+$L]K,AEK"8[>B()$/+U:JJ]V_)[0_/7EWRH=._,36 M7U/5/KD\VE037YU:YL;%TB5;:YU5X+1KUQ*))!*8(Z(ZQ4;T^;*L'\Y_E1YH MUZZ_YR8EL9=/CC_-W\O['RMY5]69UX7EM8ZQ:NUY2,^G$7OXZ,O,T#&G0%5Y M1^;/Y!_FIY_O18/'H>L6&F3>6[GR9K][KNI6,6AV^E2V$M]8)HUI"(;J>>6V MEE%U-(11HHS"!%R95F^N?\X[3ZSYC_,MQKL-IY/U[1?,$GYD>8/.E MM-;Z]?\ H!$8J6)F2DI+O>788*!%Q57?D3^35W^7FNG5[_\ +#0?)ES8:"- M36;/S+JWF>^OHVEMY'*G4(H([& FW#M&H=G;A\2B,\U7KGG+RCJOF#SQ^3WF M33Y;=+'R!KVK:EK\,SLLTL-YH>H:;$(%565V]:X0D,5'$$]13%7CG_*I/S!T M%-%\P:';Z+KVO^5/S3\Y>>;'RY<7\MC;7]CYH&JVT,4E\MK<_5Y88M1]1JP. MI9"@/Q!PJAO)7Y6_F=Y.\\>4?.:O._DS3=*\FSZ5:>9]'\U^6/,-B M=::86130M9LM2G63ZN#(:QP,H"T^(@5 WQ5\^>:/R)\]^?3J_G3S1Y9T.[UK M4O/.F^;F_+&W\R7]M:RPZ;Y9N_+20?XAM;2WFBX\S27WY7V?FS6],B,OF*33G%Y)YC6.6YNIX18 M%9 T*I)Z@(X^D.2KU3\N?R6UGRAKGZ1ATC0/+^AR_ENGE2'R]H\]U+%:Z@^K MZCJ$@#W8:26/C>#E,S4]%T M35I+5VD@:YT^QAMIC$[*C,A>,\25!([#%7B^J?DUYON_+GYK:/;SZ:MYYU_- MK0_/.BR&:01IINFW_E^ZF28B*JS%=+FXJH*DE*L*DA5Y_P#FQ_SCQYE\Y_FS MJ/YF0Z!H_G+1HAIZ:?Y.N=?OO+\UP\5CX%W%%*5J\:3F M.$R!6J W!:@5*CIBJU>UT'4 MM)^HK%KE[#'/;6276I6MK-"U6*1NDAD^%(W M=57MD/\ SD1Y7CT_61JGEGS+HOFK2+K2K*/R%<1:=+JUY+Y@FFATGZL]GJ%S M94N9K6>-/4NDXF-C)P4HSJLFG_-B6+RVVN2?EAY[76FOVTV;R,=/M!J$;I#Z M[3O=->+IOHB"DGJ_7>-?W5?7K$%7>2?SG\I>==3T'1-)@U2'5M=M=?N7TZ\B MB!L9?+%]9Z;JEGI#2-@&*R, *JL5M/^1 M_-OG:?7M)&O3:5I%I8B[L-.:[N+..XN(KN_MO4YRV3+CS!%H\&C^8?T%+KMOY7;SS)!:PZ7#K=W)':PZ=+;2W2:HLAN9D@-;+ MBLC59@@9@J^B8U7B#U)%"QZD>!Q5XWYY_-O3_)NNCRO9^4O,GGG7(-*_3FJ: M=YZ^NQ%HY#Z,7U=5*U,O!^* ME5]-:[?2Z5HNKZK;:;/J]UIEE<75MI5H(_K%R\4;.(8O5>).6&928KB"YL;F]M)E;BP(2=G6GQJH9.2J>^9=:TWRSI&L>8]9O& MT[1/+VFW.I:U?%6>.WM+2-IIYBD:L[%$0D!5)/2F*OEF?_G)F&R\\*OF#R[Y M@\B^1],_+^_\T7=CKFGP&]O)SJNEV&ERV=Q:7-U;ND_UMT],RAD8HTPB4JS* MICK?_.0%S>R>7-(T+1M1\H>9CY[\HZ1YM\M^9(["XNET7S)N9SYE\E><]!LO1O+C0-3O=/M%_3$5 MC$US/]7M%O&OH@EK'+<5N[>"D:,31J*RKU^U\]:'>^;].\H6$TNJ7VH: ?,H MO;4+-91:>;B.WM9)IT;X#=L\AMZK2589BI_='%6<2!>)/$&O<4KOWWQ5Y#Y] M_-O3_(?F'ROY37RIYE\X>:/.%AJ=_P"7=$\MVD-R\D6CR6278EGNKBUMX>*W MR.K32(K ,JL9"B.JPW1_^JWU_58]%L;F&'1[W44D4WKF-D$GK#B3Z1''DJR?2?SBTS M6M*\VW2>3O->F>:?(TMI;:S^7D]E!<:TDNI!6L4C2RN;FT87"N"'-R(XQ5IV MB168*LST./\M6ATV36+B^U"VFO[2.*6WOY M-/;U+6VFFJUXH"QL&HY1650L7_.37DRZ@$&F>5O-NH>9_P!/:EY<'D1K2TLM M5:]TBUM;K4F'Z0O;6V$=NMY&I>!-,U%])U"&YFNKRWM(Y+6[1XG!GXN5)A>48J@X?^ M:N8SSQ55D_YR7\GV-I-#K'E?S5I/F:WUG2M"?R0]E9WVIB?S MRVER@:;? M7<#1W#6DT8*S\D*\I0B?'BJ3W_\ SDE=+YR_*_RGHGY6^9-0N/-7F'6/+OGK M1YX].BU#R_=:?ID.J0Q2J-1^K.6M[F"X)CEE'HD[^L/2Q5]76ZJZ58[K1K&&2QT_1[R M6^B%Y/=7-S;1@Q-I\A:)"TQ!#1QR /P52*W_ .EPVJ7-]J%WI$>N\+26]NK:W*QV4ADR\LZ;K-YK^L6]I;/:7=S1_77+1?Z"L<4MNDJR2<_B](+(57TLX'!MN@)&*O#]8_.;2="\V6GE_5O*G MFG3M*U'5[30(_P P)K:T@T@ZC?3QV=K;(DEVE_*)+J:.!9HK1HN; ^IZ89U5 M26+_ )R)\K2VVN:[-Y;\V67D#14U0R_F:;"*XT5VT83&\41VMQ/?Q0_-_DN#2?J8L]/U:SLI'U*74KE-/LX+ M.YL;^\LF>>ZE2$+)<1\2RO)QBK)BJ3)_SD;Y2_1NH+=>7O,MEYNTO5;+1G_+ MMTTUM6GN]4MYKJS"S0W\NG4EM[::7D]Z@ C(;BY1&51UW^?%LESI&CVWY8>> MK_SI?07%Y=_E\MEID.IV%K;2+$US))=ZC;V3_) M&LS:7YMNYM(@_P /:GYG_2T\3?4C9Z(%EOHXY%+-)/%#68Q1HS>FK-VQ5X1^ M:/\ SD_I&F?ECI_F[R4;E?,&M^I+8VT^GM=S:?#I.L0:;K O[:%Y'!20R6L9 MB$@:XXHC.67DJSRY_P"JWYUZ2 MYBTE[9H[Q[15NGM9U3U[B(H8V]0)5.2K$[G_ )R6DE\T_EEY<\O?EKYEU.?S M7YHU3RKYYTF4Z9]?T&YL=(&L1"5DU(VSM+;W$-R3%+*/0Y=)@(RJ@?R>_P"< ME;76_(_DC4?S'TS5?+]YYDTF^NQYV;3A;:'J5UI%O M3VZQR"-C%(_*/DJR#_H:/R1%HVM:[K6@>:/+MGIGER;SAI<-Y;V%U-K&AV\U MM#<7=A#IU]>,?2:]MJQSB*0^JG%&(<*J^@/*>M2^9-&BU6?R]JGEL32RK;Z9 MK444-WZ2.524Q12S<$E4!D5R'"D!T1JJ%7F?YM?FGKOY<^9/RET;1_R_U;SQ M!^8_F6YT34I=)^J"2RBATB^U#FGUJ[M09"]J&H?A]))37U!&KJO/?R5_/JZ\ MX:/Y0LO..AZO9ZQYKU75]&TWSNNGQ6VA:CJ>G7-^XL;6LQN"XL[!W,C0"!_3 M;C*6*@JLJT'_ )R'\DZ]Y@L;=:LM"UZ]OM)\K^=KF*S&F:G?:6ES/TC4B)OBJT?-5"6__.1WEB309O-MWY'\X:-Y9N[6UF\H>9KB MQLWM==_2%Q!;6$5G+!>S"WDNI;J!8EU#ZJ:O\7'C+P59_P#ES^:&C?F-=>8M M.@TC5/+7F#RG-;KYB\KZT+,W=L+Z-I;60R:?$Q84/,+455>H3D M1QEP*<34\1O[F@Z^-,5?/*?\Y"^4;/4+VS\U^7_,_D.TCTG4]?TS5M?M+=8M M2L-'M_K=Y/#:V=U=7L)2VI+Z=S;PR<:*$]2J8JI/_P Y"Z9::6NIZS^7OGC0 M9[^XM;?RIIE]::<[:Y->LPCBL+NVU&>P1Z*25N;F%@HK3KBJM>?G_86#:3I4 MOY;^=)O.VH17=U+^7WU;3+34K6SLY((Y+N2:]U."PEB+7,0!M[N4DO2@*2!% M4A\M_P#.2.F>9O.GFFVA\K:F_P"5.@>1-"\^Z?\ FLL4+63V&JV^HW4LLT'U MCZWQ].R"1*ELSEUE# +Z;.J]*\B?F"SL;F\N4IP 1W)M)VCCB,DRK&?5BC9E5E7NOEW5K# M7]*TO7=)N3>Z/KMA;W^DW@1DCGMKE!-#*J.%=2Z."0P!]NN*L9\_^;[3RC=^ M15N[VXM8-?UF\LOJT%O#*ET+30]4U1X99)73T%"6+.'2I+*J$!79@J\>TS_G M)WRWK-KY9ETC\NOS!O)O/NF+K7Y::?\ HFVCN/,-JJ03W4ULLUZ@MUM$N(S( MU^ULK>]>6ZC]3ZJUM,LT=N)I?W9*1NC(SJLY_,'\Z=-_+BXN5UCRGYGNM"T>T%]Y MI\XV-K:KI6DV?%I))I9;R[MI;CTHE,CBSBN&4#CQYLJ%5B]W^?VAZ)YDU7RH M=+\T>>/,EWYIUC1O+^@:-IEKZWK:/I^GWMQ;J[74,7I+%>AQ/F' M53G3?^<@O)VI^:[#R['I&MVVF:UKMWY7\O\ GF9++]%7^LV#W,=Q8Q1I>/?J MZ26EQ'REM$C)B:C\2C.JQ#2OS^N_./YG?DWHGEC0]9T;R5^8%MKFI0:SK-A" ML&O:9:6$5S87^FW$-Q,8TD+J_ISK%.485B #<57U^DT.W\MV-^ MZ7-U>PB#TM07499%>V*5#JE&;I6E<51-A_SCWYFB\M7:VNG_ )8^0_-5EYBT M+S'Y=T_R3Y=;3-'FN?+TLL\'Z4966YG$K3%#Q(]-5!3=WQ5D_G'\N/S:\^>2 M=.M/,GF?RAJNO6^M?I2_\DOI]V?*6HV*0F"+3[]?5:\GB63_ $NC'BTM(W1H M10JL0\E?\X[>?ORPM/*][Y&\T>4TU_1+_P Y0RV\^C2V6BP:5YRU:SU:465C M9RKZ4UH]A%'$O+TF5G+ &F*H&X_YQN\^6OY=?EUY"L-<\FZY=>2]/ELV\U:K MIM_9:II]U/=R7$VH:)?:94_/OZ M>%I^7OF:TO/,0\S:E^86N^6XKCSS)=L4GFCBO@%@CY21E5D4 Q(Q* ,JXJ^S MH2BQ1_'44 #,=S4XJ^>/S#_+O\P+WSU>>>/RZU;RW#=^8/*T?D_S+I_F>WNY M84LH+JZNHYK4V4D;>HS7;JXD^&@2E#RQ5&?DW^33_E+>ZZD6MMK&FZAHWE/1 M--]>$1W*Q>5])33/5G*L8V>?@)/@4 =,5>[WBI/;75N9 AEA="=JCFI%:8J^ M7?RT_)OSSY9M?R"/FS7_ "_?W'Y&Z!J?EF)-'MKN%=0LYK&QL+.7_2I':.1? MJ9:7JIY#CBJ5Z)_SC]YE\NWNL:A8>:-#O;J]T/S1H\%EJ.EO=V4_^(O-EUYB M]&\@>2DD#03FTF W-6=:;#%7H7Y$_EOYC_+BS\S1Z_JFD06VLW44VE^2O+?U MT:%I*Q!_4:Q7499IHA-S53#&RV\:1QB&)*OR5>E^?/+-OYX\G>;_ "9<74EE M;>;]"U'0[C4(%1I8$U"WDMGEC#@J60.2 =B>N*OD_P P?\XV_F-^8D%^GYB^ MIPSW;WDKO,D_Z.]&>*@4(:INS8JGNA_\ M./>K06.E+=Z;^6WD6[TOSOY;\SSZ7Y \O-I5E/!Y?FEG;UY*B66>7ZQQ7E\$ M844%7?%4AT#_ )QLUW1_S#\M?F%YRU3RGY@MO(MUKEUKNOQ^7Y;GS3YKM=5T MF\LF&LWI]0DQ"<%;:W0P,OP)&H2)0JR'_G'OR=YD\E_EGYU\Q6UKJ?F'S'J+ M7,/D6VU]'M;R[T;0;4V6@0RK MT&]U_3!I6N7NG6LNM:)&ZNEG=30H\]NK5(812$J"#O2N*L9U/RC=WGYH>3?/ MXO$6W\J^6O,&A2:48RTMQ)K5UI%P)5DJ%41#3&!''XBXWVQ5XP?^M?3:@Y$$* ML'\L?\XL:WI.LZIK]U=^2/*]SKA\C&?1?*>CSV=M7R;YIBUZ6:>XFE:XNY[R M)?3,TY+J_P 1+C%7K'F'\H?,6J7OYWZEHWFV+2;S\V3Y=DL8D69/0CT2V2*X MLKJ6%UD,-^$:"5H#'*D4C-&RR!6"KY[U#\C-=_*FSU'\P[1/+=CJW^+M!\U: M5Y:\D^4[P>7]+N-/T?4=(D%UINF%[^>&1;[EZD$;3"4IS7T59E50?EK\C?-_ MYG6%]^86N:9Y6U[6Q^8'F+7]$TCS]Y:N8]"U*QUO3=*LC<'2;H+>VSV[V310 M>LHD95+R#]X#BKZ7\@_D_?\ E#SAHGF>YN] LX]-\C7/E6;R[Y>TI=*L()[K M56U3E9V\;%(X(PQB (YN1ZC;DXJ\V\U_\XL7_F;\L/R3_+V\\R:9*OY4>5UT M349+FQ>:TU:>"VL%C]2!G/&WDEL0)D-2T;L 0=\5370?^5O,.@_6T_,:[\V2Z5JUM=M'^CM0\L:?Y;N;99() 1.GU)Y404KM7%7U3;[*O%/-GY7ZAK6N?G'JT&KV]O'^:'Y?Z=Y M-M(WB=FLYK$ZYRN)2K NC?I9:*M"/3._Q"BKSWSS_P X]ZYYD/Y27VE>:;"P MUK\H_+UM:Z.EW:RR6U[JFG:CHFHVS3E'5UMF;2"LBJ>='JI^$U549/R4_,FX MT7\S)];UOR-YL\R?F1YDTWS#J^@ZSH<\OE[T[/2++35LN'K&X7ZO):K<03JW MJ<-'\Q:+J7ENVT#S):7*ZC-?62V-]JM[ M8VVEW5S/(\EO$VHB*MV7F*)7G5L5?5\A!1P'XDC9@:$5Q5\7^=/^<;_-/FS\ MQX?-MWK/E6]T^S\Y:!YQL?,NL:.U]YGM+;1-3M+[]!6%VSK#8VA2!@KP!7)/ M[T/SD)53Z'\F?S(/YBZAYT@\T^6/*D,RZ@\WF#R_I=S%J.LBZ@DB@BUZP>X. MG7(@9T7-3UO-$U.WU5'N+"_DD].*Z>V6WN(;81QM$68)ZK%L591IOY)>:=-_ M+_S'YV4KZ6HP@^O*[,5E60CX&C50"" MV*L5NO\ G'[\QI/(FC>7'UCR;YIDL;N\N8]/\P)KDB:$)_355T'6XKP:S!M& MW,R7!9O4=>8C"QA5]@^5M-OM#\M>7M$U;7KGS1JFDZ=;66H>9;U(X[G49[>) M8Y+N9(E5%>9E+L% )VVQ5Y+^<7Y-VOYM7/DQ[C4CIZ>6-3DDU&-.?\ I>D7 MR"/4;'X2!6Y1$4EJC@9$((LD0QLJ<;QM)MV15 X2FXD)8S-BJ8?FS_P X\W'YD^8?-_F' MZ[H]XNLKY,N-.\L:[8F]TN>Z\HW.L3^EJD98^K;7'Z14<4 92E>^*H#3OR-\ M\:$/ROUCR\GY;>4];\D^;K_7]6\L^7M"FTO06L]0TIM&G2VCMI$E>X]-A()9 M@1R/#["+BJ(@_P"<=;U_R_\ R:\AW/FY&C_+"UURQU74[:W(FO%U?0]3T7G; MK(Y$;1&^$GQE@>!'?%6&Z3_SBSK%MY%\X>2QIGY6^3FU7RRGEG2=<\H^6397 M]ZB3VTOKZK=$K(Q"VHK'&>+.Y=OL)BK[CB<49+NY6W95OHM0M-U?R=I^F:M]2O&\OZ) MI5U%HWF74-.U6UU>WNO,>DSS2VJF66TXS_5%1Y!/*'=^,=%7N_Y,?EU?_E[8 MZLFJ:+Y%\M3:Q=QS)I'Y?:(NBZ8GHQF,&4D^K<2/U+.**!Q7OBKVV>K1L$A Z_QQ5\4>4/\ G&KSEY>\_P"B>?;OS'Y4CUORM8:_IR^<['1&?S)K MTVKP+%#JNN7]Q)^^GB=/4:W7_1Q7A&(T1%55$:)^0?YBZ?8><8_5_+C3K'S! M!!;1_E99:1>W7DB],:9>S2"V9@NPLU1"Q9Y%DD(;%6.2_\XJ^9^'EC M6KT?E[Y[UO1+;4].M/)OG?3;[7O+FDV.HRV>+K4]#U_RU:>6-7\A:'Y6O%M-)>TN[/4/+_P"DA;76 MGVD4GU)+?EJ _P!'*_"$H#OLJA?R?_*/SCY%\S>8-;UFY\KZ)I>K6?U4>4?( M]M?6.DW-R)$?Z_+9WDTL5K,H1P!9I&LAFE>;U'".JKZ*U>TN=1T?4].LM4ET M6^O[.>VL]7ME1YK266-D2>)90R,T;'D P(J-Q3%7P.G_ #B!YIOH_,LVH:YY M)T6^UGR1JWDR74]#T2>.]U.:_P!2TF_&LZSJ4\K7-WB@CY1P1_!$K4J$ M791\/0#%6#_F;Y#NO/$_D*ZM=3AT^/RAK&HZI=+)&TOKQWWEW5]$")Q(H4?4 MUEJ:U5"O5@0JQ'RI^4FH>6KS\A;N;6[6Y'Y,^0[[R?J,2PN@OI;N#1X%N8G) MI&J_HMB5-2>8%=MU7S#Y9_(+\U(;K\^ORMLM:TNS\F>=K:TT7S-K>I:3=@S6 M6KQ7\UQ=Z'*L@1[BWCOO2*2\XQ)&"?M,N*O3OS__ .<;4F^!%CDO'C M65/C])$7]IL51'D#\C/S"\L:]^3?Z>\VZ'?^4?R)TB_\N^4+#3K"XCO]0LIM M.AT^"[OYY961+A4@4ND2B,EFIT7%7TUHD>JKIVF'7!:C6%MT&I?H]9$M/6"_ MO/165BX3E7CRJ:4KBJ>8J[%78J[%78J[%78J[%78J[%78J__TOOYBKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKP+_G(_7/-?E?\ )KS=K'D/68O+ M/FZ*;2K;R[K,T*SPVL]YJMG9^I+"X8/'24AP!4H30@T.*O"O,/\ SD%YJUW5 MO^<<[#R>H\M+YGUS1[G\V[)HX9[BUANKQM+;0KD<6-K<->>JS!@K<;>9%HRM M15Z=K_\ SD)!Y6_-/0_R[\S^7;/28/->L0:1Y8N9?,.GMKUV]U,]M;WB>7DK M<"S>:-Z3<]D'J,HW154+Y$_YR*OO-\?D74;_ /*S6/+GES\S[>_/D+4GU"TO M-0OKVPL[G4)X&LHR!#'+%9RM#(TM'_=U2/G\*J0Q_P#.66D:??>>])\W^7+/ M2-9\E:%>^8KOR[HGF'3_ ##?);Z==6EE<6VIPVI0Z?<"6^@41R%@W[TAOW)Y M*HW7?^6/,&GZGI M2ZB^AW7F""==9BXPR0);VP$[(G*)F8<).-&53_2/^ZK'?*O_.7W ME#S/YVL_*]K9:6+/6;_5]*\N-;>8K"YUM[[18+VXN1?Z!&/K%C$5T^?]Z[, M?2!'[WX56.>:O^!2L'H+>)(B!V-PM16)B**O1]>_,3SS^6&AZW^8WGZSM!#YGN]'L/+ M_D2?5;:'3/+DX@N#=2:EYBEA6"&"Y,:L)G3CZK1PJ.4@.*O8O+WFCS%>^4[_ M %?S%Y'O]!UW3X[EY/*UM=6NIR7/HQ"6,:?=(\,<=+TC1GL;-[>,SV>MS(8[MW-U'2,1(PI)^R@+JIPG_.2PUZ;R+'^ M7?D&;S4OGCRM8^<;2UU'5K30KVXTV_1I532K>Y#C4;B%(V,Z(Z"+E#S<"4$* MLA\N?G/K'FCS]J_E?2/R[DET3R]J@TGS!J'Z8LDUG39F=D6XOM ;C-#;2NC- M%+ZI]6'C-&KHV*L&T#_G)[S/YATWR%K%A^2FKK9_FPEQ!^6D=QK%@LUY?6]O M/>3+=H@*VEJ(;:61;@M(S*%_=!GH%6,>8?\ G-/RQY=-Q::AH>DZ1Y@\NV][ M<>>M$\P>:--T9[1K'4+S3KB'1VND_P!RK"?3KD#TUC-/2K0RJ%59;J/_ #E" MEO\ XQUC2_RUUG4/(GY?QZ-?>=/.4]Y;6IALM;TJRU:%[*Q?U)9YXH[P"6(E M.)XT=N=%59C^1?YA?F)^86M$\TZT?+GD6[\S>8M/ MTFROK^V.H-=OKK>E)!,(Q=2B&8*$)8\U/'95G MGYL_\Y9^4ORI\X^8_*VH66EF'R19VM]YSEU#S%8:3J MKJ$W$9TC2[@>MJCB M%3Q2-EY2?N@>6^*L\A_.?5M1_,[6?(F@^0)=3L/+-]!9>9]1.KVEKJT N. 2 M^AT.8)-/9$N*7'J@,JRE S1\653;SY^:'F'1?.-IY%\D^13Y[\S_ *#;S%J= MO<:K%HUK;Z:;AK1)%GEAG$LC2*1PH* 5)WQ5Y?/_ ,Y2VUQ:ZSK_ )6_+?6/ M,7D[RMY+T/\ ,+S5YDGO;:R%GY=UJQGU(-%:/ZDDUY#!;,_H;!CMZHQ5ZI^; MOYP:)^4GDW2_-VI16TZ:YJ-EI.AIJ%];Z38BYO4>6+ZY?W7**TBX1-5V!WXK M0EL5>:V?_.4FA7WY5:Q^85GI5I?SZ'YF3RIJBZ?KEG>:%;7TD$%VL\GF1%-J MEF(;F,2W++Q20F%AR%<58AYJ_/O\VM/\V7>CZO\ E;^@?*=G^6/F7S;YEO;# M7[&>_A?2WM^-WI-RD#I,J13*JAXUY2N=N,)]15EFI?\ .2NH:'!YKU%/RKUS M6/)GY:S:19^=?-S7]D)Y)-6TC2]2MUL+, -=S#])I'*K&%0U&5F#415-=2_/ MKS/I%OYLL-=_*U=%\U>5+?3M6U&SOO,FG6VCV>B:H]ZEM?WVLRHD5LS/IUQ& M8O36OS.U6\TJUTW3 MI)V\L7?F_1;7RSYAL?-%W+IEE);K.E[;6($EEL?F=&VK2>28M&\KWUL\VA:_8ZY9ZQ$[Q2+'):7\,"QO9W2<@##1Z,LB. MRLGQJL?_ .<@_,GYD:5=_E#Y3_+^SN)E_,'SA+I/F'5[/5;72]0@M;72;[5% MBMYKJUNT4R/9DNWIGX$,0HTRNBJ^]_/Y[G\OO*/G'R_Y4DO=0_,'4=>T7RUH MUU=0P>A>Z18ZW>J]Q.5*".7]#,HV)4N*]#BJ!_);\\?,'G7R_P"6;7SQY/70 M_-ES^66D^?\ 4GLKR.>TN+:_]2)!$J(IB:4P&3TSRX!N/)B*XJDVE_\ .4<. MI:7K/F=/RXU>'RCY-\DZ5YY\]^8WO+606&GZMH3ZW%!;VZDO=W$03TW0%$W$ MG/>F*LC_ ":_YR*T3\V/,>N^3XK70X-=T;3(M:9_*_F:Q\TV!M)IC;#U[VQ5 M%AG]132)P25^($],54]3_P":_.K7MMQ6^ MU+]')926-B TMPIGU*))JF/TQ\0Y],50+?\ .16KS6KWMC^4^HFVO_.&H>0? M)3/*> ML:#J?E3S7)KNO^7_ #-Y>L]0MKO3+>^T[1;75P)9Q"C7:-:WT+(8Q&4D+*P; MCBKSWRK_ ,YL^0->NS/-::>GE^[T'6/,F@2Z-K]CK6KG3]%L9=1G_2>BVW"; M3I#;Q-\$C-27]R2&WQ5%^=OST_/71](\@7^D?DK:VTOF[S7H>G6CW7F*RN8+ MK3M28EHGE2"-[>XDJG#]VZ@3/(FH^<]0_-+ROJ?FC18;J^MM)@L[;2KNPM9DO[B7U60N;\",QH]6 6BAN M2JI=%_SDK+Y@;R';>0O(;^8+WSWH(\PZ?I.K:S9Z#.,J(D:%Y&"SK15ZSY[_ #$O_*^F^3XM&\I77F+S?Y[U#]%^6/*EQ=1: M;6ZCT^XU.X2\O*3)!Z5K:3&H5PSA4&S<@J^>_P#E4_+WEB^ M\M:)!<^99?S/BM=9LX9H]3\K:CI=E=VIEELIOKEG&FH,S+$(GG+*5>+TF#JJ M?Y^_G-^;7E'6_P Z_+OEC0K?3_+OE+\I/\6Z=YTMKRW:_LKZ4ZJBSI:30OZY M:6T2)4) 4CU&)#<0JS?6_P#G)*/R7:>=&_,#R1/Y)U;R]8:3JVE:??:M:/:W M%CK^JKH>F27]_18=//UP\;CD9%A0-(7D IBK*_R6_.W2?SJ3S/!8V^G6^H^2 M[NUM=;_0FMVNOZ4QO83-!]7U.R"1RMP/[Q 4-!O4'%6#6__ #DKK=U'I6J6 M7Y-:S<:)YJ\QZGY)\FWGZ3L1/J'F#3[N_MPC6_2&R==/EE:Y9ZHH/[ENZJ;7 M7Y^ZO;^3]>UU_P O(K#5O*&MW&@^?+/6/,-AIFAZ19KGS=HUYK%UJT>J6<>EZ?!I.M MG0]1/UL!UN5$\<[K1_(GE M[5/S/\WF6VM+.TU36;:S%M;74[!8Q-<2W2R2A0%MH3ZL@ **ZK%M0_YRV\SZ M[!H=E^6WE/RYYC\TQ>=_+NA>:;/3O-5CJ^EOI^OQ7Q@6#5[.+TEN)'L75U*< MHAP8\A(**OO-6<0H[Q)#)P42Q?._E*V-[;7UY?:5'/8VDB7<4)"V4PFU.V M'$O(""[_/OF7\X/S#\L^=/+=SY'7R[Y-\KWMCY9:[M=1M%N; M_4->CGO+.\@2-Y1+%;0QN'5.#QE5&_-E4QM/S7M;+\T-2\A_H[5-0NKOSK;> M58;B>>W^JVLO^#O\3&:VB5%D6)T@,;*[,WK-R!"4 52U?S\O-1U9/*_D_P @ M7?F7S2OF'S1IC:;-J5O8QM8>4;NSL]2O8[B1)%9VEU" 10$ L"]77@:JO,_R MV_YR*\X7?D7RUS\EZI^9'FBS\O7_ )P\]DW=GIM]9Z0VL:I9VJP0,/1NKH+8 M21F$.BJR+64\PV*IJ?\ G*F2XTC7_-6E_E1J][Y7\C>7-"\U^>O,+:C9QM;: M;K6CQ:QPM+<@O>7,,3E3$/3#'CQD^.@55_-G_.40\A32:+Y]\A1^2?,]Z]A- MY3T_6M?T^TTZXL]0-Y]7EU+573T-/D5=/G!C82CGP178O7%6]"_YRJ_QB/*= MCY&_+Y_.?FGS/?Z_IJV6DZ]8S:+!>>7(;&>XD_3*@QSVSQ7ZJLL<;?O!Z9CK M\055_P#E>_G;7O.7Y$6GDOR+;77EO\PV\TVWG:WN]0AM[G3[SRU>1:=>?5G] M-Q,MM*DS*5 ]=0E.&*OK\31F@J:GL01WIX8JJXJ[%78J[%78J[%78J[%78J[ M%78J[%78J__3^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O.?S M-_+^/\R_)^I>3[K5)-)M]3GL)Y+^"-9'0V-_;WR@(Y"D,;<(2=P#48J\R_Z% MM\MIY@UCS%97\NFWFK?F!I7GG]U'SX)I4LUX-.)=VK'-?WU]=EZ;-22#\HX=1AL=4M MK>78U+2 M+W26<2H3]7DB6]:1&2M&5<5>7:K_ ,XNW]KY>U8ZOYOOO.L6F^1-6\D>6?)N MBZ?I^@QBQOKO3+U)%D+3<[WU-.4/([A):CX(R"SJI!Y*_*K\Q_S3USS[YK\^ MWWF#1KO4-.\GQ>7-6\Q:-8:6\&M>4]7U+6+>2'1+6[NPUFK75NSB2[+3/ZR@ MQ@ !5]#:?^4OF.XN/(FI>1HDX7[3.S2.S2+MQ5N*JK/^5&V@T76M&7S#.8]9_,VT_,R2=H$Y1W%IK-GK M*V*@'^[9[,(7/Q4-:5Q5*_*'Y&^8?)TD^B:?^9,C?EU$VK2:7Y432+9+X2:N M\\DBWFJM([7$4B,'52OS#_ ,XSV.O^1?)_D=O-]W:0^3_R MPUW\LK35%M8GEE@UO2['3&OG0L%$D0L0X0?"2Q!( &*O3=2\G^?M2\DV.BG\ MQ(;3SI9R++<>;HM%MVLKP@NK1W&DRS.IB:-Z<5G4\U5^= 4*K'_(_P"2=KY/ M_+37ORZ'F&Z2+S*FI+>WV@QKH,6G?I&#ZNRZ':VS2)IR1C]Y&L;-QE9Y?M,< M58=Y;_YQY\RZ'K%WYEF_-0CS"OE%/)_EYM&\OV&DZ;I=I;WL5[ T-BK3AJF, M1S(STDCHJ^E2N*HWRS^0WF7ROI'FXZ7^9$&E>;O-VI0:G=ZGI'E^TL-#$L/J M^HTFA"62.22Z,S&ZE$RR3%8B6'I %5C6C?\ .,&L>4SI>M>3/S$L=!\Y6T6H MV=[ M?M(TORY+^9C/H$>GVUCKD.N:'8:M=2SVU>.I:?<+]4^H7OQEA,BOQ=8GC1"A MYJK;G\B=8U#S[Y6\TZK^8;ZIHWDF^^O^6K:;2K=/,$)(!>T?S#%(DSVDK "6 M$P_O8U5)':G(JH_RI^1-KY5TG\B=)B\QW%]'^1CW;Z?/+!&C:B;O3+O3&]8* M:1\5NRXXUJ0!TQ5B4'_..&N^7?,/F3S-Y"_,T^6]4\[7^HW/FNXO-#MM5+6] MUJ^H:M;0V/JS1K;26[ZI<+ZC+('' L@X495D>N_\X_VVO^7?SL\O77FV^I^= M/Z/.H:G)!#+-9OI^F66EK(H C21I5LED;X5 9CQ%,591^6OY::U^7VJ_F%<3 M>;QKV@^<_,=[YFTK06T]+:73+G4IGGO(C=I,QN$9R.'*-2H'[5=E6(I^0#:; M^7?D/RAY?\WO8:_^6>M7>O>4?,]YI\5]"MU?C48)Q=:>TD23)]6U2>-0)%(; MA)7X>)52_P U?\XZZAYXT-+#S;^95[J>L2>4_-WE:\UB#3K6UB$?FP6"R/;6 MJ&D26PL%].-G8?.GD[\QG\FKYX&G+YWM#I%MJ5S M*--B^K1-IMW<2 6;^B2*M%, ]'X]5*JGYJ_)36_-WG?1/,6I>?$D\O:#JUOK M>E:1+HUJVLZ?<0,DAM]-UZ-XYK6VF,2I,GI.TD32Q,Y23X54U\]?E9YEUSS= M:>??(_GJ/R1YI71#YX#G@)I6BNN; MU"@LNVQQ5G/Y@?E8_G;R[Y;TJUUXZ'K/DS4[+6O+&N/;+>Q)?V$$EO%)_7D\U1:-9QV*T 06GZ)# M%?JQ059#.9#(6<2K4*%7B=O_ ,XCW=I'-'8_F1#I,.N^6O,_E;S=I6G^7K:U MTQ[+S+':K(-'L8[@1Z8(Y+-)V5/4629YI&'*4T5>E7W_ #C_ &-]Y._,CR>_ MF:Z$'YC:IHNIW-_Z$?J6IT;3=&TY(T2O%Q(NC*Y)W!D(&RC%5/\ ,#\A[KS? MYUNOS#TCSH_E_P Q_5]!BTJTN]/CU32HI=#?5BDMU8O-"+HTU=VCY.OHRQQR MI5L58MI__.,%[I3:1':_F=?75H4\\V?G7Z]IMM)<:Q8>>]2MM3OHDD@>!+66 M&2V"Q2I&VQ-4Q5Z#^77Y5^;_ "7;OI>J_F6VM:'I^D#1?*^FZ;H]II!M8$18 MHIKF8/=/57ET6#0K:^E+PF&7S"]G,YU&6!8 L,C!!"'F]-0)B%5>W^:?)">9]>_+S79 M-1>TD_+SS#-Y@M;:.-6%TTVCZCI!@D8D<0%U$R<@*U4+T.*O#]+_ .<:=1T^ M^\IV;?F?J$GD3R!K6KZQY1\F)I]LA#ZY8:K97*WU\6>6Y,9U622%E6+C3BZR M^8+_6-%\^^2]"\D:O M18[6=;/1=&.BF6*1?4 DFB)/P\*U;%7AFC_D3YO\S>9?S:;7?-%YY= M_+[S1^:-OYHE\I-:6]P=4@TJWT6ZL;JRO5D$EFKWEC29760N$HHCK4JO2=0_ M(B2;R;HWES2O-TVFZUY9\[ZMY^\L^8Y+2.X2VU+5-3U+4>$]GZB">*-=3DB" M^HI-%>H(H57GFB_E7YJT?\ZO(VIW$M[YEN]-U#7_ #?^9/Y@S6<.G:7=7NKZ M+;Z%:6VFVJ3SNKQQ:?"9(R2.LG.K\ JRORU_SCSJVC>6KK\N=1_,FYU#\J4\ MN7GE31O*EEI5K87T>FW=JUBGUW5.4SW4D,#'BZQQ5D^-@?LXJE^K?D%^9NNZ M+HNF:G^>*-<^3=4TC5/(L=66X]*YDN8KRR]26(V5VAE-)09 "D+JJM&2ZKU#S?^5=[K6C^1(/+ MOF^[T'S/^6EW'>^4O-6HQ#6&]?\ 1MQI$\E_!(\'UEIK6[F!8R*?482&M.)5 M2#R+^1,7DWS)H/FV?S-/K>OVB>;)O,5P;9+:"^U#S?=Z9>7ES'"KN;=(FTM5 M2,,VSFK&F*I5^:/_ #C_ *E^9&O^:=4@\^'RUI7GCR(WD+S3HRZ9%>22VJ27 MTUO>?\ \C+/SSYDUSS2?,-QI>I:AH6@Z=I< M:V\<]O:WOEO7F\Q6%V\;LOKK];""6$E0\:E>:EBP59MY#\J>;/+EI>'S;YU7 MSIJUY,CB:#38-'L;=$!4+;VD+3,"P-7+S/R;IQ&V*L(TO\BK33=%_+G1E\QW M#Q_EUYZU+SS:S_5XPUU-J4FL2/:R#E\*)^EV 8;G@/YCBK'=8_YQWO9M5U+S M'Y<\^2:-Y@O/.NH>=++](:;%JFF6\^I:=9Z;)')I[30K-)$EIRAG+AHS)( * M,<53+\KO^<>[7\K]:TW6K?SCJ?F:?3M$US17DU.*W6:Y_3GF&;S#+7+2WTVRDTH3!(OT6MP6D];UW]5VN:FB< G$\E7LOEJV\X_I/ MSB?-*:>=/@UB)/(LMH#ZDNE?HVR,KW2DD+*U^;K[/^Z^ Q5\WR?\XF7-Y%9: M=J7YI7]UH6@6WF6T\M6":7:I<%?-&F7FG7=WJUZSR3:A>+];,OKDQ\WYET8R M2.XNM(NTO23R >.32$ MHE.)#L*C;%60^0/RN\Q^5/-WFOS_ .;/S#F\]>9_-NC:1HU\#I\&F:=:PZ-< MZE/#]3MHGE>/U/TBQD#RO5U+ J&X*J\GTK\K?-WG;S-^87Y@0RWOY8:S-YZM M/,/Y:7&L64%[(AL_+$7E>\EO=-2X56CGC-SZ(,ZFC1RG^3%4[TO_ )QOUKRZ MVG:OY<_-?4+?SM9ZQYGO[KS;J6F6M[Z]KYNNK.]U*W%HKP1(ZS6$'H2[^FH9 M3&_*H5>.>:/R<\W?E'8Z/H7D*Y\]^85U/RA/Y2\P>;M$TS2M3O+RV?4=2OPL M@N+FS73[A)-2=OK*1S(_+^Z3TP'5>H^3_P#G&N2'\HO.?DG7/,+V>J?FGY%\ MN^6/-!M(XYX=-N-)\O0Z)*]H[%?6!:,N"P&*LR_,7\A&\[^?;#\R],\W/Y<\ MV:!865KY9,MA'J-C;SVDNH%IY[9Y(O7#PZG-'PYKQ8)(#\/$JISHWY2ZW%YG M_+_SEYG\]S^9->\C0:] _#3[>PM+D:XMFC+#;PEOJ\< LP44O(S,S%GZ *L; MLO\ G'_4-#O?RQU#RWY]?3;G\NM>\U:IN &++3A7DM144\?"HWWQ5HW" 5I M4BA*@BOZ\5;];=@$+<3QV\?"G;%5![BM"04"M1:L/B/RH?Q[XJJ+,JJY-!0T M"U/4=1O\L57^N*$\&J/V>_6GRQ5H7*,:#J0"H\030'%6_74[BGBV]*#;XI3>H)'3WIBK9N4 WI4 M_9%1N=]OPQ5L3@@U1@U"?3IOMBK7UA.1&XXD#?;<]L5;]=>XHQ (6HWKX>.* MM>ONRK&SE30@=J]*]L5N*K?K* D'H-RU12FW?H-CWQ5WUC=!Z9 MHYH&J*?[?MBJ\3+^T.%30!MCX8JM%PM>)!#4JH\0>_XXJX7"LQ55+-0E1XT% M=_#VQ5:;I03\/3[6^X^CK^&*KQ<1LQ6M"-B#V.QI\]QBJ[U1M058T*K7K7%5 M+ZTG\I%&(-:"@'5J>%*4Q5=]8'$'@:UXD>XZ_P"WBKC<*"010BE?F>U>A^C% M7?6%K1AQ)%5%:UIUI3%6S.M&(4GB0#X;FG7IL<57&4?#12>5:?1XXJL-RH[' M?Z=_ TK3%7?65/120.^P]Z"O7;%6_74;<37^4;GI4??3%7>NOP4!96_;'08J MHM)',%?G1*?$K5IQ-#N-C7]6*HB%0JF@%68EF'<]*F@'ABK3S*A(I6@JQJ-O MGBJ$/;%50S*HJ?"H[UKBKC,H%:;UH!7OX;8JTTX4T84%*\JBG6F_ABK7UA:CD MI4-LI\3X8JX7*JDT/ M6G?%6Q<1LP"GD":5'OTVZXJJNZHI=C15ZG%4.;I5%61E[-M6F]#6E<57F= > M)H#6@!85ZT.U>U<56&Z%/@C:1J@AKW^C%5 MWKQD \A0]*_3_3%6_64;$@-V%?E_7%5AN "?@8@;\NU-J[_3BK3SJ5HA!+5 M-13]8\,54EX1R<@I!H:@@U)K2HIX_+M7%53ZTE"Q!"BO(^ \:=<5U >YKX8JN]5:*0"0W0_[>*K!] M,5='-S/$H4)Z5IO3K]V*J^*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O__5^_F*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O,/S;_,JS_*G\M_./Y@7MNMX MGE>P:>&SK(%ENI'2"VB=HXY'5'GD0,RHQ526XFE"J^#/('YU0?E=Y2_,+RAY M6\X3?F+K5CIVA><+#6]>T_5;88I8+Z*V)#7+K>K(CL99KJ9F * M$NJ^COS*_-WSMY<\^>8O(>@#3+4W4GY?Z9Y;UJ]MY+GZI<^<=3UNRNKF>%9H MA3?-FN:WH/Y@^ M;I?RJ\V>9M!\T:MIPM8ZQY=LH+&YN?KMS)+%*]V[RL.)8K#1:Q_$J]]U M[\S_ ,V/)FK>8_(>LZKY>UOS+=R>2F\O>9K32Y[6STS_ !OK]UH/I2V7UN0W M@L6M#,K>M"9>7!UCIR*KTS\H/,_GK6O,?YK^4?/MYH^H7_Y<:OI>FV&LZ+9R MV*7L%YH]IJ N)K>::?TY2\Y'!695 X\FZXJQO\PO.7YIO^9_F'R5Y*USRWY> M\O\ E3R#9><]0U'5M+GU2^EN);[4K9[2&);NTB$4D=H*R,_*,@45PYX*O-;? M\[?S4ATOR%K?F;7?)VBVOYT^1KGS?Y?(TZ]EB\K"U&DOZ)=9O5UB62+5OW48 MBMR\R+$O][554CT#\^?SKUJ\M?(<=K8Z3YN?\P-)\K3Z_P":/+D^CGZAJWE[ M4]7:X_0L.H71#VQL5,1^M%9J%&]%2755EVH?FY^:"^7]7TJ#S#I"^=O+'G+4 MO*4U]IWERXU?4=>;3[2TO!)IGEY+^ 1@)=,9FDO"L2Q@_$9>*JJ/DK\Y_P V MOS0D\MZ5Y;_0GE'6[?R[K'F#S"?,.EW$AU";1/,%WH'U&6VBN5?33,UH9)6! MN6A+F-1+P#.J\Z?_ )R4_/+7K/RY/Y0\FW.MZY;?EMY2\Y:QI&A^6GUBWU;4 M_,>GR7K:>U[)J=I^B4,D!C1REQ17]0@\.+*O1O-?YO?G5IG_ "M[S7I<_E+_ M U^6'G?2O*>G>5;FSNVNM5;6+70Q2ZU*.]EM M=333(;S]U+=QV\K\(8JL TS5_S-_-W\SM&\JZOY\@T?RK=>3? MS'\J?F!H>G:;,B:O)Y>\SVWEV;4K5FON-I/(#*)*JJ]$\T>< MOS%\@>=M)\JIK=AY)_+[2H=(TORC?Z_H=SJ&GZZ@@B1H[SS%:W2#3;II!,@2 M2T9.,22^H3-Z:JO8_P T_->I>0;/RSYGBBMIO*EIK=O:?F TD=9;;2[]'M%O M8275$%M<2PRS$AB85D55Y$8J\CU/\V?.^J>3/,'G'R[JNE:!I&M^;9=)_+.X M?29];U74["RB,!:TTV"Z@%]/?7=O(\-985BMFYR4,; JO [K\]/.L]I#^9]W MIL=CYV_+GR'^;=A%::C8RV275UHFL>5((YKS3!G>9M5LY[TP7NK:SJ.G3#T+=U:Z<1 MVR"WMDXM+,1&7'/95\WV/YI?GGY[\V^0?*P\S/Y&UCRY^:$&B:[?ZGY7ET^? M5;34/)^K:Q$EUI"ZO(L<41A*K6XD#OZ9]7TN.UAM1?V?H,19>K)*9'YO(QXKW59/9?F MQ^:_YDZGY'L_)E]Y:\BZ=YE_*+1OS-U2;5-.GUNXMKK4I&Y65NBW5A')&4/$ MR.RE2H(#:7_ .9U[^95[Y:_-*?0].$/E?RQ^6$L7E/40UW9PZC^9>MZ M5)_+C MR]HTFF7C/9QV6K:Q:V^L3W2W59)4BTS>T6)4D:A-Q&&;@JO\N_F-^>GFC\SM M:_);3/-'E+2M1\EV^I_ISS]-Y?GF^MR6C:1+"]OI2Z@B1!TU0Q.K7)IZ8D4G MD8U58]YU_P"58["MQ^7]GY\U_\N=*T"Y\Q7G&:T-Y,+^\^ MN6$>FVO*,113%)7>KR",B(@JLPU#\V?.5K'YGF\GZ7Y:TO7-;_.+RSY/2XNK M29H7M]:\M:+>S75V8I%>>XB^M%$<4#)''&0H!;%6-V'YF?\ .1%KH6FZ]J/F M;R/JC7?YFZC^5>G:='H=W9I,]OKEYHT.M3S?79S R?5RWU2-9%DXK^_3U&$: MJ+\V?G?^;'E..3R# MOYD\\6OYA2>3I?./E_RV]Z\\(\KVWFLW$?E\ZE%\5+ MGZLX^N[!3-U/IA5.]!_,'_G(/SAJ7Y=>2?1T;\NM>\Q:'YOU37M5\S:'-+>^ MCY:]3\V MV.F^3M2_+3RMJUS^7<6GR31I=7>H>8[%IK:Z>\"PN\UF)'?T&+Q^G$:>D)&5 M>O\ YY>;_.'E>V\OP>3-=M].UC5I9C%I-OH,GFC6-3: 1DQV6EQWFGKZ<4;O M+/.\ZB/A&@#-*!BKPSR?^=_YS_F=!!/Y>N?+7D>UT[\M[;SIK/Z3TJYU&^:_ M75]9TZ2T6V%Y;)#'-'I@9JR,T$@X+ZH)954%Y^_YR0_,72/*FD?F+Y;CM+_2 MK;R5IGG7S#^7ND:%<:[);PWFGIJ+)J^LF\LH]+1ZND<@@G81J9VC/V,59)Y# M\\ZKY)UWSYJNH"!?R\U+\[/,OE_SE>RJ[3V-SJ$6GQZ-:I+S5]#\^+Y9N?-!CTPRB/3/TE M:6=]!)"MU$BW,=S&L@831H\<1C9BJI0_FC^:#Z/YNU/RMIOE_1=/LO/][9>= M?/?EW1IO,L5K FCZ5=)?-I\5U9RWL4AGD+W2/S6*..D+E_A5?6OY<^89_,7D MCR_KMYK&E^89K^W9WUW1HY8+2["2-&LRV\U98'95'JPN289.<19N'(JO%O*W MF_\ -SS3;:U^9$/F7R=8>3+'6/,^F?X+U6QN+-K*W\NZE?:4+Z;75N9>0>2P M$TBFT5421EY$QJS*O!9_^5M,O( M[KS#INCA88#?WLUS;SQZAZ@F_=/'\)]%RU J^I?R[\R>>?\ &_YA_E[YYU73 M?,6H>4;#0]9L/,6F:>^E1/%KS:C&;/ZH]Q=DM;G3B1+ZM7]2G!>(+*L&_,.U M\]ZC_P Y$^0=/_+_ ,PZ9Y7U"?\ +;S,VHZMK%E+JL<$$>LZ'00V,5Q:++(S MT3D\RA5J1R.Q5>/:A_SDG^&_N/R[T/SSJ.E:/Y;?S''>WV MM3ZE"FGR73ZCIPT]0=+HLI68L)22J^E\:K[0UKS-?>7_ ,N=:\YWNC"#6-)\ MM7&N7V@-.:BYM;(W+VC3JI/PNG#F =MZ8J^>[CSM^>>A^0_*?FV_\U>5=<_Y M6K>>6-,T"1= N+*3R[=>9[RTMXY'B%_.NHI#'=.S O;DM&HZ2-P52V;\T?SI M7S-:_E1::UY5OO-J?F%'Y0U3SQ>:1^3;KS2MU%I<=Y(4GMF18UC-P M5F"$LT7*JJI5)^H+55F#A.)F4R'TU4S\L_F5^:>IZ7Y,@\_P![Y>U"+\Y_RJUG MS=I^GZ)I\]D-#GTVPTUWM_K$]Q,UVMQ^E0:E(C&8Z#F&)"KQ[RI^>/YS6?EG MR=Y8_+ORGJWF2'\OOR[\E2R:/8>7CJRZ[=WV@6M\+:ZUE]2LQIC220LJ^BDN"Y"F,@4JQ]^U,5?%6A?F5^8VK1_E1Y5\B1^5?)EY^8 MVO\ YF6VK:C-I<]Q!91^6=:NHH)[>RBNH5DFF(Y3!Y%5V=Y.2FB,JNT'_G)/ M7-'M-1O_ ,P]*MI[&[TW6[?R&-&B^JW&LZ[Y4UR\T"[T]!/.RI-J,J6TEM&3 MPB]0H\K4#XJA[G\V?SLTG2/-'F_6=6\K);?E1YF\N>2_.GE"TTJX_P!R^H:G M!HAO;VUU*6\Y6:"36O@B-O*0L(!D^.JJI;Y(_-^Y_*RR\]1>;[<7OD^^UW\R M=0\BM:#A>W6L:7YVUJ.ZTEY99>+2W:S0?50%5$"R>HX^'%5GG?\ .K_G(+1- M<@\GZ'Y5?6_.'E3R/H?F7S;9^7O*\NKVFJZOJ[7ZG3C-+JMF=+0/IW%9&%P2 M)"Q ].CJL]\T_F7^:NB>?M-M-7NM(_+?RM>KI2Z);ZQHEUJ&F:M-=PQ/=6]Q MYAMKI%TVY2=IXECDM73C%'+ZA,_IHJ]1_.76Y/+>G?E_-#INGZG^E_S$\J:5 M)%J5OZZPI>ZC'"T\0Y+QGC!K&^_$@;'%7GG_ "N#S:?*XULVNG/QS+$Q>0Q0LK!"J.&;BJCM>_// M\\?)?E2T\TWM_P"4=8/S(\MQ1Z5=V36.H6#:$UMIEVJWJ M.6G5ED<_[K0(.:K/M1\U?G]9>ZN M;VU30XK)M0C$H4V+O]<:9&-546^[,JKSS\O_ /G([\XOS&\SZ#JV@^1;^7RG M=:[HNDZIH5GY?-SI\-K?I927]\_FA]0A],V<5X\QC^H,6,?I _'S55/-'_-; M\Z=7\N^4/,VI:SY7M=-_,_S%YF\D:'I]CI-PT^G3Z;'KLMEKW?\XVS>;;K\C?RGU3SQYI7S=Y@USRIHNJ2:R+1[65TN["W ME1;DO<7333U8B28L#(:MQ7%5WYY>;O-7E33="3R?KEKI6L:O=O#;V2Z-+YDU M;46B3F(-/TJ*ZLA+Q7E)-*\Z"-%'4MBKR71?SD_-CSSIWY(:7Y?.C^3_ #!^ M9%UYVTSS/?Z]I4\LEHWE"ZDLTN$TR.[3TYIG@YR6SSE8^;()G,8:15$^7/S9 M_-KS[J_E[R;Y9OO+6A>9+#3/-&I>8=8O]-N+NUU:7RKYFF\M"%+>*ZC>Q2]: M#UV7!5EX\F5>I?\XO222?\ ./'Y$/,SRSOY#T)KB0NT@#FQB+?&P#-4 MUW.^V^^*O?\ %78J[%78J[%78J[%78J[%78J[%7_UOOYBKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BK&/,/D_R_YJ_0XUVS:]70=7M==TM/5DC5+Z MS+&"1A&R\PI8GBU5)ZC88JE7G7\M/)?YA_HX><-(_3"Z2MTNGHTTT0C^N0^A M*:1.E32C*34HZK(G%U5@JPFR_P"<?19+B33;K]*SW3WB3VOUEUBF242(G% W%$ 51FE?D1^5OEZQEL-.T"4" M]\T:?YROKFZU"^NKF[\P:7' EOJ-S//>M0U@6$&K^?=6MM5U M'3-/O[_5X8I+6P@L!*^J:FJ7EY)<+;B6669*\CQJU.6*O79?)?EJ]UO5_,\] M@9=7\P:'%Y=U.Z]:2DFF0RW$T< 0,%6CW4IY !OBI6@ "K"M9_);\M=4TGRK MINI>7*V'D#17T/RA,+ZZAFTVT'U)UDAN$E5XYH&TVVDBN.7JQ/&'1U;GUS1]6U#2]1%Y?0P07 MACO;*XAGCBGCM81)"CB)_30LA(KBKQGS=_SCQ;V=CY7T7\J/)WE>'R]HEG?Z M=+Y8U'6-?T!'M=0O9+^XMY+K26G-[82RS/RL;F(PBIIM\&*LS\M_\XW>0+3R MQY*\M:K+JM_<^4/*FC>5-7O],U34=$M]?LM'M5M84U:QT^ZB@NXBH=?2N!(H M1W055FJJ])O_ ,K/(=[I_FC1KG1?5L?.FM6GF3S':BXG7ZQJ-@+%;><%9 4" M#3K?X$*H>&X^)JJI)K'Y2?EK^8UTOG>9;B76M8M[%K;SIY0IK^Z\N7L]YO(UQ5*8?R1_+ZU\RZ)YNL+/4]*UW0 M+[6[^RN;#5]1M8Y'\Q7ZZGJD=U##<+%NIY@\U_7(7UB[LX;_1?T[J%GHNKW,7"*U%_I4=U'97TS"-$7UH79E1$W"* M J]4UC0M-U_2=4T/5X3>Z7K-K-9:C:LS*)(+A#'(G)2&%5)W!!'4;XJPS7/R MI\E:UY6T#RI<65Y9:;Y1$/\ A2\TO4+O3-1TPP6[6BM9ZC9RPW4+- [Q.RR MNCNCEE=@56-Z1_SC_P#E/I-I+I5IY+MAH\]GK]G-927%Q/#+%YHGM+K6%D26 M5PWUF:RAD+'<,I*TY&JJVS_YQU_*RSB\P5TS5=0U'S3:Z?::[YCU'7-5OM7F M&DW4E[ILPU*YNI+I)K*>4R6\R2"2(A>##@M%4#_T+;^4L$12#3=9MK^37;/S M/<:_!YAUB+5I]8LK&72X;R748[P7,DC6L[Q2%I#ZBGX^6*H*?\GOR3U)M/T7 M3;FXT;4-/_2MI!#Y<\S:AI.H3127C:AJ-G=2Z?>P33Q1W-X9&AE+)$9.B\]U M7J>G?EUY,TS4H=7TS0H=.N;;R[!Y3LX;( Q5CNC?D=^67E_P K3^2])\NFW\N7.I:3JTUBUW=2L;O0S8G3W]:25I ( M3IUO10W$\=P>3553B'\K/(UM9:#I\.C&.R\K^9+OS=H5N)YB+?6+Z>\N;BZ! M+\FYR7\[<&)0<]E%%HJ\+U'\B?(?FO\ .G7/.%GK:PR66DW4'FRPT#7]0T[7 M[+7M3DT^3ZPUW87,,]I'-96$:&(.@=0IX$5.*LTU_P#(3\E?-CQ^6=:\O16L M#^7QHEWY0TS4KS2[/4=#LU-O;17FG6EQ"EW#:B(3B*8JIZW M^3OD'S,=6N;W3KZPU+6M9C\P7.MZ5JE_IFH1:BFG0:5Z]I>V5Q#-;E[*!('$ M+JKIR# \FJJFOEW\L/)GE6\T34='TZ=-1T#3M1TRPU"ZO+J[N'BU>ZMKW4)+ MB6XED>XFN)[2*1Y92TA8'XOB:JK#-+_*?\K?R]U_R[YATPS^6+[1]&;RYI%L M=>OH;2YTZU-]?)#<6W4UM81":4@%KG495C"_$2X0 M=% 52G6O^<8OR7U^P_0^I>6+IM"ET>RT/4?+T&JZE;Z?J%KIMNEK8MJ%K#9==U&:Y MDEL+N[X-)K.GH%FY7MK+!#/;Q\HH_40'G'2N*LAUK\G/(?F(Z-!]6U7RR?+. MGQZ1I#>5-8U/R[QTR&BPV3OI5S:^K!'3X8GJJ&O$;FJJ$D_YQ]_*Q--_16D: M+>^4X$U%]3M;CRUJNHZ)T"R^HZ78>HT49D>65Y9I6N)YYII&:26:>9VEED=B\DC,[LS, M257G;?D!^5\NJWVHW>BWFHV6H2WD\_E"]U._N?+@GU%9%O9H]"EG;3T>X]:5 MI&6 %FDD8_%(Y*J6VW_.-?Y20SWUY=:/JFMZEJ5G;:=?:OK.NZMJ=[)9V5_! MJ=K;&YO+N67TH+JV22-.5%^(#X7<%5ZK:^5-#LO,6M^;+:U:/S!YCL]/L-8U M#U')F@TMKE[1.!;@OIF[EW503R^*M!15B7G7\GO(OG_5])\Q:_9ZC#YET"QN M=.T+S+I&K:CI&H65M>RPRW,=O=:=<6\D?K&W0.5-2HX?9)!52G5OR"_++58= M(M4TO4=!LM&TN'0X[#R]K&I:);W.F6QM+P2<.J^K+0?O' MJJ]0DT+2)M*ET.;3X)M&GM#82Z5(BM;M:-'Z)@,1!4QF,E2M*4Q5Y';?\XZ? ME=;V=Y926>N:C%/##;Z9+J/F+6;Z;2$MYH[B']#37-Y))IICEAB=3:-&08XR M/[M**LAT#\F_(?ER31KJRL;^]U/0]7EUZWUW5=3OM2U&?49M/FTDW%Y>WD\T M]R4LKAX$$SL$3B% X)Q50?F+\H?*&I>5?,WE>STM+>+S#K4WFR1Y;FXXIK[7 M"WL-Z2)"P"W4:2%!\&U.-#Q*K&ORH_YQ[\F?E[Y8\M6,UM+J6MZ9Y4MO+5W* M=0O[G3[9#;00Z@FD6MS,\>GQ74D >1;=(^952X)44532;_G'C\K)#I:0Z5J> MG6.F:;I^D3:-I^MZK9Z?J-CI<*VUI!JUG;W4<.HJD""(_6TDY1_ U5VQ5E,/ MY4>1;>"*.+1BMS#KY\T1ZM]8G_2'Z5:0LURU]S^L$LA,+ OQ,'[@CTO@Q5$^ M1]"U3RYHD&D:QYEOO-5]#J&I7)UJ_'&=H[Z^N;N* U=_AMXY5AC'(_ BF@Z! M5#:3^5'D71+WRSJ.F:,UM=^3Y]=NO+TOUB=_J\WF2X:[U5Z-(0_KRN6HX(7H MG$;8JMB_*;R%#8Z!IJZ)RLO+'F.\\V:) \\S>CJ]_ZWYEE\T7]EJ1N;N\M]1U71H-7UK^^M?3]"[OM(BN$ ML;J9/1BI)-"S?NHM_P!VE%4TE_*?R'-8:3IDFB<[/0_-%UYRTV-KB=BFM7MY MXNY7,;$IO0+15 507G+\FO(WGK55UG6XM7MK^2UCL-4;2-:U/ M28]3LXF=H[74XK"Y@2]B3UI0J7"NH$D@ H[550VM_D=^7?F'6?TQJ6GZBT,<:G9%HJAOS,\F^8?/>I M_EYIMK/I^G>7/+GF;3_,^OWLSS/?M-HMU%=6<%K"L9B9+AU997>13&*%5<[8 MJMOO^:KW0[N>_L]>@\TZ?I_Z4U!=,M=<@F%Q^DK?35N!:17$ MDG(RR)$&EYN)"P=@54#'_P X[?E7I^IV^OV&@2'5-&.HR>5;;4+[4+_2M(;5 M;6XL[R.QTJ:Z^JV\$\=RXE@A5$?X:BJ(RJO&/(W_ #BZ\OF.]O?S$T[11HD7 ME'5/)0L=(UW7M5DU'2]6N-/F:!FU4K)I=M:_HY?0M+65XT,TE"O ,ZKZON?( M_EJ[U[5_,T]@SZUKNAQ>7-5NQ-*!+ID,MQ.D'IA^"T>ZE/-5#?%3E0"BK =' M_P"3KW5;_ M %2"[2\AM8;)9+B_N9I42Q6W*P1CDJAVX!>ZK+_./Y;>5O/T>E2:_%J$.H:, M\DND:YI.HWFCZG:BX55GCBO=/FM[A(Y@BB2,/Q?BO('B**I;Y9_)C\M?)L7D MRW\K^68M%MOR]?6'\FVMO--Z5C^GIFGU!8T9V4K([FBL"$&R<108JE6H?D#^ M5VHQV<4NBWEHMK7O)_E:P&E>6_*NG6^DZ#I:N\BV]G:1B*"(-*SN0B*!4 ML3XG%618J[%78J[%78J[%78J[%78J[%78J__U_OYBKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKQ+_G(?S9YH\D_E!YH\R>3=3AT?S-:7&DV^E:G< M6R7D,+7FJVEH[26[E1(O"9@5Y*2.C*:,%7S)?>2],\O7,-Y8Z3JEU^F8I;2VU'U(EU1XX_J;Q*46W'QR^ MK)(JGWYO?F5^9NDVOY\^5=&U"X\Q6T.I:I_SD'<^0K7G M!;+)/HL/FNYTTV<2&/XF6SAH74>IQ5G+5!8*O./RU_,O\V?,FC_IV;SZFCZ1 MY,_)_2//5YH=IHVG1QZGJ\VH>98G6XE]%O2LY(=-B$D=NJ.2%:.:+XQ*JFGY M?^=_^6G-:'38- CMYUL^%W M-ZK7OJ%#]6!<%I/45>V?DOYAUR\U3S-Y5\U>:_,U_P"9=*M[*\U#RAYVT_2+ M?6+".YDEC%S!>Z%#:65W9S-"R1ND34ECE_>,*(BKR+0OS>\^'\WORUM;+S5J M_F[R%^9_F76M!MM7OH/+UCH,R:;IFIWLC:'80*-;/U>>QCA,]Q/+"P,AV+Q$ M*LG\PZ-KMS_SDUYXOQYVUFVT.Q_)VSN;GRA#'8MIUPT][K%N4=Y+1KA.++ZH M9)58OL28QZ>*O%/+?Y@_F3^2GY*?E;J<7G"/S5;ZK^0&L>;-.\O:AIUI;Z=I M-QY4T#2[C3HK);9([IHV%UQN/K%Q,6*@Q^E7CBK.OS-\[_F_^6>K^8O(&C?F MG=>9-1O-(\F:OHGFOS1I6DRW%C<:SYSL]!N8?0TNTTN&6!K>5CQ9?4Y'X94V MHJC?.?F?\SO+J_GY+:?FUK+M_P XX^3+?S-8F73]!IYBN)=/O]4:/7*:6*1\ MK18O]"^K'TR=_4I)BJ<:Y^8[>WU/0?S@\N>3O*K(R:;'+<-++-5BWIB%:!54B_YQOUCSWY.\ MJ_\ .(VD7GG637_+_P":/E&2WE\JR:=96MEI5OI>AK>V9T]X(A=M+1%29I[B M57)=DCB!545>M?F!^:GF?RU??\Y-^EK]KING_EQ^5VC^9/*L]Q';+'9:G?0> M82TS/*G[SG)8P ++5?AH%^)JJO*-2_,S\XXM$_-K\Q1^8LD%A^6.J^5+70_) M$.D:<+6]&J:#Y,6[P/&2P:1TX+&JA?.6M^;?-\OD[S M7K7GNFDI_P Y%V?E33?R]>ST];(0^7O,T]C;RV,X1+[ZT5L_6G,DTR$>J$BC M6C1JI[^1/YD_GUYVUO\ +CS9Y@MM2C\D>?Y-2.L-JMYY7315A6VNYK3_ ]: MV"IK/J>K!'5;N6:D/JLXY .JJ3^6/,WY^>8OR_\ (7G>Z_,[S#KL'FVSU+4/ M,>B^2],\LPZWI]O877HVUSI]EJ=C=?7(!&S+>JH>9IFM?JZ0H94=5K1O,MV? MS$\Z_FBOY]W:^6='_)C0=2N=;;1[$:&Q_27F.U>>XT[T?K*R02P&1HX[I"TW M)&_=!8E52X?F[^=ECJ'G3R%'YAUK1M;L[S\M9-#UWSO:^6]2U6WC\W>:_P!$ M72SV7EZ.S@CB>RC#)#.B7"NSGU*<0JK.)O/'YEVOG.[_ "8'YCZC>O-^8&D> M6H/S':QT?_$,5C?^4=1\RR\8DL4TWF)K%8E9K)J0L]09.,BJL%_)SS-YCT3\ MP]+R\EO,&02>DX,KK,L3!'DK5%"JB M*JT?YQ?G)Y%_+;R/Y^UOSY%YYU7SY^2?F3\P;W3K_2K*TTS3]3T'0[#4K8V< M=E'#<<)7NR+@37$@:G*+T1\ 5>\^1M9\\Z-^>FI_EEKOYEW?G[0K?R#;>8XT MU6QTJVU2UO;C4Y+8_67TRWM$*M&E(E]%* -4R'=56"^9?S%_,6WNOS/\]V?G MB[LM-_+7\T- \B6/Y?QV>FOI%[8ZE-H,$\]Y+):/J'KTUB1E,5W&@*1_!3F' M59#_ ,XR^5-1TG\O?.[W/GC6=9O_ #!YU\\0+KMW:Z1'=6K6GFC6;19XVM[" M'U7/$2TN1*BGX(U6(>GBKYU_(;R=YQU"^_YQQL[3\VO,.FWVH?D"=1N/-7U+ M1[G5(K2>]T1HK"U:XL&MEB5MR\]O-,R[&0'XL53?_E=G_.0_GW3-*U#R9:WY MO]._*?RMYVO7\OW/EC3](_2^O1ZH[KK1\QK//]3#Z>A'U-XF6,SF55?4 MWYI>;?,6C:%^4-U!-:17WF'S[Y3TK7&2&"Y@:&_FXW:VYE63B":A)%/,#=6[ MXJ^?/)7F[\\/,OE7_G&Z_O?SENK?4_SWOKL>8;BVT/1@FG6-EH6IWRQZ;$]L M_&XD:WB9Y9VE3FI*P+&QBQ5-/,_YL_F)Y;_,/RE=:1YKUKS7Y0U?\R-,_+_5 M+NXA\N67EA;B>\^HWME;0F--:N[VV"N9)H)O0%PDM8ECB>)%7FFK>;O/6MZ? M_P XZ?FMKWY@1ZGJ/FZ3SOKNG^1KG3],$&F7%EY-\PB.32C'%'<-;Q@A9ENC M<\B\?[R/=957I'G?\T?S!B_+[R;JWE?S5K0\QZ3^5^E^<_-?E[R[;^6K""VB MN+21SJ.L7WF"&6VCMI9H&CAM[80R$1W+!V" 1JO/O(_FGS]+K/G/\RYO/%_. MWF[SK^35O?>4Y;/3GT:(>9X/+37GU5);,W41BCNI(HJS54-S;E,!(%7I?EO\ MS?S*?1/RR_,G4//EWJ,'YJ>9_,WEV\\D266F)I.F0Z9IWF*]MI]/>&S6^]57 MT6('ZQ6J$\"BK(/RA\X_F=+J/Y"#SK^8+>O--4JIC](?#BJ2?F7^8OYDZ9YB_YR:U+1/S& M;1=/_(/RIIWFSR]Y)M[#3)3J#_HJYOYTU*:Y@FN#9326_ ^B8I0>?"<;!553 M7/S!_-:*R_.GS/!Y_:TM/+7YE:7^7OE+R]!ING^E:6NM7OE^QEO99989)9KJ MW&I2O;@D1!J":.<;8JA-7_,'\T/+_GN__)5?S'U#4VN_-WE'1[;\Q+JPT@:] M;6GF#2]9U"Y$:0V,6G,4?2D6-GLFHCR M=-:_,76O,NK:Y'JFN:)%Y7L/,\%OIMA;WL4$SZE"=(YJ;@-(?JD3M$T7% P: M215 W/FK\^[KRWY+?6M7UO29+.'7$\Z6/D/_ SK'F]#9:O+9:?YEF=E>.[C@6.6U )?U ZK[96=VE*\>(#<2&!!V-*_ M32H\1WQ5%XJ[%78J[%5-XHY/MBM=CN1^K%5R(J*J(H5%%%4; 8JNQ5Q%00> MAZXJL$:!N7$@Z+YETV;1O,&EVVLZ3XM;Z37Y;.-[E;FT= M)+>97(8+)&T:D.M&VZ[XJR+0O(?DORPI3R]Y6TS1D.FV^CE+2VCB!T^TEN)X M+6B@?NHY+N9E7H#(_P#,<58YY=_)3\I?*;>8'\N_EYH6E'S7"UMYB$5G&5NX M'+,T,BL""C%B2H'$[5&PHJFWDC\LO('Y;6E[9>1/*6F^5K;49!+?I8PB,S.J MA5+MNQ V%:#?Q.*H#3_ ,G?RKTKS1+YVT[\O]#L_-LMX=0/F&.SB%TET89K M=IHY*5C9HKB1&*4Y!C6N*IGJ?Y;^0]9\UZ5YYU7RGIM]YPT2RFTW2O,)60;$(H(VQ5C'E_P#)'\H_*NG7ND^7OR\T32].U*[LK^_M M8K5"LMSIUQ'=69?-OD?2/,&O: M(8SIFJ7MLLDL?I.)$!)^T%85 :H^\XJ@]?\ RB_*S6_,2^;];\@Z#JGF=UMX MDUB\LXY)2;25+BV;D0:-')&K*].2\10[8J\@E_YQUBN_S1M/S#O=6\N/;6GF M1/,MK/8>7%L_,5S\U9+UK:2WC]9E;A8QR.JIZDC2!Y'5>_:5Y)\GV M-MY3BL?+>FVT7D2&2T\F)#;)&NE0M#]4>*S6G[I?2'ID+^SMTQ5+_-WY4?EI MY^U"QU7SKY&T;S1J&FV\]I:7.I6D=P5@N5*2Q,'!#HP)V8$"IIUQ5,9?R^\C MS:;K>CR^5-+DTOS)+;3Z_8-;1F*\ELX+>VMWG4BCF*&T@12>BQH/V1BJ2S_D MY^5=UYKF\\W/Y?Z'<>;I[FVO9/,$MG&]S]:LW1[>X5V!XR(T:D.M&VZXJJ:' M^4/Y8^6?-5_YWT#R-H^D>;-3$HO=>MK94G;UR#+0C9>9&_$"N*H;7/R6_*?S M+Y=T;REKGY?:)J'EOR[(TN@Z.]J@ALV?ES] +3@&+$D#8G<]!BJO+^3_ .5L MVL:-Y@E\@:&^L^7](;0-&OS9Q\[?2W65&LE%*>B1/)\!%/B;Q.*H;0?R2_*/ MRQ;_ %70/RZT'2H3)82OZ%G&&=]+OCJ5BSN068VUV?6B+$\'W6F*IMY@_+#\ MO/-5MYAM/,7DW2M7@\V36EQYD6XMT8WLUBBQ6LDS !F:)%"J:U"[=,5:T7\K MORX\N-:-H'DC1=&:Q%Z+,V=G%#Z?Z12".]X\%%#<+;1"0_M<%Y5IBJ%O_P O MO+$FFV6E:;I-CHDGEW1+K0/)=Y!96LCZ19W5M';/%:1W$4L/I\(8@8V0H0BJ MRE13%7DOY._D)#^5OF/4?-5U<^74O;K1TT"RT[RAH\LR&MYX@117 MB(JI'3MBJ76/D;R=IEOY6M-.\LZ;96WD?U/\'P0VZ(FF>K!):O\ 5 !^ZY0R MO&>/[+$=\58_;I+BVO#Y@ELXWN16K>[LXY([.V5%00 M1H1Q],*@ 0@K[8JAK?\ )'\HK76H?,=M^76@P:Y;VVEVD.I)9QK(L.B26\NF M(*"G^BO:0F(TJGIKQI08JB-._)S\K-)\SZKYSTWR%HUEYHUN*>'5-9BMD6:9 M+H 3@]AZ@%&( )WKU-560VOD_P I:5_AE[#R]I]BWDW3GT7RF\4"+^CM/F6" M-[6VH/W<3+;1 J*"B+X#%7EA_(+R1K7YD>;OS"\XZ/IOFR[UBYT6ZT&VOK-& M;2YM(MC &24LW,2M1^)%!X'%7J5QY&\G76F>9M&N/+.G3:5YSGFNO-=@UNAB MU">XB2&66X6GQNR1(I8[T4> Q5BMI^1_Y16/E*_\B6GY>:)#Y0U2<7.HZ$ML MOHS3*05D>OQ%EH*&M1VQ5J?\CORAN?*-IY#G_+O0Y/*%A<&\L]"-JHACN&)+ M2K3XN9KN:U(VZ8JUK7Y&?D_YBT+R_P"6=:_+G0K_ $+RK&8?+NFO:HJ6<;?: M6(K0@,=V%?B/Q&IWQ5$W?Y,?E/?>9=+\X77Y>Z%+YET2*"'2M5^IQJ\*6P*P M!0H"_NP:+4;"E.@HJSS3M(TW289K?3;**SAGN[F^FCC% UQ=S/<3RGWDED9S M[DXJF.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]'[^8J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78JPSS?YOT3R-HMSYH\RW8=+TNUUJ6!XV19+*]GN+>.2&4JLHE56+Z# M^;?Y?^9_+GF7S3HGF:*^T/R8]RFOWZJRB-((O7YJ&')TDB*O$R[.I#*348J] M#T#5K+7=#T;6].:5]/UFRM[ZP>>)X)6AN8UEC+Q2A71N+"JL 0=COBK%?S _ M,/RA^6VE0:WYSUQ-#TN^O$L+>XE#$>JR/,[T7<)#!#+<2OLJ11R2-\*DXJS\ M5X@$T:F^*L&\L>%XWYZ=;?+WE_S7Y>N);S0?,NF6FK:/?2HT9FM;Z%+B!RD@5U)1 MP2"*@]=\591BK5 >HKBK05*4 %*GIXGKBK$O.GFO0_(^AW7F;S)>RV.C6MMY<\W)"K^G;:FMO%=/;^HP"N\:3H'XUXM53N-E63ZKJ^EZ=<:+87^H M165WYBO'T_0X'<))=726T]VT4(ZLZP6TLI WXHQ[8JH^6]=TCS)I4&M:!J=M MK&D7ID%GJ%H_J0R&&1H9.+=/AD1E-.XQ5/:@UH:TZXJDDVI[$T=K M'>?7C;RFSX.[1^FL]/3:6JU* \@I#; @XJG"*O%:KO3OUV\:]Z8J\;\W_G3Y M.\I^8+CRN8=;\S>:;*&"ZU;RYY5T6]UZ^LK2Y+BWGO8;&*5H(YC&XC9ZN6"5H)G@F5#05,E32O78XJEOF?7M-\KZ!K7F7 M5YVMM(\NV%UJ>K721O,8K6SA:>=PD8)8B-20 "2=@#BK'K'S[Y?U!M'ACO)+ M2;S'.D'ET7T4EJ=39].75 ;!9%'K!;8EG*?9*2*?B1ABK/(J\:,34$]<55,5 M=BKL5=BKB*['<'J,5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BK__TOOYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKYR M_P"@SV8U;\@+FXDF\G^1$\V?F5-I=U=S11>;-(U71[B MW.H1SR,)9Q:#5"L%#ZH$BE6(6BKT.71/S6FN?+MKJ-YJM[I/_.3^OV&JZ[I; M7)4Z!:6>J7&J75B)EDJC/H$D< G3TN/U!(PIFG50J]L_YR'_ ,7>7M4\C_F' MY(TV75]?GL=:_+R.%)!%]5/FU+5K&ZB;7]3UGS]I%K^9HU+7Y_S"\F6FB:RWF>YL MY%O8X[77[R759[.*WC9[:99!9Q@RI;QH5YT=5[#^:^D^<_S8_,_4?*>D>1=" M\[^1?R_\NRVFLV'FC5[G0[;]/>8X'C,J<-*U3ZT]MIC\8W0*B?6IT9G8\8E7 MFDWF9/,&F_D?8?\ .1;S6WEWR5^1H_*8M)LO,4OY@^2_R+ M\E#\I+>&6\4V.MS>2)XS+867)8S=M*PC8\"U>*G<8JFWD+RYY4?RY^;%SY<_ M.'1QY3N?+UE%YBM_R]\N>8%T6UG34(Y9+K4WNM3U&202P P7,4,L,BV9F?FE M!(BJ1_\ (,;WR,84OM#\N^2_+FO1F>1;K7K[\M/--XUHQH;@%+K2KNBU*O>9[ZWO\ ZWJ<?FK;^;)]9U#\X8_-WE*+ M\N(D6^^O7'E-/\-O(_U:&L7Z/-Z+YIFD'%9.?)@1BKZ&_P"N*O'M"\D66@1>6 M_P QM#@U>+S?JG_.16KZ4NJK<7C>GY;O?-FHQRVL4#'TTLY83S8<.+%VDY5> MN*I)_P XQZ3>3?F%Y,U;6/S"TD?F=##J3--T765\PW$CV\\;P^9;^?5 M+FRB$%PT>;M-U"&3T:22K$EVDRPQO_>K&[*0N*L/\I^6V_+7\MO^<@/+WFCR M]J&IQ0:[Y/A\S1O=SVUJUQ>^7=&DU*\U6_LZR26$$TK_ %N2/F6A1@>1J2J\ MDT/0/R[U'5O*D7YDRZ;K7Y7^6OSBBL/*VIVEAK>D:!%IVM?E_>SLVGPWEY>3 MB"ZU/TSZQG9)):<" 2I52KRYH7DC3_RX_*K0K35?+/DOR98:CYY@_-H>;+/6 M+[2(?-%OJ%FFCVUU#::CILR7?U'ZP8*R\/3$IX,Q5@J^F_RB\@V^L?F;Y,C\ MU>8-<\_6'E#\L=$U7RQK%U'JFCZ=/J \R:NUI=KIL\S$O;0"-+CQ+%@ MP;%4W_YR%DUX:O\ \Y"_HV35H2O_ #CI=OI[V3W2\;QKW503;&$CC< !>+)\ M8^&A(IBKT#R)Y/L_R^_/[7O*OEJ+4;7ROJ_Y?VFNZNMU=7-TE[KIU>>%[^>> M/SCYL'F?RGYNU&.=-,U& MQN]/MK=+&VO"C!Y[1K5_5@_9$BLE0QHJ\D\D^;_\"_G)YF_,7SW:>8/)/DG\ MU+#7KCR/Y>U>PO;>\DO9-0L;>*Q32U0L+Z[^I2W,<*KZC),C']Y(ZA5-/^<7 MO*I\Q:[Y=\R^<4UF[OO*GY1?E3/Y?AU*XOT@M;^YT?4$O+E[>5UC:Z->$K," MP!XM0XJGGYG^6?S"_.#\RO/=AH?D_1O,'DWR)HB^5=&U#6M=N?+\UCYDU.-+ M^]O["/\ 0VJB:>S@:R,%P D8+NO[UE;TU6O+_P":=[IGG+\I///YJRW'EHW/ MY=ZUY2\U6Z)=2V;^=[#6]/M[O3+5%5C8_P!/3?D!HY_):!CJGZ4EU^6UUP:VEA!#^^DNN'U 72."0G -05Q5 MEK:)Y/N/S#_*[6OS0L2-*TC\SM.L-.U"^>\6VM#_*S7?S0TK2M M,T+\VO./Y0SZ9>-IQ5X$?^<0OS&K4 M?\YL_GC2G$#Z]H_?J?\ CF_+W^_%7'_G$'\Q30-_SFU^>)'^3?Z.M/I_1N*K M3_SB#^8QXD_\YL_GC4=A?:./#M^CL5;_ .A0?S$KR'_.;/YY K]@&_T<]/$? MHVAKBKO^A0?S%Y!_^AVOSQV-0OU[1_#N/T;0_=BK8_YQ!_,2E!_SFQ^>0!H# M6_T!V*FE[HXV'V3_QS3]/G_5NQ5M?^<0/S$ W_YS9_/.I&X^OZ/M_P!RTXJT?^<0/S%V)_YS:_/( MDGXJ7^CC;Y?H[%5S?\X@_F(U1_T.Q^>2U()/U_1^U>E--%.N*K?^A0?S%XD# M_G-C\\QX5O\ 1R?O_1V*M?\ 0H/YCL&=O^T>ORK M^C:XJT/^<0?S%Z_]#L?GG6NW^Y#1_P 1^CO;%7?]"@?F+R)/_.;/YYT_YC]' M_P"\=[8JX_\ .(/YC=_^/^<0OS&4; M?\YM?G@6V-?KNCD5^1TWI[8JM'_.(7YB* 1_SFM^>A9?B .H:,:GPH=.I]^* MN'_.(7YC(M?^AV/SR9]]OKVC4W/@=._CBKE_YQ _,10M?^M#[_HX8JN;_ )Q#_,8MS/\ SFO^>18B MH"WVBJ!3;=?T;0[8J]M_)O\ )_S)^51\QC7_ ,Z_//YR#7OJGU;_ !I/93#3 M_JWK<_JGU2VMROK^J.?+E]A*4WQ5[JHHH![#%6\5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?__4^_F*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*L-\Y>=]*\C6.F:GK5M>-INH:M8Z3-J%N MB-#9M?R^C%;M4TX:C; M+Z7^CTD2ZEAA,E:\Y8K&YD6BE (F#,K-&KJIEH'YD>5O,>K>8M'L+P1W/E_6 M)-$62=X4CU"XMX8GN6L*2%IDMYG>VE( *SQ31D5C.*LWCE60D*K"G4G;_.N* MH74=5TW2($N=4U"VTZWD<1)/=3)"A<@D*&D9020#MBK%&_,7RU%YSU'R/=7! ML=4T[1M+UQ[RY:&*TE@U>YOK6VBBE:2K2\M/E)7C]GB03N JKZ=^87DW5M<\ MV^6[#7[6;6_(LL47FRP+<&LC-:QWBM(S\5*B*9"6!*J3Q)#;8JF<_F.R_1]M MJ.F*=>M[J\M[.,Z?-;.*SW"P/)ZDDT<96'D7<*Q?BI"*ST4JH^+5]+FN_J$. MHVTU]Z/U@6:31M+Z(8*9. 8MQJ0*TI7;%6K76-+O9KJVLM0MKRYL6X7MM;S1 MRR0MR*TD1&)7<$;C%6):?^97EG5O/+>0--EEOM5'EY?,OZ1M_2EL#:M=O9>F M)XY&K*)$)*\:4[]L59X\BQA2QIR8*/F<52]-9TJ2^FTQ-1MGU.W3G/IBRH;E M%HK5:$,7 HP.X[CQQ5J#6M*NYY;:SU"WO;F!$DGM[>6.62-)4#HS(C$@,I!! MIN"*=<58M#^9'EFZ\ZVOD6RG>_U.[T.[U^/4;4QS6(M[*ZM[.:-IDD)$JO/'[-37MBK.T8.O( KN11A0[&F*I3=^8-%L3*+O5;.V-NOJ7 EN88_33U#$& M?FXH"X*U/[6W7%49#?V=RMO):W,5U'=Q>O:R0NKB2$@$2(03R7XAN-MQBJ7? MI^T%UJ$,B&&RTVUBN;C6'FMA; N\R21']]ZB-$(N3ET5*, K,P<*JC+75M-O MXH)]/OK>_AN0Y@EMI4E5Q&0KE2K$$*Q -.A.^*JRWUHR0N+B/C<V]Q%)##Z:\W]217XKQ76]',\USY(DT^/4KXB,VL_Z2M$O86M94=O441N Q(' MQ5 KUQ5FCR*E:@D@5H!4GY>.*L>E\TZ6]@VH:1+'YCB2ZMK5UTVYM'XFYFCB MY%Y9XXP(Q)ZC#ER*@A%=RJ,JF*:UI4EQ-:)J-LUY;E$N++U4$T;R+S1'C+P68)O)K>>*5(: M^\9&(38'=B,58]H'YA>7O,OFWS/Y/TAY M;F^\J:=I.IWVH+Z;V4T.LM>I;BWF21N;*UC('V &U"=Z*LU>58R@;JYHH'L* MXJEL.NZ1V9I=V,$R231'EPI)&K%E^(TW'7%6[;7-&O%,EIJM MG=1J[QO)#<12*KQE5=258[J9%!'8L/$8JI2^8_+\'U;UM;L(1>2/#9L]S$HF MDC;@Z1DL S*VS ;@]<55I]:TBUO(-.N=3M;;4+JGU2PEFC2:6II^[C9@S;[; M#KMBKCK>E"ZCL6O[=;N8.8+8S1B201\O4*)RY$)Q/*@VH? XJIIY@T22R.IQ MZM9OI8%3JBSQ&V^V(S^^#<*\CQZ]<57OKFCQ6B:A)JEI'8/%ZZWSSQK"8BRK MS$A;B5JP%0>I'CBJ01_F%Y.D\W-Y#77;8^;!I4&MIHW+XY+&YEEAAEC;[#\F MA?X5-:#D10@XJR/3M7TO5XFGTK4;74H4/%YK2:.=%:@/$M&S &AKBJ*GN(;9 M3).XBB12\DS$!45=RS$] !U/;%5HNX"XC$B^H4]18^0Y%*TY@5J14]<58)I_ MYI>3[WS):>3)M233?-]_876K6/EVXE@>:;3[:]:R6Y22"66 K,X#1KZG/B?B M12'5543Y#_,7RW^8OE?RYYK\OS.+7S-H]CKEKIER8EOK>UU"%)X/K,$4FG":,W"B@:IBY88D-0 J>0KVWQ5"C7 M=&:]ATU-5LWU"X0206*SQF9T*\@RQ!N9!7XJ@4IOTQ5C'D3\Q?+_ .87E:Q\ MW:&+B#3K][J-+>]6..XC-I-7N YHOI*6Y/4G;B#7%6->2;*.[U:5YII-1T?3?T5: M-#)>!M;U.UTFVF:%I%(B6>[C+MV6I )^$JLY)H"?#%4KNM;TJQB,U_J%O81* M 9)+J:.$+4T%2[ ;D$#WQ5?;?,-IHNFQSP6S32N&8RW,\5M&HCCY.?WD\8 M8@44-R:B[XJFY22&*5)XI(YW 1C+P MDX.2I(7@59E45C&7]*WBJ.:YD:.W75+*1;S3FG9%8B);J& M(R U0$4-<5?-">2_.&L_EM=_G+>Z->P_FK>>:;'\RK/RTUO+'?)8Z+;064. MAA"AN(VN;&!Y)+16X_6IY8U/INQ*KYJT#\B]<@USS&?/]UYLL_-WGWS+I_F_ M3O\ #WDB+69?6U:VTZ]U-[#S3@-^9/Y=:_\ F%Y(N_/7Y96'ESS'I]]IL7EV M[\UP1:Y=WFC2Z?+)I=E:WTBO]6MKQ5N/1XH"T9=3*%=5\B:/Y#ET9;>+\V?R M@\Q>9=7E_)33="\H:O+H-YYCM[#7&UCS%/!:/%;K=&"Y6*>V=9FBI;K\#RP> MHJ2*IYY9\D'RK#^;VG^9/R7E\P?F#JVE>1)M2U.]\OWFH6MS:6NCZ';ZUQ23SZ?'O-!G_.'\K- M8\H?6/*Z^6$ETJSU31+B_O;;1+:*&.VAB,4LDS&*.0%6>95(KBK(?(/Y2W?E MSRE^2&L:9^7MQH_G^Z\_>;7\[:TEG)#JBZ=>67FMH5O;L@2Q6CW#6C(CL(@Q MB*J&X8J\K_+[\G?-,/D#S'::'<^;F_-BV_)_7- UC3H_)L/DVT_Q%?Z=!"/K MNNF"R?5[E;F%Q;W$>22."PNH;9HG2-@7)@C+U# N!4*OLR=>494F@; M8G;;PV/7?%7YLW'E3S!=_GUY#U_2/(.I>5+[3/S,N?\ &=AIWE5N"Z/)%J7I M:CJ/G&6(2WRWS-%+Z%M-)#"K102I&T1Q5)[#\D/,'EW\I?R#T[\N/R\O/*_G MC5/RE\TZ7YRU"Q@FL;]=8NO*O&PAU6_6K;\K+K1_,.K7'ERZ\MV-WK8U6PE:&.VN8;:LR*CEY M/142@CC)*(SZ:K[FB):-6(I4;5%#3MMBK\NO-OY*.EM9>9YO*-WY?:__ #D_ M,74?S#\Q1^4CYMOKC2;N_P!6&C\]%FM[R6YM97:WEC$4+1HQ%SQ5F:3%7JNE M>0_,'Y>?EIY'_,/\N[37?,_FGR)J&OR6VBZSI"Z1>:IY?\QWQDN+!-)M8P]G M;12BWN+>V6.%XU@C614HZ%5YOYR_)/SCH=CYMTBRM]3OCJ&D_EGJ?G[SA::3 M^ETU.[3S7YBU/S5,+$0E-28)=!Y+586,B2)^Z/( JJVF_EGYJ\O^6H/-7Y2Q M>8-2UO4O,]]H@EU;RV?)L,6E>8]$CTJ2.QT:SMH9;.QBU2"SO;J4V\3&2W>= M2Z4YJN\V?D7^9.DZ7^8'Y9>5X=0USR_Y'\G>8M=_*O5RQ6Y;7_,MM:Z?:&%P ML4*W5HD.JQF*-POHW4;,':8\%5VC_EM96_EOSUJ/EJU\T>8_+]UJOD0^;/+L MOY?CR9IDVD:/YC34=92#0(K*RN=1G?3VD%P!:OZ\(2W3U'Y1!5]"?\XX:)IV MG>&>:ULIU1X(_54KZ12, MH0:QH3NJ]Z_,+2[;7/)?FW1;N#5[JVU71KVSFL] G%KJLRS0.K)8W#21".YD\OZYHOE7\M&ETR'S#^7DX\\:=Y(O_(]S>I9><=,N MKJ"]T&XMK1)I+6!'G:[MX!&L0XL05.*H*UT31-(\V_DC#J?D'4++\T8?SJ\P M/YD\_3Z3/%;W5G??XEGTZ)]894AU0M:/"L:0R7'U<*4?T2I&*H2T_)37_+GY M0?DCI?Y:?E[?^6?/6J?DGYITKS?>V4,MCJ)UVY\KV\>GV^J:@[(ZR+?.5@$\ MH]-A1.'"BJH:Q_*R>7RG^8%WY,7S7JUQ)I6A6GF#1$_+Z+R#ID]O!K^GWVIQ M-8QV=A/J=RUE!,H"12J8B\():8(ZKZ1_YQ^T31;3\W/SRU[R9^6^I_E[Y U[ M2?)J>7EO=%N= MKZ>T75TO)+/3[E(G@5"Z*Z&&$\JR&,B022*OK:X7F@6M*D M4.QW&XV/7%7Y0/Y,\\WOFRQO_)7D35_(FMWVC>==/\QZ%I_EH:+:Z-?2^7=1 M@TR"]\XS+!/K$LESZ;FX]:6U,_[T2(P@Y*I7YW\H>7]9EF\N_E]^4FN:%KVH M_D?J&F>8HXO+]YH3:Q?P>8O*QO!:V;1VTL\L8=FDNXH.+ATX3R>G2)5ZQ^>/ MY/:1%^84]I:Z=J7EKR'=^2M/TSR-9>6/R^M_.$8UCZ_K$NIR6Q-G=+I-RPNK M5C<.81.Q5GD?T"8U6->_DG8ZEH7G'5;O\MYI/ M-OF'_G(*&XN]9%G,FJ2>6;CS59K=R0W*@3Q6,UB']4PLL3Q%R_(.Y95*_P Q MORKU.UUCS?I.A>7+SRC^5>F_F?H6J26.C^54US3%TI_)-S;3O:^7$MYX;Z,Z MM+ )!%;R&.;]^0#$755-OR]_)/R_J'FO\G;77/*^M>=O(UA:?F+JDC>;_+T> MD6%O/J5SH*64?Z#2.."TMG2.5]=T^/5M(\R:;=:7J>ES\O0N+:[B M:&6*7@0P1U8J2/OQ5^=H\B?GZOE%?S<^NZFWYR16(_+LV_[]IS"FG'0#KPA- MO6OZ:/Z0^SZ/U2EUPY_!BJM^0/Y4:'^6GYE?EE:ZC^4T^EQ:3H?GG0O)^KIY M;NKR/398_/%_<:>K:A]5E^IH^GN6@DGD0-&_PL>>ZK*?R5_*8^08?^<.+K1_ MR^F\J:POE/4%_-F]BL98;HW$FAQM'%K-PX,AXW1(CCG>B, L:J%4!5^@K4*' MENI&_P L5?FQYG\L:W??GKY2UW0?(^I^6]5T[\T;5M>@TORDSF;0S=3LVKZA MYREB$EQ'>*ZR?5;6=T@B:*WFB3TI2%7I/_./?E7S1HVH_P#.-\FL^7-2TE=# M_)37='UHWEM+#]4U"35= D2TGYJ/3E9()&"-1B%8T^$XJ^VY2 %8]%8$_+Z, M5?GO^57Y/6NN-_SC#9?F3^6S:EI/E/\ +7SE#J&G:YI[O9V>HWFL:&;:&\MI MQZ1>2&.5XUF1OL%U 9.2JI3Y)_+?\U-*\A>2M#T*SU#0G_._35\L_F?+>QR1 M7F@3:;-,JZP$EAD*/-H<EZIY3\V1^7KMH[7R)8ZU8W/I1^:!;FUB@32898_JQNPQ3_ $?TRS^F MRJSR3^6_YI>7/)7EFP\L65_Y20:ZJ-"X1VT M@S0HT]4,R6,?"DLC!5(OS0_)6/\ Y63YST.2+S%Y;\L7&C^7=#_*"U\L^1HO M,UQ;VMGIB6)CTK7KBVGCT*6*9 L;27%N$&VT"X\S16EQ)K5(Y M)M*MH;J5^9!"/]7<(0>31\JLJ\$_-/R!Y[D_*[1?+]_^7VKC\S]%_)W2K/2_ M,%EY9'G'6-5\QVFD213VL&L3^O;:.UA,@9IO6BFGD97@>1T"LJSG\Q/R9TW5 MO)7_ #D7YIUS\JY/-7FR]_,+RQ?Z/J:F][%:W?E;2H)KG2QP9?J1C@A>&V7ZNYB9C"57VE^5 MNI_\Z=Y7T:Y\HWGD;5-/T'3I[[RGXCT[ZPKJEJM^X:.=HC$0X61F0%.?' MFM57IHW /CBKX<_+[\EM8U*_\U^1?.5B;3R)^6.E>8?)/YFTRW5GYGN([ MR&^4W2&*:;3K%+>W6=/B]:2]B>H4%E7A_F'\L_S(URRT+S/^8MMJ5@GEOS%I MOD[S+/::!/YL];RWY6T/5[2"[FT&XMKE]32ZUO4&G2?T)"%DBFH@BY*J^U?^ M<;_*EMY0_+M=.M+C7KJVO-5U'4;2;7])B\OR^C=SET6VTB)(OJ5JO^Z86CC9 M5^U&I.*M_P#.27E9_.OY=Z5Y;_0UQKUG?^>O([ZQIULLQ?\ 1]OYGTR>\E9H M"KI'%!&[R.".*@L2 ,5?'OYH?DS%=?FGY_TM[77?*?E[6+/1K+\J;'RAY"M= M>:"..P6&Y_1&LM:20^7Y4NN7$M-;*C_Z145]3%7O'F[\M_,S_F)J_D'1+ M^ M4GYZ7D6O?F- M5KGSMIFM>7O*4&G>;;>TMO\ E7Y\]C])S^=-7O%;]&R6-^;%I;.:.1;AHD$J MLHYL$IBKTV+_ )Q]\W:UK,7Y32W_ )CT/\N-6\N:/YHU7S1=LIU0ZY9^7Y-! M9[^>,2VSZC).\-W*HD8+);0S1-5:XJPWS3^7/YB>9;K1/S$_,K1KG0UU_P S MZK#YT6P\K2^=1:VVE:7:Z7IELVA7%G=2SVYU"*_FM+@P.5AF20NGK$!5G>F> M0=(\NWGY3_,-KY?L[[RPTE[%KVI>8/K]GZ6E6$931#]5D M9+627ZLMK#Z<4CP,A1%7U)_SC9I&IZ#^0OY)Z'K6G7>B:QHGD;0['5-$OT9+ MJUGALHDD@G5JE7C9>+5/4'KUQ5[IBKL5=BKL5=BKL5=BKL5=BKL5=BK_ /_6 M^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*I-JVN:;H.GSZIKE_ M:Z/ID+1I+J-[,D$"-,ZQ1+))(RJ"\CJ@WW8@8J\Y7\[/R:GL[35$_-/RE+I] MYJAT*TOCJ]FT4NI4#-9(_JT,X# F/[5"-M\53>/\R_R[E\UM^7L'GK0I//:1 MF23R4-0MVU,*(EG^*S#^L*Q$.*K]DUVQ5OR]^9_Y=>9]6GT3RQY^\O>8]>@L M$U*;2-/U.VN;E;)B*3F.*1BL?Q*.1%*XJH:%^:_Y;>=5UZ/RK^8/EGS"?+ $ MFOMINJVMW]02K@O=>E(?2 ,;_:I]D[XJLT[\W/RJUC0]0\Q:1^8_EK5/+NEV M;:CJVLVVJVDMK;6?J2PFXEF20K''SAE0,Q Y(PKMBJG;?FS^5<_ERU\X0_F+ MY8F\I75=-M=3M)9]2MHPY:6SC20M*B^F^Z#]EO#%438?F MA^6VH>9-5\EZ;Y]T"]\UZ#%++K'EF+4K>2_M([<+ZS36X7<-K<1B2UXQK,!RN M>2K"&($A90#N,51.E?G9Y-NX/-OF&[U2PTW\N/+46ESZ=^:ES>P1Z#JD=^'1 MC9WA(A802J(GHY^,\=L5>AZ'YIT#SEHMOYA\IZW8>9/+UZ"]CK6E74=S;S!' M*.8YHBR$ J0:'VVQ5YO^9'YT^1OR[]33;G5],U?SA')HZIY"@U"W@U5[35M5 MMM+6Y%NQ,OIQ-<\S\.X4CWQ5E]O^9/Y>7OF^[\@VGGK0KCSY8J7N_*":A;MJ M<2K&LA9[-9/6 XN&W7OBJGHOYE?EQYG\P:QY5\M>?=!\P>9?+_JKY@T.PU*V MN;RR]%_3D$\,?IJS]$ZJJAS9(YEXF958$HOQ;XJCI/S7_*R+6CY=?\Q_+,6NV\-W+)H9U6 MT6[CBT]Y8[QVA,G.D#P2"2H^$HW+H<56Z3^9WD_S"^F:AY;\V>7-=\LZAI>J M:H?,-EK=K-'PTJ>WM[@QHG(211F?]]*' B;@K"LBT57:+^;7Y6>8?+^M>L-9MI63]%RVL4PC2+F)HXS8M$_,?ROKNAZ=>06&H:Y8ZM:S6D%WQ_,_P JZ[Y;L?-7DWS)Y>\V:)>ZS8Z0-7MM7M_J1EN[V&S9(KF+U4>8 M-,!'#LTLG&,<2X.*JFG_ )E>0?,'F ^5]!\_^7]6\TM9RWA\N6.I6T]W]7@E M]%YC;JY<*D@*.2-B".N*KM#_ #*_+KS-JUSHWEOSQH/F+6+*YN+.[T>PU&VN M;B*YLR@N(VBB=W#0:.6S@DY4DF1[>56126!1P1\)HJQ[R_^9OY M=>;M3N]%\K^?= \R:I86D-]7?-]B-$EUJ?S9#KUI%I<+PZK8Z9)92W""8++_I MH9 ?M,%CV+@XJ])O_P R_P NK7S':^3=1\^>7['S3>WC6-CY;FU*WBOI[E(8 MKAK=;=G$A<13Q.5 KQ=3T(Q5"ZAY^_+"XUS4?(&I>);:]U[5M M3O+A+2W,JE889M1N)UM87?A\$91&(0%3Q2BJ&U?\[O(T>EZ3K7E76-/\_6U_ MYTT;R/>2Z-J-O<+87^K7<=F?7:)I KPB8,R;,1X=<59+9?FG^6.IZYKGE[3? MS"\N7_F+RQ#/<^9M&@U6VENM.@M2HN9+F)9"T2QFG,L !WQ5&>7OS%\B>;K[ M5--\I^<]$\T:AH20OKNGZ3J-O>3VB7 9H7E2%G*B0+\-1N-QBJ8^:?-GE3R3 MH]WK_F_S)IWE30[1XH[O6]5NXK.VB:5@L:O-.RJ"S, !6IZ8JQF]_-O\K=)\ MJZ;YYU;\R/+NG>2];E6#1/-EQJ=K'IUU+(&*K!YB9"^@:9INI//Z?$,1(NI", 'X2A).X M&*O:M3U/3]'TR]U;6-1@TW2],ADN=2U*YE6W@@@B!:22:5Z*B*H))8BF*L&L MOS<_*S5O+6H>?-,_,?RY?^2M'#ZI_P Y1?E;9>8=;\I:=K%EK&N>5/.]AY-\YZ:M_;1O8&^A@GFU)P7=OJUL M9_2D)"\94D38IBKU ?FW^5\7E)?S#;\Q_+*>1+J;ZO:>!Q5YEY8_./1=;_-7SO\ E!-IU[IOF#R;]7DLM1G9)+;5XGL-.O;MH&4U M1[3]*6ZR)(!4.K1E_C$:J;?EO^9FB?F9Y3\H>8@J:%?^;[*]U#3O*]Q+FP6B\U!^UNJWK?YN?E7Y:L]$U+7OS.\M:/I_F1IH?+ MU_>:M:0Q7[0OZVM[NYT_BP>*24QJ/64EE2I-!7?%61^8?S6_+3R?9Z)J?FG\Q M?+GE_3O-$8F\N7>J:M;6L-_&RH2UJTLBB0<7!^$T/(8JG&J^?/)/EO4]/T;6 M_-NC:)JFKSVL6EZ?>WT$$UT]]*T%JL$4D@=S+)&8T"+1FV6M#BK&_P UOS(U MGR'9^3XO+GE.+SAKWGCS+!Y:TC2Y]27284EFL[R\:66Y>"YH$2R<<5C+$D4Q M5@&@^<-4@_-;R]:?F9^4VG>0_.7G'0M2LO*WF32]>&M"6RTEX[Z\MKFMG8B! M5:975@'Y-4'C2I5>FZ!^:GY5^:=*U[6?+'YB^7O,&C^65,_F74]/U6VN+:QB M5&DYW4T;E(EX(6JQ %,55=(_-#\MO--G8W?E_P#,;R]K,.HS6T%C+I^IVMQZ MTUV9A;PIZ7ZM*%4;MP>E:&BJ6ZY^9^AZ7YX\F^2K4KJEWYGO]7TW4[JT MNHRNF7.E:8NK/'=0T)#R0R(0I*D!U?=2,58MK_\ SDU^1VA>4/,OGM?S+T+7 M_+WE*>RL_,ESHFI6EXUM<:AB M+^9GE9M7\Y6L%_Y2TK]*VGUC4[:XY?5YK1!+RF23B>!4$-3;%4YD_,'R;%YF MA\DR>;M#3S?.[D"VG/U28[>:.5@!4(RM3B0<53FVU?3 M+Z]O[*RO;>]U#19TM-9M+>>-Y[2>6%+F..>,&J,T,B2!6H2C!A4$'%7FWG;\ MR=7T+7]/\D>2_)5UY^\]ZIITNKR6*7L6G:=I]E!+'$LNJ7TBSO;"Y9I$M0L$ MGK/%*!Q6.1U548/SF\N^7O+\FK_FU+9_D_?V=^-+U&#S'J$,5C->/$)U_1VI M3""&\C>+XE9 I&ZNB.K*%4_U_P#-S\L/+T-A<>8/S(\M:!%J4%M=:7X$4 M3$N-5M8_TG':O+_E31]! MUO\ 01U2\UFW6#UVMX9T2Y,GHBWG;U3^X)9N'%_LN**JFL_FW^5>@Z98ZWK? MYC^6M*T?5K&+4M-UB]UBT@M[BRN&58;F"220+)&S.JAUJ-P*XJ]%MI(IY%EB M,<\;QJZ7:$$,& XL*;$,-ZCY8JC\5=BKL5=BKL5=BKL5=BKL5=BKL5?_U_OY MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKP;_G(GRAJGGO\ )WS+ MY2T?2E\QWVM7&C1G2&]$K,M^7GYN7GF'\KM*G\H>9=-L_)'GCR_JNJ:=IEQHUGY-72+.<2R7YC M!:^OM19F]:Y)$061G"F58E:95F/E+\HO.6@?EQ_SB_I%OY#T^+5_(A\Q7'G+ M0;QK:*Q6[U+R[K%JHOS$9!(MU=W:+*R+(27+$'H:)INBV&LW&J^7[I;31[.R9_JEBT=DXADFF;EQ5 M6$7'DZJ>^<](\Q_FK^8OYLZAH7Y>:[Y U4Z)^5/F":QMYM+A\T7L&@>:]9N; MBXB,4MS:I>K% T5LLT[!E5.1C4T55Z1Y1_*C4;O7OR]\RWOD[SA".%8V=ZTF^'?BJG$7Y5^:(/+WG M=(/*2QZQYC_YR#T;SC)*@MDFN]$L?,^DWGUUY59>2Q6=L[*K-SXIQ"UH,5>> M?ES^3_G'1=6T?0O,6B_F1?WGDG6/-.NZ=+=ZKI$?D6"?5(]7BMI=-CC!OYG, M>J>FL9_R0\[G\F/RH\H^7?(I@O_+/_./WG3RIJ^B61M+< M0:_J^AZ3%#:4$D<9DN+N"<%P>!<%GZI9V$L]O%=N5*$1S2 QI&W(%B MBJOG/S]Y$\_R2?F7Y-L_RJN_-!\Y_FUY:_,30O.:RZ>--T_3;.XT"*X<-3?RJ\S67YBZ=IOF;1?S)U"#0_S(\Q>=M.F;5= M)A\A6Z:IJNI:C93VR*&U&65(;]0T#(H]8R?%Q4$JIGY:\I>==4_(^W_(2^_* M2]T_S5Y6_+74_)T/YAZX^GQ:/^DI-&DTP2:3/#+7226 MRVVFSF4RLAH5558L>*KVWSU^66J:CYH_YR+UC2_*-O-+YJ_)W2_*/D?4HX[9 M9IKF,>8VN;"!ZAXTY7-F6#<8R2FY*'BJ\S\M_D?YCM?R@\K^5M1\@0#59OSK MLO-GF[2Y$LY/K&EV^OB?Z[=-R9)^-I%&0&9GXJJ@?"%"JMKWY/>:=6_.[\ZO M,6L?E[+YG\B^;/+VKVUA:B]@M!J+SZ;Y'BA@CDY,\3M+I5UQ+J!RB^+9E)53 M+3M"\^^9O*/GAO./Y?>;=?L-/DT*?R;J>K#1=)_,/U-)NY;M#'+93SV=T=.8 MI?:S^6?YU?F3I_FJ;4O*$EG&*1'<-%&K2"(D)BK./-WDWS;^2K*/,WY=>=+_P U_FKJ5IY>DDL_,7YE_E-K>DW DB43V'EV^T:?5)P"X(%L MMM*2& )X_"&-*JI)Y<_*OS7I'D7\E=,;RM%I.I:+^9_FOS/YTXFVB]&UU*U\ MU107\\D;4?\ *R/^<4-)OO)AT>Y\C_E7KGEJ M7SF\^GW*:Y]1LM"C,NF2V4T[2V#E?6AED:/GS_N@:G%7U-^:OEO6?,FK?DM< MZ/IQU&#RK^8EKK.O251/JUA%I.J6[3L)"I8++<1BBU-6Z4!HJ^?-&\I?F5;W M?Y5^0#^6VI+8>0_S@UGSGYA\\27-@NEMIFJWFOW]K)8J+@W,[*-3BCF#11F- MZTY@5Q5CUW^0?GB7\EO^5M;VNG:UKOE M=;-?K!AY!O5OI',DD:O\19VK6I50'GOR+^9/YD:Y/KVD?DQJWE=8?(NB^6'O M=5ETJ#4-0O=.\VZ-J+I)':W4U!D 5&_O%7I?G3\J/,]_Y<_Y MR?\ T5Y/2?S%^8_YA>7=4T"Y3ZK'<:GI>EV7EI S3EE/"![6["+(05H_$?$. M2KS;7?K>GZCY%\H7/D]=133?^DPE!=PM'5?0?\ SEJJ7'_../YIV[00WB7&G6T;6-PX$,G.^ME$ M,K,LE$EK1B5(H34=L5>9:[Y1\\>>/.'^+M/_ "TU3RAI]OYA_*K3ET#4WL(I MX[;R?Y@U74=3O84M;F:,VB0:A'Z32/ M,>EQ>6I/-T6IZ/;7>C67DK3QJ'EG6M.TQ?+]G!2[G]26YCC>XF:(AGY&&DA, M*KZ"_+W\N];\M:]_SCGP\M0Z+I7D+\I]8\N^8TMQ;PPV.J7C^6GCM_3B:A,C M6=R:Q@K56J?B6JK-_P [+?S1_AG29_*.@7>KW5MK"/K&H:#%93^9+"QFMKF" M>YT$:BT=NMXS2B$O(Z^G!+-(O-U$;JOECRY^7/YB^4/)\OF"_P#)_P"8/^.H M/.WFW4O+GF;1;W1-5\QP66L-9RP#5;:>2TLKVVNS:QM:/^0'YBZ)IGF7S:L#WWG?\I=0$7Y*Z6"J)J.D:?=ZC>&U023^F@N;7 M5Y[&S$A1;9DC8CTT48JQ74?^<>?-_ERXUORA?V7YB>9="\\>1O+OE6_F\@:A MI>F:7JEW9Z;-8ZM-YADU(M=0&[GG>1IHA*Y5W<\I.JKV?RQ^6OG:T_/O_%UU MY?E@\M?XV\Z:FVJ&:W9/J>J>7O+]E9R\!(7I+-9S(!QJ.!+ J2J]_\ S4B\ MQW7D+7%\I:'I_F#7EBMY]-TS4HHYHI)(KF*0ND,_%)9X45IH(Y&16F2-6=%) M=57QOHOY:^=;J\_-/S1YD\C?F=KEM>R^3+[R9J6JZUH8\Z07&DC5TN+NR2VX MV,-+O5K33IKBUCN5:-H%].:3E!'"Y*LS1HJ^?O-'D+S?KOGWSGH]W^7& MHWV@ZG^=?D_SXWF&Y&GR:/=:-IVC:-8W("O=-*9;>XLY&9&@'V0R%C3%4)^9 M'Y7^?[GSMKGG.PTOS9%IFG_FDWF.WE\EW.G0>8KC3KCR%IOE_P!:P2_;T&5; MU)(Y5E*'@K.M?AY*OI#\D/*W^$?R^2SDTK7])EU/5-6UZ^M_,]];7VLR3:I? M2WDDU_):J($EE,G-HXZK'7@&-*XJ\]N_RM\TZOYD_.3S-8JNA>9X_.VD^9_R M?\QW3*UN;BV\J:;I%RTD<;,6BFI=6D@=0>+,5I\#XJP+\O?+'YA?EII'_./_ M )AO_P M-8U;4/*?E/S;Y;\R>4M)GT^>\L+WS%JNEW]L\DTUQ;0/;QII\@EF MC=F!9/W9Y'BJD/Y3^5OS'_*�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haynieconsent2023.jpg begin 644 haynieconsent2023.jpg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end XML 17 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2023
Mar. 27, 2024
Jun. 30, 2023
Document Information [Line Items]      
Entity Central Index Key 0001038277    
Entity Registrant Name INTERNATIONAL ISOTOPES INC    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Document Transition Report false    
Entity File Number 000-22923    
Entity Incorporation, State or Country Code TX    
Entity Tax Identification Number 74-2763837    
Entity Address, Address Line One 4137 Commerce Circle    
Entity Address, City or Town Idaho Falls    
Entity Address, State or Province ID    
Entity Address, Postal Zip Code 83401    
City Area Code 208    
Local Phone Number 524-5300    
Title of 12(g) Security COMMON STOCK, $.01 PAR VALUE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 13,000,000
Entity Common Stock, Shares Outstanding   520,081,365  
Auditor Name Haynie & Company    
Auditor Location Salt Lake City, UT    
Auditor Firm ID 457    

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

 XML 18 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 2,688,141 $ 2,375,817
Accounts receivable 1,469,298 1,596,886
Inventories 927,111 744,793
Prepaids and other current assets 672,934 1,023,129
Total current assets 5,757,484 5,740,625
Long-term assets    
Restricted cash 880,752 840,049
Property, plant and equipment, net 2,465,077 2,024,486
Capitalized lease disposal costs, net 688,462 228,125
Financing lease right-of-use asset 6,611 12,621
Operating lease right-of-use asset 2,183,988 2,311,082
Goodwill 1,384,255 1,384,255
Patents and other intangibles, net 3,538,458 3,703,353
Total long-term assets 11,147,603 10,503,971
Total assets 16,905,087 16,244,596
Current liabilities    
Accounts payable 559,597 382,392
Accrued liabilities 1,482,179 1,472,504
Unearned revenue 932,682 879,365
Current portion of operating lease right-of-use liability 140,733 131,572
Current portion of financing lease liability 2,832 5,513
Total current liabilities 3,273,756 3,514,694
Long-term liabilities    
Accrued long-term liabilities 75,000 112,500
Asset retirement obligation 1,474,463 942,378
Financing lease liability, net of current portion 0 2,832
Operating lease right-of-use liability, net of current portion 2,091,511 2,232,244
Mandatorily redeemable convertible preferred stock 4,063,000 4,063,000
Total long-term liabilities 9,594,706 8,387,360
Total liabilities 12,868,462 11,902,054
Stockholders' equity    
Common stock, $0.01 par value; 750,000,000 shares authorized; 519,787,870 and 514,889,916 shares issued and outstanding respectively 5,197,879 5,148,899
Additional paid in capital 126,168,605 125,654,486
Accumulated deficit (127,329,859) (126,460,843)
Total equity 4,036,625 4,342,542
Total liabilities and stockholders' equity 16,905,087 16,244,596
Related Party [Member]    
Current liabilities    
Current installments of notes payable 0 620,000
Long-term liabilities    
Notes payable, net of current portion 1,620,000 1,000,000
Nonrelated Party [Member]    
Current liabilities    
Current installments of notes payable 155,733 23,348
Long-term liabilities    
Notes payable, net of current portion $ 270,732 $ 34,406
XML 19 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets (Parentheticals) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in shares) 750,000,000 750,000,000
Common stock, issued (in shares) 519,787,870 514,889,916
Common stock, outstanding (in shares) 519,787,870 514,889,916
XML 20 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Sale of product $ 12,267,385 $ 11,181,988
Cost of product 4,888,409 4,891,927
Gross profit 7,378,976 6,290,061
Operating costs and expenses:    
Salaries and contract labor 4,032,155 3,390,652
General, administrative and consulting 3,545,766 3,568,590
Research and development 577,354 533,716
Total operating expenses 8,155,275 7,492,958
Operating loss (776,299) (1,202,897)
Other income (expense):    
Other income 160,173 2,110,576
Interest income 78,890 9,502
Interest expense (331,780) (613,943)
Total other (expense) income (92,717) 1,506,135
Net income (loss) $ (869,016) $ 303,238
Net income per common share - basic: (in dollars per share) $ 0 $ 0
Net income per common share - diluted: (in dollars per share) $ 0 $ 0
Weighted average common shares outstanding - basic (in shares) 517,777,847 510,794,145
Weighted average common shares outstanding - diluted (in shares) 517,777,847 510,794,145
XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statement of Stockholders' Equity - USD ($)
Series B Preferred Stock [Member]
Common Stock [Member]
Series B Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series B Preferred Stock [Member]
Retained Earnings [Member]
Series B Preferred Stock [Member]
Parent [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Series C Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series C Preferred Stock [Member]
Retained Earnings [Member]
Series C Preferred Stock [Member]
Parent [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Total
Balance (in shares)                 502,584,176        
Balance (in shares) at Dec. 31, 2021                 502,584,176        
Balance at Dec. 31, 2021                 $ 5,025,842 $ 124,469,034 $ (126,764,081) $ 2,730,795  
Shares issued under employee stock purchase plan (in shares)                 245,081        
Shares issued under employee stock purchase plan                 $ 2,451 12,320 0 14,771  
Shares issued for exercise of employee stock options (in shares)                 648,948       1,200,000
Shares issued for exercise of employee stock options                 $ 6,489 (6,489) 0 0  
Stock grant (in shares)                 187,231        
Stock grant                 $ 1,872 (1,872) 0 0  
Stock issued in lieu of dividends on preferred C shares (in shares)                 2,271,980        
Stock issued in lieu of dividends on preferred C shares                 $ 22,720 181,760 0 204,480  
Warrant exercise (in shares)                 515,000        
Warrant exercise                 $ 5,150 56,650 0 61,800  
Conversion of preferred B stock (in shares) 8,437,500                        
Conversion of preferred B stock $ 84,375 $ 590,625 $ 0 $ 675,000                  
Stock based compensation                 $ 0 352,458 0 352,458  
Net income (loss)                     303,238 303,238 $ 303,238
Balance (in shares) at Dec. 31, 2022                 514,889,916        
Balance at Dec. 31, 2022                 $ 5,148,899 125,654,486 (126,460,843) 4,342,542 $ 4,342,542
Balance (in shares)                 514,889,916        
Shares issued under employee stock purchase plan (in shares)                 316,866        
Shares issued under employee stock purchase plan                 $ 3,169 5,229 0 8,398  
Shares issued for exercise of employee stock options (in shares)                 0       (0)
Shares issued for exercise of employee stock options                 $ 0 0 0 0  
Stock grant (in shares)                 343,560        
Stock grant                 $ 3,436 (3,436) 0 0  
Stock issued in lieu of dividends on preferred C shares (in shares)         2,266,500                
Stock issued in lieu of dividends on preferred C shares         $ 22,665 $ 67,995 $ 0 $ 90,660          
Stock based compensation                 $ 0 464,041 0 464,041  
Net income (loss)                     (869,016) (869,016) $ (869,016)
Shares issued for issuance of RSUs (in shares)                 1,971,028        
Shares issued for issuance of RSUs                 $ 19,710 (19,710) 0 0  
Balance (in shares) at Dec. 31, 2023                 519,787,870        
Balance at Dec. 31, 2023                 $ 5,197,879 $ 126,168,605 $ (127,329,859) $ 4,036,625 $ 4,036,625
Balance (in shares)                 519,787,870        
XML 22 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net income (loss) $ (869,016) $ 303,238
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 350,094 374,196
Gain on disposal of property, plant and equipment 0 (1,797,978)
Accretion of obligation for lease disposal costs 53,126 50,292
Accretion of beneficial conversion feature 0 274,443
Equity based compensation 464,041 352,458
Right-of-use amortization (4,478) (2,528)
Changes in operating assets and liabilities:    
Accounts receivable (127,588) 743,211
Prepaids and other current assets (350,195) 18,706
Inventories 182,318 (179,982)
Accounts payable and accrued liabilities 240,040 (441,317)
Unearned revenues 53,317 (28,588)
Net cash provided by (used in) in operating activities 582,589 (1,497,719)
Cash flows from investing activities:    
Proceeds from sale of property, plant and equipment 0 4,000,000
Purchase of property, plant, equipment and patents (149,058) (120,014)
Net cash (used in) provided by investing activities (149,058) 3,879,986
Cash flows from financing activities:    
Proceeds from sale of stock 8,398 76,571
Payments on financing lease liability (5,513) (8,543)
Principal payments on notes payable (83,389) (540,032)
Net cash provided by (used in) financing activities (80,504) (472,004)
Net increase in cash and cash equivalents and restricted cash 353,027 1,910,263
Cash and cash equivalents and restricted cash at beginning of year 3,215,866 1,305,603
Cash and cash equivalents and restricted cash at end of year 3,568,893 3,215,866
Supplemental disclosure of cash flow activities:    
Cash paid for interest 163,920 54,071
Cash paid for taxes 10,176 9,097
Supplemental disclosure of noncash financing and investing transactions:    
Decrease in accrued interest and increase in equity for conversion preferred dividends to stock 90,660 204,480
Increase in equity and decrease in liability for the conversion of preferred stock 0 675,000
Property acquired in exchange for a note payable 452,100 0
Non-cash increase of capitalized asset retirement obligation for increased funding plan 478,959 0
Cash and cash equivalents 2,688,141 2,375,817
Restricted cash included in long-term assets 880,752 840,049
Total cash, cash equivalents, and restricted cash shown in statement of cash flows $ 3,568,893 $ 3,215,866
XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Insider Trading Arrangements
 12 Months Ended
Dec. 31, 2023
Insider Trading Arr Line Items  
Material Terms of Trading Arrangement [Text Block]

Item 9B.      OTHER INFORMATION

 

During the quarter ended December 31, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Rule 10b5-1 Arrangement Adopted [Flag] false
Non-Rule 10b5-1 Arrangement Adopted [Flag] false
Rule 10b5-1 Arrangement Terminated [Flag] false
Non-Rule 10b5-1 Arrangement Terminated [Flag] false
XML 24 R8.htm IDEA: XBRL DOCUMENT v3.24.1
Note 1 - Description of Business and Significant Accounting Policies
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Business Description and Accounting Policies [Text Block]

NOTE 1 – DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

 

Description of business – International Isotopes Inc. (the “Company” or “INIS”) was incorporated in Texas in November 1995. The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include all operations and balances of the Company and its wholly-owned subsidiaries, International Isotopes Idaho Inc., International Isotopes Fluorine Products, Inc., and International Isotopes Transportation Services, Inc. The consolidated financial statements also include the accounts of wholly owned subsidiaries TI Services, LLC, (“TI Services”), and RadQual, LLC (RadQual). TI Services is headquartered in Youngstown, Ohio and was formed with RadQual in December 2010 to distribute products and services for nuclear medicine, nuclear cardiology and Positron Emission Tomography (PET) imaging. RadQual is a global supplier of molecular imaging quality control devices, and is now headquartered in Idaho Falls, Idaho. 

 

Nature of Operations – INIS and its subsidiaries, (collectively, the “Company,” “we,” “our” or “us”) manufacture a full range of nuclear medicine calibration and reference standards, a wide range of products, including cobalt teletherapy sources, and an FDA-approved radiopharmaceutical drug product. The Company also holds several patents for a fluorine extraction process that would be used in conjunction with a proposed commercial depleted uranium de-conversion facility which would be located in Lea County, New Mexico (the “De-Conversion Facility”). The Company’s business consists of four major business segments: Theranostics Products (formerly Radiochemical Products), Cobalt Products, Nuclear Medicine Standards, and Fluorine Products. The Company’s headquarters and all operations, with the exception of TI Services, are located in Idaho Falls, Idaho.

 

With the exception of certain unique products, the Company’s normal operating cycle is considered to be one year. Due to the time required to produce some cobalt products, the Company’s operating cycle for those products is considered to be two to three years. Accordingly, preliminary payments received on cobalt contracts, where shipment will not take place for greater than the operating cycle, have been recorded as unearned revenue and, depending upon estimated ship dates, classified under current or long-term liabilities on the Company’s consolidated balance sheets. These unearned revenues will be recognized as revenue in the future period during when the cobalt shipment takes place. All assets expected to be realized in cash or sold during the normal operating cycle of the business are classified as current assets.

 

Principles of Consolidation – The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, including RadQual and TI Services. All significant intercompany accounts and transactions have been eliminated during consolidation.

 

Significant accounting policies

 

a)      Financial instruments and cash equivalents

 

The carrying value of notes payable approximates fair value because they bear interest at rates which approximate market rates.

 

Cash and cash equivalents, totaling $2,688,141 and $2,375,817 at December 31, 2023 and 2022, respectively, consist of operating accounts and money market accounts. For purposes of the consolidated statements of cash flows, the Company considers all highly-liquid financial instruments with original maturities of three months or less at date of purchase to be cash equivalents.

 

At December 31, 2023 and 2022, the Company had pledged cash on deposit in a money market account valued at $880,752 and $840,049 respectively, as security for a surety bond.  The surety bond is required as part of the Company’s operating license agreement with the Nuclear Regulatory Commission (“NRC”).

 

The Company maintains its cash accounts in various deposit accounts, the balances of which are periodically in excess of federally insured limits.

 

b)      Accounts receivable

 

The Company sells products mainly to recurring customers, wherein the customer’s ability to pay has previously been evaluated. The Company generally does not require collateral. The Company periodically reviews accounts receivable for amounts considered uncollectible and allowances are provided for uncollectible accounts when deemed necessary. At December 31, 2023 and  December 31, 2022 the Company had no allowance for doubtful accounts. 

 

c)      Inventories

 

Inventories are carried at the lower of cost or net realizable value. Cost is determined using the first in, first out method. When indicators of inventory impairment exist, the Company measures the carrying value of the inventory against its market value, and if the carrying value exceeds the market value, the inventory value is adjusted down accordingly.  No impairment was recorded for the years ended December 31, 2023 and December 31, 2022.

 

d)      Property, plant and equipment

 

Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the asset.

 

Leasehold improvements are amortized over the shorter of the life of the lease or the service life of the improvements. Maintenance, repairs, and renewals that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Gains or losses on dispositions of property and equipment are included in the results of operations.

 

e)      Goodwill and other intangibles

 

Goodwill is not amortized but is tested for impairment at least annually. Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets recorded as a result of the change in ownership of RadQual. As of  December 31, 2023 and 2022, there has been no impairment of goodwill.

 

Patents and other intangibles are amortized using the straight-line method over their estimated useful lives and are evaluated for impairment at least annually or when events or circumstances arise that indicate the existence of impairment. The Company evaluates the recoverability of identifiable intangible assets whenever events or changes in circumstances indicate that an intangible asset’s carrying amount may not be recoverable. Such circumstances could include but are not limited to: (1) a significant decrease in the market value of an asset, (2) a significant adverse change in the extent or manner in which an asset is used, or (3) an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset. When indicators of impairment exist, the Company measures the carrying amount of the asset against the estimated undiscounted future cash flows associated with it. Should the sum of the expected future cash flows be less than the carrying value of the asset being evaluated, an impairment loss would be recognized. The impairment loss would be calculated as the amount by which the carrying value of the asset exceeds its fair value. The evaluation of asset impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and actual results may differ from assumed and estimated amounts. During the years ended December 31, 2023 and 2022, the Company had no impairment losses related to intangible assets.

 

f)      Impairment of long-lived assets

 

Long-lived assets are reviewed for impairment annually, or when events or circumstances arise that indicate the existence of impairment, using the same evaluation process as described above for patents and other intangibles.  There was no impairment recorded during the years ended December 31, 2023 and 2022.

 

g)      Income taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in income in the period that includes the enactment date.

 

h)      Use of estimates

 

Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period to prepare these consolidated financial statements in conformity with GAAP.  Actual results could differ from those estimates.

 

i)      Revenue recognition

 

Revenue is recognized when products are shipped. No warranty coverage or right of return provisions are provided to customers. Amounts received as prepayment on future products or services are recorded as unearned revenues and recognized as income when the product is shipped or service performed. See Note 14 Revenue Recognition.

 

j)      Advertising Expenses

 

Advertising expenses, which include promotional expenses, are expensed as incurred and totaled $142,188 and $118,465 for the years ended  December 31, 2023 and 2022, respectively.

 

k)      Research and development costs

 

Research and development costs are expensed as incurred and totaled $577,354 and $533,716 for the years ended  December 31, 2023 and 2022, respectively. These research and development costs were incurred for corporate business development and in our Theranostics Products and Nuclear Medicine Standards business segments.

 

l)      Share-based compensation

 

The Company accounts for issuances of share-based compensation to employees in accordance with GAAP which requires the recognition of the cost of employee services received in exchange for an award of equity instruments in the financial statements and is measured based on the grant date fair value of the award. Compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (the vesting period).

 

For the years ended December 31, 2023 and 2022, the Company recognized share-based compensation expense of $464,041 and $352,458, respectively, related to stock options, stock grants, and restricted stock units. This expense is included as part of salaries and contract labor in the accompanying statements of operations.

 

m)      Net loss per common share – basic and diluted

 

Basic loss per share is computed on the basis of the weighted-average number of common shares outstanding during the year. Diluted loss per share is computed on the basis of the weighted-average number of common shares plus all potentially dilutive issuable common shares outstanding during the year.

 

The table below shows the calculation of diluted shares:

 

  

December 31,

 
  

2023

  

2022

 

Weighted average common shares outstanding - basic

  517,777,847   510,794,145 
         

Effects of dilutive shares

        

Stock options

  —   — 

Series C redeemable convertible preferred stock

  —   — 

Weighted average common shares outstanding - diluted

  517,777,847   510,794,145 

 

For the year ended December 31, 2023, the Company had 24,787,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were not included in the computation of diluted income per common share because they would be anti-dilutive.

 

For the year ended December 31, 2022, the Company had 24,993,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were not included in the computation of diluted income per common share because they would be anti-dilutive.

 

The table below summarizes common stock equivalents outstanding at December 31, 2023 and 2022:

 

  

December 31,

 
  

2023

  

2022

 

Stock options

  24,787,500   24,993,500 

4,063 Shares of Series C redeemable convertible preferred stock

  40,630,000   40,630,000 
   65,417,500   65,623,500 

 

n)      Business segments and related information

 

GAAP establishes standards for the way public business enterprises are to report information about operating segments in annual financial statements and requires enterprises to report selected information about operating segments in interim financial reports issued to shareholders. It also establishes standards for related disclosure about products and services, geographic areas and major customers. The Company currently operates in four business segments.

 

o)      Recent accounting standards

 

In August 2020, the Financial Accounting Standards Board issued ASU 2020-06 Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). The update simplifies accounting related to convertible debt instruments. The standard is effective for fiscal years beginning after December 15, 2023 including interim periods within those fiscal years. INIS is currently evaluating the effect this standard will have on its financial statements.
XML 25 R9.htm IDEA: XBRL DOCUMENT v3.24.1
Note 2 - Business Condition and Liquidity
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]

NOTE 2 – BUSINESS CONDITION AND LIQUIDITY

 

The Company has a history of recurring losses with an accumulated deficit of $127,329,859 at December 31, 2023 and net loss of $869,016 for the year then ended. The Company’s working capital has increased by $257,797 from the prior year. The Company has cash flows provided by operations of $582,589.  During 2023, the Company sought to improve future cash flows from operating activities through execution of new sales agreements, improving operating cost control measures, making improvements in current manufacturing processes, pursuing new service contracts, and developing new products. The Company’s net loss was $869,016 in 2023, compared to net income of $303,238 in 2022. This is a decrease in net income of $1,172,254. This decrease in net income is largely the result of the approximate $1.8 million gain on sale of assets that occurred in 2022.

 

During the year ended December 31, 2023, the Company continued to focus on its long-standing core business segments, which consist of its Theranostics Products (formerly Radiochemical Products), Cobalt Products, and Nuclear Medicine Standards, and in particular, the pursuit of new business opportunities within those segments.

 

Due to changes in the nuclear industry, the Company’s plans for the design and construction of a large-scale uranium de-conversion and fluorine extraction facility were placed on hold. The Company will continue to incur some costs associated with the maintenance of licenses and other necessary project investments for the proposed facility. The Company holds a Nuclear Regulatory Commission (“NRC”) construction and operating license for the depleted uranium facility as well as the property agreement with Lea County, New Mexico, where the plant is intended to be constructed. The NRC license for the de-conversion facility is a forty (40) year operating license and is the first commercial license of this type issued in the United States. There are no other companies with a similar license application under review by the NRC. Therefore, the NRC license represents a significant competitive barrier, and the Company believes that it provides it with a very valuable asset. In February 2024, the Company entered into and Asset Purchase Agreement to sell all the assets associated with the planned de-conversion facility. The Company expects to close the transaction in approximately 12 to 24 months, subject to satisfaction of certain closing condition. Proceeds from this sale would be $12.5 million in total.

 

The Company expects that cash from operations and its current cash balance will be sufficient to fund operations for the next twelve months. Future liquidity and capital funding requirements will depend on numerous factors, including, contract manufacturing agreements, commercial relationships, technological developments, market factors, available credit, and voluntary warrant redemption by shareholders. There is no assurance that additional capital and financing will be available on acceptable terms to the Company or at all.

 

 
XML 26 R10.htm IDEA: XBRL DOCUMENT v3.24.1
Note 3 - Purchased Asset and Investments
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Asset Acquisition [Text Block]

NOTE 3 – PURCHASED ASSET AND INVESTMENTS

 

AMICI Asset Purchase Agreement and Medical Devices

 

In June 2023, the Company acquired several medical devices with related assets and intellectual property rights from AMICI, Inc. and has been working on FDA 510k transfers, and start-up of manufacturing. The Company anticipates the assets will be part of a fifth business segment of the Company called “Medical Devices” that is planned to start by mid-year 2024.

 
XML 27 R11.htm IDEA: XBRL DOCUMENT v3.24.1
Note 4 - Inventories
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Inventory Disclosure [Text Block]

NOTE 4 – INVENTORIES

 

Inventories at  December 31, 2023 totaled $927,111, and inventories at  December 31, 2022 totaled $744,793. Our inventory consists of work in process material for our Theranostics Products, Cobalt Products, and Nuclear Medicine Products segments.
XML 28 R12.htm IDEA: XBRL DOCUMENT v3.24.1
Note 5 - Property, Plant and Equipment
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]

NOTE 5 – PROPERTY, PLANT AND EQUIPMENT

 

Property, plant and equipment are summarized as follows at December 31, 2023 and 2022:

 

  

2023

  

2022

  Estimated Useful Lives (in years) 

Furniture and fixtures

 $287,463  $284,020   3 - 5 

Transportation equipment

  114,708   114,708   5 - 10 

Plant and improvements

  526,205   501,334   5 

Production equipment

  4,569,980   3,997,193   5 - 10 
   5,498,356   4,897,255     

Accumulated depreciation

  (3,033,279)  (2,872,769)    
  $2,465,077  $2,024,486     

 

Included in fixed assets are assets purchased during the planning phase for the construction of a de-conversion facility in Hobbs, New Mexico; these de-conversion facility assets are included in the DUF6 Asset Sale. Although construction of the facility is currently on hold, the Company has determined that these assets continue to have future economic value based on what it considers a strong likelihood that construction of the facility will occur in the future.

 

Depreciation expense was $160,567 and $185,193 for the years ended December 31, 2023 and 2022, respectively.

 

 
XML 29 R13.htm IDEA: XBRL DOCUMENT v3.24.1
Note 6 - Patents and Other Intangible Assets
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]

NOTE 6 – PATENTS AND OTHER INTANGIBLE ASSETS

 

The Company owns certain patents and patents pending related to a fluorine extraction process (FEP), for various uses of some fluoride gases as fluorinating agents, and some of the RadQual nuclear medicine calibration sources.  The FEP patents were developed in an effort to expand the potential markets for the high purity fluoride gases the Company had planned to produce with its fluorine extraction process. The feasibility of expanding the fluoride gas markets through the use of this patented technology is uncertain. The RadQual product patents were developed to give RadQual a unique competitive advantage by offering calibration standards exclusive to RadQual.

 

In October 2012, the NRC issued the Company a 40-year construction and operating license for the de-conversion facility.  Capitalized costs associated with the licensing and planning process for this license are being amortized over the 40-year life of the license.

 

The following table summarizes the patent and intangible activity for the years ended December 31, 2023 and 2022:

 

  

2023

 

Beginning

 $5,370,878 

Additions

  — 

Disposals

  — 

Ending

  5,370,878 

Accumulated amortization

  (1,832,420)
  $3,538,458 

 

During the year ended December 31, 2023 the Company recognized $164,895 of amortization expense, and during the year ended December 31, 2022, the Company recognized $164,370 of amortization expense.

 

Patent and other intangible asset amortization is based on the remaining life of the asset and estimated amortization expense is as follows:

 

Years ending December 31,

    

2025

 $164,895 

2026

  164,895 

2027

  164,895 

2028

  164,895 

2029

  164,895 

Thereafter

  2,713,983 
  $3,538,458 

 

 
XML 30 R14.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Convertible Debentures and Notes Payable
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Debt Disclosure [Text Block]

NOTE 7 – CONVERTIBLE DEBENTURES AND NOTES PAYABLE

 

Convertible debentures

 

As discussed in Note 9 below, in February 2017, pursuant to a private placement transaction with certain investors, the Company issued 3,433 shares of Series C Preferred Stock and warrants.  In connection with the private placement, two investors holding convertible debentures exchanged aggregate principal totaling $205,000 of the convertible debentures for shares of the Series C Preferred Stock and warrants.

 

Notes payable

 

In December 2013, the Company entered into a promissory note agreement with its then Chairman of the Board and one of its major shareholders, pursuant to which the Company borrowed $500,000 (the 2013 Promissory Note). The 2013 Promissory Note is secured and bears interest at 6% per annum and was originally due  June 30, 2014. According to the terms of the 2013 Promissory Note, at any time, the lenders may settle any or all of the principal and accrued interest with shares of the Company’s common stock. In connection with the 2013 Promissory Note, each of the two lenders was issued 5,000,000 Class L warrants to purchase shares of our common stock at an exercise price of $0.06 per share (Class L Warrants). The Class L Warrants were immediately exercisable. The fair value of these warrants issued totaled $384,428 and was recorded as a debt discount amortized over the life of the 2013 Promissory Note. The Company calculated a beneficial conversion feature of $15,464 which was accreted to interest expense over the life of the 2013 Promissory Note. In June 2014, we renegotiated the terms of the 2013 Promissory Note. Pursuant to the modification, the maturity date was extended to  December 31, 2017 and each lender was granted an additional 7,500,000 Class L Warrants to purchase shares of the Company’s common stock at an exercise price of $0.06 per share. The Class L Warrants were immediately exercisable. In February 2017, the 2013 Promissory Note was further modified to extend the maturity date to  December 31, 2020, with all remaining terms unchanged. On December 23, 2018, all 25,000,000 Class L Warrants expired. In December 2019, the 2013 Promissory Note was further modified to extend the maturity date to  December 31, 2021, with all remaining terms unchanged. In January 2022, the 2013 Promissory Note was further modified to extend the maturity date to  December 31, 2023, with all remaining terms unchanged. In February 2024, the 2013 Promissory Note was further modified to extend the maturity date to  March 31, 2026, with all remaining terms unchanged.

 

At December 31, 2023, accrued interest payable on the 2013 Promissory Note was $301,734.

 

In April 2018, the Company borrowed $120,000 from its then Chief Executive Officer and Chairman of the Board pursuant to a promissory note (the 2018 Promissory Note). The 2018 Promissory Note accrues interest at 6% per annum, which is payable upon maturity of the 2018 Promissory Note. The 2018 Promissory Note was originally unsecured and originally matured on  August 1, 2018. At any time, the holder of the 2018 Promissory Note may elect to have any or all of the principal and accrued interest settled with shares of our common stock based on the average price of the shares over the previous 20 trading days. In June 2018, the 2018 Promissory Note was modified to extend the maturity date to  March 31, 2019 with all other provisions remaining unchanged. In February 2019, the 2018 Promissory Note was modified to extend the maturity date to  July 31, 2019 with all other provisions remaining unchanged. In July 2019, the 2018 Promissory Note was modified to extend the maturity date to  January 31, 2020 with all other provisions remaining unchanged. In December 2019, the 2018 Promissory Note was modified to extend the maturity date to  December 31, 2021 and the 2018 Promissory Note was modified to become secured by company assets, with all other provisions remaining unchanged. In December 2021, the 2018 Promissory Note was modified to extend the maturity date to  December 31, 2023 with all other provisions remaining unchanged. In December 2023, the 2018 Promissory Note was modified to extend the maturity date to  January 31, 2025. In February 2024, the 2018 Promissory Note was modified to extend the maturity date to  March 31, 2026.

 

At December 31, 2023, accrued interest on the 2018 Promissory Note totaled $40,970.

 

On December 20, 2019, the Company entered into a promissory note agreement with four of the Company’s major shareholders (the 2019 Promissory Note). The 2019 Promissory Note authorizes the Company to borrow up to $1,000,000. As of December 31, 2019, the Company had borrowed $675,000 under the 2019 promissory note. In February 2020, the Company borrowed an additional $325,000. The 2019 Promissory Note bears an interest rate of 4% annually and was originally due  December 31, 2022. According to the terms of the 2019 Promissory Note, at any time, the lenders may settle any or all of the principal and accrued interest with shares of the Company’s common stock based on the average closing price of the Company’s common stock for the 20 trading days preceding the payment. In connection with the 2019 Promissory Note, the lenders were issued warrants totaling 30,000,000 warrants to purchase shares of the Company’s common stock at $0.045 per share (Class O Warrants). In January 2023, the 2019 Promissory Note was modified to extend the maturity date to  December 31, 2024, with all remaining terms unchanged. In February 2024, the 2019 Promissory Note was modified to extend the maturity date to  March 31, 2026.

 

At December 31, 2023, accrued interest on the 2019 Promissory Note totaled $159,131.

 

 

Notes payable as of December 31, 2023 and 2022 consist of the following:

 

  

2023

  

2022

 
         

Note payable to related parties bearing interest at 6% all principal and interest due on March 31, 2026, secured

 $120,000  $120,000 

Note payable to related parties bearing interest at 4% all principal and interest due on March 31, 2026, secured

  1,000,000   1,000,000 

Note payable to related parties bearing interest at 6% all principal and interest due on March 31, 2026, secured

  500,000   500,000 

Note payable to a financial institution bearing interest at 5.99% monthly installments of $1,046, secured

  34,365   44,521 

Note payable for purchase contract bearing interest at 5% monthly installments of $4,442, secured

  —   13,233 

Note payable for purchase contract bearing no interest until the 25th month after the anniversary of the closing interest at 8% thereafter monthly installments of $10,000

  392,100    

Total notes payable

  2,046,465   1,677,754 

Less: current maturities

  (155,733)  (643,348)

Notes payable, net of current installments and debt discount

 $1,890,732  $1,034,406 

 

Maturities of convertible debt and notes payable, excluding debt discount and debt issuance costs, at December 31, 2023, are as follows:

 

Years ending December 31,

    

2024

 $155,733 

2025

  124,838 

2026

  1,745,595 

2027

  20,299 

Thereafter

  — 
  $2,046,465 

 

 
XML 31 R15.htm IDEA: XBRL DOCUMENT v3.24.1
Note 8 - Lease Obligations
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Lessee, Operating Leases and Finance Leases [Text Block]

NOTE 8 – LEASE OBLIGATIONS

 

The Company leases office and warehouse space under operating leases. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments under the lease. Operating lease, right-of-use assets, and liabilities are recognized at the lease commencement date based on the present value of lease payments over the reasonably certain lease term. The implicit rates with the Company’s operating leases are generally not determinable and the Company uses its incremental borrowing rate at the lease commencement date to determine the present value of its lease payments. The determination of the Company’s incremental borrowing rate requires judgement. The company determines its incremental borrowing rate for each lease using its then-current borrowing rate. Certain of the Company’s leases include options to extend or terminate the lease. The Company establishes the number of renewal options periods used in determining the operating lease term based upon its assessment at the inception of the operating lease. The option to renew the lease may be automatic, at the option of the Company, or mutually agreed to between the landlord and the Company. Once the facility lease term has begun, the present value of the aggregate future minimum lease payments is recorded as a right-of-use asset. Lease expense is recognized on a straight-line basis over the term of the lease.

 

  

Year Ended

 
  

December 31,

 
  

2023

  

2022

 

Operating lease costs

 $287,108  $285,159 

Short-term operating lease costs

  7,200   12,066 

Financing lease expense:

        

Amortization of right-of-use assets

  6,023   4,172 

Interest on lease liabilities

  395   649 

Total financing lease expense

  6,418   4,821 

Total lease expense

 $300,726  $302,046 
         

Right-of-use assets obtained in exchange for new operating lease liabilities

 $—  $— 

Right-of-use assets obtained in exchange for new financing lease liabilities

 $—  $— 

Weighted-average remaining lease term (years) - operating leases

  11.1   12.1 

Weighted-average remaining lease term (years) - financing leases

  1.2   1.1 

Weighted-average discount rate - operating leases

  6.75%  6.75%

Weighted-average discount rate - financing leases

  6.75%  7.93%

 

Maturities of lease liabilities as of December 31, 2023, were as follows:

 

  

Operating leases

  

Finance leases

 

For the years ended December 31,

        

2024

 $287,108  $2,929 

2025

  287,108   — 

2026

  287,108   — 

2027

  287,108   — 

2028

  287,108   — 

Thereafter

  1,738,084   — 

Total minimum lease obligations

  3,173,624   2,929 

Less-amount representing interest

  (941,380)  (97)

Present value of minimum lease obligations

  2,232,244   2,832 

Current maturities

  (140,733)  (2,832)

Lease obligations, net of current maturities

 $2,091,511  $— 

 

 
XML 32 R16.htm IDEA: XBRL DOCUMENT v3.24.1
Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Equity [Text Block]

NOTE 9 – SHAREHOLDERS’ EQUITY, REDEEMABLE CONVERTIBLE PREFERRED STOCK, OPTIONS AND WARRANTS

 

Warrants

 

On February 14, 2022, 515,000 Class M Warrants were exercised for an exercise price of $0.12 per share. The Company received $61,800 of proceeds as a result of the exercise. On February 17, 2022 the 3,625,000 remaining unexercised Class M Warrants expired. On May 12, 2022, the 2,925,000 remaining unexercised Class N Warrants expired.

 

The following table summarizes warrant activity for the years ended December 31, 2023 and 2022:

 

Warrants

 

Outstanding Shares

  

Weighted Average Exercise

 

Outstanding at December 31, 2021

  7,065,000  $0.11 

Granted

  —   — 

Exercised

  (515,000)  0.12 

Forfeited

  (6,550,000)  0.11 

Outstanding at December 31, 2022

  —   — 

Granted

  —   — 

Exercised

  —   — 

Forfeited

  —   — 

Outstanding at December 31, 2023

  —  $— 

 

At December 31, 2023 and  December 31, 2022 there were no outstanding warrants.

 

 

Mandatorily Redeemable Convertible Preferred Stock

 

The Company is authorized to issue up to 5,000,000 shares of preferred stock, par value $0.01 per share. The Board is authorized to set the distinguishing characteristics of each series prior to issuance, including the granting of limited or full voting rights, rights to the payment of dividends and amounts payable in event of liquidation, dissolution or winding up of the Company.

 

At December 31, 2021, there were 675 shares of the Series B Convertible Redeemable Preferred Stock (the “Series B Preferred Stock”) outstanding with a mandatory redemption date of May 2022 at $1,000 per share, or $675,000 in aggregate redemption value. The Series B Preferred Stock were convertible into common stock at a conversion price of $2.00 per share. These preferred shares carried no dividend preferences. Due to the mandatory redemption provision, the Series B Preferred Stock were classified as a liability in the accompanying consolidated balance sheets. In 2021, 175 shares of Series C Preferred Stock were converted into shares of common stock. On May 31, 2022, the Company paid with shares of the Company’s common stock all 675 outstanding Series B Preferred Stock outstanding with a mandatory redemption date of May 2022 at $1,000 per share or $675,000. The May 31, 2022 average price of the Company’s common stock was $0.08 per share. The Company issued 8,437,500 shares of common stock to satisfy the $675,000 redemption amount.

 

At December 31, 2022 and December 31, 2023, there were 4,063 total shares of the Series C Preferred Stock outstanding. The Series C Preferred Stock are convertible at the option of the investors at any time into shares of the Company's common stock at an initial conversion price equal to $0.10 per share, subject to adjustment. At any time after February 17, 2019, if the volume-weighted average closing price of the Company’s common stock over a period of 90 consecutive trading days is greater than $0.25 per share, the Company may redeem all or any portion of the outstanding Series C Preferred Stock at the original purchase price per share ($1,000) plus any accrued and unpaid dividends, payable in shares of common stock. All outstanding shares of Series C Preferred Stock were to be redeemed by the Company on February 17, 2022 at the original purchase price per share, payable in cash or shares of common stock, at the option of the holder. In February 2022, based on approval of a majority of the Preferred C Holders, the Company extended the redemption date of the Series C Preferred Stock to February 17, 2023. In December 2022, based on approval of a majority of the Preferred C Holders, the Company extended the redemption date of the Series C Preferred Stock to February 17, 2025. Holders of Series C Preferred Stock do not have any voting rights, except as required by law and in connection with certain events as set forth in the Statement of Designation of the Series C Preferred Stock.

 

The Company pays dividends on the Series C Preferred Stock in February each year. Dividends payable totaled $243,780 in February 2023 and February 2022. Some holders of the Series C Preferred Stock elected to settle their dividend payments with shares of the Company’s common stock in lieu of cash. The Company issued 2,266,500 shares of common stock in lieu of a dividend payment of $90,660 in 2023 and 2,271,980 shares of common stock in lieu of a dividend payment of $204,480 in 2022. $153,120 of dividend payable was settled with cash in 2023 and $39,300 was settled with cash in 2022.

 

The outstanding 4,063 shares of Series C Preferred Stock originated as follows:

 

On February 17, 2017, the Company entered into subscription agreements with certain investors, including two of the Company’s directors, for the sale of (i) an aggregate of 3,433 shares of Series C Preferred Stock, and (ii) Class M warrants to purchase an aggregate of 17,165,000 shares of the Company’s common stock (the Class M Warrants), for gross proceeds of $3,433,000. The Series C Preferred Stock accrues dividends at a rate of 6% per annum, payable annually on February 17th of each year, commencing on February 17, 2018.

 

The Class M Warrants were immediately exercisable at an exercise price of $0.12 per share, subject to adjustment as set forth in the warrant, and expired in February 2022.

 

The Company allocated the proceeds to the Series C Preferred Stock and Class M Warrants based on their relative fair value, which resulted in $2,895,379 being allocated to the Series C Preferred Stock and $537,621 being allocated to the Class M Warrants. The allocated Class M Warrant value was recorded as a discount to the Series C Preferred Stock and will be amortized to interest expense over the five-year life of the warrants. At December 31, 2022, the balance of the discount to the Series C Preferred Stock was $13,440 and the net carrying value of these 3,433 shares of Series C Preferred Stock was $3,419,560. At December 31, 2023, the balance of the discount to the Series C Preferred Stock was $0 and the net carrying value of these 3,433 shares of Series C Preferred Stock was $3,433,000.

 

On March 24, 2017, the Company entered into an Amendment to the 8% Convertible Notes (the Amendment), pursuant to which the 8% Convertible Notes (the Notes) issued by the Company in July 2012 were amended to give noteholders certain additional rights. Pursuant to the Amendment, the Notes were modified to provide each holder the right, at the holder’s option and exercisable prior to May 12, 2017, to convert all or any portion of the principal amount of the Notes, plus accrued but unpaid interest, into shares of Series C Preferred Stock at a conversion price of $1,000 per share. Holders that elected to convert their Notes into Series C Preferred Stock received a Class N Warrant to purchase up to 3,750 shares of the Company’s common stock for each share of Series C Preferred Stock received upon conversion of the Notes, with each Warrant having a five-year term, a cashless exercise feature, and an exercise price of $0.10 per share of common stock. On May 12, 2017, the Company completed the retirement of $1,835,000 of the Notes in early cash redemptions, and $780,000 of the Notes were converted into an aggregate of 780 shares of Series C Preferred Stock and Class N Warrants to purchase an aggregate of 2,925,000 shares of the Company’s common stock. In 2021, 150 shares of Series C Preferred Stock were converted into shares of common stock.

 

The Class N Warrants were immediately exercisable at an exercise price of $0.10 per share, subject to adjustment as set forth in the warrant, and expired in May 2022.

 

The Company allocated the proceeds to the Series C Preferred Stock and Class N Warrants based on their relative fair value, which resulted in $675,947 being allocated to the Series C Preferred Stock and $104,053 being allocated to the Class N Warrants. The allocated Class N Warrant value was recorded as a discount to the Series C Preferred Stock and will be amortized to interest expense over the five-year life of the warrants. At December 31, 2022, the balance of the discount to the Series C Preferred Stock was $4,737 and the net carrying value of 630 outstanding shares of Series C Preferred Stock was $625,263. At December 31, 2023, the balance of the discount to the Series C Preferred Stock was $0 and the net carrying value of 630 shares of Series C Preferred Stock was $630,000.

 

Employee Stock Purchase Plan

 

In September 2004, the Company’s Board approved an employee stock purchase plan for an aggregate of up to 2,000,000 shares of the Company’s common stock. The plan allows employees to deduct up to 15% of their salary or wages each pay period to be used for the purchase of common stock at a discounted rate. The common shares will be purchased at the end of each three-month offering period or other period as determined by the Board. The plan is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code. An amendment and restatement of the plan was approved in July 2020 by the Company’s shareholders, which increased the number of shares available for purchase by 3,000,000 shares. At December 31, 2023 there were 2,224,544 shares available under the employee stock purchase plan.

 

During 2023 and 2022, the Company issued 316,866 and 245,081 shares of common stock to employees for proceeds of $8,398 and $14,771, respectively, in accordance with the employee stock purchase plan.

 

2015 Incentive Plan

 

In April 2015, the Company’s Board of Directors approved the International Isotopes Inc. 2015 Incentive Plan (as amended, the “2015 Plan”) which was subsequently approved by the Company’s shareholders in July 2015. The 2015 Plan was amended and restated in July 2018 to increase the number of shares authorized for issuance under the 2015 plan by an additional 20,000,000 shares. The 2015 Plan provides for the grant of incentive and non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and units, and other stock or cash-based awards.  The 2015 Plan amends and restates the Company’s Amended and Restated 2006 Equity Incentive Plan (the “2006 Plan”).

 

The 2015 Plan authorizes the issuance of up to 80,000,000 shares of common stock, plus 11,089,967 shares authorized, but not issued under the 2006 Plan. Unless earlier terminated, the 2015 Plan will terminate on July 13, 2025. At December 31, 2023 there were 20,292,546 shares available for issuance under the 2015 Plan.

 

Non-Vested Stock Grants

 

Pursuant to an employment agreement with its Chief Executive Officer, the Company awarded 560,000 fully vested shares of common stock to its then Chief Executive Officer in February 2023 under the 2015 Plan. The number of shares awarded was based on a $28,000 stock award using a price of $0.05 per share. The employment agreement provides that the number of shares issued will be based on the average closing price of common stock for the 20 trading days prior to issue date but not less than $0.05 per share. Compensation expense recorded pursuant to this stock grant was $22,400, which was determined by multiplying the number of shares awarded by the closing price of the common stock on February 28, 2023, which was $0.04 per share. The Company withheld 216,440 shares of common stock to satisfy the employee’s payroll tax obligations in connection with this issuance. The net shares issued on February 28, 2023 totaled 343,560.

 

Pursuant to an employment agreement with its Chief Executive Officer, the Company awarded 307,692 fully vested shares of common stock to its Chief Executive Officer in February 2022 under the 2015 Plan. The number of shares awarded was based on a $28,000 stock award using a price of $0.091 per share. The employment agreement provides that the number of shares issued will be based on the average closing price of common stock for the 20 trading days prior to issue date but not less than $0.05 per share. Compensation expense recorded pursuant to this stock grant was $27,692, which was determined by multiplying the number of shares awarded by the closing price of the common stock on February 28, 2021, which was $0.09 per share. The Company withheld 120,461 shares of common stock to satisfy the employee’s payroll tax obligations in connection with this issuance. The net shares issued on February 28, 2022 totaled 187,231.

 

Stock Options

 

A summary of the stock options issued under the Company’s equity plans is as follows:

 

Stock Options

 Outstanding Shares  

Weighted Average Exercise Price

  

Weighted Average Remaining Contractual Life

  

Average Intrinsic Value

 

Outstanding at December 31, 2021

  20,777,500   0.06       627,615 

Granted

  8,150,000   0.09         

Exercised

  (1,200,000)  0.04       57,000 

Forfeited

  (1,734,000)  0.08         

Outstanding at December 31, 2022

  24,993,500   0.07       — 

Granted

  3,100,000   0.04         

Exercised

  —            

Forfeited

  (3,306,000)  0.08         

Outstanding at December 31, 2023

  24,787,500   0.05   5.4   17,000 

Exercisable at December 31, 2023

  19,372,500  $0.05   4.6  $16,000 

 

The total intrinsic value of stock options outstanding at December 31, 2023 was $ 16,000. The intrinsic value for stock options outstanding is calculated as the amount by which the quoted price of $0.04 of the Company’s common stock as of the end of 2023 exceeds the exercise price of the options.

 

The Company recognized $199,554 and $280,393 of compensation expense related to these options for the years ended December 31, 2023 and 2022, respectively. At December 31, 2023, the remaining compensation expense was $99,768 and will be recognized over 1.71 years.

 

During the year ended December 31, 2023, no qualified stock options were exercised.

 

In March 2022, 1,000,000 qualified stock options were exercised under a cashless exercise. The company withheld 388,889 shares to satisfy the exercise price and issued 611,111 shares of common stock. The options exercised were granted under the 2015 Plan, and, accordingly, there was not any income tax effect in the condensed consolidated financial statements for the year ended December 31, 2023.

 

In August 2022, 200,000 qualified stock options were exercised under a cashless exercise. The company withheld 162,163 shares to satisfy the exercise price and issued 37,837 shares of common stock. The options exercised were granted under the 2015 Plan, and, accordingly, there was not any income tax effect in the condensed consolidated financial statements for the year ended December 31, 2023.

 

During the year ended December 31, 2023, the Company granted an aggregate of 3,100,000 qualified stock options to 32 of its employees. These options vest over a five-year period with the first vesting at the date of grant and expiration at ten-year anniversary for all grants. The exercise price for these granted options was $0.04 and $0.06 per share. The options issued during the year ended December 31, 2023 have a fair value of $82,176, as estimated on the date of issue using the Black-Scholes options pricing model with the following weighted-average assumptions: risk free interest rate of 3.94% to 4.26%, expected dividend yield rate of 0%, expected volatility of 68.65% to 79.21% and an expected life between 5 and 7 years.

 

During the year ended December 31, 2022, the Company granted an employee 1,000,000 qualified stock options with an exercise price of $0.10 per share and 25,000 qualified stock options with an exercise price of $0.08 per share to one of its employees and a total of 125,000 qualified stock options with an exercise price of $0.03 per share to two other employees. These options vest over a five-year period with the first vesting at the one-year anniversary of the grant and expiration at ten-year anniversary for all grants. On February 21, 2022, the Compensation Committee granted 3,000,000 qualified stock options to the Company’s executive officers and 4,000,000 non-qualified stock options to members of the Board. The exercise price for these options was $0.09 per share. 2,000,000 of the options granted to an executive officer vest one half immediately and one half at the one-year anniversary of the grant. The remaining executive officer and board member options vest one fourth immediately and one fourth each subsequent year. All these granted options expire at the ten-year anniversary of the grant. The options issued during the year ended December 31, 2022 have a fair value of $442,295 as estimated on the date of issue using the Black-Scholes options pricing model with the following weighted-average assumptions: risk free interest rate of 1.37% to 4.14%, expected dividend yield rate of 0%, expected volatility of 65.19% to 70.09% and an expected life between 5 and 7.5 years.

 

All options exercised were issued under a qualified plan and accordingly, there is no income tax effect in the accompanying financial statements.

 

 

Restricted Stock Units

 

A summary of the non-vested restricted stock units issued under the Company’s equity plans is as follows:

 

 

 

Non-Vested Restricted Stock Units

 

Number of restricted stock units

 

Weighted average grant-date fair value

Outstanding at December 31, 2020

 

—

 

$ —

Granted

 

—

 

Exercised

 

—

 

Forfeited

 

—

 

Outstanding at December 31, 2021

 

—

 

Granted

 

—

 

Vested

 

—

 

Forfeited / Cancelled

 

—

 

Outstanding at December 31, 2022

 

—

 

Granted

 

7,250,000

 

0.04

Vested

 

(250,000

)

0.04

Forfeited / Cancelled

 

—

 

Outstanding at December 31, 2023

 

7,000,000

 

$ 0.04

 

 

 

The Company recognized $121,202 and $0 of compensation expense related to these restricted stock units ("RSU") for the years ended December 31, 2023 and 2022, respectively. At December 31, 2023, the remaining compensation expense was $168,798 and will be recognized over 1.72 years.

 

On March 3, 2023, the Compensation Committee of our Board of Directors approved the cancellation of 1,000,000 outstanding stock options held by a member of the Board in exchange for the grant of 750,000 RSUs. The RSUs vest over a three-year period beginning on the grant date.

 

On May 8, 2023, pursuant to an executive employment agreement entered into with its newly appointed President, the Company granted 6,500,000 RSUs to its President. 1,500,000 RSUs vest on April 17, 2024, 2,000,000 RSUs vest on April 17, 2025, and 3,000,000 RSUs vest on April 17, 2026. Each RSU represents the contingent right to receive one share of the Company’s common stock.

 

On September 5, 2023, pursuant to an employment agreement with its President, the Company awarded 2,500,000 fully vested RSUs under the 2015 Plan to the Company's President upon his promotion to Chief Executive Officer. Compensation expense recorded pursuant to this RSU award was $150,000, which was determined by multiplying the number of shares awarded by the closing price of the common stock on September 5, 2023, which was $0.06 per share. The Company withheld 778,972 shares of common stock to satisfy payroll tax obligations in connection with this issuance. The net shares issued on September 5, 2023 totaled 1,721,028.

 

 
XML 33 R17.htm IDEA: XBRL DOCUMENT v3.24.1
Note 10 - Income Taxes
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

NOTE 10 – INCOME TAXES - TO BE UPDATED

 

The Company paid no federal or state income taxes during 2023 and 2022. Income tax benefit on losses differed from the amounts computed by applying the recently enacted U.S. federal income tax rate of 21% to pretax losses as a result of the following:

 

  

2023

  

2022

 

Income tax expense (benefit)

 $(182,493) $72,207 

Book and tax differences

  40,577   (72,207)

State taxes net of federal benefit

  —   — 

Change in valuation allowance

  141,916   — 
  $—  $— 

 

The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets (liabilities) as of December 31, 2023 and 2022 are presented below:

 

  

2023

  

2022

 

Deferred income tax asset

 $—  $— 

Net operating loss carryforward

  7,918,996   7,736,618 

Valuation allowance

  (7,476,180)  (7,363,815)

Total deferred income tax asset

  442,816   372,803 

Deferred income tax liability - depreciation

  (442,816)  (372,803)

Deferred tax asset (liability)

 $—  $— 

 

At December 31, 2023, the Company had net operating losses of approximately $37,000,000 that will begin to expire in 2024. The valuation allowances for 2023 and 2022 have been applied to offset the deferred tax assets in recognition of the uncertainty that such benefits will be realized.

 

In accordance with GAAP, the Company has analyzed its filing positions in all jurisdictions where it is required to file income tax returns for the open tax years in such jurisdictions. The Company currently believes that all significant filing positions are highly certain and that all of its significant income tax filing positions and deductions would be sustained upon audit. Therefore, the Company has no significant reserves for uncertain tax positions, and no adjustment to such reserves was required by GAAP. No interest or penalties have been levied against the Company and none are anticipated, therefore no interest or penalty has been included in the provision for income taxes in the consolidated statements of operations.

 

The Internal Revenue Code contains provisions which reduce or limit the availability and utilization of net operating loss carry forwards in the event of a more than 50% change in ownership. If such an ownership change occurs with the Company, the use of these net operating losses could be limited.

 

 
XML 34 R18.htm IDEA: XBRL DOCUMENT v3.24.1
Note 11 - Commitments and Contingencies
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]

NOTE 11 – COMMITMENTS AND CONTINGENCIES

 

Dependence on Third Parties

 

Sales during 2023 to the Company’s top three customers was approximately 22% of its total gross revenue. The Company is making efforts to reduce its dependency on a small number of customers by expanding both domestic and foreign.

 

The production of Cobalt is dependent upon the DOE, and its prime operating contractor, which controls the reactor and laboratory operations at the ATR located outside of Idaho Falls, Idaho.  On October 2, 2014, the Company signed a ten-year contract with the DOE for the irradiation of cobalt targets for the production of cobalt-60. The Company will be able to purchase cobalt targets for a fixed price per target and with an annual 5% escalation in price.  The contract term is October 1, 2014, through September 30, 2024.  However, the DOE may end the contract if it determines termination is necessary for the national defense, security or environmental safety of the U.S.  If this were to occur, all payments made by the Company would be refunded.

 

The key isotope materials used to manufacture our radiopharmaceutical product and nuclear medicine reference standards are supplied to the Company through agreements with several suppliers. The loss of any of these suppliers could adversely affect operating results by causing a delay in production or a possible loss of sales.

 

Contingencies

 

Because all the Company’s business segments involve the handling or use of radioactive material, the Company is required to have an operating license from the NRC and specially trained staff to handle these materials. The Company has amended this operating license numerous times to increase the amount of material permitted within the Company’s facility.  Although this license does not currently restrict the volume of business operation performed or projected to be performed in the upcoming year, additional processing capabilities and license amendments could be implemented that would permit processing of other reactor-produced radioisotopes by the Company.  The financial assurance required by the NRC to support this license has been provided for with a surety bond and a restricted money market account, in the amount of $880,752, held with North American Specialty Insurance Company and Merrill Lynch, respectively.

 

In August 2011, we received land from Lea County, New Mexico, pursuant to a PPA, whereby the land was deeded to us for no monetary consideration. In return, we committed to construct a uranium de-conversion and FEP facility on the land.  In order to retain title to the property, we were to begin construction of the de-conversion facility no later than December 31, 2014, and complete Phase I of the project and have hired at least 75 persons to operate the facility no later than December 31, 2015, although commercial operations need not have begun by that date. In 2015 the Company negotiated a modification to the PPA agreement that extended the start of construction date to December 31, 2015, and the hiring milestone to December 31, 2016.  Those dates were not met and the Company is currently in the process of renegotiating a second modification to the agreement to further extend those dates. If we do not succeed in reaching an amendment to extend the performance dates in the agreement then we may, at our sole option, either purchase or re-convey the property to Lea County, New Mexico.  The purchase price of the property would be $776,078, plus interest at the annual rate of 5.25% from the date of the closing to the date of payment.  We have not recorded the value of this property as an asset and will not do so until such time that sufficient progress on the project has been made to meet our obligations under the agreements for permanent transfer of the title.

 

Defined Contribution Pension Plan

 

The Company has a 401(k) defined-contribution pension plan (the “401(k) Plan”).  Employees are eligible to participate in the Plan after completing six months of full-time service. Participants, under provision of Internal Revenue Code § 401(k), may elect to contribute up to $23,000 of their compensation to the 401(k) Plan which includes both before-tax and Roth after-tax contribution options. There was no employer matching contributions made for 2022. Beginning in 2023, the Company began matching contributions according to safe harbor 401(k) rules. All amounts withheld for employee contributions for 2023 were paid into the 401(k) Plan. The employer reserves the right to terminate the 401(k) Plan at any time.

 

 
XML 35 R19.htm IDEA: XBRL DOCUMENT v3.24.1
Note 12 - Asset Retirement Obligation
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Asset Retirement Obligation Disclosure [Text Block]

NOTE 12 – ASSET RETIREMENT OBLIGATION

 

As part of the Company’s NRC operating license and as part of the Company’s facility lease agreements, the Company is responsible for decommissioning any facilities upon termination or relocation of operations. The Company has developed a decommissioning funding plan using guidelines provided by the NRC and has estimated the cost of decommissioning the facility in Idaho Falls. The decommissioning cost estimate is reviewed at least annually to validate the assumptions and is revised as necessary when changes in the facility processes or radiological characteristics would affect the cost of decommissioning.

 

In accordance with GAAP, the Company has recognized future estimated decommissioning costs as an asset retirement obligation and a related capitalized lease disposal cost. The Company has recognized period-to-period changes in the liability (accretion) in the statement of operations as amortization expense. Changes resulting from revisions to the original estimate are recorded as an increase or decrease to the capitalized lease disposal cost. Capitalized lease disposal cost is amortized on a straight-line basis over the remaining life of the facility operating lease agreement.

 

The following summarizes the activity of the asset retirement obligation for the years ended December 31, 2023 and 2022:

 

  

Obligation for Lease Disposal Cost

 

Balance at December 31, 2021

  892,087 

Increase in lease disposal costs

  — 

Accretion expense/amortization expense

  50,291 

Balance at December 31, 2022

  942,378 

Increase in lease disposal costs

  478,959 

Accretion expense/amortization expense

  53,126 

Balance at December 31, 2023

 $1,474,463 

 
XML 36 R20.htm IDEA: XBRL DOCUMENT v3.24.1
Note 13 - Fair Value Measurements
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

NOTE 13 – FAIR VALUE MEASUREMENTS

 

At December 31, 2023 and 2022, the Company had no assets carried at fair value.

 
XML 37 R21.htm IDEA: XBRL DOCUMENT v3.24.1
Note 14 - Revenue Recognition
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]

NOTE 14 – REVENUE RECOGNITION

 

Revenue from Product Sales

 

The following tables present the Company’s revenue disaggregated by business segment and geography, based on management’s assessment of available data:

 

  

Twelve Months Ended December 31, 2023

  

Twelve Months Ended December 31, 2022

 
  

U.S.

  Outside U.S.  Total Revenues  

% of Total Revenues

  

U.S.

  Outside U.S.  Total Revenues  

% of Total Revenues

 

Theranostics Products

 $5,685,244  $1,157,654  $6,842,898   56% $5,338,010  $707,757  $6,045,767   54%

Cobalt Products

  932,915   104,158   1,037,073   8%  1,137,066   20,470   1,157,536   10%

Nuclear Medicine Products

  3,405,508   981,906   4,387,414   36%  3,173,755   804,930   3,978,685   36%

Fluorine Products

  —   —   —   0%  —   —   —   0%
  $10,023,667  $2,243,718  $12,267,385   100% $9,648,831  $1,533,157  $11,181,988   100%

 

Prior period amounts have not been adjusted under the modified retrospective approach.

 

Under ASC Topic 606, the Company recognizes revenue when it satisfies a performance obligation by transferring control of the promised goods or services to its customers, in an amount that reflects the consideration the Company expects to receive in exchange for the product or service.

 

Product sales consist of a single performance obligation that the Company satisfies at a point in time. All transactions in the Theranostics Products and nuclear medicine standards segments fall into this category. Most sales transactions in the cobalt products business segment fall into this category but other cobalt product sales are recorded as deferred income as discussed below. The Company recognizes product revenue when the following events have occurred: (a) the Company has transferred physical possession of the products, (b) the Company has a present right to payment, (c) the customer has legal title to the products, and (d) the customer bears significant risks and rewards of ownership of the products. Based on the Company’s historical practices and shipping terms specified in the sales agreements and invoices, these criteria are generally met when the products are:

 

 

•

Invoiced.

 

•

Shipped from the Company’s facilities (“FOB shipping point”, which is the Company’s standard shipping term). For these sales, the Company determined that the customer is able to direct the use of, and obtain substantially all of the benefits from, the products at the time the products are shipped.

 

The Company’s revenue consists primarily of products manufactured for use in the nuclear medicine industry, distribution of radiochemicals and radiopharmaceuticals, and cobalt source manufacturing. With the exception of certain unique products, the Company’s normal operating cycle is considered to be one year. Due to the time required to produce some cobalt products, the Company’s operating cycle for those products is considered to be two to three years. Accordingly, preliminary payments received on cobalt contracts, where shipment will not take place for greater than one year, have been recorded as unearned revenue on the Company’s consolidated balance sheets and classified under current or long-term liabilities, depending upon estimated ship dates. For the year ended December 31, 2023, the Company reported current unearned revenue of $932,682. For the period ended December 31, 2022, the Company reported current unearned revenue of $879,365. These unearned revenues will be recognized as revenue in the periods during which the cobalt shipments take place.

 

Contract Balances

 

The Company records a receivable when it has an unconditional right to receive consideration after the performance obligations are satisfied. As of December 31, 2023, and December 31, 2022, accounts receivable totaled $1,469,298 and $1,596,886, respectively.

 

Practical Expedients

 

The Company has elected the practical expedient not to determine whether contacts with customers contain significant financing components.

 
XML 38 R22.htm IDEA: XBRL DOCUMENT v3.24.1
Note 15 - Segment Information
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

NOTE 15 – SEGMENT INFORMATION

 

Information related to the Company’s reportable operating business segments is shown below. The Company’s reportable segments are reported in a manner consistent with the way management evaluates the businesses. The Company identifies its reportable business segments based on differences in products and services. The accounting policies of the business segments are the same as those described in the summary of significant accounting policies.

 

The Company has identified the following business segments:

 

 

●

The Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry and includes consolidated reporting of the wholly-owned subsidiaries RadQual and TI Services.

 

 

●

The Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources.

 

 

●

The Theranostics Products Segment (formerly called the Radiochemical Products Segment) includes production and distribution of Iodine-131 generic drug product and various isotopically pure radiochemicals for medical, industrial, or research applications. These products are either directly produced by the Company or are purchased in bulk from other producers and distributed by the Company in customized packages and chemical forms tailored to customer and market demands.  Iodine-131 is the predominant radiochemical sold in this segment.

 

 

●

The Fluorine Products segment historically involved the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. During 2013, these testing activities were completed, and the pilot plant facility was closed.  The Company has developed or acquired all patent rights to these processes. Future work in this segment will involve license support and, as financing permits, further work related to the de-conversion facility.

 

The following presents certain segment information as of and for the years ended December 31, 2023 and 2022:

 

Sale of product

 

2023

  

2022

 

Theranostics products

 $6,842,898  $6,045,767 

Cobalt products

  1,037,073   1,157,536 

Nuclear medicine standards

  4,387,414   3,978,685 

Fluorine products

  —   — 

Total segments

  12,267,385   11,181,988 

Corporate revenue

  —   — 

Total consolidated

 $12,267,385  $11,181,988 

 

Depreciation and amortization

 

2023

  

2022

 

Theranostics products

 $25,287  $63,493 

Cobalt products

  53,331   49,202 

Nuclear medicine standards

  114,833   114,990 

Fluorine products

  115,879   115,598 

Total segments

  309,330   343,283 

Corporate depreciation and amortization

  40,764   30,913 

Total consolidated

 $350,094  $374,196 

 

Segment income (loss)

 

2023

  

2022

 

Theranostics products

 $3,037,375  $4,182,151 

Cobalt products

  (126,504)  (95,779)

Nuclear medicine standards

  386,592   39,223 

Fluorine products

  (105,099)  (139,860)

Total segments

  3,192,364   3,985,735 

Corporate loss

  (4,061,380)  (3,682,497)

Total consolidated

 $(869,016) $303,238 

 

Expenditures for segment assets

 

2023

  

2022

 

Theranostics products

 $3,420  $3,379 

Cobalt products

  49,774   17,105 

Nuclear medicine standards

  35,137   75,478 

Fluorine products

  —   4,100 

Total segments

  88,331   100,062 

Corporate purchases

  60,727   19,952 

Total consolidated

 $149,058  $120,014 

 

Segment assets

 

2023

  

2022

 

Theranostics products

 $849,351  $1,075,252 

Cobalt products

  274,513   406,629 

Nuclear medicine standards

  3,538,558   2,744,394 

Fluorine products

  4,980,118   5,147,325 

Total segments

  9,642,540   9,373,600 

Corporate assets

  7,262,547   6,870,996 

Total consolidated

 $16,905,087  $16,244,596 

 
XML 39 R23.htm IDEA: XBRL DOCUMENT v3.24.1
Note 16 - Subsequent Events
 12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Subsequent Events [Text Block]

NOTE 16 – SUBSEQUENT EVENTS

 

On February 8, 2024, International Isotopes Inc. (“INIS”) and its wholly-owned subsidiary International Isotopes Fluorine Products, Inc. (together with INIS, the “Company”) entered into an Asset Purchase Agreement (the “APA”) with American Fuel Resources, LLC (“AFR”), pursuant to which the Company agreed to sell to AFR all the assets and certain specified liabilities of the Company’s depleted uranium deconversion and fluorine extraction plant (the “DUF6 Plant”), subject to the terms and conditions set forth in the APA (the “Transaction”). The Company expects to close the Transaction in approximately 12 to 24 months, subject to satisfaction of certain closing conditions (the “Closing”).

 

The purchase price to be paid by AFR in the Acquisition will consist of (i) $50,000 to be paid within five business days of execution of the APA (the “Prepayment”), and (ii) $12,500,000 paid at the Closing, less the Prepayment. The APA contains customary representations and warranties, covenants and indemnification provisions for a transaction of this nature. Closing of the Transaction is also subject to certain closing conditions, including (i) transfer of the U.S. Nuclear Regulatory Commission (NRC) license related to the DUF6 Plant (the “NRC License Transfer”) and (ii) transfer of Purchased Assets (as defined in the APA), which includes licenses, patents, agreements, and other records of the DUF6 Plant.

 

The APA may be terminated, among other things, (i) upon mutual written consent by the parties to the APA, (ii) by either party upon material breach of the APA by the other party, subject to applicable cure periods, and (iii) by AFR if there is reason to believe that the NRC License Transfer will not be completed by March 31, 2026.

 

In February 2024, the 2013 Promissory Note was modified to extend the maturity date to  March 31, 2026, with all remaining terms unchanged.

 

In February 2024, the 2018 Promissory Note was modified to extend the maturity date to  March 31, 2026, with all remaining terms unchanged.

 

In February 2024, the 2019 Promissory Note was modified to extend the maturity date to  March 31, 2026, with all remaining terms unchanged.

 

 
XML 40 R24.htm IDEA: XBRL DOCUMENT v3.24.1
Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Fair Value of Financial Instruments, Policy [Policy Text Block]

a)      Financial instruments and cash equivalents

 

The carrying value of notes payable approximates fair value because they bear interest at rates which approximate market rates.

 

Cash and cash equivalents, totaling $2,688,141 and $2,375,817 at December 31, 2023 and 2022, respectively, consist of operating accounts and money market accounts. For purposes of the consolidated statements of cash flows, the Company considers all highly-liquid financial instruments with original maturities of three months or less at date of purchase to be cash equivalents.

 

At December 31, 2023 and 2022, the Company had pledged cash on deposit in a money market account valued at $880,752 and $840,049 respectively, as security for a surety bond.  The surety bond is required as part of the Company’s operating license agreement with the Nuclear Regulatory Commission (“NRC”).

 

The Company maintains its cash accounts in various deposit accounts, the balances of which are periodically in excess of federally insured limits.

 
Receivable [Policy Text Block]

b)      Accounts receivable

 

The Company sells products mainly to recurring customers, wherein the customer’s ability to pay has previously been evaluated. The Company generally does not require collateral. The Company periodically reviews accounts receivable for amounts considered uncollectible and allowances are provided for uncollectible accounts when deemed necessary. At December 31, 2023 and  December 31, 2022 the Company had no allowance for doubtful accounts. 

 
Inventory, Policy [Policy Text Block]

c)      Inventories

 

Inventories are carried at the lower of cost or net realizable value. Cost is determined using the first in, first out method. When indicators of inventory impairment exist, the Company measures the carrying value of the inventory against its market value, and if the carrying value exceeds the market value, the inventory value is adjusted down accordingly.  No impairment was recorded for the years ended December 31, 2023 and December 31, 2022.

 
Property, Plant and Equipment, Policy [Policy Text Block]

d)      Property, plant and equipment

 

Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the asset.

 

Leasehold improvements are amortized over the shorter of the life of the lease or the service life of the improvements. Maintenance, repairs, and renewals that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Gains or losses on dispositions of property and equipment are included in the results of operations.

 
Goodwill and Intangible Assets, Policy [Policy Text Block]

e)      Goodwill and other intangibles

 

Goodwill is not amortized but is tested for impairment at least annually. Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets recorded as a result of the change in ownership of RadQual. As of  December 31, 2023 and 2022, there has been no impairment of goodwill.

 

Patents and other intangibles are amortized using the straight-line method over their estimated useful lives and are evaluated for impairment at least annually or when events or circumstances arise that indicate the existence of impairment. The Company evaluates the recoverability of identifiable intangible assets whenever events or changes in circumstances indicate that an intangible asset’s carrying amount may not be recoverable. Such circumstances could include but are not limited to: (1) a significant decrease in the market value of an asset, (2) a significant adverse change in the extent or manner in which an asset is used, or (3) an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset. When indicators of impairment exist, the Company measures the carrying amount of the asset against the estimated undiscounted future cash flows associated with it. Should the sum of the expected future cash flows be less than the carrying value of the asset being evaluated, an impairment loss would be recognized. The impairment loss would be calculated as the amount by which the carrying value of the asset exceeds its fair value. The evaluation of asset impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and actual results may differ from assumed and estimated amounts. During the years ended December 31, 2023 and 2022, the Company had no impairment losses related to intangible assets.

 
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

f)      Impairment of long-lived assets

 

Long-lived assets are reviewed for impairment annually, or when events or circumstances arise that indicate the existence of impairment, using the same evaluation process as described above for patents and other intangibles.  There was no impairment recorded during the years ended December 31, 2023 and 2022.

 
Income Tax, Policy [Policy Text Block]

g)      Income taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in income in the period that includes the enactment date.

 
Use of Estimates, Policy [Policy Text Block]

h)      Use of estimates

 

Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period to prepare these consolidated financial statements in conformity with GAAP.  Actual results could differ from those estimates.

 
Revenue [Policy Text Block]

i)      Revenue recognition

 

Revenue is recognized when products are shipped. No warranty coverage or right of return provisions are provided to customers. Amounts received as prepayment on future products or services are recorded as unearned revenues and recognized as income when the product is shipped or service performed. See Note 14 Revenue Recognition.

 
Advertising Cost [Policy Text Block]

j)      Advertising Expenses

 

Advertising expenses, which include promotional expenses, are expensed as incurred and totaled $142,188 and $118,465 for the years ended  December 31, 2023 and 2022, respectively.

 
Research and Development Expense, Policy [Policy Text Block]

k)      Research and development costs

 

Research and development costs are expensed as incurred and totaled $577,354 and $533,716 for the years ended  December 31, 2023 and 2022, respectively. These research and development costs were incurred for corporate business development and in our Theranostics Products and Nuclear Medicine Standards business segments.

 
Share-Based Payment Arrangement [Policy Text Block]

l)      Share-based compensation

 

The Company accounts for issuances of share-based compensation to employees in accordance with GAAP which requires the recognition of the cost of employee services received in exchange for an award of equity instruments in the financial statements and is measured based on the grant date fair value of the award. Compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (the vesting period).

 

For the years ended December 31, 2023 and 2022, the Company recognized share-based compensation expense of $464,041 and $352,458, respectively, related to stock options, stock grants, and restricted stock units. This expense is included as part of salaries and contract labor in the accompanying statements of operations.

 
Earnings Per Share, Policy [Policy Text Block]

m)      Net loss per common share – basic and diluted

 

Basic loss per share is computed on the basis of the weighted-average number of common shares outstanding during the year. Diluted loss per share is computed on the basis of the weighted-average number of common shares plus all potentially dilutive issuable common shares outstanding during the year.

 

The table below shows the calculation of diluted shares:

 

  

December 31,

 
  

2023

  

2022

 

Weighted average common shares outstanding - basic

  517,777,847   510,794,145 
         

Effects of dilutive shares

        

Stock options

  —   — 

Series C redeemable convertible preferred stock

  —   — 

Weighted average common shares outstanding - diluted

  517,777,847   510,794,145 

 

For the year ended December 31, 2023, the Company had 24,787,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were not included in the computation of diluted income per common share because they would be anti-dilutive.

 

For the year ended December 31, 2022, the Company had 24,993,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were not included in the computation of diluted income per common share because they would be anti-dilutive.

 

The table below summarizes common stock equivalents outstanding at December 31, 2023 and 2022:

 

  

December 31,

 
  

2023

  

2022

 

Stock options

  24,787,500   24,993,500 

4,063 Shares of Series C redeemable convertible preferred stock

  40,630,000   40,630,000 
   65,417,500   65,623,500 

 
Segment Reporting, Policy [Policy Text Block]

n)      Business segments and related information

 

GAAP establishes standards for the way public business enterprises are to report information about operating segments in annual financial statements and requires enterprises to report selected information about operating segments in interim financial reports issued to shareholders. It also establishes standards for related disclosure about products and services, geographic areas and major customers. The Company currently operates in four business segments.

 
New Accounting Pronouncements, Policy [Policy Text Block]

o)      Recent accounting standards

 

In August 2020, the Financial Accounting Standards Board issued ASU 2020-06 Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). The update simplifies accounting related to convertible debt instruments. The standard is effective for fiscal years beginning after December 15, 2023 including interim periods within those fiscal years. INIS is currently evaluating the effect this standard will have on its financial statements.
XML 41 R25.htm IDEA: XBRL DOCUMENT v3.24.1
Note 1 - Description of Business and Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Weighted Average Number of Shares [Table Text Block]
  

December 31,

 
  

2023

  

2022

 

Weighted average common shares outstanding - basic

  517,777,847   510,794,145 
         

Effects of dilutive shares

        

Stock options

  —   — 

Series C redeemable convertible preferred stock

  —   — 

Weighted average common shares outstanding - diluted

  517,777,847   510,794,145 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
  

December 31,

 
  

2023

  

2022

 

Stock options

  24,787,500   24,993,500 

4,063 Shares of Series C redeemable convertible preferred stock

  40,630,000   40,630,000 
   65,417,500   65,623,500 
XML 42 R26.htm IDEA: XBRL DOCUMENT v3.24.1
Note 5 - Property, Plant and Equipment (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Property, Plant and Equipment [Table Text Block]
  

2023

  

2022

  Estimated Useful Lives (in years) 

Furniture and fixtures

 $287,463  $284,020   3 - 5 

Transportation equipment

  114,708   114,708   5 - 10 

Plant and improvements

  526,205   501,334   5 

Production equipment

  4,569,980   3,997,193   5 - 10 
   5,498,356   4,897,255     

Accumulated depreciation

  (3,033,279)  (2,872,769)    
  $2,465,077  $2,024,486     
XML 43 R27.htm IDEA: XBRL DOCUMENT v3.24.1
Note 6 - Patents and Other Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
  

2023

 

Beginning

 $5,370,878 

Additions

  — 

Disposals

  — 

Ending

  5,370,878 

Accumulated amortization

  (1,832,420)
  $3,538,458 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Years ending December 31,

    

2025

 $164,895 

2026

  164,895 

2027

  164,895 

2028

  164,895 

2029

  164,895 

Thereafter

  2,713,983 
  $3,538,458 
XML 44 R28.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Convertible Debentures and Notes Payable (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Long-Term Debt Instruments [Table Text Block]
  

2023

  

2022

 
         

Note payable to related parties bearing interest at 6% all principal and interest due on March 31, 2026, secured

 $120,000  $120,000 

Note payable to related parties bearing interest at 4% all principal and interest due on March 31, 2026, secured

  1,000,000   1,000,000 

Note payable to related parties bearing interest at 6% all principal and interest due on March 31, 2026, secured

  500,000   500,000 

Note payable to a financial institution bearing interest at 5.99% monthly installments of $1,046, secured

  34,365   44,521 

Note payable for purchase contract bearing interest at 5% monthly installments of $4,442, secured

  —   13,233 

Note payable for purchase contract bearing no interest until the 25th month after the anniversary of the closing interest at 8% thereafter monthly installments of $10,000

  392,100    

Total notes payable

  2,046,465   1,677,754 

Less: current maturities

  (155,733)  (643,348)

Notes payable, net of current installments and debt discount

 $1,890,732  $1,034,406 
Schedule of Maturities of Long-Term Debt [Table Text Block]

Years ending December 31,

    

2024

 $155,733 

2025

  124,838 

2026

  1,745,595 

2027

  20,299 

Thereafter

  — 
  $2,046,465 
XML 45 R29.htm IDEA: XBRL DOCUMENT v3.24.1
Note 8 - Lease Obligations (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Lease, Cost [Table Text Block]
  

Year Ended

 
  

December 31,

 
  

2023

  

2022

 

Operating lease costs

 $287,108  $285,159 

Short-term operating lease costs

  7,200   12,066 

Financing lease expense:

        

Amortization of right-of-use assets

  6,023   4,172 

Interest on lease liabilities

  395   649 

Total financing lease expense

  6,418   4,821 

Total lease expense

 $300,726  $302,046 
         

Right-of-use assets obtained in exchange for new operating lease liabilities

 $—  $— 

Right-of-use assets obtained in exchange for new financing lease liabilities

 $—  $— 

Weighted-average remaining lease term (years) - operating leases

  11.1   12.1 

Weighted-average remaining lease term (years) - financing leases

  1.2   1.1 

Weighted-average discount rate - operating leases

  6.75%  6.75%

Weighted-average discount rate - financing leases

  6.75%  7.93%
Lessee, Liability, to be Paid, Maturity [ Table Text Block]
  

Operating leases

  

Finance leases

 

For the years ended December 31,

        

2024

 $287,108  $2,929 

2025

  287,108   — 

2026

  287,108   — 

2027

  287,108   — 

2028

  287,108   — 

Thereafter

  1,738,084   — 

Total minimum lease obligations

  3,173,624   2,929 

Less-amount representing interest

  (941,380)  (97)

Present value of minimum lease obligations

  2,232,244   2,832 

Current maturities

  (140,733)  (2,832)

Lease obligations, net of current maturities

 $2,091,511  $— 
XML 46 R30.htm IDEA: XBRL DOCUMENT v3.24.1
Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Warrants

 

Outstanding Shares

  

Weighted Average Exercise

 

Outstanding at December 31, 2021

  7,065,000  $0.11 

Granted

  —   — 

Exercised

  (515,000)  0.12 

Forfeited

  (6,550,000)  0.11 

Outstanding at December 31, 2022

  —   — 

Granted

  —   — 

Exercised

  —   — 

Forfeited

  —   — 

Outstanding at December 31, 2023

  —  $— 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]

Stock Options

 Outstanding Shares  

Weighted Average Exercise Price

  

Weighted Average Remaining Contractual Life

  

Average Intrinsic Value

 

Outstanding at December 31, 2021

  20,777,500   0.06       627,615 

Granted

  8,150,000   0.09         

Exercised

  (1,200,000)  0.04       57,000 

Forfeited

  (1,734,000)  0.08         

Outstanding at December 31, 2022

  24,993,500   0.07       — 

Granted

  3,100,000   0.04         

Exercised

  —            

Forfeited

  (3,306,000)  0.08         

Outstanding at December 31, 2023

  24,787,500   0.05   5.4   17,000 

Exercisable at December 31, 2023

  19,372,500  $0.05   4.6  $16,000 
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

Non-Vested Restricted Stock Units

 

Number of restricted stock units

 

Weighted average grant-date fair value

Outstanding at December 31, 2020

 

—

 

$ —

Granted

 

—

 

Exercised

 

—

 

Forfeited

 

—

 

Outstanding at December 31, 2021

 

—

 

Granted

 

—

 

Vested

 

—

 

Forfeited / Cancelled

 

—

 

Outstanding at December 31, 2022

 

—

 

Granted

 

7,250,000

 

0.04

Vested

 

(250,000

)

0.04

Forfeited / Cancelled

 

—

 

Outstanding at December 31, 2023

 

7,000,000

 

$ 0.04
XML 47 R31.htm IDEA: XBRL DOCUMENT v3.24.1
Note 10 - Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
  

2023

  

2022

 

Income tax expense (benefit)

 $(182,493) $72,207 

Book and tax differences

  40,577   (72,207)

State taxes net of federal benefit

  —   — 

Change in valuation allowance

  141,916   — 
  $—  $— 
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
  

2023

  

2022

 

Deferred income tax asset

 $—  $— 

Net operating loss carryforward

  7,918,996   7,736,618 

Valuation allowance

  (7,476,180)  (7,363,815)

Total deferred income tax asset

  442,816   372,803 

Deferred income tax liability - depreciation

  (442,816)  (372,803)

Deferred tax asset (liability)

 $—  $— 
XML 48 R32.htm IDEA: XBRL DOCUMENT v3.24.1
Note 12 - Asset Retirement Obligation (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Change in Asset Retirement Obligation [Table Text Block]
  

Obligation for Lease Disposal Cost

 

Balance at December 31, 2021

  892,087 

Increase in lease disposal costs

  — 

Accretion expense/amortization expense

  50,291 

Balance at December 31, 2022

  942,378 

Increase in lease disposal costs

  478,959 

Accretion expense/amortization expense

  53,126 

Balance at December 31, 2023

 $1,474,463 
XML 49 R33.htm IDEA: XBRL DOCUMENT v3.24.1
Note 14 - Revenue Recognition (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Disaggregation of Revenue [Table Text Block]
  

Twelve Months Ended December 31, 2023

  

Twelve Months Ended December 31, 2022

 
  

U.S.

  Outside U.S.  Total Revenues  

% of Total Revenues

  

U.S.

  Outside U.S.  Total Revenues  

% of Total Revenues

 

Theranostics Products

 $5,685,244  $1,157,654  $6,842,898   56% $5,338,010  $707,757  $6,045,767   54%

Cobalt Products

  932,915   104,158   1,037,073   8%  1,137,066   20,470   1,157,536   10%

Nuclear Medicine Products

  3,405,508   981,906   4,387,414   36%  3,173,755   804,930   3,978,685   36%

Fluorine Products

  —   —   —   0%  —   —   —   0%
  $10,023,667  $2,243,718  $12,267,385   100% $9,648,831  $1,533,157  $11,181,988   100%
XML 50 R34.htm IDEA: XBRL DOCUMENT v3.24.1
Note 15 - Segment Information (Tables)
 12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]

Sale of product

 

2023

  

2022

 

Theranostics products

 $6,842,898  $6,045,767 

Cobalt products

  1,037,073   1,157,536 

Nuclear medicine standards

  4,387,414   3,978,685 

Fluorine products

  —   — 

Total segments

  12,267,385   11,181,988 

Corporate revenue

  —   — 

Total consolidated

 $12,267,385  $11,181,988 

Depreciation and amortization

 

2023

  

2022

 

Theranostics products

 $25,287  $63,493 

Cobalt products

  53,331   49,202 

Nuclear medicine standards

  114,833   114,990 

Fluorine products

  115,879   115,598 

Total segments

  309,330   343,283 

Corporate depreciation and amortization

  40,764   30,913 

Total consolidated

 $350,094  $374,196 

Segment income (loss)

 

2023

  

2022

 

Theranostics products

 $3,037,375  $4,182,151 

Cobalt products

  (126,504)  (95,779)

Nuclear medicine standards

  386,592   39,223 

Fluorine products

  (105,099)  (139,860)

Total segments

  3,192,364   3,985,735 

Corporate loss

  (4,061,380)  (3,682,497)

Total consolidated

 $(869,016) $303,238 

Expenditures for segment assets

 

2023

  

2022

 

Theranostics products

 $3,420  $3,379 

Cobalt products

  49,774   17,105 

Nuclear medicine standards

  35,137   75,478 

Fluorine products

  —   4,100 

Total segments

  88,331   100,062 

Corporate purchases

  60,727   19,952 

Total consolidated

 $149,058  $120,014 

Segment assets

 

2023

  

2022

 

Theranostics products

 $849,351  $1,075,252 

Cobalt products

  274,513   406,629 

Nuclear medicine standards

  3,538,558   2,744,394 

Fluorine products

  4,980,118   5,147,325 

Total segments

  9,642,540   9,373,600 

Corporate assets

  7,262,547   6,870,996 

Total consolidated

 $16,905,087  $16,244,596 
XML 51 R35.htm IDEA: XBRL DOCUMENT v3.24.1
Note 1 - Description of Business and Significant Accounting Policies (Details Textual)
 12 Months Ended
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Number of Operating Segments 4  
Cash and Cash Equivalents, at Carrying Value $ 2,688,141 $ 2,375,817
Accounts Receivable, Allowance for Credit Loss, Current 0 0
Inventory Write-down 0 0
Goodwill, Impairment Loss 0 0
Impairment of Intangible Assets, Finite-Lived (0) 0
Impairment, Long-Lived Asset, Held-for-Use 0 0
Advertising Expense 142,188 118,465
Research and Development Expense 577,354 533,716
Share-Based Payment Arrangement, Expense $ 464,041 $ 352,458
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares 24,787,500 24,993,500
Series C Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares 4,063,000 4,063,000
Asset Pledged as Collateral [Member] | Surety Bond [Member]    
Money Market Funds, at Carrying Value $ 880,752 $ 840,049
XML 52 R36.htm IDEA: XBRL DOCUMENT v3.24.1
Note 1 - Description of Business and Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details) - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Weighted average common shares outstanding - basic (in shares) 517,777,847 510,794,145
Stock options (in shares) 0 0
Series C redeemable convertible preferred stock (in shares) 0 0
Weighted average common shares outstanding - diluted (in shares) 517,777,847 510,794,145
XML 53 R37.htm IDEA: XBRL DOCUMENT v3.24.1
Note 1 - Description of Business and Significant Accounting Policies - Schedule of Common Stock Equivalents Outstanding (Details) - shares
Dec. 31, 2023
Dec. 31, 2022
Common stock equivalents (in shares) 65,417,500 65,623,500
Series C Preferred Stock [Member]    
Common stock equivalents (in shares) 40,630,000 40,630,000
Share-Based Payment Arrangement, Option [Member]    
Common stock equivalents (in shares) 24,787,500 24,993,500
XML 54 R38.htm IDEA: XBRL DOCUMENT v3.24.1
Note 2 - Business Condition and Liquidity (Details Textual) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2025
Retained Earnings (Accumulated Deficit) $ (127,329,859) $ (126,460,843)  
Net Income (Loss) Attributable to Parent (869,016) 303,238  
Increase (Decrease) in Operating Capital 257,797    
Net Cash Provided by (Used in) Operating Activities 582,589 (1,497,719)  
Increase (Decrease) in Net Income (Loss) (1,172,254)    
Gain (Loss) on Disposition of Property Plant Equipment $ (0) $ 1,797,978  
Discontinued Operations, Held-for-Sale or Disposed of by Sale [Member] | Assets Associated With Planned De-conversion Facility [Member] | Forecast [Member]      
Disposal Group, Including Discontinued Operation, Consideration     $ 12,500,000
NRC License for the De-conversion Facility [Member]      
License Term (Year) 40 years    
XML 55 R39.htm IDEA: XBRL DOCUMENT v3.24.1
Note 4 - Inventories (Details Textual) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Inventory, Net $ 927,111 $ 744,793
XML 56 R40.htm IDEA: XBRL DOCUMENT v3.24.1
Note 5 - Property, Plant and Equipment (Details Textual) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Depreciation $ 160,567 $ 185,193
XML 57 R41.htm IDEA: XBRL DOCUMENT v3.24.1
Note 5 - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment, gross $ 5,498,356 $ 4,897,255
Accumulated depreciation (3,033,279) (2,872,769)
Property, Plant and Equipment, net 2,465,077 2,024,486
Furniture and Fixtures [Member]    
Property, Plant and Equipment, gross $ 287,463 284,020
Furniture and Fixtures [Member] | Minimum [Member]    
Property, Plant and Equipment, useful life (Year) 3 years  
Furniture and Fixtures [Member] | Maximum [Member]    
Property, Plant and Equipment, useful life (Year) 5 years  
Transportation Equipment [Member]    
Property, Plant and Equipment, gross $ 114,708 114,708
Transportation Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment, useful life (Year) 5 years  
Transportation Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment, useful life (Year) 10 years  
Building [Member]    
Property, Plant and Equipment, gross $ 526,205 501,334
Property, Plant and Equipment, useful life (Year) 5 years  
Production Equipment [Member]    
Property, Plant and Equipment, gross $ 4,569,980 $ 3,997,193
Production Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment, useful life (Year) 5 years  
Production Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment, useful life (Year) 10 years  
XML 58 R42.htm IDEA: XBRL DOCUMENT v3.24.1
Note 6 - Patents and Other Intangible Assets (Details Textual) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Amortization of Intangible Assets $ 164,895 $ 164,370
XML 59 R43.htm IDEA: XBRL DOCUMENT v3.24.1
Note 6 - Patents and Other Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Beginning $ 5,370,878  
Additions 0  
Disposals 0 $ 0
Ending 5,370,878 5,370,878
Accumulated amortization (1,832,420)  
Finite-Lived Intangible Assets, Net $ 3,538,458 $ 3,703,353
XML 60 R44.htm IDEA: XBRL DOCUMENT v3.24.1
Note 6 - Patents and Other Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
2025 $ 164,895  
2026 164,895  
2027 164,895  
2028 164,895  
2029 164,895  
Thereafter 2,713,983  
Finite-Lived Intangible Assets, Net $ 3,538,458 $ 3,703,353
XML 61 R45.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Convertible Debentures and Notes Payable (Details Textual) - USD ($)
 1 Months Ended
Dec. 31, 2019
Dec. 23, 2018
May 12, 2017
Feb. 29, 2020
Apr. 30, 2018
Feb. 28, 2017
Dec. 31, 2013
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 20, 2019
Jun. 30, 2014
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)               $ 0 $ 0 $ 0.11    
Class of Warrant or Right, Outstanding (in shares)               0 0 7,065,000    
Class L Warrants [Member]                        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             5,000,000         7,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)             $ 0.06         $ 0.06
Warrants and Rights Outstanding             $ 384,428          
Class of Warrants or Rights, Expirations (in shares)   25,000,000                    
Class O Warrants [Member]                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)                     $ 0.045  
Class of Warrant or Right, Outstanding (in shares)                     30,000,000  
The 2013 Promissory Note [Member] | Major Shareholders [Member]                        
Proceeds from Related Party Debt             $ 500,000          
Debt Instrument, Interest Rate, Stated Percentage             6.00%          
Debt Instrument, Convertible, Beneficial Conversion Feature             $ 15,464          
Interest Payable               $ 301,734        
The 2018 Promissory Note [Member] | Chief Executive Officer and Chairman of the Board [Member]                        
Proceeds from Related Party Debt         $ 120,000              
Debt Instrument, Interest Rate, Stated Percentage         6.00%              
Interest Payable               40,970        
The 2019 Promissory Note [Member] | Major Shareholders [Member]                        
Proceeds from Related Party Debt $ 675,000     $ 325,000                
Debt Instrument, Interest Rate, Stated Percentage                     4.00%  
Interest Payable               $ 159,131        
Debt Instrument, Face Amount                     $ 1,000,000  
Conversion of Convertible Debentures Into Series C Preferred Stock and Warrants [Member]                        
Debt Conversion, Original Debt, Amount     $ 780,000     $ 205,000            
Private Placement [Member] | Series C Preferred Stock [Member]                        
Stock Issued During Period, Shares, New Issues (in shares)           3,433            
XML 62 R46.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Notes payable $ 2,046,465 $ 1,677,754
Less: current maturities (155,733) (643,348)
Notes payable, net of current installments and debt discount 1,890,732 1,034,406
Notes Payable, Other Payables [Member] | Related Party One [Member]    
Notes payable 120,000 120,000
Notes Payable, Other Payables [Member] | Related Party Two [Member]    
Notes payable 1,000,000 1,000,000
Notes Payable, Other Payables [Member] | Related Party Three [Member]    
Notes payable 500,000 500,000
Notes Payable to Banks [Member]    
Notes payable 34,365 44,521
Notes Payable for Purchase Contract, One [Member]    
Notes payable 0 13,233
Notes Payable for Purchase Contract, Two [Member]    
Notes payable $ 392,100
XML 63 R47.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) (Parentheticals) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Notes Payable, Other Payables [Member] | Related Party One [Member]    
Stated interest rate 6.00% 6.00%
Maturity date Mar. 31, 2026 Mar. 31, 2026
Notes Payable, Other Payables [Member] | Related Party Two [Member]    
Stated interest rate 4.00% 4.00%
Maturity date Mar. 31, 2026 Mar. 31, 2026
Notes Payable, Other Payables [Member] | Related Party Three [Member]    
Stated interest rate 6.00% 6.00%
Maturity date Mar. 31, 2026 Mar. 31, 2026
Notes Payable to Banks [Member]    
Stated interest rate 5.99% 5.99%
Periodic payments $ 1,046 $ 1,046
Notes Payable for Purchase Contract, One [Member]    
Stated interest rate   5.00%
Periodic payments   $ 4,442
Notes Payable for Purchase Contract, Two [Member]    
Stated interest rate 8.00%  
Periodic payments $ 10,000  
XML 64 R48.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Convertible Debentures and Notes Payable - Schedule of Maturities of Long-term Debt (Details)
Dec. 31, 2023
USD ($)
2024 $ 155,733
2025 124,838
2026 1,745,595
2027 20,299
Thereafter 0
Long-Term Debt $ 2,046,465
XML 65 R49.htm IDEA: XBRL DOCUMENT v3.24.1
Note 8 - Lease Obligations - Lease Cost (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating lease costs $ 287,108 $ 285,159
Short-term operating lease costs 7,200 12,066
Amortization of right-of-use assets 6,023 4,172
Interest on lease liabilities 395 649
Total financing lease expense 6,418 4,821
Total lease expense 300,726 302,046
Right-of-use assets obtained in exchange for new operating lease liabilities 0 0
Right-of-use assets obtained in exchange for new financing lease liabilities $ 0 $ 0
Weighted-average remaining lease term (years) - operating leases (Year) 11 years 1 month 6 days 12 years 1 month 6 days
Weighted-average remaining lease term (years) - financing leases (Year) 1 year 2 months 12 days 1 year 1 month 6 days
Weighted-average discount rate - operating leases 6.75% 6.75%
Weighted-average discount rate - financing leases 6.75% 7.93%
XML 66 R50.htm IDEA: XBRL DOCUMENT v3.24.1
Note 8 - Lease Obligations - Schedule of Future Minimum Lease Payments (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Operating lease, 2024 $ 287,108  
Finance lease, 2024 2,929  
Operating lease, 2025 287,108  
Finance lease, 2025 0  
Operating lease, 2026 287,108  
Finance lease, 2026 0  
Operating lease, 2027 287,108  
Finance lease, 2027 0  
Operating lease, 2028 287,108  
Finance lease, 2028 0  
Operating lease, Thereafter 1,738,084  
Finance lease, Thereafter 0  
Total minimum operating lease obligations 3,173,624  
Total minimum finance lease obligations 2,929  
Less-amount representing interest, operating lease (941,380)  
Less-amount representing interest, finance lease (97)  
Present value of minimum operating lease obligations 2,232,244  
Present value of minimum finance lease obligations 2,832  
Current operating lease maturities (140,733) $ (131,572)
Current finance lease maturities (2,832) (5,513)
Operating lease obligations, net of current maturities 2,091,511 2,232,244
Finance lease obligations, net of current maturities $ 0 $ 2,832
XML 67 R51.htm IDEA: XBRL DOCUMENT v3.24.1
Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Details Textual)
 1 Months Ended 12 Months Ended
Sep. 05, 2023
USD ($)
$ / shares
shares
May 08, 2023
shares
Mar. 03, 2023
shares
Feb. 28, 2023
USD ($)
$ / shares
shares
May 31, 2022
USD ($)
$ / shares
shares
May 12, 2022
shares
Feb. 28, 2022
USD ($)
$ / shares
shares
Feb. 17, 2022
shares
Feb. 14, 2022
USD ($)
$ / shares
shares
May 12, 2017
USD ($)
shares
Mar. 24, 2017
USD ($)
$ / shares
shares
Feb. 17, 2017
USD ($)
$ / shares
shares
Aug. 31, 2022
USD ($)
shares
Mar. 31, 2022
USD ($)
shares
Jul. 31, 2020
shares
Jul. 31, 2018
shares
Feb. 28, 2017
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Feb. 28, 2021
$ / shares
Sep. 30, 2004
shares
Class of Warrant or Right, Exercised (in shares)                                   (0) 515,000      
Class of Warrant or Right, Exercise Price, Exercised (in dollars per share) | $ / shares                                   $ 0 $ 0.12      
Class of Warrant or Right, Outstanding (in shares)                                   0 0 7,065,000    
Preferred Stock, Shares Authorized (in shares)                                   5,000,000        
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares                                   $ 0.01        
Share Price (in dollars per share) | $ / shares $ 0.06     $ 0.04 $ 0.08                         0.04     $ 0.09  
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares                                   $ 0 $ 0 $ 0.11    
Share-Based Payment Arrangement, Expense | $                                   $ 464,041 $ 352,458      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value | $                                   $ 16,000        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)                                   (0) 1,200,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                                   3,100,000 8,150,000      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) | $ / shares                                   $ 0.04 $ 0.09      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares                                   $ 0.05 $ 0.07 $ 0.06    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)     1,000,000                             3,306,000 1,734,000      
Share-Based Payment Arrangement, Option [Member]                                            
Share-Based Payment Arrangement, Expense | $                                   $ 199,554 $ 280,393      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $                                   $ 99,768        
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)                                   1 year 8 months 15 days        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value | $                                     $ 442,295      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum                                     1.37%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum                                     4.14%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                                     0.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum                                     65.19%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum                                     70.09%      
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)                                     5 years      
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)                                     7 years 6 months      
Qualified Options [Member]                                            
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)                         162,163 388,889                
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)                         37,837 611,111                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)                         200,000 1,000,000       0        
Share-Based Payment Arrangement, Expense, Tax Benefit | $                         $ 0 $ 0                
Qualified Options [Member] | Share-Based Payment Arrangement, Employee [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                                   3,100,000 1,000,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)                                   5 years 5 years      
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)                                   10 years 10 years      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) | $ / shares                                     $ 0.1      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value | $                                   $ 82,176        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum                                   3.94%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum                                   4.26%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                                   0.00%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum                                   68.65%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum                                   79.21%        
Qualified Options [Member] | Share-Based Payment Arrangement, Employee [Member] | Share-Based Payment Arrangement, Tranche One [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)                                     1 year      
Qualified Options [Member] | Share-Based Payment Arrangement, Employee [Member] | Minimum [Member]                                            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) | $ / shares                                   $ 0.04        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)                                   5 years        
Qualified Options [Member] | Share-Based Payment Arrangement, Employee [Member] | Maximum [Member]                                            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) | $ / shares                                   $ 0.06        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)                                   7 years        
Restricted Stock Units (RSUs) [Member]                                            
Share-Based Payment Arrangement, Expense | $                                   $ 121,202 $ 0      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $                                   $ 168,798        
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)                                   1 year 8 months 19 days        
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)     3 years                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)     750,000                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)                                   7,250,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)                                   250,000    
Chief Executive Officer [Member]                                            
Employment Agreement, Minimum Price Per share (in dollars per share) | $ / shares       $ 0.05                                    
One Employee [Member] | Qualified Options [Member] | Share-Based Payment Arrangement, Employee [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                                     25,000      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) | $ / shares                                     $ 0.08      
Two Employees [Member] | Qualified Options [Member] | Share-Based Payment Arrangement, Employee [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                                     125,000      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) | $ / shares                                     $ 0.03      
Executive Officer [Member] | Qualified Options [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                                     3,000,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)                                     10 years      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares                                     $ 0.09      
Executive Officer [Member] | Qualified Options [Member] | Share-Based Payment Arrangement, Tranche One [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                                     2,000,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage                                     50.00%      
Executive Officer [Member] | Qualified Options [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)                                     1 year      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage                                     50.00%      
Director [Member] | Non-qualified Options [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                                     4,000,000      
Executive Officers and Directors [Member] | Qualified Options [Member] | Share-Based Payment Arrangement, Tranche One [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage                                     25.00%      
Executive Officers and Directors [Member] | Qualified Options [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage                                     25.00%      
President [Member] | Restricted Stock Units (RSUs) [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares) 2,500,000                                          
Share-Based Payment Arrangement, Expense | $ $ 150,000                                          
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares) 778,972                                          
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares) 1,721,028                                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)   6,500,000                                        
President [Member] | Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche One [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)   1,500,000                                        
President [Member] | Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)   2,000,000                                        
President [Member] | Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche Three [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)   3,000,000                                        
Employee Stock Purchase Plan [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)                                           2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Percent of Gross Pay                                           15.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)                             3,000,000              
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)                                   2,224,544        
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)                                   316,866 245,081      
Stock Issued During Period, Value, Employee Stock Purchase Plan | $                                   $ 8,398 $ 14,771      
The 2015 Incentive Plan [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)                               80,000,000            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)                               20,000,000            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)                                   20,292,546        
The 2015 Incentive Plan [Member] | Chief Executive Officer [Member]                                            
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture (in shares)       560,000     307,692                              
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture | $       $ 28,000     $ 28,000                              
Shares Issued, Price Per Share (in dollars per share) | $ / shares       $ 0.05     $ 0.091                              
Employment Agreement, Minimum Price Per share (in dollars per share) | $ / shares             $ 0.05                              
Share-Based Payment Arrangement, Expense | $       $ 22,400     $ 27,692                              
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)       216,440     120,461                              
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)       343,560     187,231                              
The 2006 Plan [Member]                                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)                               11,089,967            
Conversion of Convertible Debentures Into Series C Preferred Stock and Warrants [Member]                                            
Preferred Stock, Shares Outstanding (in shares)                                   630 630      
Preferred Stock, Convertible, Conversion Price (in dollars per share) | $ / shares                     $ 1,000                      
Proceeds from Issuance of Preferred Stock and Preference Stock | $                     $ 675,947                      
Preferred Stock, Discount on Shares | $                                   $ 0 $ 4,737      
Preferred Stock, Value, Issued | $                                   $ 630,000 $ 625,263      
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares)                   2,925,000 3,750                      
Debt Conversion, Original Debt, Amount | $                   $ 780,000             $ 205,000          
Debt Conversion, Converted Instrument, Shares Issued (in shares)                   780                        
Convertible Debt [Member]                                            
Debt Instrument, Interest Rate, Stated Percentage                     8.00%                      
Repayments of Convertible Debt | $                   $ 1,835,000                        
Subscription Agreements with Certain Investors [Member]                                            
Proceeds from Issuance or Sale of Equity | $                       $ 3,433,000                    
Conversion of Series B Preferred Stock Into Common Stock [Member]                                            
Preferred Stock, Redemption Price Per Share (in dollars per share) | $ / shares         $ 1,000                                  
Conversion of Stock, Shares Converted (in shares)         675                             175    
Conversion of Stock, Amount Issued | $         $ 675,000                                  
Conversion of Stock, Shares Issued (in shares)         8,437,500                                  
Conversion of Series C Preferred Stock Into Common Stock [Member]                                            
Conversion of Stock, Shares Converted (in shares)                                       150    
Series B Preferred Stock [Member]                                            
Preferred Stock, Shares Outstanding (in shares)                                       675    
Preferred Stock, Redemption Price Per Share (in dollars per share) | $ / shares                                       $ 1,000    
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount | $                                       $ 675,000    
Preferred Stock, Convertible, Conversion Price (in dollars per share) | $ / shares                                       $ 2    
Preferred Stock, Dividend Rate, Percentage                                       0.00%    
Series C Preferred Stock [Member]                                            
Preferred Stock, Shares Outstanding (in shares)                                   4,063 4,063      
Preferred Stock, Redemption Price Per Share (in dollars per share) | $ / shares                                   $ 1,000        
Preferred Stock, Convertible, Conversion Price (in dollars per share) | $ / shares                                   $ 0.1        
Preferred Stock, Convertible, Threshold Trading Days                                   90        
Preferred Stock, Convertible, Stock Price Trigger (in dollars per share) | $ / shares                                   $ 0.25        
Dividends Payable | $       $ 243,780     $ 243,780                              
Stock Dividends, Shares (in shares)                                   2,266,500 2,271,980      
Dividends, Preferred Stock | $                                   $ 90,660 $ 204,480      
Payments of Dividends | $                                   $ 153,120 $ 39,300      
Series C Preferred Stock [Member] | Subscription Agreements with Certain Investors [Member]                                            
Preferred Stock, Shares Outstanding (in shares)                                   3,433        
Preferred Stock, Dividend Rate, Percentage                       6.00%                    
Stock Issued During Period, Shares, New Issues (in shares)                       3,433                    
Proceeds from Issuance of Preferred Stock and Preference Stock | $                       $ 2,895,379                    
Preferred Stock, Discount on Shares | $                       13,440           $ 0        
Stock Issued During Period, Value, New Issues | $                       $ 3,419,560                    
Preferred Stock, Value, Issued | $                                   $ 3,433,000        
Class M Warrants [Member]                                            
Class of Warrant or Right, Exercised (in shares)                 515,000                          
Class of Warrant or Right, Exercise Price, Exercised (in dollars per share) | $ / shares                 $ 0.12                          
Proceeds from Warrant Exercises | $                 $ 61,800                          
Class of Warrants or Rights, Expirations (in shares)               3,625,000                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)                       17,165,000                    
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares                       $ 0.12                    
Proceeds from Issuance of Warrants | $                       $ 537,621                    
Warrants and Rights Outstanding, Term (Year)                       5 years                    
Class N Warrants [Member]                                            
Class of Warrants or Rights, Expirations (in shares)           2,925,000                                
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares                     $ 0.1                      
Proceeds from Issuance of Warrants | $                     $ 104,053                      
Warrants and Rights Outstanding, Term (Year)                     5 years                      
XML 68 R52.htm IDEA: XBRL DOCUMENT v3.24.1
Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Schedule of Warrant Activity (Details) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Outstanding, warrants (in shares) 0 7,065,000
Outstanding, warrants, weighted average exercise price (in dollars per share) $ 0 $ 0.11
Granted, warrants (in shares) 0 0
Granted, warrants, weighted average exercise price (in dollars per share) $ 0 $ 0
Exercised, warrants (in shares) 0 (515,000)
Exercised, warrants, weighted average exercise price (in dollars per share) $ 0 $ 0.12
Forfeited, warrants (in shares) 0 (6,550,000)
Forfeited, warrants, weighted average exercise price (in dollars per share) $ 0 $ 0.11
Outstanding, warrants (in shares) 0 0
Outstanding, warrants, weighted average exercise price (in dollars per share) $ 0 $ 0
XML 69 R53.htm IDEA: XBRL DOCUMENT v3.24.1
Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Option Activity (Details) - USD ($)
 12 Months Ended
Mar. 03, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Outstanding (in shares)   24,993,500 20,777,500  
Outstanding, weighted average exercise price (in dollars per share)   $ 0.07 $ 0.06  
Outstanding, aggregate intrinsic value   $ 17,000 $ 0 $ 627,615
Granted (in shares)   3,100,000 8,150,000  
Granted, weighted average exercise price (in dollars per share)   $ 0.04 $ 0.09  
Exercised (in shares)   0 (1,200,000)  
Exercised, weighted average exercise price (in dollars per share)   $ 0.04  
Exercised, aggregate intrinsic value     $ 57,000  
Forfeited (in shares) (1,000,000) (3,306,000) (1,734,000)  
Forfeited, weighted average exercise price (in dollars per share)   $ 0.08 $ 0.08  
Outstanding (in shares)   24,787,500 24,993,500  
Outstanding, weighted average exercise price (in dollars per share)   $ 0.05 $ 0.07  
Outstanding, weighted average remaining contractual life (Year)   5 years 4 months 24 days    
Exercisable (in shares)   19,372,500    
Exercisable, weighted average exercise price (in dollars per share)   $ 0.05    
Exercisable, weighted average remaining contractual life (Year)   4 years 7 months 6 days    
Exercisable, aggregate intrinsic value   $ 16,000    
XML 70 R54.htm IDEA: XBRL DOCUMENT v3.24.1
Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Outstanding, number (in shares)
Outstanding, weighted average grant date fair value (in dollars per share)
Granted, number (in shares) 7,250,000
Granted, weighted average grant date fair value (in dollars per share) $ 0.04
Exercised, number (in shares) (250,000)
Exercised, weighted average grant date fair value (in dollars per share) $ 0.04
Forfeited, number (in shares)
Forfeited, weighted average grant date fair value (in dollars per share)
Outstanding, number (in shares) 7,000,000
Outstanding, weighted average grant date fair value (in dollars per share)  
XML 71 R55.htm IDEA: XBRL DOCUMENT v3.24.1
Note 10 - Income Taxes (Details Textual) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Tax Expense (Benefit) $ 0 $ 0
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00%  
Operating Loss Carryforwards $ 37,000,000  
Unrecognized Tax Benefits 0  
Unrecognized Tax Benefits, Period Increase (Decrease) 0  
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense $ 0  
XML 72 R56.htm IDEA: XBRL DOCUMENT v3.24.1
Note 10 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income tax expense (benefit) $ (182,493) $ 72,207
Book and tax differences 40,577 (72,207)
State taxes net of federal benefit 0 0
Change in valuation allowance $ 141,916 $ 0
XML 73 R57.htm IDEA: XBRL DOCUMENT v3.24.1
Note 10 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Net operating loss carryforward $ 7,918,996 $ 7,736,618
Valuation allowance (7,476,180) (7,363,815)
Total deferred income tax asset 442,816 372,803
Deferred income tax liability - depreciation (442,816) (372,803)
Deferred tax asset (liability) $ 0 $ 0
XML 74 R58.htm IDEA: XBRL DOCUMENT v3.24.1
Note 11 - Commitments and Contingencies (Details Textual)
 12 Months Ended
Oct. 02, 2014
Aug. 31, 2011
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
The 401K Plan [Member]        
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount     $ 23,000  
Defined Contribution Plan, Cost       $ 0
Land in Lea County, New Mexico [Member]        
Number of Employees Hired   75    
Property, Plant, and Equipment, Fair Value Disclosure   $ 776,078    
Asset Purchase, Interest   5.25%    
Asset Pledged as Collateral [Member] | Surety Bond [Member]        
Money Market Funds, at Carrying Value     $ 880,752 $ 840,049
Contract With the DOE for the Irradiation of Cobalt Targets [Member]        
Contract Term (Year) 10 years      
Other Commitments, Annual Fixed Price, Escalation Percent 5.00%      
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member]        
Number of Major Customers       3
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member] | Three Customers [Member]        
Concentration Risk, Percentage       22.00%
XML 75 R59.htm IDEA: XBRL DOCUMENT v3.24.1
Note 12 - Asset Retirement Obligation - Schedule of Asset Retirement Obligation Activity (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Balance $ 942,378 $ 892,087
Increase in lease disposal costs 478,959 0
Accretion expense/amortization expense 53,126 50,291
Balance $ 1,474,463 $ 942,378
XML 76 R60.htm IDEA: XBRL DOCUMENT v3.24.1
Note 13 - Fair Value Measurements (Details Textual) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Estimate of Fair Value Measurement [Member]    
Assets, Fair Value Disclosure $ 0 $ 0
XML 77 R61.htm IDEA: XBRL DOCUMENT v3.24.1
Note 14 - Revenue Recognition (Details Textual) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Deferred Revenue, Current $ 932,682 $ 879,365
Accounts Receivable, after Allowance for Credit Loss, Current $ 1,469,298 $ 1,596,886
XML 78 R62.htm IDEA: XBRL DOCUMENT v3.24.1
Note 14 - Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Sale of product $ 12,267,385 $ 11,181,988
Percent of total revenues 100.00% 100.00%
Theranostics Products [Member]    
Sale of product $ 6,842,898 $ 6,045,767
Percent of total revenues 56.00% 54.00%
Cobalt Products [Member]    
Sale of product $ 1,037,073 $ 1,157,536
Percent of total revenues 8.00% 10.00%
Nuclear Medicine Products [Member]    
Sale of product $ 4,387,414 $ 3,978,685
Percent of total revenues 36.00% 36.00%
Fluorine Products [Member]    
Sale of product $ 0 $ 0
Percent of total revenues 0.00% 0.00%
UNITED STATES    
Sale of product $ 10,023,667 $ 9,648,831
UNITED STATES | Theranostics Products [Member]    
Sale of product 5,685,244 5,338,010
UNITED STATES | Cobalt Products [Member]    
Sale of product 932,915 1,137,066
UNITED STATES | Nuclear Medicine Products [Member]    
Sale of product 3,405,508 3,173,755
UNITED STATES | Fluorine Products [Member]    
Sale of product 0 0
Non-US [Member]    
Sale of product 2,243,718 1,533,157
Non-US [Member] | Theranostics Products [Member]    
Sale of product 1,157,654 707,757
Non-US [Member] | Cobalt Products [Member]    
Sale of product 104,158 20,470
Non-US [Member] | Nuclear Medicine Products [Member]    
Sale of product 981,906 804,930
Non-US [Member] | Fluorine Products [Member]    
Sale of product $ 0 $ 0
XML 79 R63.htm IDEA: XBRL DOCUMENT v3.24.1
Note 15 - Segment Information - Schedule of Segment Information by Segment (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Sale of product $ 12,267,385 $ 11,181,988
Depreciation and amortization 350,094 374,196
Net income (loss) (869,016) 303,238
Expenditures for segment assets 149,058 120,014
Segment assets 16,905,087 16,244,596
Theranostics Products [Member]    
Sale of product 6,842,898 6,045,767
Cobalt Products [Member]    
Sale of product 1,037,073 1,157,536
Nuclear Medicine Products [Member]    
Sale of product 4,387,414 3,978,685
Fluorine Products [Member]    
Sale of product 0 0
Operating Segments [Member]    
Sale of product 12,267,385 11,181,988
Depreciation and amortization 309,330 343,283
Net income (loss) 3,192,364 3,985,735
Expenditures for segment assets 88,331 100,062
Segment assets 9,642,540 9,373,600
Operating Segments [Member] | Theranostics Products [Member]    
Sale of product 6,842,898 6,045,767
Depreciation and amortization 25,287 63,493
Net income (loss) 3,037,375 4,182,151
Expenditures for segment assets 3,420 3,379
Segment assets 849,351 1,075,252
Operating Segments [Member] | Cobalt Products [Member]    
Sale of product 1,037,073 1,157,536
Depreciation and amortization 53,331 49,202
Net income (loss) (126,504) (95,779)
Expenditures for segment assets 49,774 17,105
Segment assets 274,513 406,629
Operating Segments [Member] | Nuclear Medicine Products [Member]    
Sale of product 4,387,414 3,978,685
Depreciation and amortization 114,833 114,990
Net income (loss) 386,592 39,223
Expenditures for segment assets 35,137 75,478
Segment assets 3,538,558 2,744,394
Operating Segments [Member] | Fluorine Products [Member]    
Sale of product 0 0
Depreciation and amortization 115,879 115,598
Net income (loss) (105,099) (139,860)
Expenditures for segment assets 0 4,100
Segment assets 4,980,118 5,147,325
Corporate, Non-Segment [Member]    
Sale of product 0 0
Depreciation and amortization 40,764 30,913
Net income (loss) (4,061,380) (3,682,497)
Expenditures for segment assets 60,727 19,952
Segment assets $ 7,262,547 $ 6,870,996
XML 80 R64.htm IDEA: XBRL DOCUMENT v3.24.1
Note 16 - Subsequent Events (Details Textual) - Subsequent Event [Member] - Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Feb. 08, 2024
USD ($)
Prepayment for DUF Plant [Member]  
Proceeds from Sale of Productive Assets $ 50,000
DUF Plant [Member]  
Proceeds from Sale of Productive Assets $ 12,500,000
EXCEL 81 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 83 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 85 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 249 382 1 false 81 0 false 6 false false R1.htm 000 - Document - Document And Entity Information Sheet http://intisoid.com/20231231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://intisoid.com/20231231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statement of Stockholders' Equity Sheet http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity Consolidated Statement of Stockholders' Equity Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 7 false false R8.htm 995452 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies Sheet http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies Note 1 - Description of Business and Significant Accounting Policies Notes 8 false false R9.htm 995453 - Disclosure - Note 2 - Business Condition and Liquidity Sheet http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity Note 2 - Business Condition and Liquidity Notes 9 false false R10.htm 995454 - Disclosure - Note 3 - Purchased Asset and Investments Sheet http://intisoid.com/20231231/role/statement-note-3-purchased-asset-and-investments- Note 3 - Purchased Asset and Investments Notes 10 false false R11.htm 995455 - Disclosure - Note 4 - Inventories Sheet http://intisoid.com/20231231/role/statement-note-4-inventories Note 4 - Inventories Notes 11 false false R12.htm 995456 - Disclosure - Note 5 - Property, Plant and Equipment Sheet http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment- Note 5 - Property, Plant and Equipment Notes 12 false false R13.htm 995457 - Disclosure - Note 6 - Patents and Other Intangible Assets Sheet http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets Note 6 - Patents and Other Intangible Assets Notes 13 false false R14.htm 995458 - Disclosure - Note 7 - Convertible Debentures and Notes Payable Notes http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable Note 7 - Convertible Debentures and Notes Payable Notes 14 false false R15.htm 995459 - Disclosure - Note 8 - Lease Obligations Sheet http://intisoid.com/20231231/role/statement-note-8-lease-obligations Note 8 - Lease Obligations Notes 15 false false R16.htm 995460 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants Sheet http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants Notes 16 false false R17.htm 995461 - Disclosure - Note 10 - Income Taxes Sheet http://intisoid.com/20231231/role/statement-note-10-income-taxes Note 10 - Income Taxes Notes 17 false false R18.htm 995462 - Disclosure - Note 11 - Commitments and Contingencies Sheet http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies Note 11 - Commitments and Contingencies Notes 18 false false R19.htm 995463 - Disclosure - Note 12 - Asset Retirement Obligation Sheet http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation Note 12 - Asset Retirement Obligation Notes 19 false false R20.htm 995464 - Disclosure - Note 13 - Fair Value Measurements Sheet http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements Note 13 - Fair Value Measurements Notes 20 false false R21.htm 995465 - Disclosure - Note 14 - Revenue Recognition Sheet http://intisoid.com/20231231/role/statement-note-14-revenue-recognition Note 14 - Revenue Recognition Notes 21 false false R22.htm 995466 - Disclosure - Note 15 - Segment Information Sheet http://intisoid.com/20231231/role/statement-note-15-segment-information Note 15 - Segment Information Notes 22 false false R23.htm 995467 - Disclosure - Note 16 - Subsequent Events Sheet http://intisoid.com/20231231/role/statement-note-16-subsequent-events Note 16 - Subsequent Events Notes 23 false false R24.htm 995468 - Disclosure - Significant Accounting Policies (Policies) Sheet http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies 24 false false R25.htm 995469 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies (Tables) Sheet http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables Note 1 - Description of Business and Significant Accounting Policies (Tables) Tables http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies 25 false false R26.htm 995470 - Disclosure - Note 5 - Property, Plant and Equipment (Tables) Sheet http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-tables Note 5 - Property, Plant and Equipment (Tables) Tables http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment- 26 false false R27.htm 995471 - Disclosure - Note 6 - Patents and Other Intangible Assets (Tables) Sheet http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables Note 6 - Patents and Other Intangible Assets (Tables) Tables http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets 27 false false R28.htm 995472 - Disclosure - Note 7 - Convertible Debentures and Notes Payable (Tables) Notes http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables Note 7 - Convertible Debentures and Notes Payable (Tables) Tables http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable 28 false false R29.htm 995473 - Disclosure - Note 8 - Lease Obligations (Tables) Sheet http://intisoid.com/20231231/role/statement-note-8-lease-obligations-tables Note 8 - Lease Obligations (Tables) Tables http://intisoid.com/20231231/role/statement-note-8-lease-obligations 29 false false R30.htm 995474 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Tables) Sheet http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Tables) Tables http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants 30 false false R31.htm 995475 - Disclosure - Note 10 - Income Taxes (Tables) Sheet http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables Note 10 - Income Taxes (Tables) Tables http://intisoid.com/20231231/role/statement-note-10-income-taxes 31 false false R32.htm 995476 - Disclosure - Note 12 - Asset Retirement Obligation (Tables) Sheet http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-tables Note 12 - Asset Retirement Obligation (Tables) Tables http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation 32 false false R33.htm 995477 - Disclosure - Note 14 - Revenue Recognition (Tables) Sheet http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-tables Note 14 - Revenue Recognition (Tables) Tables http://intisoid.com/20231231/role/statement-note-14-revenue-recognition 33 false false R34.htm 995478 - Disclosure - Note 15 - Segment Information (Tables) Sheet http://intisoid.com/20231231/role/statement-note-15-segment-information-tables Note 15 - Segment Information (Tables) Tables http://intisoid.com/20231231/role/statement-note-15-segment-information 34 false false R35.htm 995479 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual Note 1 - Description of Business and Significant Accounting Policies (Details Textual) Details http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables 35 false false R36.htm 995480 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details) Sheet http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details Note 1 - Description of Business and Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details) Details 36 false false R37.htm 995481 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies - Schedule of Common Stock Equivalents Outstanding (Details) Sheet http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details Note 1 - Description of Business and Significant Accounting Policies - Schedule of Common Stock Equivalents Outstanding (Details) Details 37 false false R38.htm 995482 - Disclosure - Note 2 - Business Condition and Liquidity (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual Note 2 - Business Condition and Liquidity (Details Textual) Details http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity 38 false false R39.htm 995483 - Disclosure - Note 4 - Inventories (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-4-inventories-details-textual Note 4 - Inventories (Details Textual) Details http://intisoid.com/20231231/role/statement-note-4-inventories 39 false false R40.htm 995484 - Disclosure - Note 5 - Property, Plant and Equipment (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-details-textual Note 5 - Property, Plant and Equipment (Details Textual) Details http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-tables 40 false false R41.htm 995485 - Disclosure - Note 5 - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) Sheet http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details Note 5 - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) Details 41 false false R42.htm 995486 - Disclosure - Note 6 - Patents and Other Intangible Assets (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-details-textual Note 6 - Patents and Other Intangible Assets (Details Textual) Details http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables 42 false false R43.htm 995487 - Disclosure - Note 6 - Patents and Other Intangible Assets - Schedule of Intangible Assets (Details) Sheet http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details Note 6 - Patents and Other Intangible Assets - Schedule of Intangible Assets (Details) Details 43 false false R44.htm 995488 - Disclosure - Note 6 - Patents and Other Intangible Assets - Schedule of Future Amortization Expense (Details) Sheet http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details Note 6 - Patents and Other Intangible Assets - Schedule of Future Amortization Expense (Details) Details 44 false false R45.htm 995489 - Disclosure - Note 7 - Convertible Debentures and Notes Payable (Details Textual) Notes http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual Note 7 - Convertible Debentures and Notes Payable (Details Textual) Details http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables 45 false false R46.htm 995490 - Disclosure - Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) Notes http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) Details 46 false false R47.htm 995491 - Disclosure - Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) (Parentheticals) Notes http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) (Parentheticals) Details 47 false false R48.htm 995492 - Disclosure - Note 7 - Convertible Debentures and Notes Payable - Schedule of Maturities of Long-term Debt (Details) Notes http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details Note 7 - Convertible Debentures and Notes Payable - Schedule of Maturities of Long-term Debt (Details) Details 48 false false R49.htm 995493 - Disclosure - Note 8 - Lease Obligations - Lease Cost (Details) Sheet http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details Note 8 - Lease Obligations - Lease Cost (Details) Details 49 false false R50.htm 995494 - Disclosure - Note 8 - Lease Obligations - Schedule of Future Minimum Lease Payments (Details) Sheet http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details Note 8 - Lease Obligations - Schedule of Future Minimum Lease Payments (Details) Details 50 false false R51.htm 995495 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Details Textual) Details http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables 51 false false R52.htm 995496 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Schedule of Warrant Activity (Details) Sheet http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Schedule of Warrant Activity (Details) Details 52 false false R53.htm 995497 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Option Activity (Details) Sheet http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Option Activity (Details) Details http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables 53 false false R54.htm 995498 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Restricted Stock Units Activity (Details) Sheet http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Restricted Stock Units Activity (Details) Details 54 false false R55.htm 995499 - Disclosure - Note 10 - Income Taxes (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual Note 10 - Income Taxes (Details Textual) Details http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables 55 false false R56.htm 995500 - Disclosure - Note 10 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Sheet http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details Note 10 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Details 56 false false R57.htm 995501 - Disclosure - Note 10 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details Note 10 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Details 57 false false R58.htm 995502 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual Note 11 - Commitments and Contingencies (Details Textual) Details http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies 58 false false R59.htm 995503 - Disclosure - Note 12 - Asset Retirement Obligation - Schedule of Asset Retirement Obligation Activity (Details) Sheet http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details Note 12 - Asset Retirement Obligation - Schedule of Asset Retirement Obligation Activity (Details) Details 59 false false R60.htm 995504 - Disclosure - Note 13 - Fair Value Measurements (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual Note 13 - Fair Value Measurements (Details Textual) Details http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements 60 false false R61.htm 995505 - Disclosure - Note 14 - Revenue Recognition (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-details-textual Note 14 - Revenue Recognition (Details Textual) Details http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-tables 61 false false R62.htm 995506 - Disclosure - Note 14 - Revenue Recognition - Disaggregation of Revenue (Details) Sheet http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details Note 14 - Revenue Recognition - Disaggregation of Revenue (Details) Details 62 false false R63.htm 995507 - Disclosure - Note 15 - Segment Information - Schedule of Segment Information by Segment (Details) Sheet http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details Note 15 - Segment Information - Schedule of Segment Information by Segment (Details) Details 63 false false R64.htm 995508 - Disclosure - Note 16 - Subsequent Events (Details Textual) Sheet http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual Note 16 - Subsequent Events (Details Textual) Details http://intisoid.com/20231231/role/statement-note-16-subsequent-events 64 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 62 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:EntityRegistrantName, ecd:NonRule10b51ArrAdoptedFlag, ecd:NonRule10b51ArrTrmntdFlag, ecd:Rule10b51ArrAdoptedFlag, ecd:Rule10b51ArrTrmntdFlag, inis:ContractTerm, us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent, us-gaap:AssetsFairValueDisclosure, us-gaap:ClassOfWarrantOrRightOutstanding, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:DebtInstrumentInterestRateStatedPercentage, us-gaap:DebtInstrumentMaturityDate, us-gaap:DebtInstrumentPeriodicPaymentPrincipal, us-gaap:DividendsPayableCurrentAndNoncurrent, us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense, us-gaap:GoodwillImpairmentLoss, us-gaap:ImpairmentOfIntangibleAssetsFinitelived, us-gaap:ImpairmentOfLongLivedAssetsHeldForUse, us-gaap:IncomeTaxExpenseBenefit, us-gaap:InventoryWriteDown, us-gaap:PreferredStockSharesOutstanding, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod, us-gaap:WarrantsAndRightsOutstandingTerm - inis20221231_10k.htm 8, 10, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72 [EXG.rendering.tooManyDimensions] Presentation group http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual with 12 axes could have more than 9 billion cells. Split up this presentation group and see EXG, Rendering, to see how to reduce the number of combinations by selecting fewer members for each axis. - inis20221231_10k.htm - inis20221231_10k.htm inis-20231231.xsd inis-20231231_cal.xml inis-20231231_def.xml inis-20231231_lab.xml inis-20231231_pre.xml inis20221231_10k.htm auditopinionjpg_page1.jpg auditopinionjpg_page2.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 88 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "inis20221231_10k.htm": { "nsprefix": "inis", "nsuri": "http://intisoid.com/20231231", "dts": { "schema": { "local": [ "inis-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "inis-20231231_cal.xml" ] }, "definitionLink": { "local": [ "inis-20231231_def.xml" ] }, "labelLink": { "local": [ "inis-20231231_lab.xml" ] }, "presentationLink": { "local": [ "inis-20231231_pre.xml" ] }, "inline": { "local": [ "inis20221231_10k.htm" ] } }, "keyStandard": 352, "keyCustom": 30, "axisStandard": 34, "axisCustom": 0, "memberStandard": 40, "memberCustom": 39, "hidden": { "total": 66, "http://fasb.org/us-gaap/2023": 55, "http://intisoid.com/20231231": 1, "http://xbrl.sec.gov/dei/2023": 6, "http://xbrl.sec.gov/ecd/2023": 4 }, "contextCount": 249, "entityCount": 1, "segmentCount": 81, "elementCount": 589, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 847, "http://xbrl.sec.gov/dei/2023": 35, "http://xbrl.sec.gov/ecd/2023": 5 }, "report": { "R1": { "role": "http://intisoid.com/20231231/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R2": { "role": "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "longName": "001 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R3": { "role": "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)", "shortName": "Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": null, "uniqueAnchor": null }, "R4": { "role": "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "longName": "003 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R5": { "role": "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "longName": "004 - Statement - Consolidated Statement of Stockholders' Equity", "shortName": "Consolidated Statement of Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "i_2021-12-31_StatementEquityComponentsAxis-CommonStockMember", "name": "us-gaap:SharesOutstanding", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2021-12-31_StatementEquityComponentsAxis-CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R6": { "role": "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "longName": "005 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "inis:AccretionOfObligationForLeaseDisposalCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ecd:MtrlTermsOfTrdArrTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ecd:MtrlTermsOfTrdArrTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R8": { "role": "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "longName": "995452 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies", "shortName": "Note 1 - Description of Business and Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R9": { "role": "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "longName": "995453 - Disclosure - Note 2 - Business Condition and Liquidity", "shortName": "Note 2 - Business Condition and Liquidity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R10": { "role": "http://intisoid.com/20231231/role/statement-note-3-purchased-asset-and-investments-", "longName": "995454 - Disclosure - Note 3 - Purchased Asset and Investments", "shortName": "Note 3 - Purchased Asset and Investments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:AssetAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:AssetAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R11": { "role": "http://intisoid.com/20231231/role/statement-note-4-inventories", "longName": "995455 - Disclosure - Note 4 - Inventories", "shortName": "Note 4 - Inventories", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R12": { "role": "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-", "longName": "995456 - Disclosure - Note 5 - Property, Plant and Equipment", "shortName": "Note 5 - Property, Plant and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R13": { "role": "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets", "longName": "995457 - Disclosure - Note 6 - Patents and Other Intangible Assets", "shortName": "Note 6 - Patents and Other Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R14": { "role": "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "longName": "995458 - Disclosure - Note 7 - Convertible Debentures and Notes Payable", "shortName": "Note 7 - Convertible Debentures and Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R15": { "role": "http://intisoid.com/20231231/role/statement-note-8-lease-obligations", "longName": "995459 - Disclosure - Note 8 - Lease Obligations", "shortName": "Note 8 - Lease Obligations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "inis:LesseeOperatingLeasesAndFinanceLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "inis:LesseeOperatingLeasesAndFinanceLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R16": { "role": "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "longName": "995460 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants", "shortName": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R17": { "role": "http://intisoid.com/20231231/role/statement-note-10-income-taxes", "longName": "995461 - Disclosure - Note 10 - Income Taxes", "shortName": "Note 10 - Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R18": { "role": "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "longName": "995462 - Disclosure - Note 11 - Commitments and Contingencies", "shortName": "Note 11 - Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R19": { "role": "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation", "longName": "995463 - Disclosure - Note 12 - Asset Retirement Obligation", "shortName": "Note 12 - Asset Retirement Obligation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:AssetRetirementObligationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:AssetRetirementObligationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R20": { "role": "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements", "longName": "995464 - Disclosure - Note 13 - Fair Value Measurements", "shortName": "Note 13 - Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R21": { "role": "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition", "longName": "995465 - Disclosure - Note 14 - Revenue Recognition", "shortName": "Note 14 - Revenue Recognition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R22": { "role": "http://intisoid.com/20231231/role/statement-note-15-segment-information", "longName": "995466 - Disclosure - Note 15 - Segment Information", "shortName": "Note 15 - Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R23": { "role": "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "longName": "995467 - Disclosure - Note 16 - Subsequent Events", "shortName": "Note 16 - Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R24": { "role": "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies", "longName": "995468 - Disclosure - Significant Accounting Policies (Policies)", "shortName": "Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:FairValueOfFinancialInstrumentsPolicy", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:FairValueOfFinancialInstrumentsPolicy", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R25": { "role": "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables", "longName": "995469 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies (Tables)", "shortName": "Note 1 - Description of Business and Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R26": { "role": "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-tables", "longName": "995470 - Disclosure - Note 5 - Property, Plant and Equipment (Tables)", "shortName": "Note 5 - Property, Plant and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R27": { "role": "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables", "longName": "995471 - Disclosure - Note 6 - Patents and Other Intangible Assets (Tables)", "shortName": "Note 6 - Patents and Other Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R28": { "role": "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables", "longName": "995472 - Disclosure - Note 7 - Convertible Debentures and Notes Payable (Tables)", "shortName": "Note 7 - Convertible Debentures and Notes Payable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R29": { "role": "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-tables", "longName": "995473 - Disclosure - Note 8 - Lease Obligations (Tables)", "shortName": "Note 8 - Lease Obligations (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "inis:LesseeOperatingLeasesAndFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "inis:LesseeOperatingLeasesAndFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R30": { "role": "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables", "longName": "995474 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Tables)", "shortName": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R31": { "role": "http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables", "longName": "995475 - Disclosure - Note 10 - Income Taxes (Tables)", "shortName": "Note 10 - Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R32": { "role": "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-tables", "longName": "995476 - Disclosure - Note 12 - Asset Retirement Obligation (Tables)", "shortName": "Note 12 - Asset Retirement Obligation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfChangeInAssetRetirementObligationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AssetRetirementObligationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfChangeInAssetRetirementObligationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AssetRetirementObligationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R33": { "role": "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-tables", "longName": "995477 - Disclosure - Note 14 - Revenue Recognition (Tables)", "shortName": "Note 14 - Revenue Recognition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R34": { "role": "http://intisoid.com/20231231/role/statement-note-15-segment-information-tables", "longName": "995478 - Disclosure - Note 15 - Segment Information (Tables)", "shortName": "Note 15 - Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R35": { "role": "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "longName": "995479 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies (Details Textual)", "shortName": "Note 1 - Description of Business and Significant Accounting Policies (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R36": { "role": "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details", "longName": "995480 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details)", "shortName": "Note 1 - Description of Business and Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R37": { "role": "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "longName": "995481 - Disclosure - Note 1 - Description of Business and Significant Accounting Policies - Schedule of Common Stock Equivalents Outstanding (Details)", "shortName": "Note 1 - Description of Business and Significant Accounting Policies - Schedule of Common Stock Equivalents Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "inis:CommonStockEquivalentsOutstanding", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "inis:CommonStockEquivalentsOutstanding", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R38": { "role": "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual", "longName": "995482 - Disclosure - Note 2 - Business Condition and Liquidity (Details Textual)", "shortName": "Note 2 - Business Condition and Liquidity (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncreaseDecreaseInOperatingCapital", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R39": { "role": "http://intisoid.com/20231231/role/statement-note-4-inventories-details-textual", "longName": "995483 - Disclosure - Note 4 - Inventories (Details Textual)", "shortName": "Note 4 - Inventories (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:InventoryNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": null }, "R40": { "role": "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-details-textual", "longName": "995484 - Disclosure - Note 5 - Property, Plant and Equipment (Details Textual)", "shortName": "Note 5 - Property, Plant and Equipment (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R41": { "role": "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "longName": "995485 - Disclosure - Note 5 - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details)", "shortName": "Note 5 - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R42": { "role": "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-details-textual", "longName": "995486 - Disclosure - Note 6 - Patents and Other Intangible Assets (Details Textual)", "shortName": "Note 6 - Patents and Other Intangible Assets (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R43": { "role": "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details", "longName": "995487 - Disclosure - Note 6 - Patents and Other Intangible Assets - Schedule of Intangible Assets (Details)", "shortName": "Note 6 - Patents and Other Intangible Assets - Schedule of Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R44": { "role": "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details", "longName": "995488 - Disclosure - Note 6 - Patents and Other Intangible Assets - Schedule of Future Amortization Expense (Details)", "shortName": "Note 6 - Patents and Other Intangible Assets - Schedule of Future Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R45": { "role": "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "longName": "995489 - Disclosure - Note 7 - Convertible Debentures and Notes Payable (Details Textual)", "shortName": "Note 7 - Convertible Debentures and Notes Payable (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "USDPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2013-12-31_ClassOfWarrantOrRightAxis-ClassLWarrantsMember", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R46": { "role": "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "longName": "995490 - Disclosure - Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details)", "shortName": "Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:NotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:NotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R47": { "role": "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals", "longName": "995491 - Disclosure - Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) (Parentheticals)", "shortName": "Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) (Parentheticals)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "47", "firstAnchor": null, "uniqueAnchor": null }, "R48": { "role": "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details", "longName": "995492 - Disclosure - Note 7 - Convertible Debentures and Notes Payable - Schedule of Maturities of Long-term Debt (Details)", "shortName": "Note 7 - Convertible Debentures and Notes Payable - Schedule of Maturities of Long-term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R49": { "role": "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details", "longName": "995493 - Disclosure - Note 8 - Lease Obligations - Lease Cost (Details)", "shortName": "Note 8 - Lease Obligations - Lease Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:OperatingLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LeaseCostTableTextBlock", "inis:LesseeOperatingLeasesAndFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:OperatingLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LeaseCostTableTextBlock", "inis:LesseeOperatingLeasesAndFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R50": { "role": "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details", "longName": "995494 - Disclosure - Note 8 - Lease Obligations - Schedule of Future Minimum Lease Payments (Details)", "shortName": "Note 8 - Lease Obligations - Schedule of Future Minimum Lease Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "inis:LesseeLiabilityToBePaidMaturityTableTextBlock", "inis:LesseeOperatingLeasesAndFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "inis:LesseeLiabilityToBePaidMaturityTableTextBlock", "inis:LesseeOperatingLeasesAndFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R51": { "role": "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "longName": "995495 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Details Textual)", "shortName": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "inis:ClassOfWarrantOrRightExercised", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R52": { "role": "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details", "longName": "995496 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Schedule of Warrant Activity (Details)", "shortName": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Schedule of Warrant Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "inis:ClassOfWarrantOrRightGranted", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R53": { "role": "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details", "longName": "995497 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Option Activity (Details)", "shortName": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2021-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R54": { "role": "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details", "longName": "995498 - Disclosure - Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Restricted Stock Units Activity (Details)", "shortName": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Restricted Stock Units Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "i_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Share", "xsiNil": "true", "lang": null, "decimals": null, "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2020-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Share", "xsiNil": "true", "lang": null, "decimals": null, "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R55": { "role": "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual", "longName": "995499 - Disclosure - Note 10 - Income Taxes (Details Textual)", "shortName": "Note 10 - Income Taxes (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R56": { "role": "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "longName": "995500 - Disclosure - Note 10 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)", "shortName": "Note 10 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R57": { "role": "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "longName": "995501 - Disclosure - Note 10 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "shortName": "Note 10 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R58": { "role": "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual", "longName": "995502 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual)", "shortName": "Note 11 - Commitments and Contingencies (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31_RetirementPlanNameAxis-The401kPlanMember", "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31_RetirementPlanNameAxis-The401kPlanMember", "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R59": { "role": "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details", "longName": "995503 - Disclosure - Note 12 - Asset Retirement Obligation - Schedule of Asset Retirement Obligation Activity (Details)", "shortName": "Note 12 - Asset Retirement Obligation - Schedule of Asset Retirement Obligation Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:AssetRetirementObligation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfChangeInAssetRetirementObligationTableTextBlock", "us-gaap:AssetRetirementObligationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2021-12-31", "name": "us-gaap:AssetRetirementObligation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfChangeInAssetRetirementObligationTableTextBlock", "us-gaap:AssetRetirementObligationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R60": { "role": "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual", "longName": "995504 - Disclosure - Note 13 - Fair Value Measurements (Details Textual)", "shortName": "Note 13 - Fair Value Measurements (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "i_2023-12-31_FairValueByMeasurementBasisAxis-EstimateOfFairValueFairValueDisclosureMember", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31_FairValueByMeasurementBasisAxis-EstimateOfFairValueFairValueDisclosureMember", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R61": { "role": "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-details-textual", "longName": "995505 - Disclosure - Note 14 - Revenue Recognition (Details Textual)", "shortName": "Note 14 - Revenue Recognition (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:DeferredRevenueCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:DeferredRevenueCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } }, "R62": { "role": "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "longName": "995506 - Disclosure - Note 14 - Revenue Recognition - Disaggregation of Revenue (Details)", "shortName": "Note 14 - Revenue Recognition - Disaggregation of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "inis:PercentOfTotalRevenues", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R63": { "role": "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details", "longName": "995507 - Disclosure - Note 15 - Segment Information - Schedule of Segment Information by Segment (Details)", "shortName": "Note 15 - Segment Information - Schedule of Segment Information by Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SegmentExpenditureAdditionToLongLivedAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "ix:continuation", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "unique": true } }, "R64": { "role": "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual", "longName": "995508 - Disclosure - Note 16 - Subsequent Events (Details Textual)", "shortName": "Note 16 - Subsequent Events (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "d_2024-02-08_2024-02-08_DisposalGroupClassificationAxis-DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-PrepaymentForDufPlantMember_SubsequentEventTypeAxis-SubsequentEventMember", "name": "us-gaap:ProceedsFromSaleOfProductiveAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2024-02-08_2024-02-08_DisposalGroupClassificationAxis-DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-PrepaymentForDufPlantMember_SubsequentEventTypeAxis-SubsequentEventMember", "name": "us-gaap:ProceedsFromSaleOfProductiveAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "inis20221231_10k.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Accrued long-term liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r31" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r23", "r707" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-details-textual" ], "lang": { "en-us": { "role": { "label": "Accounts receivable", "terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r270", "r271" ] }, "us-gaap_AccretionExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccretionExpense", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Accretion of beneficial conversion feature", "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations." } } }, "auth_ref": [ "r690", "r774" ] }, "inis_AccretionOfObligationForLeaseDisposalCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://intisoid.com/20231231", "localname": "AccretionOfObligationForLeaseDisposalCosts", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Accretion of obligation for lease disposal costs", "documentation": "Represents the amount of accretion of obligation for lease disposal costs." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r27" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "negatedLabel": "Accumulated depreciation", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r61", "r166", "r542" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r97", "r707", "r895" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r431", "r432", "r433", "r573", "r756", "r757", "r758", "r872", "r897" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Stock based compensation", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r72", "r73", "r397" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Advertising Cost [Policy Text Block]", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r144" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AdvertisingExpense", "terseLabel": "Advertising Expense", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r439" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AllocatedShareBasedCompensationExpense", "terseLabel": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r429", "r438" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent", "terseLabel": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r174", "r272", "r276" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AmortizationOfIntangibleAssets", "terseLabel": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r8", "r55", "r58" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r225" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r43" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r465" ] }, "us-gaap_AssetAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-3-purchased-asset-and-investments-" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Text Block]", "documentation": "The entire disclosure for asset acquisition." } } }, "auth_ref": [ "r871" ] }, "us-gaap_AssetPledgedAsCollateralMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetPledgedAsCollateralMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Asset Pledged as Collateral [Member]", "documentation": "Asset pledged as collateral." } } }, "auth_ref": [ "r466", "r591", "r705", "r887" ] }, "inis_AssetPurchaseInterest": { "xbrltype": "percentItemType", "nsuri": "http://intisoid.com/20231231", "localname": "AssetPurchaseInterest", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_AssetPurchaseInterest", "terseLabel": "Asset Purchase, Interest", "documentation": "Percentage of interest on asset purchase." } } }, "auth_ref": [] }, "us-gaap_AssetRetirementObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligation", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_AssetRetirementObligation", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees." } } }, "auth_ref": [ "r298", "r301" ] }, "us-gaap_AssetRetirementObligationAccretionExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligationAccretionExpense", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details" ], "lang": { "en-us": { "role": { "label": "Accretion expense/amortization expense", "documentation": "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability." } } }, "auth_ref": [ "r299", "r303" ] }, "us-gaap_AssetRetirementObligationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligationDisclosureTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation" ], "lang": { "en-us": { "role": { "label": "Asset Retirement Obligation Disclosure [Text Block]", "documentation": "The entire disclosure for an asset retirement obligation and the associated long-lived asset. An asset retirement obligation is a legal obligation associated with the disposal or retirement from service of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees." } } }, "auth_ref": [ "r150", "r297", "r300" ] }, "us-gaap_AssetRetirementObligationLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligationLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details" ], "lang": { "en-us": { "role": { "label": "Increase in lease disposal costs", "documentation": "Amount of asset retirement obligations incurred during the period." } } }, "auth_ref": [ "r302" ] }, "us-gaap_AssetRetirementObligationsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligationsNoncurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Asset retirement obligation", "documentation": "Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees." } } }, "auth_ref": [ "r772" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Segment assets", "label": "us-gaap_Assets", "totalLabel": "Total assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r134", "r169", "r193", "r234", "r255", "r261", "r273", "r312", "r313", "r315", "r316", "r317", "r319", "r321", "r323", "r324", "r466", "r468", "r483", "r536", "r610", "r707", "r721", "r776", "r777", "r879" ] }, "inis_AssetsAssociatedWithPlannedDeconversionFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "AssetsAssociatedWithPlannedDeconversionFacilityMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Assets Associated With Planned De-conversion Facility [Member]", "documentation": "Represents assets associated with the planned de-conversion facility." } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "us-gaap_AssetsCurrent", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r161", "r177", "r193", "r273", "r312", "r313", "r315", "r316", "r317", "r319", "r321", "r323", "r324", "r466", "r468", "r483", "r707", "r776", "r777", "r879" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AssetsFairValueDisclosure", "terseLabel": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r77" ] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "us-gaap_AssetsNoncurrent", "totalLabel": "Total long-term assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r193", "r273", "r312", "r313", "r315", "r316", "r317", "r319", "r321", "r323", "r324", "r466", "r468", "r483", "r776", "r777", "r879" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Long-term assets" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r724", "r725", "r726" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r724", "r725", "r726" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r724", "r725", "r726" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r425", "r426", "r427", "r428" ] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r120" ] }, "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies" ], "lang": { "en-us": { "role": { "label": "Business Description and Accounting Policies [Text Block]", "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r114", "r115" ] }, "inis_CapitalizedLeaseDisposalCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://intisoid.com/20231231", "localname": "CapitalizedLeaseDisposalCostsNet", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Capitalized lease disposal costs, net", "documentation": "Represents the amount of capitalized lease disposal costs, net." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 }, "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "terseLabel": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r37", "r164", "r679" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "totalLabel": "Total cash, cash equivalents, and restricted cash shown in statement of cash flows", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r37", "r111", "r190" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "periodStartLabel": "Cash and cash equivalents and restricted cash at beginning of year", "periodEndLabel": "Cash and cash equivalents and restricted cash at end of year", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r37", "r111", "r190" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "totalLabel": "Net increase in cash and cash equivalents and restricted cash", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r111" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of noncash financing and investing transactions:" } } }, "auth_ref": [] }, "inis_ChiefExecutiveOfficerAndChairmanOfTheBoardMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ChiefExecutiveOfficerAndChairmanOfTheBoardMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer and Chairman of the Board [Member]", "documentation": "Relating to the Chief Executive Officer and the Chairman of the Board." } } }, "auth_ref": [] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r763" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "inis_ClassLWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassLWarrantsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "Class L Warrants [Member]", "documentation": "Represents class L warrants." } } }, "auth_ref": [] }, "inis_ClassMWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassMWarrantsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Class M Warrants [Member]", "documentation": "Relating to the Class M Warrants." } } }, "auth_ref": [] }, "inis_ClassNWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassNWarrantsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Class N Warrants [Member]", "documentation": "Relating to Class N Warrants." } } }, "auth_ref": [] }, "inis_ClassOWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassOWarrantsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "Class O Warrants [Member]", "documentation": "Relating to class O warrants." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r156", "r171", "r172", "r173", "r193", "r214", "r218", "r222", "r224", "r228", "r229", "r273", "r312", "r315", "r316", "r317", "r323", "r324", "r353", "r354", "r357", "r360", "r366", "r483", "r567", "r568", "r569", "r570", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r598", "r619", "r637", "r656", "r657", "r658", "r659", "r660", "r733", "r750", "r760" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r69" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "inis_ClassOfWarrantOrRightExercisePriceExercised": { "xbrltype": "perShareItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassOfWarrantOrRightExercisePriceExercised", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercised, warrants, weighted average exercise price (in dollars per share)", "terseLabel": "Class of Warrant or Right, Exercise Price, Exercised (in dollars per share)", "documentation": "Exercise price per share or per unit of warrants or rights exercised." } } }, "auth_ref": [] }, "inis_ClassOfWarrantOrRightExercisePriceForfeited": { "xbrltype": "perShareItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassOfWarrantOrRightExercisePriceForfeited", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details" ], "lang": { "en-us": { "role": { "label": "Forfeited, warrants, weighted average exercise price (in dollars per share)", "documentation": "Exercise price per share or per unit of warrants or rights forfeited." } } }, "auth_ref": [] }, "inis_ClassOfWarrantOrRightExercisePriceGranted": { "xbrltype": "perShareItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassOfWarrantOrRightExercisePriceGranted", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details" ], "lang": { "en-us": { "role": { "label": "Granted, warrants, weighted average exercise price (in dollars per share)", "documentation": "Exercise price per share or per unit of warrants or rights granted." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "terseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)", "periodStartLabel": "Outstanding, warrants, weighted average exercise price (in dollars per share)", "periodEndLabel": "Outstanding, warrants, weighted average exercise price (in dollars per share)", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r367" ] }, "inis_ClassOfWarrantOrRightExercised": { "xbrltype": "sharesItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassOfWarrantOrRightExercised", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details" ], "lang": { "en-us": { "role": { "label": "inis_ClassOfWarrantOrRightExercised", "terseLabel": "Class of Warrant or Right, Exercised (in shares)", "negatedLabel": "Exercised, warrants (in shares)", "documentation": "The number of warrant or rights exercised." } } }, "auth_ref": [] }, "inis_ClassOfWarrantOrRightForfeited": { "xbrltype": "sharesItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassOfWarrantOrRightForfeited", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details" ], "lang": { "en-us": { "role": { "label": "inis_ClassOfWarrantOrRightForfeited", "negatedLabel": "Forfeited, warrants (in shares)", "documentation": "The number of warrant or rights forfeited." } } }, "auth_ref": [] }, "inis_ClassOfWarrantOrRightGranted": { "xbrltype": "sharesItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassOfWarrantOrRightGranted", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details" ], "lang": { "en-us": { "role": { "label": "Granted, warrants (in shares)", "documentation": "The number of warrants or rights granted." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "terseLabel": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r367" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ClassOfWarrantOrRightOutstanding", "terseLabel": "Class of Warrant or Right, Outstanding (in shares)", "periodStartLabel": "Outstanding, warrants (in shares)", "periodEndLabel": "Outstanding, warrants (in shares)", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "inis_ClassOfWarrantsOrRightsExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ClassOfWarrantsOrRightsExpirations", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_ClassOfWarrantsOrRightsExpirations", "terseLabel": "Class of Warrants or Rights, Expirations (in shares)", "documentation": "Represents the number of warrants or rights expired during the period." } } }, "auth_ref": [] }, "inis_CobaltProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "CobaltProductsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Cobalt Products [Member]", "documentation": "Relating to Cobalt products." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r123", "r306", "r307", "r664", "r775" ] }, "inis_CommonStockEquivalentsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://intisoid.com/20231231", "localname": "CommonStockEquivalentsOutstanding", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details" ], "lang": { "en-us": { "role": { "label": "Common stock equivalents (in shares)", "documentation": "The number of common stock equivalents outstanding." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r710", "r711", "r712", "r714", "r715", "r716", "r717", "r756", "r757", "r872", "r893", "r897" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals" ], "lang": { "en-us": { "role": { "label": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r96" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals" ], "lang": { "en-us": { "role": { "label": "Common stock, authorized (in shares)", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r96", "r598" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals" ], "lang": { "en-us": { "role": { "label": "Common stock, issued (in shares)", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r96" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals" ], "lang": { "en-us": { "role": { "label": "Common stock, outstanding (in shares)", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r96", "r598", "r616", "r897", "r898" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.01 par value; 750,000,000 shares authorized; 519,787,870 and 514,889,916 shares issued and outstanding respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r96", "r538", "r707" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r269", "r663" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r269", "r564", "r663" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r269", "r663", "r739" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ConcentrationRiskPercentage1", "terseLabel": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r269" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r269", "r663" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r197", "r236", "r253", "r254", "r255", "r256", "r257", "r259", "r263", "r312", "r313", "r314", "r315", "r317", "r318", "r320", "r322", "r323", "r776", "r777" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r197", "r236", "r253", "r254", "r255", "r256", "r257", "r259", "r263", "r312", "r313", "r314", "r315", "r317", "r318", "r320", "r322", "r323", "r776", "r777" ] }, "inis_ContractTerm": { "xbrltype": "durationItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ContractTerm", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_ContractTerm", "terseLabel": "Contract Term (Year)", "documentation": "Term of the contract." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Unearned revenue", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r369", "r370", "r381" ] }, "inis_ContractWithTheDoeForTheIrradiationOfCobaltTargetsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ContractWithTheDoeForTheIrradiationOfCobaltTargetsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Contract With the DOE for the Irradiation of Cobalt Targets [Member]", "documentation": "Represents contract with the DOE for the irradiation of cobalt targets." } } }, "auth_ref": [] }, "inis_ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Conversion of Convertible Debentures Into Series C Preferred Stock and Warrants [Member]", "documentation": "Represents the conversion of convertible debentures into series C preferred stock and warrants." } } }, "auth_ref": [] }, "inis_ConversionOfSeriesBPreferredStockIntoCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ConversionOfSeriesBPreferredStockIntoCommonStockMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Conversion of Series B Preferred Stock Into Common Stock [Member]", "documentation": "Represents the conversion of series B preferred stock into common stock." } } }, "auth_ref": [] }, "inis_ConversionOfSeriesCPreferredStockIntoCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ConversionOfSeriesCPreferredStockIntoCommonStockMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Conversion of Series C Preferred Stock Into Common Stock [Member]", "documentation": "Represents the conversion of series C preferred stock into common stock." } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockAmountConverted1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockAmountConverted1", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Increase in equity and decrease in liability for the conversion of preferred stock", "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r39", "r40", "r41" ] }, "us-gaap_ConversionOfStockAmountIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockAmountIssued1", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ConversionOfStockAmountIssued1", "terseLabel": "Conversion of Stock, Amount Issued", "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r39", "r40", "r41" ] }, "us-gaap_ConversionOfStockByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockByUniqueDescriptionAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Stock Conversion Description [Axis]", "documentation": "Information by description of stock conversions." } } }, "auth_ref": [ "r39", "r40", "r41" ] }, "us-gaap_ConversionOfStockNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockNameDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Name [Domain]", "documentation": "The unique name of a noncash or part noncash stock conversion." } } }, "auth_ref": [ "r39", "r40", "r41" ] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ConversionOfStockSharesConverted1", "terseLabel": "Conversion of Stock, Shares Converted (in shares)", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r39", "r40", "r41" ] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ConversionOfStockSharesIssued1", "terseLabel": "Conversion of Stock, Shares Issued (in shares)", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r39", "r40", "r41" ] }, "us-gaap_ConvertibleDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Convertible Debt [Member]", "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock." } } }, "auth_ref": [ "r125", "r326", "r327", "r337", "r338", "r339", "r343", "r344", "r345", "r346", "r347", "r691", "r692", "r693", "r694", "r695" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r19", "r254", "r255", "r256", "r257", "r263", "r762" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "Cost of product", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r104", "r518" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r46", "r269" ] }, "us-gaap_DebtConversionByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionByUniqueDescriptionAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Debt Conversion Description [Axis]", "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction." } } }, "auth_ref": [ "r39", "r41" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DebtConversionConvertedInstrumentSharesIssued1", "terseLabel": "Debt Conversion, Converted Instrument, Shares Issued (in shares)", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r39", "r41" ] }, "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1", "terseLabel": "Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares)", "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r39", "r41" ] }, "us-gaap_DebtConversionNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionNameDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Name [Domain]", "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r39", "r41" ] }, "us-gaap_DebtConversionOriginalDebtAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionOriginalDebtAmount1", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DebtConversionOriginalDebtAmount1", "terseLabel": "Debt Conversion, Original Debt, Amount", "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r39", "r41" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable" ], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r124", "r191", "r325", "r331", "r332", "r333", "r334", "r335", "r336", "r341", "r348", "r349", "r350" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r22", "r91", "r92", "r135", "r137", "r197", "r326", "r327", "r328", "r329", "r330", "r332", "r337", "r338", "r339", "r340", "r342", "r343", "r344", "r345", "r346", "r347", "r492", "r691", "r692", "r693", "r694", "r695", "r751" ] }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature", "terseLabel": "Debt Instrument, Convertible, Beneficial Conversion Feature", "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date." } } }, "auth_ref": [ "r67" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DebtInstrumentFaceAmount", "terseLabel": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r81", "r83", "r326", "r492", "r692", "r693" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Stated interest rate", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r29", "r327" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r154", "r691", "r874" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r30", "r197", "r326", "r327", "r328", "r329", "r330", "r332", "r337", "r338", "r339", "r340", "r342", "r343", "r344", "r345", "r346", "r347", "r492", "r691", "r692", "r693", "r694", "r695", "r751" ] }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentPeriodicPaymentPrincipal", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Periodic payments", "documentation": "Amount of the required periodic payments applied to principal." } } }, "auth_ref": [ "r30" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DeferredRevenueCurrent", "terseLabel": "Deferred Revenue, Current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r742" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "totalLabel": "Deferred tax asset (liability)", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r869" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_DeferredTaxAssetsNet", "totalLabel": "Total deferred income tax asset", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r869" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforward", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r76", "r870" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_DeferredTaxAssetsValuationAllowance", "negatedLabel": "Valuation allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r453" ] }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment", "negatedLabel": "Deferred income tax liability - depreciation", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r76", "r870" ] }, "us-gaap_DefinedContributionPlanCostRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanCostRecognized", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DefinedContributionPlanCostRecognized", "terseLabel": "Defined Contribution Plan, Cost", "documentation": "Amount of cost for defined contribution plan." } } }, "auth_ref": [ "r385" ] }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount", "terseLabel": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount", "documentation": "Maximum amount the employee may contribute to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_Depreciation", "terseLabel": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r8", "r60" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation and amortization", "label": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r8", "r239" ] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "DirectorMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "auth_ref": [ "r763", "r894" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-tables" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r780" ] }, "us-gaap_DisclosureTextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureTextBlockAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-10-income-taxes", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition", "http://intisoid.com/20231231/role/statement-note-15-segment-information", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-3-purchased-asset-and-investments-", "http://intisoid.com/20231231/role/statement-note-4-inventories", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants" ], "lang": { "en-us": { "role": { "label": "us-gaap_DisclosureTextBlockAbstract", "terseLabel": "Notes to Financial Statements" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Discontinued Operations, Held-for-Sale or Disposed of by Sale [Member]", "documentation": "Component or group of components classified as held-for-sale or disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale." } } }, "auth_ref": [ "r3", "r4", "r5" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r159" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r9", "r18" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration", "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration", "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r699", "r700" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DividendsPayableCurrentAndNoncurrent", "terseLabel": "Dividends Payable", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r92", "r94", "r136", "r718", "r889" ] }, "us-gaap_DividendsPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPreferredStock", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DividendsPreferredStock", "terseLabel": "Dividends, Preferred Stock", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r6", "r129" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r724", "r725", "r726" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r724", "r725", "r726", "r728" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r727" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "inis_DufPlantMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "DufPlantMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "DUF Plant [Member]", "documentation": "Relating to the DUF Plant." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "Net income per common share - basic: (in dollars per share)", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r185", "r203", "r204", "r205", "r206", "r207", "r212", "r214", "r222", "r223", "r224", "r226", "r478", "r479", "r534", "r545", "r683" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "Net income per common share - diluted: (in dollars per share)", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r185", "r203", "r204", "r205", "r206", "r207", "r214", "r222", "r223", "r224", "r226", "r478", "r479", "r534", "r545", "r683" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r43", "r44" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r194", "r447", "r461" ] }, "inis_EffectiveIncomeTaxRateReconciliationBookAndTaxDifferencesAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://intisoid.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationBookAndTaxDifferencesAmount", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details" ], "lang": { "en-us": { "role": { "label": "Book and tax differences", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to book and tax differences." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r430" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r430" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "terseLabel": "Share-Based Payment Arrangement, Expense, Tax Benefit", "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement." } } }, "auth_ref": [ "r429" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "inis_EmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "EmployeeStockPurchasePlanMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Employee Stock Purchase Plan [Member]", "documentation": "Relating to the Employee Stock Purchase Plan." } } }, "auth_ref": [] }, "inis_EmploymentAgreementMinimumPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://intisoid.com/20231231", "localname": "EmploymentAgreementMinimumPricePerShare", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_EmploymentAgreementMinimumPricePerShare", "terseLabel": "Employment Agreement, Minimum Price Per share (in dollars per share)", "documentation": "The minimum price per share under the employment agreement." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r722" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "http://intisoid.com/20231231/role/statement-document-and-entity-information", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables", "http://intisoid.com/20231231/role/statement-note-10-income-taxes", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-tables", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-details-textual", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-tables", "http://intisoid.com/20231231/role/statement-note-15-segment-information", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-tables", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual", "http://intisoid.com/20231231/role/statement-note-3-purchased-asset-and-investments-", "http://intisoid.com/20231231/role/statement-note-4-inventories", "http://intisoid.com/20231231/role/statement-note-4-inventories-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-tables", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-details-textual", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-tables", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables", "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r722" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r722" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r731" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r722" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r722" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r722" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r722" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r732" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' equity" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r14", "r157", "r181", "r182", "r183", "r198", "r199", "r200", "r202", "r208", "r210", "r227", "r274", "r275", "r368", "r431", "r432", "r433", "r457", "r458", "r470", "r471", "r472", "r473", "r474", "r475", "r477", "r484", "r485", "r486", "r487", "r488", "r489", "r506", "r559", "r560", "r561", "r573", "r637" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual" ], "lang": { "en-us": { "role": { "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r339", "r482", "r692", "r693" ] }, "srt_ExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ExecutiveOfficerMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Executive Officer [Member]" } } }, "auth_ref": [ "r763" ] }, "inis_ExecutiveOfficersAndDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ExecutiveOfficersAndDirectorsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Executive Officers and Directors [Member]", "documentation": "Represents executive officers and directors." } } }, "auth_ref": [] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual" ], "lang": { "en-us": { "role": { "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r20", "r77", "r339", "r692", "r693" ] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r480" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r12", "r21" ] }, "inis_FinanceLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://intisoid.com/20231231", "localname": "FinanceLeaseExpense", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "inis_FinanceLeaseExpense", "totalLabel": "Total financing lease expense", "documentation": "Represents the amount of finance lease expense during the period." } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details": { "parentTag": "inis_FinanceLeaseExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Interest on lease liabilities", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r495", "r498", "r706" ] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiability", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Present value of minimum finance lease obligations", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r494", "r505" ] }, "us-gaap_FinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Current portion of financing lease liability", "negatedLabel": "Current finance lease maturities", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current." } } }, "auth_ref": [ "r494" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Finance lease obligations, net of current maturities", "label": "Financing lease liability, net of current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r494" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "totalLabel": "Total minimum finance lease obligations", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r505" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Finance lease, Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Finance lease, 2024", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Finance lease, 2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Finance lease, 2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Finance lease, 2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Finance lease, 2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount", "negatedLabel": "Less-amount representing interest, finance lease", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r505" ] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_FinanceLeasePrincipalPayments", "negatedLabel": "Payments on financing lease liability", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r496", "r501" ] }, "us-gaap_FinanceLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Financing lease right-of-use asset", "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r493" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details": { "parentTag": "inis_FinanceLeaseExpense", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Amortization of right-of-use assets", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r495", "r498", "r706" ] }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Weighted-average discount rate - financing leases", "documentation": "Weighted average discount rate for finance lease calculated at point in time." } } }, "auth_ref": [ "r504", "r706" ] }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Weighted-average remaining lease term (years) - financing leases (Year)", "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r503", "r706" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization", "negatedLabel": "Accumulated amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r168", "r295" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "terseLabel": "Thereafter", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "terseLabel": "2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r118" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "terseLabel": "2029", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r118" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "terseLabel": "2028", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r118" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "terseLabel": "2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r118" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "terseLabel": "2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r118" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsGross", "periodStartLabel": "Beginning", "periodEndLabel": "Ending", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r117", "r520" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 }, "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Patents and other intangibles, net", "totalLabel": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r117", "r519" ] }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinitelivedIntangibleAssetsAcquired1", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Additions", "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition." } } }, "auth_ref": [ "r294" ] }, "inis_FluorineProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "FluorineProductsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Fluorine Products [Member]", "documentation": "Relating to Fluorine Products." } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfPropertyPlantEquipment", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_GainLossOnSaleOfPropertyPlantEquipment", "terseLabel": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Gain on disposal of property, plant and equipment", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property." } } }, "auth_ref": [ "r8" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "General, administrative and consulting", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r105", "r621" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r167", "r281", "r533", "r689", "r707", "r769", "r770" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r13", "r54" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_GoodwillImpairmentLoss", "terseLabel": "Goodwill, Impairment Loss", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r8", "r282", "r288", "r292", "r689" ] }, "us-gaap_GranteeStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Grantee Status [Axis]", "documentation": "Information by status of recipient to whom award is granted." } } }, "auth_ref": [ "r396", "r398", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r425", "r426", "r427", "r428" ] }, "us-gaap_GranteeStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Grantee Status [Domain]", "documentation": "Status of recipient to whom award is granted." } } }, "auth_ref": [ "r396", "r398", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r425", "r426", "r427", "r428" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "us-gaap_GrossProfit", "totalLabel": "Gross profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r103", "r193", "r234", "r254", "r260", "r263", "r273", "r312", "r313", "r315", "r316", "r317", "r319", "r321", "r323", "r324", "r483", "r685", "r776" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r724", "r725", "r726" ] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ImpairmentOfIntangibleAssetsFinitelived", "terseLabel": "Impairment of Intangible Assets, Finite-Lived", "negatedLabel": "Disposals", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r748", "r771" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse", "terseLabel": "Impairment, Long-Lived Asset, Held-for-Use", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)." } } }, "auth_ref": [ "r8", "r59", "r121" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r122" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r699", "r700" ] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r194", "r442", "r448", "r451", "r455", "r459", "r462", "r463", "r464", "r572" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncomeTaxExpenseBenefit", "terseLabel": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r141", "r153", "r209", "r210", "r242", "r446", "r460", "r546" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r180", "r444", "r445", "r451", "r452", "r454", "r456", "r566" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details" ], "lang": { "en-us": { "role": { "label": "Change in valuation allowance", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r867" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details" ], "lang": { "en-us": { "role": { "label": "Income tax expense (benefit)", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r447" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details" ], "lang": { "en-us": { "role": { "label": "State taxes net of federal benefit", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r867" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Cash paid for taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r38" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable", "label": "us-gaap_IncreaseDecreaseInAccountsReceivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInAssetRetirementObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAssetRetirementObligations", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Non-cash increase of capitalized asset retirement obligation for increased funding plan", "documentation": "The increase (decrease) during the reporting period in the carrying amount of asset retirement obligations." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredRevenue", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "verboseLabel": "Unearned revenues", "label": "us-gaap_IncreaseDecreaseInDeferredRevenue", "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r676" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventories", "label": "us-gaap_IncreaseDecreaseInInventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r7" ] }, "inis_IncreaseDecreaseInNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://intisoid.com/20231231", "localname": "IncreaseDecreaseInNetIncomeLoss", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_IncreaseDecreaseInNetIncomeLoss", "terseLabel": "Increase (Decrease) in Net Income (Loss)", "documentation": "The total amount of change in net income for the company." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapital", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncreaseDecreaseInOperatingCapital", "terseLabel": "Increase (Decrease) in Operating Capital", "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "verboseLabel": "Prepaids and other current assets", "label": "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock", "calculation": { "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock", "terseLabel": "Series C redeemable convertible preferred stock (in shares)", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method." } } }, "auth_ref": [ "r219", "r220", "r224" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "terseLabel": "Stock options (in shares)", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r215", "r216", "r217", "r224", "r399" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "auth_ref": [ "r729" ] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets" ], "lang": { "en-us": { "role": { "label": "Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r293" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "us-gaap_InterestExpense", "negatedLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r82", "r140", "r184", "r238", "r491", "r622", "r719", "r896" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r186", "r188", "r189" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_InterestPayableCurrentAndNoncurrent", "terseLabel": "Interest Payable", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r84", "r889" ] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-4-inventories" ], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r277" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-4-inventories-details-textual" ], "lang": { "en-us": { "role": { "label": "Inventories", "terseLabel": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r176", "r680", "r707" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r143", "r163", "r175", "r277", "r278", "r280", "r517", "r681" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWriteDown", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_InventoryWriteDown", "terseLabel": "Inventory Write-down", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r279" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "Interest income", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r106", "r237" ] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LaborAndRelatedExpense", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "Salaries and contract labor", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r746" ] }, "inis_LandInLeaCountyNewMexicoMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "LandInLeaCountyNewMexicoMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Land in Lea County, New Mexico [Member]", "documentation": "Relating to land in Lea County, New Mexico." } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_LeaseCost", "totalLabel": "Total lease expense", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r497", "r706" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-tables" ], "lang": { "en-us": { "role": { "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r876" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "http://intisoid.com/20231231/role/statement-document-and-entity-information", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables", "http://intisoid.com/20231231/role/statement-note-10-income-taxes", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-tables", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-details-textual", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-tables", "http://intisoid.com/20231231/role/statement-note-15-segment-information", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-tables", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual", "http://intisoid.com/20231231/role/statement-note-3-purchased-asset-and-investments-", "http://intisoid.com/20231231/role/statement-note-4-inventories", "http://intisoid.com/20231231/role/statement-note-4-inventories-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-tables", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-details-textual", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-tables", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables", "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "inis_LesseeLiabilityToBePaidMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://intisoid.com/20231231", "localname": "LesseeLiabilityToBePaidMaturityTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-tables" ], "lang": { "en-us": { "role": { "label": "Lessee, Liability, to be Paid, Maturity [ Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's lease liabilities. Includes, but is not limited to, reconciliation of undiscounted cash flows to lease liabilities recognized in statement of financial position." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "totalLabel": "Total minimum operating lease obligations", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r505" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Operating lease, Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Operating lease, 2024", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Operating lease, 2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Operating lease, 2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Operating lease, 2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Operating lease, 2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r505" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "negatedLabel": "Less-amount representing interest, operating lease", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r505" ] }, "inis_LesseeOperatingLeasesAndFinanceLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://intisoid.com/20231231", "localname": "LesseeOperatingLeasesAndFinanceLeasesTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Leases and Finance Leases [Text Block]", "documentation": "Disclosure of the operating leases and finance leases that the entity is a lessee in." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "us-gaap_Liabilities", "totalLabel": "Total liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r26", "r193", "r273", "r312", "r313", "r315", "r316", "r317", "r319", "r321", "r323", "r324", "r467", "r468", "r469", "r483", "r597", "r684", "r721", "r776", "r879", "r880" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "us-gaap_LiabilitiesAndStockholdersEquity", "totalLabel": "Total liabilities and stockholders' equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r101", "r138", "r540", "r707", "r752", "r768", "r875" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "us-gaap_LiabilitiesCurrent", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r28", "r162", "r193", "r273", "r312", "r313", "r315", "r316", "r317", "r319", "r321", "r323", "r324", "r467", "r468", "r469", "r483", "r707", "r776", "r879", "r880" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "us-gaap_LiabilitiesNoncurrent", "totalLabel": "Total long-term liabilities", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r22", "r88", "r89", "r90", "r93", "r193", "r273", "r312", "r313", "r315", "r316", "r317", "r319", "r321", "r323", "r324", "r467", "r468", "r469", "r483", "r776", "r879", "r880" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Long-term liabilities" } } }, "auth_ref": [] }, "inis_LicenseTerm": { "xbrltype": "durationItemType", "nsuri": "http://intisoid.com/20231231", "localname": "LicenseTerm", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_LicenseTerm", "terseLabel": "License Term (Year)", "documentation": "Period of the license." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "Lender Name [Axis]", "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit." } } }, "auth_ref": [ "r24", "r751" ] }, "us-gaap_LineOfCreditFacilityLenderDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLenderDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Lender [Domain]", "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "auth_ref": [ "r24", "r751" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_LongTermDebt", "totalLabel": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r22", "r137", "r338", "r351", "r692", "r693", "r890" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Current installments of notes payable", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r170" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "terseLabel": "2024", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r197", "r343" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "terseLabel": "2027", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r197", "r343" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "terseLabel": "2026", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r197", "r343" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "terseLabel": "2025", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r197", "r343" ] }, "us-gaap_LongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermNotesPayable", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Notes payable, net of current portion", "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r30" ] }, "inis_LongtermDebtMaturityAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://intisoid.com/20231231", "localname": "LongtermDebtMaturityAfterYearFour", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details" ], "lang": { "en-us": { "role": { "label": "inis_LongtermDebtMaturityAfterYearFour", "terseLabel": "Thereafter", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r30" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r30", "r62" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r269", "r698", "r780", "r891", "r892" ] }, "inis_MajorShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "MajorShareholdersMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "Major Shareholders [Member]", "documentation": "Represents the major shareholders member." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r308", "r309", "r310", "r311", "r389", "r516", "r558", "r588", "r589", "r643", "r646", "r650", "r651", "r653", "r674", "r675", "r688", "r696", "r701", "r709", "r778", "r881", "r882", "r883", "r884", "r885", "r886" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r308", "r309", "r310", "r311", "r389", "r516", "r558", "r588", "r589", "r643", "r646", "r650", "r651", "r653", "r674", "r675", "r688", "r696", "r701", "r709", "r778", "r881", "r882", "r883", "r884", "r885", "r886" ] }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsAtCarryingValue", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_MoneyMarketFundsAtCarryingValue", "terseLabel": "Money Market Funds, at Carrying Value", "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months." } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r730" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "auth_ref": [ "r269", "r698", "r780", "r891", "r892" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "totalLabel": "Net cash provided by (used in) financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r187" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "totalLabel": "Net cash (used in) provided by investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r187" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "terseLabel": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r111", "r112", "r113" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 }, "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Net income (loss)", "terseLabel": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r102", "r113", "r139", "r160", "r178", "r179", "r183", "r193", "r201", "r203", "r204", "r205", "r206", "r209", "r210", "r221", "r234", "r254", "r260", "r263", "r273", "r312", "r313", "r315", "r316", "r317", "r319", "r321", "r323", "r324", "r479", "r483", "r544", "r618", "r635", "r636", "r685", "r719", "r776" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "ecd_NonRule10b51ArrAdoptedFlag", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r730" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "ecd_NonRule10b51ArrTrmntdFlag", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r730" ] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details" ], "lang": { "en-us": { "role": { "label": "Non-US [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r899", "r900", "r901", "r902" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "us-gaap_NonoperatingIncomeExpense", "totalLabel": "Total other (expense) income", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r107" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "auth_ref": [] }, "inis_NonqualifiedOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "NonqualifiedOptionsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Non-qualified Options [Member]", "documentation": "Represents non-qualified options." } } }, "auth_ref": [] }, "us-gaap_NonrelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonrelatedPartyMember", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Nonrelated Party [Member]", "documentation": "Party not related to reporting entity." } } }, "auth_ref": [ "r753", "r754" ] }, "inis_NoteToFinancialStatementDetailsTextual": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "NoteToFinancialStatementDetailsTextual", "lang": { "en-us": { "role": { "label": "Note To Financial Statement Details Textual" } } }, "auth_ref": [] }, "us-gaap_NotesAndLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesAndLoansPayable", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_NotesAndLoansPayable", "totalLabel": "Notes payable, net of current installments and debt discount", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r22", "r137", "r890" ] }, "us-gaap_NotesIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesIssued1", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Property acquired in exchange for a note payable", "documentation": "The fair value of notes issued in noncash investing and financing activities." } } }, "auth_ref": [ "r39", "r40", "r41" ] }, "us-gaap_NotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayable", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details": { "parentTag": "us-gaap_NotesAndLoansPayable", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details" ], "lang": { "en-us": { "role": { "label": "Notes payable", "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r22", "r137", "r890" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details": { "parentTag": "us-gaap_NotesAndLoansPayable", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_NotesPayableCurrent", "negatedLabel": "Less: current maturities", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r25" ] }, "inis_NotesPayableForPurchaseContractOneMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "NotesPayableForPurchaseContractOneMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Notes Payable for Purchase Contract, One [Member]", "documentation": "Represents notes payable for purchase contract one." } } }, "auth_ref": [] }, "inis_NotesPayableForPurchaseContractTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "NotesPayableForPurchaseContractTwoMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Notes Payable for Purchase Contract, Two [Member]", "documentation": "Represents notes payable for purchase contract two." } } }, "auth_ref": [] }, "us-gaap_NotesPayableOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableOtherPayablesMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Other Payables [Member]", "documentation": "A written promise to pay a note to a third party." } } }, "auth_ref": [] }, "us-gaap_NotesPayableToBanksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableToBanksMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Notes Payable to Banks [Member]", "documentation": "A written promise to pay a note to a bank." } } }, "auth_ref": [] }, "inis_NotesToFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "NotesToFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Notes To Financial Statements [Abstract]" } } }, "auth_ref": [] }, "inis_NrcLicenseForTheDeconversionFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "NrcLicenseForTheDeconversionFacilityMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "NRC License for the De-conversion Facility [Member]", "documentation": "Represents the NRC license for the de-conversion facility." } } }, "auth_ref": [] }, "inis_NuclearMedicineProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "NuclearMedicineProductsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Nuclear Medicine Products [Member]", "documentation": "Relating to Nuclear Medicine Products." } } }, "auth_ref": [] }, "inis_NumberOfEmployeesHired": { "xbrltype": "integerItemType", "nsuri": "http://intisoid.com/20231231", "localname": "NumberOfEmployeesHired", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_NumberOfEmployeesHired", "terseLabel": "Number of Employees Hired", "documentation": "The number of employees hired." } } }, "auth_ref": [] }, "inis_NumberOfMajorCustomers": { "xbrltype": "integerItemType", "nsuri": "http://intisoid.com/20231231", "localname": "NumberOfMajorCustomers", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_NumberOfMajorCustomers", "terseLabel": "Number of Major Customers", "documentation": "The number of major customers." } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_NumberOfOperatingSegments", "terseLabel": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r761" ] }, "inis_OneEmployeeMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "OneEmployeeMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "One Employee [Member]", "documentation": "Represents one employee." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "us-gaap_OperatingExpenses", "totalLabel": "Total operating expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "Operating costs and expenses:" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "us-gaap_OperatingIncomeLoss", "totalLabel": "Operating loss", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r234", "r254", "r260", "r263", "r685" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Operating lease costs", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r499", "r706" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Present value of minimum operating lease obligations", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r494" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "label": "Current portion of operating lease right-of-use liability", "negatedLabel": "Current operating lease maturities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r494" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease obligations, net of current maturities", "label": "Operating lease right-of-use liability, net of current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r494" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r493" ] }, "inis_OperatingLeaseRightofuseAssetPeriodicReductionIncrease": { "xbrltype": "monetaryItemType", "nsuri": "http://intisoid.com/20231231", "localname": "OperatingLeaseRightofuseAssetPeriodicReductionIncrease", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Right-of-use amortization", "documentation": "Amount of periodic reduction (increase) over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Weighted-average discount rate - operating leases", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r504", "r706" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Weighted-average remaining lease term (years) - operating leases (Year)", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r503", "r706" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_OperatingLossCarryforwards", "terseLabel": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r75" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r263" ] }, "inis_OtherCommitmentsAnnualFixedPriceEscalationPercent": { "xbrltype": "percentItemType", "nsuri": "http://intisoid.com/20231231", "localname": "OtherCommitmentsAnnualFixedPriceEscalationPercent", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_OtherCommitmentsAnnualFixedPriceEscalationPercent", "terseLabel": "Other Commitments, Annual Fixed Price, Escalation Percent", "documentation": "Represents the escalation percent of an annual fixed price as part of an other commitment." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations" ], "lang": { "en-us": { "role": { "label": "Other income", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r108" ] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParentMember", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividends", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PaymentsOfDividends", "terseLabel": "Payments of Dividends", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r35" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment", "negatedLabel": "Purchase of property, plant, equipment and patents", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r110" ] }, "inis_PercentOfTotalRevenues": { "xbrltype": "percentItemType", "nsuri": "http://intisoid.com/20231231", "localname": "PercentOfTotalRevenues", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details" ], "lang": { "en-us": { "role": { "label": "Percent of total revenues", "documentation": "Represents the percentage of total revenue." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866" ] }, "us-gaap_PledgedStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgedStatusAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Pledged Status [Axis]", "documentation": "Information by pledged or not pledged status of asset owned by entity." } } }, "auth_ref": [ "r466", "r591", "r705" ] }, "us-gaap_PledgedStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgedStatusDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Pledged Status [Domain]", "documentation": "Pledged or not pledged status of asset owned by entity." } } }, "auth_ref": [ "r466", "r591", "r705" ] }, "us-gaap_PledgingPurposeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgingPurposeAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Pledging Purpose [Axis]", "documentation": "Information by pledging purpose of pledged asset owned." } } }, "auth_ref": [ "r515", "r705", "r708", "r736" ] }, "us-gaap_PledgingPurposeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgingPurposeDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Pledging Purpose [Domain]", "documentation": "Pledging purpose of pledged asset owned." } } }, "auth_ref": [ "r515", "r705", "r708", "r736" ] }, "us-gaap_PolicyTextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PolicyTextBlockAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "us-gaap_PolicyTextBlockAbstract", "terseLabel": "Accounting Policies" } } }, "auth_ref": [] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual" ], "lang": { "en-us": { "role": { "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r481" ] }, "us-gaap_PreferredStockConvertibleConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockConvertibleConversionPrice", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockConvertibleConversionPrice", "terseLabel": "Preferred Stock, Convertible, Conversion Price (in dollars per share)", "documentation": "Per share conversion price of preferred stock." } } }, "auth_ref": [ "r355" ] }, "inis_PreferredStockConvertibleStockPriceTrigger": { "xbrltype": "perShareItemType", "nsuri": "http://intisoid.com/20231231", "localname": "PreferredStockConvertibleStockPriceTrigger", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_PreferredStockConvertibleStockPriceTrigger", "terseLabel": "Preferred Stock, Convertible, Stock Price Trigger (in dollars per share)", "documentation": "Price of the entity's common stock which would be required to be attained for the conversion feature embedded in the preferred stock to become effective." } } }, "auth_ref": [] }, "inis_PreferredStockConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://intisoid.com/20231231", "localname": "PreferredStockConvertibleThresholdTradingDays", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_PreferredStockConvertibleThresholdTradingDays", "terseLabel": "Preferred Stock, Convertible, Threshold Trading Days", "documentation": "Threshold number of specified trading days that common stock price to conversion price of preferred stock must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature." } } }, "auth_ref": [] }, "us-gaap_PreferredStockDiscountOnShares": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDiscountOnShares", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockDiscountOnShares", "terseLabel": "Preferred Stock, Discount on Shares", "documentation": "Discount on preferred shares, or any unamortized balance thereof, shown separately as a deduction from the applicable account(s) as circumstances require." } } }, "auth_ref": [ "r130" ] }, "us-gaap_PreferredStockDividendRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendRatePercentage", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockDividendRatePercentage", "terseLabel": "Preferred Stock, Dividend Rate, Percentage", "documentation": "The percentage rate used to calculate dividend payments on preferred stock." } } }, "auth_ref": [ "r354", "r644", "r647", "r649", "r654" ] }, "us-gaap_PreferredStockDividendsShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsShares", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Stock issued in lieu of dividends on preferred C shares (in shares)", "documentation": "Number of shares of preferred stock issued as dividends during the period. Excludes stock splits." } } }, "auth_ref": [ "r14" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockParOrStatedValuePerShare", "terseLabel": "Preferred Stock, Par or Stated Value Per Share (in dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r95", "r353" ] }, "us-gaap_PreferredStockRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockRedemptionPricePerShare", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockRedemptionPricePerShare", "terseLabel": "Preferred Stock, Redemption Price Per Share (in dollars per share)", "documentation": "The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer." } } }, "auth_ref": [ "r64", "r65", "r66" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockSharesAuthorized", "terseLabel": "Preferred Stock, Shares Authorized (in shares)", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r95", "r598" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockSharesOutstanding", "terseLabel": "Preferred Stock, Shares Outstanding (in shares)", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r95", "r598", "r616", "r897", "r898" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockValue", "terseLabel": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r95", "r537", "r707" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Prepaids and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r745" ] }, "inis_PrepaymentForDufPlantMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "PrepaymentForDufPlantMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Prepayment for DUF Plant [Member]", "documentation": "Relating to prepayment for DUF Plant." } } }, "auth_ref": [] }, "srt_PresidentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "PresidentMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "President [Member]" } } }, "auth_ref": [ "r763" ] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivatePlacementMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "terseLabel": "Proceeds from Issuance of Preferred Stock and Preference Stock", "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfWarrants", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProceedsFromIssuanceOfWarrants", "terseLabel": "Proceeds from Issuance of Warrants", "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProceedsFromIssuanceOrSaleOfEquity", "terseLabel": "Proceeds from Issuance or Sale of Equity", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r2", "r567" ] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProceedsFromRelatedPartyDebt", "terseLabel": "Proceeds from Related Party Debt", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r34" ] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProceedsFromSaleOfProductiveAssets", "terseLabel": "Proceeds from Sale of Productive Assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r109" ] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of property, plant and equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r109" ] }, "us-gaap_ProceedsFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromWarrantExercises", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProceedsFromWarrantExercises", "terseLabel": "Proceeds from Warrant Exercises", "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants." } } }, "auth_ref": [ "r747" ] }, "inis_ProductionEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ProductionEquipmentMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Production Equipment [Member]", "documentation": "The production equipment member." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r10" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r119", "r147", "r151", "r152" ] }, "us-gaap_PropertyPlantAndEquipmentFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentFairValueDisclosure", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PropertyPlantAndEquipmentFairValueDisclosure", "terseLabel": "Property, Plant, and Equipment, Fair Value Disclosure", "documentation": "Fair value portion of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r873" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r120", "r165", "r543" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 }, "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment, net", "totalLabel": "Property, Plant and Equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r535", "r543", "r707" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r10", "r147", "r151", "r541" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-tables" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r10" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r120" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, useful life (Year)", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "inis_QualifiedOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "QualifiedOptionsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Qualified Options [Member]", "documentation": "Relating to qualified options." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r308", "r309", "r310", "r311", "r383", "r389", "r425", "r426", "r427", "r514", "r516", "r558", "r588", "r589", "r643", "r646", "r650", "r651", "r653", "r674", "r675", "r688", "r696", "r701", "r709", "r712", "r773", "r778", "r882", "r883", "r884", "r885", "r886" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r308", "r309", "r310", "r311", "r383", "r389", "r425", "r426", "r427", "r514", "r516", "r558", "r588", "r589", "r643", "r646", "r650", "r651", "r653", "r674", "r675", "r688", "r696", "r701", "r709", "r712", "r773", "r778", "r882", "r883", "r884", "r885", "r886" ] }, "us-gaap_ReceivablesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable." } } }, "auth_ref": [ "r764", "r765", "r766", "r767" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r384", "r507", "r508", "r592", "r593", "r594", "r595", "r596", "r615", "r617", "r642" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r195", "r196", "r507", "r508", "r509", "r510", "r592", "r593", "r594", "r595", "r596", "r615", "r617", "r642" ] }, "inis_RelatedPartyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "RelatedPartyOneMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Related Party One [Member]", "documentation": "The related party one member." } } }, "auth_ref": [] }, "inis_RelatedPartyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "RelatedPartyThreeMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Related Party Three [Member]", "documentation": "The related party number three member." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r507", "r508", "r878" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r384", "r507", "r508", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r592", "r593", "r594", "r595", "r596", "r615", "r617", "r642", "r878" ] }, "inis_RelatedPartyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "RelatedPartyTwoMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals" ], "lang": { "en-us": { "role": { "label": "Related Party Two [Member]", "documentation": "The related party number two member." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfConvertibleDebt", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_RepaymentsOfConvertibleDebt", "terseLabel": "Repayments of Convertible Debt", "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r36" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_RepaymentsOfNotesPayable", "negatedLabel": "Principal payments on notes payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r36" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "Research and development", "terseLabel": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r86", "r441", "r888" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Research and Development Expense, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r440" ] }, "us-gaap_RestrictedCashNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashNoncurrent", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 0.0 }, "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "verboseLabel": "Restricted cash included in long-term assets", "label": "Restricted cash", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r142", "r741", "r749" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "terseLabel": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r98", "r129", "r539", "r562", "r563", "r571", "r599", "r707" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r157", "r198", "r199", "r200", "r202", "r208", "r210", "r274", "r275", "r431", "r432", "r433", "r457", "r458", "r470", "r472", "r473", "r475", "r477", "r559", "r561", "r573", "r897" ] }, "us-gaap_RetirementPlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanNameAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Retirement Plan Name [Axis]", "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans." } } }, "auth_ref": [ "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r701", "r737", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839", "r840" ] }, "us-gaap_RetirementPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanNameDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Retirement Plan Name [Domain]", "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans." } } }, "auth_ref": [ "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r701", "r737", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839", "r840" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Sale of product", "terseLabel": "Sale of product", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r235", "r236", "r253", "r258", "r259", "r265", "r267", "r269", "r379", "r380", "r518" ] }, "us-gaap_RevenueFromContractWithCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer Benchmark [Member]", "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r269", "r738" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r155", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r382" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Revenue [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r620", "r677", "r682" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets obtained in exchange for new financing lease liabilities", "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability." } } }, "auth_ref": [ "r502", "r706" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets obtained in exchange for new operating lease liabilities", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r502", "r706" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "ecd_Rule10b51ArrAdoptedFlag", "terseLabel": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r730" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "ecd_Rule10b51ArrTrmntdFlag", "terseLabel": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r730" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]" } } }, "auth_ref": [ "r394", "r759" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [ "r211", "r394", "r734", "r759" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfChangeInAssetRetirementObligationTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Change in Asset Retirement Obligation [Table Text Block]", "documentation": "Tabular disclosure of the changes in carrying amount of a liability for asset retirement obligations, for changes such as new obligations, changes in estimates of existing obligations, spending on existing obligations, property dispositions, and foreign currency translation." } } }, "auth_ref": [ "r772" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r30", "r65", "r67", "r80", "r81", "r83", "r85", "r127", "r128", "r692", "r694", "r755" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r133" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r132" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r56", "r57" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-15-segment-information-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r51", "r52", "r53", "r54" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r16", "r17", "r71" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r69" ] }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Weighted Average Number of Shares [Table Text Block]", "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)." } } }, "auth_ref": [ "r42" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r57" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://intisoid.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r723" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r231", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r263", "r269", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r304", "r305", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r689", "r740", "r891" ] }, "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentExpenditureAdditionToLongLivedAssets", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Expenditures for segment assets", "documentation": "Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets." } } }, "auth_ref": [ "r245", "r687" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "auth_ref": [ "r267", "r268", "r585", "r586", "r587", "r645", "r648", "r652", "r655", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r678", "r697", "r712", "r780", "r891" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-15-segment-information" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r230", "r231", "r232", "r233", "r234", "r246", "r257", "r261", "r262", "r263", "r264", "r265", "r266", "r269" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r247", "r248", "r249", "r250", "r251", "r252", "r267", "r686" ] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r743", "r744", "r779" ] }, "us-gaap_SeriesCPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesCPreferredStockMember", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Series C Preferred Stock [Member]", "documentation": "Series C preferred stock." } } }, "auth_ref": [ "r743", "r744", "r779" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Equity based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r702" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "negatedLabel": "Forfeited, number (in shares)", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r417" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "Forfeited, weighted average grant date fair value (in dollars per share)", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r417" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "Granted, number (in shares)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r415" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "Granted, weighted average grant date fair value (in dollars per share)", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r415" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "periodStartLabel": "Outstanding, number (in shares)", "periodEndLabel": "Outstanding, number (in shares)", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r412", "r413" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "periodStartLabel": "Outstanding, weighted average grant date fair value (in dollars per share)", "periodEndLabel": "Outstanding, weighted average grant date fair value (in dollars per share)", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r412", "r413" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)", "negatedLabel": "Exercised, number (in shares)", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r416" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercised, weighted average grant date fair value (in dollars per share)", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r416" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r426" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r704" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercisable (in shares)", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r406" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercisable, weighted average exercise price (in dollars per share)", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r406" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercised, aggregate intrinsic value", "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares." } } }, "auth_ref": [ "r419" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)", "negatedLabel": "Forfeited (in shares)", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r410" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Granted (in shares)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r408" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Outstanding, aggregate intrinsic value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "periodStartLabel": "Outstanding (in shares)", "periodEndLabel": "Outstanding (in shares)", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r404", "r405" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share)", "periodStartLabel": "Outstanding, weighted average exercise price (in dollars per share)", "periodEndLabel": "Outstanding, weighted average exercise price (in dollars per share)", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r404", "r405" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details" ], "lang": { "en-us": { "role": { "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r425", "r426", "r427", "r428" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercised, weighted average exercise price (in dollars per share)", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r409" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Forfeited, weighted average exercise price (in dollars per share)", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r410" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Granted, weighted average exercise price (in dollars per share)", "terseLabel": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r408" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheThreeMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche Three [Member]", "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r395", "r403", "r422", "r423", "r424", "r425", "r428", "r434", "r435", "r436", "r437" ] }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedPaymentArrangementEmployeeMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Employee [Member]", "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires." } } }, "auth_ref": [ "r398", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r425", "r426", "r427", "r428" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharePrice", "terseLabel": "Share Price (in dollars per share)", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r841" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r703" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r424" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercisable, aggregate intrinsic value", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r70" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercisable, weighted average remaining contractual life (Year)", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r70" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Outstanding, weighted average remaining contractual life (Year)", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r131" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock." } } }, "auth_ref": [ "r419" ] }, "inis_SharebasedCompensationArrangementBySharebasedPaymentAwardPercentOfGrossPay": { "xbrltype": "percentItemType", "nsuri": "http://intisoid.com/20231231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPercentOfGrossPay", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "inis_SharebasedCompensationArrangementBySharebasedPaymentAwardPercentOfGrossPay", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percent of Gross Pay", "documentation": "Percentage of gross pay for share based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharesIssuedPricePerShare", "terseLabel": "Shares Issued, Price Per Share (in dollars per share)", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Balance (in shares)", "periodStartLabel": "Balance (in shares)", "periodEndLabel": "Balance (in shares)", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation", "terseLabel": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsAmount", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount", "terseLabel": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount", "documentation": "Amount that would be paid, determined under the conditions specified in the contract, if the holder of the share has the right to redeem the shares." } } }, "auth_ref": [ "r63" ] }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Mandatorily redeemable convertible preferred stock", "documentation": "The amount that is required to be paid, determined under the conditions specified in the contract, if as of the reporting date, the holder of the share has exercised the right to or the shares are mandatorily redeemable after one year from the reporting date or operating cycle, if longer." } } }, "auth_ref": [ "r63" ] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details" ], "lang": { "en-us": { "role": { "label": "Short-term operating lease costs", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r500", "r706" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r158", "r231", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r263", "r269", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r296", "r304", "r305", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r689", "r740", "r891" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r156", "r171", "r172", "r173", "r193", "r214", "r218", "r222", "r224", "r228", "r229", "r273", "r312", "r315", "r316", "r317", "r323", "r324", "r353", "r354", "r357", "r360", "r366", "r483", "r567", "r568", "r569", "r570", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r598", "r619", "r637", "r656", "r657", "r658", "r659", "r660", "r733", "r750", "r760" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r14", "r33", "r157", "r181", "r182", "r183", "r198", "r199", "r200", "r202", "r208", "r210", "r227", "r274", "r275", "r368", "r431", "r432", "r433", "r457", "r458", "r470", "r471", "r472", "r473", "r474", "r475", "r477", "r484", "r485", "r486", "r487", "r488", "r489", "r506", "r559", "r560", "r561", "r573", "r637" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r267", "r268", "r585", "r586", "r587", "r645", "r648", "r652", "r655", "r662", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r678", "r697", "r712", "r780", "r891" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables", "http://intisoid.com/20231231/role/statement-note-10-income-taxes", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-tables", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-details-textual", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-tables", "http://intisoid.com/20231231/role/statement-note-15-segment-information", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-tables", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual", "http://intisoid.com/20231231/role/statement-note-3-purchased-asset-and-investments-", "http://intisoid.com/20231231/role/statement-note-4-inventories", "http://intisoid.com/20231231/role/statement-note-4-inventories-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-tables", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-details-textual", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-tables", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables", "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r198", "r199", "r200", "r227", "r518", "r565", "r584", "r590", "r592", "r593", "r594", "r595", "r596", "r598", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r611", "r612", "r613", "r614", "r615", "r617", "r620", "r621", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r637", "r713" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r211", "r394", "r734", "r735", "r759" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables", "http://intisoid.com/20231231/role/statement-note-10-income-taxes", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-tables", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements", "http://intisoid.com/20231231/role/statement-note-13-fair-value-measurements-details-textual", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-details-textual", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-tables", "http://intisoid.com/20231231/role/statement-note-15-segment-information", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-tables", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual", "http://intisoid.com/20231231/role/statement-note-3-purchased-asset-and-investments-", "http://intisoid.com/20231231/role/statement-note-4-inventories", "http://intisoid.com/20231231/role/statement-note-4-inventories-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-details-textual", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-tables", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-details-textual", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-lease-cost-details", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-tables", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables", "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r198", "r199", "r200", "r227", "r518", "r565", "r584", "r590", "r592", "r593", "r594", "r595", "r596", "r598", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r611", "r612", "r613", "r614", "r615", "r617", "r620", "r621", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r637", "r713" ] }, "us-gaap_StockDividendsShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockDividendsShares", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_StockDividendsShares", "terseLabel": "Stock Dividends, Shares (in shares)", "documentation": "Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits." } } }, "auth_ref": [ "r14" ] }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockGrantedDuringPeriodValueSharebasedCompensation", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Stock grant", "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r68", "r74" ] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Decrease in accrued interest and increase in equity for conversion preferred dividends to stock", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r39", "r40", "r41" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Conversion of preferred B stock (in shares)", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r14", "r32", "r65", "r129", "r342" ] }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Shares issued under employee stock purchase plan (in shares)", "terseLabel": "Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)", "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan." } } }, "auth_ref": [ "r14", "r95", "r96", "r129" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_StockIssuedDuringPeriodSharesNewIssues", "terseLabel": "Stock Issued During Period, Shares, New Issues (in shares)", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r14", "r95", "r96", "r129", "r567", "r637", "r657" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Shares issued for issuance of RSUs (in shares)", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r14", "r129" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Stock grant (in shares)", "terseLabel": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r14", "r95", "r96", "r129" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross", "terseLabel": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture (in shares)", "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Shares issued for exercise of employee stock options (in shares)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)", "negatedLabel": "Exercised (in shares)", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r14", "r95", "r96", "r129", "r409" ] }, "inis_StockIssuedDuringPeriodSharesWarrantExercises": { "xbrltype": "sharesItemType", "nsuri": "http://intisoid.com/20231231", "localname": "StockIssuedDuringPeriodSharesWarrantExercises", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Warrant exercise (in shares)", "documentation": "Number of warrants exercised during the current period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Conversion of preferred B stock", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r14", "r33", "r129" ] }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Shares issued under employee stock purchase plan", "terseLabel": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan." } } }, "auth_ref": [ "r14", "r95", "r96", "r129" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_StockIssuedDuringPeriodValueNewIssues", "terseLabel": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r14", "r95", "r96", "r129", "r573", "r637", "r657", "r720" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Shares issued for issuance of RSUs", "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period." } } }, "auth_ref": [ "r14", "r95", "r96", "r129" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross", "terseLabel": "Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture", "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueStockDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockDividend", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Stock issued in lieu of dividends on preferred C shares", "documentation": "Value of stock issued to shareholders as a dividend during the period." } } }, "auth_ref": [ "r14", "r33", "r129" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Shares issued for exercise of employee stock options", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r14", "r33", "r129" ] }, "inis_StockIssuedDuringPeriodValueWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://intisoid.com/20231231", "localname": "StockIssuedDuringPeriodValueWarrantExercises", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Warrant exercise", "documentation": "Value of stock issued as a result of the exercise of warrants." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-balance-sheets", "http://intisoid.com/20231231/role/statement-consolidated-statement-of-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "us-gaap_StockholdersEquity", "totalLabel": "Total equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r96", "r99", "r100", "r116", "r600", "r616", "r638", "r639", "r707", "r721", "r752", "r768", "r875", "r897" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants" ], "lang": { "en-us": { "role": { "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r126", "r192", "r352", "r354", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r368", "r476", "r640", "r641", "r661" ] }, "inis_SubscriptionAgreementsWithCertainInvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "SubscriptionAgreementsWithCertainInvestorsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Subscription Agreements with Certain Investors [Member]", "documentation": "Represents the subscription agreements with certain investors." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r490", "r512" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r490", "r512" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events", "http://intisoid.com/20231231/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r490", "r512" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-16-subsequent-events" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r511", "r513" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity" ], "lang": { "en-us": { "role": { "label": "Substantial Doubt about Going Concern [Text Block]", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r87" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow activities:" } } }, "auth_ref": [] }, "us-gaap_SuretyBondMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SuretyBondMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-details-textual", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Surety Bond [Member]", "documentation": "An obligation arising from a three-party agreement that legally binds together a principal who needs the bond, an obligee who requires the bond and a surety company that sells the bond." } } }, "auth_ref": [] }, "us-gaap_TableTextBlock": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TableTextBlock", "presentation": [ "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-tables", "http://intisoid.com/20231231/role/statement-note-10-income-taxes-tables", "http://intisoid.com/20231231/role/statement-note-12-asset-retirement-obligation-tables", "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-tables", "http://intisoid.com/20231231/role/statement-note-15-segment-information-tables", "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-tables", "http://intisoid.com/20231231/role/statement-note-6-patents-and-other-intangible-assets-tables", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-tables", "http://intisoid.com/20231231/role/statement-note-8-lease-obligations-tables", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables" ], "lang": { "en-us": { "role": { "label": "us-gaap_TableTextBlock", "terseLabel": "Notes Tables" } } }, "auth_ref": [] }, "inis_The2006PlanMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "The2006PlanMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "The 2006 Plan [Member]", "documentation": "Represents the 2006 plan." } } }, "auth_ref": [] }, "inis_The2013PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "The2013PromissoryNoteMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "The 2013 Promissory Note [Member]", "documentation": "Relating to the 2013 Promissory Note." } } }, "auth_ref": [] }, "inis_The2015IncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "The2015IncentivePlanMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "The 2015 Incentive Plan [Member]", "documentation": "Relating to the 2015 Incentive Plan." } } }, "auth_ref": [] }, "inis_The2018PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "The2018PromissoryNoteMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "The 2018 Promissory Note [Member]", "documentation": "Relating to the 2018 promissory note." } } }, "auth_ref": [] }, "inis_The2019PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "The2019PromissoryNoteMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable", "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "The 2019 Promissory Note [Member]", "documentation": "Relating to the 2019 Promissory Note." } } }, "auth_ref": [] }, "inis_The401kPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "The401kPlanMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "The 401K Plan [Member]", "documentation": "Represents the 401K plan." } } }, "auth_ref": [] }, "inis_TheranosticsProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "TheranosticsProductsMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "http://intisoid.com/20231231/role/statement-note-15-segment-information-schedule-of-segment-information-by-segment-details" ], "lang": { "en-us": { "role": { "label": "Theranostics Products [Member]", "documentation": "Represents Theranostics Products." } } }, "auth_ref": [] }, "inis_ThreeCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "ThreeCustomersMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Three Customers [Member]", "documentation": "Represents three customers." } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r763", "r877" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "auth_ref": [] }, "us-gaap_TransportationEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransportationEquipmentMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Transportation Equipment [Member]", "documentation": "Equipment used for the primary purpose of moving people and products from one place to another." } } }, "auth_ref": [] }, "inis_TwoEmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://intisoid.com/20231231", "localname": "TwoEmployeesMember", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Two Employees [Member]", "documentation": "Represents two employees." } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies", "http://intisoid.com/20231231/role/statement-note-11-commitments-and-contingencies-details-textual", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity", "http://intisoid.com/20231231/role/statement-note-2-business-condition-and-liquidity-details-textual" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r465" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://intisoid.com/20231231/role/statement-note-14-revenue-recognition-disaggregation-of-revenue-details" ], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_UnrecognizedTaxBenefits", "terseLabel": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r443", "r450" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "crdr": "debit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "terseLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r449" ] }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "presentation": [ "http://intisoid.com/20231231/role/statement-note-10-income-taxes-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "terseLabel": "Unrecognized Tax Benefits, Period Increase (Decrease)", "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns." } } }, "auth_ref": [ "r868" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://intisoid.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r48", "r49", "r50", "r145", "r146", "r148", "r149" ] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants", "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866" ] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "presentation": [ "http://intisoid.com/20231231/role/statement-note-7-convertible-debentures-and-notes-payable-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_WarrantsAndRightsOutstanding", "terseLabel": "Warrants and Rights Outstanding", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://intisoid.com/20231231/role/statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_WarrantsAndRightsOutstandingTerm", "terseLabel": "Warrants and Rights Outstanding, Term (Year)", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r874" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details" ], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding - diluted (in shares)", "totalLabel": "Weighted average common shares outstanding - diluted (in shares)", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r213", "r224" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://intisoid.com/20231231/role/statement-consolidated-statements-of-operations", "http://intisoid.com/20231231/role/statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details" ], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding - basic (in shares)", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r212", "r224" ] }, "inis_statement-statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-common-stock-equivalents-outstanding-details", "lang": { "en-us": { "role": { "label": "Note 1 - Description of Business and Significant Accounting Policies - Schedule of Common Stock Equivalents Outstanding (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-1-description-of-business-and-significant-accounting-policies-schedule-of-weighted-average-number-of-shares-details", "lang": { "en-us": { "role": { "label": "Note 1 - Description of Business and Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-1-description-of-business-and-significant-accounting-policies-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-1-description-of-business-and-significant-accounting-policies-tables", "lang": { "en-us": { "role": { "label": "Note 1 - Description of Business and Significant Accounting Policies" } } }, "auth_ref": [] }, "inis_statement-statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-10-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "lang": { "en-us": { "role": { "label": "Note 10 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-10-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "lang": { "en-us": { "role": { "label": "Note 10 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-10-income-taxes-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-10-income-taxes-tables", "lang": { "en-us": { "role": { "label": "Note 10 - Income Taxes" } } }, "auth_ref": [] }, "inis_statement-statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-12-asset-retirement-obligation-schedule-of-asset-retirement-obligation-activity-details", "lang": { "en-us": { "role": { "label": "Note 12 - Asset Retirement Obligation - Schedule of Asset Retirement Obligation Activity (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-12-asset-retirement-obligation-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-12-asset-retirement-obligation-tables", "lang": { "en-us": { "role": { "label": "Note 12 - Asset Retirement Obligation" } } }, "auth_ref": [] }, "inis_statement-statement-note-14-revenue-recognition-disaggregation-of-revenue-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-14-revenue-recognition-disaggregation-of-revenue-details", "lang": { "en-us": { "role": { "label": "Note 14 - Revenue Recognition - Disaggregation of Revenue (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-14-revenue-recognition-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-14-revenue-recognition-tables", "lang": { "en-us": { "role": { "label": "Note 14 - Revenue Recognition" } } }, "auth_ref": [] }, "inis_statement-statement-note-15-segment-information-schedule-of-segment-information-by-segment-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-15-segment-information-schedule-of-segment-information-by-segment-details", "lang": { "en-us": { "role": { "label": "Note 15 - Segment Information - Schedule of Segment Information by Segment (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-15-segment-information-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-15-segment-information-tables", "lang": { "en-us": { "role": { "label": "Note 15 - Segment Information" } } }, "auth_ref": [] }, "inis_statement-statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-5-property-plant-and-equipment-schedule-of-property-plant-and-equipment-details", "lang": { "en-us": { "role": { "label": "Note 5 - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-5-property-plant-and-equipment-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-5-property-plant-and-equipment-tables", "lang": { "en-us": { "role": { "label": "Note 5 - Property, Plant and Equipment" } } }, "auth_ref": [] }, "inis_statement-statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-6-patents-and-other-intangible-assets-schedule-of-future-amortization-expense-details", "lang": { "en-us": { "role": { "label": "Note 6 - Patents and Other Intangible Assets - Schedule of Future Amortization Expense (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-6-patents-and-other-intangible-assets-schedule-of-intangible-assets-details", "lang": { "en-us": { "role": { "label": "Note 6 - Patents and Other Intangible Assets - Schedule of Intangible Assets (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-6-patents-and-other-intangible-assets-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-6-patents-and-other-intangible-assets-tables", "lang": { "en-us": { "role": { "label": "Note 6 - Patents and Other Intangible Assets" } } }, "auth_ref": [] }, "inis_statement-statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details", "lang": { "en-us": { "role": { "label": "Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-7-convertible-debentures-and-notes-payable-schedule-of-longterm-debt-instruments-details-parentheticals", "lang": { "en-us": { "role": { "label": "Note 7 - Convertible Debentures and Notes Payable - Schedule of Long-term Debt Instruments (Details) (Parentheticals)" } } }, "auth_ref": [] }, "inis_statement-statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-7-convertible-debentures-and-notes-payable-schedule-of-maturities-of-longterm-debt-details", "lang": { "en-us": { "role": { "label": "Note 7 - Convertible Debentures and Notes Payable - Schedule of Maturities of Long-term Debt (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-7-convertible-debentures-and-notes-payable-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-7-convertible-debentures-and-notes-payable-tables", "lang": { "en-us": { "role": { "label": "Note 7 - Convertible Debentures and Notes Payable" } } }, "auth_ref": [] }, "inis_statement-statement-note-8-lease-obligations-lease-cost-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-8-lease-obligations-lease-cost-details", "lang": { "en-us": { "role": { "label": "Note 8 - Lease Obligations - Lease Cost (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-8-lease-obligations-schedule-of-future-minimum-lease-payments-details", "lang": { "en-us": { "role": { "label": "Note 8 - Lease Obligations - Schedule of Future Minimum Lease Payments (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-8-lease-obligations-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-8-lease-obligations-tables", "lang": { "en-us": { "role": { "label": "Note 8 - Lease Obligations" } } }, "auth_ref": [] }, "inis_statement-statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-option-activity-details", "lang": { "en-us": { "role": { "label": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Option Activity (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-restricted-stock-units-activity-details", "lang": { "en-us": { "role": { "label": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Restricted Stock Units Activity (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-schedule-of-warrant-activity-details", "lang": { "en-us": { "role": { "label": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants - Schedule of Warrant Activity (Details)" } } }, "auth_ref": [] }, "inis_statement-statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-note-9-shareholders-equity-redeemable-convertible-preferred-stock-options-and-warrants-tables", "lang": { "en-us": { "role": { "label": "Note 9 - Shareholders' Equity, Redeemable Convertible Preferred Stock, Options and Warrants" } } }, "auth_ref": [] }, "inis_statement-statement-significant-accounting-policies-policies": { "xbrltype": "stringItemType", "nsuri": "http://intisoid.com/20231231", "localname": "statement-statement-significant-accounting-policies-policies", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1B" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1B" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1D", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1D" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-11" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "30", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480513/718-10-30-3" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "30", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480843/718-30-35-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-10" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.4-07)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "210", "Topic": "954", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "20", "Topic": "410", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-2" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//410-20/tableOfContent" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481999/410-20-25-4" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481879/410-20-45-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-48" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481639/420-10-35-4" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r722": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r723": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r724": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r725": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r732": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r733": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r734": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r735": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 89 0001437749-24-010010-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-010010-xbrl.zip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

W47 FDM5'9NS]/+S"2K*L;-6[ /78GRECXXNBX"BNP)RLN;E9 MW-*:#1 I:EXK%TL?7MF'O] NFC5-H:!-AO*(7QD7KZ>TR\?(26;NN%?QX*)G M[[Z!:L?0F;[NY5Y(U^]);:R%M6HG\(CJYB=IQPS1>1TRH?ENJ8O?HX].9-@C M_)(:8T=9(@1FW?JW%!S_62[<"@;[-IDBUL?]O &:^J/&UQRQ,ZM=:);Z7KF6 MB60L5%E+=.]?DW)MX$U\8 5)FVU]YROQ5/K-X&O*>UHB\&@#=/G(S.3%,?^? MCQ"#$85< PTL@:&%>/(!9^>ZS;)Z*#!43YO]V[QR:$&-K51OJU4:O.]C]R#/ M^OHY$72/&TDJJZ'5GH]K_&N.L*:,L T0@9CP*,_%(DF8])(5J!%PM]V2X+)/ MY\,//_3IE(+MF=59/D9Z9YUE84:]&R#BY(M<(Y:@#8![<]'+^N@^KM3YN773 MK,4*=6@ UH.O*_9AY CB[6VP>D&_,$8RZ_7Q*=Z=F^YIL,M#$3/ C[()[#%> M>_=8SV8HA29J84ENKQKX 1,-! SMXYA5:N&X_^VZBA#8OJH3\/EG;XQEYR+Y!7F-[ MO.R]XM0U]!W6HH2DYHJCB$^B"-13\&F3'F)X^-1-$J1>'/6OGM-B.]8R0UKL M>R]PS$KKAC&;;ZQ7?0@_=V"Z27T;(!6A)]N?J)E%_HP5MQ)T,W6S\1BM7XC)KL["N:9:(JRM.]C\ M;A,?]?C9:ZL=8N'D\MA'(N:T4N ]T%8"J/$*^5K=K:&U?!=\5GVK5]1,ET%! M0$7M;ZG^]?/5%8@)8R6#.8A:S@7I-/76K*.7S;Z>E:> ^)-9!A?5G4*DNBTQ MO2S]4%:H6X?4):#FVM"JA)25N7HYE1I1K)3Q\23,,[?OMLRQ#WV=;B]>W1+9 M'.Y-W W\?SZ9_E(TUDU,A18@YD]H-J5/DWG/ M)*9_11ZR@DUO@&@>;VT=]*E ,E!^[B=U!JS%W\HP[:^E]O:(\]IHCX)*1BT# M@DMZN!):UHW$L;FHB;A1S]=WS)._.LQ\%'&OBJVA]^I!4,-X??J9$*H2\,Y M>AZ>B^1/XTM9@V,_OU\K-4PN>)7P75>2G*'WKG4?RHE1+"W-F?6+0OE MQY/*J#MPK+>I A4X="OT=WRP(2\CE?.31ARYRH*LI%+F&U!>N3K[H'X[$C\E M#H6E,>9XU[Z*501WDC*;EFA"++^G]76K)9_$S7T(P,(D,%[?8V=M:, YJ!M@JLO5&_UX@;0_*66^^( MH'Y8H^?F>[-69K:EJZCKU;M-C\R)ENJN'[G/W -!!>'/VH=-8%HO!1\$(RS: MJ!< EN*>9HGET%\(VO,^"V^^+YZKI'Q&^#:)$BK:>@>1=X<&V);7/W#-!IN0:>=QJW]$:RXZ]97$4I::Q1GEWVH!Y<>V$Y:8_03/K2B(;5JP M4X* D"R=WV0S5?YQ4S]Z?7P%.7$Z(R^9U^:27!&Z]T('4_ #KJHHEMQRP07F M%ZTJ;PJLML% ()N]6_H]*_]5RJC_:O._4+.W6)OUJ!";:$'O7YW0/ W8T[Y M0E9^/YDY74VW,5S[?.2U3OP/>+KQ)IS- 8J'"(&"2JFD6W0C-ML4?Z=2@^&2 M_8P0=8GF%]_UP^[*OC/';Q[_1237&("%".RVSB$G:XZ;O!\.E0I]9%<_A,L/ M? FF:;=-AT?GG[9(@R'C,E/@H, WIV$0)EW> *R!/S]'(HP(K:M3.]?EG_N. M*7E\05J;I=#A*>?-9>8-I]Z1+8CE,B+7:V.G6U;,-Q5O+6K$^Y^2' MF$D/&1E8$?_M9B>SXW%BD"+R.WSW7._2S2W,_N8C5X,<#LPD!2X;:%7@5>N@ M?S06(VKR)GR%]H.+%QS+1]%7_=86?Y1['I2? +7([KGN>V_-AT;(: M3O*=3')+S74;6IU0LQ#0![_4\O43#0B"MOD*PM%)OS"E17#.AR&=3MEK'4Q' MSQV6FTLO?0%/P)GR94?6Q)8SE$+-5_5. [AUOZ_3RR593]J' ; (< 8DA8@B!6:OMH [1^;J!.(^O,KWLT)-[D=Z;SC M[5W0!:]S%@^>?@%YE@48"8-F>-:PFH&015/>N GM9?^MDJ&*6T4QSR$!VND9 M.D6MB:H^2@2IPES@G[",H,"4!VUFN)X2B1 >5NTN%)9FMW M,^ZNAZC%Y($:3WY4]M#11>-HB2!24,$,,P$ @OZ/I5A,D[:;:K*B' MJ]X)+^?+9@F2MFH1=C&G'E?^,#OU) CF 4 AR9P'\&+)YFZ,R:TR'G6NM3H M4%%,J=^0RV=G9-N;\I@ #BUK2M[PZG3Y2?)U_(P$778#9#PVVPF$E1AZ^%#& M%[XK25:H"M/K:K0CX)6Z=Y2H6L,Q,3F9-1?.QL%%+&OQG=9=E=MZ3K0&#^JF MEHX""7]\G*E7D@=PM9=Z/1K"?#U4+RA\5+&^V.6;?7$^*8YA&PC%T=3'R*3*1.3W*B&ZG8 MPNZQAM1;F%6Z]NQB'K:>YV83;V1UPZG[Q)'@E<^WC1'IG ]VM6WV.?=Y_$Y) M7Q*\B;\KXU8HLC+,W'(?K"E7FZ%,.KX8N1]4*)Y. M9&!D<"Y^:PB?%%IC0#YBTG(U[NNI%.?2I(,*@WUJYHH_7 FIDC(>UV'QYL ^ MP%"97H'-I\5YK >[1G,/F"PBO.T@,A<_Z]HJ15VZD7SJ8P=A J^V,#%";'0IGD(/3> MB01]+(U7\*?8"8UPMI8<'6M9@^0*_/N[\/@R)$+Q>@WX<[;N_[9&;40R.^WR M+ORZ!^0)),U? MQ KS-H?:0QV8KD-*R(6?35I)*[-G^,;5KT:.XAT76/7@CC<'WG=X)::+QXJ( M[/6#(11> .*\0MX";YC*X6FE542T!%,,,1C*Y!6)I<"OM2E8<%O/API>SYQX MUKT3G@Y:1[X_V%H& >PV0.FEO87\PX#J!^"MS_K8?"E30=G/NF+?'>$# KW\ M/0D22VMHLZ<8,/!GY];QZ;44 P4_UKI/RHU];U5X7V$P([$!DJUM8^T@<5H3GKI5TP97L;+Q'&R%QJZ&#"[CQ?/N M^J6?U5I%1=+IY#(VN<;5>M.@=R(JJ3G@.@C8B3TN=/\8,^/K_5R$R5(,J34, MIG\0/>X@-?TJ"SW*9!4T#RXNK M.O?R&T\4O-E%'/;"CG7T]JO'S-\)O$>9H'T%7(%(('O]LH#/01JHZJ<>Z$;H M#4^I?G8&CU\-U*_4/LF)*=*^[AH-Z>EX6GN#A4C-^$[-J$-&7]PF9$X;0E61R_H M*;R[;V:;;P#O_[+>FADC>ZN*Y/@L[7GAUN/)B&.QA2O671"&@;+S)R=?E/G@ M2K.>&M)-]=/;[6>OHO>A5R'4U?*WU6K^^,CT@,%VUK;9Q6V @'9Z9Z2% M@?)[+'"_N/-0>A[255KDZ,?<6(/RN<\*VG%)J(IWN(BXR_Y\G$6+]OC5P5O+ M5:N*2-DHWD\VBS5E+!<3S6"N-RG HQZOYKZXLD WC"WYOZU#_EUS _1?J&+X M'\T/#QO_X\J-?ZS5/W#,MS;'5"-6)OF?R!^./_[^S['&+O<7)8W5^HG\K[NJ M!.VZLB/H/_[\GWYP?%VF6W99(F8YMAXDOL7PR__C,?UK(?9OJU8,;RMO!9N"O+QZDM92,C%_ M9XY5/N_B GX!48D565HZ&K<>AWX#=P4 M^I:^KG-F:N^1C28[E6]/R/L6Y!@66RQ&&)'F1>+'$(K7$CU?27C3=BB'O2D?\D&WUT*+SSVQA.,U5M5' *!DEJL)_F MKP?!3-W)3L0MC7(B'KE8?LFC:0SD,UKHWBIZM]\L&?$A[7Y<=I;_V?KZZ+P> M](@*OX"!@QSK!ET MH),$=$Q>PL?29Z1IC<7 (9YYE:R8W+0#,7UJDG&S;J6$:96E;A&(W>'/4,L3 M,3HLEZ'0$T$''G+<@(\0;6&(T!5+Z!YJX!BDA[CJ]+::U36G3*W9#.TL\DF8 MN5J/U7.N\O*I4[N2ERIVPO'7B218!LYLMM5=P&6JNP&=]!X)94N%-=M78$ * M"+I=1,T(@78-KKLO;( DP";2)3YSIUV\W,;(U'MTP9R@9M! 39<.Z.%G='9O M@%1UV]%@=C9'=O5?;JJ45L+-.S(NFVNQ@=G=^&.K !NGR@"(="NZ6Y M96[CPZ9K>#>S2J#E$_/U%9UAGC^-ANN:7Z;O*B,$72?W9PK/3,M7^L72-0S. MURWWXC7;@9I-]_<'R_6E-6]V9 \\+!8F\QNXJ :EHPPTQW?%W M+!;]O#C^:31V5M:[O59KY-:5N6,83^#!\Q'9L]//GSUU)AH'/ M^98RVQT<)C)31TUF1"*H@+=7*-!7.;C0YZV^[7W;FZ-43O[/OD ]I!<>6X: ;H%XY'!QG#5!Z)"-C[].[I7H,5.<; MUMGEW#]WS*9?-Q#LDXLRG48_;->,LDS/L='98A(>$-M:GFC;8#Y51^2>K%HR MRD;>#74^?^006_7LYQ^5EHI73!06 GRNT]!U-'^;/3(MTV(M@S=D=[" M62DXE\+E?+C]7@H\,9$)HMB[P![A?(5H7[?T\ .YQ60G%#JUOB[Y6("]Y;8"F&LF_ZG^3;N$1(OZ8,1K1M C56/U(: MHH[^B9#-=6<&U&(@AJ$*A6PW5X/=^0\M74?' YZ YL.GRN4R-T!:$4\XDUH M>E/DP?GG*ANR(WH"[N/]"J/M946U0QM?-S;3-*0<8QQL=-/V3^Y>-G9J2/\; MBZ- /#=;L4\.Z_E):./\Q]=?'\_D9NR+1\'VGOFSPS?V6OWG&$Z0FGR@K$G% M2?/8EJF#+H>DK3_E!" MVQT)A.TC8<&'>X]>\E+5N7W%N8Q\]R2%W]!#)[D1<3=Y%9+^0[0>#&!;#- M M,"HX&!9O'=UGR]^^OCT(_!Z=Z]7,%)_7ACU+2&@S>FEZ'"+_);;U&"^1^+?* MXT-NMIO* 8MQX9VG?".^_SR;S_?IDK09DFE(-1.T]!=AE=17F3/W%L%6^?)N MB%T5SY][^JL=B6T=XY<*IN5FA'$<*3F<3[CP&J\^;F;/C1H!55 ^=!X]/F&W M\O[LGJJ%$]%L]KLARP2MURV^CN5S)QGWR( U[P]>.$1_2JXGR$B327CVRCAKKZY2$5S=O>OZ#-+BYQ-#\&"&SN.B5]1']AU%C MD\_.KGD9Q=+6>%J]&Z"<#5#N&&'&_C-VM$*7@N8NY(C;\C\^"MP V=0/J:L[ M'21P8+FO&'K=43=S%X$@N];,HV(*5$W!I@1Z$288$7 $S8)/ ]3:%J@PB,#[ MS;>V;:*U#/VZS->LDGYX*Z096AYX:@8J#\Z++\4>8@468^-$['\HK+^#="UO M,HT:=BN>05?'>6&U>'2HF,*LX]@RAY43=K[\W>['1QC[YI4\Z^ PZLG^5]N, M;_M^HASC2V7@9Y0$[P'[2J&IOZ0Y[[HC,?>A7(:G@%G#=Q58?=]];4_8N;2, M@-OGDHV=3F5/<>P,VVSH:7 W$CXEH^E/XN9X9Z0@NE^HV.BE4TL:B8P)(W/7 MO3H!JH,2^N_V0<4[*\\W;&5/F!_H()17K>QM@3IL#O$[/:8R8C.B+M5Q?5J; MGVM43A+K-&+HGIF5X-<9%PA%L-UVVN@&R>"=Y^>&O M,,0.V#:12/-IU_N.?.M40357(IC1D&O'JFM1W;=HWS7R^?K/8QVQ-QJ2TY(= M_!,S%'B30)=B9. "#]JKJ:V14(A?O^[W4]+]J6F"\^J6?!>W\;9*<2=WQPQS M_8*AB L_CJ!TAD3N^7 Q LZ)7]:=8@>S 4O@?L4F^TQ96HUTHNSYB2^4$M,% MU?DHZ\!)6 I_A32\)*EXKT!9]-+KE.T>P&$5."/76A#%6\ZJH\21-E7J!D@7 M=P>'0VM7DRT\+6IJ2L,'<,8YLRJ6O#:&UK04R[2)%N#+0(QF3M!V. MKGD&7/PF_LU<$&R I)*GFOD$[J'DD)."'(KP-C9V3SZ/FQA*KM5J>C*1D_)P M?TS *2A:YQ*2&:9J'BRW]S3,SJ!K4] 8,.A*.#= QYGW6#]$T,"#<$/8@8)Q MEJ"A;!??FE342&]L>>J@V59I)QL-?UC:@(V[: SS$NLGK[CUN6W&2&\UUZ"3 MI#C'=FP4--0+/O!#;K^?GI6+Y?>&+^64?L3(;>M?!8>,AWG'7AZ=Z*)H.-\G M\Z0N+4A&"EC\#= TJVX7Y]"+S0D6]/E0VKET[;F1<,N9='6J\@&-H94PPK>9 M$:]H9E!C9E]P\#&H.F./3:3FGMCJ ] N$C]EDD\8>YH;FEPZ*40!44@PO$O; MM>U/'3NK N_[BRF\^D6KBEY@CT?WMSVSMG64?YLWO3GUT]0(_F;CZV/"P6. M"8-:,."ZK*S\/>7-KI M=U,-:3E751X4TOV1RT4I.9?O?BY/IAIA@/?TP=;;@W@-V@S0SOT#Y=]E03E, M :>HI37[T.SO3UY/5QQS_&3#5)R05ZL==(U&;OK<3,MH0X$!I M@UWN"FK? "GH\'H'#63:[WH3A3-]VMV;<5^J64AV54^=0"(^5ZBD*=N9QCW: M=E@>AB.-(DTQ6]]5FXI]%+'U.NV@$"N_5Q.TY?2*-<-+0KVW>,MTTDXBVP"JQREF6-RH%#4+YF3"%6N&"!!$(#(O<3 M39YX!]ZV\WY(J0D]>TUL9?<7PWI5I<:Z;P_''^U("YN5#*MV&1" MQ:&0%\9K[Y#*DG2E\?'9M)AB(,Z0Q-_6C<(("NI8X(PO2A5UIU)4PK:K\IQ8 M2SURVDL5.6M?&_EDQ]8'%PP;KL-^;!I& M>4J_^T$&O* M(_#@5D1,#Z:WYZKE(2.6QX/.7825#J9F<86UC9<]1ORBU;6(&Z%M;D9"N-!U M4\[I&_'".#/I7T39;KR$'(DG,6=VW2G\FF+$I"4@3 ,K/J3&MNPYH_"%@>O9 MNW>P.27\]Q1YY;L@"%;K/Q+X=+G-\;$'(LANO'E+XR7RDM*.+>4_+I'_R;L[ M*6*WTJ<0>P2Q//[Y_A2E*\60:H0JQ>%;1-5ZS#;;2JVA M1%6VSU[#[?X%#QTOO2,GKEYILX>0J7+N;?OC.[L6W9K]?Z^VV?68<"?-HM9L M:8V:++'(6D*8UG91IT$1B(P"R+R@7'W;+T_J4_R,:*6 #_3-)%[>#&\X[N8L M7!)1/Q(PSC!(TG>@6:G-H1P2,';W1TRO3$5:>)OZZ'RWV?7&1.'WL$=2 2^M ML?2#OV_83X,$A?ZHJTZTAXT.!YKV,O&G8?8#Q_/V7NBW#U@?>O>:_,_SDX>- M=TWR $^JFF"&AR'B+VZ E"*^3"?* 0V" U5 R=N5C@A6M>Z@LU'P[^88:8=[ M?>5S:MMUZ_U/P_#3RQQX.EYVT['H5F[:>HH]FM-W ;$/+?V;H59SZGSNS25> M1_?T[RFJU=Q_CRW_S\U_=Q^K4!=7(#+=B7I>\MB3:L#\:[@@=8E:""S?D7W7,B+*LX/.74@^.+ M5W8J 3G36WD,A"ZJ6Y:N7A]@#C$F^%OLQ=;SJ'+?^-$3T*9=6K;'0=K&XY\ M;+@Z-G7)GM7@O-7L7<6]#$?82EM&MG?I*,*/I3G@//?SB*RFIHITA4W[X7UB MTO$/;.1WW8))[@")5.J\@.T$CQ#U5Y\+OXW_]Z_ MV<(K\RLXZG!XM[?"FP?&N_,7%F.;+OW1F$JSV7%\2__!!YC^>YYE#U]*O1?! M_'=/R_]Q2_/?G!SD]_70=5R$2*$3\+OO9_@=] F<93]F-3ORO*EO!N=;'O:Q M\;!+6:!ZV<[QOVLQDJ33M "&]Q T[-F>NIZNHM0*0:I6#H;4%Y*$0 M\[CA[TJ1ZARS MS@B9.+OJINTVZ?R6*Z4Z ?7*]ULH'>O$GFUIC+XL@7"(23FS\]O!E9,4&5X# MUS6A ? J$OHN9*@!.N8T'@](=7K%9,;4,FRWO'[A E+\7;S?N:Z?MAP$V)>, KM^$>P\JW5Q->'% M6Q=8O/$&Z+(>(*%MK4'G2CSIH=T^Y4Z+WM=YIBG96K2^-LO]0NB=DR*:_2=R M\Y^6POP5*-B_:34 .4\E48S!: N[T%NT4)1PH')EK7H,JL[Z.'7?+(!][^B% M2O9EA(/M,="K[TIU,&W6!DB/KDBC5XYB\?;\)T7PD7YD;\W; \/#:4?8H)\\ M5[=Q(W#QJX[G$M=YQ3:4/U$'%?+E9M8XUW%>C;Q"[%C["I=T/[C$OW]W(%%< MY[=MYZ)R5<8QS/;2GT?-18JFE]/V-'G526/!6;VO^VF4E"SJ M8$2H7%-UMMT#P^_"B4I:2H+#+P=!M2/Z/VVKE[O\=\N5_^+9!QZF+_&"OQ G MR! P>=:$+]$S+GR?]- .;/ZUVE&^PDG,E+>BYF?+8.=*S,_?I+2I4$%/DXR M6D[TTE/9:$&EH)K7D*XA=1[H\,=Y#J^,*][?]["H-8X\:I9RYXD'2=S=D,0B4V7H^<+#L#]Y3@E/1;Q(208IB.6D.BG& M'X/N5D-F89.@HM_-^!6?2YG)@3H/E1#F8[QEFT2?@#__<&Z_G-M4O:0.KC"S/^YB+GUI+ MA8D2/;6V-%N+PF&3R*>23F3O37;MZYEPZ\1GZU_9[.>QYEH8+A![JX /)X3N MRNA:N]XZ\&7(VU)_\)LZZ]#6=Y'&J41S'=U9O[/78,_Y2Y)W)KVZ7@'0OO M1:QH3P"#F0/'NB;YL0A4:8F3[&1:T\?R?9XD]::I7K@[ZZ5?? MES#+G\AN%[F7D7QTPMD)2.QN M]4GYR$^;E_%]?=3GBC#/0TH$_XQ<3N ^G0Z;034"?U-(-N%>M-X8 DOAO+JF>*.KZ*N93MDK2T>R68/[D=?Z*1>#A"N*YTJS:%LOIN]M^OT7[3IN$E<&J%-KI9R/J MD7ROOG(TV1DM-!7D-S-K,0RGBANJXT[TS"6"/3U*_,DYGWLB=GNN/>\YEG]M MZF049?%_%;?^*T'T;[X?OML J40P6XUYJ8U^(Z)P1ZE"YV%HRV=&0,YA=@OMG/-L87A@8I67:^6NZQ[=#!Z MV$=\J4Y'W!66;HX?X,'=(V@EP!T/^)6@VDZ+\N\TZ,*VJ;Q6D@$)EY^_:-7V MK"#P*+WAI%Q=DO#,\&+ /\Q=F8*!PL=UCO&6K8G< T86#;^<@:JVHN["L910>-EV>8JX^6(!AF M5Y(<+J@(G"C[>"3!M"GA*0?#H6?K+MQ1TNWD4L_[L=$C(8MBO>AGE7;K\BQI M^[3*PTV-28;^56W%2=]1+DY/4(73D.Y%*?[6 %3OD/E(!+7*-PZC7\PAJ?D- M^H7'(E&G'%D+_2E%;]7&K/S[.O#&BUW?W[MS B?20K1N0Q9"DG\8;E4Z+?ZA.E^,V%6S:G) M6,SD*?%!C_/3':BZ$MQM &+':TBE??73^S5$XY=_FEU7S@:_J)Z_4(:R7 W& MA-VX0MS5X/[Q'VV6"-Q/GLR$3>:@ IEXY4W*_3VSN)[==%<&>2-H S<@K";X ^$* M<"C]]U%)%#NESF/ M 5"K_D!JU73T.[P%LJRL;+]\I(9/X-D;^.L[IZP4'FV \I-XW*R9LI7(?89, MC0W0>?][GG,DXE/X4E2[C5<\?%37P9T>W^61S2%#N4?<14WWULD M3#TLS#XL^<)S40"21RER]AW;KQF!%+45"X:^1 MT.R33Z8FQMZ!P>G*N3?KCWZ&_8*0MWL7P?X)VP#Q8R7Q(Y"(MQ7^!,GKM?SS MI=,0;:R.,[]";1ZN3>!K]P9HRG6;34UC8X#Q>9+URU?$L:7AQ0Q9&%JU M4]IJFKF58C%58= AZ2( !/0H:R7#?*';/,X6KP$\@FE_:UJJQ)3%&[B,0#0P M:X]]!XT6C"5&45).4]_HM[;94/;P3 5?9W)"#'H/G$3O=8Q$_$3.K*HAS_ZDX-8UUM*BS&%<)^< =F?AZ:W(5R*. M%TU/P9;P*6[I5"!4*LN'P%OKH!-2T;RQPCF0F^.ZN1XWO0X M[3EQS5UE]33C&FP/9GJY9P,D[2_T3^2QOG:%]Z7I3E2B%NJ)89EL8==7QDAX MX1\ONWLW:J*_S_L%WY<=<9'5_*B,BFV\VDJL,.VC;VJES/7Z:CFB.E[5M]6; M+]$@H,3%F=/>#,Z5XT.G*WW@S,">MR_KL!VE48ZHC;=[*?$LCJT5 MPM*MI>*8L(43VIKEP"@ P7,F]7S#Z(0Q$BDD.QOL9NHL.C5C"5:4O>4\(-(G MXKS[S*U[B:=A6TJP<+YICV0 #]< 9.]*7UFP9@181'H98A0G)EW-R?XGM"/9 M"8,3YU:+]OD<1;*[A<\Q*JJJCMY.?164]D4#Z0V0YEE!$V^$PZK9E4(;X/0I MH[4[7_-"EPK+WQU*VAD+[-\$7L M0B/U=*!\D43"ZJ=%::QK 9H15[>>]7K7VHZL_2HKM9E:B;%<;#B> M/CJFV> =WO5*W%7?Z>&;B;,W]#10MI\[;,@:48$ ^RK;=&XK+9_6F+&Z6*TZ M0'?F"V2]FZ7>).?-6E$_-=?[HOI>.RE(9'IJ3X0%;WW,\TR4^\['TQ^:AV'M MVPDE3I(/RIWN5#!23^$#P^:07]:65!$)^A8(MF^O5!SO8JCIW3/W<8QCJK4Y M$#8JA\0&V@#/ 9R/W6@CNOMRA0UJV7O;ZWTRPI)%\QS;6X;6:KP5);.AWLD MG&[(AS4E^$L\PQ*7]Q;A5Y.Z4/JN -F9S=T9$3T.!)KG<@]_O)QMQ%Y:2TM+ M^[APO)3C)Q*^\].R-S:3BDO%1FNW1S*CD[_;01:BPMY% %5*C]SGIL^;SH6? MK"Y.[8NZT=C8T#)B\T%Q;M6#6M1.;"4JC>U1.9LE<:7Y=M'@3'6.;C8#TTON M)4R?0VM^9(NN4$:AQ$>Y:ZU6O9$25D-2PQI]6I26[_G%\^M>8(6J"D,WZ/26 MQ^68<>TFP[P@2]JQ[.^P?FRJ(R M)43&8ALTU! :?Z:N(N255,/=.3J;Y7>@"9\#E+%3V<*^9,6EB+;2C[ZI'Q:Y M%^LX,R->1+779QB9P?+.\BM@Q_TACE6*0Q[K8 DUHU.O8D7,+%X1OMR%,Q5! MHA3J? 80IS;=^M]36U M17]2C6WN["W3=T$?'$H[$^ 0MT!F)VA#5C(CMD'T<$5?YCHLC,V#U2!&+\VE M+TP_)Q+T_+^?ZU->X_N"-1>*%4V(.O+: ^_*< />3OKT<8-;V()Y@4/'S%K9 M]M'TM\UD%B<,VXK:V+_1OZPG-["3-]E,=;3CKSA6CD)"O==<+60AS[J!LQB? M.3=%=/@5MHLRD-W%18^0UFBY=[9!5NA;(NNVPQK.+_?1BAV4NR6M._ D3&N> MJA/DNU"2T+75%4J2U@+L%J>-79U#6O&I1K1?SH:%$UQUS+2#GSRN<#;R>PJ] M/'9K MU^XJ!2]!UQT>2T?+. 0U:MW3W -1W8?[!(TC= 1-[T0)#%#KA]EPWG+>L%8R MJB-FOK>DK637#X!A\(V2?J([>A^MK6_196&]IML_X59LPV"Q7/+AHX)[A;RL MT3ILYYYN(!I($%I/)VT"C70""@P7MA?&JOFVG&.VF$R^KCS7,@R6$G@PO)Q3 MTSS3X7DP#AT(P7)1@$%_>P3K,8N1HLMTGTL-O)L_(_]Q29^^N1CF-[8H;(X$ MUP/(WKF':(%KER[LFX$6V$MBY Q4OA2SK#)UV^C5,K[M8:R0QWBTNW5$79AN MP\:UHF"?(('IJTE.%K%>C^OG!2^TWIQ=B%JN( EYK&.>BNVD8H\!][D5Z1\) M].(IE9Z[?\76TM;!K,T7596 )93R)$X,O]XK+QZX0):Y\K=<%C#+ M#=!BU?6SF1LC8VE!D3I]!'JN1!^4VP9'J7MP%]YR>1<_S\?_A4,=DN(5Z$#; ML732W*R-*W![#XKQLYEQ^)\II/XO!\M_Q0 ]\O'95D"GV, I@JQ4W#*_Q&(2 M4E) 7940?_)N!LW>)@'VX*C1A$?U/A:#5M$"SHDHJ(YRXQH"CUAF$6WA@>$, M2Q1D=)721;04A*\':*:\@&^,$B3JTU.<+4CFSXVM7K1#FC MC[%3>\.X1#%Z?E:0!4:-3)=?N).=>SC24"WJ>TA-ZRFONAHUO=K7ZE?UQ&W\ M37)JJ\^*L9^*_EAI_KT]P*U/'E-NPE !7,CI;LX&CIH39),S1@LD1-?B@\OB MJ^C!L)=;"I!E;9#8A]/FW-0NT3!R@-2*_XVAI1L-5(65 M:X78=V;'-#HHTUU)9SU*SD$N'H@R;_?*MDCO%! BJ0-?"[LR*.,+$.RA\' E&!"J&R"G>4RL1C/N$U MJ/^JO?,D!_(5]6PG@Y/JQ62%Y(6S48RDU& #)?@&(UOW,VY^RG%H#2[9LI$3 M,G5U:'53(]4A2RK>OKYA2]:O7T0#9=U]D^\4?X/%TP9E3@>TT/[?X%E(T9K\![O!H+ MS&HU91$[&FF/=BB+S?9DB/7RGYV:]M._6<.V7,]P=JZI:Z'.CJ1>QR(0^^[9 M!N N=B&W+IJ"$^Y6XPC#&,8)W70:$LRUM\KCY)=P[[/&LM?>#G%*2E\&!P;X M*"4\UQUM&/NF3KV2DLW,"T^6^^NJE:!QTT-'_$;CSQ(G_]-:UG^8*7O+F:59 MGAJ V;&/I^IV"-;-Z\.I5>IM'@>\[DJ&(W"]-GC*R4,/"$>O^ZG8?7'^9G]P M,]G8XS>)Z=+-%7($Y+,G-Z"51=>[/./L,Z800<3!)A:@G;2.ALJ@/&@[B92Y M[._33+UP8H*B&^, _>HS^6PD&I*%Z2EG_<6IVXF *XH^HM>V>#<.&,L\==T0 MS>>OB$2E$]:JW-HV.L&V(ULK2N$SY3Q9Y'.D(CK2B].'Q -)W>WPYEHB5<- M#7"S;QI:J:ZH:#-"HD(E;U80CIE_R<$^KYD.C*M9S ?>&E":IBFU:-AF;WZZ M(BV<=TO-FU]-6W<1=1&_:U%+56M6<'U<=7?!*IN A!:A-Y[ ME41=);09V3:/@/-M1XE;'K05XAG#;P4Q$RZN$]VDQ*\.EYX>I\@M1:"$#T:P*E!C83!OD^O[":.O;M;'MZ:K!?W&J'K3R9 M,JW@I]V834RXW#4]P&@[/$")@CV),[?T;HQK+=? M[BT9C)'6K0%0^(6P_M3RQ?'1 MS[<:8]&[AOFV^[)5;F1$HQ\BK[HUMXD(6M MPNGKJ[!EJ-?DZL0DT&!C#HE5E3 WH-BA('(XFF>DODDFC9%\;FZ@H_B.4Z-G M3]W]UK_S?I-N_<5KD M NO'C@X2+H!(5//DPC7O&T5W5.PDN3>&*H/ESP@S;.OO.XYXYKF"S;$W$^DS M.OZBK1W'E+V/;L3WW/>+F\$WB(QFAN/\LO3:RQ&AA/G"_2.K\\6V>K63\KK[ M?:,5[IG8V.43C:YEX"<14&K]J:"VD6 =2^F^LL:&XZ&UDLJ95=X6=SWI<*#W^Q"SZ/OUU*<-U<$S10@/PO=2@>':>G8W"+(I8Q9N3B,]Q51TV.FVA%M1S6MI5E?"R MCY'>X^]*6M+.6>NMOOL(->J./5V:99SPVV3NO2J&D)4*Y()CX;!8;)9BR._? MA:;2F'$DUBS;@?6]LZ\ARHC,9J1_B5@JKXU*8#W82*A=4..A7<1.;!E:[7]> MXLP-(?>*ZPQVV@N$C=:V(27^.]M8%I04/ EP"[5<*R>K,S$BK0GX:$( M;5AQQ:AV[A."!FFAY%F]?W$,J/S4:8CN3D5Q7;W%1TQ%1!+G5D$.R.X.QZIT M!DIA,>ETF%9F?9NYZ0^AK]!%I\F^'4&4.FC+=CK_V*> C]^L/G$_?C:D/&U-^O MQ:K_L88X3Z2T7B#R6@KVG6A)&9HADXO>>$UWM>@.X\_CD"L \F6!AFI:O)[A5*3AL.'BZ1A$T-.6VPI[[6Y=DUM5 M@1Y<*_W[/W';QC]-=[#!_2A95_0BJWJ@W99:]3:W @%5G- ^3&"J5_O@%+R^ M+!23_[).AZFD((V1\C)[^8[EQY10@A[2P M'"*KN@^3-H]]1"=2*0[Y-O'66SRE@[_6#IY)E'L=3%8%4GNTR704[>9T%@PUW%X>2CM 2@]A,;=!,[Q]IKW7 M%U+,RO@LE[#C0](;<63\-S$S@6NZ'T8"[.6!0. #$$US7!O0 L8::"] PF\V.HC!LIQ%A![;#B<>!O])AUCJ M,LIW3#9T06"P^H9(V-I:;F!/V%ANQ.S^-/HI-T4+'XP^ <5D?IV>@(=.$2N? MA+X=EU2N>%)3G'+AMA]A_FA5U W8CU=NS);*Z7S=ZM(H=QC@]\IY&Z0[[O): M^J^Q]?T::96H T=_?X9-/'DW[5 /A^^\D)L\(B^8,T1=UBT''&C;(#5T'^EC M]2*^'3E(>EW-5';[.%Z:6@XS"2Y!%WZT:GXP[C)P R+L#,F(O4D[;6@-<9EIMP 9P'UK,F&:FHH$D/(#&A>OZ[B+85WLQ# D&Y MLFP^D18-F1XVM88^M%FYP V*"FBDK6?Z!SWV9FV#LLEG2RY6'J(%V"^MK?1/RS+UW0=U.QG20U^"MS!= M89KYZNW>M6R#C"]GV<(M&[#*L$9E9L,?B&/.7YUM)96$;V8NA.V#-6^#SC-^ M#VG';(-RTJFV_0+ *EP?^>Z6?$T MA-8>R:&P_1\#E46+[5!V7C4.';P3N>K\XGX!?M"W^67SBP&XA88&AQ9DXKU; M>VV.4%<=Z.!MVXIW_*. =6] M-^U((.3I%BU\3G,8(C\=,\C@GZN,H@RTC"02*^':2TMY26?::_:WH9&(TYHK M?.TE&!32YW2ZA7RKB&&.I^_+\M-QU1J<@F9.81(WH':*VCG_XG# MP*'@W#<]&M]N8Z?;4Z]'.F0:@92&3B0T;I8)>48%L3$Y2_YD#=WU,NX-!-1K MG99.%TOG%-$PY]Y\7RQV93K,7ER[V5J7(IV'OC+"V&+@BX4L'_&-6/@3P;W, MRB",!J:'QCZMI1_ 663ST]YHWSK"7"QC;AR*\AI5\'1T1T19A0IJN@M\GDC# MCX@]>H-W+4&TW][ILOK!;EV15NSIWBR>9YQ&5)5)V<*>V6M)L)%B(I%5570D M'$#&^CPD.M]WG!%K+E3^&YWFV)F#.4]6(6*Z5^2Y-QS18S;W^V$NG*I:-CGK M"U+#4H>B+45PD?HIMD+R#0PV&HFC4\ZB'>[7A7C^?N'X);4!IRDV*E5&<-W.AE!SBV!OG*?G- MD_(9PHR"LQGY0>0+B/RG@^B4!; 6\+'W>_J4"1M?K"CU"*L11!ZN0FRF'LGK M"$HPG)I2._7(I%&5+.N(Q_'W\9VR92DNIQ:CM6"C.T-?KSF,4CRE6@[@M:=6 M$"LENP-#6'Y:FE"\N<8I,_/$/Z5B.^8GCLC A8XZ%')]@%+Z.FNVJ_SY#M>T MR?GTNOB>]1;^D=7XMA G=6;U[&QH^._?F"_J;VOT+K]34_#]5JBF723W;:4G MJ0^CO["A15,/&\@<\C?(F?)F76L-7EM$6OH'3Z[%@*[LQ>]K'>_$Q8!$K6@/ZVH C07NS'9+"@:$H;S>J^PY T QD,3V=PY]8A1-HBUX5 MOSRWK*$NEZDI;H#+!_T2P7NRR<;)M98BY7]6)"=?UY=R,R_+)"W^WGZ+'1?E MBZ#"N##N+2"4Q39AU:>.:V;BYL?"L(]*)US0J2"$J04%'8$V?G(!0Q"Z0S,+T&$LS\+'WDL($&<:!JRA%H%Z.L*,\?#[,O MH)DMWPK:,D3H:=2//IB$CS6\'3S[M/Y=_0OS_NZ% S7V$. ^W:K7:2T)Z.)# M6'(&1DGDLBC+**@O[ YK.GV55N<,7PNA$N,_2+:C;Z"E&IY]*.P^<.,4SJO# MJ3T>CX#YL]WR2"/547?\VDV2NJ(00T%G)(SO.?-&'@YW3CAE0G8/100?11M]"*E(ZUZ133+Z=GR M[&!)K/2"Y#MU8RK2JVZUM*A%HWYAU]0:-]+#X.JLIN22S3?TWA$2KFHC_F]3F\P3A,;*"@6($M72^12OSQR'' M=70],4IL#1!N-J*>K4-!_&[GF(9TSY*YIP1;6GN7P M[^,)3U-./LSM-5.'E=27J_._? FS[HJ;AT-N')@X!)$=(673^*+X_,=<655) MEKI)XXN&N'?%]5<\&T.B)0Y I1H>7Q_"2UR4[?#%)V7KWI]STQ]W M=D0S=H;)N0JW2K6$0Z#+V0A/DQ10BC"TTD=6:X\F M]]JP$G;S.BLG3.H>/'52YK :Q?OL$=)]*E0%RI&(C)'K42?+HSV-7&75W93@ M88:^]OPE\W O'[ZFNIKD(A]BX]'"#6LUHY-_/K.Q#OG[LER\B&9B)4&5:>\W MSN89<[QT0JOBK,6-,9FD%:LBD4Z'ZG\5A(%4[,'%7(DM+-G MRGF(0[Q)$=#(2_/9EV-R(\$]]G;T4=]DG(G@AXM[;T' 39PV%A\C0XJ-G$[F MD(/IY:.3WFSU<2_"PN&&.Z8:+Q"E3WJ,58T3TU /T\P'<1VN95P8P&/&UBQ@ MN,IW<=VH$32"1"<>:!B[2GQDVVQV\+A3M8"*>O03Q/5>Q)N[AR!CF/0I0S)[ M+U"[V2VRCY%U,X87K4O1ST9(/W\'[3O30?)F%JFFQ?FF&)_&5>!?/;S48:W= MF$+*K?Z("(&N/*M'^@WT4O:@4X:XKZ;HBI>0OLC1):G+QP[@SO/P)/EYX"9Y M*>UNK/94G^=H'T,JI[4 OF#_VH2JZ%%?'VV1?N[/LW;&^S(:7I?+")F##<"Z MT3B@L'- Y%$RB1S)<%41UM/J6Q?QJF@I:1&_01!:?.M]<2]QSXN%B&MRDRNT M]:=$L-I[]$=KUN5H#$-/5E@1W#>FC=PI72NC+\\WNU.ZO>BZ_,$[^C)"EIC7 M4:ZKR,IMT$7XU,.\(NEJ.,^(^V?A(H5:*ZD9L(A"GT(5_=(W86\/OVMRK!4U MKAG WY>'<=,$4@V'@C=U$O:OF(UP2G#,D'2L%M5E$K[^!R:H[O*,6:&K]OG! M%Y)@S ./BD4(A\P"9Y2\4^)TSE7N=6MC?5%]^7QR0019.8Q5<1%/O$E$>P8* M=,4)W3MR0%#'H_P^VJ*GE&)#);_6MIK?NO$J&'',BZ!4A)E&EQ8,I5#J.-%J-P4?F&H:G&V M.O3!XXB0YD2CHYXB*39I,[K[Y3+1\3U<)W94:O!S=!VEQ2=+77[V%&R^I:U8 MJR'U1.[-)]V_S\]WG#12O/QFC[9'.9+QHPWXP5/ M6W03O=93PN6M8\TI3B( M[#1"Y!M\UZ)D0_7)Q^_5_2YY2>/YW>,*5L@*VR E#4MIO;VV.[Z:*BHPBLC* MT58<3?/1*(2]S _>DFN[-7IPQ>14 _""EF1K+2FI\^^,DRZ3^LS,A^^ M(=P2DQE8 K5 Z>YA5C^P>?--,.BX$O7;N;P"\/>$ ,@)LOPV2%%\+"A)W0@( MI65$]-$V'2OJQ52DD[T;1S4'C=WC>!')Q\L%X:<$(9=!LG+[5.R=RIAA_JE^ M"O65VA^OU@KT*=?7/SP;/]R45I;YM_C>9RDZ.B*0#*Q.:ES-A1^'5"DPQC0P M:@,[__Z81*'S.MW:22:4VY-OCHV-UKT1Q_)FIQXO5T")// *$<<=-%&QOZ2% M);7>U@C.OTCU<5-V*LVO5L"^>-%>GR"JWMB,S[?7,',UU+/;[VY^+*YX)QX- MTANYGE3=SY%S!DI30*-QW'EUE/I R;@9;MSD./B:3GA#+$6D3'-&Z"\A]84 MB.4IUGJ7ONM8<)(Z@-D)^4'2 %TXF;@-4F&.>U56;K$M9 AGFYOC-+ VK AD M7X)S8+L<%DU@);'*!J!/H)VY9(6(,L89&*]7W2.[,77G,X8TQ7>9HT)8^LG3 MXCX>@B)VJ=-"IC"N,]=U ?H]@9YKV@5S(;,-TL_&35.F/)N&*J7(+V+V]!T* M:00?Q0H]:14Z\*\]EMHS%;FKD]J6AM/VD?H?UBPLT!5+P=*/^=[8K_.?ZCMH M;BIE)G+BPS,1%1.9+T\@B0N]W>YO\O]G\6B7>[_,G*7 M^[OYO\O]7>[_+!;M:MT%&N=N@\^1M4'K^ MQ6W0O:9M$/Z"*3U@YS.=Z57P.)F59) +"(O=R#\YR<;- #J:? ME_MPTX%KS6 I;8,*^G]<1KX-H@P\Q[QTP8RO7" M-/O'?9?H5?Z_Y9,VBI+^VR/ &\>7W #3_*Y6[B,=;@!F&P36C]X&[=OYSBZ MTV_ V+<-,MPB;(/^9 /',8,,3#]X&T1C#!I\JC)82#3([.1\(L^[$3$T4RS^\8=7R+]WLUIVA@SO7_5-7S7!\Q]KT=^Z-& MMD'/T)QX\GP@F7%\&\1BSXM]=1!;,Q7KG>7>=MOUQ*XG=CVQZXE=3^QZ8M<3 MNY[8]<2N)W8]\>M[@KP]]C62)^8VQR:J?R;_[J;KI<])@NEQD;-+P3PQNC8P MV?4DXK#HB6]F=\NF],>NW_7LD-HMMEMLM]A/76Q[\&O,[94/_O_E;UC^7R5F M^\-_ %!+ P04 " !&8'U8\+6(K?<" -$P #0 &5X7S4V.3(U-RYH M=&WM6&UOVC 0_EQ^Q0FI[2:1 EV1*@)(=&N[:+1C0#_LHQ,;8LVQ,^="RW[] M[/#64FA+6VVE0@*,SS[?W7./+[%K(4:B40L9H8W<3@TY"M;XVKMHP2GEJ'2M M.!;E=LQHQ)! $!*=,*SG4^P[Q_G&6"I)Q.KYOM(1080X$ADZA*=/HFX&%5A[W>JT.WQB"5PR:ZAHR(B MQ\("9.(")$SSO@N97L+_L"J42S&Z$!-*N1Q4H<0EE [*7+H0I#I1N@HD1>5: M#^*IV8CH 9=F*?J-6M+-,$S=R3XU1L/Z;#7%/^DGLKHCJJ1ZN"FY(-"<2 MJR M<84+A"LPA&;:S>#O7IUTO2]>L_,36EZW-\[ 72>7J+X:UK<= M=N=@_3N45B!SQQ$DOF#@*TV9KN=+IB@P(29;=-9/8A),^R_W^YI3#&VGM&OW MNBE>IK9I\\>V=&I@R#3R@(BI^Q&G5+"9]E%EUYVX[?@*445F1;-_$B4X!3WP M/Y0*8#\?,QMFZ?\)N2'CI2G"H/K03?V$4T[T:,9'ZUT1Z9H(E U\#R=X[24W M#M0N$F3@R4#I6&EB'VO+4#5MQB]#LZF_/@E^#;1*)74")>RSQX9W6#HJP.&G M8_-3J("0X3&,8EQ+.1RRQ,(L!+%*K8+.A1$BJ+ MPL$+Z?1"ZKP!3F10/#_]E4J6^:205LKF@:8;*GP"E38R$K0TT0F MIA)B-@)=IH<\8%M"O/_:T"'T1TI$ 5JMS]M,O^>MW_-F^WJ;;9OM[R%?E>R< M:>T!9^61Z]Z9=^UT/'ZLVT ;E \A$"1)ZOE6L]MSVLWS4^>D<]K\9B]G;HVV MS\]ZG059V'>TNKXOM"=):)]?7EW,K9D9]KYI26.\*-K[)_,RGUV#_0502P,$ M% @ 1F!]6$?HXB2. 0 &P0 T !E>%\U-CDR-3@N:'1MS51-3^,P M$#W37S'* 2Z$MG!!C1NI*W6+Q(>J;OD!3C))!ODCV .T_'KW\P;CRUJUBH5-&T00VH\*FM@;'QD9I3_2[E"*SQ1H\ MKU6[W7!<2DUJ/8*3)6GT<(WK%$0P'#2?0R*(@ M4XT&9.!L2";9Y&FVXEJZBLP(!LT*6CKCBF.IJ J@HZKF+R3W*CI^?+*<')35 M@0>UA:YL=GZ+KZ"5I=-531DQG%^<#44_2T5_PPI+D_;^UZ/"\L=:/#:9;Y)] M5P4];]4_VLC#.*%KSS8PWK^"= 52A3FKY=H0AK'S@7<^" U[:*H(O,O_%0OY M.J&]Y4-7OZMEL#L>3G:>_YK-E?1^'-U,_BSC^60VC7\MII/K=Z/;Z'SV>[DX MP.HR=O;E,YBC4C"?W=W?[K)]877K./QL;F/H1_LHO %02P,$% @ 1F!] M6#S;X0Y !P 82, T !E>%\U-CDR-3DN:'1M[5IM!Q_]5W/2^]$OT?QQ\_L&$LO;&]9MF$ODQXSJ*4 M6R?\1:WP2>.LUB];-<_$12TQ-N.^$0LO(B^-KK'(:"\TI+U0(D^-%A?:U/JO M>LURP=[$Q OF_$*%X=HW$IY)M3AG;\8R$XY=BSF[-1G7;^HLM-29$U8F71:D MG?Q%G+/6<>Z[+.=Q+/7T_%AJ=M22NDOKY,O),VZG4I^SX_R>!7$O[GV#*SE% MHY73U#\QY2.-7G\MC.]NJ%4V;N@&K]#(;V(7YIKTA_>IG$C/.JVC5J\YZ?>: M)(6?O/]J5QN52/;6Q-=ZXO+N,U;MJN%SQLVXE5S[CR\%X='/-/GV^O?L\N!ZS\0V[&UZ&MLYQF]UL9O_?!C^EPTNQ]33/CYNE]%ZWJ M7W571@0;'IE065 90-TKW_U93ONY M<%XF"V@RJK.[E*>"O>-38>.?,4$=/K74S7S*_?D^:+D__FH=E;KL\G?$4CX3 MS(J9%',1PYW2,:YUP14:/PSONX'VX.ENP+]K,E8BGHEZ&HXI#;*"M-CXD/XYDQ/6"%=K; M0L!([D4&FJ$ <>B&$$E$)^$1FBPS&5C>FU)N2T"+2#C'[8)$,OY%8-VU.1W: M8BB#)14E-%J#!")IHR*#F,9P:!(+R^:IC%+F"OJS&C\75E23D &9= II&DF5 MS:5/8:#+D=EI=9HWAVHFAIDS#(O99+'NAKT([/Y K/."O?XLQ@1+I$84"1"K MJ-4!,(BCVZ[U2UU68]C]^#]218PY@8RU$-6!*FG5@N4(+&&2L*K4"G15O-W& MTL U2D-,7">)0D$ 2 .YV+"<"_I$W*4L46;NEC"T8BJ=M_ 8^DB95R!<41ZUJ@2!+DUD8C1[-@!8AX+@*@,[/ > M!PD]%6P /KDM%"1:'=YHG;(#<1C&MDYC/.*I?)1E-E/+!1BQSAHH2Y"0,KNO ME*RO1(^'P=1-L$*$DN\_U[@_('X3 C8A22T&\C MJ$[Y,>*%VWT():J) !BJEN0"*KF$L788C('=>\K5/8;Q]$+<#R<<54$[J(@BR2AJ[P9PN.>*.1>_^NL MW?J^ZW;AXO+QZ=HNP!8#P:.NK" GIO#/:[!+MN /TH+*X^2WCRQLLBR\PTX4 MI2>@3Y"O#;E*39R!1#CHZ\=7-8>E)BEW#\4& M,5] NHA#2@C65W2]P''^BU#5J7]#OOX_.&1/<+T_(*[U3__ 8U6XP8N7**^O MZ(;8;QUU*^8A]+R@EM@J3J$4+\)['/>0N$,#)LLRZ;T0VZR.01.#HH!Z8@F= MPO #H!+TZ8B>\4NE\7+[B*^%A,IAPQ0ZO/IQA_\7ES0O E9UPBBO!9X@)1YCH!,/ MG/0$"*N:$L+ $TJ_>IFK';T4*C+X#SX.9E2<_^1%UI[PU5\P#[_D)#- NDTL M6**.N(M :4!.N ^N(%8O\Y?4,Z-F@I*8YM/J6MM6+"BR7)F%0.\\-27U\4< M!N">R.7.X#SZV[U>J_5_@*//68^SF'O>\!.E3'11:[?O6[6'IO*5^\GI M6>?D=-4Z([$:D_%%38FX[+UJ'[<[9ZU.Z^V_3]YV3MHG;\].SFK]C]QB4[?/ MZ@S])[TF__N]J*SU>T6_Z9I;[R5[S>+_^YZYUM]^-7J92I&PX;V("CK@L)NR M6OBSH_"'KO$-/CW8\.NCQ6(Y8Y'BSEW4/@SNQHU/@_?#QKO;X> G^AADK??3 M^ZOQ[49;FC2LF6\W1@*Y]]/[Z\\?5ZM!@KYB>>('6C3IJQ;@*WQ:\RM02P,$ M% @ 1F!]6)VC_ TO!P H2( T !E>%\U-CDR-C N:'1M[5IK<]NX M%?V\^148=29Q9B3K9:>N)6M&\0!$4T(, 0H&3UU_= MKN4VN[.SSA=)!"Z ^S@X]P)4/W&I&O03P:/!JY_Z3CHE!K],/GUDHT@ZD_>; M9=.KG]";"L=9F/#<"G=1*US<.*L-RE;-4W%1BTV>(A!.ADT;76&BT$QK2 M3BB1)4:+"VUJ@U?]9KED/S#1@EFW4'ZX=HV8IU(MSMF;B4R%9==BSFY-RO6; M.O,M=69%+N,>\])6_ENGK>DIH=MZ7NT3K9W(E[U^!*3M&8RVGB]DRYH='K;X5QO2VURL8MW> 5&OE=[,)2:W?.-,%3 M;7HE!#I%WF,KU[F>=_GEZ'8ROAI?#B?CFVOV^G3';O[Q8AFG)F4N079TJY'0$M0F$MSQZK/"P8_$[5$6$.1'S->?7@1>9JP7+$#)"&Z%0 MJ16T+*^AA.[5&9'VQ<#E9-G0&6RX=Q0T\%&X(#;@L%B7:7-]JG[$B\]6/;IQ$>\50^RC*WJ.4"C)AB#6YE M^$F9PU>*-U:*L1)9NHU"2% F?"%%0BDA0>PTK/O.*W?$WQZ.MI^%Q?1POL\( M3T.C3LDJY(4]? AEC4 @RM5*91XR18X)P! S:3WO0$IH/P]5>2O&6F>]7"CN M85,EHE7DZQ4C4J<$>T$7:Y2,N/.*!E9&$NXE V29+CT/:YJIL)3"_#:S/M]Y MEC)60"&WJ*Z)E;D%M*D.(\SR/%KB!XB6/)!* MN@4EU7W+TF[R4/,H*C?"ANA:'>?)_[XR*"OR#"BVO@@(0Y-'7@%?T4V%1FY7 M #-Z1$:[A$10K9: Q6Z2&>CW!V2?@&SX#,B.9EP5GI$HGB*.Z9YNADC8/175 MZ[^<==I_[=E#&+9\W%]D>81B(-C1EJ5<8 KWN :'Y #^("VH3HV?/A6P8%D! M^TTG2D] GQY-_@-D_QUDT7-XL8S?+@[H-%I55[YGJ\Q\!@]2?C9A6.04Y[5D MN#%?:JQ#"]WP818;8HIO!;(H)CW:$8X!4K#2EERE)LX=PA^;]>:5QMM2DX3; MAVJ!^,R#6D2>Z+WU%0DO<#C^*E1UAMZ2K_\?#GD2PG^>@K,V./T-CS+^#BM: MXK>^X@RBL'4\K>B#G\U\M>9OV):7&<^"3%76EX?L/43"(PRT MXH%']L"KJNX@#*2@"*N7J=32"YDBA:O@8V]&Q=-[+WQ^I,GO?'P8(AO&.;9Z M'2$6GI< $G_Y6:&I7J87J6=&S03E&,VGU1UN7E&92#-E%@*]\\24_,4WL IL M[4FW#[7=P3@\?AED41O\#.^?LSYG.+KSA@N4,N%%K=.Y;]<>FLK7W2>G9]V3 MTU7KC,1J3$87-26BLO>JT^ITS]K=]KN_G;SKGG0Z[UJML]K@$\^QJ3MG=8;^ MDWZ3OXB7A+]7"/O%H&F;6R_Q^LWB]WVU_(ARVZ\6+Q,I8G;UL.-NRHIDKZK? MX<7]EC8;08ODC(6*6WM1^SB\FS0^#S^,&N]O1\-?Z:\4:[V?/UQ-;K?:DKB1 MF_EN8RB0/3]_N/[R:;4:).@_('N^H$63_A."4/F_IOP'4$L#!!0 ( $9@ M?5A?'\BB-@4 *T: - 97A?-38Y,C8Q+FAT;>U946_:2!!^3G[%R%73 M1#)@&T@)!B1"28J:A @YQL==X>_;:72])N%]_L[8A0*"M[BJ..X47R[.S MLS.SWS>SBUN!C,).*Z#$ZQP?M223(>U\=FYOH.\Q&8M6)1?A6$0E 3<@(J6R MK6H+6E(DR#FM,UCK7/9 LEHV(F#*.RLDS M9-,E?98E$K(I"@6;!G++$G_35\R7FKDUX@\;!C[\($ZT->GTGP,V81*J5MEL M52:=5D5IX2/I'/]LC"'U#S;$$SY)$WM'5#_KX:[@'HE@A,LF< 7<<#TK+N*6 M"AM>4B?M+.6]_L@97 UZ76]<XX:L0S#RG=N=W"O\F:_!)3%LQ9.$4WA>.[W M(H][3.#762J9/]_,X("KJL#S"@%/3 8@ PI=SFS/M,T"C5^@-NEGZ@EZ*S/J<$@&4 M>]2#%@&/2%*2DS",W;9F7CR;VE*4%[):O5&MU5ZDCVW-LC1@7EL+J9>/7EF& M56V85?/\HG9>K9D7#=.TM,XGZM)H0@5431V42JM".CJ0%'R&,Z] )&?32& MQB7#H:'O,Q>]P80J8T6R=,#"&,W!)0EQF9PK]]*9&^B(>J$V38<$Z^4,]Q9D M#&8CA\]#>5SNE97G:E=RF5FM&UEXQ(L3B0&N3BPT09&@\&!,Q(1PFI:&SR&= M0]?--EN10,=QDDU3>A.:9B/HY1\\?L+436ESCQR19!*B%['PJ&AK!K8R&H9% M8UF^IRI]Q7OATA/S9*!(8KPOZ, 0=HHC6'M5XSDZ/L(V*Q;ZCRKA+@D7K$&4 M9UI*R=LP6CU?\U-ZW]?+!K=S_4>%>)/N/\S=J7F6)4XMN=NQ1?/=HV,.8FFE M'LS"$&&/+ @5\99D%/3;C D:X4:E"G4+X)K54X(E18!9/_7.?4K$/!HX^-2)G^V(C1]IFMRL!F#O$I%&3PJ59\ M _]A@M\Z'/"O=.!% W[%!\;SD[I"N#JA$\81F=@2Y#I9"!/(ED305/$B:QHD M#+&?8V=FV)1Q($&BI'HVT6><<%?)T2;>'91UU=E0:Q;FM,(.+K)ETXV&5#X0 MX!\RN=;Y9,,JV?[A*7O!RR5R,P"IPXXOU]=?O3)H\%CH(6^UW)^V5C?>;X+\ MU>WC%]XU-DYSEK7C-%?_[FFNOGF::S2LBW.M9G!7F;3J_M,1ZQ!$G:6OY<[OGE-N$=T;V Q,=3>.0 M>3LBK.\5 K_PNEE)*VLWSG% L$A=DBD5WE>D]]9$;DN!:?U74_#ZQOVZ+*_5 MB@,H OL*?V>\>^7T 82[5X*_D?"-A&\D_)=)N../I3Z7+D?][A?U^61E]/[ZRAEMR *_).*GUT)UMX'[Z[N'VY?54$-] M$=KR0"\JZ@L1ICW[3/474$L#!!0 ( $9@?5CF7D,\+@4 %L; - M97A?-38Y,C8R+FAT;>U9;7/:1A#^'/^*'67LV#,")/$2C( 93'#")#8>D*?M MQT,Z6==*)^5TV)!?WSU)@,$09UK7<5OS1:.]O=O79WG@#:Y&5!)P R)2*CO:3/JEIM;-J9Q$M*/YL8B( M+'E44E>RF&O@QEQ2CMR2AC0)8DX[/-:Z!^U*+K(]C;T%I'(19MNY+/DD8N&B M!4=?9[&T'1;1%"[I'8SCB/"ZSZ40WW&7=+!"-]R\&D-/KUR^ W MZ/4=M6(91A&Y_<8]\)N]-BBS9\.O,;"FA/Q-)4 M.>>^F2N;EH;J,-3AES)<$(EL=[AOKD,_8-2'<\8)=QFZ;>3[S$5ET)_JK,)7 M.F)&J'#H@$4X6H!+$N(RN5!JIC,WT"'!DCS#T(*,P6SFV7-=GI3[9:6X"DI. M,ZMU([..>'$BT;[[&PM.4#@K-)@0,26$ZPH LSZL7>2YWF">UV5'?HJI]=(7J&X2&SSM%K+ MMT5Y]3DVZU#@Z'TS4D>_;\9X]HFMJL"V#_$I5,K@4TE\3?Z7F?S6"TY^QO/) M7Z6SFO@)XYB&6/;E)C(($PB-1-!4@2!K#"0,L:%C%U:=!!<21$6J9QO]58?! M,_$VHDY770RY9F&.(>S6(A.;;G6?\@O)\I>,I$WPV' ?67]S:E^"<)6F&?C4 M8./+3?GWKR :W!9\"%(MUZ>CU8W#[8Q^<)MYPKO+UN1F67LFM_IW)[?Z]N16 MJS4,0^M>$.$&8#6SL:VFQK;OH7K;0[L=5#W<6;(V7([CC2!)1\N?JQ"&MD/S#1KVD<,F^/P/JS1N0);Y.5M+)QH=P<;7>&8I<#3.O? MZH"'U^F'-7(#N"\ D<]E_EY[J_\S@W_OC=$N:Q6W!#DJ8=[4MOXI2N>A\'I;/QH/=9?>JYMWKU\=P9;]$" MOR3BNX=$=6^"JX^7UQ=K:* 6%?4U"_,H^ZCV)U!+ P04 " !& M8'U8';^IU> 3 #0 P$ $0 &EN:7,M,C R,S$R,S$N>'-D[5U;<]NXDG[? MJOT/7+_LV:IA;-EQ)DXE<\KQ98ZK[-AK:W;./IV"2$C"#D5H -*VYM=O R I M4@(ID )C*F+5U$0&&NAN](=&X\K/?W^=!,Z1R>?!H.'.^>WX85S?'3\WCTZ<8\_NNXOGU^Y_XE[4SQ# M#D@0\D^0\.5@&D7S3X>'+R\O[UY.WE$V.3P^.AH<_O/N]DG2'B3$'HW#B"VR M J\C%KSCV'LWH<^'2284/3[)"L2,@5YE)9+<0A$?$STU9!0)(^9&BSGF!?EE M$:$!9!^*;%'FR#T:N,>#M"3V?#T+R"BPP*_>M(02<@JD)"1+04@8$4Z)_\ZC M,TDU@/]2RH"$?^A%AD8_.139(\1Q2AXBXG&]$#*K( 4GGIX4,HJ$+,H(QXB/ M)'](7"5::>$\J(QB@.0 M)@[_C%% Q@3[T-D#/,-A5"#(94>(37#T# 7'D5V;S.:414ZX M5K!*,^4/;JF'(NF-2HN(O]RTG"N2W,&Q>S)X!ZP/#@VD*$6O3@1>7D#]=,7/ M9KR+OLJ(>[Y(^L<6$N0O9IP^9>NGFS M]D[IY:_F^&K0Y.LH:]#>):/6%D87*?5DV!SUE(FSJ:3\FS?TL,78SLS%YLMD M?VWC9+-XSLS')N3BQQ8V@.YS=LAH@ ]#/!%1NED/#!@KE!+=\$P,L(,/JW*@ M,*21K$JFI:GS.0G'-$F"1!&-?$KCR4<\=F1\\@DQ3_"ICF(.YXS.,8L(=*M< M2"HKF#(\_G(@(EXWC4'^%:#1.PB14I(U!L5(0NH)17!PNQ0O+2M0]^6 0V,' M.-'ZNZOCH:"N.E#$BP-IE8XJY>-Q7:6@"-3189WF#-?5"8IPB+T;64I4, 0" MA\ 4$@+A2(;QKD^]6/Z Z;H+_Y)HX8J^R&:2RX$CROWV>%,=R"OQS&O-9$NE M6UI+35=,IIF_'!T=.:YSF?#*_SP/?>=*LG5NEFP_'Z[P6A,CYMB_#W^1OU=Z M15(XH:@J6$2>>;E5Z^I+)JFI.,(V_"( M>G],:>!CQEW\9PP#HE4 E/&P!83W1D 0.'C*2?&?SI44HT>$IKMZB$_=<4!? M6G %N;IM(>#4W!5< '?G6G#?7\/#[!J[ ]?'W&-D+A@(NXQB3D+,N0S'.9F$ M9 R#I0C//;D>3,*).X=6]6#NTA 5%AC;@G[4Q% 7!+N!93'#,,?WT \ M1\23ETL!!6:^)@(Z(*#SM!30.<\$=!X2 ?<<5<=+:X(+\*6$TJX! 6_K-Q]: M3&NWB(\3+3X$:C) 7*122&C*\%@8#&0RJ%$GYT'((/OP M52K#GMO^@SN'OX4_%9:AT10SZ(H1"B=D%&#E>K?JV68,+.+@9RT.!#H>E"#2 M_O="$/ !J2#*O>^[)_A91%S/8N="V,;'(\B!1E2V$Q1BG6^!(',;2-3@8A$7 M'[6X^%E-)%-I8%*02B-A(F@X $=*L^?@^.@&&)K3I:. 3+9:0BRMSJ*YS[3F M%B"X%6R=^R7;/;?KFQAZL.1%E,":4\YH=,UQY^$)9M% MV>B[E?&K:[9H>OTJX4 @0JT+/682Y"*+?3?\B3M&A+G/*(BQ.X.P*U9-M%V/ M+Z_5HL'U*X(#@8-KX.[\C^#NW.6X[[NQWT,O?,8AV(1ACTZ4C%L96E^C12/K M%P<'PO:/BC/\FW'>=P.?NAQ/Y-_;GPJLJM&B@?5K@@.YDZPX]X<"E^;XX/)X MQ&'*)9($_K=TU+KZ+!I7O] W$#9_RO@Z5\_[[9PW;+5ON]EO7+U%PZ^MY&W8 MK7?^EO[:XR.!VY_*@.GS*'C#4R$I?XM(TB\2;GDXQ/G;4 JZ[V#;L/>W/9K, M&-B#R\_Z];^-6XP](&IL!5K 12T^%N&A7PTTW'GL05)W<] "4NHSLP@7_7)B MG0W)'C.E6XD6P%%1JT44Z%<6M?N4O;E;VB.T );69+((-?V:9CO;ESU6M9N/ M-N90^AHMXJ1D671U5[,WL\"%U$TM-,AU MB40WYWZI6]\)C"].VXPV&G"S"#[]XKG)M>T^;JBZ>VL3(=456P2#?@U]Y9)O M;_=ZV^<6@5"3DT5DZ)>\#7;L>ZS4L6 ^'#$Q=8M@JBV*1;3I%\XWHZT8\Y@A M<]\1:7;(PZ(3:\;0(KKTJ_+&QTMZC]; G'EO4FKL]E%E)H9%K&WUB,**/RO' M8H_!NL8?Q^(HD(MFE$7D+[4/@%_G..3X;=!H(I!%7.IW*)KA\EJ*[ISG1'>N ME.@]0NL?D+,XU&[!U2+6]+L6]<[G]8-N4\/FG4Q PTF$V4R4B.3'FUBL[GM; M\'FMR60/BF?ZS89:4"SZOEN0WA7BBT)B5S<3OW=]+>/"SE/LWU5$BTC6;QJT MC.3^97@KN)DAH"+BJR;K*'H[1VPBE44 6SBU7P3P72:_!LZ],RX_BZ]2/,JM MH,^0@T4DU3GYGZ9=@"P]*"I,IIF;SD#X63Q+B,&%6 L=[0A@$5+Z[8XR2&DF MPW=*U(3\(1&U1UQKMSPLSIK;%\XB4O5;)6W=1>FGX2TCI7 <3R6ZR(O(<^X8 M2+>P;22Q1<#K=V]: OS*,4*5[)PGZO7NO#54J<2.0[],2(MHU^\?M89VE=P# MO'V @\ 1(UZ44<6@-^\XX$V%MM@!]!M5K76 QTS#Y*SL;T+#OD-LNHYK\_;- MAJHM@JOD/LWZ!=T^[JTT43X&Q.,Q%KT%YTAI1+GB)Q'D%A>$EU*W#LA _/[Z7 FS)Z&;Z5;'0WK\K*(I*;OM/?C M9;V')_).HXK.YN2@+9$LPJ_96_$K?JV*LH_JC9^$M^K2S+E81%/]A^A[-V;V M;HI-:)AQL B+>D_7]Y P-!CA:#)A.!DE8!!)J6P,74UY6H1-R>)^9!-+P?+^<1UY3)8S[0W'/*42#.EH$3"M$,?SFH58($@=BY^'(0 ML1@?. (P$8EB4>171N/YEP-A<_*) +(.G B42E-F- 03LL4-Y AE#QR5/D(! M"CT@\_&(1&GJ'#-"_:$L[\=,?2[FL$IO,8M*/^%^$T98[ 1E*I9D-M'&CY@K M?G$AHP5$3#O^G'H$.ZO].HJFX'AQB_Q*K M#3$N+(3$-UR@E&V< M"'?/'L6S<-#/F49C#<%GGMZV$"L^V0U:(./!&07[W.B2K- M]9J44+Z5/N7C$X5X,GI@U(^]M?%)G]>-\4F^TB@/GN7>:,P]T;A48C-AFU:I M",9SRH32.D/,9DNY"VG-14R;LP7H* G%U Z"_$LJQCWX<0,=P%?G;^['"D-# MQ"9X'5Z-RWTVUIJ)P;8[(BE.@DW1*_B?&7Q>.572H6C@;Q+ N0, MAQ[FYS/QP'*JW/;5=&VEM]2Z5[-Y0!<8R\Z5+O(*RQ;-O9FL&_:78LK>-6%8 M9B8W=>7D[R&9M!6U,B%O?[+89/US=0F3 R O"0/L4K8R*)N1=L*(UR042)>+ MT\D[8ZD6^JR=Z6S704S!1V/]S*4TMQ-6 5?(Y'8!5O_>A-]PI/SC+>79A'(S M68O6 I:^O=V%6YAJW82 M0OAU!??\,L=?B4>+5IM(U4GK'>+.<R]&-*O M^ $1/WE392$_4"0VA[\&X-\SU6H6VD[3**W)DK+W4 Z)0\O26PA_E_<>O$3; M&J4ZHR[XGMIN%+&9/GAL1C/2E^SL>0\K\8L6L:+[N3 >'.>) [ M]'^4Y>\Q%EU'>78G)S??:/AGC (R)MA/KE<6]:DBZ*A&$1Y2U<$)"I[2(SW) M<9EA>BPH5<^0NG-3./FL5O*JUC5E:?R>KF7=AWC5D,;TG;5KA?S#%UI+WSQ] M=_7509,7-"RCZ"9>M=*>)T4VZY6C[)Y^S$M&:+5XO/ED4JT2W<1H[ 4PA-_! M^.J53H$V$74BEE8?E[L?IVLB_!\PC_:7*I3D-D*T0FZRTG',L3I;*6LCWB,6:!?A=C*) MSM1J6KIK*R/+]A OS^0.G'\H,Z)9DW1H.!;'E3- M-$[$N1\/:82"Y')(UOE*6@\6#3]D9#)9]L1:)=YT=76S MDL,IPUQ,T89BCS><7*(%WZAG2:%6G6F3.2HHD+RT"9&%?J^GFJ23T482.4"Q M[(M0JSJ5$W12H_^NG'J7YG92ET<Y4-L(/:%9)%S<99D(DF_+I8DR7.]YR^(^=G "[)RL0:0 MJFNUQDY$(.HX!>=&'5IX>N[Q0W*==*A#:?X^.CHP_IY M!EU&=S48G$"X,B.<4[80*UX:74I).JS5*/FRU51M)A MK@8?,\%N*/<.Y.LI,HI_ [/5D6E?;!8)+=LV0L9DAUK5UL.RFQK6&I\? MHVWKOQV]10,W8+:[K6S:T\N*[9#F;;VUNJGI6N/[P[2]*0@-:]FA=FG\2N*F MIFI>\H7:P]T#BIC:SR&GGV]<49QM*[TX[G+IS1J%Z&(3F@8SJ M(>S$Z2YX 065A*9HL\_OAVEK0^R9UK([[?+!GL;'=:J>%7 M[(O?K1?''IA\3<$PHS.P^]H3'6Y?CA;3-3MR7%NN%:"[7< M-\Q8_Y 6,'3C36KT*#?4Y)]MH_Q)Z6_N[W,)=MG^Q5.*ZC$ M+AC/4*Q]MISAR-(BXYUH_4TG1=(?50U9HX[OUB;J S*BG\P0_/G_4$L#!!0 M ( $9@?5@SV.D @0X )K> 5 :6YI&UL M[5UM;]LX$OY^P/T'G^^SZKQLNVW1[,)-TB* \X(DO=W[M) EVN:M+/I(R4GV MUQ\IR8X3B]10DJEQ<$#1UA))S3,DYX4<#K_\^CB/>DO"!67Q2?_PW4&_1^* MA32>GO1_W'G#N].+BWY/)'X<^A&+R4D_9OU??_G[W[[\P_.^DYAP/R%A;_S4 MNY^E<4CX&9N3WN]?;T<]KW=P_/GP\.:R]^/^M'=T=*?),3P='!P?'@U7I?E%?/GT:9&_7104M*R@;/1S\?CFZ"V9D[GLT5AP) M%"V"?A;9PQ$+_"1C8R6$GK:$^N6MBGGJD7=XY!T?OGL485]RO=?+6<=91&[) MI*?^_7%[L?XFC1,J& W?!6PN6SPZ/I1_!JK40%*>PO.%H0G M3]XB\N53V<,>^6]*%UD9A2E,(^*QB;E@2!*?1D)R(B-LQLGDI$]C*KS5YQ7M M_W3S]>1I(4>HH/-%1/J##7X%?A2D4=8_(_F[**[X@H=U.?'D,2%R'A6]O:(_ M8L$+!BN:Q6K43WPQSH90*KRI[R\RZ@$+_RI[?%#AN% SY[GP%8D5\Y(])=-+?5?,Y;R(U MQ1@O>G9GO-%2\YTS(32(895PX+@BNGZ#5#%AV)AG0Q[T&)<:X:0OMIF/RAGP>O)B!V^*P*#$0Z7R>->I1.1%7]2>HI)B$$L.GUF" MAB,V0_@9YY=!F81M55=]\!;R=YR(3("R9$:X5,%2 T_I6,I97P@BWVW*W>VW M]?34#K[L1D?MC'!'^NF;[)J$C.B2A!=KPH8971L3=W.":B1:_8:\\ J(=4]0.)9>\,2DYYI%?W^Z9I)FJ1" M!JSZQQH" DVT0>MY3NIPDA#^;^+S;[)"#94$;!&+/"^A]TKVR_T#B9;DDL7) MK(;FLF@4,1]:'01[U/\9J2SE[>'>: PY[GOYY?8Z_$5KV)$_L/9P/[>%!76G M=NM^&&YVJNO-VJ]@X0WEP-%;X<"6&(=RX/B-<*!$GD-9\--;8<%KT0YEP/LW MP "S$>O4R_W9"UB\)))"Y8V%9"S?2.\K]]94"2']MR=?O=STT20+4TX3*E_+ M7Q&+IU+ SU7]NAN!NR?$C;_K"@?,Z=UFNWKRQZAH_TPV?YE_^>E91V_;[':5 MG-IJBJK[@BJ-9596I#,:+]<=?4OD0% #1UQ/;CB- [KPHXL8Z#:WTB9>+E0X MCXW:PHW:Y#HV:PPY;JWCV*0IG/Y6J41B[?8S)L>J?;QUS4<73E2K:*&V8O>> MDPYV'>,!DSO4^N UP=VMR2]-4\$B&JHM16_].#,Y U_,O$G$'BP,=ZOF=FY^ MUZ"FD1$]# *>!0A=3Z['$9UF"+XQ/B*^(&=4+)CPHU,FDM5631PV247NJ=X03EE(@UOIE 2*FHM8DI@'VFZ1WZPEIY;(FM.% M]ZV/5"PMYI364SE0AW&H_E%!5TL_4D-XF)SZG#]);O_+CU(= *NZSE&](NN6 MB(330$[5@NR7#S9*&M V;G-_N)!/J=4\.B/YO_)WE*H8_?/'8.;'4W(KI=[Y M9$("G2_<#1%.^0P)XM1PQZ:JZQTI=,2$ MN([OY(!2=M%&G&E5)+E=9:>XMF>$5"8L53,F7^I30TBJEY2$(^J/:919B!J< MS1I#@ON6!$1*#4FM->S8,I)G B>T9-OL&7)_N"@@)Q3?.YA="I,KHNYZTQ50/>VMKF9CVGYH- \C( MQ[3MU RM>=47TS94@P%>=Z\!4TQ>V[+-Z)U#@7_ +]7K+)M!X?^\A_UNOY@& MY<9']-RP7]Z&8O^$?R)8+&N![1H7L4+-4!O<;S#*PWWL7/M%/2@_NC3E32M; MK/F*Q1X8]% .U%T$V(=18%J_9;8K!S7Z'"M@BQW//?#7@* ME_%JC.^= >\H M&($U$C+H!"5:+E9N4V":A&BY6+E9]V9F=+D.@ZP@OYGI6,:"&G%]3H\0'GHA M$0&GBXPQ;.*-4T%C(O(C;X).8SJA09;U,O>])@D4T4*?=-@_!Y7U#0L]? M2LDQ)5Z$JU="K4K63=[6(85N#AUV#M!1"IY,PBK8:KDR,W RFH:)G$WC M-%'&[3T[SR4 M'[\5XW:8#]NK;-1>3\YHE,JG.8;K-,GR5\O!KP%?LQ4,2+>(D]U# SN^*-Q:"<1_2/+S,0Z"2W?,T/U3E-,D#F S4 M*1XL43@RJ;*%0>E>C)@?5T0BF8JZC3NLCIKJ/%)JDX!38Y"4H21.E6LI)2:/K>,Y2I.HSJ5(GJ?SHO!J.Z"F]&[UFVY$]0Y(=I=M M=KV7L0I->%KM99QICZ% JW5V>JV,*&"N7/LV4*&$Y\.MU0PJK T[$W4_5N>U MM:J.#EM%[EJ[^OC0F?+3VM1VFTV)"$'(RT!E"ZU@6QTE-HB6:-062M30=' - MFT.)O:7.WHM^KDIX5[,9M%B-:>[JMH,7K3ZY7;U6<*X,6.L9UJKHQK2>X((5 M^/.).^,"ZISBKKB /*^X,S9@SBWN@@GMY(QT=/$$;+E*$^7;OE1T=,_$;E#7 MEH*.[I;8">H&4L_1A1*[@5U7RCFZ0J)UT.U(-4?W1[2.'F3VNHCV//!H=J#, M2_S'5\Q$,HEZM;O93>^+1\]'*NA&<[7[5453F+HAVM/VT.C=W[S_F9^4V MCL?J[\ "UG*<#O(531;DHZ'YV>9C0F2!WQ/&'WP>ZM8#:[30+4(5Q9[+ZBAB M#TH40I'I:W:%:&/4VR8OJMD*TH0TQ@G%&O0I)FN^-DCHE$1U)!4JXLN!VX]I MU#UMA5VC4EQ9;X;T^"P?B+( W"RS:J[+W/\Z:AP94BJMSO7D.V.ABBZ[(WQ) M R+N6!1J-$!U!;I+"&A"I,2B>+FDIB3Z0-KN46B+I274F="M2FF MMTLX/M0C?3PB$C-O-:4<4ZH.2*LYEF<76=&D)=E&DFXI5LEW;(<( MK)+K/*A$&F[J7/8969*(99:K&0:HCF,46>X[E3GDE,5210?);S29G:8BD?SE MYX]%_@)END3+VHZC\251RBO3 M+>2]?M_-2DT5F?J"CN]*D=VI+K6NHE=?$-<)A4HYH@G% @]S#/JU+LA6#%HW MYTM>#S(&'XH8>@@$I$H&8++!2X' E'8G&]]C/U)4>6)&-A+ 6VYWES?B=I/; M1$,CF^S47]#$C^A?)-R^'V8[=LZJCE,=!KGIH_(&LWJ-=(G3G&S(7+@3NI]O M%U,9D$'4FZJXQO!J,%0",)=W2WT84B655))\&E[$Q336T6XN[99R98S=DH3F M*?F>;[4"S&B+JNXQZ39P.[R%./]TQ;@N*],!E;#>[[JGK3)ZOPX/L\\&[@K5 M\Y431@":8HYIW=[@7)^Z,0]UFZK=9[\Q8X%4Z1Y#Y:0&UL*RTF:_NM85 NGW MC>A2W4*1^/%4I3NM.D(#J^0V[I.Q\(%&.K/F]6OG<93J"KHG/4?+BKA=6=V^ M&/'UVJKNZD3W%*I@'*5:9BP*"1=*129/U60;JW6%Q2R[D?@0-LXT'I]YQ.*I M6BH\(^,*E]-0LA.* ;F/344[W/4 VB2P2AAP5(YW<+T.TPU7W4]REX_^0(+EGEWX/,&V35L* M[VQ@RFU4":O1W858YE:)Y&*U-C[Q3:QR:/;F!;ZY9D;6[K6B[J::&97-XANF M;&$0;.7+=)BR?D%06/A14&@?D$ #+U_C$_"E"GF?[",]@*:BS4E4GWXE\Z6% M! F=P-0Y8&"5(3F8]"L,5>6Z*2;E"H,$WRW%I%QAV&Q673$I71@Z^SU[I/+1 MK(*K%_Z12D"5.+"3>;6$#J6NA53USK8 M$JG@+16W^VF*5D#9AXXQK-&_T/JF2$-,O0/#8[O/A$GWP1""0LPQ#41P"%'Y M7,,[(NL J]HY QSX*EZHO\92*S"8P M)"<( !4 !I;FES+3(P,C,Q,C,Q7V1E9BYX;6SMO6MSY#;2)OK]1)S_X./] M3-O==OLR,;,;NO:K6+5*KZ2V=\Z7"8I$57',(LH@J5;-KU^ K+L(, &"8+(: M$0ZWJ@H \P$3B;PA\??_];I(OWDA+$]H]H]OWWWWP[??D"RB<9+-_O'MY\?@ M[/'BYN;;;_(BS.(PI1GYQ[<9_?9__<__]__Y^_\7!!])1EA8D/B;Y]4W3_,R MBPF[I ORS?\Y?[C])OCFAQ__]N[=_:=O/C]=?//^A_<_!3_\&+S_-0C^Y]_3 M)/OS;^)_SV%.ON%$9'GU\1_?SHMB^;?OO__RY_QL6VPW[C#]_7/VZ;OAGZRX]5VW>__?;;]]6OVZ9YTM20#_KN^__S MZ?8QFI-%&"29F)%(T)(G?\NK+V]I%!;5-+9"^$;:0GP*-LT"\57P[GWPX[OO M7O/X6S[KWWQ33UW((D93\D"FWZS__/QP\W8NDJSX/DX6WZ_;?!^F*2>Y&F'. MR%1*ZF8"!04?Q+/_QU[/8K7D;) GBV5*OOV^.U$Q781)%BS(XIDP0_(:Q[!. M:+(@F5@I0?TX4UHEP]@F=\['8U'Y3(+M$PTI5HS4XQR3:5BF1?=)/AQ'2O"& MVF-2.85)3I/XNX@N^+/>__B.__=]12P7 @7ASRF"C!8D>/%8G_\6W!RNUPZ\W)4)69,KH 32XU6 W\R2[Q2527&J)* M^- V$>X6B$*CD;RN0_ZB %$+1/3.^JLYW(N,WDWSAM85T?I+FA6R:)R1)320['JZI=:D#D >VP!>T __W[!GW2KIK\/@CSG!0!(T7" MZA_HIS)OCH8 5:J]0 M>X7:*]1>H?8*]3XV\]W4I6;]:Y 2$3?::9W;%P54IQ4C.-&A6Y_O%>=35IS? M\J?XAH_,EQ^9+$6PF5NSMX)%\K,LODXR$86M/\L4X@XC>'W8Z\->'_;ZL->' MO3[L]6&!K?-FZE(=_C%8EBR::"I'<,'=*(LZY+C M=>=3UIWM.)W/HK_*)*\8%.1A5K7WZK-7G[WZ[-5GKSY[]=FKSV_U;IR-E M.:916?TAU$=2<9E9 C-PH+Z58RTR>E&*S_CC8T'"=1K.&M2]QM][5$#/RCCA M@UXG;'$3-]'3]'O_]&R.S,@I.F[1/TUWX>)8EY'\VB,M%V(+8"2\H'$3,4T_ M]TE-R9C@52[CPO2?)&1767S)%UL392U->Z3RVURB994Q=4\D>H M*-O[N71VE+5S3>4ZXFI_]_ MLI1H%NV-75%:F7\3=L_H2U*?M%;2*FG>.[47?%&P,+WA)L3K_R8K*9F2=OW3 M1Q<+RK4';EL^SD,^4Y.RJ$[S)UF3Q@'OU#_EM2JY/<,@WG#C=@YICB/D@(L: MAP&0^K%7"\)F_-5\9/1+,>=,M@PS^8I1MNZ=UNLD)7?EOL/G#8%OFSBABEUP M23>C3#YSC:UZI^TFBRCCBZ]2_BIQ?$%++O16RJT&U,L![041OKKDA7"M,%S+ M$@71JN:]4WM?/J=)=)W24$YB0YO>Z7H@LT3X/+-"XD11->N=NLV):Q&*+>U[I_=WFG+Q$;): M",IG4]*N=_K^X/SUOS.N^3^2,*<9B6_RO%3,9TO['NF]B:9L[?4\*PHBW.MR M3U5[XY-*KP#01(4#;,[?F'3!R)KT2-4CB4K&)^'=^]E34C1ZV3=Y4SX%ML*^6ZGA+';]&>9!;%Q[ XP'$]AXI-I4*"X3V(SIHBJ T M$--/Z##!XI% >!_0P0/&VX#X?D:.3Q*I Z+[!2VZMT$5(*1?T4*21]>!T'Y# M"TT1/X3NV/WGI1FSHC+R",6'5261>6RAN+"J(QI.5"A4?.J)AG\)"A*?O@(, M9D,!XM-80'%P*#Q\"@L\)@W%B$]M@>8(0!'BTV+D^9503/C4%[6W$6J/X]-< MU/Y**"ZL&@O(_0\%B55]4<9BH."P*BR0O!0H1JSZ"B0>#L6(5651)%5 H6%5 M5Q2192@TK%H*((D("A&?F@(-ND(1XE-:= ] 0'WO^-28MO03*#*LBHPT'PD* M#*OR L^5A2+%I\E(#[]!(>%37)3G"Z&P\.DJBH.<.U"]'B:.:);3-(G%M7#! MDR(-E*/3".2D2;HMJE*;4'[/O(\:F%/D2/ -EH(^C!,_>9G(? ML@FK/(CQ[V%:DGO"JOWEB'*#GD,AJK?'L[*84Y;\AQR?0]?H,2R"R@4#IOZP M];"4R\_^Z'3Q19%.K"C25Y-AZ8L&C2^WTGG1H/XM:#U(VCL[U-V#%Z=ZWX=: M9]CQ-6D&0&S]V],=L0&<( XN&N,"+X]8LA2C!W0:/*]]W%5AJ#R99546B2@4 M%44B8893&RRY616,<'67==AB,KT*6<9Y+=_L:N>KY@$:$#M\(H(9%'[81H[4[78* M6*RM.N.2R??CK849OJ)K=V%!Y6M$CY$3)EMRN:>.-YI9#4MP^V[*VXZ)Z4"YY)(SO(1?W?#3" MF&!?+M64\@_0PWNUW7NU[=/)=^AB=4ZS6,T.DF:#>>#]M03CB#"H@;BT0JFI MM8=QPN2*'M70KM BDZ@IQ]C4FL'H0FE +=[Q6VN7M"H^.[[" 6C%HPH:=EUT M_5P],BQ[J@P)G PJ%184JN;@94I#>=F),2U%0RTRIC-?-CH&!RLT>[,%]'"A M9'ID^B(& =\3EX#] &YS#'SBDK_M[(1O.^L8%7*9,O)^EPW!&2.N'E+E1:3) M7R47-\7V6!8P+P0^H)/D#UUR?(;'*6=XO.7>ZG[ORK3-^?]IE(A:%,"':K\,H2?G3&UVMW0>R .2.1;=)Q#W<9LLP%F:SBI:<*P!WE).S_::J/!=6Y[IS=?J, MV2BGCW30F.SXJZSM_+](&G,A^ABF9,)X$^%NBB?3\Y7X M1OGV.H_G&CTG)4P_,EHN+](PS[<5]A19&,!>6) H\QS _4X#S=#28D==?I,) M3Q/Y1G)T77H&X-DK#=+<_Y.7VX3ZGZ"1RBI[%4:8BX5Q!R^?B[)F6Q4?*&>""\IG3UE(F5'S&+5D"&)$#M6FJ;'2BA&UXRU9-GFF>B.F M*6UW]U MG]MH<\X ^Q2ZH)JI.*,=W=6H L-];P(8=&FCJ'729%_A0D7!7("LKTZV(U]G62ZJAX MLL]J/.6L1I_+PA7@FO-7#81)($"Z^'CFB57^]9&S<43.O!+LE> 35H+A>X]+ MM?=#L&24K[MB%2S3JAYJ%@?DKS)95FTT%6'@:$Y48RU:O++LE>635I;OUVM! M>+Z%?_AJLQ#@RK/)$%Z9]LJT5Z:],NV5::],VU2FS?[I ME6NO7'OEVBO77KGVRK5=3[7F%N12I_XEJ',VBTJYC,DS_T7D-E;*IV@A[J9> M[;\4H&*M/[ 3[=J4+*]BG[**+:D%=3%/R/3JE415P)FP1 M9I/ITYR,OVJ'N-%,&QQ)?)<[':P\]7G+/FK M)/O%=Q4%O73Z#HBJO3)22_,QTCXX5\%=M2VMG5-^DW&;OFRI;B-O.""](&Y1 M-1\C[4,7IQMYB$6XY[CEPHV2I-@X:IN0D:+=3P#+L%:TL M>0D+6*4]9 53=V&_02I2%J;5_(FU],/M$RD@F<1*RU=X"5'%%6WL?BO>A> OE]]JE#X7[^# "5%AU5->* MPHH/[K*ANBX2C)#;?9]O>;;=T8@1::MI1DU-((QHV_<\:JZ7CRX/2E,30)=: MH_&"J)[)B"H!K"?F/;%*E4 C!QT3*S2>'N\5=UK:H= M[3O3!26C6U>53Z1N(S0 AI+/E58;U\P*PM=-P+<:)0< HR2JZUY53"8+C9WSH!6;+H(&J+W&[Y M_6XM'ONO&)!SC.X5:\LEY9D$(+R?T6PK_JBD-B)_5-+144E0"N@.9/_'(W\+ M\CUMNJIW5ZP"OCL0LA#3?W":<+EQ=@2Y\'8$M/(/U$<+OZQ%R 8*\!1E;\]W M2:@A9%Z@7)A#8K.2!:@7/&MA*X(J4:_+UDT#W,1DLWD- .[V"#NR$ 3]_Y= M)HQ$?$0%_VMTLT#D'*V\\NN%3D^Z\H2)VKVI8VL M'6G^<)-%'#-?40!*E*UMD/2%;CA7\=+DK;KG N>LV,L#YI]V>I:X9*O1M]1( M*;!U[Q1OA*.4R.8&O=,%GL2!Y^]3^)HLRH64O,;?^Z>*+P0E54V_]TX55V_R M))8=)U*TZ)VR!W&9<(-EU/B;&VJD<]3P*QZ*[)\J:J'L*2E$DMU-%B^=J,J5W1K>Z?4?Q1;L" F+,I?:-:N4 M/7S5+3T$(COQ/,Q)?$$72\*YHTZ492("4<7FSU>[-O?AJCI*)QRR.Z]L%H/D M7)^/\G,&?]2P:[X94$4L!Q7-R21KCHMU& $9PB?^I*X8&\; AO(+[8KQ>(2! M$&Z6U6[5*5/"S ?P]1;UJ;_U]1;MTLG?ZOJTPE5U6$$<:H-7,-?N?[K5)*U3 M_SNWM))LIJ"WH<40%"I5FL8VN*G4T9B&KA[F:XBBKR':G -'6Y+1,"& ZP0C MKX+:G'I$71JU&*?E:RR>JIL10A5]1P7\ZZD:JPI]47F[L>!KT@XI2#'#B*8Q M"$7?_CX6/"=4Q;==_5$GCU,+&=J8$#>F!;6NV@UMDOHJ7?K44+W,+SU:6UJDL#@L4H5Z2O+JVTH,998!IB"#;5F#8MS(&2 MLWNRI,>U]3BNC(^O:/;7<3V'A9H7*-8H) M)* $X"GZK'2<8YSB4M\^-2D>![* MQ:H7Q!C)2FQY:]#"9FZ=%99PR4O' >'\@D9> (O\H!$:74)&5+-^'"IATE= MK9.X^14-'ZMS>7#QL).THKTY 1Y@1\7N@^9FC60+[IM_P 5G@3/S&SIIT5(D M 9W$4*4--*X)O4,I*"6 :3Y%MT6,)[%"44P3#7_*-='/M;M*H%>4VO-;OHE=>PH!.]-M8];+J)% 1AR<#U=\5JXWHV=\5 MZ^:N6,-B&SO8_=\>^^Z'(,EX*Q(4X2O1O?M5TKN&T?/-K55\) M^U\W%>L_A:_PTC^0+KY&E/L:44.'LGU%&@0'E+TF[#7A$]:$X7N/4^7W7<#; M+)*BX<4VR*-'7AH'#N5&/M8CQ^O(IZ\N2RX4O.#^(!2N<94]S M6\_A-=DO""UIF MW-0F7SZ1UR1JKG*KT<,":7PB?OKAW9^M%THW-[)" "/DHLP++H55UW^KVG77 MM5MO%OXW9=N'2ZXUE3?JG;[Z<.0! 8WB!-1V'-0.>_?H7GSC+(OO:!;NOMD[ MH]K,SQU'.7VDP[[;/"?%?4KB&8G/\@N:IEQ[86&J!@CJY!3'Q4['XE-^L:]A MP3TS9H,XQED=!V+53OZ0Y'^><_KFBY"UW%\+['8*6(:^Y_*(N-66//4]JJ!N M0V,Y/D;0#J/Y(,E0"-X>V6]#("M<.48$PZZ,M4+SAC[U7;"P7CYJH7G?6K5W MM]Z *6TW'+5*WE>T' _% ]]JR.GA6L]]R98T5U]N*&TY),7MLRUK.RZJA^42 M1I>$%2OA(RFXJBR2*I9";V[5$#1ZXD#4NM]J]#P=1 /?OEDDK#*F 7>PJAL/ M3+?R-;0U'R/M _/-"\E*CKLS=.X88OKJT7JW.:Q>K; MZR3-G-(J!/-DNN=W5 A$95N?'^/S8SI>6: (#%&MF PF8$!M@NKNWA@Q0IQX MU,!C-A*LS7Y7%6"E+QTC:ATCC':P=#!B5V]_^V60NL0K,2*7._.HA@<-+3*) M*^H8F]K[,[ID4^W("[H,1LC^L0]4)R" *M/6_OZ*H8A*OSRL"(+B9V297D [ MN17&PM.=]:@3N9H%DBR'AI=AYAD%9RFB8M:.UBF&"BP6I2W #X2&+;OJY-1J M=C0JIN[;KCFQ*T=:,AK0<;S*'MM_J1H9F2C9U]0X/;'[1EJ3*G RJ-2H/KC( M2A4HP3<')P;Y[>3OR-Y_(&G301="S= M&F.BL"-M*%FW>ZCM1.YE\/4$M!'Y>@*.Z@ET.3&UP^Z@PL"/P31,6/ 2IB7A M$Q *NBJR-S1!:PNT#N2FJ@"0#%]/X)3K"?B3+/^ZRHMDP9?&9'K-U\/O8CEL M_]C1JLS@,QG"*<8M->>K3[N5?A[FB>KL#K#7,$AV\YJW'3_42?NA6A)YVYPQM9&\CC]-&]*JR5Y6QJLIF^Y!3K?GG("^?<_)7 M*;X2Y.K''1]XPLZ]LJKREK MIP/0W-L/N@B6- _3CXR6RXLTS/-DFD3UA9'R&"^P%Q8DRI)1X'ZG@6;0J.FYCR.'F(+_)HK2,Q76NC72V M%CSK.-K7AWQ0_J^O0=HJ\NB%Z9[#^'RE!50AM-T^ MW'N*3J(6W<9:N!+&0DM!.D7;(:ENJ0S;TGIHRI4RL+7].*D?-C/KD*K6/,'6 M]MZWZWV[%O*?VN04U18+&%%"+4MJ;,!A1.U8-9--GJG],+I0B-;>C\ZWWKZ\ MY1!'D_UF0]R=2(Z;D=<-'=?"Q;0,DR>S+)*!^%_AU$D M*A9QZ1$L:9J(>@S;/S;$M6?+Z([8=_*,&3T^E^:4\)>YR'C,"0 'L-4^=@ M,KU.,JX=)V%ZDW$F*:L:+36)$CQ:?9VB^DAI_"5)TS-1%*\(LUG"=_2J\BB0 MZ?0'<)L5L%CRN1>S/&$;77PRO:79[#9Y$755X4B[##5 )L13^ K$U=+<,>U" MZZ)L!:5=W=PI[7?DR]X^PFC&_XS(W@J'83(=QG$UD0,:6K;7EM9N*9?5P82] M'=WNCD^L121Y$4894*:U=W!,?TZX937G\WI)7DA*JYF]>EUR^YPH=UB-GD.< M(7S8':*%OAA@/[?Y&[6_X8$L13&$M;(,%&M:?=VB$BKF>9B3^((N!,/4EP8L M*Y>%4&O$E29\BQ=+7JWG=1C)Y_2=0$[?YYQK^)M2*;(Y;6XT^DPFT!Z/*4%D M1%E,WN?N?>YC\KFWR0*J[WE#AQ% >%.]&K@'"%TL4P\QU+1PFSUA'2;, ^$V M1&L=I)G1"P1MZ4(IZZ!-/9M V)8N*K+/T)W=G, )L'0A3@\K&N(/!8*T="N* M=9 J(P0(S=)M&CUL/%JN$R#:WY"BU0KZ054*K%J4MI1"E^1Y$&9Q M:QI341E"&^JA18TL/M)-$23K!/M$+Y_HI0H,1',2EZFX)9D3$B=I*7;#1Q*5 MC+,TR:]>1<(UB>OB9XME6:POA#[>5UJC5[T]:*#Y^H,DLWG![3FN/H8SW>I\6'MCM.U.SHK$2,.7-C7%EQ: M9;\$?$542<'"((G),_]%U&NL#!;1(N #VZ3M74<",^GL%B'9^O#/D^$+02IFA:GWC#>E/*FE#>EO"GE32EO M2GT-IA1L[Q^QY62F +BTCGX-4A+F)*#/:3*KRZZ;F4'M SFQ=Z!D>,/FE T; MR17@MR3/";E-PNHVNE)J;^0!.M<];P?WBY#-(#6UI[>T1 M;X]X>\3;(]X>\?;(Z=HCH$UP1$9(5TW%I?GQ6Y"+DRUSFO+IRZLS%L4J8"0F M9%$%)?:C%TN^(1+&?PSR@E,=T&6MWXM0QI>0L3 S3:_KFPPGIH\;$-YP.F7# MR6($I;E6SP/)"Y9$!8D?!=]]YLR?GW&&B\^B(GEI,\)Z?@JJF:HHKTL;Y58G M!S[P4/,A"%R+L:M*BMUQ^?;'6BI-V(,X.ZH18C0[]".\^R%(JCK%W&9]-:XOJ!S$3<5 M G> O<6.# GLW;Q/(6O=:[V619O/(*)=E4[H]$&0GXUG1(AH/D#7V:B M!'86<7HKV:8)WWQ(;T=Z.]+;D=Z.]':DMR._!CNRZTXY:E.R@Y;DU%YZ7Y?F M"!@I$E;_L$N9-#2?=,9T8TWI4^2-*V]<@4R,BWF8S;B(JU;YPY:_)EOVTK0O M#,?SQH4W+KQQX8T+;UQXX^)K,"XZ;9-.->R?N-99W;S'_]U>O6>H64/&0O8;L-62O(7L-V6O(IZLA M&VR)3K7A#\'Z/0=)-J5LT<7/#!G+C38,I\1KPUX;AAU^.+KT^&;'6.>K]8\: M1Q],1O,:L]>8O<;L-6:O,7N-^70U9BN;I%,=NM-M\C$IPB3- \%)9;AE!*C. MW<>SW>CH_5'N=7JOTRLTL+.XJK; N6VV+HDNT<+D#=W2FU8/(G'S6: 6#%J= MG>/Z$F81N:;LDI;/Q;1,S^JUGC^0B"0O8J^X*!G;VU0;X&F/X19EUNENX;.% MP")#;W/L,+99BPRD"DN4SPJ1L[ MI7M'PF3ZYKZ:ZBJ;5%QE(P&BV7LP9**<='4E3TW:?Y$TYMK)9ZF*IM77+:KL MA5-%V>H/+EJY4/TBD\3RAD[I_40SLOH4LC])<5UF,5!* 7LY17)7"N$RF4Z6 M7/P+TW?M[I M\M;V3JE?[V#",56J=#)IN^&H52HA9Z8Y*+1/0P\> 3R &_%@R4JS.:1:KV4'2;+ X\*D$3=5 7'J,J*EG M!N.$R=4YJJ%#H44F44:.L:GW_]%E!P!U=72!9A6?43./&ZH\B*Z+KI_$B&'9 M4V4NX&10J;"@4#4 +U,:RLM.C&FIB*-%QG06=T+'X&"%9F^V@'YVE$R/3%_$ M(.![XA*PG0Q$^R,:J>%S,;7EUJGE8KI;>C!(P-""VPW:&CJ#$+5;H6(-J5:8 M"XCQ)V08.Z2# 1%_0(:X+?(*A/4S,EB0I 4@M%^003-*8P!B_14Q5F!J Q#I M;\B0MN4*0S=_;$>V-,)J4(C8%!R3%&DH5FSJ3@\9PRZ/VKS?G1+A"G]<%SD2 MYT72A"MOL;A7L=MY&O,'.#DTTY4\?S+FE$_&O.7NZLK9=;WC/*=1(L3<'TDQ MOT_#+"-R .0FBYBX$Y@_K/KW)KLC15W,NB'_ M5:>+!>)NDTAL$T^$+9H(:?C9PD/O6+0>F*M23W.B]S[U>W?/DLA9L9!,1QHPGT_.5^$:)O?-XKM%S4L+T(Z/E M\B(-\[PZG5V9._(<7F O+$B46;+@?J>!9NBUMJ..:VO<..56:..*N>"+)HG7 M'R!@#88;#GNNIK;]B&3'T;X^Y(/R_4=.@#!+)EFU 4SO&>4D%BMA9!4B/+7< MCVD>G_/3ZNSX')DPN+9ZVGF8BAC-XYR0@F_[9W'MR A3\7)2FI>,Y.H MV(3":.G\9" ;;R30[.4$N MS[[\%"3KLY[=KXT!C>7D1(L&)?[PRBD?7K%7K)IO,D+-/JCKDL#LA&6^^H7)D-[D3;ZD*:5[^\^J7* MWB=+1D2T2W$.HZ&)5[^\^N75+Z]^>?7+C=M+*H)=JE\_!TO^.2OJNWYI,2H839MM M7F_S>IO7V[S>YJ9NGX90=JG)_1+4V:Q%I;+$Y)G_(K(^*Y5&M,BYDK,*ZQ^[ MJ'/='^1$I[-%IE?L3EFQDU1SNY@G9'KU2J*J/.=D.DTBPD1Q\KDHHAORA?\T M)^>LCTJWJ,%P$^ M3N**%8N2G-PSKE:]W:;?Z6"$CC4\ZLT-0+N"\1?<0A?)Z\=$Z^#7'W7XF9B4 M!3?X,I$JK .UH9OCV/QSL=/&SE>?L^2ODBMB><2295L-3YV^ Z)J+PC8TGR, MM ];I?. J E+9HDX^LN_K:^)D$E#<#_G:&ZRO&!E2RDK><,!Z=VSK\Y)5AUT M"]/=)%^34%A<($1Z0PV(^3J,CBXD4>)ZVWQ VKGI2[@%7#R$17VQ6UV1'50MO(8"=DYF>Y5$U-R M%+SCJ> 9=(T ;MD^!@2]E]MU'LZ^EU*QA;2V]UE/)U"WN'JK-WE>DOBR9$DV MXYIS0NO;'_,[\J7Z23[7.IW=XBJ?\R1.0K;:$RPJ;F]K[Y3ZC=./ZYVUUZ_= MUP;IXO/IG-0:;I><](V/5!KCP@A0X?6ANE8M5GQP-R_5=:MBA-P>^WO+L^V! M-HQ(6TUC:FJ"8D3;OJ]1;"GABY;0-PN;HN+95M:-]9WJB9'3KJO*)%*F&!LA1 M\KG2:J.Z^;=H^=;.:LON21?,P)UP-*%@8%9-,48Y&MV__Y#Y]H<;DONEK@=Q]FU YE69%&R MW%6C5&)IZ^SVE.IZ1QAYF?\(Q-+9W2OW!KK5+758L74 /# B4"P+49]PHACVW[,_- M2GTX_G2CR8DBB-2A1@L<(UJE>D3U%!*W^&SFA[;JB.BRZUK>!S749% E?]CA M40S)=19Y%:P4H6-9F*2D<-7ZS$>X4NN:<#0IFK$-U;--M1 M%'8ENK?8CK"#_QY=JI8=M"A6J$][]6FOIY?VVG,2(;8$#FAH!)T@-8$'BY:X MS%+Y+YR,T.:'74NIQDICA&XW-2OL*] M;Z+UZ>R/-'^%'98K[/:IJA]^?OAP0=4%72QH)J_9:V&D7J!<6(.B,Y(%*%=< MFZ K0JK1-S;S?1IF_=)LO#1YD)U?V*A.$IP&:X:-SNC 2P0 M_M]@UE.WM$!*M?J?N>"*N71=DBP/:[.<[WVS2EJF^2-K)%P+L/-YEX0UQ@ RA1MK9!TA>Z$8R*ER9OU3UC*&?%7K80_[0S,_F' MYJHBC90"6_=.\6;OE1+9W*!WNL"3./#\?0I?A98E):_Q]_ZIJG4_.55-O_=. M%=^'\R1^4^AWCRY)B]XI>Q ;58-CJ/$W-]1(YZCA5SP4V<\I;:'L*2E$>>6; M+$Y>DIBK49*WJ&SGGDJA0E3I!D+;FR?+)ZKPFW88X?20#9JU?)96#R)UC9OS M8XWWZE7\*C:A*&PM5X3#>@Q7@3#ROYCNNJZD&OWN\:2D?7#@$9S M]3=V&@#')D"NOE)9V=9Y/03P;1X-Y1 T+WD9!-66P7?9B! >,QL$%\Z=KK*. M?W6$W#;>@.A;Q3GLJL9QT3[H/@0NW:L$TUKRUR&:DZ[<(YR )(MS0-G'8V0: M70?"=)"(T JCL;53RK>Y3X2]< .[V7%Y1ZL@.(DK#V'^1 M1=W7W^P7-BSM: M_),4#R2BLRSYSYN426?/.XW9JT\I7%.V_DJTDXFQ88C -\]/X6M=%K@0U^4^H]"A2/5KE3F"OU>VFXX:I5*DJ+E>"@>5*/S M5>1&1?>@O++.-LPGTZU>)2%>T=(MQ6E8F4X*KFYJ,@B-2FYH;H2=SF&Y59:I MO#-$JTB7#(EF]P&Q729Y)*SH25;[IT"(9)T&Q5'+"F% M]K>.ET'Q'0?L@FK MO0&_AVDI.WABUGE 7 \D)HM*K56=IS'J.R"J>BFLT.([VX#"P MUX!(*KX'47_0TC'%NZN^A'<\S$3^Q)OCD?47A/^HY/9"W(NOB%,,#66YMB*/8J00"H(=C!'G! MM[=BO68_9TF1/SQ^5GJ-0'V9L+,9E"RR7#.YX*GF%K0#<=9E?R&J#' M @NM!$H>[A%T.C/?GMT\_SXZ&;UO]_YVM_>^RJ+0/3QB'',4;V?[J*M>57' M]VD>9NN\A,JSFM]D-3K;\V?X^!.9V]^K@-9@<]O\^'',[768L,HT.>,*8FWU MBM(P1&SR^UX+VY.J^]SQS^;O5)QS2CDK"5SKPZ(NIU5)P,G-;WWL=<#Y/21@ MO//[D.1_7C-"]O.'''(OX/$G-K?N.!?P^'',[1U=[\5O]NHZH&U=)P _<"3S MMSY;=!;'57)/F )=S0Z>.*X9=#5O)S5;+V&2KHN;5\NGYTF3/6X<<[[&V/X@XF$GBLQ?"PADY.(S; MTRQJ/AW7S.9*3U>5GY;%H)R5/A_EYPS^J&']Y\: &D52'ZO9/@489KAB!TYY M-">R:] [C( ,H?Q^]4YC8$,IN;B]PP@#(=RLLMTB5%:<-1_ /;Y6432PI# I M@;H?Y*HK=;2F$?;ZK'',VJY0?;N58W/\<L.0+*-6]L/0/U] MF(CSG4_AJRC)*.JD\WV#?]&L"RF!F0TU .;'\OG?7&P]T4]A%HO'KG:9WX^D M*.KK](1,R^LR $K8QJ.Y1;ZY$VN_#J'B^%%K^V&HOSV^YDU&]IN&P]![<".B MC-:&:Q.=T;EW1B57GM)1-75/Y**$93X:'N1WY$OUDQ'0 M-YWQX-+;B,Q'PHY8&;;H.!PB[+NR!+GL[K7N V' 6^FM4@&C!QDV%AK4AJ*J MN2\:5-:6+70TM\C+YSR)DY"M]@XTP" -I-A47O-O>JB\G]] ?OP>AZ^D,P7:^EMPFD M^5X6VG)!"B8$<%MZ[Z[RMGL-, )LOC:"MD;6+*8R8)P6O:JT5-9Q3)"U*X=3 M1=]1 6^]'^/M&F^_C (C4F6Y+2IO-Q9\39H@!2EA&-$TEI&B;W\?"YYVNV)_ MV]$\ZXT)FKS8(Y4T&A[9G#^31>4S";886W3!0Z=_V^;P MUBYU_.9J:VYQH'$#=L"C-T,W=\2+MI\VAE8'/?Z==<8\M%?[V>2;K6+'D'MX MHW=XWJC%!0D,A6)=D$V6Y#XZ:+D-E"NRHVG=:2&^1\>I9OU]8#DEV 0CM ?#^B6]' , JZ):QA>6U6LH"Z M9>P9([5?4!@S%X05O,=-=7\!90BT"^CN9-=8[;1V?T+'V^UUV]&Q=8M/ZXT( M5MZKAI)ENWGW.G'H!W0<:G"M'#J6;8TE-&E2A]S+IZ@^ U[0QAWW+(OQ&'Y M/K<>FQF+8M5)M[[H2[?^&=W:E]^_@&Z)2WSXF]\='UAEIP5EG#]\'-'.+^@D1?M<1I<0J-+R&@-]V*>D.G5 M*XE*P9B3Z32)"$,O3/H*J'42-[^BX6-U+@\N'G:25K0W)\!+\U"Q^Z"Y62/9 M@OOFGVK#^V\N09)I0C9'6#MPSF_HI$7+Q8SH)(8J;:!Q3>@5RD I 4SS*;HM M8CR)%G))C3"3YU:VZZJMA=:0R4D31*-.PE,2V'M?IT* M%OT)[GQ=3@R(.YK]9<^&L!0'[I<9+A-&HH)B<"HY$5N2NH)N Z<][[#'"UR< MK]R\YRX,W;]T<^UNTKAMSVUXK=]%?\](+JK+=$F6<"?Z;:QZ6<54J(C#DX&J M.G6,3P/3/"/=2?F2JL_K+VE6D-?BJJX2QA<"F8D_M!&':=KRSF[?5,1JRG%O MJ$6%;L-50]H=1S@^NB"I X-.M'3%5]46[ ;6X:8*XD_X/^ M*U!KAK%_O5#O)38RK?1:=S2JC2ZGOKVZ7G9;#Q"BI62'GB#>AVS"JHYUY:+F MHJ9 J);BX;V^S:X<:RF*UQ/&7?%218E:QT$@:U"M5&QU[ KNZ3WOI?CN\CP; M:NL[MD5Z0KM_LZRL'CX4*3;=Z$U*;\WEZQ=,CB_4AL+$HB%)8=9KLZZ?9X@1 MFX8DN^ "B@>;,B1AS4[O#(LV5&GN4IDJ?#NYJ('^Q$*A*5R&*T./"!:52(VW M5@4%YSZQ9#8S]6AATXVV!:_OPY7PC%R4''Q6G&7B(MBH_F#F34"G&K76]X8B MPZ;W[-[A ?.:@4.GYM11!FY6;V&: <.FU9C4*X=B1:?:-#E&MG?7$BYG. 2N MT85I2N+SU;&?R&P2L.D^^RX^\7+#+"(35I^*KB_;-L.)3B=J==V^]02:J4KO ML:A*RE<\?7.8M/Z"\!\["&HL:I,:^^9%FV'$IBWI54Z&AB*P:4K'GH4\$G;H M).N@,_V(36R')K"QQ5'S$#B$UQ.GR_ M$Y;,DBQ,Q;>U)]#P/6)3DEK9N+L/[4=LRE%K9ITLL6YK)-F(L_Z(19^JZV&9 M7I6YENN3:75;#/_%:#)^PJ9V=>:1LSBN0(:I%6[Y"9W.9FD1O81)*GR=UY15 MIP+-9@>;FF?EHC\H>&RJH(5[PZ#0L6F%=N[&@Z+'IA1:N6(,"AZ;P@B\;QD* M#XNBN%?4J1+AFUJ9ZT/"%I!B4P_/TNJ6+1(WLZRXA3[+#;%BT?D.F;;+7=I MY!_0*7A=+V^% D>IN)EH^H?WFPJ=[28K^,SE251)>#/K\ ,VU6VKH1#VPF5; M,RO*?I'@@$9UEQGK_!VS*76_34Z\_+G76 M7XEVABPU+JVP_>Y@*&YL^B"(5_BNH7='>.KY,)L.E#JJT4'HQJ7S M!Q'!8KXUO1 6SLA!+H31A/V,3K7MJ.']7FW=F_FZ#A/60;_[&:7^:R)OMA-Q MQG?R^OQ&_I#D?UYSBW@_WKFVC,UF"YLVW/]LU>6MS&8+FW)L=;:$^B/*,NR? M)C&;)G3ZC@K;-U:.G)9NOO MWQ]-%J?VS_J7Z@>!]H%,OQ'_?GZXV"L2%.$KR8.8%&&2YH$H5E2&VUI# M_P^ST6J8>;)8IF2#M 'HNO7!.[>.K*:%?\?U?+[(#Y@TI=$!?D%#OF&\G$3? MS>C+]S%)*D+$']7D5!-S7%MJ\[@T?";IV])3A]1445#*CI:,.VJ:"V'U0I6D M/-<>8$T;2(M]\LZ-PZTZ?3KDFFKQP^UEPU%/X*C1W M$2[)(J[(UU*AN"91G<[(EH)UJ& =2)"@;&GME/+) MD@A/;3:[I7E^$3*VFE)6!<:D:X M@G9)ZG_U,*O'4*'LM?4W27NU&D+X# MQ(;-)K:NL0+G 5O$":H60A-4D<$#*3C0Q(9Q8(-L]5"'\3@0ZRMT3GU3[P+> M9I$4E0LO9U5&1LSPGQ>9@ MUV81'U'0WM "(1><45D8%?NE0/:?W_2[Q<>*DQ1/MZH>'N&W$#4,[WD>3-96Y'WD?#44X?Z;#OMM*44A+/2'R67]"4 MBU[AUE #!'5RBH.K,V*OJ$\HB%Q@;@!&\T7(_FQ<;+K=3@'+H'SVEKC5EKR& M'4:WV]!8JAOQM& <]Q@6P2Y[\!T40D.783&(&=5;(&][C!?!L*M[K:R\H4^Y MC0![.45R*3Q<(AE.'#]_+BLSA!L"XE#QV]/61WBT^F) M4[,KRVP_1^%HWAC MT!Y>' .#;#"PT_GX1#.R^L3W$%)"/)9@=5,X_ GLY1;+6PJHH M5).IUMIN.&J5DD[162+6FNTDX4+8>DN'VV96W'1?6P7,+H MDK!B):2VN Q$I'4OZ[SO%IU6HR<.1-L#6*+0=4KSDLD$OE3#BX86F<0==8Q-[0$:W4$?[7BAX_?7GJP-V3_V@>J$@%"=NMW2 TR+7MV0U MH.-XE3VV_U(U\FM1LJ^I<=J)/2V=P;7-GJK$"IP,*C6J]TL:* ,)>)G2T*_0 MB3$M'96VR9BZN1OX&%7#>TD-3@_BY.#>/+V=^-M2"6*+_ U)HT#'TJTQ)@H[ MH(B2=;N'VCJQJ*7"S[Z6DZ_E=#JUG,"'QMUZZ:R5A($?67+K]K'SXN0U)MR: M\W;0=*P*X-9$M,:A6B=*W%H;=J6+JCJ&6RW3VKLS3Q)WJ[/8>9& BCI 6-@N MFK!]A VJ!&"[5\+@].(.JH-2:3\&4[ZP@A>QLCC<4*RKNG18QR)IV@.[*8]F M2)8OC-9ND(RW,)J=>A\Y_"A4:WNGU%_E1;+@RV0RW5+40)HR ]YD"*<8M]2< MKS[M5OUYF">J\[W 7F[/=%&V+I5K^K(,1CA=A(.>1O+G=@P<5\:NN%,^5:(K ML:@%<> 6O\5 AI981Q?1,'E?U,96CM#X_TZQ@!FD!. MG2$_!:S.-0_65>^+FD<[.4*T!G7C!#$@R3M O -$Y0")(N&SS1](1)(7(:3N M2'%1,D:D1G5C;T1Z(Q*E$>EU2:]+GIXN"1'&(\VV M@>^23C7EGX.\?,[)7Z7X2LQZ]X"AQI!NM&1M@KR.?,HZLN3ND M6) H*^2!^YT&FD%#;0?4U1](/)F>KQY#OJ?20CB@JHOR2OYU?45GVXTD-H8< M;@[$)8YI&2?9K)G.UOJ.'4?[^I /RO_UE9U;I?,\Y-(_(H]S0D2:Y5D<5VI3 MF.XY4J:WMA\G]3I[CO>@6DO#:5L) M5)OQ,**$VF+4V.3!B-JQ,B.;/%.->W0!!ZW=!5VV5OORED,<31*6#7%W(JE6 M1GXJ=%P+%],RR)W\(2B9O(_=[D3J-PYIY^->.P:[--7UUZ-<+:/3DC#L/PZY MRP)#X:G7Z7-2M,6>STGIO9"!EGO79?K&;T$^#QF9TY1/71YP=9PS6\!(3,A" MO(" L\4+844B_EZR=79-D!X8WYZZXQ?_?V,8IE0];SG\4 MC/]9\/W#X^>6:_T ?=QZ_X4\. ]S43=DL>2J1&UD[DI0D+X3>3MW M0GW,.>"Z;)SSV9<\_]1F%Q_;ZY-V(N_D]PKU8+*^^?$G.;?XF-Z0/EQO)Y?! MWUE860RZA+W/1_DY@S_*EYD:/J?3Y[=9RX%J]O10EW)GM'E,"B\9NEAVKZ^1 M&OG@4(7R!ET/&"+6/GCK@[>G%[P=R!DRTAH%^#P8;A-81C"1*O0>Z^ LXGMRI?!8LW ^<)R8PSF\+#+[+4/P7)] M25"P%!FL5>X3V=P3%.31G,1E2@(Z53E.,LUZI=WGCYUR_IBT!%&= MTTJS[45=J@)$+8V[.YES5NPYF/FGW53Q#_]:7S_52*+T]_ZIXK.CI*KI]]ZI M>A#;20-#-?[FAAKI##7\BH>B04,_9U%4+LJ4;P/Q)5DR$B7UZ3/"]YE*;&=SLUYF:3B[(PR.[2YD5,ZKTN655H9G['KY+72 MSY0TMW=P72('>L'ZVQHYX*O942#ZR&BN#>:@$PX<=T2VXB%=<&!H+9JBT?-T M$ VZ&TGI^YR3:9G>)E-9M%^CIT^M.(%R64\LS/(EUQS"=N-"JX]/$.D52+-U M0%O4=$P(3'0/R 76. H[6H\I;Z)^M3R0=1>'?0,/ M,F%*6QU&J'@2NEE@X*P.;T/N5$0#H:-$U-"\T.6X&$)6^870I9]H8M3QUKM] MGS[=T*<;GEZZH8YG$)W\[ A1YK]!)T/!]S7U$! 9:8H>W%?L,G_DYV#)/XLZ M.2*K@8HDAR<[R1OIC6Z?,W+*.2/= Y^" M@\EM\B(R^#8,51=/VY.S^_)4XADV'P@+7E5@$=H-"Q9Y;9%J*4'@0[KVA@+R*$TK$ MF<-$@P:DKA-M!-Z)XITHADZ4/1Z[JEGL;%H0]D\2LFO>P<"; AP1\0S<\?7T M](6D+^035U+G!DX7C4$1SX-5)AC1^Z](I:7T;$6GP9#C?N)/MO?"#T;#COP+ MM8=[-Q86U*-RN7HGGG?B>2>>=^)Y)YX-Y7+4+KY.V^Y(?7Y6%*T3] %"M>O3 M\P."#2H@=&SUM*PY%(#XL57 PNH"_N7@ZKF8//-?Q&&GRIS 7(6_%*>(_\T\IS6;\A2U$?].B2_T3XL09[ J&]PB?LD=84HKI=LT7EYPM M/M4:9%&R#-.; M#.A3MC(FWEEH\:QV&@LW:I5?M=M@R'%+O:I=AO+.2.^,],Y([XSTSD@GUJE% MK62DOLCNF]5(79$V=).1>B(M:*,C7[K7?@ES4:9_3E$]2 M7M77+E8!(S$AB\H)M.\M6G+UD##^8Y"+&[("6I=LKUQ'7T)675EQX#5:?QF$ M49&\B('-7&_#$NG$+861^H2M+"YCLPGJ*DPC26IU#QI%'-6&5L;2&H*J#V^*11S=B>E\7)8FU]WEAGK]?=5_J< ML<[6 +NOYM-QS6RNNP?V,<&]$#&N>6[8*(>8:4,RQC77AUOL$-.L3X'[&7YN MEXC/[?;(X5XLRP_H_X%CG;\CWG@@PMG!=YH+RG&&45&&J<@>=3"QNI2,:L;E M>[@,Y_N>9KP#)3ZYY 1NFWX4;N&;/"])?%ER23:K]XB*9_+JQR.E2&JZ&P_D MDVE\,HU/IO')-,>0^O4UC#3[9A#OPV1)1O9 M4OQ&EG:$PTB7.'3B4.KA#H(T+C.EW_T0)!EO18(B M?"6'U1+(=$I$!B[9:Q(PWCU@)*)9E*1)?26663)T'X]VDN_<'^$^I?F44YHE M!^6O-BQS4W',4_CZP/GEX8!=SBG]\RR+^6^7"6_.2!8148^[S(Z+LMH$[YIA*K:RDI.W.GCU>E/3[1D89JG:T#EWWW(JTFT;(@O1&H[BX\V^ MF,%62_3Q5Q]_]?'7/NVO'G>KD<5>[2MY(PVH=MJX1QHFM:W/.G4WO*^OV>;6 M<)&P^@?ZG":SVBC>MZ15[3H>P^Z9"C=."!<8O#_BE/T1G57\2KX\;/EJLF4K MB;;?VAX']6=1)!;+]I(S732R_CC0W2;A,]\S1 5MOI.48JO0!:@8PIO$WB3V M)K$WB;U)[,06 .ZH(S-ONV] (S5G#54*IQ;&MO-/W^O-I^ M;6BSV7ZN&RNM'ZJ]77;*=IFLH#I]#M/BGM&XC(K\$VFHBM':S@(9UVE)&1=B M[82H6UH@Y:Z,4A*R3R1.(A!%H X6"'N:$Q9F-"^2*&^GJKUU=RLE9\6>A<(_ M[?B:?^ \D^4T3>+:H2ZVIP;V;F\X )V-$@+2= RT6I-LQAX$F45]^*/;&PHH M6U*14G5'L\=ZEVQ<6^#V3JF_)$M&HMIES_].*ZWN+(O/%I05R7]4[C.=KDXQ MW9&B#DK4/Y 7DI7DFEL4F\S:/Y)B M?E'F!9]0=O4:I:7(A1>+DO\G0C\25!U&]46 JV^"FJ^V]VE+/ MZ9!>;340@,).=91E3-CTUB\%;1NCBTA +3+'+T[N#@7Q&M74PE"%7;JON4Z1 M&$L@+?"FP0:+ADW5LH)J^FU0\:<=N8F!1SN_OW9'*;ZXF1*0AGL37X!,B0SB M2D;#?;J;'-!!Y989?;Z$SY^ZQC?!@$"JG SCS3=W]CI M!L2+KIA?$2YWSUF>]$-]GV?9S5QY02DI\]YY7:)L/;XZ/<9CEP&KF")OZY M^JM,7L*T.:Y%_4:^7Y+ZWRUL M;B96AVW%>>OZ%'8?LVQ,A/-YON:ZXQV7M/S/F^R%XQ%B-(NODRSDXG=?I H& MX5:&,&+4T#6]1[*9J]MBY7*J5L)G*EB>*^!\-]P[L23' MU&$P)+BYQDWX_B7/ ]+I.C0FV6$LC3?8.L3 &#?%0M9^<3 P2;^!T0@M(>-/ MUEED#7T&1K&U1"_"95*$:8NFI#_ P/CN&5ERH;UAH;5C@DNW23$G3)F VFTP MQ[@+PKC.VK:1-;9RG;W?Y!!I4+,E(/0'0(JO9:69#X0![\Z$,GR?B@&0XC-[ MGX"!,.!M<%CJX50,@!2?V?O$YMD=QVFI.UJ0O+Y$2>:V:&KBE,:-$?Y$SR)N MN#)R8,MR):#-%M8?P"T^1B-"XERDJXAY%FZ(R?2"+A:BQ"&-_I3!@O8;#$V# MZP'RNO1'<'Q.;[EFJ,FT6AQKRUT"IZVY8]KWW=#"[2K*JDA?15MSMR>0&J]_ MD5"N;NQ/>IW6%=+2>^$;FKBEL5PNZ_S.,-T$.VYV)6!:5!W-WOZ:T.@*SF$&-+_^X_*PH=*_0*V45FO3MAX6JJ3"+/Z!9TJDZ2'H%G]?JP&>?89NF[4])YK&9P4"Y/ M\MQ*T'6@6]G?<;FYNCZJ<+\EW,Y>1[N4UWV!^@Q7-$]"7L4KS\?Y/0^"U_.D M((^$O201J=^/R*29U>M-53O.U6/=%F9*PSQ?:\3*V[KD#<="[Z!7C.WY_%NN M9)2T+X..TZ M&Z5>_(EP+6=Q7JL/,J(A?1P?.RTX2Y+X*F095R74=W*J&SN^3%&DA)T?3JB2 M>$"/ 1!<:"-0]G!_[#>?E 77^C,1VY#1+6LWS.'9_3T;0Q1^97.7M-A@> MW'J5.,Q'0H18_#A95N&3C=LK-@*L&@@#WDH$6Q9M>F.BF06I*#) WSH6&M26 MA!IL+#2H#TQE Z2-_7&AZR:^VL=QCW8=];DZ"/HTP6EL.%2YG#YN759;C_AR M@N0.>&K@2W&,3_/J9>F[H?H>?GSI31IO$N!3 WJ1$(1Y<]" 8)"22@2PX$HY.'IARSI;+ZGZ7=<$0 M.\D9NP+UV5?6Z_?HB3KDA$YR0E^4VF)")S(U8'7U.J-+ENZ$7<^+2SD)M] MSE"X6#2JKJGR4+Q8=*V.*?90N*/2P30#A- Y&),NUM,48%/*W)X^@,X2-AVN M>X'R=Z-2T(#!8BAVE$I:MSBYHW.%&2U(\"Z(21ZQI+(3Q#F[YS+G\/(\"+,X MR!.^WJ9)Q+>H(*Q+2')$P9*F2<3%5)!'R$%[>)[JOT1R::T>H+(^*;R9V_H=UN;@SH>'/R$'E.)/) WL$_!/( '_ MC[4H /"AC. H&I&^(XVR?1'HXU6/X.]2&SZGQ=ZAI MOR,?Z>W7>.L@2T8:!;:M>HPT:FQ5'1UI]+B3PC!.GT54O>NZME!55&A=YRF@ M.YR#NRU,B!R9Y\(G++S0E+T:B]!>:\XF]PDTNODMC"4\ $_\2[YZJPR+Y;E;HUDL MLNKNP@51@R[C&+^+Z@TTR.&>M9_Y+*=+VA#M=M,B#97T)XX'S/*79K"!L(7H409+E M?':KW=$PDEEZ0M 2Y5TT%I5GJCU8W'1O>P%TD(.<-M]5L:9L<731_?)Z%HZIYF *U8 M:+PXO/)-0>I%T^5P U \*>:$K?]6WR4![#48DB=Z'F9_PC$TMG=*_<$^POA2 MX]N]L.KD0AS0 P,"I6@$]1DW"ASQSC?VN8\8^HBA24 -(G6HT0+'B%:I*%,] MU72T<J3!GS2 MP.DD#;3[7B?H]5L314A9JU^V. M#EOEI^H [J _/G1?:!=LN][#(_NU3XA\=5K1/+\;"$^Z>!K&\-MIAE_ M/"&3)6&A*.>BN_?I=D>)#;(7=AH+)6K@WMAU.)38+;WL4;SGEKW3=!BT6%5[ MJ?$X>-%*]U;#4? @U=QK.XWE%+6$1@FNEM88*%=[+&"=,.!H]5J ^_DL3)^% MN8UD8,K"],%<'\P]O6"N'2-EI('?;M[+D4:%.VFW0,S8"CH;>;(PVJC&"[_-%V65OP4A'Q/+.KR@ND:0&)^Y[7=ISK)X>^%9I_%[[/X%9'!RS5?/86O M9Q57W>X8ZH[(HK+ 7L,BT2 ?#?Y="G466\NXXTL4%[SQUI+D.[ CC2A(5.:L5($Q>TC!&GGH^? M D9>2%82_F]$9_5C^ :9A[,9(_4Q?6'<;UH9NCHZ/L:-;\,*D1V<&55T@:UJ M/7+]8:="KK_XU^?'([7Q[0\X'!FXJ#DUMXKTUNSG,"VX-(W+J&BN1=W:S@(9 MUVE)&9>([82H6UH@Y:Z,4A*R3R1.(A!%H X6"+OGU@@7/I/I$RW"]*$6*L?< M FAI@92G.=<9,YH7292W3U![Z^XV=%_T\)QQ?=J#5]S77)3 MUN^/I)A?E'E!%X1=O49I*>XI$]HB_T\HCA(D'49RZ_FJ^5I]]7=3&]Q4XJBT M?U[F?*?*\S5I.>1V<54?[\/U/ERIGW!('ZX:"&PGHEIJ 29\>FN8@@3KZ'SP M&NJ&XWI40&\>^Y?5D^#\#G 9Q>'D!G/Q ^ MB:G$#7:,.PJG!C9Q_:!3>;'5CM[%5LIX]D5XJ(;>QC>L(,-WDP=:DJ">X MM3T.ZL^>\TJSUT5QW&^8NIIK8F1<(VTW++4M<][:?ACJ6]>HHJ5;BL7]Q[K+ M%=;)<49'3KBI.>=2^I+;H2FMLI?5,$!]?%Z*SS[H/_O .IU_D&0VY[K*V0M? MHC-R5PI'SV2Z-B(J@R*?E$5>A)E@ PD0PU$P('U#G,I&-!K#9Y/X2("/!/A( MP!&DKRT2H.LBQ!= !<&3NH5&>@X0:#BA2Y9IIYOJ.6[0B1DMA%H^5G2210NJ MAKF&3L9H 6WQQ* 3.&;@9(X/(#QL9XPUG7_HY"JUD(V@ M=G#- 2? 7;UDFQ, \\$ZRKZK"GC\&J2BM&Q G].DKM:1K[^):%X8EB[1&]1) MH1(3DGP^WBGGX\FJ<.P57&Z.1+8U MZ>-4#.(V_4P\7GC,)1#>_#Y,&DL;F?*& ])KO#Y,A\&#%;Y&3(=QFPYS*(4G MSURSRDA\DUV]1O,PFY%KRI2WBQPGQ70=#QUZO6O++8SH-MEFSK==P7YM MT"?_.+N*J6W@AA=8 3XIEKV%W3!$/T;H< 6+[I8B#Y6 M&X$M+/%GF L)7=@#>@MFE^6&[99':^HWNL"&/?SV+HO$?5>DKL4-U05!(XSE,!;U!/B>D,"T-TCR(TX(@*A)\V/$K M##M>A,ND"-/D/R2N%B-??4N:AZG0HQJN/-3JX]0]=1954B._#U?"0!8YSE'$ M95R\?WW+F_MKC]Q79H,,B?-"!T_C1!#6<4V#4J[JXQG#$#*T MU.W=4A_'U6X2IO=APA7I]3*6T:YN[99R80$\D")AU98VV>72M*]HC:[N,"1G\J 4B:.:;U[6'6K8=&+5QT MNKJMR,;9@>O?ZG70W&BPM"C@G$.Z#(^A57 ">V%),P2@D/1PC2 I^'R^".]K M$6:S1)A&Q_>>LY#/:U,1M&N+.C)&0 MV-!B* I%50&Q!-=:2&YJZKI2):M+6]R'K%BU MW;DH;SM@"C-0GX5UPH"C5=: ^PV(!J;7@OHX17'/R#),-I5>^-Y?E2B >, T M>CI&),Z,%JO[-.0R/8N% E-5/I'KE9 NCNM:[@2/\G)/><.QT#OHC:0/T,U MWG P>I]8F.5<71&._//5_B^*ZU3U!W!=E;9@2<3I$,['UHVAK;ECVNOTK$VM M@;,H*A=E-:F79)I$T@+Z\(Z.#Y.(D_*/Y?._250\T4]A%HO'RC,?!+^:$UG(!VV#@I75$9WF*CK MCHJNH)GB#4G@(KB9$W:KJFW617[/JMX;!?@YW"+S)_W\2;_3.^D'2,%!MR6H M:=ZO9:V?,8+N-8+!PG,RT9W>!&.41UK1'=T$8])V6*([N0EGTPUPE.TT(J26$H-8)VZ,[" MZ^!LSOY"=Q)>DT'!*7CH#LGK %7GRZ,[_ZX/#;G4!)9G .9[H5-C (0W&$BJ M(W?HU!AMB)!C;>BT&#V4^N<0T"U,/< Z25/H=!H]J/#S#NB4&CV@K?F2Z#0< M37QV9!"V^E,:*;J8MTN@CM/AT#WFG12&OCT]&/,^JJ'%:AW"QKR5ZKL'6K-V MT8DI;;B::F:K-D=U=++75K9W:-SQ[: ML(H\%DN]NK(S63 #288Z,I"*B.1#O_[PB%=F!A" XQ6L6;,9-8M$P!T.=X?# MX8]_^Y\OZQP]X;+*2/'OOWO_[?>_0[A8DC0K'O[]=Y\_'1U_.KV\_!VJZJ1( MDYP4^-]_5Y#?_<__\7_^'__V?QT=_8(+7"8U3M']*[I[W!8I+L_(&J/_=7)[ MA8[0]W_XR_OW-Q_0Y[M3],/W/_SQZ/L_'/WPT]'1__BW/"M^^PO[G_NDPH@B M453\G__^N\>ZWOSEN^^>GY^_?;DO\V])^?#=#]]__X?OVM&_:X:SOZ9U]\%P M\(_?B3]V0P^F?OX#'_O^YY]__H[_M1M:96,#Z:3OO_M?'ZX^+1_Q.CG*"D:1 M)<.EROY2\5]>D65293/)9X-?Y=7I8[GS$\?F9X MO/\3P^._CI/CWWUGC>D-+C.2GA>.41Z?U@ONG^JDK'U@?SBQ M8_SO2)WD;C$_G-(USE2%8</V#%_[$_H#E\ HO4ADIK8Y6S4%?VI M&<@F5"A5#J]1X8.)\4N-Z7G4:,UN;K+<64169!5%](<_O/]!*-G_QG[S]S.R MW*YQ41\75%G46?UZ6:Q(N>;ZO07#T10S:(T7:.7LE"!EL^"=)1O.>Y0/J:E% MI$/RE[@BVW(I#E4*FAW[N#CZ_.EW_Z.%C2AP)*"C ?A_^Z[']G MQV5+YZ1< M3N#6C/AN2>B)NJEWU[4JR=J$R,28H.+BB-S7):4ZICA>O+: M#[E)7CGZSTF97B19^=9P:' M:\CAP?#S+2G!%J*6N3=#W5IRLBI(S%$\XCBBX3K08"'L$C(8;K),NK.WKL;Y-\[(PV^Q)R6NM!\*V-&!;HCJ .#]0A@AI,4(-*^#/<BFR5+1/Z<[)Z+C# ]TTX,.SIY--(LXI[X&5"RI11^^/4EPMRXSK[B.R.KK?5EF! MJ^HH*=))7.OD/M?G=>< 70F#,\2"*/;WZ(AJ\0Y51%;HI$$54531FQ I][R@ MDCE/&QSLWGA9+,D:WR4OMY@1.\LS;J%UOV8V5U'A$US@558?UQ?S/;;;A8P 'F=&,3D\J+TGIA6#9G8J4UB@D 0T^1/S#01 M*'&3Y)JAQ*2J08G)'45I1@8*: \G[13XQO@2@C\?41(]4E>JMW0[ M.8)L1$51?F4(020!/+M3<3#&(HA,_)G*Q&F/%SKK\.(BPL94[*1B&,U(,.!; M.BD=EOOD2T1^.LHQB_XC]WGVP$\\T*DP/8U3II>#"\+=/U'NOF((H.L>@1FQ ML<9N3/*K+HE],>;/1Q6SMAY)GE*[F=]WZ06XQ"G&:RXE0W':4!"XI'^DLY#E M;T=$6&%4*KT=B J*;MZ?I[^E% MA3T44(Y^ 3XV*Z=P^WP\"BK,@_#W5$TWKU!W#/B,%.S$#DP_VFJ0U1L#_B"N MQU0;UUDI_M ;7B!^-)G1+7OJ0 [#K3]0;N7.%VI$M+@,3/8Y,:_1=DWSLOD> M?$5/1I0V,9^,=L'/]LE(H/GU/!F)].OC#XB"/P_\4- MOU)1>RR::I*$W@S=/U*3Y D76TS_NR0/108V<'5FJ/1Q5^X/_.!NF<$%;5F 0 M-Y/7B;O&DI5Q3]KN68 MWO.Z;76IPOWJOK;KEIY@^TX?UN">>>;$L5)0Z3;'[,-GG#T\LFHMR1,NDP=\ M5&S7][AD?^*O?A6%Q--7S2R7>/C-*.,.M(ZWD*#'3+1F;>S37YNUH6.Q-O21 MKXW]B4M5A=XU.=!ALXUFM[<&QF%LQIN_YEJ2]9I.(<(,6%#"4Y)C%EU MG7% M2@&R+^,J+PB*,]5?)DMY@RKLE"]/A 3Q"*)F>>BZ7]Y7KL5 S!I0D<$Y\*NZ M/H?+:]-"8,;7YS>)S.CAJ:,< M"+$N/<$.F;YOBN,\$OWW+#[UV#F:>KXXQ[:0@!T[Q(C[/A7!PM/!WGL#[2.\ MFPE#&26'D"'&@PO\:TEQ;<4B>#UNU 1VSRD^?9\KQH/21TD5[BK2".7UZD-2 M;TN.T?6*A?O?X7)]AN_K._;0.!67 YT&>BTP!.>]]M_@P.@Q8O_BB1,,*9:B M6J,O'"\4.[ 'O%W$U1[$K4LP/(H._PHQUSS C5#50 N_.14]V#/6#O\^1P/- M!Z\XJIX 8(#Y2/)JRS+>CY(U*>OL7R),IJEC%TBF#3"(+-T:F,Y8SB\X]NAX M@#TZ;RL6?A42;\))'F3?F#UF4&)EB'].S1"6KLJ^J'F'JY)WT( =[KZ1B%6P MQ0C9V=5UV=,)?8HRM[0O^Q7,4B5XYRF7%6,L&"7LH]K]M//YWL3YS*XR[U6/ M:%X!VCR:>4$LZ".9EQ6 '\5F0L^9/H)Q#\>[O^&DC%,H.H L[K]S!6"(MV94 MT:^8*_,1U]DRF8F-)<'I;9AG>SLZ;_"B:9C 7C66@JOIJ9TEEW MSN7#I06\RQF@,0?5HH'NW+7)R#M*KUN^HAN="6?YTAC&[!*R7*CXS9)4,($W MF])[&=%#T/%*BG:_.Z7HS%*F##$LE4UD?HU0R-B<"8,]FUQ06M0XSYYP MVK^ZBT?WXR5=.5V9[ '$Y%/@4X8."-_2>YRF6?@*_" B$QO*O9T35/QR;H?F M!%8S/RCL*B-7/+#/V:M>,VE)E6\U-(1EB M.7,%I;F:MZVP;KM%-C4&/K-%_E=38*:,&T&A@;@Q5'^)X74#KU:8(84'0XY* M^CDO?-FWO(:50/$ V&LO"QL$XW3 V+O@G[=(#P;QO'.TV\%\EIK""[L8-]YP MQP,QY#EME1/#M(G<9IIID/?H7)0!,(-)L0%NLQ#@L]808(+;)#X( MZF"C'GAX=M4@+S&DV?RK#8LWK4$:%R_.8%,T9]@M_"[DL;G"9D;0M[]]4 M]^=_/*-K[Y(>97;6W/ +7:O8]3I\RR:'B-,%:GL&H*9G 'K@P8XY8L93A M)YXR_"XK4$KR/"DKM,$EXF]Q$?.$Y[!'TK3B.2 7Z!P[OJ<()\O]^IJ&7[D] MU]K9HYYOZ$N+1MC;D2GEIX^\<7):,FO M*-=?)$M>-OH#9HU,QIC,:B((WX$ >H]O%8]0/5:(H84:O-!9&QW!,$,M:NB+ M0&Z"0>/1("5+K@NY#M6FQ2W>T+]R&4R:M[F>+,^,+%2SHDU#FG2'-*L&XV_# MRZP=(Q-W._,5&+5_Q57-8J;G:M0"\9N=46NX#M]:\/P%E\NL^M]FK1MN"V+6 M6K'0;!XH^IA/[A_F$9]\_4Y?*X!0/#U=&&(3_1UC-"[W[3UK0)G X(W#:F>_ M O/A@I0KG/&B&_.S'2#(S@FSZR.QPS MF>:GFTE_"['L-.EQKT"Z$4?=HPV\AG^JDK*^,MFO0.];K,?+U$?N\ M2.=)ZC=W8@/T;Y#S&LI#MH]6Y?(J6[)V!]1@N'O$9N\*YE^#'K&TH7A_S+H] M10TJ:$5*[B-W_6S@<[76;P5LP8P(^1X19O- .!(8DGXK\!>[FYWK8LQUH7] M$(/96;\'F+Y](_=@2?,RKVPH_K.@>,&B^;&A#37P>11;)O?<0N)64>!(TICR M%]);(=OBKT#%=O;=Q^V(-14-_NS4ZQZ>;U^Y[BUH7JK5FMIN? &FZO6-DLGN M%O_5GT$R%17V_CVVQ9:7[.9:P1K?C-VB1_X,N28/IO&M-??A&5]RK7 %M(9J M+^W:[9M0M;B"4XL4MV<^F.<*L>XU R119+H3G-DZJZ:DN&R7U0JG$0 M,1J;S[<\<9CHJB^0!O8>N<'>VD^T;!;4EA&+P+-*OB#:Y/H*KAZ[21&1DY-F M>_'813-8:M'<35];LL3IXRB6M=.9333BO5X,ZI'W[K<#><9%J&!?NIP?9).[0\&[* M],] U&R5M$1CZ"*!+SK=KQF[6RH6;@G%I)F3A[;E#BD'E5M1W^^,ZBY*RJHE M95?2%54=*6/:8![$A_C>WZ_ XMO-%XB;329X+'4&M-=Z"%C4M:*/PN(J\Q(!F\S>'&O9OU PC^%X, M9:N ;LILZ3SB'P8]M#%DAF6@'&2&QDAT,FY0H;<9BLM7$98,9!(7QX;-SH>5 M_?OIU=T;K^X6KQ-Z7RP>Z!V15VC9)CG3=[)>?Q$QL=$)83&.JQ_*%BWF$VGQ M0GFVPEI/NSYU0R3&V=<3,;GA+>J,2[H@:L%E2YY@$4 U2 #&UP![B 45]+;J M-F9.38&%R$P"WZ%G0I,XSHO./;%#Y&XQ2"-K4,9XI!BURO;NF2CRL R_!9<2U( 1IJ!@@PA/0&I102TN"T2QLA';<"7_RF77QK"Z'ZF<1(O#)E06)%[6!6QA ]M3]+,1)XKH_,&.J58@0T MY!2V6X&-T_D*5]5?T+)QSZV3>EOR=EE1#CP5:Q #:KT9VWK7%=VE+ONRK*? M1;*K96@%?6KT@'\,>]P=+2-;X_N/A0O$%O.&K?%)X7-HB^MQ@5]+_+K 8$O\ MX%L/EG@'8Q:6.,7&FR5NL=(@EC@I8B1K&+.@IB4NH?9;>Q_$72#J':F3?/=* M[_=Q4 MTW)=!)8H!2Q,#?8'S?O?3VW_WCWX&F_K6I)GI*C\9]5-PXK_@A\F0 M'P!\NW%;DYOIYZ7=)I-=E( MU^4M4PY-:O"8=TEG/+CF@63><$T6VY0_8/:$AY7 O$1WC[A-=""K?EFD1"7# MIA+E=W$:JRC"% ,18UKZ$(/.&: M" =?.!.%;N8@A774*+@1"8L5 =Y/1'T3 M*@P-$DP6.!I=DRK:7\$*@\V-7F8HF%36)B7Y7*_+H"& MHU)2XH2!G<,"8))^O"9;)MHKE%.4CAA.K-) W;YR+5!%YV$^@M6V2%&)_[G- MRJ9O&"LT0'AJ;(673:@-RJIJ2Q5[_9C4B*I ^D6*Z867>1+O7]$CR5,ZGOYM ME;W0852EI)@!S0H^1&3_L(E9HX)%$\-#H7,RHQ5=1OU(OZV628Y>*:WHK_*< M/',G1A/W,_CKM_2H6>;;5-1,P&6VYG,G1<$\':) 8X6>'W'1_;W]I>ZJ'R3NN(P45?&.0XK4,G2$O,Z!61?SO09J#=X4:&4V!?M86I,#,OMI);]_VTV9@V4P,L)6H?,-Z4CIW#L/+*W*T/-TO9NG'-H8.I[.SPU MA'5^!+\10CIN]OKUEE,R/6_\Q(>X+Z<$MO"[-FHP&__@O*[QC=D(;)5V2N M^V(:$[O=*R<$4Q-M.LBO6?UXNJUJLL;E59;<\R;TZC)$)I\"Q5$'A&\1^ES@ MI"PP"T-ZPD6DE 8C6A,; KZ= VJWV5.,L\D<@UC'DCZFX9[$YN.%BTD]3Q[F M2M?%O-^9SH^?>:Z& D""7=H(4,9Z.TKZH#!$##T-0B*6JC9"-F3LYW^A^P., M85QJ!@LN"*8^4%X;)\4"1D\[K6SH:P"CO(4?A]VG"$F-J MV;=+%55U!YW<=YR0(W\'-BSMY@GC81X A+0*M< 6$J_>5HAC$+4*;#C'&N@> M9OB25=N>E,./TU?TD$W))%TLA>>._A6WUW5%TV#5.(@PC0.D/E]0&2C-.7M9.]S[) MZ[ND?, 3S;&MYK(Y6$QA!FA[+30Z0XRKQ[/K(YPN8L_?/(KL="GEU8"G >OT.U(/AEX:1 M20/<&#C4J T[)^A)S(@4C&=N2K+$.*TNZ&(^)3F^7M'?I-MEG3WAXZJB+"WA M'_T/@;PT#2!4C/:&>.GE!:0_=^+(3(^F?-ELVZOZ5%2C*7YF6X;#I M-U6=+=$*I[A,DKLOL?EOS8D]T@GO)3D>X_[L21^*#]^9O;7XDA5#$Y__<9O7K M95'5)1>%:KP$03B H>W/2<1F;XA.KB"H*>:!GG%RB>E"CL1*D%@*&JRE"?\R MJ8DZ-VM/7R)=F'V&;&';'XZ;E->K#\D_2-D]UHR9=>J1H-YOHS,&>6(?!VW> MT\W1"@!R^[%+;.+ 4?Q%N$C26O.UQ'S:G&!S8D TZR=Z_,?OW__&RBRIWN/\LU2-G1$E"=Y&2,0/2K975L<#I_B&6)(O[@/BQM< MUJ],'&MZ5V;6WF8M?Z$&S.#RJ7$<6X^H^L'*_HH!YI8_SOSAC4^-\%#;:;;5=@9?QW MP%'<1;@P_G&WED>&1$3C7\+F^\:_BFB6HLF?YMNNU9>LAC^N1E];E ,A@CDZ M81"Y'(5LS-&.\ =()8?<]8U?H-A+@,GD#::_IQ\]\+,V:Z C4J"$KZ]M#1]! M/-6\3O2I%\[N(WFV?+W#+_4)G?NWX_N*AU#*;#SU:*@]-SYKL'BQ^ M< 01PQ!Q%..TDK'?2>)\>X*)Q4=2X^J2-XI\+^'TL2% YAU.%< 1S_W1*%GR M1IDL#A/AEZ5@39;ZF*""XA,UZ6R4MD2'8&\@#+%Q.?*_5L=/298S.E^0DD<% MR?2J9W#!0Q#5:,T_ %&-?]CP0]>TC!1\V#T?B(6@;B5<+?&UO.'00TTY=!)X M:,(0X30FMWV59^K8$*AF&DSE6YNLA07*4]?X%>A.(P^MA5$A[Z6'@K.M/?37'^_S_7-<\?UZI>2 M5"P+?6?*NS!X> MQIW%YE]#U*H^E"!J4Q\=8_GVN5)0L8T=9_<"#3!:-.YN40^ZPMH:A5H J>J;@Q07&TWAI$[07>S7N)FM,J;%FO6F%".JG))Z5_F)^M_\L6]P^6UTYKX>6V_I!1J_L)!J7BM3 M0-WTIB*KV\\QE.+BZAPPJ#6S?ESJ%3GI""5VF)21T[S1KBH M.6&?5G?D6#PW&"=+&$\ C:W3!A0LW$X;(U $GH_UVG0N;.,\1_)"%GU2"'>G M;>CL1:S:;>8,2>RI'DQ@+YFGDA\)>1.B('S(@ZHH=^30ZSSH52 19'<3 P7< M'H%0@F^/*40AQ* /Q,/�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�'"G$Q0]&%>=:/@^-9DSK)S8AZQS[1(JDG*=SC M0Z*F0CCMO]UL\K8D1E(]7N3D^;)8D7(MQ%Q],S;\&JKU]:#X+]G7HX'2K%KF MI&*%][G/IWI$*XH62EAA?7Y#_4L<96^X(\22S)8>VD'+6U;E]BG)V:OT];:N MZJ1@=:K'G+':'T'\KI.3>W?-#"NCXQX%_>38,*N")P/U%>*7LK62'K,H39]U M&8S Z!NNUCHE_L=DC14>JK$AT'KI@ZE\BPF/C6; 8GJI1FE'= @2G .4CJKQ M099<$,95->"#F,XJ"05'>"&JNZH-I/J$RZ=LB9M%!-# ME?ZV1J^X1CVV"R2>C:,H(/^21H)O^-M7B^+M^X*4S:_8.%E6;!PDYJ9 1Y%] M\UIU=%6S4K6.Z!Y7_S9YN2QK:+",F'FZD80ZA*[6X)AY*?"[Y.4$%WB5U1=T MCX9_.7]A/\IB\=U.[E/A3B(Q*T4ZB:TW!>F!3CX47X/, E%\48/P?+68O@28 M:B?#[8K]=#[HN:2LDG!'\3PN4BT/C4]0ODJG %#RK9]$_@D#'===Y'4[3+ED5VY6;(3DV3+#U1U^J4]R>0L-\#Q ,3&& MYUL&6H30 "->VK''";5(H2\,+<3QBB,I\.TBSO8@X&M\B>O7$U*DZH KR3#P M^_KN=/X?TAD\Q !&CHR2T9'H$B<89WS$M:@S<44JV4O>Z!@@3^S,Y;V\/KW& M9QP:>I=3>$;OVXXP!MCO#.W+!FT&]!LT;"3#.HO?)"Q)(<9JS".D##?!DTB. M\S#1(DRX@,/.-I(_JX^.@88?#N<*:2+'>UD?)Q_1HDDP/KC(BJS&5]D33B^+ MFA*1]=$2X7S4MMBNMSEK>7X\2).4, M\(B!'F0,,Y3DRQPRB7KVNWZ;C_0"Z M07ZM)R&T8$OBCM9S$&=YN36]C]R+:8 R;#=T7U@P'KL;DOH1E]0^:)&H%JC M(,O&]9H IHY X8CC@'HDD,!B@3Y.K2R\O$EJSYD0,Y@**FL'+NNF:^)FB M6-U^^JR\TFI] Y0BY=S>*R9TP!&'CCAX](XB0"\,4:^_>C0G($+.06G_4LKO MRKJ?N5?&-I\YSQ" M?&XGSJX8Z)TY(W0+'P+ 5)/H"Z@\<2;'VS[4[\\;/2-5(!/WS)FF^MCCL)J4 MX=SSRT><;G-\O3HNZBS-;DN>\G7^LLRW*4[;5^JM2(ZY7ITG)=-2 M5=L&9NJ-RA\@Z!.!J11B[6HQC3 FWW48L[[,W'_7/T2H)]D?9M[]TA(ACNFD#K#/),+F M11;-R6 HW<^<"DG (*5Q3E_,(,U-F_*3;!L]GNB&3H/+LO%EG+( Z+)F5QGQ M8T5EB+?ND_"@Z>?09$I-,*$<"KKX0"[D_M8*>-SOD!%N.Y9TT.'3_H-AU#3Q MA+3N])6*:LJ9Q'8+@LDL2[//:AZW>%RD%"<6O(4+%KIUUA7DF+I.-_ISC-DIQ\#!Z M4[*2P?4K"\BMZ=]8K8D-6Z+,4'(\/=2@^]R6@M2O!1Q[9H/,)V*J53^T]JJ&!O> ]*6M^#N(6/CBJP>V* #$- M_;)NNF6=&RS+FS&JP40$0L=@HO,+(>ESEN<2,=G_,U DVFE\LW\+)T['S7U: MD2D"Q%>0JB@"O8]<*\D@$003^N1A.GH@M$:1/EB;$#)<%PI2/+"6(6?XOIX( M)5<-A7:>&)G2-T462-P82C59B1&M(EH>3?F%ZB9Y96%UHB!# MN<7IH,V;MC5B,IDS"T4'J/=@D08'M!%(\(MZ(M"(WM[/G)R//08E\WKO: # XP:R*P0 H<=5VM.$YD84RX*1UVS5,SF M9WV^4GSE@+M&9@_*8PO$,6C_.2-64]%=PG"3Q QY:),UODM>FCI[314^^:FL M&@T_=L=F#>@-& ,/= &X60GLWL\JN[!"D@UT]*Z!'R=*;8I9B"'=@LE$YUQH ML)'9J-)Q0#DXF"^4!!P AO"^ ^S!7=_Z-NM8:P6>.%[.$$2;3L&X_(Q*6(%Y MV!RO:,5"6BAI61WHR:8?1M\"I4$+1B@)T4(&(C6>5@DX/QI,T! 5_C(LJK%' M$2@S/B-69 T7;4(/MS+)V74V7;/>8C73!T]87:)<\RMH;(IZ=N\A*P+\ B4[ MT+FG@[))M2>U)2Y&XQSV)0&Y3J MP=#@L=%)O5<"2?*D9/EMC;W(7\]1SG")$SJF)BTQHU>X5+6<[S=.QWM*J-G) M[&-HFID6D&!)9%K8@%+$/*W38PNC..E@9DQ'["@<,Y*"%5^[Q7565%^W@.V5Q"*Z:W4!U0H;DO(9.C2ZQQMDB&P9.5=Z8+$, CX#%FO.=/ M6\N,7F.7?8F)%4[J;1E)B$#0 N73O60.E%K.]$DL]=L-J M2UIT\.;!M>!?XG)#PIE@,IM0US8S_1YJM.G""6?--;$FWPV[N+2_C&/)&>\% ML28PB%$KO/SV@3Q]E^),\"C]H6=-^H^_'U,<4H;'19X\[+&>].^&K'4PCW?6 M:8$A!BTHB\AI1B8)X6F+3[/Z]9C>3$])NJ]<9'\&;/!P&N^/.1068L 0@Q9\ M?TP@)G9SX/FSR4IZ(]+T0]=$%+\[U0E4>@TX*QL,W#>W>GX>:=G^ Y&LV-- M\&815SL0+H8TR0K6'O>Z^)2P!@X[!9"F:H::?0R-*-4"$LH3HX<-Q/?B:YT M;PM#I>U336^B9UFU(576/CRTB#75ON:U:)L"I7S9=(TI7R_+!EFAC:H$9)PX M8C.A(W;$CF34W_#V:-FR"12X*;-BF6VD)8?,/G9B[,N >"^VU\!E2?SKZ?B^ M(,;_),&E%P$]*@9C0A[#45UOZZI.^*.]A-^DXX"L=3"?;RXZ2>@_FUX$O/] M-9':Z0UO>$/'F2W!N)>C\0(\R;*%E2N<57?4H2HP4CO]_3ZL*1_ M2![T7GYT)G!R.50!\I[#PN&AK$$!E9/\%GY%+B* 6HP00XFJ:['L'JL9W(NU M^$UZ-]8G>;B\,!;^S6H?2,3MX._0[*]VGE!&30<0(BD6V((+U>0\)R%FC-#A M7I-)DD1,?*&&T";)TK/&'&I"D(Z+E)=0XS%+^BDP)I,Y2X;1 6K.@4^XO"< M8YFA(O(D"2^GMVS,'9X7 THZ#K5BF(: 83>3?!\C?E5F_IAO2?AJ:USY_(JS MAT=Z9AY3!J<')NOCR!YCV6':'*,2:8=.8UNK31.<;WYO,3A*! KL-8SCP U) M=#0HD<;/H,@%TDPW::Q^&HCRGN[*9V3)C3]Q Q//(Q?T=_MGD]98P&U9.J=O MOFL!M_=E 1IQV,&OR].4)4;DBJ0#%9:Z?* 3/1;"=K_>541H26'.01O);.(I M"@71*,RGHZ=/#D9::Y-NQM"ZA/O>YJ!)#FDZJD)]D]\OJ^3EC!NLOB_&7YR.K$ M7)#R(BM8T 1'O.W>\2IA-.OY@*P(ANN;63EB1V1UM*7:33AJ$&FP8ZW=<(,? M+V!2X&>TXECV&C%VDQC['27.M\FSV7;3!A=)7DR5XRQ,MIWY@AELS:TOVCNI MFII$FT2STIF[%P\76G-B1H]Z4P)Y=IISWY9\"YIS:E<-=:?65LW#.WR+6:/= M]H_,I'X/\0XKIO'A'1X!%]P[7+8X-'S.+U+O7ND%MOIFQ%F,WK&[;9SH*?#6 MZ?J,)_?#DZEP7M14KBZR''_X?* L]TM)GNM'5GDR*?9/=LW18%X8G3406[2PD0".&NB16$1-7V)( MM$AA=A?)VEL$)P+!I.%8@(&,K)--$I# MHD<8SVK^LEB18^.LO)6 M=[,%=%B7J 4:T6=]2,8#M[6$-I$C]S-CUSJ$O#&B< M2#$%-:4>N4,2>=4634+Z+=ZPTNC% TN$'0U>UAD.UA_CTP92)&TA@0XZ$N C MJ90)$A-3ND52,A^3-3XC[,%62]4<#G>B40R;R!>8="/?F/@40L?"00B<30,OP:6IM #TJPU'P]=$ U M"7RM%."8['%AA8E[;)! 9X$$0D=7\UFL337FLZ8*D/*SM$67T;<.=(L41@S-(D7&5M0]\+#^@5(F%$]&,B XY,& MZ^XQ"AW4V,+1.B#=.QK0"S2P&*?7X4E")KB$F)$L8)WQ@M7\*?GSZ&U6_=;7 M7I2E!NE\ JXS+I\ZE&RH<(!(B-LU >1D!P'$,%C$+A^JQ4($0L.(E1>;-EC5 M+5[B[&DD* 3RJ;.JBH<@ M50; &CLH/LIFJBBQ4!KTL:N,RD(J*"LY3U#Z>( M&TS.CM-_;*M:6(WD.$UY>ZXDOTFR]+(X3399G>2\W/L]Q3MET;6XJ(2>8/VK MJJS&GW#YE"VQ2&.G"R(/!9_EKTF^E7;I#@06*-^^T?-?O)L:_X@CAY8#[.)T M 0^UUR36!GI]&[I+7BY3NI!LE2TYAA/9N1/CP6]#DGD#O0U1Z&@7?-PLWBDJ M$V/2^8U_X>9=?EFD^.4_L3Q>3C(.'O&R.U^H4!,BH2;1)I%7 MIKC%#UE%88M ""E/C \#L\3N=($XH@?* U8B\8.$DD27/%ZY832*2?9G\.Z' MB5)J=CU*6)*49&2*#N&\4M0V(FM<'MS[/^ 1T\+P*ZAO2CV[;XYIP:-#=P[Z M(E"(\S2@2W4")*4GG7*%'Y)8>@__OZ1*J5MCM]_?__C^^.RO"O719U>Y,E^6TRML88,HYS3 M-\,H@9LX;QVO O#X0:$?,?"(P3]ZCR@&K&R?*!6"RW56\'9J7QA"8;6D'M<0 M(R*&\\JN6:+#O_C!?1C])?.I:GT$]8@J)P_U,J#& O+NX7I= !D:HC :DAG' M:ZO'301&RA VR"G]\;J\(\_R2ZUTI*W]T<\8VOI@D!$I$8,=U_(8H>J8W2$C ME2>K0]OD<&YOQ#,VW%@:$O:%-^/"C-^/4[*AM-)@^)&1EAP_F#$T MRP] V_"\U0H<,GV#QQPX?HQ-1EA>2KD09L -J>HD_W^SS2E)Y8\B(@8]K$HR3=\PJ4- L!-/P1MG7Y4U)GK)B."9+=DB$)=Y9$0>8Q\EY<+XL]2'[?1@>X]6X"-7#MW2IQ7ZX%4YM2(?OAIL M,^[2E4G*BOD, ME=276/ELFA0G9F2,IZ(87RNK^VA\X4I%]3-'4U$QJ_SH4%JEI&3D\QMV2=9K M4O!H;!YM7%UO:WJO*9C$2N\4.A_! S(5DX>*SN0HB%JX])+!L4 #-&(%:^J0 MGV])&E)^(/I$"L;GNZ6INXK50@PE+*_U#9#[E7.'R?;)6+DIWD4RS_"6F89I MBP:BZG;3%2$_1970N>_H6/%CG$YZ>AM"0%0.5X1#GP$]\%T,=E/!AFA>-VL MZ%XA-X-"_9_F(1>ZXC C*;C%3[C8X@NZ#FIY4[-[6?^:U8]M)+(RKMSH6Z"< M:,'P+3@-$HCM-FK10,\9ZS?8AI^?X&+YN$[*R%'G9GM"K @=L:; 94&QI8R4 M276VUC?.J@@,Y@Y4/F T4W9 *LEP XB)1(S*10PQC7*"@%2.H:U;'@1T_1L M6U*37Z1"\_SGG:-'9>Z8?&]C ^G F:D='L_&,-J/3CO31W#K#JR-63T_C9-=_0:EH&5$QFN1,GM%D'SFC/%VIX_+>+-Z5) 1 M7LEZ*FK.XK2F*%/CL.)Q^>+GF@7F?\)+.K*6&[].YO1PJD_"#L#1#0+L?.^/ M]!-41>OPYV:S-$]YPQV(+07"-^)8# PG=2L'FL C"\(\7&GV6SB7^B(1F0Q@A[I #@GLD$"O]:TO4(NB>/]'+9*(8SEO?:'!VKJ*0G>C M?%7GH,*7WSR2 DN+RYP/]XO6'7 MG.K\!9?+K)(V#()/Y.,T& 48]B!8$7H,-*"9:;1W)!"!G-?#P!$5(.< @W]T MPLN/#FMK[@2IWK^BX;B;Y%4$V#\G)3TN&KSI>=%@7C&/JEC>K*EFTZNH@S?O MNK[W)R.+DW6 MU?1_:FY+;-D7W'N+J[K,EG43-\DMK%]*>4O9C0IF0&?6W MGS[/W&4QO5NZYIKF%L3F^#X&P>[F.CV/KVB5MW!OG1.C:^R42>C*3&XD*CP= MZ7.]N3RP^8RU^>P8VX4"-R%ZP(CQG#E(;I*R?KTKDZ)*EESP3EZ'?U%$:YE/ M (X=UP7D/X"Y'&S0 M+"( ?NX=ORYI 76:5\UENW\O'?61]V[T!;K']"##Z(*4*YS56_KCK&\D.IRN M[4+6W;(HIYHRY%,^T,$I%2:L<_0TBAG-J:"IY-R98\2FBK7='2WA3Y4PV13UP="1ZL+>$0D*PKLC9\0C@Z'>]H,W8NHZ^V=F-XQ@-=NCDM1_2;"!WX33NRE_8L5==%F*12MWA M#Q)4K[C'R+?.X2!-PG1FO/+(\5UB#7UP%_L-74=\$\6CG)" +/!F5%A_]'3+ M\:3"%) BJ; 1C(*93>Y1CZ$*G5 PLBHFKZ4"IW"@^(F+M?&T 9 MMD@@"A<)-(:%71>\:C5Z]S>JTQ&E67R3++,_J MURO,XE.5[PZZGP%%;&IZ[ZE?K.^8BTQ[#O]]73]2UJT? MDP+M?A25FZ&;1QSM2%C??>/Q&7U8A7A+Q.#7=HM(<(9VUL\H_).FH8ZR15)\SQB"&J5UERSW#(,+.? M.*L_DIP2M3K_YY:B)N4CO<_ _*2>/I0BG\(#HL+=KZTF=9*;*>\[]@G*>U3X ME:$:(/-[A#66Z$V@--F+0.D:VW;B1A[0=!K_UD-,SEP,IUUD7,?;S,=L:D)M M>JMI3I:2A.LT V9#<.BH 8^2"O4(Q&W_H4ES B-D[!Q#\Z1"?UF$P=,&T0#X#),' M#;,%(]Z])!AI9_U(OW'+8!%R@799;"X907)Z3[-9U+>V6UQA"N:1WHO.\!/. MR88]CZC;>VI] V8TQ=S^&4T YS?>M IZ4!;W+5,?+Y7:]Y<)]AE?9,JNEDJ/[(5A\I@!X-SM[B%2$.$B8 M^+A?"$B&!!JHQ0.]&RZP027.LX4!,Q$X8WZJ/=-W;LJ0BKKJQC0RSN:,- MI@OESMJ'"^HJ;8T[W#U,BH>CF@7<)1R)>!?),5;8OSI*::3+W%E!;P*,8]_3 M_^-H,-.5@]J6\^[@&C#K*F6\'O,E)"]1G] M?B3 1<75CQAM^B7A;DEKCL:W0?E;DUV(&?&"*?(S?%^?9=4R)]6VG"Q\/#$: MJ-8EL_J6"@86]7#1%P89<=!Q[JA3U"6&) MK#5!;)2MYO-[U?9X]<)$>O.5= M"J4NR^2"3&%C16B"\LV#;;=7WB24_Y!FU894]-1>DBKF46VZ%_O'.(C P3CV MLJ#V$*XF?">244"^VYLME/&Z!Q;6VQF*N4W65PL5X8@N$!D+$$WJQ-?!^J<[ M9 K7.CB"'2#>WGID4(_-K,P#T/;HJ.7Y&!*'S<^O-YBE.!0/I\DFHY?9X_NJ M+I.ES.%@/@%8F>L"\IX]\LCR)'B>,&E1:"[ZW)D\" [[2R05:KPGQ)[0X6Y0 MA](SP:0:7T!O4O*90YD;"A0@IH?3%8%;SM0$761%4BPS:IA_JJDMPS.5XMP2 M-;B' @8+I)R>\^R9FM*RS.RO:^/[\FV_H4P@6:K+XLI.\5\ FA,I38@[ZE2 M/2:(HX(2A@OBR* &F_@F"F!GB#VY YHG3U3L2?FJ;U/K? (V0>13^_=;-+!G M92%K$9M *!A4.>)_;MFK^9/LA4)KK(7*.Y@SA'830!&'&C?D44U68D2K8'S3 M&<57S$AN'6VODR^TVM\!^6ER?G/>>L+E/3&UXSH\&CD)*1(XK(Z7,A 1,Z M9)1>TU_E-*D>)R5P:C@\-F]TVD#RUH-'2PH?9<4RWZ;T7^RAPR@>P??RS(1K M;UVQPO+4'$-,Z13[F#([G/P<2?Z#,'#%].P32Z-BBG>=%=EZNQYX[0Z.ICDI M8P,5/ _;F;6A4"1X3(QV8S^WLP:WH&-WA)JBKMR,'B=9; UU"K&B3WV:T*=A M#KS37?.0*:Y]A35N8#JTGKSQ7F07]:MU;)-TXNK7MS1WT!X3[G&=S@9/267N"41 Q7:!!3X%ARM6Q: M451G6UE(O>GGT,*#FF""%2#4Q =4B-#;6L$9IW-U;1MS'[$E?\4'1 !1L!9K@= M)1PB*O%&O LS&D4+35C)G%_1 MCQ=E6((&$4,R5%93+)YP>EG4E.K9?2XN<(S1RSK[%Z=HDSQZO*(:@'5%NZ ? MR-G.=D8X_2<=O, NO06BI/[3_,PBY58 G D2^LZ2?R_HWCE@W^$T ;B7 M@8O!O'^>/?/N; 20=P^I.T_6E5M;T&E"L&X NVJ,=7^:/^M*# @[ZD:YA.H] MY6E\X>!"&O@9;S\F82;/>#JTEEQ&W]83GLYEU&HNSSHRZ 7T0%%&OGK9;0Q M9\[ANF5V0>3&]3-QXF;9FRN(@Z6!.4_72H.W.H8AN4'-L%/\"7\@1?TH"Z:TG8Y_(7#\)O M*OYW4LA,OH5*CPX,[V(AD$ =%K-SHYMM!;&B[TRO+)IW3!KG"A+ZGN\'2 M_Y7&GBZPJTTD>*([1W$3/]5L >V3WZ])62;4O+TN MKS<\,>FRJK8X?2_1 ];S 54 &&ZPKCU0!$$]?<)1 R#SO"ULC]X"=0@.WM07 MJ,41D1(U6"*!)GJ7%:AZ3"B,.+WF[;F<.-\L794A:=[=M/K*_H53?K\]:[JD MGK(FJ1\/PF*-OC&4::VYO9?ZZ^&/]HWE5;N,.WN[7Q6LP?=MFQ1=H?H1HR95 MFM4@TUEVA/[?VJQ&0)0.=S%D6NN$XI,V?J-C)ML/O-O9^7J3DU>,U2UIC"> M7A&U 7F_)S),CC@JJ,$%#9!9H!:=R%UMS'>&V)/;4NT?-G^DLD%_2=;XBE3[ MMSV33R!*?V)JWXRF@X.QRG>^)H#%U35!?]=B\0UK$T(100(3]([A,F%,A5@< M[#B[HV<8+Z4U/,EXUU:V3%9>,Q/+7%%;DAUX]!^;I'B-<)#I2@^!4#C",79* M*4GOLSO[)3U)Q@9;'T_#27UKB/-_;K/Z%=WSLV@Y !SYQ!DE[.CI(J?6?'P. M'%M;1\/H)+Z\"SO 9N-2V,'*BQ_!5(6 M6?%0W>"2HZ/WWJ7Y%5!T)V;W?F TX!&%+YAR=H]NR^PA*Y*< M_584/-,[2A3?.3D]1N:/4GT_ M2=5(,G;R^KG(_KFEEY-J66;<.:WH!V?TK1-9D\#P+6][S(@&X&-VC#.COY09 MM8@:B2$_)FMULZNIX4[8KI\V,*%QF3)KB_M==QZ%!]$+G6J(Z>4.W")Y]782]>;5&-ISH M4"2>CM4)H]#[R)5VC1(FH<8"POZNUP40B-.=(X C,;>@!TW64AT((J(:A >!LG$RC;*Z/'&& !BM UUV'VNCW M2RO^WL^-L=JP@ $ENX]/O7$]'5NB_24XS&02@G]G^OZ#9(\$^A+[4<=D"X@% M76,[',T?=63?N74[AGO4T4;$H?/19G6._8]]1E;L(T*?TZ:]D-&?I8;.T)LR M6^(V^T9I_RG&6QEY(_.&M>1&$(";:TY6 [7)6H_] G$$^E0Q+C\IR?.DK-"& M_I;+4DQK2\5-!R;5)%'CG51FB2NFG[LZMR*EKW#8,\Q?,=X&E5*?5Q;+ 7J3 MB2P:7[ABPW#I+*-61?R4%AU:JWC--K%%4KOG%N=)S>H%E?7K=3%>-FIZ(*1. MS^B$_J/X.%#$H2(*5K/RYCA$*$BC9@ZB3[' *1"G MV[*DM)>HQ]$Q5JD.S5QATQL:H/"4!C#6O)R2F3%[QRLP+05$T3Y\HER6U^R% M_F?ZR%#;4WTP9=ASG0-V<[);K<'5V5YL&7Q4\V7-XI ?XY:Q8UY* MOLA5YD01Y.,BO:1K+NKL";/H(W6S:HN9G-:G4T*,7$=U-MDO-ILU6?/.8 ?" M\3F[)+(G1WIK%!4&/Y(:ZS_N&7\/Y6E=.('*,$9_TC,G/+&FIDL3XYEH&AC[ M ZW-BW;"P,;%,W%D6L#Q=VU8T"7-PZPXX)%1HV*<<)9,_2'Y1Q.IT@5H-+^"NAK4L_L6EP%XQ.#/QMS5I3H!DC+@(]9Z30INUO#4#^G+U?@P M\'/5[G3^WZ@8/)%KO4#_]_???O^>G6_#72*YADWXCN9@14?__85C5ORWM';C%;7);CG<+Y=^0T MJ1YO2O*4I3@]>?U706Q8T;IK,XF:\#Y! 56M.Y1\J^=.YQ132BS-UCS MY@WT/L1_RWY>4KS1ID$NBXTYK3YXCL"_LC97_FL*=+?W+,()1RFMKC!X&:A/$83(2GZ3+7[FA7C"5F M#S2) M"BPYU^4*?Q8K+/ #XZXKHX5V@%&BMR!OB;GZ7$4L"&DG8%59#X2+_JL7+/J/ MO]^RA]%11[+DKX8"LC>+_ZAN2LFJSI9)CC[@A+TPB5??&)&U,@J2";)XW? / MR4NVWJZE6S[Z=\"F[\SC_Y6 XO3&E5.-3))BG#V'+T?7U#UPF*[Z(^7Q1.N M^-6X2"^R@BJ=G6MR_SX[X1AR-2W4$K0$[UT=;3>;G&L@JH_2/DV7K% A4$:K M%D_N"\W:%2"*7U$Q%P\I(OEWG.TM\;5A?A5E5J@5Y=C?(8IR.(]W12F 1524 MHU0CDZ2(=\L8]%V?,HF'+=H=W2,.FK@'O#A0V$YN"J U@$/ST[90<-,-N4Y> M1/CU/"X)0QY1W0H.B.;_&C"2'#KZ-^@5($Q:I^0"$#ZCIX:G 9G_?A7KH[]W=FC60"[:#@Q!FQ7!K +6AQZ4P"]Z_H-Q.J5K<=.*@M! M1'HQ!8?%:<5D#/%9UK5$Z$DWBA&.+ M-258R2ROZY+>XC>D2O+K%8I]XY;SX!4-GI _+.< TF7,<=U'6=W3$.V"%B3_;X M1S;XH/9^/,_D4)Y)1U2#?= YA?VD)A\OER4OQ7^]ZLN,7Y#RBG5";(U:GN^T MQVW KR&YGOI0O&=,M)BPBP[IR[*SFWC.>T>F[4UHR? QS@GUN50G::*)Z.M" MEY\8TB)"'BF /8GE1O@UA?'#OHDU6J]2:RS$%);-&=84CA4\-TU28D2G2*]K MFJD^>A\Y>7,+G?"CAX7]2YS]NEP\RC7UKH_GD]>DR5K2][J99#>Q<+&"LOVK MZJ7A< CXF:&?RG]3#P$KPT8FC!M4 3S? 5R@R8=!;V\A(SM-=&@2[AA@G;9( M<=PWBASI&#D:8&@Q _2 T(?D_;(I4$%)/6PBNA/-$R-\T69/B -"1[)>#-/_ MS#YV8LW$2@(TP\;>NG&W3A=6#L6&O40*?!H9G653#T..E!I!,TN'/*_J;$V1 MN5Z!3Q?(%$")-0'EO;!B@POSH\SQ@ %M"W%!:TO?YL?M,L=)^0&GV3(K\$U) MTNVR5M2IT_H XL%43NR;OQK@J(6.6O#PTG6.UP/U3.:B\DQ-D'2-$;R.>EQ$ MS$EI*0ZGY#[)ZVDI4(V#,/_8?/X+(C"8#CC=#?+V#-XL:!./K95L0;3)9[MUN(">O@XO625)EE:(II>97P$OIQ.S>D[$'%TX. M-&;?25U*$R#Y++4Q9V:1YG:V+:FPWN R(\(1\VO"^GO4YR^X7&85'@V<@7P/ MT=,F<'SS5P,/X0:@L7[VNQB8LA:^&K(2M=>Z.L(52ECQX&W.0V68%F]7S?[] M+)"-8<6#&(]8;T"DQP+F7F+Q2M>%>#+6>B20?>3D<6!_\CB/ OM8V#\&V*_+ MQ2- BP4B!=)961 7OY2?I*Y]-3']'%T"DL79I9[ X>$U#BCTZ:4?1!-^9;"C M[*-H;C,XG[K%IBCE:/*3K&TVNN$XS^<,FV# B4-,A_:>*^']@Y2G6VI'K*DF ME"0XR0>!:N+M3^;=+=L BY7.I" ?T:.)K0\^3ZKJ8\-E*A^\8AS(!S\RG_?- M9C#11]1"M7#".\'>@1-^;T4QO/ JQB#:]/*JR3XF:WR]VI$D:9CZY%B 7I/. M&4Z]Q0I1GR8G,:)1I'O;+4[QFC<-O2FSI5F,U\2W3FYQ$AAQ+G,29.SO=,Y6 MZ>)JUR.#.#9O(;AKBA6E%T MREN:(O_/-LFS5893T9U788RH1T+,D?$9?8M/ M!Q4U8.$6B:L%V-LD_^P6100J$8R2"08A!D1S85]_T+2O)>/ ]O6'&/;U!U?V MM37V;EX[]U<5R\:6,0?1IID+5KY>M1"NR]OLX;&NSE\V6*3* 588**Z\\7 /'J3B$3*:=?E)0*F MJ1,[YR8DK%:*%Q MK#EYD=XF-?,OL^2%Y$'OA47]J:,PN3$0L8+EQG!Q$3+G9HUN N<$+H@ALT"Z MRPP4/Z=D-T44W31]G9P^?S [?93#X:?/Z+2!3I\_N#Y]'"W&V>ESL,!HIX^: M>X@I%8.=/A]QS3I74(R85*8GK_2&E5X6U_3ZQ8G=MUF2@R'L"B56U?^SL@DT_.[YN=&P1F4SQ?G^ $3,5@7-<^ MJAU38Y^_JEUOZZI.BI1*B83A=#X!\IIJZE W6!4.D)NKVS4!;JS=>SA[?A H M(.TU>9(A+1XB$"*&,V#:MBU768$OZ8^R%$GY0*C9<3"A=XNBA8B^,)B( XUD M'\BI2?1)%(Q+CG-ZUTCHJBY(>4:V]_5JFQ\O>8IB10\#G#TQJ^M4Y(5)& @T M!Y"WC&"%4LE&2$%TM.=5 Y1V"QWUX!>H0Y-WBC@M<9K5Z(I4U0)I+=Z32,+X MDS@AOY-(0#1@C*#7:U=!K];8VWL8E\V*(A:%4#(&T:97.%\BCQ.\ M7G4.H>;V*S->)L=#/8.R>4.=*5($(.>'P]4 SHH^^[R#C_16X\N5.V$_C]I7^!]#:<-*)?0M0!YF[7EK8<4N2:Y"9F-/. MU@Q_S/#J_ 4OMZP,Z/5JE2UQ24&>/K(NX4EQO;I[Q"DU&HXHAX) M.=3'9_1N(S90'31<<+4 ^P/X8%$1#M8)!B$&1(N?3Z<7"F+ZN>O,NL"!(1/I M=4VXR%S"1HPW1R?7SDD0B4077U.SN#PEZW56 G'*2^N<5\LD MYSJB"1$?4]/@22 :W!A8D)(+QE@9*_X ZP:XW3A6:(#6 @G$$,=,U*):H!XY M-./U.RG2@/NE;@0B[/9)[Z")H,N*TV7#:W0E%;TLE.T PFFY[)88X3R%2S)Q MLTW!3F&.YT=2=+'AEP6E/#Y_V>"BDN5YZ7T$/''5D_O68D*0,PXRRM&I25L" M(UA\Z^[D]8[BH&B>8O"E:YNNA^";S:Y(\7!TE3U1%7A'?Y^Q:/3CJL)US&8J M)I37,=ADY+2TU1J%>;VZ(W62-\'&HU6NU",A5M?XC-Z-__X K1E<4#$#I_@[ M,1$V7;;EPB30E]AN)),M M(!9TC6\5,T-IM/@]X$O75G$/(:)5'*-2/H3V.G:QC*"6=O%54J27Q15.3EE\ MU.M'_/P!OV1+(G]7TOL"8B>K9_;.1\P[GA6(PD<"@06B*""! _S1R?6J[!^? MR.>K-"V2)M.D=2P6O9%8>B?PK[#1 MELSHXDH6QUR%DY>!9"W:,[R_V>^T:#D1).=#(GD%.M8(=Z++5"$O*@&I@J8$.*W5@7XMZ*>P06/-BZ[/ 3 ZI' M\EP<7%S[.V\4G>"&]8F7G7L;.D4X/<2CX8942?Y+2;8;^@53FJ2HLV++&E/B M\=YZ,5&(H;$,47T3"LYP3<'UH7>:BQO5ISHI:S,ERNM-,UVYKT%'%6A2HWO\ MD!4%N\E1U?F*D_)K)>9YD7HF)6O*H$7$.9X\4(WGZJ"RXH)@Y]IE\421)>6K M7H+2&;UK=N[^#.+MEMDM#$E'H!XY&H"-3X)D^6W(159INK!X.CCL8F M]9]-R:&B#FS<-/0)RA(S<@552!5/;Q*1GI=%C=G1I%!(JN$6"FEL6O\*2<") M&9H[25)B2J>W<4N[X5;580O!YA@_?UD^TJW"K*73^6J%I9[N.$C$N*D9(_LF M[FK&JPI^P0A =X"[BX5J90U.HD2/P77C[=TOX)+JZH9AR0;A$HK&6RI=M"_, M?4LEB48UGP":K_IX.HE CHP 2MQ@IE B-0 )D1DKC,&O2+DNTIY8 M?FS'B091PN7D;>^K+,V2\O53PCN6L3:LBHH D^.A^7>R>;UGW25-PSH&,&;& M_S1EB3&YO$:OGF4E-8Z(/&!U? @1G5W(M\KJ#L MD$"DPR)>_+DNV??#T8UH&=M'.=+VWT\:3^'KB[['-)AKT"!O4+(6E%Q>@3+I^R):X^ MD3R5L._T!]"03.G$WDL;4,CLO6R200PR[ M!6KQ0Z1$ D/TQ; ^FZ^73.L=)9;$8\H&V"8G=A*$,RT/($/O2 M!?X YW@'%G&X1^DD^K[3)P\98BQQ4D*E<%;#8T*I^FE[_P^\K._(!WHU9?SZ M>HM3O-XP8?R$ZSKGKV9WN%Q7Q[R6F56]"C6XLI*J';:H1W>!>H01QYC^ABU2E+!:(!U:^3*G+)F=.-ZW M8#I#&'D3KS[C@X 2OCN9=T-_Q[C'''84#I/0D.@1)K!I/1+Q/CW0B5D=(L9] MU*@.'^FN05&I0>TZMMW(G!;)V3?)*[L)MV4ABW0RSLK@2[#!/0DAG 4^B0K, M)/>P0I"-WI08:!")9)_K,Q2QH&&,]AZ#7"AIMQZ)G %GL6_SH0,ME/P9H@61 M17\K_UFLO, /28T-ZW.U6+5!+'7RTN7]O:(CE+)ZULLL7MPGE#W'FY^84SZ< M- ]+=HE_X/1Z=<*3U#Z2>KR$E[+0D8LIH7)N =I_CIK #7'D%JA%C[GW[U\1 MPW#!7/IHB"3JL8Q;8\G)IA(?.Q5'5$[SI*JR5;;DB"FR;S6_-DG5, MQ.E-0NT6Y[7J[.,A8\6 MTFZ/BI'0V,O#&4-=Z49 0ZYM3E8 <)FT<)E1JKD 7V&B"JX@!H3RZI6^H:1D M0,S,%"!X6X.+ELLMH1S0($C &G2PQ3JL+BO9E56U9PZKK4I1C M$*\E,K6G_2$X GT*0#"E.(D)2$=Z6!]$939H(,:XJ$6$1>.U145TEN@MV%Z; MR0B51%W&'A3 E;K,NA EXAO86%5+V'[#2E=B6T#*)R M+TB)ETDEMV[5 RV4[>Z$OL6CA1;/U)T@)-&G3A0=V_#H^0LNEUDE38_6^<2! M?MV?.H9VW"BB]Y*+)_\=?A M$US@5<;;*)$UIK^XH5*>L\?BXR)MXT#&&XD[G!$H=Q:00XFE!8H0J0U*$8!0 M#_%#%!_48KA D?^RPY+GCS>15)IT<63Y+M@[]EW6IPQ,X ^!F;@C) MM_AQ=!B3]@C%\Y-"=X$X(&UDG^HI6:])P3.8C-RJ(]\Y]:P.YO?_4CJ\)5>- M\JP8Z.@W9#7!)WV/4BJ&58N25"_E.!HB4BT*1/YD+HIFUP,T7.G2,4O,/VC^#TP?'#KVFD0SSG?48(@UB!+4)M%EYTE PVY=P M#1?2-&-&=)+?)%EZ69PFFZQ.>RMTP!&#?I05J($?UY^F M1W "HF+ <.=2%@:J&@(.<"[#!8)R6'%99)1T1(<> :MJ=E>C?%4F*JJG")CD^5$/!50\.IPRE_,=@@WIV.5D# MI#L7 XPV N("%9BW^FA;'V4%%<<\%VGNS$&?4B,&I:S>4*S*ODH&(B84C6M^ M*5P9D^-=FE%!"K3*[(.8KHQI*D]IXX@NC%%\E(X,C2]#B[EEFMS>TU?H *OVWQ&U;E[@9JM52WM_&YKL_-95I_=2'/QC$E,75 2DD: M5TU^W+*'T^O5)TPO4;R,\2F]0;&.P/NW=1,M:CZK2R6K#SVJ#M9'TYE<^Z2, M6PTN,.7]$3M&5GIRD @C"E2*![&+R+0).@I>[6K1YLV1-@=]+0 MI?]WH=M4^+==!T TNS+^#>P%TEJ'K[*[:BX9*U_125/,DKXL\V;^ Z TVY'WUI+YY__+TXA8U MH-$ -F+ @[*,)G&)&<5"%@5/'AY*UGF#(G*]:OB8=_V=:K-L]"V\./@TC % MP@=(,".A06,N[9'-=H)8D7"H@QXWR%N/ MW 1$0T\VWAE9\FZSQT6Q3?);S) 9L>Y4PP!VW=ATWL_8!B820)& &MR44U*2 MZ)(GX!FYZ:K64ZWXA,LZHT>W(@17XPOP22B=.=156($"K*J.PQ4!+L4]?&9S M#C"(%\ZKPSX$0,& $K/$V1.S;ZL;DF?+UVD[[GQ@%/Y#EE85_EZRE)]\,"#+\"G-D:LWO/H>$H MH!T<%HACP?SF#2:(H1+\7#R MJ&,:6(MHX8HS+'G$;58\\.. 55J]K[B+0"(3TQ] RS)()_9>DZ&#C%K0Z$L+ M/%(YAFDJ$W/2>;YJ\TL_+PHQ>=V6#;6XS:W0..??664I68D,HSEUQD MU!A8U^=E2(?2%H116 M'QGN 8$1UO-E@UH75!5F3_@LJ9/Q( ?=X1;7B[%I@]TK.N"(08\2(:!-8F)* MM]BWAQL>1DFO.R5.*GR&Q7_-[A3J.=S>-,9A1;Y_C"/E\%;B:M5NNST(K%"+ M%GK7(A8G- [&G=.W&QWB!W1D:K;2E@\$.RY#-]&^G4\';04UB3Z)/-D*38SF MZ_L?'GAQW1'[0#8$8!/L3Q6LOO'[']X]?-,&ZH;MAJHD(=&A2Y0"MD-^5#P. MZGSBH!CM_M0Q2L[NXV!;6-9^3=;E8W>U9+0G0BTFDI2!55,Q7# /!72].F;A M[0_\&JM(1U>.A0;OC,WIOQIC3C_@+QWTAC4 SDL;#/]]73_B$M6/28%V/XJ8 MKZ[>!F)$VW!^ZZK"]2VNLY)CDV)+]KN_ ?.TPLB MFMZ7=,B&5/3/JY-7]AOEUC%2F/1,>Q$K7X ML?O"_2OBOXYZ<;3?2^)\@\*5+,8/O,HM:WJ99O6VQ&WE]3O"*D!>4>LAY=(L M+6!L/@.TG+$^).^>[QX':N-3KJX$;BCAX./4. 9L!'% 74\NDR8;ZV.R'O.6 MC/P5X"@9S.(]"J#)B6.P@CM&QJA%)DC@=ULOLG)]FK*T^H!S1($?X1@@GVRHK M<%4UAXM6(P35-[:-$,;F]LTR+:Q9]#]0$G>L_\$TQ4+;JLIR@:-C[.S-,"4! M>RZ)60%PG'R'5F+4*G_#W!6-BG]3PQUD586L!#@%WS:?"KB6G\5:"I:QC@W= M6C=E5BRS39*C/JVJ0$7TDH>3G"-)J)I!*<2;'*;@FNX3,^H3,++]9)I&X=[MBCI+LWS+'CW[NFCG+\M\F^)4E*A8;[9U4U7E M/"D+*G@L?HRC?KQFB0ZR-SZ7Z.%0"2/D0TV&!PQ;7 MMFI,ARU[-6GQ9=&=B&.\0 +GZ+4/W4^(54.(YE?U8U+SP5@D M761T%/T;6R#*BF^#2KL-]Q('>Q/,G/BU:>!T+/HWM157SY@BPBG7+-5T?7G@ M+$ 3P1":;V'_=;\'UE+T%A:G%"*# NU'*!5(VI8R]TX"0,,BOW3P=)Q#.9]_8*J:K3I"Q?5Z1\3LI4IBZF/P!RAGSB4-=[.0:0 M,]OE>@ 7\<%=A,)'!LOQ) H:C$/,J1<^ N!.\3(W/LCVC?\NQ"M<7T=!5)J. M_*Q_)WN64E$E/#-'+?0]A<2"1L.#$:R'F26;U;>IAUR*7W3\Q?DX87T?[N^9,AELA]A\LU*^'T M(:F;,+IA[D*7BW%9_ TGY1T%+'/?VTT&Y$ 8T%!G"PP[R,D2B@Z (%W7FXA!]G.."Z=*3P9#R@S=2UG<^'0T8<:18!B)OS:[H[,-0$E M^3P-T(_XI;Y[QOD3_D"7\B@[B9S,&<(@W8<]2\-T'TGO!JH]56"&ZA_G;ZA* MF15JL*II/4\MP._,S\299ZF?*IA?Z9G,4M0;W,+XE" T@ GVC_,7['U&M/(G M[5/6,EOY;+NZH22M1_-6%",@V<:[,WDW S]?( Y.,W7% \*P/&#>4H&]MM6$ M)_9V"XF0S"O9?*)!H&#GRS SF/=MPY6H5BMMAJ;Q!?"T4,SL_RU,@&,ELGAN M.,JSY#[+N4:)HB1UR$P M+-4>3=EJUXO2#FM_S2&0Y2A8EKO69X=:%ZBVH&B M=+H8>ZVYD2PP@@+5X1YB2L4HJO6JT2:O-XUM8 ME](_7I.RSOZEBN(S_-J!K"F@>"^O/8#%0D]+ALH161UM*4M&[*U@N@D2IM2F M[&PT/W\,S9Z@)\#^YYY.@A:,;_:\&*K(!:+4_"DZ.VJ1W4!)CM-R-@QYO*(W M!DNN')W#$VONP K,GW>/]'*5, 1FR:7CVV# J@K:ADLG63[B=)OCZ]497N&R MY'VI19N/]S05JO$K> +FF M$@/2KACH*S7%<@^)XXV)( KGJQ5>LE*=(K:#(GV;U/@6,^I1C+G!8R@/\"FM MA<(<=$C)Z+!#390\DY#_O[EKZ6T;AL%_1<<.2 Z[[I9F+3!@"X)VW=V-U-/41#"3G%E[?\)C1I:-C9&X_I=WC M/%4Y9'=T54OSNW\[VC1&-FJ4#)][')VNI%$9G5'>0C0>WGI.I0Q@35UF/==S M3?>\)=#!5J^DD('TQ7D8YWKV?59HVO9]TSQ_->>4B6E.6#&!3BNQDYF&!^HT M"3SH;G XK5Q)FLZ4\[\^,\?QZ8#QG@CY-T-TILE"<76Z8[0'G6L2!XN&&XC. MSX?$8XQ[AD-$IKEIY^YX5TPFO$\W*4*JOT+G^GC(F'B$BW)#2*:Y+.;L=M>8 M>+HK8:?F71"$?95[8CCI;BGOH4D'QNE"/(#3KBP6D=Q2$F MCP(NRI?5;\NQ#,T:8D\NN849_H'"32Y7$@:3QS^XSND&(_QE]1%GT&;U6 M-LCT)0'-FP-?MYM/(Q,\N8$E/0TS([+;ILWSUKZ(5R:#MD#YMZW9>Y'3_/;P MU-#\6W6O>F(%H7HQ&BU,1GA!V*(;S@I#PUT00+X( DA1$/ #SMG1EB]I*G;@ M.X?Y\W@\ZML)GYA6[3T%JK 2KK1W''F'L\8:E'N4C*75G6]!K&V4!U,QFZXD M'D)&-+P&'L<%RQ@5T;FAP$;SHQ=_^8(X&\S M2!3YE95=_SHE7T!@WZ"9@?P)GL7K,L> X.NP,(44%7E7NDFFE">D;?'2:0-* M%G\]$9%N!3805=YLLP-D>JS[4]ZJRJVQ!I='T40J=A7Q6'#MMN 8;T.\(XK= M5AI"I"6).&$<4,7FN#%>FI^H1?'8/?_A*^A/]B.K^6+[M819XI&U; M]E6G^ %4YFE8!Z WN=B$O[GZ0P]=95%1'@B??2D_ZD-"'T M; /DYFD2_+SU(PO6.=$&2W_/9_>W*_JJ5[:$5VM[)+BU*%P1*UDK=:>O6 MVIW,G#T7;SVG=4&;]58M':(LAA%3$Y[ KL%ZR<%SZH5JLB9'Y7WAD[3(FN)J MAO!?9'3=.J/+^,0L=(U*CH2NVVM$E]G5 W1-\%\T=(FJ\&!(UG:-D3K5T!*) MIA&)P1E=>I5]K+9)RW9J09 ^<<(FJJQH=/$)GKO=: M*9BTSH30=Q M*8YP\>70D6T&(6LVS8R#SIC\,LHL(NTBO6%BLA.F71^Q#*;W1AEET%T2#?ZR M"E#U*K\D-<;0NJ4U$L(:J:%!>E1+E-ZTP72;6__ =02P,$% @ 1F!]6/(SW48.9P 6[P( !4 !I M;FES+3(P,C,Q,C,Q7W!R92YX;6SMO5USXS;6+GI_JLY_R,F^5I+N3B?IJ9F] M2Y;M?EW;;?FUU M+@#K"PM__U\OJ_B[9Y123))_?/_NAY^^_PXE(8EPLOC']U\?1^/'R_^ MS\7#[7>C[W[Z\+=W[^Z_?/=U-OGN_4_O?Q[]]&'T_K?1Z'_^/<;)GW_C_WL* M*/J.$9'0XN,_OE]FV?IO/_[X[=NW'UZ>TO@'DBY^?/_33Q]^W+7^?MN<_QIE M^P['C3_^6/ZX;_IFZ&\?BK;O/GWZ]&/QZ[XIQ54-V:#O?OP_7VX?PR5:!2.< M<$1"3@O%?Z/%E[K6/T M_8]'U*]31%F?HO$M^V+;GI/9."@E0TPZMQCNZ(A)>,(O?S3=R1)%X0\+ M\OQCA'#Q?/Y' 48!!/OPKRM&8K9A A_@_>/BX G%__A>]'-)3QG#-@_H4S&[8J2B]:21C,[CQ7^:1[LESE*4Q3=EL\0[I+%+E 0PAY8 M[/1_XV\81?_X/DOS/15!&IYL*6\'VK;X<1VD?/L(ESB.=KWG*5GI+U0$!@U[ M<$NP9$R90[=6L '(*S%:8MI#QX[0R#9;HE(.ALZ\0OP)0!QE:KH7*;A:;S+$<*VNX7/0E=WHK:SAJ0G>RO)6EK>RO)7E MK2R;5I:Y1F77W/IM%",>#CL8(OOW![2Q)"-8,JR4%'AKJE5KZA8Q84?3-8]7 MXV1QRU\&'2=1J6V@\K/(!*DQ@C<$O9'DC21O)'DCR1M)WDCJG87@C21O)%4; M2;5U/KLVTH?1.D_#):,GVD9P@B0:X>09T:S8'D::)A-\0$L6E"Y!WJ#RX2FM M\-0X_"O'%'-I!<6B9.V':Y$,GP-O4WF;RMM4WJ;R-I6WJ;Q-U2>;2E-]LF9! M123,BS^X18$*J34[% 4.% 43$E414_5S MF]3D*5\#K]DZ%\3_1$%ZE427;+)54:9HVB*5E]M9/TZ2/(C+[.D*"F7-+%#' M].S';)5=I2E))X2!%7+Q%BP3\$Y6*.?O]!ZEF$37[+LJCXNRK34ZN>S!J'S3 MT@*--X?=2&0P0YO;I;;*7(8TM4!E*6WBI4G:S@)]LS1(2HU/N3:)FMJ@DCU" M1MG1SRU2LS6>HHBIA'3[#Y?\=T*WLZ2M+3KYKCQ-9^2;V#DN;&F+QGO"U.3X M_\=K@6:A;FR+TL)ZG*;W*7G&9;$)*:V"YJU3.V&3(@WB&V9"O/QOM!&2*6C7 M/GUDM2),>V#VY>.2F;)TFF=%01.<5&D<\$[M4UZJDOMCM>O4WN=/,0ZO8Q*(2:QHTSI=#VB!N8WD!#G#( 1^MH3NFM(@\^' ZG=%8-7SP<(4=T6 WO)AP;1Y1:8*X#'!='U%I0 M=@4<%4>T6GB"!!P:1W1;:)X+'!A'5%UQ:C$<"D=T7'G4 Z'(_JM/%P!][0Y MI=>"@H9P;)Q2*7(4X=%4I]1=8:XK' ^G M5%SX00DX0([HN\(#TW D'%%OI4?9X6@XHM%*2@T4&/;OBJ-PQQWFV)"G^#WI=ET2C1[<<%"X_,/6GK;NE M7'P65*>++S0(H7,T#9)%65CYU*E0:;CR44I-+(P."IAZR%H^!5,^:CL-JKEE'_[U MYN$BM1_6N+9#04SIERR-9RA=T>E\ED;LX:(R^K#&+5)Z1Y*'/$;O?GKZ^(X] M>AR1-=ME*HZ;RQLW4&E>F]99NDHR(*F'ME8HA4/:)9Y@,.L@.2P5#;AR$+V9 MVYYF9K$(OAXT0+EN3SGK+3+P1;0]-:VWX,!6&C PVF&RW@(#WL^LQ MC2)$PQ2O^>@C,A\];=.PBG+K%"^2XLP.+[\>AOQ4$V-SM"8Q#C'2O;JXD6>U M'V=KFE8??VLF_G86MW2GET_E5 MD"9,\.C.GW2QJ1Z@XJ58?&(/$.2)*Y631;>;75[XY2+W,8H6*!K3"8GC@&=5 MQU]016DLO4Y6^=BE]EX>EM1Q$HWW"^?]=MU4W55G/(Y5;OT==GVXP^Z**0AD M@U#A-IP6LB*=-LKV5JG?SM_R0(ED]1:VZXY:Z3(K:6F?8KYBY.F:60Y?#BA7%CS3;LB7Y8U(J#/S!6! MM8PNV!/B7#9HBSGV/3UWZW/L7R,!B8D+](9L@9)M\<;JHR"N( M\5\Y6R&R?7T*8&8%?$!+Z1.Z!/D>?3H(+OOPKT=&3I!BP@A"84"S2N+5#:W1^36A:Q3B.68R637W06W;IW8G M@SM2*A8%93N[V2A'AT78WGI'&#G[;XHZ^4%1<(K*TU/,1AEN_L/P.>@H@X-3 M1+CREJ-HND9E>7WZ7RB.V +S&,1HFK(FW(\23><7&_Z-5/)JCV>;>T9*$']. M2;Z>Q &E^^+YDFP%8*^^<"+-8@#WZXX;>I-PXY_9%]7"I4P[K#F:5<[Y-13FWOO>SX1:5R1#>PO(6EK>PO(7E+2QO M87D+JS\6EOE>;M?B^F6T9I_9/E"8(R1;HG3$>@?) K,7/@J*_ 1-NTMK3$O6 MEP%-W@;S-IBWP89D@]WL)W295Z43S +W]!:7M[B\Q>4M+F]Q>8O+6US]L;BT MMW"[AM:OHS*=.ROLC0@]L5]X%GEAC_ 6E%DHF^-W#K2V] >V9'*9$N;MKE;M MKLD2H_G5"PJ+^J+3^1R'*!TGT609X'05)-/Y;(DN2)!6W[A1:XPFR.=GAV[_ M*$X39]4UI)3MFB)C"B1#T*X),O9'1*;SR6&V7>XG&UL5266%6/:V -0W/WP# M3'\)_DW*6KE+$K.=3,* HJEC;@P!B6PNOO_IW8=[MKMB2DFZX4\78P9HWAA1 MO^D1)6W>&%&?](B2-K=J?9>+S;R8@-)Z4N*&7="[72BFZ0->+&7E:93MNZ<> M KNLAUV?'WK*#DO\Q>9K@O_*T7%M9$D).9V^'7*EKJVF:&Z==KC74M':.N4W M"=N[_,+68:;PXVQW0ELB]JGGGM-]R MJSN5S@)H-\N9=_B9:<_W<1 6*K2TNJN\L=U8"2]A4>I@?#UA-O.A+);T+< [ MVN7'G4MQ0D<*A.((!^GF:.+)I$+5WD<* M0FJEC9@;8,Z I,Y-@>F^SB3KZ$@-Q/7@###P+":Y[>P<(!!]K_DK70=?V]0@ MW.2*Z&AK@.VF;H!A'6R]46BDRB4!$YM=>CDA8$P&6W=4+Y[CBHQ + AXQA48 ME<&79@6FK+@B)B S')B?Z8IR UY> =EMKF "7D[J91J[HJN 10B0B^B*"&DN M-=(<;# FO_0;$QOGIWX=*@3^_)3T_!0HF=#NF:E/(WJD2!;%\K+-B*&-T(J_ MW9,#1OM7,:+5AG41,,[!+$\2]LI7X[:N7.$4A&U$B_QK=&CDTE_R5 M!W%Q?^1T77$/[.E9.47C\SC%-TW03HK$6 D;-4# ?X/?F+QE Z3PN.L^^K%( M40DZOSQMPA9NIAKP M=4+O&F8S1US/"G7^1+AK!18^<.937H )=+6 M39#TC>PD5_+2Q*WJIP33-#M*!V:?#JH@OW6MTA-522FP=>L4[]9O(9'5#5JG M"PQBQ_A]"5[P*E\)R:O\O7VJV$204E7U>^M4,0V,XDAT^D;2HG7*'OAUQ17& M6^5O=J@18E3Q:^L4S7#&4Y=ND@@_XXCMW *LI.WL4\DWZ@<4EW>K+O%Z1B2> M@QHC6#UJ,OX6I-&,/5%RO*2RC2\SX,L,]+;,P(G!SF5!K]* ;O=N>5.>) ?T MZ("#G;=+?GI6VM:7KCCOTA6^*$$/BA*<.!I+]XMT1BO;6Z7^,]^P.#%!EE/) M#!:VZXY:Z425M+1;]H$DBPRE*[YP*-1,6=-.:987J) VMEN6(@Z*)5F"<563 M3FB48EK=R"J=#X@MJCC,M@$>MF%G].'QJW1E _7Q!3]J%_QX%4<$%/R0]O E M2_0XX D>%P%%T82LUHA)19FDE')/4A'1N-@*\;H&Y??2%T>7X_0$8>[Z728;=)@ ML/D ON"2/O6WON!2LW2RM[I-6KPJ],J\;)0D)O M18LN*)2J,I5M?%DN7Y;K-1R^+-<.$;?+-$J9=D1X3*[JQ(_+."5DWY6I[7H[+U\$V,:H:.'4- MQFOXU465Z;>NR [4504X>P*&9/!E17TY[,&5P^[YCM^@VJ1?C@<,XF#K+ZI3 M_EV9GR(GLWX=)%>FEA01:'$55W1G-1CBFC=@# 9;HQ18:&'H:P4XS@ NHP-& MY+=^(@+?023U'X8N%N#4&^"I55X&IK8"0^]1L)]?10' UV98J 8H^F MIS_@( TV)BFI_C1T$9'FLDJJ@PU]M93S+:[5Y@+?2F4*4AUTZ"8&' A5&4GX M$M#3-0"^7PJ/ZPQ]&02F_1D?Y1UZ+ )L@S5J?O5TZ8!IVL!*U$,/0X E0U8_ M=NB[:F/+A^ $^=!=WO#-5KNT_-!75K ;0Z-$S=!=G^ U15HFV)5MIOZB(BJ] M =?:>K[NVKC*[%W/Q<3?908XAUT-BU$%B -:-FXW>_?3"">L%1IEP0O2O9M, MT+MDI/6;Q:1/]_>"M7HO6)_NJJE=K<-7C>U#U=B;8B[/@A=XD1U(%U^-R7XU MIF'M[[Y2C:]4XRO5]-8^&BH$WCR2FD?PO=NR1?1NQ-JL<%8L_L7-PR%)N*<$ ML8U!WT0"#F?+9M(BQQM1[5ZNS)#GTX.?/)HMT25!UR1E?]RD:1#AXHWS@P)/ M0Y9&3ZLTRT'+=#!P.H>A%=5<<57"#> M+&+@.G(8GVJGI0PDJ=/6%:1T;$Y2P[!S!2^Y_G96*XB BGG#XC:N9/7I;NTZ\117,#(2&TG4TA5<3-0> ]>:*V?; MY>615*D\0Q<:M<$)S+ERY52R>E4!..^&+A5@/;?!U$]7"AY RA]+8]>N" ]( M[==):P,#T].2,IH2(HN].R4C:F-('N !@]'3*C(:.3'T;S M *>CYR#.T6B% DY90?B.*NC!2>5 MHY, @GQAR5]Q1F?[#ZD9/6O6@_C](R)8C]&Y)%@OEC=#UHTD%L M><\ 1'C/F?><><_9D#QGBGQ%E5M&M[OW7WC_A?=?>/^%]U\,TWX:K GI[2>I M_62VCULVI7X9T?R)HK]R_A4G6#\503*$+3-*28(WHEHUHB[S>9'\**Z+6]W" M,?M-0.)]BM;E[>[7)%5#!6@^7)-L^!QT9%0RBM:$!O'GE.3K21Q0BNI>I?JF;M4% R T M -'%G(F4&*]LYYF":.2D<@66NHM]+;_0^>1V=N$C<45$[>^R>O$/5Z2X(YP; M@7:P!=.:R]\8?,DOG[]1[:>!>;.L)6Q0O$@*'8']'80AKQO$)OQH36+,2UWL M_X#G;^B.V'XZAQE%/KNCU>R.H]=C_**.$QR:&,^J'WR\)^A^2X8B?4#=P2[] MT3-*V>QC]$P(S6A!U$;ES0?VLEN4(D@31@^]1^GCDBWX,$Z O;HIV#"=[^,' M-PD3DKP(()0D"OC1ZFN5J\^$1-]P'(]Y=;LL2!:8Z1Q%&4V@T.D/8#?>OUHS M[#G*TW2G@4_GMR19W.)G7B04SFF=H3K(<9@%+T"^%,TMT\Y5-Y)NH+3+FUNE M_0Y].]I'4I*P/T-T-,-A/)D.8[GPRPD-BNU5T7IXE'=UG[&H<"E,LG2[6SZ$ M%R+\S$U>X'JL[F"9?HJ8:;EDN%ZB9Q23 MFKES5**))J!QH]NS@6^7 XZ Q] M,URQ=7CBX"B:$)67&#* OGKPM'#53)^ M>0=33_B4E^NH-4;RF88.9!I^I=7$NF!I)4P -<@G=*UM9WS<)R<4K5KNX_A MN#FEA&NENL QIRLYM271LA4S#)8KR MF%\6SXB*<)QSS>$1A7G*5'E$KU[XX1D4E94:5^L\VUX+_WHS5<;U6WM01WC] M@?!BF:%HS!3[8('N+2.BZV5;;5H%T V\UQHC6G)-6% D_<]=.-[T'I5(.>"PD/6&[+>D/6&K-HVT]6*[-I:OXS6['.2E?Y,DBU1 M.L+[)-114&13FIE<)D-;LKS,2?,&6#<&F,D; ]EAYJ)@/3AYS3C)4)'E_#I/ M7#,TJ3U2)QP3&9W7>9:G:+SB&4W_*9:%;4ZA%A1-/L(;M=ZH[3.=YV?4&JWM MWK;UMJVW;;UMZVU;G;BCH4;IBM# H6I>X[3K,/AU%)*D./;$M] (/;%?>('V M8HOE+2C;=#><7#.O@?'XEEP'->GS_H-N_ ?&KPWD1*@I%-8]"9?H*3LJ> %W M'*@Z=L3/ER#;9KJ4)\%G*%UQ4C7=(GK#>'O?V_M]IO/\['WS9=@;_=[H]T:_ M-_J]T:]C],.T05=D1 <9$TW2KAW_VRA& 44C\A3C17EIFIG!KA[(DF4.)<2; MX*V:X+>(4H1N%O:V<)_I/#];&+#:>*/7&[W>Z/5&KS=ZU:8=2/]Q13#$<-15 MT.W:N)]&E!]J7I*8H4Z+XTS99L0P1VA5>(&/W<7[%\)V4K[HDW6Y:7+?\;<@ M38/$-!&^;3(LV==VV/#6>34J:?DIO4*JH+PLA4L;!0<^<%=X< *WT^&JF UW;)[\L97N M:?K 2Z-HY&\8CN?=.]Z]TV.>2=0SIQ_UKZE2NB MHP58(WHY&+F>7WU1'[E:YIY=[]R[GT:XN).*J1XOQC<22 >Q=<< @ COU^KH MU@#INP%YI2"OMX,C'.4J-@M>RK-CXR3:N>2Q=JUZH]$ZXOQJ/D=\,4/[&^T> MV.OB-Y4E(:.WF-.:[)L/Z3TCWC/29SK/SS.B6*V]7\/[-;Q?P_LUO%]#Q]BL MJR"Y(CUZIV.,=6K+AOC[LA32*$493LL?#FFCAG:YSIBVS'1]FKS5WI'5KO.J M8$:\_LNW;ME.ED&R8$MLL5P\[.F<[LG4-&L-Q_,VK;=I^TSG&=JT6HN7-W&] MB>M-7&_B>A-7QURKI2Q9-MA^9AO!,TIRQ/X-R2+!-0PUR%BV##0X+=XPZ\@P M@[PBF$$&?]F65-%+3(/%(D6+[>6(#R5Y( U5JZ\WL+R!U6<&9&:Q+C$"/*^F8!CNDH8ZSD0:QKJK7Q;%NF77NT>U.P55.0GP*? MD6NEV6[V1V^DJ.33^]GE85WG%45!AA(KC87E,G4'K?-H0IOLU3 M'!C\M%@#Z@$.%GOI%,\I1O.!(& MP6-TQ2>;G1&.KUS7;._D[R;.MU_$J2!,F=?0>I<5; M&Z\X-R+^FQA[F+A<;*H'J%@H+3ZQ!PC>!2M4N8'I=K/+"\]ANH]1M$#1F$Y( M'+-U*PWB+VCUA%(1)Z!.5OF8!'0Y3B+^#Z^F\AS$;.6AXVP2I.F&2=/O09R+ MEFM0WXYFZQ53%,D&H:,Z)])7HVQOE?K/A$3?\ ;OW*HN&"X).Z_4!RQ/?VK4+4!]>V*K^29 MT472S1]L:66+ZC?12ORV84<4?R$)VGP)TC]1=ITG$7"]4O3JB)>[G"\ST_ET MS;8";D]N_0BBZ2YLWQ']V_V,FTVY3)L1MNN.6JG:(6EIGV+VFN_S=$TH4B%< MW;)+BM4HB]I:I?H!412D(==H+M$SBLF:SRJYP2KMT]%\?$0I4X\G]SN7:Z'1 M2'4?0 \?YG4@S/N8IRC;7) DDHN#H)EC 51-MU_G 5,?'[06$K+A>"&F#@Y7 M0!;K@T1#"7,*#8'N]AH/N;KD"B+J"+7"HG E5 ^:*#JN15> 4J(S")R!0K@ M\B%7[WC+?6VR,@K_M+=B]Q4DSZ-3>DMM;A&HE1;6W/O<6+W44%@S* M1V= @25!@('YQ1E@#%,JP$C]ZB12X!0-,$Z_.8.3.M<8#,HG9T#1B@3#U45W M=&FSW&XX4NYHUJTD2=L]?O3^<&XF)$E4EOKA)VABS&R%B%^D6N^,D?D#+!TD MJDN@/RW4ZFFA[74!E)(0\T7I#YPM[^,@21!;OLN+?2E[8]WL'I'A5_(N"EKX MQ2QW) D.W\S87S0(B_MGY6=FS$:Q7=:4S;H,)SF*MKYB1M#6:'P,8C1-61,> MF(VF\XL-_T;*<^WQ;'//2 GBSRG)UY,XH+0X(UTHZ.)D96"OOG B36(&]^N. M&[:_,_.!V0F5LC5AXH6C[0<(DQK#=90&?4(NE=.K/H-85N)*ZW^$N@IB'#1Z7"&5L:QA'I9D5 MQ/RU,%,^9Q;=Q4;KU4D6++L/MXWK*XM@'_&V51]1M[VK';XH!Z@_0'8=",Z^RC:%=U\"Y&F8X,7-XYZ<:AV&^ MRGEZ(K.0V3:)14N1NF-7+/D#*NW0.6,/F\Z/-'[)2\I5K M?ZT(@2LHJ45&RQ7I"BQF6V$3;FE73FVH!:L+EY$K\FE? 6DJGN_^J1E@G''H MHJBMA,D"V>X?)&KN+)5V6GI?(/!GJ20)LMK>W#,\527WV)_A\2G]"-,9GJ R M#U:=T?$IH]S'FJ#*K/T1A>F,=G._ALAZZ=3SUU1GKG M4RTO@G@_LJMS?ARMM_;4:!T7]\@ET0CMK:IZ2JC9X):TTCK$>375JZG:!T 0 MDU\>Q),<:3EJXM54KZ9Z-=6KJ5Y-]6IJ9VY4R7YD5TW]9;1FGWFE2ZZED6R) MTA'>5P\;!4663$UMM=8S+"FM#=#H=5>ONVJ73ECQ^^7_LZWP]+ILGT#KDG?R M^JW7;[U^Z_5;K]]Z_;8K_59OA[*K\?XZ*K.[LT*QB] 3^X4GE1>*'V]!F2JX M"J $^6&,VO7E!8% R=SN6A$3)>O5:''%R?X8S'0^.2P1E_L5@JWLI/*2&292 (B;'[X!IK\$ M_R9E@=TEB=F^+&% T=11HU= *ELXWO_T[L,]4Q&%&?](B2-K=J.6\7H6(B2FNIB1MV0>]VP=BNF9*",\KVW5,/@5W6HWL. MF Z2AIBB^Y1I(&]WM'G;(5?J2IF* MYAW2/DWQ O,CX^S;\I8$T7JB[->AA-TD-$MS174T<<,.Z3U2YB]04ASZ#.(# MS-V%F(F5_; [(3"6(CNV:[*G4P+ MV)N2#= +#D$KFJRYY<,7)9SWI>=M>RM>6= M+#\(V #T[.A]<)\Q,_69%8^S M76$-R=JF:MXY[;?6/+=),0H8CR MJY$>4%%2X#Y(LPV?N$+JQ5VZBI07IVT+JYBO,=/Y45%&J2S!.]KE1WW+]&M& MH/=2V\X%./982!8F97N?>>% D>+BK=Y0FJ/HDEG5R8+I,YB4U]K1._2M^$F, M-:1S5RM0_D1QA(-T<[2DR.1=U=XJ]3N7!M-H2I^&VH\@ZP)[!\/*W_!Y/3ZO M!Y3%(=S "-R-[PHH$E<*T3427<($[JTDNMY!5V!2AXS>SB=U?,85=)1V/#&U MEUU!2*U@$7,ST!F0U)F8,#W5F=14':F!N'&< 0:>LRNWX)T#!*+O@;TS8'0& M7]_;(&CKBNAH:X#MIO:!81ULS6UH9-$8N&)7!ER<'IC*Z(B8@,QQXR, 5Y0:\O *RGEW!!+RJSW]J+>XZ20LM:<[ M]1:>)LZ(@&'[;?"P&=8. "/T:? (U3@[ ==#W='8H2>9X-BXHZ3KGED]8-2S MZD ],\Z62FJ"J?W65 MFN/*%V%JO0HIW>X.UR2]S]-P&5#$M(TL#<)LFD@*>>CV;9_VRP2Z&4-FR8D!EK"22EHFG3Q,C>F+1A X0J0X?TE^YL'+*UM/B8XB3$ZS=EN\PZVST$O9T[#L\+:D M::O3;OZOKT6GVZHR3&;D(DC_A/%2VMTK]R:9ZR+27 MB#Z@1Q\XD$X$4!]_S-D7F <<1.V-BN:/N)[/$5?((DR,UCM7$))J:$1/)W(% M$T#BM5*O=26;%BH?6BJG*^"H!06L!;H""7#%A?KO7,D4-85%X,!S):G8&!:1 MB]45>3%9=B56LBORHH*E1H2EO2RD:+>\XG4YQ3UCI!XRZ=1 MQJR;:IT)2N( C',+B08JL%".W7R@3R-Z=%IVA/[*V6L;,FF:-'DLY0);Y\=D_[5[!QG/[O@ O#Q.T:XJ, M.R 9@G:-WV%6E=R_^Q )J8-U;_96,]ES]2EMDSA_+UQ_[H4[IJI\^,7IPSE5 M$[):D41< ;N!D5IA9=(8*SHC-<#*%=N_R0:A8O2=,7L?!XF89F"7QH@K#LTO M4E2676,_K/)5L;PQ?; XXRHF4MFUT6G]NM !/WUTB5,4LA$ETU6C6R,9KF(K M;<2V@S5*Z-;@9YOUHI#ZB\VAR=9"'C.C9^=?F;AVG?^!L.6$BP.RE&R8+5+Z\FH[1 /E%59>??I%OI\)&31'P[N--PM\1 MVV$ E$A;-T'2-[);'B4O3=RJ?@X:3;.C_#/VZ6 ?LP_5-8LJ*06V;IWBG;(@ M)+*Z0>MT@4'L&+\OP0M7#(7D5?[>/E6ENBJFJNKWUJEB>S'%$1+<>25IT3IE M#WRKJO!H5?YFAQHA1A6_MD[1#&>\R/5-$N%G'#%U18"5M)U]*OE&7>0O<*UJ MB=A,H:31>O]:ZK%_ZG*.<9UKFCJY$*I5!QM*6RC54J M_17LG5/OKV#W5[#[*]@[NX+]Q/%G'3JE)-=9%!^A[&TK?63X>#K-"H. MAFO>0M()5WLA/Z0^0:1,;Y .KY27$GG8[;>>])I,B\;K!?_*Y1QV#6 GM%>4 MSP4Q 2B[VTF5B5:K@'3%(7>!H"2BDGI\(MX 73OGZB0PJ&3DI'5'M.^3)U#Z MS$R]:A?.'2E"4B@J/"5T1C)>C_/P^X30[(YD_T39 PK)(L'_>9-WU?KS7,.O M3"Z^)NGV*]Y.M*#9):+/2,^"E[)D;,;KA<-]F,T,WC4R?!TIM0JI]JQL;Y7Z MSUP=0L4.E5.)MBQLUQVU4E5)TM+7>'*TQM,V$X5.Y_M=7D!T15<$5 M>8E<5#7IA$:I'%0WLDNG*#/L8&X4'G41!\#N74G*"7F7F(;<6IHFI1T/XNEU MIYYP4LY ;B@I;2Q(UUYP=1^DT[2T^WX/XER4G:S7N1>:<><:(.1BEZ]8*70OY!]!)PUZE/G*2/ 4\?NBH.FNIP<]*Q!QQMP=UE%D#> MS.LN'7'Q@-9[;?U5Y$G A*1'9SS0C&UXV7;V?DUP1A\>OTK]!* ^=FMP%B*] MCR-/Y]#RI_".=OFI.BTH?2> 'AUP,-'F0-K#+@>5OKZW1TTN7A\U*?[W.YLC M^QLN1?[9)A_1T?IAS$*Y_QRB4K0H*3A;!LDV_EGXR>A-4O+7-(*:CW<.W=\+ MEW]GZ)X^?FCH7@B6/'QJZ M=V2[+[_9M\M@9>/Z@?*!@T-P>RI@'$5%,D00 YVV+3YQJ!C:0LXQO)X#'&^+ MO1:3J&787C]N:.AM#1%&_ASA;;6I=HPA\9,&BMFI:5P4U&@)LXHG#12SH^C5 M'X@?K4+1^!FEP0*='*EK"4?@T_N*+97ZP8J,I"0"Y8*T^:B!8%8YM=J0R>8H MZ)=<%H+ : ^72'1W;8T1>L:A^%+<6F/TC4O!;;LU1NB(P]T\.TQ#:24X\P'L M\Z=-33<#C5OU5I[$^,/#1^9PW6&TI4T)MG* M X>&X'3'0Z&)<%OW)LE2G% <%GPVCJ#R@0-%\#38MY>3MO 3/:Y+]+:G>2%Y MJ<+VG=)_'V!^WFL6O/ R5;R6*=M#V!?5FI&4-;VA.N7Z,7_Z-UO 9N0+,Y[Y M8S>'/.%'E&5Q><$.6]UH>418RKCV:%WQOBM0?%Q52G(,1-F^&^IOS_K^Z!;H M/#K70*5G.ZJ:=B;+O#A]L9A>YND^7:JD25@A7LJ8_FA]Y/T.?2M^,F)UW[F/ MG.EM2?HC#8=GJ6O><+A>\A78]-7-5I7O.=/%$**JU#YUKN*/A: ZH2F*[ DIUE7*B#%XVF//@"I1ZA3>)J*/K,&F7(B:2 MOLZ#I2QQ_W;-4M>3=P4=:64I(F[G,B95Q@0!Z?&N(%!95XJ\_=UE#-0F\/$6 MKWF,?>@@J>__(0U M=P_&Y+U3F-PU@DG/Y40]<8") ,X! G%'@ NTN#*% .NLT94VKDB/B15=KCC' M':NDZB;)R(2L5B0Y'RT% A2$P.A\&@HYXQ88%VER9(ZHDK+NWOROP4.9D+81$FQ;D\M:2(S);H_4_O M/MXD_+P@?JX/1L]U9S48/_U2&X-?^XV!>)E0.^"=6"O <8;)$J/YU0L*8[0[IUD+ MB4_]1D(]/137EKDR14"Q1]/J$W"0!AN3K$[X=$)$I+FLVTJ:+JZ6?:BTEY7>0;6/5&KQM0[>"HDB6Y%B1Z*NYHCI*W4]0XA MZ6$'R77;[=F-O87H-%-(=7-,>S;30 "Z#])I6G0L*Q*)2IBV9RT,!*A2DIJ8 M:]KY @-!Z% B55H,M[W <6]Q:JBH;(M!U-Y"=RIB1WFVAR31RLL$6HRW# 2K MXVMFQ9<'M&C=]Q:G-XG)Y?S<"A=Z>T-WB^;_<$ JUZ2RD&$-A-Q1QL4WF<#1 M<$?O%DRJVO(R?,6[,&^%^QCWNU)>6G^6!ERMO PVYI;NN^%KWW*T2IN%S[E9 MBA<+E)I#Y8X:OJ_??A]LN%MWDJ=\X''";^\-RP_F.#FDA@.*W<.]DN[HV ?Y M.9EVYM XI%*76:YT.M^#9 Z+.QJTV94#<*0<4J.K/+;["YH16YUQQ@\X!G&, MHHO-:_>W.83NZ-G'41,N6$$2HFE:E@4H;Z4W1\DA_5L9B7L;7#%7R]\/7RV7 MBM?\S8GM\@O$?JRY.0Y?19&R*Z-F3OB&@J3>K#\'7WLJB@Z MGX=OE!S5F"RVS5V!Z6W5FX9P!\;6+/8%[$)[.&X.&1/ZNZ/YL2C'C 03BW;KY-R&DKE]<)-D M#'>*PV)7-?? ?'3'3-CKLRA]9CM"M1C>D>(F E3>UDIG) OBX]\GA&9W)/LG MRAY02!9)+?OVHSN&1&O@EBL'6VVW7_%V-<3Y7"R00XE46O]T]T=W; ^0G+*= M_@(E:(XSGC;1I&[TT3%3Q,2CM17+PGU%;Y)2;.M9>!^';\34AK7XW[;$3(EI MC672'6/'6*9*!TRM'DB?0VUPYMW.Y7NZ'!"*]KS+][R.[&DRR,A#61?_W)& M5J!"AJ]).D=X>_]F3>/Z%\>L/:,4,9*4R)8G+0])N*6Y7YQ<3DK1#^7U!2Y+21]->EJ4B.H/'Y$D+0V.8RFMS*RO7\D0S-RC9,@"7$0 M[Z?@9?E.9J>O9$N204]C^.8!?2H6D^W\+S%$<49WWQS W,?AYG-F&.!G=%.( MV2QXX688C_$R4F-<+AC9-6)+8TEXSHLQGC1^Q7&#([]>5RQALJ=A&V7/4J"F->&&2?1SA^]G8YZ_$%& M[!<&I0;&Z$X1T^(N4?FO'M?58\#X%&C1/;V:U&0[KKKPHV(:@PV,GD(C4YZ( M2MD;.O.*%]SLO3=#A0"Z\;8G#+VUM(%*8'LRTEMD6C #P"BZ$TV&:^E@<-R) M @-U5?@!$->1@>E[\$POU_$RL0HL^T#?C5B;%$+!F++;'VG MJ.'PMKRDMV.J*#C^ MO94'\W.+LR6Z)+QN!/OC)N6%[(M9P&M /;'%91:D"Y2]NIFWBDC3L1I@YS;@ MR]\M"B:\$-/F#GW[@EYP2,1$PWHXZJ07D;JM*+(["D/_"[,-M)*TRI:-2NCN M$5^"?Y-TDM.,;7CIZX5"TK)18HIHX^2PHH^3A$%_C5^VA^VO:!C$NR,!/"&D MBD[M01IE@4W(GW]Z]R%<)&C1"0(K1_/3(:Q.WJ^S=IFAWY-MFGP[[$ MKYL^E:&*K4G>J'7Z[H(5>B7IE5LZJ*U5;_'Q69#RF$Q&Q2>7,^LCW"Y"M(_ M*T5.MUO'O&SV9%7,%89KV[QE!=*%%-B>-V 0\4 3^@OAW) MF("V[:F$4H,\_I%[TG9*>5F55H]IC8$[0N0+2=#F"UM_47:=)Q$=9X7W&2>+ MXHB!@%U%KXYXV>[W19"A2ME4MNN.6NDZ)VEIGV)^ZCU/UX3*=DA)RRXI5J,L M:FN7ZI2L49IM^ K";Z[CV;KK,IU7H9EH].P'1_NS3/RNBYC0/!4M.3I#=+7^ MB$A4:C(:/:UR]( RG!;&(*>,6\ 2X9,W[IAN*?RJYI9I?T9)CLJ*. =7\$Y- ME.J26GU]UJ<#69^/;+G+-AOS%7V^HMOY MB@J_.-%R20\=#*""070W=%=P@?@CB8';S&%\JMW.,I"D;G=7D-*Q'TD-\\45 MO.1:RG$I\#J!-E?0$OO=B(:SRRDT!#ZRUWC(W5*N(*(^F0".O+ER6$-W:]>) M);F"D9'82.+.KN!BHO88.)#:.ZW1%S&")"D-76C4!B,9Z^"9 B#NV*\(#4?IV$O?8.+O520F1Q=*=D1&T,R<,88#"T MRUSV3BYTX_S.R(F>@TK[; H8)^WRG7T3(4BTWA6I40<.(,%IC5-A[2T8O4/%)).^/5=)[^!1GK=MST_03RQJ M'U=LSR[N'6"&:>;MV86]0TCCV'![5E'O4&DB5[@]"Z!W<,&K,K2G^O8.E/9. M]+2G/ \-1/E9L -.5BKK?!C-V:HP>BYVE!4*^*)0UIFI65-'>V!;U70,"?-U M='SY<:/#^Q1^RD?8OJ,C/5#;"Q8MFC\?,H+=-X1]MJQ_PQ M=;T96H/:\F08$.6]&-Z+H>W%"$/NT*4/*$3XF:^0=RB;Y"E?1D2.#$F7[HI? M%8ON-L=?3G]U8W]EF+=ZO=7KK=ZA:-V#-3R\UBV+*0)VIC/,1--1.2Q;)+^, M:/Y$T5\Y_XJ_M_K158TA;5DCVB1Y6Z156^0RGQ<90.+B^-4M'#6#!*3>IVA= M7@U_35(U9(#F=JT:3->$!O'GE.3K21Q0BNLN,,I9U^7M]^I;BMH8LCN,."WC,5YA)-%-9W**I4U M1[/*>7FCVG[QN@C8*A&BQR5"/!]S'$6%IRZ(#SY3>K'18E RN>T^W':)V1"A MB/("#5SJIW/V3907%W"6[FA18H.RH_?M.%88=*>*7G%-5%$=5-*V2ZH5Y:X5 MK;NF7+J:*]M[3Z#W!)Z))U QC8GVK'$%&:B90HRM 5>0LJSSB0 W50T MCS9DSW;&P6^\LIUGOI61>\856.HN]K4\(N>3R-:%=\ 5$;6_R^KYG%V1XHYP M;@3:P=9U;"[M8/"5"7W:P1M(]!VH=F/LGT9TR5A=DCCBA7F8*LED>,1@1VC% M7_.(+0+/*,TP_WO_3D8T(^&?([(N%H51D$2C;T5E>L8.+P20XC#;M\H3S+[F MA>J?^=C;T+9FX+YS.BUE _2$3Y]BT&J*P>&E]^WU'\?L^TNEW31N1F6D""E4 MMK%*Y<,>P4<.X%>.W\/C5\6]?X ^=L,A7*XN LJ+?ZS6**%;S6!?09K9J/LF M]Z5R7V!_526S[ M)_:&]#GR=NZX)D(9PV75.^OHOWK^Z&>/;ZOX?G05W_XM+'#2W)7Z0;\5U^;* M[P7?G6DYIX]W3[D_Y:]_DF](7[_>#A6Q?_ P)%'U[<2Z0-=XE$_U]<>X 1<*QQL8[:'<^]L+F-L2>?AU4N\2LY,Z!6Q7C#>VA=EG3O>VJ%$NSGL'T?K[;BG?O%7J?19YJUGDNY,D)-G?5"DKP*9HW&9:>TM2!DI6 M;U7"ZX04:9H=A1/9IX-DL0__VEX96?E&A;^W3Q4#6TI5U>^M4_7 ][J*^5?Y MFQUJA A5_&J[*GV^RF-N,UTBMIF$N*SR@=A&4V@.231>\7N"_E->*RVZ%%<0 MV&YJ^*[R9RYRIH_A9"$].%'=R.[U>WF:%&8) ^T:OQ0&BI1F=0?;)>FJ7_S% M1G'61J-G/SCZG!*JSOK,+@>*.,Z8@4[7;),-U,:!5I]SR4]KRV;P66?N9YU5VQQ$H?P/G6L3 MY8S4V'-=P4N=-*2M[KJ24F8H2E [QQ68Q!(D\7X,G7GI(BOQ00T]Q4C.M]@C M.'2^:ZX)&LJM*PE2ADC)/%NN%#+3A$8G?.+*/+.1SMWS"=3G=.X^IN#H>#*' MKGXTA(S(_=;"*M+_9+G6 D?M+4@9R8*XCUCJ^./MYNK\,EJSS_S$)O>4$9YQ M-&*]F4I;G/4,RI*8QPZVM[^:Y>FT\&1+.3JM4>[S<[JI\MC""P6EPK0F2+9B MWHR]#-WB9Y[WO".LK*)[M'L<[Q*B6+CV0%VE(T@HE8655=TZJLC3%C?=5+*1 MD"4.E;E;K *=\\9O.7U-V1+2 +6#O MSJK\^,CY\.QI^YNSCS>['V^VZ;(;BCNFARZ[GM<#T%48G1,9 #HZ2LY9NO!, ME:;V/'2]/KFG:]:<9=F !DSU]@H ]-8!K&=E]MT%/,]Y%L\H.'[)Z(6?=476 MG,$:-/36+:S-@W<0#\5!K/%J6W(5:PM7]UZZXUWCJB1U/,]0^D\4I->L@X'W M6#'BZ\O>>HG!'9OVLV\H?D9?2)(M#;RR@$$'@42C@C H&2B();GP,*'18(/A M?,:>W-Q++T8;#N_?2'.^'T[^VU MU,WJ[NV)DB, "G2A]DX+N(1;E?;<8DZO.\A5F5SMG>%Q";@**[W%(((;P$G] M7&#TX.5_?0C&/ 3SZ\D%2Q%Z8K_P<]*%/<);4&:A;(J;F(ZMD%7 6N$,LY_9 MIY@D"_;*5[R_:?',]@FQ%(RQQ8B/R+0:D;G=OH%+]@*^E.]F;$0,8H56A#Q\KSGOTF7Y-PC]'I+S+ MJM"BOP5I<6WGB0*]_7(4A!E^Y@.;>;*[)=*2E[L/3'H/>*L>\$D<4+9I_%&^ MBVGZP*]^NWI!:8@I8EM)B'8?7I=.,.UNA>C]A9EF1+_I;H7HXJ(]4Y)?=6Z; M8'TJ38MGZ%"G_]KW/2Q0I_M^FW^E0F]4MRL]*-#4A\W(DOM4/=OW/]+MKU14 ML,=HK([J177/=S>5I2IIG>89FP$)K\ZLP^)1MSZ]Q0:XZ>;=^-#+ +WBO=Y) M?%C&AV5\6*8789F>5VG2W>#;$YDA J6KY+87ANE3C2M-<[.]$,LP0%'[6,ZJ M3).)FZ>]8,H 14C@#FWAP,00A4CLC0,#].L9")' /0W&Z#>GZNKI.@[ ,'UR M'R9=A]C0(\'EE_T+_BKH&FR\%\27#_%V4W;.^NON*,X#$D);[EG.VT7 ]H,) M6?&#M-M-)^6W?'(0+C:')O=E4M>8<1)-2\ZV"S8'XBZ7W._>VG.&BM8?B.]H M*!HSV0D6Z&3C:Q]#R-.'B"RB-\E]H?7,>&+;39*E.*$X_#V(\Y9A!3UZ4)AN MU7I^"F3'6DL05CRILZM-:K)2^&3V7,BN%6KQ28-"[,@TLC)?E<\;*GJM;L!O MGM-1-'^X>'64+] <'QVH+,"G#U\6>XQM3^66ZJIE;4#<"A'#PKE"=^L":4,R MAH7UJ13W5"4UMG^ X>*WRO9>$#<(^3]CG"?L\875J1^N^QK--+.[( MGW8>JSI_F8&-VB1M)!1[;)XUG"(O@@!;?5B _<@C TSGJ:==]Z6@,<6$/;S'U@=:+Q M<+C=,1AM;21PPS$>]'G7WL2-X7B[8^E92("P>]+O MW4\CG+!6:)0%+^BTH Z:SQ&/D:&C)J.4=1^E*"1)B&->,D7]#+?2&. MR;<@$>8G-C=P'_#8?[V]H_0")6B.LW%VC9@&$,1\A\T9>9N3.:('3;UG] &E M0L]@R\ MHR+>MT&BK"S#47R*F2_26"??JI4UVZ=4^90JGU+5BY2J/MK6+6[Y MSHE4)9#-6R+GE0E52],!M<>(=8-S6J6GZY,/>1#0&S9'D6B^'#GK[IGCR!$2ILWU$) M@.;H[^:8O9"><1ARL2')5LG4Y4?4OQ_+@B6W1_*Y*MG'G?&?695 RA/5]3+5]3RPN\=SMYMY-W._7"[=3S\V9@=6_Z<=NKW'I]V+I\E3 M$&?W*8GR,*-?4$5I2&6[!LBXCG.2LD5"38B\90.DW.5AC(+T"XIP"*((U*$! MPF9+E 8)H1D.J9HJ=>M6_85-+P8P#V$[2U =#P%-LR/O /MTF/KL YM6"24Q MCLH )]\A*U8 =<,.Z*Q2QU+Z*BV<8J ME5.FS3.4DL56#*HW 6!KJY0_H&>4Y.B:&0F[PR1_X&PYR6G& $VO7L(XYV?4 M^,1D__&HL8 K@Y%&'97=*V&O7"ZE;;J@LC!+H^)P\3AB_[*I.".W)%G#*4 M4M3'A((&G(/M*3+/*'TB_<3-Q#/OW%HC14CB_'=NQ9$"8>SM;4^5Z?'$J@XT M6DMG"O<*1G$3RO9KRCV+84"7HWE,OFED*6D-UW[RD0$Y/J>HU9RB?9;C='Y( MYKLFZ2T**+K$=$UH$$^8O5R9W:'?NP&2]RZ?XBD/O >F><4%3.W++*+PP?$ M[9#R)'K*VU617V\DN\D1P+-.O3C2%/V;J6_%S)Z1W5EC=+(?S\B$S7=F+3YC M-K&J< S MDX?MBT?'&L4\U1BL)WPS&P>Q?4R._D:.L28JO<-%NB5)HA;C98=Z\V0RE38E5[6F4KVZ=6JKQ1%7JW@ GX !T9 M+7 "%=/-?* ^\'NPJ@S?:,4 _7JC%02:O5' 0'W@M\)CK,=GQ0#]>J/Z[G?S M@?Q9P;=4D@S1\@9?D3>CJHE5&G>V^8R,0V;,INC$OF7:@,H^A@_0E8W," H1 MBBA/2>)0F\F!]; M:U[ CJAY5^)VZJ7F/EE>DDGX-D3-.[(.JZ\+%- N;^S/9D+H92O*UGVOVILA M75PX7]H"G6RQEN_#54WLTIBOUW&!4Q#OWN[-X<2I2C3T>KMSNE=K;OBCN>X? MS56\8%^"M!_'%_J85EW7]G4%K1HX-)RM/Y0))A6K]C,:71&\5I'2/&K3NL1^ M*A%.V$Z4(%)L1S!,;T MXWECVMC)%U?67?#E>4;9'^UI6YT3.O8^?*F 57D?[:G[V2$T3HD[,P3;ER9S+5Q\45!V4KTUJ_$FA[VF\G0=@V4(6>N6Q/Q>G ]*6>#96NO6 =BZETA!BIV69'HVEI=L6P795H!Y$%*]4NJ.I]I,==YBD3KM+_561^ MTC_8^L5SP%]0&F+ZIO"&^0 -E",7/+=8:FO0+>UON9QW>5L$#T/@Z";9)F1( M;[(&]>FN*+F O$)6GEZG&3]P6: 2HD'].B @XDV!](>]JO*T&F>,?TSX8$=$=VB=L.@MJ-K$LSI[>;" M@;W'_5B;J+@H"=R^&^I?;=44PH&LCZ^7!*N7]'ADMI9XP@LGJ?OZ"DJB"DJ? MN>5:8=-66SM"9HQ'ZJIFU%OGPW&P91MAP>S5/**0-974$6UFT/[@<+5:QV2# M4-'H/D_#)<]QC -AL?>:H_6'\X-3L]R,O@5I]#D5&TKU!NL/WWKE \M.F-V1L4A$N1 ??*L7K#=4.+&FRLWG!] MXF QX+2R?[^XJ[=\J<>QS^V)"B]CYZ1A5_9Y#8I!%OHPD\?TS+(S*=ZIX+$* M!;E7Q#E A.P2 P^N*RF%!N@ O,/.H:.>3&H'G7,32LKR28JI-)CJG+! <=%( MC7 E[58;(T@\T)7L6FUPQ %JY^0%LCVIW+7,8 3L4S.\M=SP-[ M7D=R:X<7P7#]Z@Q<=3(OP'#]Y@)<&@FX8& ^N0",82P,KG4.Q6]6B5+=DTMP MF(;B1M.&"7!0"HZ2^XJZ9G8%'#KG%?;6D'-"<[=[T T.KA.*?B.WH[FAQ&WK1^PJ,,A'K@$S+ MQ2H2DJ'1NU&$:)CBPOO#2S<\Y9313^F(O;<1Q6Q?G>.0Z:X[RNC18M[R^(8^)/@[U.)6/X4YR?W^WJC,Y M0"!3DHA*J1LZ\^KT,:4.Z5P:**GN5MG& MU^^55<0]3I4OA;T_]0S]J5;/;_<-@O@3440+HI\C24HS0MQOR&2F.K]Q'[)>58#5^UY"SI:!QO^ED\4^9@DBPRE*]XC&^&$,GS+:)M9 M-*!M,BSY^^VPX3WZK7KTBVMY[\O7=$W278&-"4F*0J'3!%6ZX(SZMD_N[!LQ M)O=-WP;(?4 QOR#R/DBSC11*:<.&"9FQED!2*IHV38SLC4D;MADM:GMI \6# M[*ROECR/MUNJ+AE1BL"/K&FG-$L]\O+&=N\8Y+(Q3J);$B2[!4] =573CM*$ MCY=G&;6OFG1&XZ2\W1I ZK;E*/FMW7&R8Q#=G6"=JVK2CXL=SYA.X$E*!RH>6CND*.&I! :M]KD "7'&AGC)7 M8F^FL A<9:[$XXQA$3DS79$7DV578A:[(B\J6&K$,L 0];QV81,0U5UU>CZY M?"*$3X30+4WH+A]*G%(F"!FJ)?EWR N\1;/*_?UM"TD!&,W3>:W48S8 MPCXB3S%>%(\X36R?Y]RY-EJQ76&5K[:-UV6BK6E.3*//M)0 TP+-/MNEFVIT MC;Y*4'2_!>&Q%(^XQDF0A.B64W2+@R<EK;MGFIY#%?6I:M@;B5-=R0) M]3DY]!J]ZP\OVP,;]#(7A;I4W3K*7U"1-9XS"^N?*$BO\;,I:Y5C](K+.[:# MS;ZA^!E]87;A4A1:-1VF5[S6?)F]?H\%<20795;H=N\=;X4SL 9S)_W[Q]TW M4H>W0^_N.?N:1)@6!VU1=/42(DK'*_Y)AS_1&%UMXK>, H2F:Y0&_/BP[@8( M[=[11@@E#[(AUAJKEUP#-\BZP_62]X9>]B#>LV(#-1VFM[S*-E3C3/.QKI/LT IEEC5 M@ZCG28 M2--;6QX,EA,7$AM&$L @.7%7<3U7&!@K)VXR-HN[@3%RXNKB>FYD M,%;:EQ;W$2NS2-(N9,";!K0A6/ESN5$NME?<(S@ MZGG_<^V;B"0<) MKHOW'R2MK'.X)U-;$W]&Z1/IYQ6/VI%@.$S:ZG>/8=+,^K=[R.S=3R.^B4,[>]NPJS^Z(M"/AOT\)PS[; M\ N0LG$2\5L:UBMQUIWF*%TQZY/P9&IM3]WP=CTU[:76^C51 MOH44NT')CY%:V5[2W7!D26[26G;G_3Q*T3-* MD7%.$01!&H0P.$W:,T9--\.I_Q;>*AG+Z5SEAYRP9( MF2V9?IH0FN&0J@%2MV[5Z5US081YN1M9=>LX@&B:'3E_V*?#&L,^_.L1+3BU MGQ%9I,%ZB<,@KES^0&W;IW:'[C$-%6LCJ*WE>Z*2KZJ;H=ZTL'R34B&!UTP- MW-5/_@-GRTE.,[)"Z=5+&.?\MERNZ+'_N,XGX,1@I-'[;ER>I41+;XNJ;-.- M8_8BIVPCH71+$I7RQU>=W?S_F_W_=^PO9AHJ1A#QT1OE2:@ MS<@Y3-X$"32TNJ%'3,"31N0>&3H !B$CM:;C'"BJ94/+S&XO%M*S.:.TN(:. MA)FVB MG#"E?CK_3$C$;^MZ1.DS#A%])(>9]\I=J>Y@E?ZK($W8FD?9=']QRDA+*C=DY%AT2.&K1T1F5FR)3?+_;C9]HL>T+Z%6TMDPYTZ,0S>1R\:I5 M5\2LHFUO1-:CK>\L=UH-MJBQ_.01?'L MXS8=3<$[DI!=RG1)C!QB8?N^T:]83,#]NJFROB5&)#EOVG6$_ALZ%*@KVW=# MO7*F5K3L"O%LB5+=20OK9#F7AB)FGR[9:GW)C->8%!GC23A]Q/'K(9=AF*V[R'89<^!1 :TSF<$QPI7%#7\!F>F)6X M$IV+Z4J! !JXKJPS:G:)GG?.E15%"QBM\($K:2):"&E8_NVM-QVLOEH@*9V" M3AV_-X-&[+]S+C%-ND]INK]=V:_@;!\+CX;WU)7]RP@H6."PA0VLR\HIADC) M \-.;6)&"('CC$YM:F90R<+(8'AZ?G6;$3* C"@P/CV_^*$1?"HSK\ (]?P: M"".$:@0:P+CU_/ZV)G&#!:*LY2T+KPTOOPD)S0Q+7ND-:JG E0E1/I.YU2)2 MQ[<]5"<_B)J9Y9_HE@#2$QE0P1\3*;04FCZ&&9;A">C1&0SK^RE9I7 M'ARO2)KA_Q2( [@!].Z,LU>[R^7VDJ\')F?;(:;#](=7^"PQ'<9NBN'I M.CQ]8MMC@J*;Y.HE7 ;) EV35'IWW>M$P[KC]8Y[Q6V&!OR#[D>TE<"X9!LO M%S_5.B1NZ!-$?1&S.D7,-#5VGW7HLPY]UJ'/.@3= _IVGW).+J1HJ'9M5])] M]"\_!3L@SBO#$.QQ**X%/8*I[4U:?*]'0YF # M. M<"86:*#BZ;B4P5I]ROB8TB+D"6'%M MN58?JU[9<5C,47H?;+A7A1^-"4.VHD3'U^>1),S35!S+,AND2SXG.OQ,>D#W M PH1?N;4,$F!42_K8IN'5\*@9$#>WB[U453<)1+$]P%F&OEV&HMHE[>V2SDW M)1Y0AM-B\Y@>H@KJ&:W1U3Y/HDA7^6-'>0SEPQ62?=RF#W0JRDA)VW9 -4QN MCYIUBO&!#!#,XN9V*[D&E!__Y/_P"X:?@QCQ:NM9<<[E6J9.# M7#X/JAMUEA4(Q!S2 MI7L>E$LGL%=?LFP!7 AZV.8 9PS/9^[,S8)D@;F!M+OL7LP$H)/=*L>$1-]P M+%)[7_]LO>QNPIZS$2-:U<1N%N[!F!&0>-2B(ZWEB )>=X=O@DL21RBEY<*L M)KRR6_?,,T>EKFB)_#SC;W<<#6]"3B:DQ1 M!TNL7T*Z6"Z8?5AXI'?*BQMV1J]T414W[(S>61HDE&W[W#U^L3G^I2(N:3Z M[;+Q68I#1@=WYBD76%5SR[27V5.[JAOC,,Q7>0'J)9KC4'A1#[RCY9-)O(K# M8_[T;Q1F,_(E2"+^6"8H$5JMN=0\HBR+R]QXIB31\8H' )4OK;%Q_;DG"+W3 M>>FY<.9+5G!RY?(%W/90 WB57Q,G&X=>>RXH__ K@\P@-0.:2*X#( M63V^5T,_.\>5%02,$3QYUI65!0R-.(;NRL%@,!3:GFNGS@C#)Y,LW=65I45G M/U*%BMW:DB3UIQ!\J-)C;*@S.NK#K:JLZY./I@+(L5'JU2,0XJ0C#0 MU*=?'%2#-$PLK4(EKJQ)VE!I'?!V4!LR<0TVA]-PM"(83@TGC[NJ1@$7>,AI M6*?\BW4@.N\;Y65%4EQ1*P4\GGA 9(5Z7-$4U3B ZLVYHAVJX= ]P=6>,MC! MFJJ&1WW,I;VUM)> Z-8N.< C+EF\_87_[XFID.R;_PM02P,$% @ 1F!] M6-H@C L,G0$ #]03 !0 !I;FES,C R,C$R,S%?,3!K+FAT;>R]:5?C2)8P M_'U^A5YF>CKS')NT#21+5O,L%P[_] MM7O5.SW]Z_\Y_(]?1@E$^>OC(6S.0QO M/M%/<$]GRWRN-W<)6Y^\($[LP!'Z^M@MVQE(__OU\MNG)+*#>!!&8SL!Z,*SVCO-UEYSJZU?"I?^G ]0_-5X M9?EN[GM?I]5L=9KMCGI(&C>3Z41D0!S8<9^>HG[!1>XV6VUCD7&4S+M+_U1R M6YI$8C@7 ?N?X/=L;_.N:V\9^S-V$87^G%W0+V6[2"91.>W@+SG2F4%*GG+P MY[X=:\KQXG"[T]Z]C];XBAS))Z4DO\,DGV14Z3U,EC-'!%Y(9CD;O[ M\NC7$P^6/XPWG7!L(&HQ--V5\OX#:W&%5PYV^"$'=2_PLN=[00) \UQ<)UW5 M[F2HC.8@,LJC$8BSE&)S%SEI%(&\FY8_4?V:?Z[GS"$DS\E=*.Z<4?F5^$M^ M&6$:)-&\5?"/^6<[[IQ'.V[N0F")H6U/2GD%?\A=["91@=5S! $_?\*?I61I M-SOMC]?\UF]:O M(A"1G0C7ZD^M:Z;7(Z!7ZR*,$MNWFM;6I\X>OFC;:G<.MO8/6EO6Q7>KV:1' MC$5B6[C$IO@S]6[^MM$+@T0$2?,:EK=A.?S7WS82<9=\HG/IT^$OG^0Z?^F' M[M2*DZD/[#& 2YNQ][_BP&JW)LD7B[X8V&//GQY8__UG&B9?KKVQB*TS<6M= MAF,[X"^_6!/;Q6/RP&IY@=7:;'O!%PLH)@ZC \M.D_#+QN$OKG>CWN1Z\<2W MX:%!& C\S;L[P!6)B#]ZKBL".&KA,UQQEHY%Y#F\E;OD$L]3]W=$%@*^U>:/ M[0Z)N,!&3@>..C@&QDFF/=A\9/NG -6[?XCIAN4!M1A2H5E^V6$+>+FUM=?9 MW?WE4VX9RUG6I1AZ,1Y2R1G\,F]5A:L.3\^NCR_/NM>GYV?=;];IU?GU^<7Q ME75ZUEOR(KMC$;CP_\F);P\W+#Y(_[8!)^_!P+L3+E"%'\ME>WV- M0_IRR2OID=Q)3KS8L?U_"SLZ#MPCX);$;HG M\%V<>_WGC<.3?[_HFW'CL^_=W3C$FY?X9A"9!Y>I+]JM_DZ[&T5=-YR 9&(J MP#<[[=;^SDY[>WM_/E4LG0YP56=AL,C"]G=:K[PP725X,/[+]E.1W8(, ?<4$!VDXZ8;)DU7.-[8!NM+?H #_/3L! 3Z M9DM+![7Z![:S5;*=SOIN9WLA[#RT$?H][J;)*(Q 5W"?NH'=G58##EG\_T?N M8VQ>]A;XA[.TP0-)E0D7W\CNTLD MJN]I>XAZ4@XXD;V5E8\!:WT?7]\!9M[I,0;*BTGPQ2 MO^N0U1A?"D=X-W;?%U*G?,*^FEL@>1^YF8+8=7DS^O1>:%^GP0TL.(RFOT5> M(H["V^"5%K^SA,7_&H;NK>?[I^.)[46HU'X+X_B5-O!Y&=#7"S\?G ; %4,/ MJ*@;QR*)3\#$3X3OW3R)X9^RH]TE[^A;& R_X?IY0W\7/I@XT8_X*:K)4_9S MSQ'R.ZXM$='X2/03]&=T[[RX>18F(KZPI\C*Y\E(1/)S_%V,^R+Z_5+XJ&:! MQI5,K]$/S&^E>\W?S@/!=QBPNDAG92.^_#0 .YP,,B ?(QN83GL#X'JIP# M/]C##&+-SL(@ZVP#RB'V3U6?@VS%9)/)K2>R(5[U9502X#._JO(J-W6$:Q[>^4D8 <4[(SL6F->"+U@9 M)\3.(P&QF.-N:3!Y=>+8;FQO=QX)DVUF^00>SL#M[S]Y[&?UZ-YXK E=Q@HSR=0/W+ R<)X?\:/N=[:W&[MY\ M\BVS#7"_F'H-QL/[2%LV5N86]_W;>PVRH1+ ]OH8R3=G?GA)"WM.8 M'T&@=&_MR-6GPC]3V_<&GG#/)_C$A;3'X_'$#Z=" !/>>(X@\?$5CA*W%XXG M BQ2?-*U??=5!&+@)2=1.#9_.;[#CZ\3.-S=W2^'REX&E;U*0^4Q[II%@/#[ MKTC>@C2@-&9AK+"2CFSE /)N/WK=/;AN$CZYU^@C %7L1+2 MSC/67F=9LF&U@-5_&%C](K" M+R(+F90%2"U?0^DVJUE.+JJ0U=[K:VETM5; M .MWN;_";3E(T1K@?F1Y%H ^768=Z_U^4G,6W94[K7;B[D> M%H+=-58O82*4BPHW7$,7']\))TV\&_AE &=D]%R"O-=Z?S+(3?ID'>YYAGX; M),/CU):]=IEG= 5QL:@G94UPL701\CJ@?RVYW+[O\)LKE\L)?+&$UV5"&4VR M(R\23A)&\?N0/)V-P\[C'-![[<5R85<+,6LGANY'S)N*H5?27-KW^9^>8'9L MD:=CR_R8!\TE8 _N3*2S\ ?027QY]>.U9>C6?1K;W"K-UF&[MNF!\19^<# ]KL?9.1BM^\9'0]$DYXAZG2N_OE46L%,>>V%Y$U7U? MI]^%'8.8(H*R8X^-C&,@'E@%0$!?J3\<>;'CAWC/(BXI67PP>_/2L$M?F)7X MY) 7@2-B^!L[?QS$U.<"EFA1?Y:#$;6Z060T5:.*S;L8I /_C/T2_K81>V!- M"6I"4'PH_1V':<1_4M^: PEL0L*\RM=#>:V@JGGU%T8#$A29D44K%:5-:GJG M_\A7^Q=O/E1?Y9\^(1&@_HH3.THPS^8P6Z&Z+_M-+]/-+I5EZ_E?U-_J)9]R ML-"P00HAP""%J*>/F?(.9:N5 _A-W:]^4G_C_:6 EG&JUN?F5FL%H,N=5)+# M;%'Z0?*7QP*,8V=%D$E\4=#L:3#;IDC#[FK!3"[JN3 [@V-R,O$]!Z-K,[ S MNE<<>(D8/Y7F5H6C!'E<9EZ08KRY&.TW%77>"46\A3XXV%O!2LDSM M)-3P?*2./W,_?GDD@G#L!66/750/SCWB4W[U#ZE[\UP:;Z\5Y6RYSN*V7.=9 MMMP,A[>+:8+'?Z;8J2X<3\) 8!X2NTYTXX[59NA[MY'Q\,Q^7HA_V\L5QXLA MJ^NZ'DHQV[^P/?'M[166IR&Y/@[?,?+K8_1=H;L^?JN VCG5 M6E_+JK4J=\(7-Y]1Q#U0F$L@M8:QLJ2YWGK):I-IK1>]",FNJ3:UVK1::W/+ M)=*UT@%7FS2KJX-ZM9/HI6,?2\XLJ)T];Q'[>!,DKJF:\=;'_%NC;:T.WC>/ M?2P/1?,:#-3'VLLH+*^6>/]\)-?'X3M&?GV,OBMTU\=O%5#[F$YUE3OA'_*& ME$*A@K&/RI/F>NLEJTVFM5[T(B2[IMK4:M-JK^U@RBMHK4]2YM-H6 M7;I+7>C4X_.5LQ/XJ.Y_4O^3WR]\X0Y1O=(-:JGCD_RZ&_="'PN=(R5H^0;L M3)9&DS#FOFA7\-YD^C4,W-4F_YG-&J?+O;M^OLI9 C9#V2W ;SUXKE.3T+LC MH9L\D]Q3OSOH275G+W5K*55[* MK52:?2WEWH>4>[M4^O*A1NLGC,SEO[+X>'E;K4;.:EE!2YC3N:*H>J$8WTIR M58VXU:XDTJ[4?U,G_H(K-4VB@W\_VHLZSYPL'SQP%CG?/ >'(_# @2,!S[H1 M$8+^Q'8\WUOU/IFE^]HXI(D(B^^N6M8="8$=B?@C+YZ$L>W_&H7IA'@'(.[P MT \D 1R= /=Z08JC502/-8G_+GP7@'9E^^(\XD? SX.O4_Q&^DMYOH;FRZ^V M;P)6+0S(NX%6! M<.\;#8 ZC+!-^31PM/W M&$?)02D=;1S23Z7$]$(GS<[+Z'8740BW)E.$(B(, [ 30N14J^,G*5B9"6 . M?C_Q[O#3B@?_%]A5QCSSM[=>VEZ-RM='Y0M97,]#Y>^7J O11=]!;([3\?M& M\4)R7L.,97L.<.LA!Y9///9=33Q/(AX3<-4C'AI', DC]D+K*RI$)_?N<#T0 M^ABMH$9HQ72#>[=;:?7@:8BN-82GDU#EE(17)*%JZPE?4\]'MTZ%:"._I?5 MV6,T@1IE:W?6PS5NZE1-<2-W[]RM58_Q:BQ6FA4_LQI/W8==%Y-W $P%)CEC]D^;- MNS+,@Z-1F%H*T)=**E$DLD!2B2*A)225S"/.(]%/>CKT_G7Z(_#^3,61B)W( MF^@LD^R*\P%_3KR^#Y?U8=?HAC\-DK 4C2!%?K,QO2=9\4CE0H"0TF^)X*@@ ME9%$92I3IR@"]Q0D:Y3JW+7KD< +X" 9>W$<1M.S,%&I2=^\ #BU!T#S$I4- M(D_1/T+.E1^%O@LH6'V:RF];$M ]FW^^Q)L'/?GN.3!\,4*4Y+ ((2XWAZZF MOO=)?9ER5R2H9QH%FJ"D*B,E^7ETZ0U'3%?TR[?U./'F[D*=UHQ5O)/$!TI5!Y<:)[+'!?4!82 2TF"XG EF6,U/1:T^MCU:T""2XKIE&3 M8$V";Q-6:^^3@GF/%-Q_SQIAZ>:KI1$J"EB61K@O99KQL::M=T5;.?UN/R^N M[M/O]I?F;*:B_9:.K?''SGY-B.^7$!4Y+$"(BER696BH(_8!3]IYA3QIYZ_B M_%S>R;68-EY+B2I*B9=/6?L6!L-$1&.$L,Y10R#&%_;4[OOB/!F)2'[6=:," M^PJ[%R"FIE1"83LZ^\/\[3P0JTU79;O/4GT> ,/S">P>.$H:*X7F>E!8IZ:P MFL+R%/;RK;MK8GO?Q/;V#;GF=;^M*;.FS!5JD?NBY'A]&];DN#1RU-"L];Z: MPM:2PM9<[ZN);>6)[9WJ?35EKA=E5EWO&T6B-D262) 9/&O=KZ:RM:6R==?_ M:H);!X)[KSI@39UK1YUKH =>AU_MX.>*YP4L3EBY[51,F:I1M8X:28VURA_K M-8K7ZFQ<&*\G87211L[(CD4/'A*!/K&F$5B>G;7@UM9#%C^%46N$5H6'%SY^ M:Y2OL.K['"RN:4QD$2RN3R; D[7B&J$54)B?K4W5*%\A;0J>N&U^?*!6Z'N% M:H6^OT[7'07:Q?2EW*5+,&OA<;OFQQJ_+X3?W<7QN[M$_.(X4?/C _@]JQ!^ MSUX/OPC:!?%K7OK<4[:]X/SWKY6<_UZZJQPMK",FWRFFS6B6QR=GV.$IZ?7$"/>VE,O>D>MYXS4V55:?B% M1J0\UW&<&PJQ!.*L$?H5BIK)@:X:^B0;Y^?#V;"D7^ M8OUQV2/+\!>MC0TC0<^.?_.244]$B>T%IZ"6Q4FXZDVK5GB8&:FWCX7S2U&S M(J0%J+EXZ7/;W^W6(8\7T2N*>%K*H,2"U*F^_*CY]PET4;-R-?#KU2I&K6*L MW&GD/=NTK:FRILJ7R)E%(M]J=K;+\^UZN<&SR6K3S_T5*:5;>3G!@3!=-HKJ M.H8IND\X"*;5ZZ!!6;2*O."EQY:2 3.?7'^J1? M,@LNF,-9O'0)7HPB:FM!7UU!_S94MN3\P]Y[3@-:9/,O%OM[L_S#,H6TUAJJ MHPKJ"'Y]^%3G\'F1RL"9D50UM52.6I;KG<1!VOLXT?K"MX,S>\RVRO%XXH=3 M(6ACJE 6KUAM1)M[D/A\8";2KF+S%VC:ZFZFX3P(KJ; MQ,"RSG8EK6N$KJ2,G)<]6Z.KNHFR-6XKDA.[I\]-_EC$+0\IW3D-'-S,S7JB M=?XF7LP2WEOXM%1P7U90I$;CTL(@!,[XN""2?K_V$LR7.@U<[\9S4]MGU\W($X/C.^&D>/GY8. Y(GH/:'WP M=7&4')3";.,0?[H'<"^IX9H%??=KN+E+GV]AUL16?6)[N:)?13]K3Q?O!%&K MU3I@>7O,VN+Q(=JIY=H[D&NS[?H6.T0[RSU$:V)[#\3V(@T89#O %93-[1=O M,M&]M2-7IT#F/)#G%'I=;>+/+3_+?YR[C_?A'Z^1NN:.\80W:2QEQ^/+(C\=6.<0[F%,'0Q32S(57'JE.K\H2P\+MFX&<4 M-R\,R J>$V]!C[]?XO=TTW= ^C@=UW3Z.G2ZD,&ML<-&=@Y%-0-.9KG60-*7U]_1!O08]S7//G@:CI=@4E])R@ &U[!FJL(CLTBKF60Y3/(O$2=>,"S4>\R,%BV@ =167.2YJ3R$V.]4AU>@P,>R'-X_7R:5:6SLS#X\S&D=N1% MPDG"-22QN3M],2K+PZI:U.75HJNJHNM%AVF_^*E7ZXMO37*U7KC:>N$C.00L MVYI#UHM#-,IJ#GDDA\1=6)Y4V^+Z0'D!=N$>"0^#O3Y>WB'SU&?-FC//NSYY MYJ:VKWE^UM-3]Q>B]3=)CUIW,EK#)*=7)J-7R3%Z.]];JY1V+D%L1YZ3R&:9 M/P(OB2^O?JPEG=R[EQ=R>+66Z_ JZ3E>XVNY'/@F[<"]&J,OQ8'M5W8YU_A: MWS.PQNA+<."2@SX/E@/4^'HN![Y)IKM78W1].N+A_QD?5Z _1I& \?\6(^#< MI4LH5BK IJ;EY4NGMT/N3K.U9WY\!'+G>+TO(A$3CMX1"3SXU@?BHP68O22I M(987)#7STG4@M8I'(M>#1!?>W.(8\TDKQ-FK)G$!/_//K]*N LVAL1S\EA]V((!4G43B&:^%")_G- M2T:]-$["L4Y1+WF,YE%UZ(>&&=K>0#8U0HJKBY1 M__[=_B.,U$5<0T_:G?ZJ)O[5(?Z%3L=9C.J^[[-XK1Z?M;>;[5:SU3$_(@;. M!T8G F8-@PRN1^(H%"=A!!].X3K7(YS@$.F^[2?7=C04JSXGNW27V5SL)^WU MI>A#H68!^BA>^MP9A#51K!)1&)/T"GA^IA+9;LL.S,;'BRB$IR13G'B1= /W M^,_4F^!2C0/SFQVXI\$W8??"-$BF9^+VN[CSG!7WYBZP,XGT^_?W8OS>SG=G MOH_?VTMKY.S5R'\KY!M\7<#G"^1]78K$BTBZ%>?[;+?:/U=_6F;Y^K-Q/?E= MO*138W4:F]8X75\]/)?"=V)[T;]L/Q5?I]^%':<,E*]V[+&Y>1PGWAA>=#[0 M5^H/1U[L^"'>L]K(?F"/1HW2(S;[8J[O924!YG*E:S2O%II?/ML:V_\Q -+8 M"T0<7_%*E1=)@,T1 B"<&!04-W64^9#=^*L(AY$]&7F.#'G\N%I5U-^[V4RJ MS]GR\SPZ<^&U<>B@'A=-#WY<55 K>!V:.PN#'RMNQ*\H\:GE&1"LJ? ^*GQG M]+6^."^Q1^K3[NT%SBN<=BL5'ZQ/NQ4BOM<\[2I!A>^,OM87YX_6<#@F]$[. MN;+-KO,)MT::]"/IK")GVZL27&W#+4QY[X:FUA?/C]9>ZI-LC4^R-=*2ZY.L M4B?9FE/>NZ&I]<7SHS66L]3QA1U]%RX (!#OY$B[=]?K?+:MD:[\5,JKR"'W M-B18VVV/I\7W1V7KB_E'ZSGU^5>I\V^--.SZ_*OX^5<56GQ_5+:^F'^TYG/B MIV'T?@Z^\NVN\XFW1EKVHVFM(D?=*Q-=;>,]@OK>$5VM+ZX?K<_4I]J:GVIK MI#O7IUKE3K6UI[YW1%?KB^O[-)@U.*#>_I!83>5SG>3]"LGL;BIT5L-[NV%T20$ MJ(BS,)!@65\$S]W,N^;@&L7KQ\5>'1Q17 M'2!9@P#)FLFLFJ;6BZ;604[5X8EE$M>KA2?63'+55+;N5+8.LJP.'JQ)\&#- MI%=-5^M'5RLAK]X#B52 _6LTK18WU9& M>&H&E4KP544:MMNMCK-UI[Y\"$8Y&=_+9O!XZX&@F!T\N[KNOAU;:?34J-OTYS;XSA$7[J@A0K?Q&M M\2(2$WN*;S@)HZ-T0./1E=Z6]F/Q9PJ_'=_ /WH ?.'[U21)178/("FCS^=@ MZ_DJWNN@6^J*]R!]"+W$IF721R6[CTN<'YBDJ,6DB\#R%1 MRX7GR85?/GEW!X"!,(T<$8.8P+]'PG9I]:YWC*V/M?<6"U6Y-$?G%C1QY@^< *PFAL^U^LL1T-O># PDN 7VUK%(G! MWS;^,PF=C6>_=./PVN[[P@H'5@_A!*;5+Y]L@,<$-S6*U M&PAN.8%%;D[LO MEA/Z871@_6>+_N>+U;>=GT.@YL!M%G^Z]=QDA*]J_06N"R, -NXL$-F^MB:) MU=KX5/Z^]O+?UX+_-=Y9BK@"\+YD4"-,Y1 E\80TUK1];Q@<. !&$7V1+Y1X MZQ_^.#N]/CZRKJZ[U\=7OWSJ*RB_W@JNCGL_+D^O3X^OK.[9D77\?WM_[Y[] M>FSUSK]_/[VZ.CT_>Y-E_6;'(Y" 21@TK*/-WJ;5:>UL[S^TE+\6UO+711:3 M>S7S\!.WVWGR=D_.+[_CYN3K89<@B(!&S](Q2"['"FP\<%WA'1R%3CJ6LGG# MDH+L$KE_3D+I!INR=S?-=FM_>W?CL-UJ_H,$7?;\PU4 [-(EHV7 W9* WW@8 MLMT@2&W_4H EG&S :^#!"0(07B^<@WX8^GW;]\.D']X] 0%["(K]W>W/7XHX M8 AUS\Y^=+]9E\<7YY?7UL6/RZL?W;-KZ_K< DZ]!G:TVEO6^:75WOG@?K3. M3ZSKOQ];!A-K!N[VKO'G]O[6]EMC=OD2 FPB*QD):P :DNU;4V%'%ISYPI6+ M>0C'%Z0/'+.6D$/R@0O?-,>PI!'>UG3M:1,?WQ3!$["]OW%X)!S6M[;:#0NO MF^6]JF$GC-YZ3ZLB2ZXC&U1L5-M?2)[LM*0\V9Z1)];U9??LZI1D1BU.%A(G MB4:7Q1:#-8C"L?5[]C]6$II_PO]4#QJ]<#SV8K0,0;Z"(1"D*+\.'A"MQV35 MG< -9W3]$VBY3;Z#9J>SOU92\NEJW^G9]?'E61?Y$,[\TZOSZ_,+8+K3L][F MZVO='X[O;"$G( M+&4+[F\;+2 PX?L3VT57B?X[GMB.^OOQ8&-;D4Q%7D?3%X/DP$Z34'T1D15* MWP .06J[4_A/!/_OJA?R$IO],$G"\0%%7-!JU2;IC8@2[*4GD9&$$_GB[;W- MO;_ 8ZU7M+0>8&CT9W%0".0!N;5ZW+^Q%[IB]CB+\8I)%-[@S^?DO!I$MZ;';N_S8%4+BM7UW*EVP[#%]LHC>VCC< MW6YV=C]O[6WM/H"B3\ 5_U%@C;E0DPSU2D"C'[T 87+09NE'M&V!(A"")A!9 M?Z21%[N>0\H B$//Y .Z# 2!%]"?'TOI\J&MEI/=Z@+H]!+4P?'$#Z< GCPY M66?AYL<9S'^2PO$3">[ZE'C>*<'7K>Y!T77=2,2Q_,\W+Q#M)\B7[8W#[?;6 MKH4ZJ(@<8?6\R/'%?$FS:OOOP.K:H] Z 8MPY@1L+.8A MS"V'I-IY= $G,DBP%SFP/\M%O]2!G2/\I9[9>99:O6-;XO B!"3Y_[\W897K MT0C:W3CQN''8PKYUGGXV*B M^%L(E'(Q"H.G^T3V-PYW.MO-G:U6Z[%!FQ=P$5QJI\!?8RL1OIC@YJ2'J(%* M,F"P[240D7&N21G&*WI(DM. *4HO;G0_]CRB? MT+G8=9(#4)0#L?G.03+,@60FKZ#$TVX],_;?V;DWU0#E]NM&_N<)# G':;LS MO/82_PD"ZW-KXQ!C]^=GUM7U>>\?#>N_-EMMZZ)[:?VK^^W'\6/\JB\@0&A7 ME%J"&5QK+AS^2&.P@:?YEYX&+EK%8().+6\*IZL65;MV", M-G\&8"Y8L;!C($T7?HA3E*9V;+EBX 7L=+U, 7#;K1W%.P;+ 1MM6O\6,>]7 MAH,6S9@ QH(^WXN'=X#K($S@FS]3#R4C M"$0*K404%8S+)>46NIGT7Q2@R^3F$Q'^K]!/@\2.*% 3Q4] =*=&M$;T[4B0 ML[" [0_MC]8(N!=1[%I@RFL\FP30%_(">&8>YSE<&WQ^?.>,[&!(^,>?,1AK MN? K*%QXZ202CB#UJ]VQ*(4AMC[ \\#FM^+4&5GQ*,2@C0IN)B,[*:[]UHYG MR91NEGOX"((I<*T/'=YC7P@076G_#]@!7D^7PDVX"ODILZJ//H^#C!(./+TW\O%Y-TR+^N!C%&L! 6$@"?@+% M;C],L59-K"5ZE0_W"\MV'"!6+&AS"7^H5 6EWZ)5T"S](885PD%#'_F>C M.G/C=SO[FSLOYE\N89N<>W"'(/JMG.08T):2(D59LG"$\BUWN/69=M@MWUO9 MO\4-KDRT>C%<+I"'%?4 #L,PFLY&?;@$AR#DR(N>$OOYO(/&0-"< ?N\$ZN M *5O/2E^_H9D=C5/YLXCMP>P1<]3C4.6GB/Z^?/>?? MD]"FGO8K/:S'SUH^^G;GIOA6-\Q3K@<.[M&W,/JPH#<&S1DR8D!BYTK\][W[S@IWZ^Z\43 MWP:P>8$/9UBS[X?.SWS-!+U60O&>@M5;N7\RF+ (@]&$5Q2_U/4:^:^?5 $R MI^;U 6P_4.D[PXL-)JN&%8-$&920X-R*$X3>6AC?AMM3:D=@*I(%:B>)P&0C M%'0@\S"''%9H#\D]B 9H>_<+6.YQ#"H0?J7DH!@,!'E2 IGK@7=ZR,,!"%D\ M3*/0MT)0.@S9FREFP"PB\Z)OM[:-B.R5'?5M>&SS_,X74_*J?FCO6#\VK[#B M=+?S&<.W'W'CV2YE8+/O@SY@2/B!%XW9I33!QAUX$1P*%,EQ:<5VZGJ)7-=# M3J139Q!U\?HPZF90._'MX?*5B[W[E8O**1!QYDX'+#TV@#]7R3#9(2/#6+6! MB-4S3#\5)4MP<(]ODT[S@4^^=/C*":-(Z!1DU'VB"-WH(5+9C1>FL3]51%;V MUH<(396IG7C!53).CO'I/?W.ER&X_7=%S%,E,=S?L;.(9MU$A19Q5!S)(7G>3P$P6=]-M-LM22 MN)A(%\6FMST"_?D&J5@O06K))A>Q\][J;+)FO.AZA M3B7-&.M#2=@_YX\%,?31B/X^Y%K A[^4:;H[O_JT))!6RW6GER;6\H. LV MVKXC8Y(-"N:['DKH$ 0B@KU$3LZ>]7CA*/1=^6N[]1=4#\=A).X!MD1>#$;2 M3SH+0#D&[E+!U(Q.-JUK7*@K !EC69-$"H.Z@E2"-%9I* $< G$,= Z( L"! M&A+C^@>A/)%(4DDXK'FR8BG/=@D)W^T(.*2S2[RPS;S B:S$/B. .%R7)N2\ M099=#%,RX0YL !8#Q!TY43V7)WKTF"M\RA6]_CQ[NV:2EL$D=)7))J=G)X]E ME.UF:ZO9VSCEN-UEZ[L?5Y9Y9C&#IK3AME"8I'Y[T?WX_/KJD(^_SR MXORRBPV:OO[;NCP^.;X\/NL=K_>F2QFB)Z+$QL+N@&D'B1.3.P1[/>&7"Y#T MUNGIJ9:*W"7'NM0V/LC.L86]A5#*9-62Q<.+&BK,82,5*+_!;([P;II9,BI[ MB* N2BA8P%B*1S$E$*:4L<-W( _:^!=&>95J1T[:05(6B6?M:C=8'*"A! MZI/.9J,ER"E+(%23&3U.[V"F'XTUT_[E-9FF=M_FW;>=VGU;NV\7=-\NDQ4? MT4N2D?9*#F6L7;+IX"=,)IB<+S]+#,,U ,B%^I3,7?=RA=K>N> ;=" WF3#*YCGQ3*/ ^OTV<(L"?YDS4][L##O00OJ M=J%H^>';966I>L+>UG.?\'+5S02NV>)F0%.0.\+ ")$-- XX+H.GS1=KX_ " M_1AG(0@3O*=0F"QA3@D.SX/_J_+31??RVCHMV\KK8WWF M5]#92KL&M4F:+1F(#K?+]K*.5-I=5S*UETBGEU[\TSJQR?E;-5JUL3-T5:CU MZ[I2:W^)U/HCP-$&/D9[KQ)[,."F2F0;5XMT^QS6>1G298)"0_?IM&1BV'D( MP[UI7T0R367*NWHB>G(6/P/U 4@Z&237F?\[:\K^G25R_T443G"CHFKLW@$: MK8I:M;6FA+JU1$+])H:V;P&Y.H+J=ZM&KUL5HM?M-:77[272ZW?XKW5E#T0R MM8PI7A6CVNV7I-K:=;0T!V/M85R_?;VRT-Y94Z&]LTRAS8F9F$9R64S;4))[ M\:?%%J=J6<>46-F 9_J4ZD*Y6YR"8GW'BA>9),AMM:R+-')&MDPNY'N-5)2* MG2 [<(+L5$3O^;RF+/1YF%3Q#OJ M]2GG :+X[AKE-2>ZSJH7!CS-EZX!]DA]+O3*9O56C%=P>N3GJO#*ND:T=I<9 MT?HGUFIY6&!Z(XB,X0M?_6U8MU:W'Z:))=4HC(-5C;3MC<-.5=PT>VM*VGM+ MI.Q,3E]E!91(X5?I9.+3WW8TI5Z%%2-E;%E?%8UF?TTI>7^)E-RCV@0LJB#Z M!:EL#R,A*?HW+&GH0;*96H#.<3NB:N>3,!*P$NM_C$&8L@/)121NL"CS-,"QP/3#YA*IO(XE MK23#9"''.N:X?OMZ[0SZ32K" 2(9G24\>\DH;-XH@SSS9JJU MHG0B8C3;@ /B'%E?8]MS[O(4-Z2[F748L/9<,<&F-A544;: U'>K0NKKFJ3= M7F:6]H6>")X%1ZP3(1L^78GH!H>#5XV.MU^2CFO3>&DNE'_5'I2UV]=KB_%U M3=MN+S-O^YAO EVD))_#NG)&PDW]ZLGQG2KI(^N:/-U>9O9TUA[S*AW#&Z=5 M(]G/&X=;%>@?D>$_]H;Q,GT/\$H[65X.P[HU!)M/.P3HPZWV \3SRZ>L!]LO M>L 9_O%:M%%L5K?4]JHS#WQTA]7"$W)M0&=_>\D^J_ _6^JMNKUEX8_D O/C&PS4,A=P;Y?6U^O-VK-3/$@P3?DL M3 K)&;?PL?DM#'_BWUF*L]FU\W6:=K[>T>P=7C_0>OP#]N7^Y9-W*.==PRVY MJ_5/;?SI(W7#M[T@QL)0 J@O 6H,W<&FX7)$TUC8@3$)X"+R;C!T:W03_P;_ M&7(#]4N!*6 T50Q'/NSO[VQ:7=\^(4+^\+WQ,U#5\6C M,/7=^Z\1=[3_^R]BP!0N08CE+\,YT#FV.7];@+0C0F@'HZ:!;*] MAYHVK=, 9T, 5%*XO5&*S0,#+XXJ,FLHU-&,,,8G+L3W_DP]EZJ0);8=.QY9 M S^\Y6;[&<;A$6EDV7W/QQA8$EJV,T*@(]$,O$3^T)"#4"<\(%5.606"T#-B M8C$D\YO2P%(AGPMWX,C4$,<(P+-Q+BJ/PXGYB>J]2(1P.;S339%.X5H:406, M1/WY8X&#;7S+QVGED9R+I#KUJ[L:L@._IFLY>2=.@$G@VC3F.2EQ.F$I 6_4 MZQ^'KO E,#1]NI8WQNFL[%F [>*HFW#L.1D*X@)H@"GF+;BB<#1&+1O;& !//2)XO!*11%%RL,UXJ0&NB^C MXT (%\-,96+E9+Y$5B/RLOF1BD&QW!.DA 7R.$(T,JH4]8.2Q6(/=O^''K*& MHY,BE'@C'%&1^%.PVQP.E&VB]$YIGB03FH/BQW*]P0 H$T<=P0'FPQVTW6PY M?XT7>/,F2%6;)@+9Q+1TUF<3B>$61Z )263E>Y@9A(<=(".> 5?N4.')%W * MV#_A!EB=K4<2N7ABW]S%-8Y09O>3B,'$P#6BO!!O_[F&DQ M)8KGU7&OH&YNXM]55M MTSA,0/V)P0IP-EEH2($A1W1*:=%07]^*XC=I++\A:,HO0:V2WWZ4BA_)*@L4 M2DOKDT-$!^BS>;WRM-G>:A>T2[P!?@--RW:]T!F),5JB9"5;C@\JJ\-'F* 1 M>FR%#."@)OT0[0$ 7HI"F%H'V.@T R%-,A.D?9 Z/@[(&@L79'Z NH_O]:4. MS%JDFA9&T^_@>)*Y2-G6+$2#8&MB1N?EA=+C;3B2U4+Y&=)21ML*(./CL%99 MP%))^@/=X%:P?HVC(W%0IW4M[FS493GUG"TVZ: X!_W\=A2"3ML,;U$;C=-^ M#.8E0IM/XGD$[=JCD,BZ4?:&+_/N._'3,$(BN-"6G7Q(()^YR%,H;0T/==Z. M2N^Y_UF7MHO=+AK6MV\]7+0/)CWJ'Z!K2\M*S^25EWYDIKL^-=[P\,W&Y1\9 MP@X._M3F*-A=,1B!I&\.T$!B_80L*VEJQU*IES/##T"%!TQB9+.1O3%[2_PS K&$(XG;3 M*JSEX)5!_M1A3,:$I4<@BZ,;YJ"E+%IL!#7EP_=R"\[BA7.CGQA4SMW[@E#< M_[R[_V4FE'GOTN:NYW%AF$)@1RYO?JQ!L0 J*LJ9E82)GAA81P:Y ME/+ZO]J=S2TU,YP<"\0OFD_DX%D[EM/5HZ&($Y#NP1#HC";#PCV*NSC.,ZU9 MJ&:A=\!"V1G#D1%@!%22RI59%66"]]1=0L[PQCZQ/1E&8#D':AG4]Y$:[T(&@GJ+Y4Q2C5+5FBSP6FY$3895Y%F:[#<3B,[,EH:GVX.+[^ M:,&1.)11.^;3FD%K!GT'#*H&*;C*RV^Y@ARLTK/&Q[WT]XI.XQU8!C3-C 4WP#1*D]$ 777L-:^.[7-$1 MKPB)%/.]*$D/77DSY;DUC]8\6DT>C;&[N,5,$TXXOJ=:UUI48" D5P%KG#M) MV!<1LDB'/.^W8?23L_C06^)C@B R'S*U-/>RAV&J'Z;6XQF;!N2PE]PO5=N3 MXXL99J5DS!/1CU),L4;6I/>JA<'+NO0R)6VL[LS[.(E&O@KU ENZ@^"(1T?1 MCG(48=:1L)*LO8+EQ5DF(>[1#V/*NR7#]<[#[#(P=ML=_+&S;8T!#R-,)T_[ M?U 6#:S 3KQX(!^'@5"9P86/0GF3)2X^7N0LN;;EV:4M]]18O&IAR_;"-0QO M6M/RS)*61T+[V04M:U;/\B#V7[]Z.FFU=4*F#^E5V-B KX^X)[G]VEH#"@4U3.:&F52 M9BF4>A]T/MV@%]]3^;>Y2"X>5)QS"2>>M@)1)44KDM5".%!21QA9V?#X.)'! M=0D5[8LQ(\C9KO$ &82^']Y2V-F.;+(%8Y6N V=//_+$0":H3M2Q8#ZM!)@J M[S>K.?"RYL6H*!P+;(EH8ST-=9UE M>WC@)9@I"H>7! N?I'RX-BROD,]))5'M'5P4+@:X- Y]SR7-OW3X P=F^F*( MU(55&&")GS1WJYK(\(C:Y(>R2>:DD>A"YDK"[WK6*R,XIFSU+*\M(8T8E5ZG9FEAD(@-AQ-*/B$1Z+5 MI49=_E1ER;GHLTTI1YO$HS:9J93'_REK-.A>>8ML>:+I85NFX G#DQIP,]:1@#4H#2NC&^@9U MD_I-Y>TGTXDP4Q%U10&5XE"Z.*;>QYE0HK,CH2I_[&[IPI?(%*"OR;2S&R%3 MYU5 5]P!L*C@1_;+!EL%GD2RAQ9LO#^B V9DXT-NN3;)]_"ML."R#1.";D?X MCXD_57=BN90>Q.R!5A-M"9.%^"L4PHKY"XEE!HX&I"QM!.[G.A/4>F#1 M 9(%B&(/_MZT?@WE'K%8(.^PO 4#!TL$9,H9/NS>@%XM;P\+V7?5EJ.<\$@; MGO&/SQ.KP! DHN1]'W2*[\>&-;#[D92'6?8O4-\DQDY )%11SO(%*-WL"95 MW:*E O_5XKD\$5A)7V>*FB7DJ3>Q(W:2, M%1;8G/]=0"7()(#6(#)=@O&+(6<9#*]GK0%^+<"Y-DT!S]51+5@'TG1$Z?J(-7LPH.<* M9Q1@!UQD VP..J'@$NC^P"6>-E?@X,)\YAA+K #56,ZL3 +#Y".GW32KHI*K MTD67JC07[2"\3]"9VZ#:*[C/A;,(2&0ZN]^J\ETWD6(0-HLN1@^+"Z5Q2QI' MZ&=J0,1= H8CBW053C@GTB.M 7/+).<=G1]3KC%5Q)D*$)[2_'3;&L!&6!7, MR;B<]A*SU87F5W>,"I=-3"0K][&[T,BL[&8D<^*[-E%3[J< ;^2:;X]4*N$. MA;B%5I8!'J!#S4S6JK4WDK#*S M]4:@+\GF,@JF0L-Q!N=I(M@<@7VX>-RQBP6_$7^F M'CFCY&$H="'69&0#[)VI[B+"AME,G58&#"-[@10X;#<1N@IR#7ZU6B7-OXC, MGWUZFOIKX(,1A58'*5[>T(-_097#N^ 03-AHQ+] "P-8P F=?47.1&N$1PAB MCD^J!$\/+*>PO$2,X\TW(M6W4]^D6$?]S=IIM%JMDIH["H-D!T+@<5=[[-1B M?<#SX2.'P2.DFTC,/D'3 "HV\G2GVB4!=TGM1NE8?0&HR[@3R;&@PR!-2B9$ MTQJ.C$ZKU=ZTOB-JY[U;A0$C4M+H4-.F_*;U=U4LCDT-!&Z8U%J@FK[@8GPD M&=)8Z8!!UP0Q"NLP#:TXQ;AZ.] )I_A 9>[3"AJH!L4C$"N98W);.0IL1R9[ MDV\Z=0G0F;/5[ W3U1%%#1?9H8A=1](MX:FR-T(0'!$V&#APWJ+J@).ZR(3' MH3+RC!^0ZFHX.:@E$*&5>P7 81ZZTE$%"*3.$V/)4X7UW(X$4X(0IY M4O"C%Z$".TA]"Y4WJ=[J;P:BY($W7%K(O>5)$VG 88^.8B:_EHO;X(_E$V\=NJY'5TNCPZ MO5-'I^OH=!V=?H(]-5/?K#M?76!<&83H#]DIZT@T>UFGK!/9*:O:5A?H<6!7 M ,EY\4CZ^ <*8/H,FND/1_F.K6VS#ULA=$8&FA$RXX>"/3&D0UU'LE+*9Z(\ M+O7:8V[&C$^B\=#PW@\;)\<7&Q\W*=D+"_#8F<=*#D8HY"'HLJ\A^",-G"S( M3>$D94GAHNRL2QIH)WRC:I?V8>/HQ\GGC8]S^J;A"[X)&Y@S#;"+&B+C.U@Y M3KAIX8TJ? 6+A#.Y/VT:H2OU"A%$GC/B[ '.F9B6_):]DN(PJ*#"$\EQ1J6' MUI^8@\?N2G@XOIPTB2S;KLW9=J@A>S=260A +3;0E'5L\STXH6+5+4EYDI0S MXI)=?"&\W.R-M'%VV0-0*?5B(AE*K7S3,B;5; M9W&FA9L+Q&5>XBPPB-T6] H,/?D6F]W%TN./;M6"BY>#7ICR(355V=.-K!W@ M'8PRZ&Y62$0ARF=83=_D;&T \8 .7(#?;+HH E-U,Z0T$]Z+2B"76O;L MV6#6=RQ^1O##673(U-(K$( HL7Y3;26S5%"R'?6*91?:0CHH:?)(_=@QL2?3 M/KU8VAI#O!'>KZ1KE@\*TA"O'(M<9UF.PF-F LD;]6XJ_L+5 !L;3=9@/9'+ MO4RK&PO[I7]XJJ30^0TZL\4M*$,H61/KNVIORI-\MRA$Z7T3^C=,Q]+98CHQ=!8#]7S$4$\L9'<TNF$H7-*,3)H&Y2M[ME15VI; MMDZ-(LZ3?GZ14JW(/?V%27G6.5E2^I\<=9%#S-0AXR)\7P2*[.WE)) UZ"@*73=RZ]8O=+!S#(9JM6^Y%RJ6$7)^HI\^]P9 M!GZ^&)%2*E0U<8[BLL ,9C?*>*4J,RXSTAG( M8UP)N\DK2GN_2= 3ZTXYS6CFV-'9L?!,9GIUT%.Z+J5)YM-X@4#0NX#)&/[4 M5 5DS1NC-H ZG'*"PI#*N].VS@HGS,![ZTXX&RZG[]?J%035;F MCU@&QS#ETL,"#>D+0HD)LE&G+$F-EU*YR'%")F8F@$B>R>H7/S3D8"''CIJU M&V,<BJQR2#IR<@OE7U5D6<7@;/DV% M]+S,@T)1F+PXE=2"0R3N)]&&XVPIS M&"+.LH2?XS (A/_FOAZ,MI@OU@\W VL/KRP7V#$OSZ].!62>G6G]A-#(W%C< MO7$;,RRR(L"CBKUVJ:NLW>)LW[S722<1@M3VO?]E+D;;0V7K\ODF,VZ0/4K3 M$@W//WOCM7/?YKS'+O(9_GV-E7:7G+&(]LSU)7K(CC@3%VQS-3$)WTAUVNI- M$26OJ((&Y5_0KFK8 ^VZC^E@_$XI>@:P895\D$,N.IQ9JJD,4W(N4E(G[K=!2D$Z M9DF$<*,,@@$6QQ0PGW+-<+:7I1]S,=8LD"Z4MQ[-_*XL6]WT?A(P28HJ_W3G1*8:7+XNND9A@G%4;IJ#] %R*B\:V)/$T414>$QVGI'M M+(LVK2Z- 1-1E$Y4A_F9 "M)_>M+.1]'ZDN!&-HE)GQ1.LST\E@=JJX3DV83 MDS[7B4EU8M*S$Y/6UI2O"SL>!%'OX2$P^<1EE4[BVGBTF340SD@X17P,2-.,:\#O1W MRZJ,W :X2A*T?$8O.SXI11E"7ZW9T-X)0.D?'8$_);@=9RY1#&P*YRG90@ M;LG1@#3Y-,Z61ZI76N8GEL40DDCT0W,!*]!5:1:4Z<22#2#4Q%HO4+:Z]/YE M.I5T7B$HQFB(4 .'"O(UH1'%6$C61R3&P M49.!OK@D$>-)DLU I#0I'%!I+(JW(FE!]3507<1]="P2=RB6(W4VY"7HSA.R M"%$;P=@GC?U^)'FMTZOSYGZKU3[HM-H[="M^T][:WMMIPE>?]=-A46!*CK7> M?T.P@BVA=YJ(&EL]$FF7E+B0ET6IZ%F[B#3@7(I<_@1QN]'%2.^/ERZ#O121 MR!5&YD),1I6!$30*TG%?MN/0A=>SF12S85"OK*VM;&JKF^,:/E7=WJ*J_OFE M9A@/L7PNY3F^O% M,Z=CKE,"=F? *C(E3(79&E(KDE=:^V_*_3>[M?^F]M_4A67F<&.T# .2JY@.S/ 73CFVLPH.GV?XT]N!^1S>@%7[6 M,4A&E3T1%_MAXK*S4BQ.LBL!K8:D*I#B)E0^1?C*^G9Z$8=KJ0TE;X.,^C20 M3W)1Q^.L)-/CU,V4.=T-LK1"BPQS%RQ\2ND+V741.4%-XQ0A:G&@'T+]*EF;X_W;2NI).R9(^Q[C1J M F602D=*9FU25\);:KA6EM;(*7YH#/\0,!$I4V);97@M4^QH9$&KV5>82 MN-==0CX,9<:*K&3;.%:T>/B [Y BI!Q;4J)\9)D_K_0ZUHOC1#/RW+/':%Y- M]HEJ3Q\ " 4GY1=*?.^C(G)-4=L<2LD9A4SDZ!J"TR/Q?%/.J8P+=O%S4ITM M.\*C:(05A_V$,CV-4$,09@E7U"$1 :H9H8 @:N*2R(A2#K]AH,L6N&:9$]S_ M""EK2O,,[3*[B^5\(Q/1JC=:HDY7(A=,A+']B#)89*JQ*KC7M=_\7MFWBVTY M@!XFC/&#LG0]?CSFRFI$R4:CL42L A-\QC-*%Y9%E /V&/0TJ M;"%TY9BAO-HM!1J\C,IXD'0IM]!4CJG; YW%%%V3&AWQ(S>"F!@CDY#:OH6W MS6^HZC*PY6,(P-:';]\N?_MH781 SE.K"SQ%W^"GCPUY<$OY$&==G=!%$<8\ MGP@ Y&*_A)*B7%D+BU'K,8C;_U2($ M/;*!0!2B4J,U]L UG)M:7AC;II W(41O77?]DIJ[V0TBF&8);D[6]<*Q<6!: M0E4M4>8?-?RNAN[L>V.>E*&4+&,1&93@B9004.7B?._P?J?R.5=I(?S%-A2CHG!3 [XN)JTPP;ET,O MEK/N8AK'8Q81YI."5#:.*JRFHT#F,D@RF6F5F/FJBJE81D;([%IT\C%Y5XX$ MFH8J6^LZWY7PP]'Y==98R"RQF'.JJ1)0SMT(3$;1C^%VZRK)0;9XC4NN(ND9DY#H5BU1",=T+QFW:B]S MV;$J76$-79N)_B'RYV19?XCN2(S0T0XZ>IX4+JD/$HZ(HG:#02PU?WS/-UT! M0L[ WO%E[UOW([=0@ONX1-E[W+[D?#N8__IEB>H&JN M\6$4H;3^;O\O&'"((/9'?K<#L#T(>/ H?BTY)#,/98/,+1,><"P[@#J$K>[* MKZ/PNLH"%J,;A:I=F*2)13T';*B:217.6.[RB MNL4:4.2-J6HBM@.IH5&''2\T9V"I,#AHU8#>S+>.Z@MH0UFY3V'*BZ%?L3=0 M2)<7/?83!X.YEIG:'*"9Z8UP1 LF&3N.YS(]C302Y2X$4V%5S3T'I:F6(X.Q-L#G1SHPX:II\4KV[,3!(3.*_8T15=$R0XRALQ M#/I8!]VI=05L,6BFD[R\()B]HC@Z.0OLSQ<\]0^/S#2<[R(9A2[S2M:TI;))==@Q M6LAXDJ[!T:5@,A$_UQJLD76ML"D'#4\1LA:Q'T0:S\SP#6554!ISHXLP-Z+6 MX0X%L4P@R4;NY6(P%84^$I_LB("!I\#J*4A7F.1ZU(A*N&IR46CX#:@5K^H1 MT5#TEX =(3@W,$YR ]P=U2('J:?3^8LB'![<#M94')N]%PO-; JW;RUR>Z?" MM'AADTW40"Q_4_RC5I-#'F8F;5E=1H-G&.1M5 M@8__Z7'U(RCIF&N5T3O9.XJ !P.,VGD(.T:>!M0D MI>*E@UCBQBUY!*:Y]#$'$]7GB/1B6?M^>WN["1=Y<>BYFW"ZZZP&(R3 %5S4 M@Q!D?\YW)W/?X((K3K[!*JWC.YD7VN4I#^W]K6V:U6N/>;P7E1R85WW<9!>Y M;/I46H^>#^U$%-DS8*&O%W#HK928 #&][*DO>-+D/T)& [FT.PZB M1TYA5:0!FFZ(2BK:=W8<8@@?F^^@LYYS%G2+6<[2%SYL(@H#.<*8=XR8:.3W MG82-##>X_ ^>]U%]@\4E[=TO<;8,(%8@RE@XF\/P9M-D5C66F>H]Z"6V0TD+ M_6S@?".W)UDQ9S3UIZJ-+$5.AJ'@NARIZ$A4 9\FG55%YX4SS7/_MF&W[0VP M&Q)\ WZ4YQQ< L?):2* *[J;*"YY6??_"X^]/+WZAW72[5V?7UY56,I2@8;M MHC,W'E'XP0'>0,5XJH>-<)Q"3[A2HZHH9(&FEBT#%%B3+'.'&EFW>Q7.41$* MBL'.!C%(PMY2FY.X1$#D'1Q%>F>+-?)BV< O#:3+)^$IX:K6IB^H=[<,H29Z M-D\@JQUZ/',=MXA^EJZ12SGGV62>LM4*#_H9X#1WK/Z-.8S$&9KF4 ,E$.AKF2WM,!E0%( 9LA@]<5.A1'*V"@)%*4C[ IE.@2,K4N M6*GM4@\[7Z%7N)L53B1 AB=(7DI/P75(-?:2(*HL /HH \J#MDB8)>%:/\22 M)4D.2J 6GV"AVL979C-P!EY,(UPH111G)5$(A10]1TRXW.XDHH11^;<^[N<9 M_)R1C:TKQRFCSJ4JXP2.::U'3>C$Q%7%8/C\Q,F!&,QV51 91%40?U0N-GM, M5_TI[J]-0UUD_7QLIPY+W!5E-M$GZKXH,S>8<@Q M=M*[-LU$#%P]3Q\P'Q"KCF@-RY:I"4@1/$]F;F1:]F H"4T3-*62IYV(62W5 M#)RTJY#*QK5R/Y;BFDXDGIB5=2@/?4.9;B!>];@8[&DUC!M%2'+(0&T%K\;2 MSAM0O4A'$]&8$P1L&JG;L 2\)QQ[CD4-+N WU7W?0?JES(A"6+1A91TVX[]: MD_/J.DQ*S$9<<:#KH0_=&SU7^B4(E9?MX%#OJ4P75IK[(S\%(R425 MG*/9+>,V4H+T-"9U5V1CLIVYM!3E^NU(!(0'/,LHN5VJ.*9-[L)A/\U%$Z3$ M,TK?!ZKZG%*(4)!SU1"W[1D Y_6QQH&2<"@K@](L<-$R0T,. 51/L2AE8F # M9K(I!5RHD9+H'(^]A(WR7(900^E_,NYNI@IEZB0K;864H2>HA-46$^>Y\D2J MUXI5BE8B#0DSW;/0BTAUS?9FE""M"A5K8O0T=_U(XR'%>+1,)U/TEW\Y)]_) M5K"AG.J%S;0#K.P01%_8> )L%"!M>VP/A6&J]5%<44_R_O3>/#Y=R(:-76+5 M\4%EOZJNYN$]@)2627']Y /1 W5D.VND906N5"8H2NEDNL-R@.D#EFVCS%ES M."4C<2YD(2=0Y?.&*E_)Z%::!FR\Y=>W"DE\.J/2MJZXR\[7D.MZJ'E(OHD. M2S\:9CVOFX[1%(C67M(8:%Z+$%P[)_+J?A=F'>1,+Z& 9]MP=YZQ0*\@CO-] M5DL>'GQ4R.C5G7FR<\L;<.,D YN8%92PL9Q-."5]+DP3='600#=[5NDCO6\ MBE1Z4ML\=0A)PA2<\IQ_*Y\IFB@P$AY&<"A@)U4Q95^C&LUJ$'C6FY^:F]"J MF,QD=A/WA# .4[D8^72F2Z &VB 3D#YNY2,:L%Y, /!DFUEJW<[A="VQ#$XT M%0E)D>;@HCE#>!YG%U3ZX/FMD"W'$Y5^BFEN.N/LB4('5L FFVG@%09FJJ?" M,Z]&-N#_*TC_R/T#%MJP+@#>E,%-P.^-/#&PCN^$DQ+*SBD/)&)!CV8[HN5[ M)+LT9\_)8W]!Q2/?D<@8<"']8TH>:)U.D#9:]GHIA'3+/ TWUA.YX+78 I\Z MRVI5:%#\WA@9Z'=I:A)2_V?'UH('FS*#:Y!.0;M6&BJ6#,R'7.P4KD M'+1;==)!G710)QWDSZQ?J3.5;[BZLOY"(,/4A'*SDMP-LR"&K'E"L5NYY>?+<'<1Z;HI/76/%G@]559@KY&& M/']CE1,\O =N1C<.:G^@IKEP7@"/:!=S88K9GR[8*N0QAFOF8$:G>N+0,HIP=R4.J\-15P$BKXX8R1*KK6"?!]W C'6(AO#H5V3U2D5U28?(T;< MY U]:YD*A906&(6*CAQPY9)^K+FDC*6_2_<\PF(!OHS9/#'7#G"C[IO<8SH/ M4)G6$]GL/TQ+!\\5RJ5F)2 79Y7[3E%;A0-8(8T,.X:6')S$UEYD3SS8(0;; M= VQW Y#V0C9&Q@UNZ]DPV(C58,I9]M35HWGY"=N96WZ$,#DF. QY2K]EXO0Z=FBT#R5IT<*JU3-&B\>?5%HJS_E@\[2N>Z'?3'_:+XTRXPY6[$\\EATBZIV#8U"^RWEQN,.8",! MU#ER>!*X.HH3^T[,'K(RX[$A:3YXO B=B4[;)<=]X:QOE 2@'E:UEM/RR*R2 MJGL?O4#O(R,C"M-LRUD]@Y +^:[I+O> F]&\X3N #T;!'Q1V#_08$S7HZ ME;D)].VK7%QGD48*V/$].JBDV*-?/?($'FQ]-N3@ M3#M@Q8GPLY$:^>Q6Q7CL)MC8MM02K4K5@' M+>REMRT&G@V M[C_!J=T:S5<'P&\ZECD=,3%?+RU=W\^P_V=#NN95DQ%AI.7 MF?(>#RF5[3U[M)T[3CI175VN@.;E &?YH*XA9"4V: 1') S%QWN$BY[,!#T7 M1.6E9$U9"MTI1[/[D9,F29(WY QK(I &MR\U \=9X(N/A'N?C >U.D/IJ..9 ME/AHRE7&$XK,B>RI^$(CP^XAA69>PO(F-8JF+#"YK%*]8":)IR1;FF<[WX)9 M\ER5#LA*)].#+;0X#".@II MR*B:KSO$V1R)AFH&#.YWQN>2VB)YDZ4JYX \0IN3>\LGHHI^]J" U4(W0SRZ23GW +D=^%/O<91,5 MR\[9NEL@/IU;_,D.?[W+;MVXKV[<5S?N>]^-^^J,D#D9(>TZ(Z3."*DS0AY0 MPTXY8'', 8O'JV%F>IPQR"J;-235YY(9*YG"[?+)A*(YL-4 " +U MD)>G4?(U1M+FDFT6UB\8>^Q62.P[//-E.K6TG<=HY"KC&BX :G#5D#A5YHZG M%$ ="/,,70/PK4_1-T,5PEM9'9(NXE*]@8-OH(^EKI>H-\KR5G()V'?DCY;V MN1Z3322#&JRC>19YM&$\]D;YZM\^A3Z M3[1[)2VIU\8N!YR5@:@QAXFK BA5 "1K1LI?.^MRT]D),H^!W%%H9MN>+XN6 M, T/-V;&) M5$VVRL# P(QR:9,Y0JE+*L:#0IQJOF,M<_M@08D;U;=0SU]G@2V[RY CT3 (C "';JMG?C,XL[R>,H7K2C+_RI$ZN:DOSXW M-Z-0+4G,2 6Y,J13:+65N8C)M5$"5UUL9=;I ^T.LX@-'H,8'+83.@I MG(S@':B;X0DVP):HF%%CP]$)?/I32D]4>K!>'Q8F(S1BXC':F$,S)&)<1N)/ MX5/C$2.H$O0LXQS9)P=/=9LT>'2I:%P:^7E&86)YQAT+ !UIYN;KA#!I[' ?,#>956KB=9[6#LAH= MC0QT4^?*QG08PR!061Q/;C2-%2)KVQG1"3G;\8)CPED=/Z^H/"'W/)>794,,WU!?S.B 8@8Q$64.'_RFYHF.R*F5 C*4+(F1?ZX5!%A01F(E&S M I4&;XP2[3H.)3X/D4O"&4C12M MDU<6,]@%,$AAX1A^2"(A:WDI;131E>"\AJ9N^H&-Z/A9"DW<7\&C-G-FSJ[1 M5@1N4G>9S2 T,#\-A,T99(0&UQM0 [J$2EYS=W-*&.6H*ITH M:W>BVN?=Y%?=,!./^9J^RCF2!!,FJS 4O]^DEDT/$6^? MU$$4SCEHJ\VR5Y8B"S0%4\[Q)DO'D.$YV"IWL^'CCV7[%@RY*D]UWLTAD^Q5 M+,?L0@%[HJ9]+F:*&]?*+&$Z$[,"W>PEFE@RCM+VW527"OO"UJT&"IVT8I \[*69K),6%"#C3A3?E4F/YS/W$&.F)FZ?,7G,X4?:MD* MF2&WU.!0N5'^FA4A<"17&A(Z[=H4"F&4HRU4L$ODF/0HC4/2>*CT,[<+9)4" MA:M>!KE,6]DV!"_5@RE(HRND;,\0%DDI993#@FF(ZON9@SJG9AKH4D4/20&B M\BM9+N5@[2Z'3?5PW;)^>F5'T?5(BTD9.\)$WB8"'7&I,J"FJD3 BXMG)TU> M.#^6_K6$TOW&HFE&QKC32QAEQ?32%9B%6L&^Q"LV=0-7_6*9\<>7=:\O9]H3 M23K*EU7(Y6KCC[OBZ(*4PLA=>;663M]DG32E<62B-<5Q6&.P_Q0D*4VKOH]9-T$IC/F'(4>J,T'1 \4NU*-P'27H[N)F1'GY^ M&RIL:*C^R-5,Z4G-V/%(MHU0@Y)CD;<*LS]P-UBRGE?+I;B3AX11Q*.K#PR. MN=\[\ @SLO'.W'8S$LG6*E^04IM"9"5]()9()K,D2+F-2B25$E14D&",8,J/ M64K@7#2.WYD)2XB<^TT_0K/LBF+# MF=*J\O/P!KXT,SQS%RH3NJQ@.5^H_%V6?1:M6.YGG-/1AP 73#_('532+6&X MN8=HM\)*QM1\+3-EX?2#YV# C7L&5#F<-*^3.$Y1O<+^TY5O)XZS*-F#J$AK M3+7VV'N;\EM859XI;I^Y6 8,S%PA(__V1G>[F.M;+KX:A;MT_\&+SZ][__QJ M?<]Z%A@38=A0E!N)I^-^Z%LX[:/3^G)Z=GI%']M?5&=,\AUIQLN&R62[;Q'J1J];LWMI;I^YM?3E/2H%*5/RBZY*&BY\C58VEV+]%!BI)C<;>I8] M!Q,=!B34[ML\$@,UW!W9D:P&> MM6S2%4N&0OD.VJ%7.9CTO "JNS9R-;>V&_M; MG49K7R^0=H&C8Z(;Z:JA)0;Z%"(U^,\4%5;D'8JKE(&%O9*85:'B!<5Y%^1* MR"I=PL+EKNB3,DQ-:P#-&'7RV&>*0G8^>TJ']"CT<8*0G(4EP5>(\> X7EU* MPO1B0$="/)<2<,][E8$1Q!B -&9\8N]V.#WL(%$#[=%2T*%'F4P[\_KL".%V M\JJNA3O^JV2&?%$_^8YE8UP=?LU-=Y8!5]7@EZ):,BE,%32YHLGPIBI!_#4Q MTAPT/1#W!25$O';5Z?AS'KF@4 MDE91 ;HAA>MEB:'9S-OL+VY.\) XKQ^,U=FZ]YFBI2=3)2=4I)M?<8 M4NW]^^OQY=5Q[\?EZ?6_'R;/ZH 4C2_M1N/*'(- N2DRXX8Z2.M&.=G@@G%6+4LQ11SI0Z-C MY+PYDT> O>1&U+[H'NY#AST7([?Y4XB);NTEPSV4/"DW%&^^$3[>3FRQ$H"2 M"[U]-IKTA\Y$,- V\:,S)'P'YUSBQ*B '%E+*M(_! M'%G/DX$=&_I)[$NMQ-7]"L!0E]/&Y4/E= -%!*CAI#B-- M2G5Z;?5*FB+_5 HD27YW?DDT$YQD/:UPB-I @@&#+F?E'F+([@'3882#4RP,7C M9*= _+=P_B"??Z0 (_X?S86DA"7L)8P;I%7S!B)VPZ*;,J>>$QB-/>I5@,Z- MCR _!HVM@[T9UV$J%&>;Y%!HE/&,GBXS85JF#4F@?T&ME"NY<)8OY5;I MW!7RI%)(]<8#AIDE/34_C"V$!C4@2"F%?ZH2/=*)BS:JS$I128?%#1O3I*B4 MZ:>0'3$4;>@!OCY-L4FD2IE?3H8R7 &IVU4@?OH5!^IYJ3D'F7-W)^J0#8/ M)#C1WF4YD(#2AM6KS7M0C,\=8O"#MVS09GZ9-C@?UWQ+#::,LK4/-L2@?A#MG7XNUC7UZ?'%7_9EP7"WX0-7 )V-ASH"*_OXLYS0IU%K__M)]!&T2>&0_X$?$;>=5J?%(1'RU;L<:+&I_H:9!ZA# ML&$FJU#P)]GX!,M673,_:6R[,[-T93M#/B7D0S&/E?Q68 +ZQF*V6JK"A*U_ M#)G* E8TOO#5;/.8%O..-15VI*:IT?/U Q17]*0G(HNC8,35Y^D^@"!'&&85 MPR![@>[KS972GN_28.(<$F_I]EL>]RN?BY/C[ BD3:?5:LMD+$2D+I_W?5:F M==IO-F S4M7\8/+&Z-,>I-3[N4@C7(V(W!S+6EQ0Q[$RF3*#!R+*1;)R]]9, M?/@-D=*<(U(EYS[B<6K#DN.9UX';NND06XMW6NUV@YTLY'9R6::345B^A$:N M^;AM75QT,8[-A=&4IT[!1,Q$9-+E@@_N)41C/1.;9M &6.?.:R;^Y\P#.9 : M!SW+^+D>.0TO*P\-X@M/CB\RRI>>;%P)/9JT;&-XHC[-U.F$M$=O5L9@7PRY M+B$W[9JK LO.,-R;G^4:%<+0[6V9L8Z-E 0(RPLB_5-C?BNE<-')CLPV\J1C MC'TMNSMR]B*7-L@ZX,1D]O_'WIL_MVUD"Z._?W\%2K'GVO=",L&=L>-7M!:' M$UG2B/+DFWKU:@H$FB)B$. H&3=O_Z=<[H;"PE2%,4%)'LJDU!N<4S/# /: MP4P3[/H8\CRH9/H$((F,,3/R2.'3 3+8E$,IN2F54<6\G=IQBZ(C*@+%0@SR M7,%7)Q^P+DHRC,9D2<:?+$ZN>?2#']Q]F* V9[]TI D>/O]T-)67!YCY0>4I MZ80^'Z*6:J"/06=TE=HTAR)1C CN%(;AA13,EJ/<1680=43AG#MS(UHR#5UN M2DD^Y$@3TS]CV/ O9, BKQ\AD3P5B@J>"$ )'CQ3%LV@$7>_,(?73J5:$P2" M()XRU(07E,] N)2*5T@-[TFKQ')TSYM&HZZ7&DU@.RXU>1'Q>Y%=(3S:1 ^P M1NVD7'LKZZSY8\NE+=+ MNM:FY^J:+BDAH+98@=-#5.GY#SN;Z#?+F*W$QFPESYBMO-R8O3S_VK[4P*0] M/3\_ZUQ]W7.;5J8YF!H/F:%B ,H>GVR3GF.3WT$J,X;O,;4-;YVK7EYWO]_NM=?G"G$Y'M11" Q1 8--!0RJ M*F"@ @:'$S!8(,_OIGU[IW4Z.\SP9PG+6BPL:WG"LK:$L&S?_G%^IUU$K7-F^H\3F$19@\/2G,?5< XM2I$(],QUR_6D0_(:Y./SMJ'2DH5P9\>9L\=_H18__ MYA((-'CBT_D*RLN$O)9NE0U\]J>03Y^BGF\_<=;_*8JE^K0,#NY[[\JUFJ[) M?[W_J%%]B66ZDEOW_"CRAU+P?8K0BX@/YOUVU#S*%153QYP65;.DS+,_G9"; M G:S98W0GH#H[DZU+V/7Q8Q [8MO!K;VKCN+G-X3F#]]B.S48R_YJ!)OY%KP M*OC\?]8$FZG==N7-M=[*JD"W\K5B2BH_K_HO3B)35LY,>GL=FQ3'FU1&L*U# M++W7>'D*$,\ XM)_7#,<"DBUTCALH#CEXOF8+PU?&/W$:()CTX%*NH;_O%^S M..(F!V6G;X(J-H3)K[W:M2#\N^]=[GY6JP,HJ MS;5K(>ME3A>42_,/GCA%/07G7+JT5=Z^%//F4\R:ERV_S=H$Y.Q=A3 OG52J M*WZBO&VV>'6[!Y'2-B!20#UHW7RCRS "J1C'DFAJU!3C*!9$2JVB,X[]4#CN MJ ^8XAM+\@VEP#=*BF\4"R)*X=B6AT,Q#L4X=A@B2N'8DH=#\8VB^^$41%1(9>M\ M8]K#H1C'2]"TH1A'P2!2V2KC@%8M+U/E838,9ETD3^EBK'][AX@D^? MX#UDC#K-6*AF1D]4FW5^M%1K?5Y/GU?Q4(ABR/5@Q9D=Z)T'PO>G)E7#^"PC[@K[3M< M2M01T,>RD("W96#8P\&D#A]VTFD#N];PN;]RZ$9\9'UR7)_KF+REA\U'5F7Z M,. C)_6]?&)(/%18E(QCU]^D50,V\^!5Y]3' O_E#$4W#>I0@T,Q>$<'K,$A M:N-G3T;2QPVOPE1C5EF]SMNU\ XBR=A6['8A^P\GX)%C3"9F860*DV3'$AQK M$#)&SREF#NTI:N.L.H89DM0%@V[ENQ>P>R?D7\X,K?ZQ%@-Z)A#6'".9\\E,!5#"37.LA' @7EG7PV7B@0-TWZBCTH M]QB4!9QG4]B[G%7Q78\KONMY%=_UEU=\WYYWSV__>7ZV!<13/3PR:)'T\*B) M354/#]7#8S;T#ZF'A^1_C9C_-?+X7V.9CA=70#DX2^Z_NM0?ZGNWV[F^HLX5 M\-'EO[H=ZEAQT;EJ7YUVVI?:Z?756>=.?@?XY_?+._H*-A1OXP?[W,T")TIG M^D2(*3'O"7%YD3K^L.X'V1:5<'IK2;V MWM3D#U.72+VL/=-]"AWJL9ETT61NR*CSK9:[GYZ:=I/>C:Y0-"F5 W;$#%,/ M?;0T&@5M"MFQ/6E)E[K=9'P/?QH;D ,[HX\CU_=_<$\)'RH:-PU)_T",0$DW M"9T<#B?';7,_!DBK8WA$',UE9>&!;86#-AJ'5*_'T V,3 MX#XUQ]1U%1[@"C %;6=QU@NQSJ58)T&'DPFX_\L?2]RE/O9B+!0^078S'$&O M7?!QWA-K2'PTVB=QQ\\,3 DFY@2-);..Y)!P3Z;7^WS]P ($\!ZS]@YJK9XI M^A%W0C\"]AUJ'<\ZR7@\12=Y@<>Z?/N13;XS#L4[1-OB3:#YV%O*!_,R:FU[ M<=;FR_C:/>P.3K'!L50[.#\;TOSC,JAG D*; MWCWQ%V]LN3BN?,ALQT(7++ 2IR'X1/Y!0G2WZ]I1"SO@D"3[__!$ORJ*YHR3\ M^GT:C(>81>/M^?!OC"F(V=3DAA? FST91> ECJ=#6.*<LE5_YBQMB98Q[,C]? *S<1E>S(LU&\]EH^$3*"#"ZCYG?KO$6 M6_5&Z^.<1(^GDP\Z9+A^DT]Z.X@N4:8^LQCK!#U-P>!72206\&O MWQCEDPJ.IG!1SJ)L)'J)Z82/WL)I)7Q@2'"/PP5P4 #@&<[PX?8OIRYN_CPI M$E(D= DE,@8FJ\N1[F '@WJO _?LD*,>)..+)4E[1UZ$QC.:KY-Z^FQ,LVA M*+[]'L6447F+K4N'O.EH- AH2(TC-J=M0QF 1R5M*;-$D:PBV<,D6229*V%U M?Y-6=U?:UD2 2BE4Y'$0Y''&L^=29KS''F/1%+O;I\AE-"GE,K,F*<(B'5SQ M5Z4;1OZ$!CC>^*$3!:"(GLOFVW?^T*=9IT_:NYOSN_<:",)[X.OHD3G?$3(9*:/$\*J!P3X!6-*AH]#!I- M!K_&8Y!3$SO3 YNOK2%W>8+WWJ?99Q>:W+D[F>2&,]Q?#RS< !)NZ/!@4J!GK]+E\"W[1! MJ-FLCXE@^D0Z@[P%)Q0#W4%Y'O/IKV/'%28T&XTCD0B".1E@@F-M'4ZT1D^R MP[-?9)T="3^=IT#QX$WLE-;Y#T8#$\YIL3&I47HV;T2?L#)TD??!TT@KR>0"JM.C M=!2T9SP[=3^4$Q8R]D-#SDM%BD-R>_-&P>' HT^Z>ANI2!>(X\&1B8KHR\$3K@EI#:0]P-EV.ZA7G M]<>A^T1:GB.S7-('S3Q!JI8QZX.A@#QB17#GJF)C,\X,]Q0.O^2/Z072,1:%B1)MWS_^:A<#BY!P' M2#H+0S(U/)ZN/_$IW640=-+#Q%?*FIDYJ-))#%6N4>-# KV:]PB$4!C&\2QB M"IT0@2 &D5XY'O$DQGAR_43Y: R'3-X2MY==WXFF'Q&L %QR[%$9W+[F&5W+ M[*"19-\2%Y =\$'6L@Z*9OW]!\@7,XSR+Y08G$Q%<@7M>@].X'N4V8R4#U05 M6@X052K]%W">!'R?4:H1^XFZ#%HMN=P@(6T3D+\?OXD'PC-+4DWM'.,K PO- M?V*,,RB>-R>5JG>XU-4^AYOQ$VTE+=IQ"SU;B;9?IW@+K6 M. CPFU]]W\9?BKQ!/---@-8/WA4OL19Q>L89(O%=A[*.X_&*&+=WD3 1E^7U M$SVDV5.:A4H"&V9VIG'E8/;M+2Y387-<$' =%P0411M9PR-?Q,41#E)>.!X. MT45 G2GR2B.0"C"/;U=R^%YP?2FG7=H8-L>1_S%C"],["SKK9GO;3AIOE_;4 M\=\6*_./'TW80^%;HE(['KQ*1D[*6LCZE3+:3GDIN,C'*&R=5\(0F7KX; MKU>UDM1SH_$QE"E2D[=:E*9 BL 4@R$]XFI7H)+_P/J8VJM69\/U6WJ(.F")#N%3\M%,)QW:3%+:U"(BX*-H3=':'M :CT#>DS=1=$<3 M=GE2#J+52=/C=$EY$+6Z?$-AO<+ZW<-Z89A3W#N,$NL\A?99OM^:U*X2(T<1 M@"* %1! K/B0LUUX?DG13Y 5'9@/O#D<6M5O:LVR7FNV"M@J5R'?3B'?MKBO MBVI'S'QG*=V5VASNBSJ]XL"*"':)"*C',6"YYK&(TP"F #;K+;UDU&-->\+$ MY-\6.CI^OU*JZ.5*4RKB+\_;4_EM,_+;&BJ_3>6W[5I^VUK#N_]"[]LY%2>= M,8L-,0V[8NB<49VFN-2<+Y;W.!R<[9?'!?\(>P?Q;F9X/R9E2,1M F3[<^P( M$&(.4N[5HL,2K^Z9L/'Z1K]B7,QK+_=UI".>8I)=7J2(>Q9MKQ0& MFB#%]#4\HZGO)9#A[M^B.+\CM[9$]]1]JZO>4WHJ*WK:*#V5-TQ/!SEU-"=- M9(?F!^;-=GNSI=%U=;U9+>O-UC8F;1<91EN>*%C;Q #CM[L!BF*12ZE:TQMU M-8"S6.2RB;F];Y<4NOLQLG:#;UJ;$(#5-QC MX:O:"#=7\G4A4.BM1E.O-VN*0@H%E@U3R ':K!>NCYT&V&NLUAQ&(_-"<#?'_6SR"3FD+75$BOD/.AE>@W79"A@L?SRCKY7I# MKZS>3%,,L> ,T2@5@246&MS[2_:&;C0-O=5<>3Q*D;TB^Q=I0MLM"EU5TNQD MBBQ.H8^S^W%*^_[6VF3G;68;V+& 8<\ZJ6/HTU7#;Q)6)$LG95^[@,4U.Z98 M-6YP1T,:Y/A;7FY1J&JW$>5^ZARGYTJ3U#E/@< 9%6#LNM ?J-9 QR\J "YXX!\NT5 M'IK3594JJ5*E@X.1JH\I.HP:8*<;%4-!J$C98,8FRD,..QM,53"I"J;] HNJ MFRD@6-X9Y9)>K6^"6-XK@"P$D$U4,KT_X.PB5*+P1.&)THJ4(Z+HJE&N(^+4]XBT0%V:')M; M9'S=X\8(JA^*PH.U^E44'NP4'JS+C[./:'"PSIU/+^EA\KH"RT7:16QL$C'6 ML\J]Z,LVL]#WX_@ 5]#A6("SJ#]J,RL2<8%];8S2-5U&H^2CO&?73,L"-1?T M/JT_V;V$'[A6?\M?P!+^D6D\XU;)]5K*SZ<7/JS0J$'\9D:XY^7LJD3_1 M^#&I^XD3RM8HV6XKMM9[TMZ( J[I9BO\RT9%'#?N[!)73LK5GCGQF[B,3_Y M'!'[N,2=7^"0HP!V#@!LU $@8.'8C?!9D_.&\N[Q\>^9QP+' @9O.^.AYL!_ M;*9UCN%A-#L8W\-Z!)-GVKSL/B+B95R@]P3?DWD[X38($_F#8>T4WW MQNX/7"?,0YD3_G1_,HW]'#'XI05'=0#58)O ?XP&^ /^2SYLFP#)-^&0KM)\ M[1Y[\CW[1/O3@:]DM]"U1Z:9;NAKUC@(X W -L)H\#IC2,V\13O",#O$=-, M+3!MQ[<&;(A68PQO0JS@R[ (U#2:$:7CN+GO &X 9=^#XR.KP(RQVC M,(=7]AB/ PO![^AQ\+_P&([WP T]_03^!@_LH YTJ;TBQ >&:Z8N0Y0*#RV M&=&= R1_L$A%PUPY+:-QV\V)%KTN?AN#=T(OE-P!=="P?^V+43&NR/HW' )O"@-PZ! MV8<)0FR8G&SG0?8]NOGZY8_\GD?3FJ!XA[00>NN(EIM8[^+N=F[7AM0FXO>9 M!0;]8P"@_&3R(^S>I-U\O?K^[?G.$%,^AUG:C/2&:$93;/H!=I5G2UZG7PYB M/\Q-^^OY\9?;\_8?Q^V+N_/;7X'N'LVG4&K.Z.) R9ZYW 'CEUA&75:X;WXI MT?_@=U.>'?'1T8>\"__]+/_"$7*KN.Z[Z]-+Q_L1[P%\! @ [M'Q4&4<.NH$XY/ ;DV_&'J/LVTLZ MKJG9%_*G4_B()[B8GQ>$?NI5O@]LBF!UCG/ 'D"(]&>JSX+.)F]R%[36J=K= M?=97Q<..I(+*N?NS:FIS 36S0H(J3VDLO7U&$]4 ."DE5%0YYG?\T^/M0'B] MB>N']7QM,RYDU3**IMP/WY5/\3BMBVB/L&A6_4Q.*JZRR^");*T+EV,Q[9OI MC?NF%6$:_;UFP[(H8ITA_@6_#IC%G!$M)*4UW*;%5\)G)+6B'_A#VK9]=RN? M5H>=@771U4G=@+2OP$0X(MR>/Q#7)<1"XG!#TT$V0KT3\=. C4PG"/$CA/

,$*'@;015_"U^G'",BC6N#[I$H/F/WC0%P-H"]GVS%P@MG)3G1\=U M8[,#CTAK @=#K12?+Z$KUW_40C!3G#Z8/_ 0S@,B3+R)0!OB.8BC9]?G7-?F MI@T20"\"ZM )JV!Y7: F'&":>F.6RFT1SC!L3@MH]^RKX?FG0#+27ZG%*ER< MN!."])-FW@>,42XNT3O%S ..82BIGV [$L MN'98'4 _,I_X%L0]J06L7)\OWP>IC\ @'HR&,6D!\69REX$9ZZNXL MUK] OYQ7OK[/JF9*TV.:)RYA*"\AE)>0B/WGE-!*_3DMM.='@[3_4=##+*TS MZ_H41;^SM,Y8I8Q+Z1/5+*MZ:F_BLNXI'Z<33O2XCOUEDHB=6#.;X>F\->U_ MC.'I9UYI(HKP/C0;>$D8"96 2VE.IB2^W*=])=$_49^%YW9&R)%(N4D\['"7 M\A[CVR+-(F"H$,,1 V#HB!<(@PBYHO"'^:,1,/VQQQE\- C\\?V G'+2K6@# M0KK^*-9E09\PN>CA?K[MMQHO()>\<,?^1.GQ/C/'#J=VOKOD4SK7V&W-\Y-> M^P%8:Q'G*U-W!&J#'_R0%I'-CD',@VH5HA,8)#8WD M_R)]%BG X>88H"9H M4MPC;-FKS$SQ? M.,R?^ FD0D[LR &F:1'+'S/0!]$@D0<'Z@*^35MQ/SD 08]-&A=,:OB=B)W! MPZ/2#D2&)$IF #P+/B30-WP/U,IP# JA&6;,7:YJ:E>WI[">Q;P0-G"E/S]1 M6FF@P7#L"2N$JT"X)]PL/@UJ4-K%^4W, *:L(N"W\%3 M-D#ATI;/P'?&M>'"/3*:R8R9>'PZ@X]Q [@J6"F#?5D\ 5EG:N^.SKY?U,6N M*&./WI,FRRTH&2G4+-QLE]'3)D0M67B0!0\.FAK %'PK@W"2>PGUB)MR+MP2Z#3R06=& MI_ ;XP2:&P-T.NRAVR5WTH&P+7)^-90_>1WWA?]Y\TAB'SG?TV)>4C\:;)) MQSKQM"DB2!0/RP^C6!\6R@2I'+V8GHIFDRT!_)T8B9[L*#(12=ZV M)J3BB3/BB2T53U3Q1!5/S$[[.@463J:C5,Z1H7X%+9!2OOI.M.=CP.3SQ\:) M%)48*(O=(\UF4Z^66OD!.?BX9>BMI7PETI.: M>K99>BIOF)X*6#>;'K>Y]M%6&0"HFMDBU,BIFME=*I(KPOCO(@-HCPE5%34K M0GT9H1YD [.L)V_=H[K56FHMM99::T-K%=!^5..07ZX>;&N,:UFO-$IZJ:KZ M#1=+6]S$1**=->"V22YEHZ%7ZXI<"D4N9=4'6LT]+BAN5IMEO=[8!((JAK$X M4)1X+0@D:@VLL%)S%8H%E *+T_VP8=6DXU4HXZ5*3:^W#,4\B@26C3!S)5P7 MI)!60R]5RXI"B@2637MW#M!AY9;4B^D,C^O4' M+K><1)X+!O7FZMX\-!T65L_V[=AAK75[B6\-O=)HZJU&?:S]ZWKY59)+]6W'5(N*NX4',T/,-"5EFW:VQTL;BLX2A69=R$:KOI6(*PY6'[E-R8?]'J)^HGZB?S?_+IT$>%3_8K3UI6 MXR0QW\.)M:*9IA<%OJO93L"'"(N3,!$ M)T\^:2P>;)S>5),=0D^TCL>'1L7SIR:;B8?)](&1;+"?FFR%TYG:.EA;;QK-W49Q1%LR11>7XZH"C+7 V\_XEB])SXK MF2869,/ @2<=HI $ P)W#((G>2[LV]HW'_R NHS"'V*" M%VIP=\8,@ M8&)L1(]%$0L$2G"" 2)IQX/G$&.4AQY'C3O2YSZ#=OH)\8EO5%3YSP7'[\G));*JZPJNN\+.A?V!=X:]' M..@6)>,1LXHFM;;?159_?OFK&MP7SCU8M%[-!6O(K1K<'P"05=?U70?R6\T:F-X]4X#<<4"^V2(@ M"Y@KM\GF_//,G5]W,-5 K:764FNIM53J&*W>-5WX N-\_52$?;1+$[0 E26] MU+Y5O50IH\=KR^FC"D:S]ZWHE59)K]=43YQEEMV;GCA%!D61R*5>-?1:J;(% M8BF@\;7V9&[F871>U]KVT/&<,$+SZX%) 8TI!V"-[9!PWC)3J>BU:DUOU+== MM:3 ,@F6>E.OM513Y$*!Y=TFJI[>[X@,WC8LRF6]6=Y$F^KW!VT#W[*0F8$U M(!%[QAZ8ZX\PRW.'9.Q>-3C =N"5VLKQ7C6V*#K<*Q6]8:Q<3]M'N&]9,JU_ M],V.MQW:)[*L5O1ZI3#C90_0(S"9=LGB;-/=T4_VM@]7G-Q:% )1:+ --(AS MF!4:%%Y[67^48<>UE[VE4E$Y4!0:/?@2XDSV@2PZU5S,/I!:3JJVLO>DO1&A MJ)S:#Z/U5A>EKH]F2,F]28%FJL86JX@IS1?>9L.1ZS\Q+$62'U,)+S\!J%NR M.C.";_J!&3QE2D793V:-*3@3R@>Q>5$TEE*>GE]K\$!>2!6<6$KJ^#95'INB MJE/'6KACRPP'&OO/V(F>J#8#GIJ79,H;")B%^&UK_04RTW5Z^C?5>E4O50T. MUXFBCS>56EFOUIK\0[EH: Z9..1$'4X,"5Y;G'?4S!']<41UV7@18>1;/Z@6 MVO#PVF+Z<.PY4:C=PTU%_'R\9-L/X.[]?M^Q6""@$(-K7ZM\1.P/ M$&0J]&?%H;^DM,=F$J5=K%R/!H#FQMNDL"H.?0F 5F848,6QF 3P&9^HG?A$ M8V0 +!._%NXZ31;7ZSD["->._,YS%5[;C2VD46I(+38OF7=,$IZ;2L-S@\P[Z:#HH"%D6 P.\16 MMNS ;C3UIDJ<+!9,6GJMM(URD@)J*!OC&T(AV2'&L5>)(>\JH)HWFEN;0?9> MP7SS,*\;%;U57;\6^SS,#U!C$IE 9)7MASDVB7@50#S;'Z,'LI"AY=GG>]0Z13,-0%;,T"H8FG M%L?$YW]3U4NE$OX?SX:9#"?\GO!*Q/%H [[IM6Q!,F,*F MAUDQI&IJ(1(8]5RWX). 9W_@79TBA+PGVL[W/.QY#;=(3X0?CP+VX/CC$/8P M/0_4 N!R8*AXYFRSS5^+[L[[BFZJ)O96S(]C@86WW9?X[<3KAB9+Y"B%NYS MR,\?(-MWLGEK$L\7WZJW]$JS2<%X01!)%-Z1^U/.#<$C%:+'!)F>Z9H>MK,>,SF0+0OP87]C\)-F<2H]Q$Z/:J , M(&ZYZ5H_\(<2/ERSGX!CS-$P+Z/<++*10=9(I%@]WF%@!<,D=VY@QXSPX-O-L;,UO M!3BKPN=9'5U&Z5NGVDW ^BQ ].Y2=M([?";6=SQD0F8XL2BS&HDVAC$[WSI/J) M1XI7E%HI?4WHJ&KM+\3(.(_'/^)T.YJO&/@6 MWD;J[@)D4X7W1B$*3),EX..8WBAX4 MRXE2LA9(KU)NZZU@"TL#/(R:F,^+P M4&*Q8J^(B/<1C5VJ)P+;^W[ :97_8E\1Y"JM1LEJ+2++<+9B9E0!<6K-5'0% M*2Y/PWMFH8K>;+3T5C,=<)DLD2=C>,[/'Y5*^L&@(O/4B7]BL)(*;', MI3$MS%4^-HD+Z1@>"*0A6M;D/!8ZLCE$C9'S4[V"6B!.;35MEO F/!_'(@^8 MK^F%>;^MZ)7$U#G1%BF:T,5C3=SV.(ZK$-8VP#(I55?TB(VZ7FL82SYCK5K" M_NDQ\>TI"63CMSC+<#)^&XY[H14X)!'3@Z?)-R,CL9QU4J4T#W%0">*C+[7+ M5"5U4N;-@?C.>4]"^AZ6OD>A!^]5]&JEHH4#,^#B;U8D@O/2=PXL<8I>8.T; M\.L "[C##/.=7!^>TZC7B#TFF_!YTRF,>B?7_%.L^9Z?/A[,S-$2L84.C.OQ M&/SD#_G\2?:3!9832D/-].0[C ]@II5*)T89[6Q^,!VO_R^<&XX,Q$80\M@T M5O(2YX@&$GG%D^MRZJ+#09B-S^=%[&L&OXJYIV9DR9D3)Q6/*T+A,(:*]J>?!%SR-ZH$CVG*''+&B%C6?*N-O9!9XX TTAY E#1&$<^+ M!G#3=/>A-6#VV!63[$W\%D+T[V.74ZOV#F_W"L1*^)[ ?H\Z)[Z'HF;@NS:. M@H_3)>(9WCPE*>0_;^/)$*O>GV".1IQSD?F,SXFGG?C1AK[M]!U^,B$R^2![ MOBMW N,N.N(-_L4_^-LOS;+1^!B*5@P"61/" /Q"I/'A_IXTHZR+&XPPT.IA MMB0Z("CL"P@W OQ/Y5(D##YAY/&Q==#8QTFXM3>. CHD8HCI+I@>!F.,#,> M2]3 SQ126XV8, RBIIB&3[3?!2 (L,QEEN@O(9\(SN@$XG+I"#,WC2G,E.2> MX7/C$?Y9T1NUN8R-FF<@K.@[\QALLN%XY'OIQ\U>+0D#6E(>"ZP?$O4@]A_8 M,6D&F/VBXZ6!N*<^$3'[ZS/"[=@/F,\74W D$H_"L7X!5PXD#!,_KPDHI.7]58YS4JO8E::2D::_*A LN%0N+/* M+U@LOZ"L\@M4?L&K\PNT*>-(YS@'# RX:7]FGK&@L\F;+ K;V* N&6&YA:Y5 M];*QB%G$18K0)F=8++168K',EFND+V42UE#Q"800K;\E@61ZWAAD>Q*J\\;D MYO13(L9H? K'\:5-%+Y$_N@CD8]@!4:9N@I$@T\?X$?BZM$WA3H&:A,48 5Y M1PZ%[#:D,S9/M.X"4AON24A[1XA>%)="-Q6*@=!H22P_:9%#::E3BF)&P^(B M7)#FM);(_@/70_F/6;5FAD@'[2:UM]D'IC[UO"W07OEQ'WQW/&2"EZ"J"'N; M]_"213Z49REU\/R/NC^#) M6C8;\GUMP=>C>3(!;FKR4BC9.8%H(<]82RSQ>5AA^^@]D='#)^"G%!/B+A,= M3H7A0;2R8LP!5''-1U$L,%4-(MTO[(%G[N289]T('DG&;LY8",2:*1*9F8F] MUVEP680R*CFU1:C3#$'1P: \15MKIP'0P<4G>Z!??#+AL &M$ M"D-"3$Z@ XF'N55(8,J F8".SIJ(LI$G#0\)((I/A!Z%]UR_ROL(1:CT N)) ML#XD3/+U@2&DM2L>-@3LD6Q'U'/]?0P/4"F1$E %-FAAWC^YW[D+#[TNH7SL MO&/H:H2#%SH,"+T%%B MW80B!.+'#\*=**4//$5&%2'6DU>#E?^TI$**+3!$(1\6[U;HS+4X>LJ]-9?Y M885G%&>$*.P>N!-E-BP$ MZVD/;]9'QBO2L!@-V#/Q6;R5A!'[DT(;Z/R M/2VT4*3(J*048KD/ZB3BLKF(9$O3J-%*6 >OZJ489TC9?PDO27&1S!%1K?/Q M\A8]:%H M18Y+(6 5W/6:. $+SBJ##XO=DS![:7L>]U)^SZRW<6/FB,!7Z3< MH%@S!4OW),FF67Z/44&4)-S>DRS/CPL;7O:\G&]/&-*&/OLA-RLFTZ>J9,6D MF.&PBO--X$SM.0F]PJVW*Z95'')&'+*BXI J#JGBD#/\8JW7^<5R%7 ]7_NF M_,=M^%'YG*1'?5$1R#TJ6>+&)))K2G,=XUMU7G73W M#>AK;R/)A-TG8Q[ MQ<@+RQB M(A\QKQ4C-B1KPOL,:YA$$3;AJ2C.3K>[ @ #<'N TF.4$(ZPOK"R+5T8)Q.^ M/3B[%CTR]P$]S%XT"!&+@8OC[B(Q(&3L1]H[3#5N29$('^!&)A-F1(@.6\E6 M(G36'_/,44008K&>C\;7.! E-)1*'9^>U M,W2 ^/&=WG\H&V8C/(.*H#+\; MA[SE%&4A[RMB?>I]_NICT:FH[+L!D$C4PU(6+B/17)RU108( MH'@(,ART6P?^ V35.38JAG:/TR8=2[.#\;TDBW0A&=DV^,*#8\-+$%W45V'R M>I9L,ZLH15'*IBB%-XG(C/.DJ<"VYIJH*J.7>XQ1'SS;D +[G$8L_D:%M0\^%W9(%B'RQAWB3:EC3.[:FV-MEV!XHZ%'7L M"'6TD@;$^UA"A!'HT SN,ZSO1 W#V_:(NQNYTS72SL:+:-JNZO?)\X'_8.ETI&LVP8 M'REIP9S] PRL92+R//*(1C3%WQ)])LXYL#$W$D.Y\'.*YXVYX8!],WF2Q+QO M3&\H@(;=4BGV#-L,@,G3?B$8J3?U5,_>#3O$\-DY(=4D1UB)[UK MV69O[E$P"X/*7>- C>SUB--EG) 0BU?$@T2R&9_RQ":.+:.J#Z8[CG,89!_K MG9WG--6WWM0<^[:9$3X0[X4B2:P5<^F)\[Z+ALM$^0_-*J[O2_8<%_ M?&]?W77NVG>=?YYK[:LS#=ZXE'^?=;JGE]?=[[?G7:W]Y?K[G?:M??O'^9UV MV^G^LCS@6F%L*W7896-A75DYI$"=]J76!8%S_NW\ZJY+,JC[_>;FDOYNW_Y+.VO?M?=8V-QEV73@E#TPQ?=\U'FB)&5-GV";U![;;#'04R1-M3#QC!]^ TL$TGLFPN M3]MF/U'. K72#'-Z\HOX N.N#Z'*Y%G&MR"&IXEQPQUY&"*(=PIU3O_+L=)15'[6CSS>8_GSE P_#WR2#GV9-H5_R\C9H MH,;B%:<:^5&,9,=?.,$0V?_B;IWM(H0I=1A0.(2VF+VBSQ?'1LX#[1CD\QC@KZ^$ MT>R!XSMQ)0DQ],+G""$C3+Z([.SN@#'>6RBG/(2/O,#\__V@!K@CH(3*[E-" M G9_]#*X)Y2# +^>3L#GM2@S9E/L&3[@Y0%"5/<)(?B *K5]0A6K_PK6<8I^^PORVQ\B2L#= 3K4]PD=L-SW66'" M>]TO9IKN YSYI0"H&W-!O9\Q4.D@:\4.LE:>@ZQUHBWJ(O?N"+:9\WV*W=QKE >WP;?V*EI.-1?UP[N0@K?1&C M^"*T=V9($SP]7BMY.\:,8Z-B'ANU#GW7J-GP^AU[G^KM%%H=C\7!8'G$-D_7Z#K8UP'X7X][0B5">YI]! MUVB4-_9KP$P",4067X;C(=P.3C_EX5N^AVB6(&I[J 4\[] >RKP'?BIJ%'Q^ M&@]8"L8R'QN?*CQ)8]JL"Q9.?%[/[X\CS77@641ST%D_RKE)NI6%KI.WV1;' MSUSJ([_3Y$IGW"=>9WK$JYC&.QQ[V-:4;\F[D7CF/>/#K)+:0IZU*UM6L+@1 MBAC#*MY/HAX^;Y#"Z\!YNDDHYZ)3719Q".^KH0H=E5Z/,<"OJ7 $K?FP,G4O)1:<$D$TZQFD>]. MSZ_?BY:1^(U$C4V^<7']7J=$'NS+-[9$;UJ6<.)WZ<:2R%@$7WG7>R^3=;*, M1+S)^GWL*_+ *,<%A:?D \AAD?E3WIQC4N+D!M] M=<&-><\0>>J9YU"]SXJ1W%%3R1TJN>-PDCL64)\3@<&-"U)WX/U0:]/8(4V& M"CVMPPO47*E9\V91B7RXE6ES>ZQB7V=4'ZY[AB-0-VC@$8V"#-'5X80#&MA( MTY*Y2DY_VSBLB/JIBKNTTG>9*$9)"B)JZ>'8&O#N6,Y,E?U=_[U0VM_9[\7? M,]3VDP24SVZ/ZJ#4JM-9CEAPXGM\/E7<("A1N;C^&2?D2E&>MP-=VD]Q'M ; M1J#)D@YK4A9&]!.L]'J2P]N^_8BYL2VNGJ0)W2POU I)H[\BFS?8%%QRY_[-JB MC1XV,0-&C"8(J6;(O6;=C/9(/^SQEG>,!BW@CBSB*?E8.B6-BYX9.F#Z?6&6 M.>93Y)T(415SLKRT>4>3NU] 8IA+C#^0K9,EE9F]T'?'T=2%P1,Z89@.42WY M>/MO!\VT4>:9'(L#+U-6T0_,(7OT S[ U@HY[E=Q&O_@Y'*;S'[^NRO2(EE]/P<'*7\#G$*)A\JD&_#NY-3]!E7%1R M!Q1I@RK+?T7E&EA+ OB8NJ8X$Q$;0@*(9$&*;XWQ>LV$)KF%I.?<,?=I3%]U M\IL(2SO0@2"FV,6%BC-_PQ,BA=G&ARA[/+\^V3]C_V4^T=-<*\?T6QP!J.MY MT0S #2J0IZ17D,!6"B+E]X*H)+> YVM6#;+D^-M9>\WY"2MX M5\":L 4:GAS@=8NVJ?UOO*CCD@'_\)=&^;AB'&D><-7?CIAE__HM"MP[;$YY MW;\+['80W,&/OZ#U>T0Q&JM<+]6JKW6N?JXOKV6_NN?G\<"Q;>;]:AFE5JUF5*NMHT6^ MUZJ5%OR>L>#WRD>?/3_.<\[Y#^C6H/9C.3=GE'HUNJGC>5^B;\2]IJDI,Y?/M(OQ$7<7&P*)'Z]Y4UWN MBN+=S#>_GZ.Z:JE)Z[\SR<%]R^['O'V/UCW^(^&:'S),JRB<=.WLS$K8F94; M[SY=N,8(EDWR'K3;\Z_MVS-,C0#>==[Y>J7]_?MMIWO6.44VUM7N?F_?:3>W MY_\\O[H#!M>].>W[ZG2J_KR\N.J?G^!YFCIQ>W]Y60LX$L6>3_7P.1J,EDQ)&(U=TJ)H5Y/;EM(\YD>[TARE_II^: MU"?4;1>_O&!4_$1#O_3$L7' GA\*%Q:>^9'U0B?BP7@+-(<>#>L3V1+]@/L, MP&()[ODXBT$4C7[]\.$%=56/CX\G8#8XH>_8)Y8_%"K&B=;I4]]X$ZZ)'LH9 MPFU:@-5/\DU4,V*O73S8*U%$\B'R).$Q!06>4A".>SC"'#] ZV8HAQQDUT-G M'1?R%G91XK[><&:6A1[WP)=O\9_TS<33*.YZ7WDN5K'R&6S/=CK FYQ9K)H, ML"2URB$( O1_/B4NS'AV ;9IIW$N@"%#QJ2_*#MA6DR5%A,*>!I1G C1/3^5 MV3]&N43S3,#D1>U_;SPV,\6(D8@1(U>,&"\1(XGL.+W^=G-^U9TR$7?LWA;! M^,WA.G](A?"O0?AR@O#E7(0OOP3AX2;!B+C[EW;]YQ5H2K]W;D!KTD!INFMW MKK0OYU?GH$)A C;_G!2I;^VK]E=*XJ8_;\\O0:DZT[IWUZ=__'Y]>79^"U^Y MNX.O*\)1A*.2NUZ9W%57R5TJN>MPDKMF"KY*(O@JN8*O\A+!)T4<22]TDX'H MZV;DV=UM&_0_[D/31?T2=S)HG:NS<] .S\[WVX6@9%Q! 3>31JH)C51S::3Z M$AJYN>UY@SXO?.E M+F??SB\,=_;U;KI,]D05#=Q$+]7\=,5DWI O,N5&V*SK_ZT8_Y^DYWE-\Q+F M@GDX0-II'K.K9+Q >VI$L\I[[9SW)%@ G=;>VE F"(;9>L[G8$3Q=O$4?/HV M>>(QU6A71G1F;$6Z-(?ZJZ&!\#._.]^L!A#8&?]HND^$V*%2IV,O:\A,VC'/ MWD_YQ/B?_YG3OD(<:WX3_Y4<:^$&'B*&A8&ID%DG]_[#AW9@#4"]"#\P^]X, M/MAF9'XP2I5FN='X &:Z43-JK891+J/-7JE^$,A8-DX&T?"Y3B OB)7QAO(W MWR\C1.^S$%HK^;JXP)5J(!T"?2@>*:Z%/1A#TI$;H \&C-XS\D MO:=FE!MU_ACOBSHT09'[%+F77T#N\TC.^?G_@#CX+9?TD.12U%>M-!K55KD* MM%8 M8,^PP00->-,3,FQ3/A?P@XLQP^3G$(P7"^%!Q/@R*C1**R)#\+VEI&Q8&NG"/$^-;- @KJ(?199ZN*- M)H:4%;RDY*S,)ME_\*1C]VF2:(W2\3_(T9%-2_[[&%A,A10!HZ0DZ.[0;WGO MZ9>KRT:#U.72VN@WTX_SC.K),F3;93C#7CO%D! A!:+B+;-!]!-6WA")!M2R MT;=^3!#FZBG\14(9=1"@[(:B[-VA[,J!4+8PA%MKH^P)@=Q&F4N$#H2V!JJ? MJ^5/FM["9MTV>R@KTWG7V$/UD-A#V3 .B#W$X<%RH,BC?L#F^H[3UO M*)5JU4;CN-4X1@N_U3R)?CX[D^8%/.'+DVLFLU%?J\.79U$AGX(V@ MQNZ7XW(BK;^9H"_HFM%J-;1WF5]>^2=:I5(Y+M?+]9:BTUVA4W2Y4A%P==XH MZ_V@5R'+*4^U69.RW"BM6IC/BURUN;.-7.>QM^Y\.'+])\:$@([#93>NZ2U) M\,NYTO6$TO\^=D$GYZE!RAFW2_1'WF!WXT>)+OG:2(7Q'@SA!@ M]5#D* ].EYH4VZI(,FRU5BU'23S1^!+1BPEI1?;;QQ&M0X_[P-">C*EU2JE9R1JUD8\%J.54KJ6HEMU@KJ83OM/#=?^^Q MD+HM?-U:H]3]QH;P@6>/2?9.Y8E>@R2F$ N%7TNMV=HN_HVW^8W]="P0M-Z# M$_@>*=1GV)X]VJ*TCI^"RVKE@-XE6J_O/:WGIX^MWE.5B>*E%_5*:FRBS2/N7:JWUD5TR M7XY'1@5 MI#I%<,4GN.:A2-8JDGC+2)%X:\4T?A/X.#W$!]F#D]"?)6^CDB-6=>W6=$<# M$,W8@30B6O^[/P#:LD[QKJP?KR#NUBSJGIIQ)HLP_J B#/S)$S.#_+$+1D6) MV!VB^-8A47RE6EV?4/_FVXDW^A>#E^E3">1\/I"N8JK.X0'?3G+8P,E*.,'R M!5G3LR(RCZ-8P0ZQ J-T*+R@-I71U5QU"@A/^B!*O6/6 .>$NYAY_> ^5TC MVA$E37G5)!N8YU2C$8Z)"XU:=GLLN%\VV1-AWUR/,@ 95:Y/ G4.AZ/UN/GD.T_YF#D M#AP&)DT<))$I?_0K,*)HO)-6*<4E:ETSZ)D>"X^O?[KL26M;1"KE4JFL2&,G M2:.\FZ11+VV&-))>N8HT#HLTRB?&I#ME1TAC?1T0GI$:_7'@.>& V1-$TBK5 M%9'L*9&4=Y1(RMN2'XI(#HQ(,/[9N>KNAI[5(1>K]G^_W%YJ'0]GEUI,.Q.M MU+5CT4A?O"];K,,+.)?GTTQ4C% X/)I"U;E 42@CSLS(!&I U&"6.0YAF2CD M^T3F/6_2CO$,VQ8S,N(UD@/)_5X>ZE1(F8.4W=/?=P\I[\R?ON\>F(F)UFAAFS"I/=+-C2A'=LM-V2;#4<*%=(/-W(3#%- M_I^0+HW5QP(-1=64=H=3PH3?".\25HK&$1S&U. @ !0RD_&2$3 XA\SRAR-@ M%&:$Z2]GQ<47:M0F+Y3>.?K\/_]#YIP]=F'C@?F [@(& M=S-T"'-'XR ,=SV<<(@>LEMV+U7][O$?)]I=*J,3:R-[3]SG M%ID_& UW"\>CD4O7;;KNDW3- 6Q&V+875L1?RKW#^%PBW[S+K'$ ^B*"&4CH M_*[A/=P[>AI1CEWZZ]' C.C#0%3@X@$" M9N)@P% ;!NY$[_I+)GI?7-]^XY4OW>_?OK5O_[7'L[NO M@-85.R\&.Z^4%#M7[/QPV/FS:3,QAP^=^S!F\?R/#)/O=KY>M>^^WYYW]YA5 MWZ0L6&Y2_F?L!(R/F0=4DKD\1@4-2J/VSGZ?C **G06QHT D]ABM2E6?-%$' M8)S:V"&%VKLP:]H M07,<#?P [L'>M-19UKG\ JAR9DR+LI)G_:' *?F1$31*Y],P-K(*<"3H9."QT]W%NM=$'U,]$O M4?>DR(U0,7O,]1^E:MGW7?@+-#1M!"HF!7X\J7V*S5)J+ 5G>":O9:)F%X?+ M?/XN-F4)X2LV3=A4*NDJ5=+-H>!J'CA/O'"6VPK M&6GMR!JP8OHI-G<]ZBY2WA&E^RE^MX?\[G00.&'DCX#"M:^!'X;^@1.ZNI"I M"S$=^*(G_8)??#.PTV-&0\43%4_<)Y[8C=@#TR[-ONOLNQ_L6;>@NHI7:X J M37-&FJ8A-E5IFBI-G)UK[ZDSK?O_2[9QUVK>== KG)A2N36:SGEY?=:\O.V?M MN_,S[:)SU;XZ[%1RV@4BT4:E1" M%M<>6M4)]6/QG];7IG?08TWG;K]@B!YV#KCRDP:#O52#0:ZI+'--&TQ5-^5& M^?RKL9#D!,6S=\%>.*)Z?SC'+>YK_QNG M>X"I25!O6YD1CS/[->EH9%FI#OP M\(NRF5[XXKD3Z/&@Z6%?3)?Z:W8'C/$V!>@SR\[[*E?VA-T]FL ; MNSBN[!X]+(H2_N@5.)&0&B+#]8CQGX29T7!A_FRX_<,5NLJ+X^K^(@OF\$9/ M*\ 7JDL;F $;^"X6A8EQ@Q(1%E^>,^IS.M=A8IV$R<5Q;7\1S^JOBDF=FN% MNW#]QP-E4GB3%\?U_445SX_8RT0:SF6F_ED9M,E3*/<$!\0571PW]P8!"I3S#;YR\V&(8X55!A!==[RL#" G;V&K((!W# MF!T^F /M^+\;"AJ(#@O")R![+,@_,UT6)LD8'D7$%N)#RX?)!!H2D,^F'0E% M9W@/*!W]=F22WV8$,/&]OT;W_QZ9]\PX@5> (($U[_,/"U]Q_C,H)KAY)GAQ M;"@NJ+C@UKC@%&N30'^&8\WG5^5G^%4YYE>+/;=B0FMF0DH54TRH"$QH(E-C M5A;'&@Q,04"3%B:JB+VD!5=OL@%7YT7Y'>MK49!W_#G1C4T?)2=#AQ/AB],3 M!,7V'8\P.Y]WOXP+YDU.2'(4XFS9*2:%:;+E6DW7Y+]F)LL>I7TH\\\RG8N5 MG_/PRE7@$=#3\]M1^7EQLO NTS)S3=Z@7&+M??[$ANF]D)L.@"-1,FC*[?GI M QM.IEHH\!P >*036)'T*W!&6ZQLH#"HA3&.5:*4)J13^@(42#<-TO*&0;H@ MZRA5@6M4FFMC'>EBC-=";8'=LK:) -UL;3YV$+3#4"J9A12O*Z.E]9ZO2*L4 M\ZY6+M$GSKB=/PO";-;+.< ^'0OT:Z27^?XO3#F;Y MT A!?($I4@^FR]U[.60DG2-O5\6SEUXPSP9],VOU\MNL?L&30%:PHTB:OZ!Y MC=C*W?[MR#)*K5JMU"BWLLGR3B9#?NPY_.WOW;,CD6T_#H_O37/T*\*D[=GX MG_,$(.WHU R")U O_VFZ8W18 3RI+LMJ5X$GC6I5;[0JA6>L^Z3=W@1L9#JVF#2! M ] TZWD?7W'(:.&(RE:H;>'3S27*VK+,6P#W_.>(>2$#N_0: H?5EQ<8:,=30@4ITH]PJ&(X>E/9N-&FK.S\R7258 MBD:VC:5=,JL@T)K>J#7T:E,)$86-B(W-I=T\*\+&:DFOEVL%P\:5VR2[E"ZQ MTT(05K_T =H1"X8J84*MLI&$B7WR3=RR, H<"TMA,&6BX IC,1UZ2V=&))>/ MP>PKW[->)U^;S1+H>V7E!"X\SE27SGY8.JFQQ40B MA3F+8L[2V0_KP9Q2N:I7=R#[89\4X5-SY$1P\/\%3=AE9L@T['+@A^A3]<,H M5&QY6>)Z<5Z$XSGAKREX7"(XS@0T3A$8KZ N3!>NUI6.O .(\^)$B;4B3KG< MU(VUNBZ5HCS)E$4O3N]>L&3"NV._?SR&/\C=ISCR$H2U=+(#AP,8@-+\V.]KM+6=@%IELX_6 /2&&6]7MXBUAR@?BR:_"M6O%JJ6CH]((;' M*NFJK!O-BMYJJI*-'4"=I6/Y:T*=BF'HI>86+:L#5)"_^K[]Z+BNXKU+$-#2 M<3MYZ\NG35::51W03['9PF-);>E(W1Y@R0'JN3@VPOUI;I]JLLFQW!SV7#B>N M"ST;I8I>J:VSZD]5:;RD2L-=)&=5T>PF:7;IZFU!GJ].Q +KV:@V]'JI:&2J M,'([&+ETG?C*,+*DUT!PM!KK]+07HEYC9P3';HB+9PFB @1A^V.<<3!!$9MN M4K;XR>;2ZM(154ZK2U-H76^5:GJINRJS#@\M%PZ9OMJM"Q7J]C$ MJ6!HJ?HBK[,)>W$;KU\Z9L]QG^+K!8K8:+^8J MQ;RK0W!X?$P:F+L)U16>N-0J15VE(-)M*^UP1^;3#O3"?;DQL)U([O*M6 0\ M;C@X7ML%H]8"U5C5A3U[YF(U+*\MWSMEI>A3:9;U2DNE66V8(0=C+ Q[1J,I M#CT5DP,OG7$E )"RXU[?G!SHR&ALL?!=HXQ,_" _P;L@7GCHNO#Q22BI7.F<$(ZKOBG$PU.QR&@#0LD13V]DIY: M%1S@HZIQ=P!_EDYJ6B?^-!LMO5(O?H;L/BG#TKTW\@/"$K^O^?.*PZ32G.]A M5V0WG^R6SDO*5OFLBN",:DEO5+8X/T!ASJ*8LW3^T)HPIV+HM4;Q_1;[I#CG ML.K^1$L%Q9U?0V,KZ:2P*@HKZ\V*4J5W &M6TDIA55A3TVM&\>"^52+'SC_^7!?X4G?[M MEV;9*']4_+WX>#8G4E@0/'NV*U.YI)=*I<*+A7U4UATOC$S7'5(9,O#]C#0H M.-\_@+J<^IP@YDNH^\KW@NT1N &ZU'K].*K4;&=0NC$GP+H[*%VNZ)5JT4KP M#\J\R9U$MSLY,X= Z4M'@5>70U'1RXV*WJAMLCA("9_BHN32@>55HF3-J.KU M5M'&)*K!=+LJ$S^F!].I0ABUBBJ$>4W>]<*D5!S174C79&/Y-C?9(H:V9T\G MU[Z^Y4BCMEVWX_-;_.T_8S_Z.+$1?_/U2+72Q0;?D.-AM! M-L/ 5.[EL>V5]WG C@(Y>_3YH*/(6I./^2A+A\ M$3X"XC:&PW4,AE78XGJU :155Y5%Q<>@YO+U^&O$H%:UK%<:6YQ<=H#J^>1\ MUKB82*GJ*R2WUTP[F2X7>9[25!+Z/F#-:X:0+(,U!:]..T#%>>[(5L6JUT%T MJZ[67P79E5J&7E,SMGY_TZF^F9YN1'\#R6L!L MQH;HLT+ -V!&;"P.^[]Q:SHSI? M?[H%R ]'N%&719%+)C/Z,K:_3=ZQ$QLX@8VOIX/,JD-'0 M6Z6R7JKM:*&H&FQ8./D'JV>G$;+=F$:H5BGJ*@?E>Q"ML_SA$.0$><)U[LNHYS^J$X98_XM[^^,HC. %QK/AHQ$# MN?O 7-6W>(E 8^L5PT"0TDAB_1/1?_FNLT8+L4S-7]H!;'G%Z(^584NUJ3=; M6\260]!%)Q/OP0[!2S9=$'=@I3F>9IDC)S)=Q7.7H*+E6R_$<+@!,'2\4PZ$ MY3TJ==VH-_5Z:8MS^48+.^ M8SE%[WFP)U[(=W/)/@79)"M1"N"9U&@HJ[[@Y*+IVJLTJ4K%3+>JU: MM%2 @[)*9N7ID),^7#2462#:?99>*D OMC_&JHL)@GFS94J>?;*YI+R*?)ZV M9Z^.L(VZWBK5]%*SL4'*KNRJL#DTA&V65I'SLVJ$+5>K>JVUR43F11"6BZ(/ M4<^WG_ OK!O[K/T?#1BP[3SP5[DRXK\FSO-?'Y/ST'$R$D((""$?LL<8S=EE M\J$7V".%E18#' BRNW89TTS+\HYI&0>(VL5Q M1>P:XVCF=?KE(%:R;MI?SX^_W)ZW_SAN7]R=W_ZJF>ZC^11*GH-:C,B/PB,MW?0#G*:YO&KO%;\ M6MCS5A T1#_ *E%J1IQ%@72C("UO&*2J&&6-44%I6#1 D5A[88K)=?51X-MC MJ_!I)SGB?=/^KOE^+&,BD=;FCM>2 ?^\('_D@7EC=A'X0[2A<)\_G6AP.@X! ML5AP_M-RQTB@V&L5_K'OS)^OJ+TLUQMZI:D2!7<-TRHYF%9.,&W!_(_-89JA M&TU#;S6+W[]WIZ-X9("'T0XQ];V/K#>-Z@JD D+UNO_5]VT*=+#@P;%8V/5= M>_E@>[/9U*NE=:80JOR/W<'2V@HDREJPM 5RH[S)P+%JW9*;J/XU\,,0Q4I? M9:@7@%[K*Y J!-(;@NC2$UUQ*(/>:JB.7PHM$2T;*Q C*T#+NEYNE?12?9UM ML0N12JA\9YLSK9*&^Q8H.CPCDOT<,0_LXU]51Q>URJ['XC:G3'9-%[XLLHHM MX7W27!-D4,%URR)6$3>-Y@JTP4N\?;#;Q$S&<\[97E-?4M:-FO(M[P#ZM%:@ MM:T6?2IZ!12X>JWX(X5V6JN9M/&9!RJ.JVNF/70\)XQ0WWE@DDN'8Q?5'\6A M7TYBY=(J['4.'B"R=@8^KZ:U6K6F-^I;;/R@\&A1/#)686"O#8_J3;W66F>? M;17DF^39MRQD9F -B$G;[(&Y_@AS;@O.I0_ &59>33X(!R\0ZUD"W%=2:JW1 MT"N%ZW*LT'0[:+J:9))UH&FEHC>,HH46#LHNR)2#^[$#5+H]E9#9.O6N(KTD M]FP+@EVZ@WX3/3YZN:&ZBBCD1.1<15;)RI"SH5=;9;U56V<2H@H*'K*83(WD M]D,E'#?"?^9UQVN65Y$F$T.UXUG^D%T":%_=&:_1P!0%U;]18>@J,F;6@:&& M#KOKS=8Z4R_7T[E1"Y4WHU91>3,+._O31%1P M];*8X;-5),H0$*Y\S\]*W51%!.)5I$NLQXD*NN&4=)K M:TW'5^[Q2:[ \ !0P\<6*2<%G:88A#J;:8S:"P M9U'L6456S*JQIZ772L5/7]PG[3CFP\*Z+#@C/@3W5F45.3 2KJ_-3ZL8>J.Y M47ZN?*Z%1,I59+RL""GK1D5OJ?$XA4AO(>=*[)K<#6W^(.AU%3DNJ[:UDTA) MJZPWC")TJ%!B99O)+I55)+NLWJT(5DA=-RH;K8;%G01K)-,2([IE9]_09C/8D9]YR>SC_^7!?X4'_K;+\VR4?Y8L,%6 M"F$+@;#+1+8/$V&5--U;:6H[[CABMI*G16-/U662!!9E3V<\3D _UP9XMAV$T= ;C8;>K*HYX@I] M.?J^.)-CF^A;TANMJFY4-]D=042YX?P1:13SV&X^GQ?<I^E+O$/D2F\=B8'SF?4N[F[GSC).;2)^GUE@T#\._$?YR>1'.+E> MN_EZ]?W;\_.2IU2.60A_])GOI5T<5\6N,8YF7J=?#F(-[*;]]?SXR^UY^X_C M]L7=^>VOFND^FD^A9$BHXG@L\^ ?M0'CMUA&4A**VR\E^A_\;DJG$Q\=?*^[Z[/KUTO!_Q'K83CESS"0W?13G*99?EB,]1W+ M4=Q(H=&KT$BZK N"19MIP/.:9Q!>YVKI[4;AG(7I%],U/8M-N?N-%R4WK<$J MVOQ6K0721%9LZ<]+#*E-E+TZF UB\&R0?\>A(TYUI_YPY'L856S_=,)C[M E M?^XW@NISV2.KRP\IE?5:LZH;K^B=N^([+@IZK?LY9U7V% VM6VM!ZYQ^$^F( MZKF($R^)U7JI7-.;U>7[D"J6QNDDS()1EHXG;+K-XK=1KNI5;,%3 M67Z8K<+P7*VZE)3.6ZWJA7]5+3* J2+]R! M2N'WNCEX>6GTO@'5V8LVR[#+>J."B=C+)V&OD5UOIF)HEP)Q:GVUOEI?K:_6 M5^NK]7?-4;\]YSQWRVI.&(Z9#:HE*(X:&XY<_XDQ.!!HD]IH'%@#,V3:R#4] MY;/?MAFQ6".%E;OO\:L=PI*S<0 V]@T\CB^J/L\%PM"7;@2ZW "V+-V#MURM M%@;[\P9(O!C[EPX+K KMU]C84:'\OC'\ MQ09@K#94L#'^7M4;C4)J-RJ4H-97ZZOUU?IJ?;6^6E^%$E832@#M4&,_66 Y M(?6DF@@J^"-4 $,53MBVU9$W^6K+X03Z\)HCR+E H9FS$YX=VUUMZJWJ\M/\ ME)V];QB_V.BLS4425HON>K794LA^2,@^-ZFZD3>)J2AAA%5B?I*%72@2V+/\ MZ]V*(C06F^FTX2C"B[!>11 4NB^,[GDC@K8403@ )%>1 [6^6E^MK]97ZZOU MU?HJ!B0T+54!@J^[11@'K"^C?7TRP(' ;YH4F'GOI7*1F0R]7 M"IF,I%!^*RB_M=J"K\CR\JQG1/C>RA!>;S947Z�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�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inis20221231_10k_htm.xml IDEA: XBRL DOCUMENT 0001038277 2023-01-01 2023-12-31 0001038277 2023-06-30 0001038277 2024-03-27 0001038277 2023-12-31 0001038277 2022-12-31 0001038277 us-gaap:RelatedPartyMember 2023-12-31 0001038277 us-gaap:RelatedPartyMember 2022-12-31 0001038277 us-gaap:NonrelatedPartyMember 2023-12-31 0001038277 us-gaap:NonrelatedPartyMember 2022-12-31 0001038277 2022-01-01 2022-12-31 0001038277 us-gaap:CommonStockMember 2021-12-31 0001038277 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001038277 us-gaap:RetainedEarningsMember 2021-12-31 0001038277 us-gaap:ParentMember 2021-12-31 0001038277 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001038277 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001038277 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001038277 us-gaap:ParentMember 2022-01-01 2022-12-31 0001038277 us-gaap:SeriesBPreferredStockMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001038277 us-gaap:SeriesBPreferredStockMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001038277 us-gaap:SeriesBPreferredStockMember us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001038277 us-gaap:SeriesBPreferredStockMember us-gaap:ParentMember 2022-01-01 2022-12-31 0001038277 us-gaap:CommonStockMember 2022-12-31 0001038277 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001038277 us-gaap:RetainedEarningsMember 2022-12-31 0001038277 us-gaap:ParentMember 2022-12-31 0001038277 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001038277 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001038277 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001038277 us-gaap:ParentMember 2023-01-01 2023-12-31 0001038277 us-gaap:SeriesCPreferredStockMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001038277 us-gaap:SeriesCPreferredStockMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001038277 us-gaap:SeriesCPreferredStockMember us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001038277 us-gaap:SeriesCPreferredStockMember us-gaap:ParentMember 2023-01-01 2023-12-31 0001038277 us-gaap:CommonStockMember 2023-12-31 0001038277 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001038277 us-gaap:RetainedEarningsMember 2023-12-31 0001038277 us-gaap:ParentMember 2023-12-31 0001038277 2021-12-31 0001038277 us-gaap:AssetPledgedAsCollateralMember us-gaap:SuretyBondMember 2023-12-31 0001038277 us-gaap:AssetPledgedAsCollateralMember us-gaap:SuretyBondMember 2022-12-31 0001038277 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001038277 us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-12-31 0001038277 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001038277 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0001038277 us-gaap:EmployeeStockOptionMember 2023-12-31 0001038277 us-gaap:EmployeeStockOptionMember 2022-12-31 0001038277 us-gaap:SeriesCPreferredStockMember 2023-12-31 0001038277 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001038277 inis:NrcLicenseForTheDeconversionFacilityMember 2023-01-01 2023-12-31 0001038277 srt:ScenarioForecastMember us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember inis:AssetsAssociatedWithPlannedDeconversionFacilityMember 2025-12-31 0001038277 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001038277 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001038277 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001038277 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001038277 us-gaap:TransportationEquipmentMember 2023-12-31 0001038277 us-gaap:TransportationEquipmentMember 2022-12-31 0001038277 srt:MinimumMember us-gaap:TransportationEquipmentMember 2023-12-31 0001038277 srt:MaximumMember us-gaap:TransportationEquipmentMember 2023-12-31 0001038277 us-gaap:BuildingMember 2023-12-31 0001038277 us-gaap:BuildingMember 2022-12-31 0001038277 inis:ProductionEquipmentMember 2023-12-31 0001038277 inis:ProductionEquipmentMember 2022-12-31 0001038277 srt:MinimumMember inis:ProductionEquipmentMember 2023-12-31 0001038277 srt:MaximumMember inis:ProductionEquipmentMember 2023-12-31 0001038277 us-gaap:SeriesCPreferredStockMember us-gaap:PrivatePlacementMember 2017-02-01 2017-02-28 0001038277 inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember 2017-02-01 2017-02-28 0001038277 inis:The2013PromissoryNoteMember inis:MajorShareholdersMember 2013-12-01 2013-12-31 0001038277 inis:The2013PromissoryNoteMember inis:MajorShareholdersMember 2013-12-31 0001038277 inis:ClassLWarrantsMember 2013-12-31 0001038277 inis:ClassLWarrantsMember 2014-06-30 0001038277 inis:ClassLWarrantsMember 2018-12-23 2018-12-23 0001038277 inis:The2013PromissoryNoteMember inis:MajorShareholdersMember 2023-12-31 0001038277 inis:The2018PromissoryNoteMember inis:ChiefExecutiveOfficerAndChairmanOfTheBoardMember 2018-04-01 2018-04-30 0001038277 inis:The2018PromissoryNoteMember inis:ChiefExecutiveOfficerAndChairmanOfTheBoardMember 2018-04-30 0001038277 inis:The2018PromissoryNoteMember inis:ChiefExecutiveOfficerAndChairmanOfTheBoardMember 2023-12-31 0001038277 inis:The2019PromissoryNoteMember inis:MajorShareholdersMember 2019-12-20 0001038277 inis:The2019PromissoryNoteMember inis:MajorShareholdersMember 2019-12-31 2019-12-31 0001038277 inis:The2019PromissoryNoteMember inis:MajorShareholdersMember 2020-02-01 2020-02-29 0001038277 inis:ClassOWarrantsMember 2019-12-20 0001038277 inis:The2019PromissoryNoteMember inis:MajorShareholdersMember 2023-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyOneMember 2023-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyOneMember 2022-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyOneMember 2023-01-01 2023-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyOneMember 2022-01-01 2022-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyTwoMember 2023-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyTwoMember 2022-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyTwoMember 2023-01-01 2023-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyTwoMember 2022-01-01 2022-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyThreeMember 2023-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyThreeMember 2022-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyThreeMember 2023-01-01 2023-12-31 0001038277 us-gaap:NotesPayableOtherPayablesMember inis:RelatedPartyThreeMember 2022-01-01 2022-12-31 0001038277 us-gaap:NotesPayableToBanksMember 2023-12-31 0001038277 us-gaap:NotesPayableToBanksMember 2022-12-31 0001038277 us-gaap:NotesPayableToBanksMember 2023-01-01 2023-12-31 0001038277 us-gaap:NotesPayableToBanksMember 2022-01-01 2022-12-31 0001038277 inis:NotesPayableForPurchaseContractOneMember 2022-12-31 0001038277 inis:NotesPayableForPurchaseContractOneMember 2022-01-01 2022-12-31 0001038277 inis:NotesPayableForPurchaseContractOneMember 2023-12-31 0001038277 inis:NotesPayableForPurchaseContractTwoMember 2023-12-31 0001038277 inis:NotesPayableForPurchaseContractTwoMember 2023-01-01 2023-12-31 0001038277 inis:NotesPayableForPurchaseContractTwoMember 2022-12-31 0001038277 inis:ClassMWarrantsMember 2022-02-14 2022-02-14 0001038277 inis:ClassMWarrantsMember 2022-02-17 2022-02-17 0001038277 inis:ClassNWarrantsMember 2022-05-12 2022-05-12 0001038277 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001038277 us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-12-31 0001038277 inis:ConversionOfSeriesBPreferredStockIntoCommonStockMember 2021-01-01 2021-12-31 0001038277 inis:ConversionOfSeriesBPreferredStockIntoCommonStockMember 2022-05-31 2022-05-31 0001038277 inis:ConversionOfSeriesBPreferredStockIntoCommonStockMember 2022-05-31 0001038277 2022-05-31 0001038277 us-gaap:SeriesCPreferredStockMember 2023-02-28 0001038277 us-gaap:SeriesCPreferredStockMember 2022-02-28 0001038277 us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-12-31 0001038277 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0001038277 us-gaap:SeriesCPreferredStockMember inis:SubscriptionAgreementsWithCertainInvestorsMember 2017-02-17 2017-02-17 0001038277 inis:ClassMWarrantsMember 2017-02-17 0001038277 inis:SubscriptionAgreementsWithCertainInvestorsMember 2017-02-17 2017-02-17 0001038277 inis:ClassMWarrantsMember 2017-02-17 2017-02-17 0001038277 us-gaap:SeriesCPreferredStockMember inis:SubscriptionAgreementsWithCertainInvestorsMember 2017-02-17 0001038277 us-gaap:SeriesCPreferredStockMember inis:SubscriptionAgreementsWithCertainInvestorsMember 2023-12-31 0001038277 us-gaap:ConvertibleDebtMember 2017-03-24 0001038277 inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember 2017-03-24 0001038277 inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember 2017-03-24 2017-03-24 0001038277 inis:ClassNWarrantsMember 2017-03-24 0001038277 us-gaap:ConvertibleDebtMember 2017-05-12 2017-05-12 0001038277 inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember 2017-05-12 2017-05-12 0001038277 inis:ConversionOfSeriesCPreferredStockIntoCommonStockMember 2021-01-01 2021-12-31 0001038277 inis:ClassNWarrantsMember 2017-03-24 2017-03-24 0001038277 inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember 2022-12-31 0001038277 inis:ConversionOfConvertibleDebenturesIntoSeriesCPreferredStockAndWarrantsMember 2023-12-31 0001038277 inis:EmployeeStockPurchasePlanMember 2004-09-30 0001038277 inis:EmployeeStockPurchasePlanMember 2020-07-01 2020-07-31 0001038277 inis:EmployeeStockPurchasePlanMember 2023-12-31 0001038277 inis:EmployeeStockPurchasePlanMember 2023-01-01 2023-12-31 0001038277 inis:EmployeeStockPurchasePlanMember 2022-01-01 2022-12-31 0001038277 inis:The2015IncentivePlanMember 2018-07-01 2018-07-31 0001038277 inis:The2015IncentivePlanMember 2018-07-31 0001038277 inis:The2006PlanMember 2018-07-31 0001038277 inis:The2015IncentivePlanMember 2023-12-31 0001038277 srt:ChiefExecutiveOfficerMember inis:The2015IncentivePlanMember 2023-02-28 2023-02-28 0001038277 srt:ChiefExecutiveOfficerMember inis:The2015IncentivePlanMember 2023-02-28 0001038277 srt:ChiefExecutiveOfficerMember 2023-02-28 0001038277 2023-02-28 0001038277 srt:ChiefExecutiveOfficerMember inis:The2015IncentivePlanMember 2022-02-28 2022-02-28 0001038277 srt:ChiefExecutiveOfficerMember inis:The2015IncentivePlanMember 2022-02-28 0001038277 2021-02-28 0001038277 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001038277 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001038277 inis:QualifiedOptionsMember 2023-01-01 2023-12-31 0001038277 inis:QualifiedOptionsMember 2022-03-01 2022-03-31 0001038277 inis:QualifiedOptionsMember 2022-08-01 2022-08-31 0001038277 inis:QualifiedOptionsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-01-01 2023-12-31 0001038277 srt:MinimumMember inis:QualifiedOptionsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-01-01 2023-12-31 0001038277 srt:MaximumMember inis:QualifiedOptionsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-01-01 2023-12-31 0001038277 inis:QualifiedOptionsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-12-31 0001038277 inis:OneEmployeeMember inis:QualifiedOptionsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-12-31 0001038277 inis:TwoEmployeesMember inis:QualifiedOptionsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-12-31 0001038277 inis:QualifiedOptionsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001038277 srt:ExecutiveOfficerMember inis:QualifiedOptionsMember 2022-01-01 2022-12-31 0001038277 srt:DirectorMember inis:NonqualifiedOptionsMember 2022-01-01 2022-12-31 0001038277 srt:ExecutiveOfficerMember inis:QualifiedOptionsMember 2022-12-31 0001038277 srt:ExecutiveOfficerMember inis:QualifiedOptionsMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001038277 srt:ExecutiveOfficerMember inis:QualifiedOptionsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-01-01 2022-12-31 0001038277 inis:ExecutiveOfficersAndDirectorsMember inis:QualifiedOptionsMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001038277 inis:ExecutiveOfficersAndDirectorsMember inis:QualifiedOptionsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-01-01 2022-12-31 0001038277 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001038277 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001038277 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001038277 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001038277 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001038277 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001038277 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001038277 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001038277 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001038277 2023-03-03 2023-03-03 0001038277 us-gaap:RestrictedStockUnitsRSUMember 2023-03-03 2023-03-03 0001038277 srt:PresidentMember us-gaap:RestrictedStockUnitsRSUMember 2023-05-08 2023-05-08 0001038277 srt:PresidentMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-05-08 2023-05-08 0001038277 srt:PresidentMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-05-08 2023-05-08 0001038277 srt:PresidentMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-05-08 2023-05-08 0001038277 srt:PresidentMember us-gaap:RestrictedStockUnitsRSUMember 2023-09-05 0001038277 srt:PresidentMember us-gaap:RestrictedStockUnitsRSUMember 2023-09-05 2023-09-05 0001038277 2023-09-05 0001038277 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001038277 inis:ThreeCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001038277 inis:ContractWithTheDoeForTheIrradiationOfCobaltTargetsMember 2014-10-02 2014-10-02 0001038277 inis:ContractWithTheDoeForTheIrradiationOfCobaltTargetsMember 2014-10-02 0001038277 inis:LandInLeaCountyNewMexicoMember 2011-08-31 2011-08-31 0001038277 inis:LandInLeaCountyNewMexicoMember 2011-08-31 0001038277 inis:The401kPlanMember 2023-01-01 2023-12-31 0001038277 inis:The401kPlanMember 2022-01-01 2022-12-31 0001038277 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001038277 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001038277 country:US inis:TheranosticsProductsMember 2023-01-01 2023-12-31 0001038277 us-gaap:NonUsMember inis:TheranosticsProductsMember 2023-01-01 2023-12-31 0001038277 inis:TheranosticsProductsMember 2023-01-01 2023-12-31 0001038277 country:US inis:TheranosticsProductsMember 2022-01-01 2022-12-31 0001038277 us-gaap:NonUsMember inis:TheranosticsProductsMember 2022-01-01 2022-12-31 0001038277 inis:TheranosticsProductsMember 2022-01-01 2022-12-31 0001038277 country:US inis:CobaltProductsMember 2023-01-01 2023-12-31 0001038277 us-gaap:NonUsMember inis:CobaltProductsMember 2023-01-01 2023-12-31 0001038277 inis:CobaltProductsMember 2023-01-01 2023-12-31 0001038277 country:US inis:CobaltProductsMember 2022-01-01 2022-12-31 0001038277 us-gaap:NonUsMember inis:CobaltProductsMember 2022-01-01 2022-12-31 0001038277 inis:CobaltProductsMember 2022-01-01 2022-12-31 0001038277 country:US inis:NuclearMedicineProductsMember 2023-01-01 2023-12-31 0001038277 us-gaap:NonUsMember inis:NuclearMedicineProductsMember 2023-01-01 2023-12-31 0001038277 inis:NuclearMedicineProductsMember 2023-01-01 2023-12-31 0001038277 country:US inis:NuclearMedicineProductsMember 2022-01-01 2022-12-31 0001038277 us-gaap:NonUsMember inis:NuclearMedicineProductsMember 2022-01-01 2022-12-31 0001038277 inis:NuclearMedicineProductsMember 2022-01-01 2022-12-31 0001038277 country:US inis:FluorineProductsMember 2023-01-01 2023-12-31 0001038277 us-gaap:NonUsMember inis:FluorineProductsMember 2023-01-01 2023-12-31 0001038277 inis:FluorineProductsMember 2023-01-01 2023-12-31 0001038277 country:US inis:FluorineProductsMember 2022-01-01 2022-12-31 0001038277 us-gaap:NonUsMember inis:FluorineProductsMember 2022-01-01 2022-12-31 0001038277 inis:FluorineProductsMember 2022-01-01 2022-12-31 0001038277 country:US 2023-01-01 2023-12-31 0001038277 us-gaap:NonUsMember 2023-01-01 2023-12-31 0001038277 country:US 2022-01-01 2022-12-31 0001038277 us-gaap:NonUsMember 2022-01-01 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:TheranosticsProductsMember 2023-01-01 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:TheranosticsProductsMember 2022-01-01 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:CobaltProductsMember 2023-01-01 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:CobaltProductsMember 2022-01-01 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:NuclearMedicineProductsMember 2023-01-01 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:NuclearMedicineProductsMember 2022-01-01 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:FluorineProductsMember 2023-01-01 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:FluorineProductsMember 2022-01-01 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember 2023-01-01 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember 2022-01-01 2022-12-31 0001038277 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-12-31 0001038277 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:TheranosticsProductsMember 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:TheranosticsProductsMember 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:CobaltProductsMember 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:CobaltProductsMember 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:NuclearMedicineProductsMember 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:NuclearMedicineProductsMember 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:FluorineProductsMember 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember inis:FluorineProductsMember 2022-12-31 0001038277 us-gaap:OperatingSegmentsMember 2023-12-31 0001038277 us-gaap:OperatingSegmentsMember 2022-12-31 0001038277 us-gaap:CorporateNonSegmentMember 2023-12-31 0001038277 us-gaap:CorporateNonSegmentMember 2022-12-31 0001038277 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember inis:PrepaymentForDufPlantMember us-gaap:SubsequentEventMember 2024-02-08 2024-02-08 0001038277 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember inis:DufPlantMember us-gaap:SubsequentEventMember 2024-02-08 2024-02-08 iso4217:USD shares thunderdome:item iso4217:USD shares pure utr:Y 0001038277 INTERNATIONAL ISOTOPES INC false --12-31 FY 2023 false false false false 0.01 0.01 750000000 750000000 519787870 519787870 514889916 514889916 0 0 0 0 0 0.06 0.06 2026-03-31 2026-03-31 0.04 0.04 2026-03-31 2026-03-31 0.06 0.06 2026-03-31 2026-03-31 0.0599 0.0599 1046 1046 0.05 4442 0.08 10000 0 4063 243780 P5Y P5Y P5Y 0 0 P5Y P10Y P5Y P1Y P10Y 0.50 0.50 P1Y 0.25 0.25 P10Y P3Y 0 P10Y 0 10-K true 2023-12-31 false 000-22923 TX 74-2763837 4137 Commerce Circle Idaho Falls ID 83401 208 524-5300 COMMON STOCK, $.01 PAR VALUE No No Yes Yes Non-accelerated Filer true false false false false 13000000 520081365 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a href="#" id="a9b" title="9b"></a>Item <em style="font: inherit;">9B.</em></b>      <b>OTHER INFORMATION</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">During the quarter ended <em style="font: inherit;"> December 31, 2023, </em><span style="-sec-ix-hidden:c109551449"><span style="-sec-ix-hidden:c109551950"><span style="-sec-ix-hidden:c109551951"><span style="-sec-ix-hidden:c109551952">no</span></span></span></span> director or officer of the Company adopted or terminated a “Rule <em style="font: inherit;">10b5</em>-<em style="font: inherit;">1</em> trading arrangement” or “non-Rule <em style="font: inherit;">10b5</em>-<em style="font: inherit;">1</em> trading arrangement,” as each term is defined in Item <em style="font: inherit;">408</em>(a) of Regulation S-K.</p> Haynie & Company Salt Lake City, UT 457 2688141 2375817 1469298 1596886 927111 744793 672934 1023129 5757484 5740625 880752 840049 2465077 2024486 688462 228125 6611 12621 2183988 2311082 1384255 1384255 3538458 3703353 11147603 10503971 16905087 16244596 559597 382392 1482179 1472504 932682 879365 140733 131572 2832 5513 0 620000 155733 23348 3273756 3514694 75000 112500 1620000 1000000 270732 34406 1474463 942378 0 2832 2091511 2232244 4063000 4063000 9594706 8387360 12868462 11902054 5197879 5148899 126168605 125654486 -127329859 -126460843 4036625 4342542 16905087 16244596 12267385 11181988 4888409 4891927 7378976 6290061 4032155 3390652 3545766 3568590 577354 533716 8155275 7492958 -776299 -1202897 160173 2110576 78890 9502 331780 613943 -92717 1506135 -869016 303238 0 0 0 0 517777847 510794145 517777847 510794145 502584176 5025842 124469034 -126764081 2730795 245081 2451 12320 0 14771 648948 6489 -6489 0 0 187231 1872 -1872 0 0 2271980 22720 181760 0 204480 515000 5150 56650 0 61800 8437500 84375 590625 0 675000 0 352458 0 352458 303238 303238 514889916 5148899 125654486 -126460843 4342542 316866 3169 5229 0 8398 0 0 0 0 0 343560 3436 -3436 0 0 2266500 22665 67995 0 90660 1971028 19710 -19710 0 0 0 464041 0 464041 -869016 -869016 519787870 5197879 126168605 -127329859 4036625 -869016 303238 350094 374196 -0 1797978 53126 50292 0 274443 464041 352458 -4478 -2528 -127588 743211 -350195 18706 182318 -179982 240040 -441317 53317 -28588 582589 -1497719 0 4000000 149058 120014 -149058 3879986 8398 76571 5513 8543 83389 540032 -80504 -472004 353027 1910263 3215866 1305603 3568893 3215866 163920 54071 10176 9097 90660 204480 0 675000 452100 0 478959 0 2688141 2375817 880752 840049 3568893 3215866 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">1</em> – DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Description of business</i> – International Isotopes Inc. (the “Company” or “INIS”) was incorporated in Texas in <em style="font: inherit;"> November 1995. </em>The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include all operations and balances of the Company and its wholly-owned subsidiaries, International Isotopes Idaho Inc., International Isotopes Fluorine Products, Inc., and International Isotopes Transportation Services, Inc. The consolidated financial statements also include the accounts of wholly owned subsidiaries TI Services, LLC, (“TI Services”), and RadQual, LLC (RadQual). TI Services is headquartered in Youngstown, Ohio and was formed with RadQual in <em style="font: inherit;"> December 2010 </em>to distribute products and services for nuclear medicine, nuclear cardiology and Positron Emission Tomography (PET) imaging. RadQual is a global supplier of molecular imaging quality control devices, and is now headquartered in Idaho Falls, Idaho. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Nature of Operations</i> – INIS and its subsidiaries, (collectively, the “Company,” “we,” “our” or “us”) manufacture a full range of nuclear medicine calibration and reference standards, a wide range of products, including cobalt teletherapy sources, and an FDA-approved radiopharmaceutical drug product. The Company also holds several patents for a fluorine extraction process that would be used in conjunction with a proposed commercial depleted uranium de-conversion facility which would be located in Lea County, New Mexico (the “De-Conversion Facility”). The Company’s business consists of four major business segments: Theranostics Products (formerly Radiochemical Products), Cobalt Products, Nuclear Medicine Standards, and Fluorine Products. The Company’s headquarters and all operations, with the exception of TI Services, are located in Idaho Falls, Idaho.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">With the exception of certain unique products, the Company’s normal operating cycle is considered to be <em style="font: inherit;">one</em> year. Due to the time required to produce some cobalt products, the Company’s operating cycle for those products is considered to be <em style="font: inherit;">two</em> to <em style="font: inherit;">three</em> years. Accordingly, preliminary payments received on cobalt contracts, where shipment will <em style="font: inherit;">not</em> take place for greater than the operating cycle, have been recorded as unearned revenue and, depending upon estimated ship dates, classified under current or long-term liabilities on the Company’s consolidated balance sheets. These unearned revenues will be recognized as revenue in the future period during when the cobalt shipment takes place. All assets expected to be realized in cash or sold during the normal operating cycle of the business are classified as current assets.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Principles of Consolidation</i> – The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, including RadQual and TI Services. All significant intercompany accounts and transactions have been eliminated during consolidation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Significant accounting policies</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">a)      Financial instruments and cash equivalents</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The carrying value of notes payable approximates fair value because they bear interest at rates which approximate market rates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Cash and cash equivalents, totaling $2,688,141 and $2,375,817 at <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, respectively, consist of operating accounts and money market accounts. For purposes of the consolidated statements of cash flows, the Company considers all highly-liquid financial instruments with original maturities of <em style="font: inherit;">three</em> months or less at date of purchase to be cash equivalents.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, the Company had pledged cash on deposit in a money market account valued at $880,752 and $840,049 respectively, as security for a surety bond.  The surety bond is required as part of the Company’s operating license agreement with the Nuclear Regulatory Commission (“NRC”).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains its cash accounts in various deposit accounts, the balances of which are periodically in excess of federally insured limits.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 20pt;"></p><p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 20pt;"></p><p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 20pt;">b)      Accounts receivable</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company sells products mainly to recurring customers, wherein the customer’s ability to pay has previously been evaluated. The Company generally does <em style="font: inherit;">not</em> require collateral. The Company periodically reviews accounts receivable for amounts considered uncollectible and allowances are provided for uncollectible accounts when deemed necessary. At <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;"> December 31, 2022</em> the Company had no allowance for doubtful accounts. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">c)      Inventories</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Inventories are carried at the lower of cost or net realizable value. Cost is determined using the <em style="font: inherit;">first</em> in, <em style="font: inherit;">first</em> out method. When indicators of inventory impairment exist, the Company measures the carrying value of the inventory against its market value, and if the carrying value exceeds the market value, the inventory value is adjusted down accordingly.  No impairment was recorded for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;"> December 31, 2022</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">d)      Property, plant and equipment</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the asset.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Leasehold improvements are amortized over the shorter of the life of the lease or the service life of the improvements. Maintenance, repairs, and renewals that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Gains or losses on dispositions of property and equipment are included in the results of operations.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">e)      Goodwill and other intangibles</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Goodwill is <em style="font: inherit;">not</em> amortized but is tested for impairment at least annually. Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets recorded as a result of the change in ownership of RadQual. As of <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, there has been no impairment of goodwill.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Patents and other intangibles are amortized using the straight-line method over their estimated useful lives and are evaluated for impairment at least annually or when events or circumstances arise that indicate the existence of impairment. The Company evaluates the recoverability of identifiable intangible assets whenever events or changes in circumstances indicate that an intangible asset’s carrying amount <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. Such circumstances could include but are <em style="font: inherit;">not</em> limited to: (<em style="font: inherit;">1</em>) a significant decrease in the market value of an asset, (<em style="font: inherit;">2</em>) a significant adverse change in the extent or manner in which an asset is used, or (<em style="font: inherit;">3</em>) an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset. When indicators of impairment exist, the Company measures the carrying amount of the asset against the estimated undiscounted future cash flows associated with it. Should the sum of the expected future cash flows be less than the carrying value of the asset being evaluated, an impairment loss would be recognized. The impairment loss would be calculated as the amount by which the carrying value of the asset exceeds its fair value. The evaluation of asset impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and actual results <em style="font: inherit;"> may </em>differ from assumed and estimated amounts. During the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, the Company had no impairment losses related to intangible assets.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">f)      Impairment of long-lived assets</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Long-lived assets are reviewed for impairment annually, or when events or circumstances arise that indicate the existence of impairment, using the same evaluation process as described above for patents and other intangibles.  There was no impairment recorded during the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">g)      Income taxes</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in income in the period that includes the enactment date.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">h)      Use of estimates</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period to prepare these consolidated financial statements in conformity with GAAP.  Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">i)      Revenue recognition</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Revenue is recognized when products are shipped. <em style="font: inherit;">No</em> warranty coverage or right of return provisions are provided to customers. Amounts received as prepayment on future products or services are recorded as unearned revenues and recognized as income when the product is shipped or service performed. See Note <em style="font: inherit;">14</em> Revenue Recognition.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">j)      Advertising Expenses</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Advertising expenses, which include promotional expenses, are expensed as incurred and totaled $142,188 and $118,465 for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">k)      Research and development costs</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Research and development costs are expensed as incurred and totaled $577,354 and $533,716 for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, respectively. These research and development costs were incurred for corporate business development and in our Theranostics Products and Nuclear Medicine Standards business segments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">l)      Share-based compensation</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for issuances of share-based compensation to employees in accordance with GAAP which requires the recognition of the cost of employee services received in exchange for an award of equity instruments in the financial statements and is measured based on the grant date fair value of the award. Compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (the vesting period).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, the Company recognized share-based compensation expense of $464,041 and $352,458, respectively, related to stock options, stock grants, and restricted stock units. This expense is included as part of salaries and contract labor in the accompanying statements of operations.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">m)      Net loss per common share – basic and diluted</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Basic loss per share is computed on the basis of the weighted-average number of common shares outstanding during the year. Diluted loss per share is computed on the basis of the weighted-average number of common shares plus all potentially dilutive issuable common shares outstanding during the year.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The table below shows the calculation of diluted shares:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">December 31,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average common shares outstanding - basic</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">517,777,847</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">510,794,145</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Effects of dilutive shares</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Stock options</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Series C redeemable convertible preferred stock</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average common shares outstanding - diluted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">517,777,847</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">510,794,145</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the year ended <em style="font: inherit;"> December 31, 2023</em>, the Company had 24,787,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were <em style="font: inherit;">not</em> included in the computation of diluted income per common share because they would be anti-dilutive.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the year ended <em style="font: inherit;"> December 31, 2022</em>, the Company had 24,993,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were <em style="font: inherit;">not</em> included in the computation of diluted income per common share because they would be anti-dilutive.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The table below summarizes common stock equivalents outstanding at <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">December 31,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Stock options</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,787,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,993,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">4,063 Shares of Series C redeemable convertible preferred stock</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,630,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,630,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">65,417,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">65,623,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">n)      Business segments and related information</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">GAAP establishes standards for the way public business enterprises are to report information about operating segments in annual financial statements and requires enterprises to report selected information about operating segments in interim financial reports issued to shareholders. It also establishes standards for related disclosure about products and services, geographic areas and major customers. The Company currently operates in four business segments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">o)      Recent accounting standards</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> August 2020, </em>the Financial Accounting Standards Board issued ASU <em style="font: inherit;">2020</em>-<em style="font: inherit;">06</em> Debt – Debt with Conversion and Other Options (Subtopic <em style="font: inherit;">470</em>-<em style="font: inherit;">20</em>) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic <em style="font: inherit;">815</em>-<em style="font: inherit;">40</em>). The update simplifies accounting related to convertible debt instruments. The standard is effective for fiscal years beginning after <em style="font: inherit;"> December 15, 2023 </em>including interim periods within those fiscal years. INIS is currently evaluating the effect this standard will have on its financial statements.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p> 4 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">a)      Financial instruments and cash equivalents</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The carrying value of notes payable approximates fair value because they bear interest at rates which approximate market rates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Cash and cash equivalents, totaling $2,688,141 and $2,375,817 at <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, respectively, consist of operating accounts and money market accounts. For purposes of the consolidated statements of cash flows, the Company considers all highly-liquid financial instruments with original maturities of <em style="font: inherit;">three</em> months or less at date of purchase to be cash equivalents.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, the Company had pledged cash on deposit in a money market account valued at $880,752 and $840,049 respectively, as security for a surety bond.  The surety bond is required as part of the Company’s operating license agreement with the Nuclear Regulatory Commission (“NRC”).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains its cash accounts in various deposit accounts, the balances of which are periodically in excess of federally insured limits.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 20pt;"></p> 2688141 2375817 880752 840049 <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 20pt;">b)      Accounts receivable</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company sells products mainly to recurring customers, wherein the customer’s ability to pay has previously been evaluated. The Company generally does <em style="font: inherit;">not</em> require collateral. The Company periodically reviews accounts receivable for amounts considered uncollectible and allowances are provided for uncollectible accounts when deemed necessary. At <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;"> December 31, 2022</em> the Company had no allowance for doubtful accounts. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">c)      Inventories</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Inventories are carried at the lower of cost or net realizable value. Cost is determined using the <em style="font: inherit;">first</em> in, <em style="font: inherit;">first</em> out method. When indicators of inventory impairment exist, the Company measures the carrying value of the inventory against its market value, and if the carrying value exceeds the market value, the inventory value is adjusted down accordingly.  No impairment was recorded for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;"> December 31, 2022</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">d)      Property, plant and equipment</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the asset.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Leasehold improvements are amortized over the shorter of the life of the lease or the service life of the improvements. Maintenance, repairs, and renewals that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Gains or losses on dispositions of property and equipment are included in the results of operations.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">e)      Goodwill and other intangibles</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Goodwill is <em style="font: inherit;">not</em> amortized but is tested for impairment at least annually. Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets recorded as a result of the change in ownership of RadQual. As of <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, there has been no impairment of goodwill.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Patents and other intangibles are amortized using the straight-line method over their estimated useful lives and are evaluated for impairment at least annually or when events or circumstances arise that indicate the existence of impairment. The Company evaluates the recoverability of identifiable intangible assets whenever events or changes in circumstances indicate that an intangible asset’s carrying amount <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. Such circumstances could include but are <em style="font: inherit;">not</em> limited to: (<em style="font: inherit;">1</em>) a significant decrease in the market value of an asset, (<em style="font: inherit;">2</em>) a significant adverse change in the extent or manner in which an asset is used, or (<em style="font: inherit;">3</em>) an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset. When indicators of impairment exist, the Company measures the carrying amount of the asset against the estimated undiscounted future cash flows associated with it. Should the sum of the expected future cash flows be less than the carrying value of the asset being evaluated, an impairment loss would be recognized. The impairment loss would be calculated as the amount by which the carrying value of the asset exceeds its fair value. The evaluation of asset impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and actual results <em style="font: inherit;"> may </em>differ from assumed and estimated amounts. During the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, the Company had no impairment losses related to intangible assets.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> 0 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">f)      Impairment of long-lived assets</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Long-lived assets are reviewed for impairment annually, or when events or circumstances arise that indicate the existence of impairment, using the same evaluation process as described above for patents and other intangibles.  There was no impairment recorded during the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">g)      Income taxes</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in income in the period that includes the enactment date.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">h)      Use of estimates</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period to prepare these consolidated financial statements in conformity with GAAP.  Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">i)      Revenue recognition</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Revenue is recognized when products are shipped. <em style="font: inherit;">No</em> warranty coverage or right of return provisions are provided to customers. Amounts received as prepayment on future products or services are recorded as unearned revenues and recognized as income when the product is shipped or service performed. See Note <em style="font: inherit;">14</em> Revenue Recognition.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">j)      Advertising Expenses</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Advertising expenses, which include promotional expenses, are expensed as incurred and totaled $142,188 and $118,465 for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> 142188 118465 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">k)      Research and development costs</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Research and development costs are expensed as incurred and totaled $577,354 and $533,716 for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, respectively. These research and development costs were incurred for corporate business development and in our Theranostics Products and Nuclear Medicine Standards business segments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> 577354 533716 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">l)      Share-based compensation</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for issuances of share-based compensation to employees in accordance with GAAP which requires the recognition of the cost of employee services received in exchange for an award of equity instruments in the financial statements and is measured based on the grant date fair value of the award. Compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (the vesting period).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, the Company recognized share-based compensation expense of $464,041 and $352,458, respectively, related to stock options, stock grants, and restricted stock units. This expense is included as part of salaries and contract labor in the accompanying statements of operations.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> 464041 352458 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">m)      Net loss per common share – basic and diluted</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Basic loss per share is computed on the basis of the weighted-average number of common shares outstanding during the year. Diluted loss per share is computed on the basis of the weighted-average number of common shares plus all potentially dilutive issuable common shares outstanding during the year.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The table below shows the calculation of diluted shares:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">December 31,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average common shares outstanding - basic</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">517,777,847</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">510,794,145</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Effects of dilutive shares</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Stock options</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Series C redeemable convertible preferred stock</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average common shares outstanding - diluted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">517,777,847</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">510,794,145</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the year ended <em style="font: inherit;"> December 31, 2023</em>, the Company had 24,787,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were <em style="font: inherit;">not</em> included in the computation of diluted income per common share because they would be anti-dilutive.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the year ended <em style="font: inherit;"> December 31, 2022</em>, the Company had 24,993,500 stock options outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were <em style="font: inherit;">not</em> included in the computation of diluted income per common share because they would be anti-dilutive.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The table below summarizes common stock equivalents outstanding at <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">December 31,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Stock options</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,787,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,993,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">4,063 Shares of Series C redeemable convertible preferred stock</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,630,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,630,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">65,417,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">65,623,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">December 31,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average common shares outstanding - basic</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">517,777,847</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">510,794,145</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Effects of dilutive shares</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Stock options</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Series C redeemable convertible preferred stock</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average common shares outstanding - diluted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">517,777,847</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">510,794,145</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> </tbody></table> 517777847 510794145 0 0 0 0 517777847 510794145 24787500 4063000 24993500 4063000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">December 31,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Stock options</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,787,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,993,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">4,063 Shares of Series C redeemable convertible preferred stock</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,630,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,630,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">65,417,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">65,623,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 24787500 24993500 40630000 40630000 65417500 65623500 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">n)      Business segments and related information</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">GAAP establishes standards for the way public business enterprises are to report information about operating segments in annual financial statements and requires enterprises to report selected information about operating segments in interim financial reports issued to shareholders. It also establishes standards for related disclosure about products and services, geographic areas and major customers. The Company currently operates in four business segments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;"></p> 4 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">o)      Recent accounting standards</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> August 2020, </em>the Financial Accounting Standards Board issued ASU <em style="font: inherit;">2020</em>-<em style="font: inherit;">06</em> Debt – Debt with Conversion and Other Options (Subtopic <em style="font: inherit;">470</em>-<em style="font: inherit;">20</em>) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic <em style="font: inherit;">815</em>-<em style="font: inherit;">40</em>). The update simplifies accounting related to convertible debt instruments. The standard is effective for fiscal years beginning after <em style="font: inherit;"> December 15, 2023 </em>including interim periods within those fiscal years. INIS is currently evaluating the effect this standard will have on its financial statements.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">2</em> – BUSINESS CONDITION AND LIQUIDITY</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has a history of recurring losses with an accumulated deficit of $127,329,859 at <em style="font: inherit;"> December 31, 2023</em> and net loss of $869,016 for the year then ended. The Company’s working capital has increased by $257,797 from the prior year. The Company has cash flows provided by operations of $582,589.  During <em style="font: inherit;">2023</em>, the Company sought to improve future cash flows from operating activities through execution of new sales agreements, improving operating cost control measures, making improvements in current manufacturing processes, pursuing new service contracts, and developing new products. The Company’s net loss was $869,016 in <em style="font: inherit;">2023</em>, compared to net income of $303,238 in <em style="font: inherit;">2022</em>. This is a decrease in net income of $1,172,254. This decrease in net income is largely the result of the approximate $1.8 million gain on sale of assets that occurred in <em style="font: inherit;">2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the year ended <em style="font: inherit;"> December 31, 2023</em>, the Company continued to focus on its long-standing core business segments, which consist of its Theranostics Products (formerly Radiochemical Products), Cobalt Products, and Nuclear Medicine Standards, and in particular, the pursuit of new business opportunities within those segments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Due to changes in the nuclear industry, the Company’s plans for the design and construction of a large-scale uranium de-conversion and fluorine extraction facility were placed on hold. The Company will continue to incur some costs associated with the maintenance of licenses and other necessary project investments for the proposed facility. The Company holds a Nuclear Regulatory Commission (“NRC”) construction and operating license for the depleted uranium facility as well as the property agreement with Lea County, New Mexico, where the plant is intended to be constructed. The NRC license for the de-conversion facility is a <em style="font: inherit;">forty</em> (40) year operating license and is the <em style="font: inherit;">first</em> commercial license of this type issued in the United States. There are <em style="font: inherit;">no</em> other companies with a similar license application under review by the NRC. Therefore, the NRC license represents a significant competitive barrier, and the Company believes that it provides it with a very valuable asset. In <em style="font: inherit;"> February 2024, </em>the Company entered into and Asset Purchase Agreement to sell all the assets associated with the planned de-conversion facility. The Company expects to close the transaction in approximately <em style="font: inherit;">12</em> to <em style="font: inherit;">24</em> months, subject to satisfaction of certain closing condition. Proceeds from this sale would be $12.5 million in total.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company expects that cash from operations and its current cash balance will be sufficient to fund operations for the next <em style="font: inherit;">twelve</em> months. Future liquidity and capital funding requirements will depend on numerous factors, including, contract manufacturing agreements, commercial relationships, technological developments, market factors, available credit, and voluntary warrant redemption by shareholders. There is <em style="font: inherit;">no</em> assurance that additional capital and financing will be available on acceptable terms to the Company or at all.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> -127329859 -869016 257797 582589 -869016 303238 -1172254 1800000 P40Y 12500000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">3</em> – PURCHASED ASSET AND INVESTMENTS</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">AMICI Asset Purchase Agreement and Medical Devices</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In <em style="font: inherit;"> June 2023, </em>the Company acquired several medical devices with related assets and intellectual property rights from AMICI, Inc. and has been working on FDA <em style="font: inherit;">510k</em> transfers, and start-up of manufacturing. The Company anticipates the assets will be part of a <em style="font: inherit;">fifth</em> business segment of the Company called “Medical Devices” that is planned to start by mid-year <em style="font: inherit;">2024.</em></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">4</em> – INVENTORIES</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Inventories at <em style="font: inherit;"> December 31, 2023</em> totaled $927,111, and inventories at <em style="font: inherit;"> December 31, 2022</em> totaled $744,793. Our inventory consists of work in process material for our Theranostics Products, Cobalt Products, and Nuclear Medicine Products segments.</p> 927111 744793 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">5</em> – PROPERTY, PLANT AND EQUIPMENT</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Property, plant and equipment are summarized as follows at <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Estimated Useful Lives (in years)</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Furniture and fixtures</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,463</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">284,020</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;">3 - 5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Transportation equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">114,708</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">114,708</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;">5 - 10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Plant and improvements</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">526,205</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">501,334</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;">5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Production equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,569,980</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,997,193</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;">5 - 10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,498,356</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,897,255</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; text-align: center;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accumulated depreciation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,033,279</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(2,872,769</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; text-align: center;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,465,077</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,024,486</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; text-align: center;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Included in fixed assets are assets purchased during the planning phase for the construction of a de-conversion facility in Hobbs, New Mexico; these de-conversion facility assets are included in the <em style="font: inherit;">DUF6</em> Asset Sale. Although construction of the facility is currently on hold, the Company has determined that these assets continue to have future economic value based on what it considers a strong likelihood that construction of the facility will occur in the future.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Depreciation expense was $160,567 and $185,193 for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, respectively.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Estimated Useful Lives (in years)</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Furniture and fixtures</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,463</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">284,020</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;">3 - 5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Transportation equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">114,708</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">114,708</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;">5 - 10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Plant and improvements</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">526,205</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">501,334</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;">5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Production equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,569,980</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,997,193</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;">5 - 10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,498,356</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,897,255</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; text-align: center;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accumulated depreciation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,033,279</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(2,872,769</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; text-align: center;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,465,077</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,024,486</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; text-align: center;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"> </td></tr> </tbody></table> 287463 284020 P3Y P5Y 114708 114708 P5Y P10Y 526205 501334 P5Y 4569980 3997193 P5Y P10Y 5498356 4897255 3033279 2872769 2465077 2024486 160567 185193 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">6</em> – PATENTS AND OTHER INTANGIBLE ASSETS</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company owns certain patents and patents pending related to a fluorine extraction process (FEP), for various uses of some fluoride gases as fluorinating agents, and some of the RadQual nuclear medicine calibration sources.  The FEP patents were developed in an effort to expand the potential markets for the high purity fluoride gases the Company had planned to produce with its fluorine extraction process. The feasibility of expanding the fluoride gas markets through the use of this patented technology is uncertain. The RadQual product patents were developed to give RadQual a unique competitive advantage by offering calibration standards exclusive to RadQual.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> October 2012, </em>the NRC issued the Company a <em style="font: inherit;">40</em>-year construction and operating license for the de-conversion facility.  Capitalized costs associated with the licensing and planning process for this license are being amortized over the <em style="font: inherit;">40</em>-year life of the license.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table summarizes the patent and intangible activity for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Beginning</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,370,878</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Additions</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Disposals</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Ending</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,370,878</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accumulated amortization</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,832,420</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,538,458</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the year ended <em style="font: inherit;"> December 31, 2023</em> the Company recognized $164,895 of amortization expense, and during the year ended <em style="font: inherit;"> December 31, 2022</em>, the Company recognized $164,370 of amortization expense.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Patent and other intangible asset amortization is based on the remaining life of the asset and estimated amortization expense is as follows:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table cellpadding="0" cellspacing="0" class="finTable" style="width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 5%; margin-right: 5%;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Years ending December 31,</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 14%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2027</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2028</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2029</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,713,983</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>3,538,458</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Beginning</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,370,878</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Additions</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Disposals</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Ending</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,370,878</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accumulated amortization</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,832,420</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,538,458</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 5370878 0 -0 5370878 1832420 3538458 164895 164370 <table cellpadding="0" cellspacing="0" class="finTable" style="width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 5%; margin-right: 5%;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Years ending December 31,</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 14%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2027</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2028</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2029</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">164,895</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,713,983</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>3,538,458</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 164895 164895 164895 164895 164895 2713983 3538458 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">7</em> – CONVERTIBLE DEBENTURES AND NOTES PAYABLE</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Convertible debentures</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As discussed in Note <em style="font: inherit;">9</em> below, in <em style="font: inherit;"> February 2017, </em>pursuant to a private placement transaction with certain investors, the Company issued 3,433 shares of Series C Preferred Stock and warrants.  In connection with the private placement, <em style="font: inherit;">two</em> investors holding convertible debentures exchanged aggregate principal totaling $205,000 of the convertible debentures for shares of the Series C Preferred Stock and warrants.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Notes payable</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> December 2013, </em>the Company entered into a promissory note agreement with its then Chairman of the Board and <em style="font: inherit;">one</em> of its major shareholders, pursuant to which the Company borrowed $500,000 (the <em style="font: inherit;">2013</em> Promissory Note). The <em style="font: inherit;">2013</em> Promissory Note is secured and bears interest at 6% per annum and was originally due <em style="font: inherit;"> June 30, 2014. </em>According to the terms of the <em style="font: inherit;">2013</em> Promissory Note, at any time, the lenders <em style="font: inherit;"> may </em>settle any or all of the principal and accrued interest with shares of the Company’s common stock. In connection with the <em style="font: inherit;">2013</em> Promissory Note, each of the <em style="font: inherit;">two</em> lenders was issued 5,000,000 Class L warrants to purchase shares of our common stock at an exercise price of $0.06 per share (Class L Warrants). The Class L Warrants were immediately exercisable. The fair value of these warrants issued totaled $384,428 and was recorded as a debt discount amortized over the life of the <em style="font: inherit;">2013</em> Promissory Note. The Company calculated a beneficial conversion feature of $15,464 which was accreted to interest expense over the life of the <em style="font: inherit;">2013</em> Promissory Note. In <em style="font: inherit;"> June 2014, </em>we renegotiated the terms of the <em style="font: inherit;">2013</em> Promissory Note. Pursuant to the modification, the maturity date was extended to <em style="font: inherit;"> December 31, 2017 </em>and each lender was granted an additional 7,500,000 Class L Warrants to purchase shares of the Company’s common stock at an exercise price of $0.06 per share. The Class L Warrants were immediately exercisable. In <em style="font: inherit;"> February 2017, </em>the <em style="font: inherit;">2013</em> Promissory Note was further modified to extend the maturity date to <em style="font: inherit;"> December 31, 2020, </em>with all remaining terms unchanged. On <em style="font: inherit;"> December 23, 2018, </em>all 25,000,000 Class L Warrants expired. In <em style="font: inherit;"> December 2019, </em>the <em style="font: inherit;">2013</em> Promissory Note was further modified to extend the maturity date to <em style="font: inherit;"> December 31, 2021, </em>with all remaining terms unchanged. In <em style="font: inherit;"> January 2022, </em>the <em style="font: inherit;">2013</em> Promissory Note was further modified to extend the maturity date to <em style="font: inherit;"> December 31, 2023, </em>with all remaining terms unchanged. In <em style="font: inherit;"> February 2024, </em>the <em style="font: inherit;">2013</em> Promissory Note was further modified to extend the maturity date to <em style="font: inherit;"> March 31, 2026, </em>with all remaining terms unchanged.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2023</em>, accrued interest payable on the <em style="font: inherit;">2013</em> Promissory Note was $301,734.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> April 2018, </em>the Company borrowed $120,000 from its then Chief Executive Officer and Chairman of the Board pursuant to a promissory note (the <em style="font: inherit;">2018</em> Promissory Note). The <em style="font: inherit;">2018</em> Promissory Note accrues interest at 6% per annum, which is payable upon maturity of the <em style="font: inherit;">2018</em> Promissory Note. The <em style="font: inherit;">2018</em> Promissory Note was originally unsecured and originally matured on <em style="font: inherit;"> August 1, 2018. </em>At any time, the holder of the <em style="font: inherit;">2018</em> Promissory Note <em style="font: inherit;"> may </em>elect to have any or all of the principal and accrued interest settled with shares of our common stock based on the average price of the shares over the previous <em style="font: inherit;">20</em> trading days. In <em style="font: inherit;"> June 2018, </em>the <em style="font: inherit;">2018</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> March 31, 2019 </em>with all other provisions remaining unchanged. In <em style="font: inherit;"> February 2019, </em>the <em style="font: inherit;">2018</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> July 31, 2019 </em>with all other provisions remaining unchanged. In <em style="font: inherit;"> July 2019, </em>the <em style="font: inherit;">2018</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> January 31, 2020 </em>with all other provisions remaining unchanged. In <em style="font: inherit;"> December 2019, </em>the <em style="font: inherit;">2018</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> December 31, 2021 </em>and the <em style="font: inherit;">2018</em> Promissory Note was modified to become secured by company assets, with all other provisions remaining unchanged. In <em style="font: inherit;"> December 2021, </em>the <em style="font: inherit;">2018</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> December 31, 2023 </em>with all other provisions remaining unchanged. In <em style="font: inherit;"> December 2023, </em>the <em style="font: inherit;">2018</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> January 31, 2025. </em>In <em style="font: inherit;"> February 2024, </em>the <em style="font: inherit;">2018</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> March 31, 2026.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2023</em>, accrued interest on the <em style="font: inherit;">2018</em> Promissory Note totaled $40,970.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <em style="font: inherit;"> December 20, 2019, </em>the Company entered into a promissory note agreement with <em style="font: inherit;">four</em> of the Company’s major shareholders (the <em style="font: inherit;">2019</em> Promissory Note). The <em style="font: inherit;">2019</em> Promissory Note authorizes the Company to borrow up to $1,000,000. As of <em style="font: inherit;"> December 31, 2019, </em>the Company had borrowed $675,000 under the <em style="font: inherit;">2019</em> promissory note. In <em style="font: inherit;"> February 2020, </em>the Company borrowed an additional $325,000. The <em style="font: inherit;">2019</em> Promissory Note bears an interest rate of 4% annually and was originally due <em style="font: inherit;"> December 31, 2022. </em>According to the terms of the <em style="font: inherit;">2019</em> Promissory Note, at any time, the lenders <em style="font: inherit;"> may </em>settle any or all of the principal and accrued interest with shares of the Company’s common stock based on the average closing price of the Company’s common stock for the <em style="font: inherit;">20</em> trading days preceding the payment. In connection with the <em style="font: inherit;">2019</em> Promissory Note, the lenders were issued warrants totaling 30,000,000 warrants to purchase shares of the Company’s common stock at $0.045 per share (Class O Warrants). In <em style="font: inherit;"> January 2023, </em>the <em style="font: inherit;">2019</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> December 31, 2024, </em>with all remaining terms unchanged. In <em style="font: inherit;"> February 2024, </em>the <em style="font: inherit;">2019</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> March 31, 2026.</em></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2023</em>, accrued interest on the <em style="font: inherit;">2019</em> Promissory Note totaled $159,131.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Notes payable as of <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em> consist of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable to related parties bearing interest at <span style="-sec-ix-hidden:c109551958"><span style="-sec-ix-hidden:c109551959">6</span></span>% all principal and interest due on <span style="-sec-ix-hidden:c109551960"><span style="-sec-ix-hidden:c109551961">March 31, 2026</span></span>, secured</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">120,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">120,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable to related parties bearing interest at <span style="-sec-ix-hidden:c109551962"><span style="-sec-ix-hidden:c109551963">4</span></span>% all principal and interest due on <span style="-sec-ix-hidden:c109551964"><span style="-sec-ix-hidden:c109551965">March 31, 2026</span></span>, secured</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">1,000,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,000,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable to related parties bearing interest at <span style="-sec-ix-hidden:c109551966"><span style="-sec-ix-hidden:c109551967">6</span></span>% all principal and interest due on <span style="-sec-ix-hidden:c109551968"><span style="-sec-ix-hidden:c109551969">March 31, 2026</span></span>, secured</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable to a financial institution bearing interest at <span style="-sec-ix-hidden:c109551970"><span style="-sec-ix-hidden:c109551971">5.99</span></span>% monthly installments of $<span style="-sec-ix-hidden:c109551972"><span style="-sec-ix-hidden:c109551973">1,046</span></span>, secured</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">34,365</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">44,521</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable for purchase contract bearing interest at <span style="-sec-ix-hidden:c109551975">5</span>% monthly installments of $<span style="-sec-ix-hidden:c109551977">4,442</span>, secured</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">13,233</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Note payable for purchase contract bearing no interest until the 25th month after the anniversary of the closing interest at <span style="-sec-ix-hidden:c109551978">8</span>% thereafter monthly installments of $<span style="-sec-ix-hidden:c109551980">10,000</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: right; padding: 0; margin: 0">392,100</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total notes payable</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,046,465</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,677,754</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Less: current maturities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(155,733</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(643,348</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Notes payable, net of current installments and debt discount</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,890,732</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,034,406</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Maturities of convertible debt and notes payable, excluding debt discount and debt issuance costs, at <em style="font: inherit;"> December 31, 2023</em>, are as follows:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 5%; width: 90%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 83%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Years ending December 31,</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">155,733</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2025</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">124,838</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2026</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,745,595</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2027</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">20,299</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,046,465</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> 3433 205000 500000 0.06 5000000 0.06 384428 15464 7500000 0.06 25000000 301734 120000 0.06 40970 1000000 675000 325000 0.04 30000000 0.045 159131 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable to related parties bearing interest at <span style="-sec-ix-hidden:c109551958"><span style="-sec-ix-hidden:c109551959">6</span></span>% all principal and interest due on <span style="-sec-ix-hidden:c109551960"><span style="-sec-ix-hidden:c109551961">March 31, 2026</span></span>, secured</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">120,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">120,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable to related parties bearing interest at <span style="-sec-ix-hidden:c109551962"><span style="-sec-ix-hidden:c109551963">4</span></span>% all principal and interest due on <span style="-sec-ix-hidden:c109551964"><span style="-sec-ix-hidden:c109551965">March 31, 2026</span></span>, secured</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">1,000,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,000,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable to related parties bearing interest at <span style="-sec-ix-hidden:c109551966"><span style="-sec-ix-hidden:c109551967">6</span></span>% all principal and interest due on <span style="-sec-ix-hidden:c109551968"><span style="-sec-ix-hidden:c109551969">March 31, 2026</span></span>, secured</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable to a financial institution bearing interest at <span style="-sec-ix-hidden:c109551970"><span style="-sec-ix-hidden:c109551971">5.99</span></span>% monthly installments of $<span style="-sec-ix-hidden:c109551972"><span style="-sec-ix-hidden:c109551973">1,046</span></span>, secured</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">34,365</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">44,521</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable for purchase contract bearing interest at <span style="-sec-ix-hidden:c109551975">5</span>% monthly installments of $<span style="-sec-ix-hidden:c109551977">4,442</span>, secured</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">13,233</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Note payable for purchase contract bearing no interest until the 25th month after the anniversary of the closing interest at <span style="-sec-ix-hidden:c109551978">8</span>% thereafter monthly installments of $<span style="-sec-ix-hidden:c109551980">10,000</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: right; padding: 0; margin: 0">392,100</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total notes payable</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,046,465</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,677,754</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Less: current maturities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(155,733</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(643,348</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Notes payable, net of current installments and debt discount</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,890,732</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,034,406</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 120000 120000 1000000 1000000 500000 500000 34365 44521 0 13233 392100 2046465 1677754 155733 643348 1890732 1034406 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 5%; width: 90%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 83%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Years ending December 31,</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">155,733</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2025</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">124,838</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2026</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,745,595</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2027</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">20,299</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,046,465</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 155733 124838 1745595 20299 0 2046465 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">8</em> – LEASE OBLIGATIONS</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company leases office and warehouse space under operating leases. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments under the lease. Operating lease, right-of-use assets, and liabilities are recognized at the lease commencement date based on the present value of lease payments over the reasonably certain lease term. The implicit rates with the Company’s operating leases are generally <em style="font: inherit;">not</em> determinable and the Company uses its incremental borrowing rate at the lease commencement date to determine the present value of its lease payments. The determination of the Company’s incremental borrowing rate requires judgement. The company determines its incremental borrowing rate for each lease using its then-current borrowing rate. Certain of the Company’s leases include options to extend or terminate the lease. The Company establishes the number of renewal options periods used in determining the operating lease term based upon its assessment at the inception of the operating lease. The option to renew the lease <em style="font: inherit;"> may </em>be automatic, at the option of the Company, or mutually agreed to between the landlord and the Company. Once the facility lease term has begun, the present value of the aggregate future minimum lease payments is recorded as a right-of-use asset. Lease expense is recognized on a straight-line basis over the term of the lease.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">December 31,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating lease costs</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">285,159</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Short-term operating lease costs</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7,200</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">12,066</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Financing lease expense:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Amortization of right-of-use assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,023</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,172</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Interest on lease liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">395</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">649</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Total financing lease expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,418</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,821</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Total lease expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">300,726</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">302,046</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Right-of-use assets obtained in exchange for new operating lease liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Right-of-use assets obtained in exchange for new financing lease liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average remaining lease term (years) - operating leases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">11.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">12.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average remaining lease term (years) - financing leases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.2</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average discount rate - operating leases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average discount rate - financing leases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7.93</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> </tbody></table> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Maturities of lease liabilities as of <em style="font: inherit;"> December 31, 2023</em>, were as follows:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Operating leases</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Finance leases</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">For the years ended December 31,</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,929</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2025</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2026</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2027</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2028</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Thereafter</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,738,084</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total minimum lease obligations</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,173,624</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,929</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Less-amount representing interest</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(941,380</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(97</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Present value of minimum lease obligations</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,232,244</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,832</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Current maturities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(140,733</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(2,832</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Lease obligations, net of current maturities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,091,511</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">December 31,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating lease costs</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">285,159</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Short-term operating lease costs</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7,200</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">12,066</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Financing lease expense:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Amortization of right-of-use assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,023</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,172</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Interest on lease liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">395</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">649</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Total financing lease expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,418</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,821</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Total lease expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">300,726</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">302,046</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Right-of-use assets obtained in exchange for new operating lease liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Right-of-use assets obtained in exchange for new financing lease liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average remaining lease term (years) - operating leases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">11.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">12.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average remaining lease term (years) - financing leases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.2</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average discount rate - operating leases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average discount rate - financing leases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7.93</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> </tbody></table> 287108 285159 7200 12066 6023 4172 395 649 6418 4821 300726 302046 0 0 0 0 P11Y1M6D P12Y1M6D P1Y2M12D P1Y1M6D 0.0675 0.0675 0.0675 0.0793 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Operating leases</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Finance leases</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">For the years ended December 31,</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,929</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2025</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2026</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2027</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">2028</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">287,108</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Thereafter</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,738,084</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total minimum lease obligations</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,173,624</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,929</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Less-amount representing interest</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(941,380</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(97</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Present value of minimum lease obligations</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,232,244</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,832</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Current maturities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(140,733</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(2,832</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Lease obligations, net of current maturities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,091,511</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 287108 2929 287108 0 287108 0 287108 0 287108 0 1738084 0 3173624 2929 941380 97 2232244 2832 140733 2832 2091511 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">9</em> – SHAREHOLDERS’ EQUITY, REDEEMABLE CONVERTIBLE PREFERRED STOCK, OPTIONS AND WARRANTS</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Warrants</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <em style="font: inherit;"> February 14, 2022, </em>515,000 Class M Warrants were exercised for an exercise price of $0.12 per share. The Company received $61,800 of proceeds as a result of the exercise. On <em style="font: inherit;"> February 17, 2022 </em>the 3,625,000 remaining unexercised Class M Warrants expired. On <em style="font: inherit;"> May 12, 2022, </em>the 2,925,000 remaining unexercised Class N Warrants expired.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table summarizes warrant activity for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Warrants</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Outstanding Shares</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted Average Exercise</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2021</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7,065,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.11</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(515,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.12</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(6,550,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.11</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;"> December 31, 2022</em> there were no outstanding warrants.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Mandatorily Redeemable Convertible Preferred Stock</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is authorized to issue up to 5,000,000 shares of preferred stock, par value $0.01 per share. The Board is authorized to set the distinguishing characteristics of each series prior to issuance, including the granting of limited or full voting rights, rights to the payment of dividends and amounts payable in event of liquidation, dissolution or winding up of the Company.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2021, </em>there were 675 shares of the Series B Convertible Redeemable Preferred Stock (the “Series B Preferred Stock”) outstanding with a mandatory redemption date of <em style="font: inherit;"> May 2022 </em>at $1,000 per share, or $675,000 in aggregate redemption value. The Series B Preferred Stock were convertible into common stock at a conversion price of $2.00 per share. These preferred shares carried no dividend preferences. Due to the mandatory redemption provision, the Series B Preferred Stock were classified as a liability in the accompanying consolidated balance sheets. In <em style="font: inherit;">2021,</em> 175 shares of Series C Preferred Stock were converted into shares of common stock. On <em style="font: inherit;"> May 31, 2022, </em>the Company paid with shares of the Company’s common stock all 675 outstanding Series B Preferred Stock outstanding with a mandatory redemption date of <em style="font: inherit;"> May 2022 </em>at $1,000 per share or $675,000. The <em style="font: inherit;"> May 31, 2022 </em>average price of the Company’s common stock was $0.08 per share. The Company issued 8,437,500 shares of common stock to satisfy the $675,000 redemption amount.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2022</em> and <em style="font: inherit;"> December 31, 2023</em>, there were 4,063 total shares of the Series C Preferred Stock outstanding. The Series C Preferred Stock are convertible at the option of the investors at any time into shares of the Company's common stock at an initial conversion price equal to $0.10 per share, subject to adjustment. At any time after <em style="font: inherit;"> February 17, 2019, </em>if the volume-weighted average closing price of the Company’s common stock over a period of 90 consecutive trading days is greater than $0.25 per share, the Company <em style="font: inherit;"> may </em>redeem all or any portion of the outstanding Series C Preferred Stock at the original purchase price per share ($1,000) plus any accrued and unpaid dividends, payable in shares of common stock. All outstanding shares of Series C Preferred Stock were to be redeemed by the Company on <em style="font: inherit;"> February 17, 2022 </em>at the original purchase price per share, payable in cash or shares of common stock, at the option of the holder. In <em style="font: inherit;"> February 2022, </em>based on approval of a majority of the Preferred C Holders, the Company extended the redemption date of the Series C Preferred Stock to <em style="font: inherit;"> February 17, 2023. </em>In <em style="font: inherit;"> December 2022, </em>based on approval of a majority of the Preferred C Holders, the Company extended the redemption date of the Series C Preferred Stock to <em style="font: inherit;"> February 17, 2025. </em>Holders of Series C Preferred Stock do <em style="font: inherit;">not</em> have any voting rights, except as required by law and in connection with certain events as set forth in the Statement of Designation of the Series C Preferred Stock.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company pays dividends on the Series C Preferred Stock in <em style="font: inherit;"> February </em>each year. Dividends payable totaled $243,780 in <em style="font: inherit;"> February 2023 </em>and <em style="font: inherit;"> February 2022. </em>Some holders of the Series C Preferred Stock elected to settle their dividend payments with shares of the Company’s common stock in lieu of cash. The Company issued 2,266,500 shares of common stock in lieu of a dividend payment of $90,660 in <em style="font: inherit;">2023</em> and 2,271,980 shares of common stock in lieu of a dividend payment of $204,480 in <em style="font: inherit;">2022</em>. $153,120 of dividend payable was settled with cash in <em style="font: inherit;">2023</em> and $39,300 was settled with cash in <em style="font: inherit;">2022</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The outstanding 4,063 shares of Series C Preferred Stock originated as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <em style="font: inherit;"> February 17, 2017, </em>the Company entered into subscription agreements with certain investors, including <em style="font: inherit;">two</em> of the Company’s directors, for the sale of (i) an aggregate of 3,433 shares of Series C Preferred Stock, and (ii) Class M warrants to purchase an aggregate of 17,165,000 shares of the Company’s common stock (the Class M Warrants), for gross proceeds of $3,433,000. The Series C Preferred Stock accrues dividends at a rate of 6% per annum, payable annually on <em style="font: inherit;"> February 17</em><sup style="vertical-align:top;line-height:120%;">th</sup> of each year, commencing on <em style="font: inherit;"> February 17, 2018.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Class M Warrants were immediately exercisable at an exercise price of $0.12 per share, subject to adjustment as set forth in the warrant, and expired in <em style="font: inherit;"> February 2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company allocated the proceeds to the Series C Preferred Stock and Class M Warrants based on their relative fair value, which resulted in $2,895,379 being allocated to the Series C Preferred Stock and $537,621 being allocated to the Class M Warrants. The allocated Class M Warrant value was recorded as a discount to the Series C Preferred Stock and will be amortized to interest expense over the <span style="-sec-ix-hidden:c109551678">five</span>-year life of the warrants. At <em style="font: inherit;"> December 31, 2022</em>, the balance of the discount to the Series C Preferred Stock was $13,440 and the net carrying value of these 3,433 shares of Series C Preferred Stock was $3,419,560. At <em style="font: inherit;"> December 31, 2023</em>, the balance of the discount to the Series C Preferred Stock was $0 and the net carrying value of these 3,433 shares of Series C Preferred Stock was $3,433,000.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <em style="font: inherit;"> March 24, 2017, </em>the Company entered into an Amendment to the 8% Convertible Notes (the Amendment), pursuant to which the 8% Convertible Notes (the Notes) issued by the Company in <em style="font: inherit;"> July 2012 </em>were amended to give noteholders certain additional rights. Pursuant to the Amendment, the Notes were modified to provide each holder the right, at the holder’s option and exercisable prior to <em style="font: inherit;"> May 12, 2017, </em>to convert all or any portion of the principal amount of the Notes, plus accrued but unpaid interest, into shares of Series C Preferred Stock at a conversion price of $1,000 per share. Holders that elected to convert their Notes into Series C Preferred Stock received a Class N Warrant to purchase up to 3,750 shares of the Company’s common stock for each share of Series C Preferred Stock received upon conversion of the Notes, with each Warrant having a <span style="-sec-ix-hidden:c109551689">five</span>-year term, a cashless exercise feature, and an exercise price of $0.10 per share of common stock. On <em style="font: inherit;"> May 12, 2017, </em>the Company completed the retirement of $1,835,000 of the Notes in early cash redemptions, and $780,000 of the Notes were converted into an aggregate of 780 shares of Series C Preferred Stock and Class N Warrants to purchase an aggregate of 2,925,000 shares of the Company’s common stock. In <em style="font: inherit;">2021,</em> 150 shares of Series C Preferred Stock were converted into shares of common stock.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Class N Warrants were immediately exercisable at an exercise price of $0.10 per share, subject to adjustment as set forth in the warrant, and expired in <em style="font: inherit;"> May 2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company allocated the proceeds to the Series C Preferred Stock and Class N Warrants based on their relative fair value, which resulted in $675,947 being allocated to the Series C Preferred Stock and $104,053 being allocated to the Class N Warrants. The allocated Class N Warrant value was recorded as a discount to the Series C Preferred Stock and will be amortized to interest expense over the <span style="-sec-ix-hidden:c109551700">five</span>-year life of the warrants. At <em style="font: inherit;"> December 31, 2022</em>, the balance of the discount to the Series C Preferred Stock was $4,737 and the net carrying value of 630 outstanding shares of Series C Preferred Stock was $625,263. At <em style="font: inherit;"> December 31, 2023</em>, the balance of the discount to the Series C Preferred Stock was $0 and the net carrying value of 630 shares of Series C Preferred Stock was $630,000.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Employee Stock Purchase Plan</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> September 2004, </em>the Company’s Board approved an employee stock purchase plan for an aggregate of up to 2,000,000 shares of the Company’s common stock. The plan allows employees to deduct up to 15% of their salary or wages each pay period to be used for the purchase of common stock at a discounted rate. The common shares will be purchased at the end of each <em style="font: inherit;">three</em>-month offering period or other period as determined by the Board. The plan is intended to qualify as an “employee stock purchase plan” under Section <em style="font: inherit;">423</em> of the Internal Revenue Code. An amendment and restatement of the plan was approved in <em style="font: inherit;"> July 2020 </em>by the Company’s shareholders, which increased the number of shares available for purchase by 3,000,000 shares. At <em style="font: inherit;"> December 31, 2023</em> there were 2,224,544 shares available under the employee stock purchase plan.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During <em style="font: inherit;">2023</em> and <em style="font: inherit;">2022</em>, the Company issued 316,866 and 245,081 shares of common stock to employees for proceeds of $8,398 and $14,771, respectively, in accordance with the employee stock purchase plan.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; "><em style="font: inherit;">2015</em> Incentive Plan</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> April 2015, </em>the Company’s Board of Directors approved the International Isotopes Inc. <em style="font: inherit;">2015</em> Incentive Plan (as amended, the <em style="font: inherit;">“2015</em> Plan”) which was subsequently approved by the Company’s shareholders in <em style="font: inherit;"> July 2015. </em>The <em style="font: inherit;">2015</em> Plan was amended and restated in <em style="font: inherit;"> July 2018 </em>to increase the number of shares authorized for issuance under the <em style="font: inherit;">2015</em> plan by an additional 20,000,000 shares. The <em style="font: inherit;">2015</em> Plan provides for the grant of incentive and non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and units, and other stock or cash-based awards.  The <em style="font: inherit;">2015</em> Plan amends and restates the Company’s Amended and Restated <em style="font: inherit;">2006</em> Equity Incentive Plan (the <em style="font: inherit;">“2006</em> Plan”).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The <em style="font: inherit;">2015</em> Plan authorizes the issuance of up to 80,000,000 shares of common stock, plus 11,089,967 shares authorized, but <em style="font: inherit;">not</em> issued under the <em style="font: inherit;">2006</em> Plan. Unless earlier terminated, the <em style="font: inherit;">2015</em> Plan will terminate on <em style="font: inherit;"> July 13, 2025. </em>At <em style="font: inherit;"> December 31, 2023</em> there were 20,292,546 shares available for issuance under the <em style="font: inherit;">2015</em> Plan.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Non-Vested Stock Grants</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pursuant to an employment agreement with its Chief Executive Officer, the Company awarded 560,000 fully vested shares of common stock to its then Chief Executive Officer in <em style="font: inherit;"> February 2023 </em>under the <em style="font: inherit;">2015</em> Plan. The number of shares awarded was based on a $28,000 stock award using a price of $0.05 per share. The employment agreement provides that the number of shares issued will be based on the average closing price of common stock for the <em style="font: inherit;">20</em> trading days prior to issue date but <em style="font: inherit;">not</em> less than $0.05 per share. Compensation expense recorded pursuant to this stock grant was $22,400, which was determined by multiplying the number of shares awarded by the closing price of the common stock on <em style="font: inherit;"> February 28, 2023, </em>which was $0.04 per share. The Company withheld 216,440 shares of common stock to satisfy the employee’s payroll tax obligations in connection with this issuance. The net shares issued on <em style="font: inherit;"> February 28, 2023 </em>totaled 343,560.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pursuant to an employment agreement with its Chief Executive Officer, the Company awarded 307,692 fully vested shares of common stock to its Chief Executive Officer in <em style="font: inherit;"> February 2022 </em>under the <em style="font: inherit;">2015</em> Plan. The number of shares awarded was based on a $28,000 stock award using a price of $0.091 per share. The employment agreement provides that the number of shares issued will be based on the average closing price of common stock for the <em style="font: inherit;">20</em> trading days prior to issue date but <em style="font: inherit;">not</em> less than $0.05 per share. Compensation expense recorded pursuant to this stock grant was $27,692, which was determined by multiplying the number of shares awarded by the closing price of the common stock on <em style="font: inherit;"> February 28, 2021, </em>which was $0.09 per share. The Company withheld 120,461 shares of common stock to satisfy the employee’s payroll tax obligations in connection with this issuance. The net shares issued on <em style="font: inherit;"> February 28, 2022 </em>totaled 187,231.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Stock Options</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A summary of the stock options issued under the Company’s equity plans is as follows:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 40%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Stock Options</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Outstanding Shares</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted Average Exercise Price</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted Average Remaining Contractual Life</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Average Intrinsic Value</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2021</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">20,777,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.06</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">627,615</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">8,150,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.09</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(1,200,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.04</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">57,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,734,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.08</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,993,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.07</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,100,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.04</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,306,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.08</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">24,787,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.05</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5.4</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">17,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at December 31, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">19,372,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.05</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4.6</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">16,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The total intrinsic value of stock options outstanding at <em style="font: inherit;"> December 31, 2023</em> was $ 16,000. The intrinsic value for stock options outstanding is calculated as the amount by which the quoted price of $0.04 of the Company’s common stock as of the end of <em style="font: inherit;">2023</em> exceeds the exercise price of the options.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company recognized $199,554 and $280,393 of compensation expense related to these options for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, respectively. At <em style="font: inherit;"> December 31, 2023</em>, the remaining compensation expense was $99,768 and will be recognized over 1.71 years.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the year ended <em style="font: inherit;"> December 31, 2023</em>, no qualified stock options were exercised.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> March 2022, </em>1,000,000 qualified stock options were exercised under a cashless exercise. The company withheld 388,889 shares to satisfy the exercise price and issued 611,111 shares of common stock. The options exercised were granted under the <em style="font: inherit;">2015</em> Plan, and, accordingly, there was <span style="-sec-ix-hidden:c109551774">not</span> any income tax effect in the condensed consolidated financial statements for the year ended <em style="font: inherit;"> December 31, 2023</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> August 2022, </em>200,000 qualified stock options were exercised under a cashless exercise. The company withheld 162,163 shares to satisfy the exercise price and issued 37,837 shares of common stock. The options exercised were granted under the <em style="font: inherit;">2015</em> Plan, and, accordingly, there was <span style="-sec-ix-hidden:c109551779">not</span> any income tax effect in the condensed consolidated financial statements for the year ended <em style="font: inherit;"> December 31, 2023</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the year ended <em style="font: inherit;"> December 31, 2023</em>, the Company granted an aggregate of 3,100,000 qualified stock options to <em style="font: inherit;">32</em> of its employees. These options vest over a <span style="-sec-ix-hidden:c109551782">five</span>-year period with the <em style="font: inherit;">first</em> vesting at the date of grant and expiration at <span style="-sec-ix-hidden:c109551784">ten</span>-year anniversary for all grants. The exercise price for these granted options was $0.04 and $0.06 per share. The options issued during the year ended <em style="font: inherit;"> December 31, 2023</em> have a fair value of $82,176, as estimated on the date of issue using the Black-Scholes options pricing model with the following weighted-average assumptions: risk free interest rate of 3.94% to 4.26%, expected dividend yield rate of 0%, expected volatility of 68.65% to 79.21% and an expected life between 5 and 7 years.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the year ended <em style="font: inherit;"> December 31, 2022</em>, the Company granted an employee 1,000,000 qualified stock options with an exercise price of $0.10 per share and 25,000 qualified stock options with an exercise price of $0.08 per share to <em style="font: inherit;">one</em> of its employees and a total of 125,000 qualified stock options with an exercise price of $0.03 per share to <em style="font: inherit;">two</em> other employees. These options vest over a <span style="-sec-ix-hidden:c109551803">five</span>-year period with the <em style="font: inherit;">first</em> vesting at the <span style="-sec-ix-hidden:c109551805">one</span>-year anniversary of the grant and expiration at <span style="-sec-ix-hidden:c109551806">ten</span>-year anniversary for all grants. On <em style="font: inherit;"> February 21, 2022, </em>the Compensation Committee granted 3,000,000 qualified stock options to the Company’s executive officers and 4,000,000 non-qualified stock options to members of the Board. The exercise price for these options was $0.09 per share. 2,000,000 of the options granted to an executive officer vest <span style="-sec-ix-hidden:c109551811">one</span> half immediately and <span style="-sec-ix-hidden:c109551812">one</span> half at the <span style="-sec-ix-hidden:c109551813">one</span>-year anniversary of the grant. The remaining executive officer and board member options vest <span style="-sec-ix-hidden:c109551814">one</span> <em style="font: inherit;">fourth</em> immediately and <span style="-sec-ix-hidden:c109551816">one</span> <em style="font: inherit;">fourth</em> each subsequent year. All these granted options expire at the <span style="-sec-ix-hidden:c109551818">ten</span>-year anniversary of the grant. The options issued during the year ended <em style="font: inherit;"> December 31, 2022</em> have a fair value of $442,295 as estimated on the date of issue using the Black-Scholes options pricing model with the following weighted-average assumptions: risk free interest rate of 1.37% to 4.14%, expected dividend yield rate of 0%, expected volatility of 65.19% to 70.09% and an expected life between 5 and 7.5 years.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">All options exercised were issued under a qualified plan and accordingly, there is <em style="font: inherit;">no</em> income tax effect in the accompanying financial statements.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Restricted Stock Units</span></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A summary of the non-vested restricted stock units issued under the Company’s equity plans is as follows:</p> <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </p> <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </p> <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr style="background-color: rgb(204, 238, 255);"><td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Non-Vested Restricted Stock Units</b></p> </td><td style="vertical-align:bottom;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of restricted stock units</em></b></p> </td><td style="vertical-align:bottom;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:35%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted average grant-date fair value</em></b></p> </td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at December 31, 2020</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">$ —</p> </td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercised</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Forfeited</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at December 31, 2021</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Forfeited / Cancelled</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at December 31, 2022</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7,250,000</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">0.04</p> </td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(250,000</p> </td><td style="vertical-align:middle;width:1.8%;">)</td><td style="vertical-align:middle;width:35%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">0.04</p> </td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Forfeited / Cancelled</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at December 31, 2023</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="border-bottom:double 3px #000000;vertical-align:middle;width:29.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7,000,000</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">$ 0.04</em></p> </td></tr> </tbody></table> <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </p> <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company recognized $121,202 and $0 of compensation expense related to these restricted stock units ("RSU") for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, respectively. At <em style="font: inherit;"> December 31, 2023</em>, the remaining compensation expense was $168,798 and will be recognized over 1.72 years.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <em style="font: inherit;"> March 3, 2023, </em>the Compensation Committee of our Board of Directors approved the cancellation of 1,000,000 outstanding stock options held by a member of the Board in exchange for the grant of 750,000 RSUs. The RSUs vest over a <span style="-sec-ix-hidden:c109551836">three</span>-year period beginning on the grant date.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">On <em style="font: inherit;"> May 8, 2023, </em>pursuant to an executive employment agreement entered into with its newly appointed President, the Company granted 6,500,000 RSUs to its President. 1,500,000 RSUs vest on <em style="font: inherit;"> April 17, 2024, </em>2,000,000 RSUs vest on <em style="font: inherit;"> April 17, 2025, </em>and 3,000,000 RSUs vest on <em style="font: inherit;"> April 17, 2026. </em>Each RSU represents the contingent right to receive <em style="font: inherit;">one</em> share of the Company’s common stock.</p> <p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <em style="font: inherit;"> September 5, 2023, </em>pursuant to an employment agreement with its President, the Company awarded 2,500,000 fully vested RSUs under the <em style="font: inherit;">2015</em> Plan to the Company's President upon his promotion to Chief Executive Officer. Compensation expense recorded pursuant to this RSU award was $150,000, which was determined by multiplying the number of shares awarded by the closing price of the common stock on <em style="font: inherit;"> September 5, 2023, </em>which was $0.06 per share. The Company withheld 778,972 shares of common stock to satisfy payroll tax obligations in connection with this issuance. The net shares issued on <em style="font: inherit;"> September 5, 2023 </em>totaled 1,721,028.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> 515000 0.12 61800 3625000 2925000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Warrants</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Outstanding Shares</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted Average Exercise</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2021</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7,065,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.11</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(515,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.12</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(6,550,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.11</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 7065000 0.11 0 0 515000 0.12 6550000 0.11 0 0 0 0 -0 0 -0 0 0 0 0 5000000 0.01 675 1000 675000 2 0 175 675 1000 675000 0.08 8437500 675000 4063 0.1 90 0.25 1000 243780 2266500 90660 2271980 204480 153120 39300 4063 3433 17165000 3433000 0.06 0.12 2895379 537621 13440 3433 3419560 0 3433 3433000 0.08 0.08 1000 3750 0.1 1835000 780000 780 2925000 150 0.1 675947 104053 4737 630 625263 0 630 630000 2000000 0.15 3000000 2224544 316866 245081 8398 14771 20000000 80000000 11089967 20292546 560000 28000 0.05 0.05 22400 0.04 216440 343560 307692 28000 0.091 0.05 27692 0.09 120461 187231 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 40%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Stock Options</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Outstanding Shares</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted Average Exercise Price</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted Average Remaining Contractual Life</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Average Intrinsic Value</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2021</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">20,777,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.06</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">627,615</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">8,150,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.09</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(1,200,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.04</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">57,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,734,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.08</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,993,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.07</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,100,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.04</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,306,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.08</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at December 31, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">24,787,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.05</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5.4</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">17,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at December 31, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">19,372,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.05</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4.6</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">16,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> 20777500 0.06 627615 8150000 0.09 1200000 0.04 57000 1734000 0.08 24993500 0.07 0 3100000 0.04 -0 3306000 0.08 24787500 0.05 P5Y4M24D 17000 19372500 0.05 P4Y7M6D 16000 16000 0.04 199554 280393 99768 P1Y8M15D 0 1000000 388889 611111 200000 162163 37837 3100000 0.04 0.06 82176 0.0394 0.0426 0 0.6865 0.7921 P5Y P7Y 1000000 0.1 25000 0.08 125000 0.03 3000000 4000000 0.09 2000000 442295 0.0137 0.0414 0 0.6519 0.7009 P5Y P7Y6M <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr style="background-color: rgb(204, 238, 255);"><td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Non-Vested Restricted Stock Units</b></p> </td><td style="vertical-align:bottom;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of restricted stock units</em></b></p> </td><td style="vertical-align:bottom;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:35%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted average grant-date fair value</em></b></p> </td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at December 31, 2020</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">$ —</p> </td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercised</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Forfeited</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at December 31, 2021</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Forfeited / Cancelled</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at December 31, 2022</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7,250,000</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">0.04</p> </td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:29.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(250,000</p> </td><td style="vertical-align:middle;width:1.8%;">)</td><td style="vertical-align:middle;width:35%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">0.04</p> </td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Forfeited / Cancelled</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="border-bottom:solid 1px #000000;vertical-align:middle;width:29.7%;"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">—</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"></td></tr> <tr style="background-color: rgb(255, 255, 255);"><td style="vertical-align:middle;width:31.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at December 31, 2023</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="border-bottom:double 3px #000000;vertical-align:middle;width:29.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7,000,000</p> </td><td style="vertical-align:middle;width:1.8%;"> </td><td style="vertical-align:middle;width:35%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">$ 0.04</em></p> </td></tr> </tbody></table> 7250000 0.04 250000 0.04 7000000 121202 0 168798 P1Y8M19D 1000000 750000 6500000 1500000 2000000 3000000 2500000 150000 0.06 778972 1721028 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">10</em> – INCOME TAXES - TO BE UPDATED</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company paid no federal or state income taxes during <em style="font: inherit;">2023</em> and <em style="font: inherit;">2022</em>. Income tax benefit on losses differed from the amounts computed by applying the recently enacted U.S. federal income tax rate of 21% to pretax losses as a result of the following:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Income tax expense (benefit)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(182,493</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">72,207</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Book and tax differences</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">40,577</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(72,207</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">State taxes net of federal benefit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in valuation allowance</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">141,916</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets (liabilities) as of <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em> are presented below:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred income tax asset</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Net operating loss carryforward</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7,918,996</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7,736,618</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Valuation allowance</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(7,476,180</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(7,363,815</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred income tax asset</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">442,816</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">372,803</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred income tax liability - depreciation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(442,816</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(372,803</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax asset (liability)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2023</em>, the Company had net operating losses of approximately $37,000,000 that will begin to expire in <em style="font: inherit;">2024.</em> The valuation allowances for <em style="font: inherit;">2023</em> and <em style="font: inherit;">2022</em> have been applied to offset the deferred tax assets in recognition of the uncertainty that such benefits will be realized.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In accordance with GAAP, the Company has analyzed its filing positions in all jurisdictions where it is required to file income tax returns for the open tax years in such jurisdictions. The Company currently believes that all significant filing positions are highly certain and that all of its significant income tax filing positions and deductions would be sustained upon audit. Therefore, the Company has no significant reserves for uncertain tax positions, and no adjustment to such reserves was required by GAAP. No interest or penalties have been levied against the Company and <em style="font: inherit;">none</em> are anticipated, therefore <em style="font: inherit;">no</em> interest or penalty has been included in the provision for income taxes in the consolidated statements of operations.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Internal Revenue Code contains provisions which reduce or limit the availability and utilization of net operating loss carry forwards in the event of a more than <em style="font: inherit;">50%</em> change in ownership. If such an ownership change occurs with the Company, the use of these net operating losses could be limited.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> 0 0.21 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Income tax expense (benefit)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(182,493</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">72,207</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Book and tax differences</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">40,577</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(72,207</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">State taxes net of federal benefit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in valuation allowance</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">141,916</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> -182493 72207 40577 -72207 0 0 141916 0 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred income tax asset</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Net operating loss carryforward</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7,918,996</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7,736,618</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Valuation allowance</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(7,476,180</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(7,363,815</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred income tax asset</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">442,816</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">372,803</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred income tax liability - depreciation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(442,816</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(372,803</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax asset (liability)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 7918996 7736618 7476180 7363815 442816 372803 442816 372803 0 0 37000000 0 0 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">11</em> – COMMITMENTS AND CONTINGENCIES</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Dependence on Third Parties</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Sales during <em style="font: inherit;">2023</em> to the Company’s top three customers was approximately 22% of its total gross revenue. The Company is making efforts to reduce its dependency on a small number of customers by expanding both domestic and foreign.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The production of Cobalt is dependent upon the DOE, and its prime operating contractor, which controls the reactor and laboratory operations at the ATR located outside of Idaho Falls, Idaho.  On <em style="font: inherit;"> October 2, 2014, </em>the Company signed a <span style="-sec-ix-hidden:c109551870">ten</span>-year contract with the DOE for the irradiation of cobalt targets for the production of cobalt-<em style="font: inherit;">60.</em> The Company will be able to purchase cobalt targets for a fixed price per target and with an annual 5% escalation in price.  The contract term is <em style="font: inherit;"> October 1, 2014, </em>through <em style="font: inherit;"> September 30, 2024.  </em>However, the DOE <em style="font: inherit;"> may </em>end the contract if it determines termination is necessary for the national defense, security or environmental safety of the U.S.  If this were to occur, all payments made by the Company would be refunded.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The key isotope materials used to manufacture our radiopharmaceutical product and nuclear medicine reference standards are supplied to the Company through agreements with several suppliers. The loss of any of these suppliers could adversely affect operating results by causing a delay in production or a possible loss of sales.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Contingencies</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Because all the Company’s business segments involve the handling or use of radioactive material, the Company is required to have an operating license from the NRC and specially trained staff to handle these materials. The Company has amended this operating license numerous times to increase the amount of material permitted within the Company’s facility.  Although this license does <em style="font: inherit;">not</em> currently restrict the volume of business operation performed or projected to be performed in the upcoming year, additional processing capabilities and license amendments could be implemented that would permit processing of other reactor-produced radioisotopes by the Company.  The financial assurance required by the NRC to support this license has been provided for with a surety bond and a restricted money market account, in the amount of $880,752, held with North American Specialty Insurance Company and Merrill Lynch, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <em style="font: inherit;"> August 2011, </em>we received land from Lea County, New Mexico, pursuant to a PPA, whereby the land was deeded to us for <em style="font: inherit;">no</em> monetary consideration. In return, we committed to construct a uranium de-conversion and FEP facility on the land.  In order to retain title to the property, we were to begin construction of the de-conversion facility <em style="font: inherit;">no</em> later than <em style="font: inherit;"> December 31, 2014, </em>and complete Phase I of the project and have hired at least 75 persons to operate the facility <em style="font: inherit;">no</em> later than <em style="font: inherit;"> December 31, 2015, </em>although commercial operations need <em style="font: inherit;">not</em> have begun by that date. In <em style="font: inherit;">2015</em> the Company negotiated a modification to the PPA agreement that extended the start of construction date to <em style="font: inherit;"> December 31, 2015, </em>and the hiring milestone to <em style="font: inherit;"> December 31, 2016.  </em>Those dates were <em style="font: inherit;">not</em> met and the Company is currently in the process of renegotiating a <em style="font: inherit;">second</em> modification to the agreement to further extend those dates. If we do <em style="font: inherit;">not</em> succeed in reaching an amendment to extend the performance dates in the agreement then we <em style="font: inherit;"> may, </em>at our sole option, either purchase or re-convey the property to Lea County, New Mexico.  The purchase price of the property would be $776,078, plus interest at the annual rate of 5.25% from the date of the closing to the date of payment.  We have <em style="font: inherit;">not</em> recorded the value of this property as an asset and will <em style="font: inherit;">not</em> do so until such time that sufficient progress on the project has been made to meet our obligations under the agreements for permanent transfer of the title.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Defined Contribution Pension Plan</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has a <em style="font: inherit;">401</em>(k) defined-contribution pension plan (the <em style="font: inherit;">“401</em>(k) Plan”).  Employees are eligible to participate in the Plan after completing <em style="font: inherit;">six</em> months of full-time service. Participants, under provision of Internal Revenue Code § <em style="font: inherit;">401</em>(k), <em style="font: inherit;"> may </em>elect to contribute up to $23,000 of their compensation to the <em style="font: inherit;">401</em>(k) Plan which includes both before-tax and Roth after-tax contribution options. There was no employer matching contributions made for <em style="font: inherit;">2022.</em> Beginning in <em style="font: inherit;">2023,</em> the Company began matching contributions according to safe harbor <em class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="font: inherit;">401</em>(k) rules. All amounts withheld for employee contributions for <em style="font: inherit;">2023</em> were paid into the <em style="font: inherit;">401</em>(k) Plan. The employer reserves the right to terminate the <em style="font: inherit;">401</em>(k) Plan at any time.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> 3 0.22 0.05 880752 75 776078 0.0525 23000 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">12</em> – ASSET RETIREMENT OBLIGATION</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As part of the Company’s NRC operating license and as part of the Company’s facility lease agreements, the Company is responsible for decommissioning any facilities upon termination or relocation of operations. The Company has developed a decommissioning funding plan using guidelines provided by the NRC and has estimated the cost of decommissioning the facility in Idaho Falls. The decommissioning cost estimate is reviewed at least annually to validate the assumptions and is revised as necessary when changes in the facility processes or radiological characteristics would affect the cost of decommissioning.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In accordance with GAAP, the Company has recognized future estimated decommissioning costs as an asset retirement obligation and a related capitalized lease disposal cost. The Company has recognized period-to-period changes in the liability (accretion) in the statement of operations as amortization expense. Changes resulting from revisions to the original estimate are recorded as an increase or decrease to the capitalized lease disposal cost. Capitalized lease disposal cost is amortized on a straight-line basis over the remaining life of the facility operating lease agreement.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following summarizes the activity of the asset retirement obligation for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Obligation for Lease Disposal Cost</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at December 31, 2021</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">892,087</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Increase in lease disposal costs</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accretion expense/amortization expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">50,291</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at December 31, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">942,378</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Increase in lease disposal costs</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">478,959</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accretion expense/amortization expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">53,126</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at December 31, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,474,463</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Obligation for Lease Disposal Cost</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at December 31, 2021</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">892,087</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Increase in lease disposal costs</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accretion expense/amortization expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">50,291</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at December 31, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">942,378</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Increase in lease disposal costs</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">478,959</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accretion expense/amortization expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">53,126</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at December 31, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,474,463</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 892087 0 50291 942378 478959 53126 1474463 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">13</em> – FAIR VALUE MEASUREMENTS</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>, the Company had no assets carried at fair value.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">14</em> – REVENUE RECOGNITION</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Revenue from Product Sales</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following tables present the Company’s revenue disaggregated by business segment and geography, based on management’s assessment of available data:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="14" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">Twelve Months Ended December 31, 2023</em></em></em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="14" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">Twelve Months Ended December 31, 2022</em></em></em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">U.S.</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Outside U.S.</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Total Revenues</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of Total Revenues</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">U.S.</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Outside U.S.</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Total Revenues</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of Total Revenues</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 20%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics Products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,685,244</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,157,654</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,842,898</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">56</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,338,010</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">707,757</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,045,767</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">54</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt Products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">932,915</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">104,158</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,037,073</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">8</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,137,066</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">20,470</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,157,536</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear Medicine Products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,405,508</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">981,906</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,387,414</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">36</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,173,755</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">804,930</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,978,685</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">36</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine Products</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,023,667</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,243,718</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,267,385</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">9,648,831</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,533,157</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,181,988</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Prior period amounts have <em style="font: inherit;">not</em> been adjusted under the modified retrospective approach.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Under ASC Topic <em style="font: inherit;">606,</em> the Company recognizes revenue when it satisfies a performance obligation by transferring control of the promised goods or services to its customers, in an amount that reflects the consideration the Company expects to receive in exchange for the product or service.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Product sales consist of a single performance obligation that the Company satisfies at a point in time. All transactions in the Theranostics Products and nuclear medicine standards segments fall into this category. Most sales transactions in the cobalt products business segment fall into this category but other cobalt product sales are recorded as deferred income as discussed below. The Company recognizes product revenue when the following events have occurred: (a) the Company has transferred physical possession of the products, (b) the Company has a present right to payment, (c) the customer has legal title to the products, and (d) the customer bears significant risks and rewards of ownership of the products. Based on the Company’s historical practices and shipping terms specified in the sales agreements and invoices, these criteria are generally met when the products are:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">•</p> </td><td style="width: auto;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Invoiced.</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">•</p> </td><td style="width: auto;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Shipped from the Company’s facilities (“FOB shipping point”, which is the Company’s standard shipping term). For these sales, the Company determined that the customer is able to direct the use of, and obtain substantially all of the benefits from, the products at the time the products are shipped.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company’s revenue consists primarily of products manufactured for use in the nuclear medicine industry, distribution of radiochemicals and radiopharmaceuticals, and cobalt source manufacturing. With the exception of certain unique products, the Company’s normal operating cycle is considered to be <em style="font: inherit;">one</em> year. Due to the time required to produce some cobalt products, the Company’s operating cycle for those products is considered to be <em style="font: inherit;">two</em> to <em style="font: inherit;">three</em> years. Accordingly, preliminary payments received on cobalt contracts, where shipment will <em style="font: inherit;">not</em> take place for greater than <em style="font: inherit;">one</em> year, have been recorded as unearned revenue on the Company’s consolidated balance sheets and classified under current or long-term liabilities, depending upon estimated ship dates. For the year ended <em style="font: inherit;"> December 31, 2023</em>, the Company reported current unearned revenue of $932,682. For the period ended <em style="font: inherit;"> December 31, 2022</em>, the Company reported current unearned revenue of $879,365. These unearned revenues will be recognized as revenue in the periods during which the cobalt shipments take place.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Contract Balances</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company records a receivable when it has an unconditional right to receive consideration after the performance obligations are satisfied. As of <em style="font: inherit;"> December 31, 2023</em>, and <em style="font: inherit;"> December 31, 2022</em>, accounts receivable totaled $1,469,298 and $1,596,886, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Practical Expedients</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has elected the practical expedient <em style="font: inherit;">not</em> to determine whether contacts with customers contain significant financing components.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="14" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">Twelve Months Ended December 31, 2023</em></em></em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="14" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">Twelve Months Ended December 31, 2022</em></em></em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">U.S.</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Outside U.S.</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Total Revenues</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of Total Revenues</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">U.S.</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Outside U.S.</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Total Revenues</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of Total Revenues</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 20%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics Products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,685,244</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,157,654</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,842,898</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">56</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,338,010</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">707,757</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,045,767</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">54</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt Products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">932,915</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">104,158</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,037,073</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">8</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,137,066</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">20,470</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,157,536</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear Medicine Products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,405,508</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">981,906</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,387,414</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">36</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,173,755</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">804,930</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,978,685</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">36</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine Products</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,023,667</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,243,718</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,267,385</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">9,648,831</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,533,157</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,181,988</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 7%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td></tr> </tbody></table> 5685244 1157654 6842898 0.56 5338010 707757 6045767 0.54 932915 104158 1037073 0.08 1137066 20470 1157536 0.10 3405508 981906 4387414 0.36 3173755 804930 3978685 0.36 0 0 0 0 0 0 0 0 10023667 2243718 12267385 1 9648831 1533157 11181988 1 932682 879365 1469298 1596886 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">15</em> – SEGMENT INFORMATION</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Information related to the Company’s reportable operating business segments is shown below. The Company’s reportable segments are reported in a manner consistent with the way management evaluates the businesses. The Company identifies its reportable business segments based on differences in products and services. The accounting policies of the business segments are the same as those described in the summary of significant accounting policies.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has identified the following business segments:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:top;width:1.7%;"> </td><td style="vertical-align:top;width:1.7%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry and includes consolidated reporting of the wholly-owned subsidiaries RadQual and TI Services.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:top;width:1.7%;"> </td><td style="vertical-align:top;width:1.7%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:top;width:1.7%;"> </td><td style="vertical-align:top;width:1.7%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Theranostics Products Segment (formerly called the Radiochemical Products Segment) includes production and distribution of Iodine-<em style="font: inherit;">131</em> generic drug product and various isotopically pure radiochemicals for medical, industrial, or research applications. These products are either directly produced by the Company or are purchased in bulk from other producers and distributed by the Company in customized packages and chemical forms tailored to customer and market demands.  Iodine-<em style="font: inherit;">131</em> is the predominant radiochemical sold in this segment.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:top;width:1.7%;"> </td><td style="vertical-align:top;width:1.7%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Fluorine Products segment historically involved the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. During <em style="font: inherit;">2013,</em> these testing activities were completed, and the pilot plant facility was closed.  The Company has developed or acquired all patent rights to these processes. Future work in this segment will involve license support and, as financing permits, further work related to the de-conversion facility.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">The following presents certain segment information as of and for the years ended <em style="font: inherit;"> December 31, 2023</em> and <em style="font: inherit;">2022</em>:</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Sale of product</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,842,898</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,045,767</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,037,073</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,157,536</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,387,414</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,978,685</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">12,267,385</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">11,181,988</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate revenue</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,267,385</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,181,988</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Depreciation and amortization</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">25,287</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">63,493</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">53,331</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">49,202</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">114,833</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">114,990</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">115,879</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">115,598</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">309,330</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">343,283</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate depreciation and amortization</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,764</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">30,913</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">350,094</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">374,196</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Segment income (loss)</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,037,375</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,182,151</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(126,504</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(95,779</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">386,592</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">39,223</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(105,099</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(139,860</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,192,364</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,985,735</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate loss</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(4,061,380</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,682,497</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(869,016</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">303,238</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expenditures for segment assets</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,420</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,379</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">49,774</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">17,105</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">35,137</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">75,478</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">88,331</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">100,062</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate purchases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">60,727</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">19,952</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">149,058</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">120,014</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Segment assets</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">849,351</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,075,252</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">274,513</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">406,629</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,538,558</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,744,394</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,980,118</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">5,147,325</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">9,642,540</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">9,373,600</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">7,262,547</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,870,996</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">16,905,087</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">16,244,596</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Sale of product</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,842,898</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">6,045,767</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,037,073</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,157,536</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,387,414</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,978,685</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">12,267,385</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">11,181,988</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate revenue</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,267,385</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,181,988</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Depreciation and amortization</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">25,287</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">63,493</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">53,331</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">49,202</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">114,833</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">114,990</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">115,879</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">115,598</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">309,330</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">343,283</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate depreciation and amortization</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,764</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">30,913</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">350,094</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">374,196</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Segment income (loss)</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,037,375</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,182,151</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(126,504</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(95,779</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">386,592</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">39,223</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(105,099</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(139,860</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,192,364</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,985,735</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate loss</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(4,061,380</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,682,497</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(869,016</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">303,238</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expenditures for segment assets</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,420</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,379</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">49,774</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">17,105</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">35,137</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">75,478</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">88,331</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">100,062</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate purchases</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">60,727</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">19,952</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">149,058</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">120,014</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Segment assets</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2022</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Theranostics products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">849,351</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,075,252</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Cobalt products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">274,513</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">406,629</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Nuclear medicine standards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,538,558</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,744,394</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fluorine products</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,980,118</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">5,147,325</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total segments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">9,642,540</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">9,373,600</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Corporate assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">7,262,547</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,870,996</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total consolidated</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">16,905,087</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">16,244,596</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 6842898 6045767 1037073 1157536 4387414 3978685 0 0 12267385 11181988 0 0 12267385 11181988 25287 63493 53331 49202 114833 114990 115879 115598 309330 343283 40764 30913 350094 374196 3037375 4182151 -126504 -95779 386592 39223 -105099 -139860 3192364 3985735 -4061380 -3682497 -869016 303238 3420 3379 49774 17105 35137 75478 0 4100 88331 100062 60727 19952 149058 120014 849351 1075252 274513 406629 3538558 2744394 4980118 5147325 9642540 9373600 7262547 6870996 16905087 16244596 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NOTE <em style="font: inherit;">16</em> – SUBSEQUENT EVENTS</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">On <em style="font: inherit;"> February 8, 2024, </em>International Isotopes Inc. (“INIS”) and its wholly-owned subsidiary International Isotopes Fluorine Products, Inc. (together with INIS, the “Company”) entered into an Asset Purchase Agreement (the “APA”) with American Fuel Resources, LLC (“AFR”), pursuant to which the Company agreed to sell to AFR all the assets and certain specified liabilities of the Company’s depleted uranium deconversion and fluorine extraction plant (the “DUF<sub><em style="font: inherit;">6</em></sub> Plant”), subject to the terms and conditions set forth in the APA (the “Transaction”). The Company expects to close the Transaction in approximately <em style="font: inherit;">12</em> to <em style="font: inherit;">24</em> months, subject to satisfaction of certain closing conditions (the “Closing”).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The purchase price to be paid by AFR in the Acquisition will consist of (i) $50,000 to be paid within <em style="font: inherit;">five</em> business days of execution of the APA (the “Prepayment”), and (ii) $12,500,000 paid at the Closing, less the Prepayment. The APA contains customary representations and warranties, covenants and indemnification provisions for a transaction of this nature. Closing of the Transaction is also subject to certain closing conditions, including (i) transfer of the U.S. Nuclear Regulatory Commission (NRC) license related to the DUF<sub><em style="font: inherit;">6</em></sub> Plant (the “NRC License Transfer”) and (ii) transfer of Purchased Assets (as defined in the APA), which includes licenses, patents, agreements, and other records of the DUF<sub><em style="font: inherit;">6</em></sub> Plant.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The APA <em style="font: inherit;"> may </em>be terminated, among other things, (i) upon mutual written consent by the parties to the APA, (ii) by either party upon material breach of the APA by the other party, subject to applicable cure periods, and (iii) by AFR if there is reason to believe that the NRC License Transfer will <em style="font: inherit;">not</em> be completed by <em style="font: inherit;"> March 31, 2026.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In <em style="font: inherit;"> February 2024, </em>the <em style="font: inherit;">2013</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> March 31, 2026, </em>with all remaining terms unchanged.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In <em style="font: inherit;"> February 2024, </em>the <em style="font: inherit;">2018</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> March 31, 2026, </em>with all remaining terms unchanged.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In <em style="font: inherit;"> February 2024, </em>the <em style="font: inherit;">2019</em> Promissory Note was modified to extend the maturity date to <em style="font: inherit;"> March 31, 2026, </em>with all remaining terms unchanged.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> 50000 12500000